Clustering O 0 0.008226522244513035
of O 0 0.0001332689425908029
missense O 0 0.21043233573436737
mutations O 0 0.03182179853320122
in O 0 5.90292111155577e-05
the O 0 0.00018846651073545218
ataxia B-Disease 1 0.9984875917434692
- I-Disease 1 0.9442206025123596
telangiectasia I-Disease 1 0.997183084487915
gene O 0 0.022476037964224815
in O 0 2.868990122806281e-05
a O 0 0.00011227573122596368
sporadic B-Disease 0 0.06311358511447906
T I-Disease 1 0.9814784526824951
- I-Disease 0 0.4784270226955414
cell I-Disease 0 0.3894040882587433
leukaemia I-Disease 1 0.9962598085403442
. O 0 0.0011117456015199423

Ataxia B-Disease 1 0.9953588843345642
- I-Disease 1 0.9695652723312378
telangiectasia I-Disease 1 0.9939236044883728
( O 0 0.0011569753987714648
A B-Disease 0 0.0008995728567242622
- I-Disease 0 0.15310601890087128
T I-Disease 1 0.9174119830131531
) O 0 1.652981518418528e-05
is O 0 4.924227596347919e-06
a O 0 3.669100988190621e-05
recessive B-Disease 1 0.970628023147583
multi I-Disease 1 0.5069491267204285
- I-Disease 1 0.7991194128990173
system I-Disease 0 0.2001260370016098
disorder I-Disease 1 0.999360978603363
caused O 0 0.09082432091236115
by O 0 8.507216080033686e-06
mutations O 0 0.001046458026394248
in O 0 2.1834061953995842e-06
the O 0 3.352788553456776e-06
ATM O 0 0.00029318215092644095
gene O 0 0.000387744017643854
at O 0 1.95793454622617e-05
11q22 O 0 0.00618693558499217
- O 0 0.003291954519227147
q23 O 0 0.006848082412034273
( O 0 3.3451709896326065e-05
ref O 0 0.0009284537518396974
. O 0 8.441737008979544e-06
3 O 0 1.8651586287887767e-05
) O 0 3.128987373202108e-05
. O 0 5.982964648865163e-05

The O 0 0.00031192158348858356
risk O 0 0.18190395832061768
of O 0 0.0001367474760627374
cancer B-Disease 1 0.999031662940979
, O 0 6.785703590139747e-05
especially O 0 0.0007488860283046961
lymphoid B-Disease 1 0.910602331161499
neoplasias I-Disease 0 0.32793253660202026
, O 0 1.4719781574967783e-05
is O 0 8.941657142713666e-06
substantially O 0 0.0012359210522845387
elevated O 0 0.017138449475169182
in O 0 1.424965012120083e-05
A B-Disease 0 0.0016397078288719058
- I-Disease 1 0.8939543962478638
T I-Disease 1 0.9979033470153809
patients O 1 0.9948766827583313
and O 0 9.149754987447523e-06
has O 0 8.430683010374196e-06
long O 0 6.14765303907916e-05
been O 0 7.379344879154814e-06
associated O 0 0.00010117102647200227
with O 0 7.556121272500604e-05
chromosomal O 1 0.8910495042800903
instability O 1 0.5738333463668823
. O 0 0.0003003276069648564

By O 0 0.0004885933012701571
analysing O 0 0.0804704800248146
tumour B-Disease 1 0.9946417808532715
DNA O 0 0.006345225032418966
from O 0 0.0002299631742062047
patients O 1 0.9931394457817078
with O 0 0.00021061761071905494
sporadic B-Disease 0 0.4373399615287781
T I-Disease 1 0.9913799166679382
- I-Disease 0 0.3605382740497589
cell I-Disease 0 0.4910162091255188
prolymphocytic I-Disease 1 0.985678493976593
leukaemia I-Disease 1 0.9990826845169067
( O 0 0.013634339906275272
T B-Disease 1 0.9582928419113159
- I-Disease 0 0.14608459174633026
PLL I-Disease 1 0.9577884078025818
) O 0 1.5106008504517376e-05
, O 0 3.901380750903627e-06
a O 0 9.903564205160365e-06
rare O 0 0.001944626565091312
clonal B-Disease 0 0.2984166443347931
malignancy I-Disease 1 0.9800338745117188
with O 0 1.1974424523941707e-05
similarities O 0 0.00016436872829217464
to O 0 5.913881068408955e-06
a O 0 6.206143734743819e-05
mature B-Disease 0 0.49493658542633057
T I-Disease 1 0.9629437923431396
- I-Disease 0 0.16141772270202637
cell I-Disease 0 0.2401161640882492
leukaemia I-Disease 1 0.9991683959960938
seen O 0 0.00015615200391039252
in O 0 6.96193774274434e-06
A B-Disease 0 0.0002076166565530002
- I-Disease 0 0.07901760935783386
T I-Disease 1 0.703826367855072
, O 0 1.4234138916435768e-06
we O 0 6.675987833659747e-07
demonstrate O 0 3.927138095605187e-06
a O 0 1.0144017323909793e-06
high O 0 2.2803692445449997e-06
frequency O 0 3.959441983170109e-06
of O 0 2.321569809282664e-06
ATM O 0 0.0005522822611965239
mutations O 0 0.007023990619927645
in O 0 5.864330523763783e-05
T B-Disease 1 0.6156054735183716
- I-Disease 0 0.048985641449689865
PLL I-Disease 1 0.8443270325660706
. O 0 0.00033693129080347717

In O 0 5.707475429517217e-05
marked O 0 4.7100551455514506e-05
contrast O 0 2.9678036298719235e-05
to O 0 2.6852603696170263e-06
the O 0 2.553414560679812e-06
ATM O 0 0.00013977395428810269
mutation O 0 0.0007057310431264341
pattern O 0 9.525500354357064e-05
in O 0 4.801454906555591e-06
A B-Disease 0 7.592249312438071e-05
- I-Disease 0 0.016465403139591217
T I-Disease 0 0.23728060722351074
, O 0 1.2075671520506148e-06
the O 0 7.028937716313521e-07
most O 0 1.145587020801031e-06
frequent O 0 3.026093872904312e-05
nucleotide O 0 1.4143669432087336e-05
changes O 0 1.0684234439395368e-05
in O 0 4.7445341806451324e-06
this O 0 1.342285395367071e-05
leukaemia B-Disease 1 0.9973286390304565
were O 0 4.6796820242889225e-05
missense O 0 0.18556079268455505
mutations O 0 0.10656813532114029
. O 0 0.00023802915529813617

These O 0 4.604261994245462e-05
clustered O 0 0.0001214620569953695
in O 0 4.102188086108072e-06
the O 0 1.1868880847032415e-06
region O 0 4.392181381263072e-06
corresponding O 0 1.8808398181136e-06
to O 0 5.345627300812339e-07
the O 0 8.690038839631598e-07
kinase O 0 0.000152398191858083
domain O 0 3.4642416721908376e-06
, O 0 5.13903501087043e-07
which O 0 2.2052903148050973e-07
is O 0 4.4535252641253464e-07
highly O 0 2.5618587642384227e-06
conserved O 0 2.7573123588808812e-06
in O 0 1.1135414297314128e-06
ATM O 0 8.385214459849522e-05
- O 0 0.00015774733037687838
related O 0 4.145117418374866e-05
proteins O 0 9.268032044928987e-06
in O 0 3.596735041355714e-06
mouse O 0 0.00021759835362900048
, O 0 5.295644314173842e-06
yeast O 0 0.00021546690550167114
and O 0 1.630359111004509e-05
Drosophila O 0 0.0010328041389584541
. O 0 9.626237442716956e-05

The O 0 4.978023571311496e-05
resulting O 0 0.00010858396126423031
amino O 0 5.199974839342758e-05
- O 0 0.00020553181821014732
acid O 0 9.403713920619339e-05
substitutions O 0 1.521165540907532e-05
are O 0 1.351322680420708e-06
predicted O 0 1.2443423656804953e-05
to O 0 1.8046200693788705e-06
interfere O 0 2.778724410745781e-05
with O 0 4.929325314151356e-06
ATP O 0 0.0007319774595089257
binding O 0 2.683949969650712e-05
or O 0 1.886805875983555e-05
substrate O 0 0.0004098303325008601
recognition O 0 0.00033122114837169647
. O 0 0.00010171544272452593

Two O 0 7.171794277383015e-05
of O 0 3.2270898373099044e-05
seventeen O 0 0.0007497900514863431
mutated O 1 0.5289425253868103
T B-Disease 1 0.7660003900527954
- I-Disease 0 0.017342902719974518
PLL I-Disease 1 0.6866917610168457
samples O 0 7.275471580214798e-05
had O 0 6.150435183371883e-06
a O 0 5.788997896161163e-06
previously O 0 2.5222219846909866e-05
reported O 0 0.00017077063967008144
A B-Disease 0 0.00023517933732364327
- I-Disease 0 0.0655282512307167
T I-Disease 1 0.8820183277130127
allele O 0 0.005268435925245285
. O 0 0.0002643953775987029

In O 0 0.00010142700193682685
contrast O 0 0.00015506528143305331
, O 0 1.1740324225684162e-05
no O 0 6.445107374020154e-06
mutations O 0 0.0003944647032767534
were O 0 8.321595146298932e-07
detected O 0 4.512086161412299e-05
in O 0 7.404826192214387e-07
the O 0 1.812529831113352e-06
p53 O 0 0.0048880307003855705
gene O 0 0.00023936395882628858
, O 0 2.2080544113123324e-06
suggesting O 0 3.952149927499704e-05
that O 0 2.389072506048251e-06
this O 0 9.815144949243404e-06
tumour B-Disease 1 0.9956775307655334
suppressor O 0 0.15200084447860718
is O 0 5.362397132557817e-06
not O 0 3.363202949913102e-06
frequently O 0 4.3403477320680395e-05
altered O 0 0.00013931050489190966
in O 0 1.394174887536792e-05
this O 0 4.369938687887043e-05
leukaemia B-Disease 1 0.9957162737846375
. O 0 0.0004992649191990495

Occasional O 0 0.013013530522584915
missense O 0 0.37553077936172485
mutations O 0 0.02788219042122364
in O 0 1.5009094568085857e-05
ATM O 0 0.00010184259008383378
were O 0 1.8951214997287025e-06
also O 0 2.2334304503601743e-06
found O 0 8.771822649578098e-06
in O 0 2.940560989372898e-05
tumour B-Disease 1 0.9979876279830933
DNA O 0 0.002301401924341917
from O 0 5.2856023103231564e-05
patients O 1 0.9884774088859558
with O 0 7.221892883535475e-05
B B-Disease 0 0.043083760887384415
- I-Disease 0 0.025076748803257942
cell I-Disease 0 0.013520199805498123
non I-Disease 0 0.01495156530290842
- I-Disease 1 0.9495751857757568
Hodgkins I-Disease 1 0.9996868371963501
lymphomas I-Disease 1 0.9985639452934265
( O 0 0.0007413437706418335
B B-Disease 0 0.004785784985870123
- I-Disease 0 0.0006383308791555464
NHL I-Disease 0 0.0003160549094900489
) O 0 2.901359948737081e-06
and O 0 1.474143346058554e-06
a O 0 6.027467861713376e-06
B B-Disease 0 0.0007051752763800323
- I-Disease 0 0.0007109300931915641
NHL I-Disease 0 0.0009923620382323861
cell O 0 0.0004255130479577929
line O 0 0.00010973070311592892
. O 0 9.863726154435426e-05

The O 0 1.9826860807370394e-05
evidence O 0 1.0595985258987639e-05
of O 0 1.5716030929979752e-06
a O 0 2.5221650048479205e-06
significant O 0 4.622550477506593e-06
proportion O 0 6.493594810308423e-06
of O 0 1.0017504337156424e-06
loss O 0 0.00035978207597509027
- O 0 0.00012681186490226537
of O 0 1.0504120382393012e-06
- O 0 0.00043651164742186666
function O 0 1.935177897394169e-05
mutations O 0 0.00014516479859594256
and O 0 5.004903300687147e-07
a O 0 9.013951967062894e-07
complete O 0 3.079669113503769e-06
absence O 0 3.844531875074608e-06
of O 0 2.1391619497990177e-07
the O 0 4.375136199996632e-07
normal O 0 4.0390173126070295e-06
copy O 0 2.012448021559976e-06
of O 0 3.375273252004263e-07
ATM O 0 1.4914638086338528e-05
in O 0 1.0585455356704188e-06
the O 0 1.2948163430337445e-06
majority O 0 6.464202215283876e-06
of O 0 7.710889804002363e-06
mutated O 1 0.6099507808685303
tumours B-Disease 1 0.9971612691879272
establishes O 0 0.0830371230840683
somatic O 0 0.0354510098695755
inactivation O 0 0.005031939130276442
of O 0 1.7798521412260015e-06
this O 0 2.0280560875107767e-06
gene O 0 8.902945410227403e-05
in O 0 2.3932593649078626e-06
the O 0 3.5621008009911748e-06
pathogenesis O 1 0.6150171160697937
of O 0 1.1264118256804068e-05
sporadic B-Disease 0 0.08489740639925003
T I-Disease 1 0.9513508081436157
- I-Disease 0 0.11313594877719879
PLL I-Disease 1 0.8604298233985901
and O 0 8.370118848688435e-06
suggests O 0 5.395275366026908e-05
that O 0 2.4820374164846726e-06
ATM O 0 9.122515621129423e-05
acts O 0 2.034179306065198e-05
as O 0 1.1509658179420512e-05
a O 0 0.00016055897867772728
tumour B-Disease 1 0.9940709471702576
suppressor O 1 0.7320142388343811
. O 0 0.00040390080539509654

As O 0 5.338288610801101e-05
constitutional O 0 5.20989706274122e-05
DNA O 0 4.708277265308425e-05
was O 0 3.515897333272733e-06
not O 0 1.3482513168128207e-06
available O 0 2.1287919480528217e-06
, O 0 2.048954456768115e-06
a O 0 1.1770468518079724e-05
putative O 0 0.05809038132429123
hereditary O 1 0.8567851781845093
predisposition O 1 0.9889448285102844
to O 0 0.00020255042181815952
T B-Disease 1 0.9501937627792358
- I-Disease 0 0.07064598798751831
PLL I-Disease 1 0.7681910395622253
will O 0 8.524521945219021e-06
require O 0 2.907933412643615e-05
further O 0 1.1372150765964761e-05
investigation O 0 0.00010009978723246604
. O 0 1.5445541066583246e-05
. O 0 4.8708585381973535e-05

Myotonic B-Disease 1 0.9951123595237732
dystrophy I-Disease 1 0.9975526928901672
protein O 0 0.04975215718150139
kinase O 0 0.16949710249900818
is O 0 1.8845146769308485e-05
involved O 0 1.2797563613275997e-05
in O 0 1.5116669374037883e-06
the O 0 1.5508480828430038e-06
modulation O 0 2.1775171262561344e-05
of O 0 1.7144283219749923e-06
the O 0 9.382423741044477e-06
Ca2 O 0 0.25359073281288147
+ O 0 0.04712335765361786
homeostasis O 0 0.4720989465713501
in O 0 0.00029305723728612065
skeletal O 1 0.995521068572998
muscle O 1 0.9923325777053833
cells O 0 0.46405553817749023
. O 0 0.00043128785910084844

Myotonic B-Disease 1 0.9952849745750427
dystrophy I-Disease 1 0.9986086487770081
( O 0 0.4120948314666748
DM B-Disease 1 0.9972156286239624
) O 0 0.00012706276902463287
, O 0 1.1620035365922377e-05
the O 0 8.671480827615596e-06
most O 0 0.00015101961616892368
prevalent O 1 0.9242314100265503
muscular B-Disease 1 0.9996261596679688
disorder I-Disease 1 0.9997218251228333
in O 0 0.0011890222085639834
adults O 0 0.29110637307167053
, O 0 1.3000208127778023e-05
is O 0 6.8259414547355846e-06
caused O 0 0.0012443134328350425
by O 0 7.174032361945137e-06
( O 0 3.454795660218224e-05
CTG O 0 0.07033561170101166
) O 0 6.848058092145948e-06
n O 0 2.1202833522693254e-05
- O 0 6.099838356021792e-05
repeat O 0 3.804058360401541e-05
expansion O 0 5.317723662301432e-06
in O 0 7.285007086466067e-07
a O 0 1.4883187304803869e-06
gene O 0 2.015983591263648e-05
encoding O 0 1.1088471183029469e-05
a O 0 6.053846846043598e-06
protein O 0 0.00010981487139360979
kinase O 0 0.016003191471099854
( O 0 9.335044160252437e-05
DM B-Disease 1 0.99162757396698
protein O 0 0.0003760317340493202
kinase O 0 0.02814262919127941
; O 0 2.7588366720010526e-05
DMPK O 0 0.0029755246359854937
) O 0 3.951640337618301e-06
and O 0 1.8086724367094575e-06
involves O 0 2.5570047000655904e-05
changes O 0 1.2673874152824283e-05
in O 0 6.924697572685545e-06
cytoarchitecture O 0 0.001870740088634193
and O 0 2.362446866754908e-05
ion O 0 0.0026254334952682257
homeostasis O 0 0.3488364517688751
. O 0 0.00031536747701466084

To O 0 5.072122439742088e-05
obtain O 0 5.3351639508036897e-05
clues O 0 5.525115557247773e-05
to O 0 2.5011484012793517e-06
the O 0 2.1280998225847725e-06
normal O 0 2.1327758076949976e-05
biological O 0 1.2881732800451573e-05
role O 0 4.600639840646181e-06
of O 0 9.929334510161425e-07
DMPK O 0 0.004214639309793711
in O 0 3.211977400496835e-06
cellular O 0 0.00014546990860253572
ion O 0 0.0008138744160532951
homeostasis O 0 0.037256497889757156
, O 0 3.09011920762714e-06
we O 0 1.0665833087841747e-06
have O 0 1.0260088174618431e-06
compared O 0 3.6267251743993256e-06
the O 0 2.237692115159007e-06
resting O 0 0.00171093107201159
[ O 0 0.000710340915247798
Ca2 O 0 0.06724539399147034
+ O 0 0.0022990230936557055
] O 0 8.585815521655604e-05
i O 0 1.767583398759598e-06
, O 0 3.951102769406134e-07
the O 0 2.7492279741636594e-07
amplitude O 0 4.0126219573721755e-06
and O 0 6.42940165107575e-07
shape O 0 2.8123251468059607e-05
of O 0 2.44411853600468e-06
depolarization O 0 0.10458513349294662
- O 0 0.12840431928634644
induced O 1 0.9697629809379578
Ca2 O 1 0.7007734775543213
+ O 0 0.013924045488238335
transients O 0 0.004236679989844561
, O 0 1.5148706324907835e-06
and O 0 5.340286861610366e-07
the O 0 3.350489237163856e-07
content O 0 1.1045219707739307e-06
of O 0 1.2836818541472894e-06
ATP O 0 0.0004194167267996818
- O 0 0.0001170538816950284
driven O 0 1.9824705304927193e-05
ion O 0 0.0001307755446759984
pumps O 0 0.000398671516450122
in O 0 1.5891453585936688e-05
cultured O 0 0.04572829604148865
skeletal O 1 0.9886759519577026
muscle O 1 0.8647503852844238
cells O 0 0.003506874432787299
of O 0 4.981663551006932e-06
wild O 0 0.00019130832515656948
- O 0 0.002908129943534732
type O 0 0.0007146042189560831
and O 0 2.0829536879318766e-05
DMPK O 0 0.3423324227333069
[ O 0 0.003996341954916716
- O 0 0.03743244335055351
/ O 0 0.06444067507982254
- O 0 0.008505631238222122
] O 0 0.0030310549773275852
knockout O 0 0.008980441838502884
mice O 0 0.12672299146652222
. O 0 0.0002777260378934443

In O 0 0.00027887997566722333
vitro O 0 0.004572642035782337
- O 0 0.017166441306471825
differentiated O 0 0.1284007579088211
DMPK O 1 0.561517059803009
[ O 0 0.0075234584510326385
- O 0 0.02599526382982731
/ O 0 0.04804999753832817
- O 0 0.00331485690549016
] O 0 0.0011354911839589477
myotubes O 0 0.0057322136126458645
exhibit O 0 0.00026808868278749287
a O 0 1.0594540071906522e-05
higher O 0 4.825876749237068e-05
resting O 0 0.018270624801516533
[ O 0 0.0027981395833194256
Ca2 O 0 0.1620594561100006
+ O 0 0.005417870823293924
] O 0 0.00013041726197116077
i O 0 3.928947535314364e-06
than O 0 1.2061169627486379e-06
do O 0 3.2813459256431088e-06
wild O 0 1.5918785720714368e-05
- O 0 0.00024918169947341084
type O 0 7.522058149334043e-05
myotubes O 0 0.00042971488437615335
because O 0 1.1731207223419915e-06
of O 0 2.1671287697699881e-07
an O 0 5.393546302912e-07
altered O 0 7.999259651114698e-06
open O 0 1.7915089074449497e-06
probability O 0 1.6512532283741166e-06
of O 0 6.333828537208319e-07
voltage O 0 1.3960615433461498e-05
- O 0 0.00042185065103694797
dependent O 0 0.0001693609810899943
l O 0 0.018679287284612656
- O 0 0.001103735063225031
type O 0 0.000979786622337997
Ca2 O 0 0.03558052331209183
+ O 0 0.0010458396282047033
and O 0 1.2033036000502761e-05
Na O 0 0.0069124735891819
+ O 0 0.0010207511950284243
channels O 0 0.00018031660874839872
. O 0 0.00010045837552752346

The O 0 0.00023830778081901371
mutant O 0 0.007718263193964958
myotubes O 0 0.014664564281702042
exhibit O 0 0.0005145971663296223
smaller O 0 3.450749136391096e-05
and O 0 1.1225448361074086e-05
slower O 0 0.00015731890744064003
Ca2 O 0 0.06419240683317184
+ O 0 0.0015849596820771694
responses O 0 7.848316454328597e-05
upon O 0 8.452870133623946e-06
triggering O 0 0.00034217239590361714
by O 0 1.2326002433837857e-05
acetylcholine O 0 0.011121945455670357
or O 0 1.9657003576867282e-05
high O 0 6.375394877977669e-05
external O 0 0.00018450866627972573
K O 0 0.00985569879412651
+ O 0 0.006853400729596615
. O 0 0.00014236696006264538

In O 0 4.923786036670208e-05
addition O 0 2.206576209573541e-05
, O 0 4.629706836567493e-06
we O 0 1.8724925894275657e-06
observed O 0 5.540722213481786e-06
that O 0 1.3084435295240837e-06
these O 0 3.445823040237883e-06
Ca2 O 0 0.01960059627890587
+ O 0 0.005440642591565847
transients O 0 0.022554365918040276
partially O 0 0.00013554094766732305
result O 0 4.46100830231444e-06
from O 0 8.761002732171619e-07
an O 0 1.21448624668119e-06
influx O 0 1.8826556697604246e-05
of O 0 2.1225400814728346e-06
extracellular O 0 0.0006086078938096762
Ca2 O 0 0.033152807503938675
+ O 0 0.0004472299187909812
through O 0 8.128584340738598e-06
the O 0 6.080914772610413e-06
l O 0 0.014310128055512905
- O 0 0.0013864447828382254
type O 0 0.0008293979917652905
Ca2 O 0 0.024368003010749817
+ O 0 0.0011926231672987342
channel O 0 0.00015700870426371694
. O 0 0.00010392870171926916

Neither O 0 0.00018823611026164144
the O 0 1.0863201168831438e-05
content O 0 1.4055891369935125e-05
nor O 0 1.8084783732774667e-05
the O 0 1.7764572248779587e-06
activity O 0 9.01954172149999e-06
of O 0 5.888163286726922e-06
Na O 0 0.08616805076599121
+ O 0 0.02966219000518322
/ O 0 0.06796448677778244
K O 0 0.007206671871244907
+ O 0 0.005303587764501572
ATPase O 0 0.03417486324906349
and O 0 7.934243330964819e-05
sarcoplasmic O 1 0.9064831733703613
reticulum O 1 0.8587718605995178
Ca2 O 0 0.48228755593299866
+ O 0 0.018388444557785988
- O 0 0.00441518472507596
ATPase O 0 0.05171889439225197
are O 0 1.828321910579689e-05
affected O 0 0.0004419990873429924
by O 0 3.9251448470167816e-05
DMPK O 0 0.050341326743364334
absence O 0 0.0015859107952564955
. O 0 0.00017956664669327438

In O 0 5.563924787566066e-05
conclusion O 0 3.889752406394109e-05
, O 0 4.582922429108294e-06
our O 0 4.590577191265766e-06
data O 0 4.752223048853921e-06
suggest O 0 1.8995158825418912e-05
that O 0 1.9227857137593674e-06
DMPK O 0 0.0009749644086696208
is O 0 9.903100135488785e-07
involved O 0 3.2598402412986616e-06
in O 0 8.544288334633166e-07
modulating O 0 0.0005524701555259526
the O 0 1.1410729712224565e-06
initial O 0 5.534464435186237e-06
events O 0 3.1425881843460957e-06
of O 0 1.6546171082154615e-06
excitation O 0 0.0006004871684126556
- O 0 0.002188281621783972
contraction O 0 0.017639735713601112
coupling O 0 0.001221504877321422
in O 0 0.00010617696534609422
skeletal O 1 0.9810028076171875
muscle O 1 0.9091000556945801
. O 0 8.489713945891708e-05
. O 0 0.00013985887926537544

Constitutional O 0 0.007456358056515455
RB1 O 1 0.9778542518615723
- O 0 0.3908085227012634
gene O 0 0.20728521049022675
mutations O 0 0.33690157532691956
in O 0 0.0002989953791256994
patients O 1 0.9951698184013367
with O 0 0.00041997648077085614
isolated O 0 0.3752945363521576
unilateral B-Disease 1 0.6723368167877197
retinoblastoma I-Disease 1 0.9918128252029419
. O 0 0.0019761519506573677

In O 0 0.0002791539882309735
most O 0 0.00034140891511924565
patients O 1 0.9880753755569458
with O 0 0.0002831300371326506
isolated O 0 0.44916999340057373
unilateral B-Disease 1 0.8606265783309937
retinoblastoma I-Disease 1 0.9984215497970581
, O 0 0.0011183172464370728
tumor B-Disease 1 0.9949780106544495
development O 0 0.00018482067389413714
is O 0 5.750646323576802e-06
initiated O 0 0.0001224559237016365
by O 0 4.852426627621753e-06
somatic O 0 0.0021129148080945015
inactivation O 0 0.0009998944588005543
of O 0 1.7175393622892443e-06
both O 0 5.67480992685887e-06
alleles O 0 0.0003951287653762847
of O 0 5.6640506045368966e-06
the O 0 5.622060052701272e-05
RB1 O 1 0.9778688549995422
gene O 0 0.021197710186243057
. O 0 0.0002995372633449733

However O 0 8.629285002825782e-05
, O 0 1.202920338982949e-05
some O 0 3.445086804276798e-06
of O 0 2.5116851247730665e-06
these O 0 2.0725788999698125e-05
patients O 1 0.9844111204147339
can O 0 8.50797223392874e-05
transmit O 0 0.06794432550668716
retinoblastoma B-Disease 1 0.9980213642120361
predisposition O 1 0.9645125865936279
to O 0 1.3765507901553065e-05
their O 0 2.2653159248875454e-05
offspring O 0 0.004564871545881033
. O 0 0.00013722818403039128

To O 0 2.855690945580136e-05
determine O 0 2.557355946919415e-05
the O 0 2.593738145151292e-06
frequency O 0 7.643584467587061e-06
and O 0 1.9944366158597404e-06
nature O 0 1.1248638656979892e-05
of O 0 2.6786717626237078e-06
constitutional O 0 0.00019091852300334722
RB1 O 1 0.9962397813796997
- O 0 0.35472598671913147
gene O 0 0.09320773929357529
mutations O 0 0.15107856690883636
in O 0 7.204215944511816e-05
patients O 1 0.9880238175392151
with O 0 8.478329982608557e-05
isolated O 0 0.16611692309379578
unilateral B-Disease 0 0.41163963079452515
retinoblastoma I-Disease 1 0.9962506890296936
, O 0 1.27962821352412e-05
we O 0 2.9194957278377842e-06
analyzed O 0 6.914082041475922e-05
DNA O 0 8.440545207122341e-05
from O 0 1.0442093298479449e-05
peripheral O 0 0.4658757746219635
blood O 0 0.14362673461437225
and O 0 4.883812289335765e-05
from O 0 0.00024281878722831607
tumor B-Disease 1 0.9975892305374146
tissue O 1 0.9214135408401489
. O 0 0.0005456000217236578

The O 0 4.8290257836924866e-05
analysis O 0 4.4105621782364324e-05
of O 0 1.7701542674330994e-05
tumors B-Disease 1 0.9823706150054932
from O 0 9.779591891856398e-06
54 O 0 5.2657040214398876e-05
( O 0 8.027106559893582e-06
71 O 0 1.5825877198949456e-05
% O 0 2.023401975748129e-06
) O 0 2.252366812172113e-06
of O 0 1.51437382100994e-06
76 O 0 0.000591794669162482
informative O 0 0.0111420638859272
patients O 1 0.9911563396453857
showed O 0 0.00021043051674496382
loss O 0 0.000614193850196898
of O 0 6.86354633216979e-06
constitutional O 0 0.00022444120259024203
heterozygosity O 1 0.976597249507904
( O 0 0.0023137235548347235
LOH O 1 0.9950685501098633
) O 0 6.693478644592687e-05
at O 0 6.675769691355526e-05
intragenic O 0 0.029059015214443207
loci O 0 0.014669152908027172
. O 0 0.0002978127740789205

Three O 0 7.628783350810409e-05
of O 0 3.08299386233557e-05
13 O 0 0.0004859778273385018
uninformative O 1 0.9354334473609924
patients O 1 0.9932736158370972
had O 0 0.00012224020611029118
constitutional O 0 0.0002425994025543332
deletions O 0 0.005265852902084589
. O 0 0.0002455492503941059

For O 0 0.00017644744366407394
39 O 0 0.00035303327604196966
randomly O 0 0.00025291272322647274
selected O 0 0.0001912448205985129
tumors B-Disease 1 0.9910662770271301
, O 0 4.506676850724034e-05
SSCP O 0 0.10704653710126877
, O 0 5.122617585584521e-05
hetero O 1 0.8444427251815796
- O 0 0.005889980122447014
duplex O 0 0.017753146588802338
analysis O 0 1.3725304597755894e-05
, O 0 1.8787172848533373e-06
sequencing O 0 1.0590771125862375e-05
, O 0 1.8229727629659465e-06
and O 0 9.413894872523088e-07
Southern O 0 7.802290383551735e-06
blot O 0 0.000575514102820307
analysis O 0 3.869603460771032e-06
were O 0 6.980819193813659e-07
used O 0 2.4516355097148335e-06
to O 0 5.483477252710145e-06
identify O 0 0.00032393672154285014
mutations O 0 0.011946466751396656
. O 0 9.658410272095352e-05

Mutations O 0 0.013255824334919453
were O 0 2.1919810023973696e-05
detected O 0 0.00019635967328213155
in O 0 4.276927938917652e-06
21 O 0 1.1594200259423815e-05
( O 0 5.963504918327089e-06
91 O 0 2.4240203856606968e-05
% O 0 1.934968622663291e-06
) O 0 3.2868988455447834e-06
of O 0 3.759210812859237e-06
23 O 0 0.0009491271339356899
tumors B-Disease 1 0.9975886344909668
with O 0 0.0018139092717319727
LOH O 1 0.9952880144119263
. O 0 0.0004294036189094186

In O 0 6.586055678781122e-05
6 O 0 3.676898268167861e-05
( O 0 1.7360989659209736e-05
38 O 0 1.5567513401038013e-05
% O 0 2.637791794768418e-06
) O 0 2.638249725350761e-06
of O 0 1.6179658359760651e-06
16 O 0 0.0001509051799075678
tumors B-Disease 1 0.9985647797584534
without O 0 0.0005765825626440346
LOH O 1 0.998435914516449
, O 0 4.244215233484283e-06
one O 0 1.5181883554760134e-06
mutation O 0 0.00021548332006204873
was O 0 1.45464639444981e-06
detected O 0 3.89669876312837e-05
, O 0 4.853676500715665e-07
and O 0 2.519712154480658e-07
in O 0 5.314178679327597e-07
9 O 0 2.0187781046843156e-06
( O 0 1.809491891435755e-06
56 O 0 4.136297775403364e-06
% O 0 7.075875601003645e-07
) O 0 7.047590884212696e-07
of O 0 5.908295293011179e-07
the O 0 1.4582727089873515e-05
tumors B-Disease 1 0.9978195428848267
without O 0 0.0003138467436656356
LOH O 1 0.9976081848144531
, O 0 7.89840123616159e-06
both O 0 9.627011422708165e-06
mutations O 0 0.0006821253336966038
were O 0 5.249254172667861e-06
found O 0 3.939086673199199e-05
. O 0 7.234755321405828e-05

Thus O 0 5.531030546990223e-05
, O 0 5.132255409989739e-06
a O 0 2.04147249860398e-06
total O 0 1.1118395377707202e-06
of O 0 7.237716204144817e-07
45 O 0 8.219445589929819e-06
mutations O 0 0.0007438208558596671
were O 0 1.4789154647587566e-06
identified O 0 3.35086697305087e-05
in O 0 1.650492959015537e-05
tumors B-Disease 1 0.9920146465301514
of O 0 2.2511949282488786e-05
36 O 0 0.009591824375092983
patients O 1 0.9951083064079285
. O 0 0.0005262034246698022

Thirty O 0 0.00045211997348815203
- O 0 0.00019543917733244598
nine O 0 1.0270337952533737e-05
of O 0 1.9660401449073106e-06
the O 0 3.0897065244062105e-06
mutations O 0 0.0004957003984600306
- O 0 8.519004768459126e-05
including O 0 3.0091614462435246e-06
34 O 0 8.466537110507488e-06
small O 0 5.346663783711847e-06
mutations O 0 0.0003252838214393705
, O 0 1.7628900650379364e-06
2 O 0 3.816593107330846e-06
large O 0 6.3544875956722535e-06
structural O 0 0.0018524315673857927
alterations O 0 0.0005171886296011508
, O 0 4.983830876881257e-06
and O 0 8.42820736579597e-06
hypermethylation O 0 0.23142307996749878
in O 0 1.1347137842676602e-05
3 O 0 0.00011740085028577596
tumors O 1 0.9964461922645569
- O 0 0.00024211715208366513
were O 0 6.627522566304833e-07
not O 0 7.254529350575467e-07
detected O 0 1.7553709767526016e-05
in O 0 7.032766120573797e-07
the O 0 2.206027374995756e-06
corresponding O 0 6.61848098388873e-05
peripheral O 0 0.3909077048301697
blood O 0 0.13011281192302704
DNA O 0 0.0022041143383830786
. O 0 0.00021048229245934635

In O 0 5.073588545201346e-05
6 O 0 4.312424061936326e-05
( O 0 1.21739230962703e-05
17 O 0 4.983070084563224e-06
% O 0 1.1091273108831956e-06
) O 0 6.655238848907175e-07
of O 0 2.7275731895315403e-07
the O 0 1.1590002486627782e-06
36 O 0 5.7514265790814534e-05
patients O 1 0.7749030590057373
, O 0 1.7226607269549277e-06
a O 0 4.123823600821197e-06
mutation O 0 0.0003489354276098311
was O 0 1.7586517060408369e-06
detected O 0 4.137294308748096e-05
in O 0 6.053773518033267e-07
constitutional O 0 2.028090648309444e-06
DNA O 0 5.955195774731692e-06
, O 0 2.57179209484093e-07
and O 0 1.933888142957585e-07
1 O 0 3.7091766103003465e-07
of O 0 1.9082285973581747e-07
these O 0 9.407119136994879e-07
mutations O 0 0.00019907359092030674
is O 0 8.871394925336062e-07
known O 0 2.071581320706173e-06
to O 0 6.3932230887076e-07
be O 0 8.896677172742784e-07
associated O 0 9.510063136985991e-06
with O 0 7.528363312303554e-06
reduced O 0 0.000739441136829555
expressivity O 1 0.7695848941802979
. O 0 0.00027451381902210414

The O 0 3.3554846595507115e-05
presence O 0 2.8776326871593483e-05
of O 0 2.095564241244574e-06
a O 0 4.357336820248747e-06
constitutional O 0 1.7916792785399593e-05
mutation O 0 0.00035235105315223336
was O 0 1.488633984081389e-06
not O 0 1.0556119605098502e-06
associated O 0 3.886067133862525e-06
with O 0 1.1735806992874132e-06
an O 0 2.1820283109263983e-06
early O 0 1.6482497812830843e-05
age O 0 0.00015388516476377845
at O 0 8.259444439318031e-05
treatment O 1 0.824577808380127
. O 0 0.00021373220079112798

In O 0 0.00010938125342363492
1 O 0 0.00015602490748278797
patient O 0 0.34234437346458435
, O 0 4.2396051867399365e-05
somatic O 0 0.061884183436632156
mosaicism O 1 0.7680965065956116
was O 0 6.063669843570096e-06
demonstrated O 0 2.350164322706405e-05
by O 0 1.5922620377750718e-06
molecular O 0 1.8307049685972743e-05
analysis O 0 3.0543162665708223e-06
of O 0 7.957137313496787e-07
DNA O 0 1.836132287280634e-05
and O 0 2.902466803789139e-06
RNA O 0 7.193972851382568e-05
from O 0 2.4758932340773754e-05
peripheral O 0 0.4935562014579773
blood O 0 0.1777106672525406
. O 0 0.00021918777201790363

In O 0 0.00014550377090927213
2 O 0 0.00027845907607115805
patients O 1 0.8642562031745911
without O 0 2.4838442186592147e-05
a O 0 3.300844400655478e-05
detectable O 0 0.018291771411895752
mutation O 0 0.011430665850639343
in O 0 4.547681237454526e-05
peripheral O 1 0.8693386912345886
blood O 1 0.5257841944694519
, O 0 0.00010239686525892466
mosaicism O 1 0.7965027689933777
was O 0 7.164500857470557e-06
suggested O 0 1.930495818669442e-05
because O 0 2.9427467325149337e-06
1 O 0 2.22664402826922e-06
of O 0 1.166921265394194e-06
the O 0 3.062271571252495e-05
patients O 1 0.9986200332641602
showed O 0 0.0887821763753891
multifocal O 1 0.9993197917938232
tumors B-Disease 1 0.9989224672317505
and O 0 1.4904499948897865e-05
the O 0 4.262362836016109e-06
other O 0 4.12780582337291e-06
later O 0 2.041472907876596e-05
developed O 0 0.0012021283619105816
bilateral B-Disease 0 0.013850277289748192
retinoblastoma I-Disease 1 0.9899246692657471
. O 0 0.0005534955998882651

In O 0 4.467242251848802e-05
conclusion O 0 3.124580325675197e-05
, O 0 3.834111339529045e-06
our O 0 4.078467100043781e-06
results O 0 7.210618605313357e-06
emphasize O 0 2.928477078967262e-05
that O 0 7.556318450951949e-07
the O 0 1.3189082892495207e-06
manifestation O 0 0.0010231194319203496
and O 0 5.006104856875027e-06
transmissibility O 0 0.1341916024684906
of O 0 5.65444406674942e-06
retinoblastoma B-Disease 1 0.9229593873023987
depend O 0 1.4011645362188574e-05
on O 0 5.62722220820433e-07
the O 0 4.31255472221892e-07
nature O 0 2.224517174909124e-06
of O 0 1.8581320659905032e-07
the O 0 2.9983164040459087e-07
first O 0 5.479553806253534e-07
mutation O 0 3.151056444039568e-05
, O 0 2.7730638407774677e-07
its O 0 3.278707652043522e-07
time O 0 2.6864719870900444e-07
in O 0 2.0352079843632964e-07
development O 0 1.433176180398732e-06
, O 0 2.3021230788344837e-07
and O 0 1.494165076110221e-07
the O 0 1.4873268128212658e-07
number O 0 2.4297324330291303e-07
and O 0 3.2041771191870794e-07
types O 0 2.941360889963107e-06
of O 0 4.7113397272369184e-07
cells O 0 0.00032336526783183217
that O 0 9.117910053646483e-07
are O 0 1.7532393030705862e-06
affected O 0 0.00019048376998398453
. O 0 1.1242149412282743e-05
. O 0 3.925361670553684e-05

Hereditary B-Disease 1 0.9859598875045776
deficiency I-Disease 1 0.9961259961128235
of I-Disease 0 1.1909509339602664e-05
the I-Disease 0 6.98476105753798e-06
fifth I-Disease 0 1.4471175745711662e-05
component I-Disease 0 1.6889782273210585e-05
of I-Disease 0 2.2142266971059144e-06
complement I-Disease 0 4.646540037356317e-05
in O 0 1.528375105408486e-05
man O 0 0.0002753261069301516
. O 0 9.128666715696454e-05

I O 0 0.004112903028726578
. O 0 0.0015379040269181132

Clinical O 1 0.9549964666366577
, O 0 0.0002137069241143763
immunochemical O 0 0.02576272562146187
, O 0 3.3797310607042164e-05
and O 0 1.4597280824091285e-05
family O 0 0.0001295185211347416
studies O 0 0.0004773214168380946
. O 0 0.00011425881530158222

The O 0 5.2669500291813165e-05
first O 0 2.6204204914392903e-05
recognized O 0 0.00021001922141294926
human O 0 0.0024054318200796843
kindred O 1 0.9234529733657837
with O 0 0.0008355263853445649
hereditary B-Disease 1 0.9844678044319153
deficiency I-Disease 1 0.9991419315338135
of I-Disease 0 2.190894292652956e-06
the I-Disease 0 1.7919840047397884e-06
fifth I-Disease 0 8.463630365440622e-06
component I-Disease 0 1.2881094335170928e-05
of I-Disease 0 2.3706477350060595e-06
complement I-Disease 0 8.666874055052176e-05
( O 0 3.492063478915952e-05
C5 O 0 0.014414770528674126
) O 0 1.982924368348904e-05
is O 0 1.3141362614987884e-05
described O 0 0.00021598050079774112
. O 0 0.00010648155875969678

The O 0 7.360221934504807e-05
proband O 0 0.0014572482323274016
, O 0 7.320928034459939e-06
a O 0 5.259426870907191e-06
20 O 0 1.0147433386009652e-05
- O 0 0.00024713200400583446
year O 0 3.105828363914043e-05
- O 0 0.0036664146464318037
old O 0 0.00039886313606984913
black O 0 0.007180388551205397
female O 0 0.053763922303915024
with O 0 0.2863730192184448
systemic B-Disease 1 0.999832034111023
lupus I-Disease 1 0.9999555349349976
erythematosus I-Disease 1 0.9998617172241211
since O 0 0.03408002108335495
age O 0 0.004383285529911518
11 O 0 0.0003827154287137091
, O 0 6.719533121213317e-05
lacked O 0 0.03419075533747673
serum O 1 0.9847244024276733
hemolytic O 1 0.9994402527809143
complement O 0 0.0034972294233739376
activity O 0 0.00015470375365111977
, O 0 1.3143268006388098e-05
even O 0 3.423151792958379e-05
during O 0 0.00019684481958393008
remission O 1 0.8294761776924133
. O 0 0.00025549533893354237

C5 O 0 0.08488722145557404
was O 0 0.00017738231690600514
undetectable O 0 0.05709560960531235
in O 0 2.4063749151537195e-05
her O 0 0.00013118908100295812
serum O 0 0.028357570990920067
by O 0 1.7414300600648858e-05
both O 0 3.856900366372429e-05
immunodiffusion O 0 0.30217406153678894
and O 0 0.000689575623255223
hemolytic O 1 0.997123658657074
assays O 0 0.02984013967216015
. O 0 0.0004349316004663706

Other O 0 3.5396096791373566e-05
complement O 0 6.227487028809264e-05
components O 0 2.5766734324861318e-05
were O 0 5.009716005588416e-06
normal O 0 8.687924855621532e-05
during O 0 0.0001383916533086449
remission O 1 0.9674709439277649
of O 0 0.0002151146618416533
lupus O 1 0.9998408555984497
, O 0 0.00010402864427305758
but O 0 4.426034138305113e-05
C1 O 1 0.9410982131958008
, O 0 1.628502104722429e-05
C4 O 0 0.017227811738848686
, O 0 3.015958827745635e-05
C2 O 1 0.9082958102226257
, O 0 1.1930915206903592e-05
and O 0 1.4226025996322278e-05
C3 O 0 0.3198157846927643
levels O 0 0.0004745580954477191
fell O 0 0.0004703352751675993
during O 0 0.00044922399683855474
exacerbations O 1 0.9843364953994751
. O 0 0.0004407293163239956

A O 0 0.00022356123372446746
younger O 0 0.0006836188840679824
half O 0 4.903576700598933e-05
- O 0 0.007240409962832928
sister O 0 0.0004941067891195416
, O 0 5.963760486338288e-06
who O 0 9.954695997294039e-06
had O 0 1.016291935229674e-05
no O 0 2.771784784272313e-05
underlying O 0 0.277321457862854
disease O 1 0.9994035959243774
, O 0 7.0301566665875725e-06
was O 0 1.7875308913062327e-06
also O 0 1.7777572338673053e-06
found O 0 5.2100840548519045e-06
to O 0 4.813058694708161e-06
lack O 0 0.0003736045036930591
immunochemically O 0 0.1677553951740265
detectable O 0 0.0837470293045044
C5 O 0 0.3154277503490448
. O 0 0.00034438958391547203

By O 0 0.00236727693118155
hemolytic O 1 0.9955683350563049
assay O 0 0.004803494084626436
, O 0 2.795826003421098e-05
she O 0 1.4217778698366601e-05
exhibited O 0 5.505571607500315e-05
1 O 0 3.263202643211116e-06
- O 0 1.5028301277197897e-05
2 O 0 9.825218967307592e-07
% O 0 3.421664871439134e-07
of O 0 2.4517146357538877e-07
the O 0 9.487313263889519e-07
normal O 0 3.800062768277712e-05
serum O 0 0.006786209065467119
C5 O 0 0.004873763769865036
level O 0 5.560009867622284e-06
and O 0 8.844060062074277e-07
normal O 0 5.453718586068135e-06
concentrations O 0 8.271957995020784e-06
of O 0 4.09620440677827e-07
other O 0 1.7333127289020922e-06
complement O 0 3.0500017601298168e-05
components O 0 7.93126382632181e-05
. O 0 6.959281017770991e-05

C5 O 0 0.03591318428516388
levels O 0 0.0001423832291038707
of O 0 4.421752691996517e-06
other O 0 3.289235337433638e-06
family O 0 1.1793097655754536e-05
members O 0 1.3587092553279945e-06
were O 0 5.988530347167398e-07
either O 0 1.5250667502186843e-06
normal O 0 4.631892807083204e-06
or O 0 1.006239131129405e-06
approximately O 0 1.9369904293853324e-06
half O 0 2.691726422199281e-06
- O 0 0.00010610977187752724
normal O 0 2.8139886126155034e-05
, O 0 2.4829155336192343e-06
consistent O 0 3.551168629201129e-05
with O 0 2.8303196813794784e-05
autosomal O 1 0.9407736659049988
codominant O 0 0.07591532915830612
inheritance O 0 0.00029425829416140914
of O 0 3.932595063815825e-06
the O 0 3.4018554288195446e-05
gene O 0 0.03312584385275841
determining O 0 0.029662972316145897
C5 B-Disease 1 0.993572473526001
deficiency I-Disease 1 0.998847246170044
. O 0 0.0021941284649074078

Normal O 1 0.645167887210846
hemolytic O 1 0.9971743822097778
titers O 1 0.8332418203353882
were O 0 2.5999646823038347e-05
restored O 0 7.178007217589766e-05
to O 0 7.87599401519401e-06
both O 0 2.020161809923593e-05
homozygous O 0 0.010428952984511852
C5 B-Disease 1 0.8733512759208679
- I-Disease 0 0.3403938412666321
deficient I-Disease 1 0.9938462376594543
( O 0 0.00021777063375338912
C5D B-Disease 0 0.44540318846702576
) O 0 9.379390576214064e-06
sera O 0 0.00020625838078558445
by O 0 1.7571127273185994e-06
addition O 0 3.0452938517555594e-06
of O 0 1.6573397942920565e-06
highly O 0 0.00012056567356921732
purified O 0 0.004013982601463795
human O 0 0.0012523212935775518
C5 O 0 0.19601212441921234
. O 0 0.0002393691975157708

In O 0 0.00017076298536267132
specific O 0 0.00021544922492466867
C5 O 0 0.18238064646720886
titrations O 0 0.40831872820854187
, O 0 1.1078777788497973e-05
however O 0 2.1246746655378956e-06
, O 0 9.458088356950611e-07
it O 0 5.288420084070822e-07
was O 0 4.745837429709354e-07
noted O 0 1.1771642220992362e-06
that O 0 2.994176213633182e-07
when O 0 6.271295092119544e-07
limited O 0 1.1811958984253579e-06
amounts O 0 1.3987596503284294e-06
of O 0 5.774930968982517e-07
C5 O 0 0.00041533299372531474
were O 0 8.593220854891115e-07
assayed O 0 2.1129382730578072e-05
in O 0 7.324227340177458e-07
the O 0 6.219269721441378e-07
presence O 0 1.7770147451301455e-06
of O 0 8.06472030490113e-07
low O 0 3.326871956232935e-05
dilutions O 0 0.011995286680758
of O 0 3.3225055631191935e-06
either O 0 3.472318348940462e-05
C5D B-Disease 1 0.6360961198806763
serum O 0 0.03452695533633232
, O 0 7.714501407463104e-06
curving O 0 0.00024457069230265915
rather O 0 5.8859618548012804e-06
than O 0 3.501669198158197e-06
linear O 0 0.00027160250465385616
dose O 0 0.013078168965876102
- O 0 0.0006571520934812725
response O 0 4.295604594517499e-05
plots O 0 2.0762427084264345e-05
were O 0 1.4436840274356655e-06
consistently O 0 1.6696580132702366e-05
obtained O 0 5.311013410391752e-06
, O 0 3.303636503915186e-06
suggesting O 0 3.977517189923674e-05
some O 0 9.206842150888406e-06
inhibitory O 0 0.0004402932245284319
effect O 0 0.00025788048515096307
. O 0 0.0001302465097978711

Further O 0 0.0002588885836303234
studies O 0 0.00022129606804810464
suggested O 0 4.8891481128521264e-05
that O 0 5.271910595183726e-06
low O 0 7.262772123795003e-05
dilutions O 0 0.02389567345380783
of O 0 1.0942003427771851e-05
C5D B-Disease 1 0.6312918066978455
serum O 0 0.02312149666249752
contain O 0 2.9828019250999205e-05
a O 0 7.522571650042664e-06
factor O 0 4.116369382245466e-05
( O 0 5.00197211295017e-06
or O 0 1.8750087065200205e-06
factors O 0 7.718954293522984e-06
) O 0 1.8052465975415544e-06
interfering O 0 1.158040868176613e-05
at O 0 1.487633426222601e-06
some O 0 9.47080593505234e-07
step O 0 5.895731646887725e-06
in O 0 2.471203288223478e-06
the O 0 7.664848453714512e-06
hemolytic O 1 0.9981186985969543
assay O 0 0.0003629396960604936
of O 0 4.920857008983148e-06
C5 O 0 0.010271092876791954
, O 0 3.83743281417992e-06
rather O 0 4.205278855806682e-06
than O 0 3.3291789804934524e-06
a O 0 9.503843102720566e-06
true O 0 0.00014092930359765887
C5 O 0 0.1587987244129181
inhibitor O 0 0.11311595141887665
or O 0 0.00015938248543534428
inactivator O 0 0.02866796962916851
. O 0 0.0002741236239671707

Of O 0 9.078836592379957e-05
clinical O 0 0.1905871331691742
interest O 0 1.188402711704839e-05
are O 0 2.213010702689644e-06
( O 0 2.7639468953566393e-06
a O 0 1.424132165084302e-06
) O 0 1.1992271993221948e-06
the O 0 1.0178592901866068e-06
documentation O 0 2.6911646273219958e-05
of O 0 1.978028922167141e-05
membranous O 1 0.9964048862457275
glomerulonephritis B-Disease 1 0.9993481040000916
, O 0 0.03973071649670601
vasculitis B-Disease 1 0.9994707703590393
, O 0 0.0010547760175541043
and O 0 0.002088524866849184
arthritis B-Disease 1 0.9999277591705322
in O 0 2.1096258933539502e-05
an O 0 6.719166776747443e-06
individual O 0 5.427978976513259e-05
lacking O 0 0.004664076026529074
C5 O 0 0.2463555634021759
( O 0 8.429244189755991e-06
and O 0 7.906893983999908e-07
its O 0 1.8006179516305565e-06
biologic O 0 0.005197461228817701
functions O 0 3.5867637961928267e-06
) O 0 1.5822927252884256e-06
, O 0 6.899621212141938e-07
and O 0 9.276806167690665e-07
( O 0 4.007015832030447e-06
b O 0 4.9604717787588015e-05
) O 0 2.581518174338271e-06
a O 0 3.726873956111376e-06
remarkable O 0 0.0004907760303467512
propensity O 0 0.4564536213874817
to O 0 0.00026035020709969103
bacterial B-Disease 1 0.9988162517547607
infections I-Disease 1 0.9995809197425842
in O 0 1.6484762454638258e-05
the O 0 5.775696990895085e-06
proband O 0 0.007968098856508732
, O 0 1.8693202719077817e-06
even O 0 1.75690661308181e-06
during O 0 2.236185991932871e-06
periods O 0 6.609082447539549e-06
of O 0 9.172043178296008e-07
low O 0 5.419599619926885e-05
- O 0 0.0005069178878329694
dose O 0 0.002730281325057149
or O 0 1.1332343092362862e-05
alternate O 0 6.690517329843715e-05
- O 0 0.00585589837282896
day O 0 0.0004043375374749303
corticosteroid O 1 0.9903197288513184
therapy O 1 0.9832285642623901
. O 0 0.0004414453578647226

Other O 0 4.6926776121836156e-05
observations O 0 6.686537381028756e-05
indicate O 0 2.440553726046346e-05
that O 0 1.9523574792401632e-06
the O 0 2.0218626559653785e-06
C5D B-Disease 0 0.006015433929860592
state O 0 1.9442711618467e-06
is O 0 7.536672228525276e-07
compatible O 0 3.99115060645272e-06
with O 0 1.4264402352637262e-06
normal O 0 5.318157491274178e-05
coagulation O 0 0.005161018576472998
function O 0 4.940154212818015e-06
and O 0 7.530248353759816e-07
the O 0 5.796593995910371e-07
capacity O 0 3.8045388919272227e-06
to O 0 3.493876874927082e-06
mount O 0 0.0014930476900190115
a O 0 0.0003194513847120106
neutrophilic O 1 0.9973227381706238
leukocytosis O 1 0.9972254037857056
during O 0 0.12045574188232422
pyogenic B-Disease 1 0.9976409673690796
infection I-Disease 1 0.997805655002594
. O 0 0.00017674175614956766
. O 0 0.0002480204857420176

Susceptibility O 1 0.982769250869751
to O 0 0.07970321178436279
ankylosing B-Disease 1 0.9991227984428406
spondylitis I-Disease 1 0.9995405673980713
in O 0 0.001755082979798317
twins O 0 0.3064112961292267
: O 0 1.6857920854818076e-05
the O 0 1.8942288306789123e-06
role O 0 5.994123512209626e-06
of O 0 1.7132956600107718e-06
genes O 0 0.00020162876171525568
, O 0 2.1452373403008096e-05
HLA O 1 0.718136191368103
, O 0 4.121936399315018e-06
and O 0 2.6782529403135413e-06
the O 0 6.881721219542669e-06
environment O 0 0.00041953151230700314
. O 0 0.00010388381633674726

OBJECTIVE O 0 0.0003016450209543109
To O 0 1.7881900930660777e-05
determine O 0 1.5490608348045498e-05
the O 0 3.2018604088079883e-06
relative O 0 2.7264202799415216e-05
effects O 0 0.0004789411905221641
of O 0 2.8877730073872954e-06
genetic O 0 0.00588799687102437
and O 0 1.465189598093275e-05
environmental O 0 0.003426502225920558
factors O 0 0.0002863207191694528
in O 0 8.678816811880097e-05
susceptibility O 1 0.9890140891075134
to O 0 0.009883549995720387
ankylosing B-Disease 1 0.9996402263641357
spondylitis I-Disease 1 0.9997709393501282
( O 0 0.009633396752178669
AS B-Disease 0 0.0004856740415561944
) O 0 0.00014366274990607053
. O 0 0.00013392246910370886

METHODS O 0 0.0009504876798018813
Twins O 0 0.025150731205940247
with O 0 1.0268673577229492e-05
AS B-Disease 0 8.868723853083793e-06
were O 0 1.07509015379037e-06
identified O 0 7.606084636790911e-06
from O 0 1.3640426459460286e-06
the O 0 3.3165347304020543e-06
Royal O 0 0.0003374899970367551
National O 0 0.014817575924098492
Hospital O 1 0.9974299073219299
for O 0 0.06476444751024246
Rheumatic B-Disease 1 0.9997357726097107
Diseases I-Disease 1 0.9994951486587524
database O 0 0.3125980496406555
. O 0 0.0010491517605260015

Clinical O 1 0.927263617515564
and O 0 0.0003033994580619037
radiographic O 1 0.9113288521766663
examinations O 0 0.006507133133709431
were O 0 5.505332865141099e-06
performed O 0 3.416101390030235e-05
to O 0 7.959711183502804e-06
establish O 0 0.0014333322178572416
diagnoses O 1 0.9954181909561157
, O 0 0.00010890594421653077
and O 0 0.0007816159049980342
disease O 1 0.9995580315589905
severity O 1 0.9866158962249756
was O 0 1.0286492397426628e-05
assessed O 0 0.00010818482405738905
using O 0 1.83743702564243e-06
a O 0 1.8778180219669593e-06
combination O 0 2.5820061637205072e-05
of O 0 1.8419548268866492e-06
validated O 0 6.343665154417977e-05
scoring O 0 1.74576180143049e-05
systems O 0 0.0007895462331362069
. O 0 0.00012186033563921228

HLA O 1 0.9544615745544434
typing O 0 0.011131751351058483
for O 0 0.00042801155359484255
HLA O 1 0.9790173172950745
- O 0 0.026524614542722702
B27 O 0 0.02463708259165287
, O 0 0.0001013904475257732
HLA O 1 0.9389688968658447
- O 0 0.003372445935383439
B60 O 0 0.0032644332386553288
, O 0 9.36701053433353e-06
and O 0 1.5378287571365945e-05
HLA O 1 0.9524842500686646
- O 0 0.008591242134571075
DR1 O 0 0.3652309477329254
was O 0 3.0556388992408756e-06
performed O 0 3.3290200462943176e-06
by O 0 1.2134431699450943e-06
polymerase O 0 6.891661178087816e-05
chain O 0 2.9334134524106048e-05
reaction O 0 8.855049600242637e-06
with O 0 1.9026839481739444e-06
sequence O 0 5.17581383974175e-06
- O 0 7.23033444955945e-05
specific O 0 7.85544852988096e-06
primers O 0 0.0003116801963187754
, O 0 2.4825130822137e-06
and O 0 2.4297748950630194e-06
zygosity O 0 0.0013039184268563986
was O 0 5.937412424827926e-06
assessed O 0 0.00019532293663360178
using O 0 3.6889447073917836e-05
microsatellite O 0 0.02472275123000145
markers O 0 0.0023925572168082
. O 0 0.00017721645417623222

Genetic O 0 0.012696471065282822
and O 0 3.477961945463903e-05
environmental O 0 0.00017911521717905998
variance O 0 2.383933315286413e-05
components O 0 9.310982022725511e-06
were O 0 1.2433770280040335e-06
assessed O 0 2.3422928279615007e-05
with O 0 8.924627081796643e-07
the O 0 1.40818485760974e-06
program O 0 4.3100109905935824e-05
Mx O 0 0.017590409144759178
, O 0 5.099563509247673e-07
using O 0 3.8485489994855016e-07
data O 0 4.6627607730442833e-07
from O 0 2.648721704190393e-07
this O 0 2.2359314755249216e-07
and O 0 3.2555792017774365e-07
previous O 0 1.9331059775140602e-06
studies O 0 9.735176718095317e-06
of O 0 1.726957179926103e-06
twins O 0 0.006944893393665552
with O 0 1.328097096120473e-05
AS B-Disease 0 8.773979061516002e-05
. O 0 8.603944297647104e-05

RESULTS O 0 0.00019953744777012616
Six O 0 4.815873035113327e-05
of O 0 2.201386814704165e-05
8 O 0 0.00013140466762706637
monozygotic O 1 0.8294321298599243
( O 0 0.0005317723844200373
MZ O 1 0.9851706624031067
) O 0 6.776863301638514e-05
twin O 0 0.00936108361929655
pairs O 0 0.0003185356908943504
were O 0 2.8886055588372983e-05
disease O 1 0.9978252649307251
concordant O 0 0.12796612083911896
, O 0 3.8315779420372564e-06
compared O 0 6.407600267266389e-06
with O 0 1.0572098290140275e-06
4 O 0 2.282009518239647e-06
of O 0 6.482522962869552e-07
15 O 0 8.744760634726845e-06
B27 O 0 0.004642454441636801
- O 0 0.002511837286874652
positive O 0 0.0005258466699160635
dizygotic O 1 0.7676287889480591
( O 0 0.00011695279681589454
DZ O 0 0.23195022344589233
) O 0 8.01103851699736e-06
twin O 0 0.00035469172871671617
pairs O 0 1.592756416357588e-05
( O 0 3.7885895380895818e-06
27 O 0 2.5302620088041294e-06
% O 0 5.33734919372364e-07
) O 0 5.30272245669039e-07
and O 0 3.094493479238736e-07
4 O 0 1.1343307733113761e-06
of O 0 9.155455700238235e-07
32 O 0 2.8127544283051975e-05
DZ O 0 0.1880382001399994
twin O 0 0.0012591620907187462
pairs O 0 2.974410745082423e-05
overall O 0 1.770086782926228e-05
( O 0 5.571220299316337e-06
12 O 0 3.085978278249968e-06
. O 0 1.2947558616360766e-06
5 O 0 3.888365881721256e-06
% O 0 6.00214343648986e-06
) O 0 1.933089879457839e-05
. O 0 4.293933307053521e-05

Nonsignificant O 0 0.07597516477108002
increases O 0 0.0003645181132014841
in O 0 1.36552844196558e-05
similarity O 0 4.863687718170695e-05
with O 0 8.228009392041713e-06
regard O 0 4.9100755859399214e-05
to O 0 6.9825296122871805e-06
age O 0 0.0004419245233293623
at O 0 0.0010100501822307706
disease O 1 0.9996509552001953
onset O 1 0.9936001300811768
and O 0 6.440376182581531e-06
all O 0 9.790433068701532e-07
of O 0 2.3832333226891933e-06
the O 0 0.00032857144833542407
disease O 1 0.999648928642273
severity O 1 0.997328519821167
scores O 0 0.0025856292340904474
assessed O 0 0.0040893941186368465
were O 0 3.706132702063769e-06
noted O 0 0.00011606257612584159
in O 0 0.00014067125448491424
disease O 1 0.9992163181304932
- O 1 0.7629608511924744
concordant O 1 0.9920687675476074
MZ O 1 0.9978941082954407
twins O 1 0.8216440677642822
compared O 0 0.0010438866447657347
with O 0 0.00028769820346497
concordant O 1 0.9089438319206238
DZ O 1 0.9820050001144409
twins O 1 0.5695187449455261
. O 0 0.0006295146886259317

HLA O 1 0.9673338532447815
- O 0 0.01723383367061615
B27 O 0 0.011555076576769352
and O 0 1.783425068424549e-05
B60 O 0 0.001110351993702352
were O 0 2.517550910852151e-06
associated O 0 1.8975242710439488e-05
with O 0 3.781925897783367e-06
the O 0 2.0854027752648108e-05
disease O 1 0.998362123966217
in O 0 1.1084981451858766e-05
probands O 0 0.01767844893038273
, O 0 1.5550097032246413e-06
and O 0 6.200514235388255e-07
the O 0 8.477870210299443e-07
rate O 0 5.2179102567606606e-06
of O 0 6.198331448104e-06
disease O 1 0.9975118637084961
concordance O 0 0.0036334532778710127
was O 0 8.226808859035373e-06
significantly O 0 0.00033521204022690654
increased O 0 3.34140240738634e-05
among O 0 2.8404081604094245e-05
DZ O 1 0.5565503239631653
twin O 0 0.0036113085225224495
pairs O 0 1.8370765246800147e-05
in O 0 1.5211637673928635e-06
which O 0 1.0439705420139944e-06
the O 0 2.210884304076899e-06
co O 0 0.0011936698574572802
- O 0 0.0015684874961152673
twin O 0 0.0017339354380965233
was O 0 2.82416976915556e-06
positive O 0 8.908631571102887e-06
for O 0 2.6939196686726063e-06
both O 0 7.828060915926471e-06
B27 O 0 0.004497182089835405
and O 0 5.075949593447149e-05
DR1 O 1 0.6537941694259644
. O 0 0.00019577938655856997

Additive O 0 0.007434211205691099
genetic O 0 0.010318390093743801
effects O 0 0.0020947852171957493
were O 0 2.456634774716804e-06
estimated O 0 7.3540186349418946e-06
to O 0 1.106103127312963e-06
contribute O 0 1.9757628251682036e-05
97 O 0 9.595682058716193e-06
% O 0 7.368996648438042e-07
of O 0 5.771407245447335e-07
the O 0 2.2620190520683536e-06
population O 0 1.2575582331919577e-05
variance O 0 9.371720807394013e-05
. O 0 6.228537677088752e-05

CONCLUSION O 0 0.002632507588714361
Susceptibility O 0 0.3282812237739563
to O 0 1.6867281374288723e-05
AS B-Disease 0 1.4483463928627316e-05
is O 0 2.6280144993506838e-06
largely O 0 5.04216995977913e-06
genetically O 0 6.353576463880017e-05
determined O 0 8.711001100891735e-06
, O 0 1.1069283800679841e-06
and O 0 7.455731747540995e-07
the O 0 1.595636831552838e-06
environmental O 0 0.0018523979233577847
trigger O 0 0.005166711285710335
for O 0 1.4301165720098652e-05
the O 0 5.778220292995684e-05
disease O 1 0.997808039188385
is O 0 3.9670125261181965e-05
probably O 0 0.0001785155473044142
ubiquitous O 0 0.002644111169502139
. O 0 0.00019743597658816725

HLA O 1 0.9418095350265503
- O 0 0.004038387909531593
B27 O 0 0.001151497126556933
accounts O 0 1.627581332286354e-05
for O 0 3.652037321444368e-06
a O 0 4.217496552882949e-06
minority O 0 1.4797880794503726e-05
of O 0 8.347069524461403e-07
the O 0 1.9463566331978654e-06
overall O 0 0.0001297694689128548
genetic O 0 0.007522227708250284
susceptibility O 0 0.4079819917678833
to O 0 1.4699202438350767e-05
AS B-Disease 0 8.947321475716308e-05
. O 0 9.259155194740742e-05

Cell O 0 0.0034417472779750824
cycle O 0 0.0008861052920110524
- O 0 0.0013202192494645715
dependent O 0 0.00021445605671033263
colocalization O 0 0.0015702522359788418
of O 0 7.958784408401698e-06
BARD1 O 0 0.0215456485748291
and O 0 1.542387872177642e-05
BRCA1 O 0 0.290865957736969
proteins O 0 2.2499520127894357e-05
in O 0 4.86913313579862e-06
discrete O 0 8.28413394629024e-05
nuclear O 0 0.0002559415006544441
domains O 0 0.0008779604104347527
. O 0 0.00016646900621708483

Germ O 1 0.5638889074325562
- O 0 0.002361306920647621
line O 0 0.00011264936620136723
mutations O 0 0.0006362142157740891
of O 0 5.876741852262057e-06
the O 0 3.200792707502842e-05
BRCA1 O 1 0.9893653392791748
gene O 0 0.19987235963344574
predispose O 1 0.9354060292243958
women O 0 0.0005640929448418319
to O 0 2.2426091163652018e-05
early O 0 0.0008712481940165162
- O 1 0.9882702827453613
onset O 1 0.9994631409645081
breast B-Disease 1 0.9997757077217102
and I-Disease 1 0.8400473594665527
ovarian I-Disease 1 0.999913215637207
cancer I-Disease 1 0.9998063445091248
by O 0 9.13648764253594e-05
compromising O 0 0.04527564346790314
the O 0 3.688417200464755e-05
genes O 0 0.0044409059919416904
presumptive O 0 0.20334871113300323
function O 0 0.00014613752136938274
as O 0 1.8404502043267712e-05
a O 0 0.000244283553911373
tumor B-Disease 1 0.9900701642036438
suppressor O 1 0.7394925355911255
. O 0 0.0004199978429824114

Although O 0 0.0001360862806905061
the O 0 1.766360037436243e-05
biochemical O 0 0.00047292927047237754
properties O 0 0.00010027452663052827
of O 0 8.727830390853342e-06
BRCA1 O 1 0.7740457653999329
polypeptides O 0 0.0015299537917599082
are O 0 3.0310620786622167e-06
not O 0 1.509088519924262e-06
understood O 0 7.761087545077316e-06
, O 0 6.32608930573042e-07
their O 0 5.91533137139777e-07
expression O 0 6.721282261423767e-06
pattern O 0 3.8879355997778475e-05
and O 0 2.0893141936539905e-06
subcellular O 0 0.00024956255219876766
localization O 0 0.00023509007587563246
suggest O 0 1.51142794493353e-05
a O 0 2.6739141958387336e-06
role O 0 7.4850727287412155e-06
in O 0 4.234843345329864e-06
cell O 0 0.000374190101865679
- O 0 0.000850281969178468
cycle O 0 0.000560308457352221
regulation O 0 0.0004751682572532445
. O 0 0.00015771723701618612

When O 0 0.0005133151425980031
resting O 0 0.027230361476540565
cells O 0 0.0027002987917512655
are O 0 9.173748367174994e-06
induced O 0 0.06382878869771957
to O 0 3.7968870856275316e-06
proliferate O 0 0.000768399506341666
, O 0 6.226130153663689e-07
the O 0 3.8192877127585234e-07
steady O 0 7.346764050453203e-06
- O 0 3.1845767807681113e-05
state O 0 1.2393129509291612e-06
levels O 0 5.555160441872431e-06
of O 0 1.0169006827709381e-06
BRCA1 O 0 0.15058232843875885
increase O 0 8.222016731451731e-06
in O 0 2.1063156054879073e-06
late O 0 1.3271564057504293e-05
G1 O 0 0.004193076863884926
and O 0 1.066252821146918e-06
reach O 0 3.060416020161938e-06
a O 0 2.7120620416098973e-06
maximum O 0 1.2454274838091806e-05
during O 0 4.1178613173542544e-05
S O 0 0.0032741257455199957
phase O 0 0.0010224072029814124
. O 0 0.00015819663531146944

Moreover O 0 0.0009975177235901356
, O 0 3.360839036758989e-05
in O 0 1.809251079976093e-05
S O 0 0.003289694432169199
phase O 0 0.0010771127417683601
cells O 0 0.003226852510124445
, O 0 2.443133962515276e-05
BRCA1 O 1 0.7208775281906128
polypeptides O 0 0.000977255403995514
are O 0 4.823203653359087e-06
hyperphosphorylated O 0 0.0006555425934493542
and O 0 4.225403245072812e-06
accumulate O 0 0.0003456473641563207
into O 0 7.2619127422512975e-06
discrete O 0 0.00024766201386228204
subnuclear O 0 0.051190901547670364
foci O 0 0.12905827164649963
termed O 0 0.02317967638373375
" O 0 0.00014940951950848103
BRCA1 O 1 0.7215883731842041
nuclear O 0 0.0013251951895654202
dots O 0 0.02472459338605404
. O 0 0.00029049161821603775

" O 0 0.0018790586618706584
BRCA1 O 1 0.95693039894104
associates O 0 0.059812285006046295
in O 0 2.7006050004274584e-05
vivo O 0 0.0015081247547641397
with O 0 1.6659902030369267e-05
a O 0 4.4663691369351e-05
structurally O 0 0.10589707642793655
related O 0 0.004416387528181076
protein O 0 0.001642316929064691
termed O 0 0.09823939204216003
BARD1 O 1 0.5833648443222046
. O 0 0.0006527664372697473

Here O 0 5.932592830504291e-05
we O 0 8.898069609131198e-06
show O 0 5.773775228590239e-06
that O 0 7.821054168744013e-07
the O 0 8.495408110320568e-07
steady O 0 1.2390752090141177e-05
- O 0 4.977207208867185e-05
state O 0 1.6506013480466208e-06
levels O 0 9.542561201669741e-06
of O 0 1.2015212860205793e-06
BARD1 O 0 0.0036068076733499765
, O 0 1.6362357655452797e-06
unlike O 0 7.146948973968392e-06
those O 0 1.339636014563439e-06
of O 0 1.8278087736689486e-06
BRCA1 O 1 0.6207377910614014
, O 0 5.654260348819662e-06
remain O 0 1.0946064321615268e-05
relatively O 0 2.3980568585102446e-05
constant O 0 5.1815011829603463e-05
during O 0 5.0351929530734196e-05
cell O 0 0.0027932925149798393
cycle O 0 0.004768627695739269
progression O 1 0.6749566197395325
. O 0 0.0003815721138380468

However O 0 0.0002742028154898435
, O 0 6.982061313465238e-05
immunostaining O 0 0.01708277128636837
revealed O 0 0.000420252385083586
that O 0 1.1890046152984723e-05
BARD1 O 0 0.06472262740135193
resides O 0 0.0004983054823242128
within O 0 1.0225644473393913e-05
BRCA1 O 1 0.6450070142745972
nuclear O 0 0.00018685308168642223
dots O 0 0.007167333737015724
during O 0 3.166104943375103e-05
S O 0 0.0007197842933237553
phase O 0 1.4955501683289185e-05
of O 0 3.696220858273591e-07
the O 0 8.778582696322701e-07
cell O 0 4.766418715007603e-05
cycle O 0 1.9576002159737982e-05
, O 0 6.30879867458134e-07
but O 0 5.866600645276776e-07
not O 0 4.006868152828247e-07
during O 0 3.2335806281480473e-06
the O 0 5.941456493019359e-06
G1 O 0 0.04056856408715248
phase O 0 0.0009320087847299874
. O 0 0.00012381226406432688

Nevertheless O 0 0.001130198477767408
, O 0 7.106045813998207e-05
BARD1 O 0 0.009014962241053581
polypeptides O 0 0.0003055073320865631
are O 0 2.865953319997061e-06
found O 0 1.901116775115952e-06
exclusively O 0 1.5413259006891167e-06
in O 0 3.2366486379942216e-07
the O 0 2.470107176577585e-07
nuclear O 0 2.1691148504032753e-06
fractions O 0 1.5200282632577e-06
of O 0 5.412209134192381e-07
both O 0 3.3462656574556604e-06
G1 O 0 0.04796929657459259
- O 0 0.00034875833080150187
and O 0 1.0719822967075743e-05
S O 0 0.004331481177359819
- O 0 0.0012266909470781684
phase O 0 0.0011104129953309894
cells O 0 0.002341903280466795
. O 0 9.480879089096561e-05

Therefore O 0 0.00019373562827240676
, O 0 4.4126321881776676e-05
progression O 0 0.021595435217022896
to O 0 8.729229193704668e-06
S O 0 0.0012209184933453798
phase O 0 5.427772339317016e-05
is O 0 1.513138045083906e-06
accompanied O 0 5.209845312492689e-06
by O 0 8.435906693193829e-07
the O 0 9.030102319229627e-07
aggregation O 0 1.3157163266441785e-05
of O 0 1.8434203639117186e-06
nuclear O 0 8.945744775701314e-05
BARD1 O 0 0.006323089357465506
polypeptides O 0 0.00034265159047208726
into O 0 3.0701256036991253e-05
BRCA1 O 0 0.48607444763183594
nuclear O 0 0.0006846895557828248
dots O 0 0.019834240898489952
. O 0 0.00022822360915597528

This O 0 9.352614870294929e-05
cell O 0 0.0004470008716452867
cycle O 0 0.00028852446121163666
- O 0 0.000693462323397398
dependent O 0 0.00019326439360156655
colocalization O 0 0.0018090000376105309
of O 0 1.1037637705157977e-05
BARD1 O 0 0.04713841527700424
and O 0 2.240800495201256e-05
BRCA1 O 1 0.579841673374176
indicates O 0 5.874646012671292e-05
a O 0 5.228789632383268e-06
role O 0 2.137287810910493e-05
for O 0 2.010434945987072e-05
BARD1 O 0 0.38936302065849304
in O 0 0.0001650341146159917
BRCA1 O 1 0.9947748184204102
- O 1 0.806469202041626
mediated O 1 0.9657653570175171
tumor B-Disease 1 0.9970335960388184
suppression O 1 0.5286045670509338
. O 0 0.0006275316118262708

Ethnic O 0 0.0003866530896630138
differences O 0 0.0003087269142270088
in O 0 4.720613651443273e-05
the O 0 7.468039257219061e-05
HFE O 1 0.6376857161521912
codon O 0 0.0036320174112915993
282 O 0 0.040451399981975555
( O 0 0.002606599358841777
Cys O 1 0.9846367835998535
/ O 1 0.6537007093429565
Tyr O 1 0.9526879787445068
) O 0 0.0002953082730527967
polymorphism O 0 0.002289689378812909
. O 0 0.0003043375036213547

Recent O 0 0.0010985422413796186
studies O 0 0.0004360703460406512
have O 0 2.5331486540380865e-05
shown O 0 0.00013230514014139771
that O 0 0.0001279449788853526
hereditary B-Disease 1 0.9964788556098938
hemochromatosis I-Disease 1 0.9997465014457703
( O 0 0.33602604269981384
HH B-Disease 1 0.9990266561508179
) O 0 4.318799255997874e-05
is O 0 4.516296939982567e-06
likely O 0 7.494851161027327e-06
to O 0 6.857297876194934e-07
be O 0 7.943141895339068e-07
caused O 0 7.439606997650117e-05
by O 0 1.467944116484432e-06
homozygosity O 0 0.0005602369783446193
for O 0 2.412453113720403e-06
a O 0 7.594263479404617e-06
Cys282Tyr O 0 0.013941661454737186
mutation O 0 0.000633504125289619
in O 0 5.017585863242857e-06
the O 0 1.1824676221294794e-05
HFE O 1 0.7691283822059631
gene O 0 0.0012823486467823386
located O 0 5.050908657722175e-05
4 O 0 0.0001089411525754258
. O 0 0.00012029512436129153

5 O 0 0.0015896722907200456
Mb O 0 0.0928068608045578
telomeric O 0 0.23349131643772125
to O 0 0.00023818013141863048
HLA O 1 0.8782050609588623
- O 0 0.003518633311614394
A O 0 0.0003601659263949841
. O 0 0.0002066873712465167

Population O 0 0.00011843191896332428
studies O 0 2.8153872335678898e-05
of O 0 1.7280940483033191e-06
this O 0 1.4035700814929442e-06
polymorphism O 0 2.744108314800542e-05
are O 0 8.333650498570933e-07
facilitated O 0 1.642942152102478e-05
by O 0 7.028810387055273e-07
the O 0 7.240270747388422e-07
fact O 0 1.843775521592761e-06
that O 0 7.56716474370478e-07
the O 0 2.196396508225007e-06
Cys282Tyr O 0 0.00890347734093666
mutation O 0 0.0013774846447631717
creates O 0 0.000201035596546717
a O 0 2.641576975292992e-05
Rsal O 0 0.017965134233236313
restriction O 0 0.00016698315448593348
site O 0 0.00014168195775710046
. O 0 0.00010617301450110972

We O 0 6.993315764702857e-05
have O 0 2.1909734641667455e-05
studied O 0 3.052702595596202e-05
the O 0 1.3581802704720758e-05
codon O 0 0.00025687809102237225
282 O 0 0.002487119985744357
( O 0 0.0006375222583301365
Cys O 1 0.9869515895843506
/ O 0 0.2770264744758606
Tyr O 1 0.6493885517120361
) O 0 1.632879866519943e-05
polymorphism O 0 4.472664659260772e-05
in O 0 2.4573564587626606e-06
different O 0 5.068970949650975e-06
ethnic O 0 3.517055665724911e-05
groups O 0 5.963853618595749e-05
. O 0 8.898345549823716e-05

In O 0 5.307265018927865e-05
agreement O 0 2.550699355197139e-05
with O 0 7.60613556849421e-06
previous O 0 1.3153738109394908e-05
observations O 0 3.617162292357534e-05
the O 0 1.2578603673318867e-05
Tyr O 1 0.8783619403839111
allele O 0 0.0012194023001939058
appeared O 0 1.1301906852168031e-05
to O 0 1.2009004421997815e-06
be O 0 1.4844489442111808e-06
rare O 0 6.598357867915183e-05
or O 0 6.137756372481817e-06
absent O 0 0.00010235858644591644
in O 0 4.110238933208166e-06
Asiatic O 0 0.006130658555775881
( O 0 1.3953507732367143e-05
Indian O 0 8.410655027546454e-06
, O 0 4.0408394852420315e-06
Chinese O 0 2.704486541915685e-05
) O 0 2.869011768780183e-05
populations O 0 0.00033002812415361404
. O 0 0.00011490313045214862

The O 0 4.985491978004575e-05
highest O 0 7.079882925609127e-05
allele O 0 0.00019807537319138646
frequency O 0 2.0501196559052914e-05
( O 0 7.32566331862472e-06
7 O 0 3.212491947124363e-06
. O 0 8.022078077374317e-07
5 O 0 1.394162268297805e-06
% O 0 7.535032864325331e-07
) O 0 1.120991441894148e-06
was O 0 7.837240900698816e-07
found O 0 2.1219896098045865e-06
in O 0 4.028718649351504e-06
Swedes O 0 0.00023766563390381634
. O 0 5.9796446294058114e-05

Saamis O 0 0.012322675436735153
( O 0 5.329275518306531e-05
2 O 0 9.725137715577148e-06
% O 0 2.772148945950903e-06
) O 0 1.9369442725292174e-06
and O 0 1.0411588391434634e-06
Mordvinians O 0 0.00038068427238613367
( O 0 1.7213139926752774e-06
1 O 0 8.841917633617413e-07
. O 0 3.4808886084647384e-07
8 O 0 9.078855214283976e-07
% O 0 3.6041956263943575e-07
) O 0 5.851179025739839e-07
had O 0 7.118965186236892e-07
significantly O 0 1.1365483260306064e-05
lower O 0 3.379642066647648e-06
frequencies O 0 3.442741899561952e-06
of O 0 1.950704927367042e-06
the O 0 1.689177952357568e-05
Tyr O 1 0.5787174105644226
allele O 0 0.004430633969604969
. O 0 0.00026853790041059256

Comparisons O 0 0.00026628386694937944
with O 0 2.56251914834138e-05
allele O 0 0.00022560446814168245
frequencies O 0 2.0705341739812866e-05
based O 0 5.2577115638996474e-06
on O 0 5.178006176720373e-06
prevalence O 0 0.08651453256607056
estimates O 0 6.72093010507524e-05
of O 0 6.440155630116351e-06
HH B-Disease 1 0.9952213168144226
showed O 0 3.830786590697244e-05
some O 0 1.9475151020742487e-06
disagreements O 0 2.713828689593356e-05
with O 0 2.2037986582290614e-06
the O 0 2.9127045308996458e-06
RFLP O 0 0.002145655220374465
data O 0 3.6627277495426824e-06
, O 0 3.212093815818662e-06
particularly O 0 2.199460141127929e-05
in O 0 1.277210503758397e-05
Finns O 0 0.0009683551033958793
. O 0 0.00010874956205952913

The O 0 0.00018853247456718236
newly O 0 0.00046615878818556666
described O 0 0.000942709855735302
HFE O 1 0.6378957033157349
marker O 0 0.00044309464283287525
provides O 0 4.2980384023394436e-05
a O 0 5.325077381712617e-06
new O 0 2.476265990480897e-06
approach O 0 4.34112780567375e-06
to O 0 7.113278002179868e-07
the O 0 7.377744282166532e-07
screening O 0 6.192092405399308e-05
of O 0 2.260423343614093e-06
HH B-Disease 1 0.9883525967597961
as O 0 9.920210004565888e-07
well O 0 6.747252427885542e-07
as O 0 4.3024081719522655e-07
studies O 0 2.2240506041271146e-06
of O 0 2.5534993142173334e-07
the O 0 9.795700179893174e-07
relationship O 0 6.365820445353165e-05
between O 0 9.45535248320084e-06
the O 0 4.530773367150687e-05
HFE O 1 0.9889284372329712
Tyr O 1 0.9910978674888611
allele O 0 0.04715995863080025
and O 0 9.070771193364635e-05
different O 0 0.00046435423428192735
disorders O 1 0.9987450838088989
including O 0 0.10085229575634003
cancer B-Disease 1 0.998166561126709

Autosomal B-Disease 1 0.987468957901001
dominant I-Disease 1 0.9388017654418945
neurohypophyseal I-Disease 1 0.9932053089141846
diabetes I-Disease 1 0.9994608759880066
insipidus I-Disease 1 0.9977837204933167
associated O 0 0.0017801767680794
with O 0 3.7891346437390894e-05
a O 0 9.091813990380615e-05
missense O 0 0.05847373604774475
mutation O 0 0.009928339160978794
encoding O 0 0.000551180331967771
Gly23 O 0 0.2652910649776459
- O 0 0.03739754483103752
- O 0 0.0489676296710968
> O 0 0.12865082919597626
Val O 1 0.7831680774688721
in O 0 8.535838423995301e-05
neurophysin O 0 0.047658246010541916
II O 0 0.0193713940680027
. O 0 0.00033174981945194304

Autosomal B-Disease 1 0.9890323877334595
dominant I-Disease 1 0.932113528251648
neurohypophyseal I-Disease 1 0.991415798664093
diabetes I-Disease 1 0.999485969543457
insipidus I-Disease 1 0.9979974627494812
( O 0 0.08994663506746292
ADNDI B-Disease 1 0.9462128281593323
) O 0 0.000279642001260072
is O 0 0.00010889139957726002
an O 0 0.001898831338621676
inherited B-Disease 1 0.9994829893112183
disease I-Disease 1 0.9998949766159058
caused O 1 0.9430230855941772
by O 0 0.0002889522584155202
progressive O 0 0.48976075649261475
degeneration O 1 0.9989333748817444
of O 0 1.0143601684831083e-05
the O 0 2.2231804905459285e-05
magnocellular O 1 0.8962918519973755
neurons O 0 0.020602356642484665
of O 0 2.368164587096544e-06
the O 0 5.729789336328395e-06
hypothalamus O 0 0.031189028173685074
leading O 0 1.7571213902556337e-05
to O 0 3.2405605452368036e-06
decreased O 0 0.00011523471039254218
ability O 0 1.2014975254714955e-05
to O 0 1.4071458735998021e-06
produce O 0 7.256574917846592e-06
the O 0 9.140667316387407e-06
hormone O 0 0.06569887697696686
arginine O 0 0.06216222047805786
vasopressin O 1 0.6789163947105408
( O 0 0.000640637706965208
AVP O 1 0.6446329951286316
) O 0 0.00015125350910238922
. O 0 0.0001140216481871903

Affected O 0 0.07125569134950638
individuals O 0 0.0003642252995632589
are O 0 1.5152207197388634e-05
not O 0 2.1204572476563044e-05
symptomatic O 1 0.9571163654327393
at O 0 3.372647915966809e-05
birth O 0 0.0009049325599335134
, O 0 7.079196620907169e-06
but O 0 1.1449008525232784e-05
usually O 0 0.00023629190400242805
develop O 1 0.9803255200386047
diabetes B-Disease 1 0.9998643398284912
insipidus I-Disease 1 0.9984020590782166
at O 0 6.0715345171047375e-05
1 O 0 4.412350244820118e-05
- O 0 0.0005159812280908227
6 O 0 7.486122194677591e-05
yr O 0 0.09967001527547836
of O 0 1.5565077774226665e-05
age O 0 0.0001898623740999028
. O 0 9.987086377805099e-05

The O 0 8.895665814634413e-05
genetic O 0 0.0019100267672911286
locus O 0 0.000930295733269304
of O 0 1.2375069672998507e-05
the O 0 6.866118201287463e-05
disease O 1 0.9972930550575256
is O 0 1.8341494069318287e-05
the O 0 2.1346049834392034e-05
AVP O 1 0.9633241891860962
- O 0 0.18181301653385162
neurophysin O 1 0.6081762313842773
II O 0 0.05109493061900139
( O 0 9.964426863007247e-05
NPII O 0 0.029758647084236145
) O 0 1.3234946891316213e-05
gene O 0 0.00016164286353159696
, O 0 2.5111773993558018e-06
and O 0 3.5564999052439816e-06
mutations O 0 0.002656119642779231
that O 0 4.508077381615294e-06
cause O 0 0.02412550337612629
ADNDI B-Disease 0 0.05953364074230194
have O 0 1.5387381608888973e-06
been O 0 5.934429623266624e-07
found O 0 5.051961124991067e-07
in O 0 2.1880033784782427e-07
both O 0 2.544490200762084e-07
the O 0 3.1904374964142335e-07
signal O 0 2.7509377105161548e-06
peptide O 0 1.121337936638156e-05
of O 0 7.715552783338353e-07
the O 0 3.4225108720420394e-06
prepro O 0 0.01731518656015396
- O 0 0.01000420656055212
AVP O 1 0.7902700901031494
- O 0 0.003852306865155697
NPII O 0 0.012331719510257244
precursor O 0 0.0001516798511147499
and O 0 4.270430963515537e-06
within O 0 1.7604203094379045e-05
NPII O 0 0.020582228899002075
itself O 0 0.0002460709074512124
. O 0 9.412937652086839e-05

An O 0 0.0002774002496153116
affected O 0 0.020009206607937813
girl O 0 0.003145274706184864
who O 0 1.5228463780658785e-05
presented O 0 7.224452474474674e-06
at O 0 2.499453103155247e-06
9 O 0 4.614287718140986e-06
months O 0 4.93484731123317e-06
of O 0 9.543028909320128e-07
age O 0 2.0868270439677872e-05
and O 0 3.5627531360660214e-06
her O 0 0.00011045012070098892
similarly O 0 0.003683730959892273
affected O 0 0.03947991505265236
younger O 0 0.00357955414801836
brother O 0 0.00012087511277059093
and O 0 1.1579375041037565e-06
father O 0 6.66559390083421e-06
were O 0 1.6633124744203087e-07
all O 0 1.5909583339634992e-07
found O 0 4.900682029074233e-07
to O 0 3.2689320050849346e-07
have O 0 6.78698029332736e-07
a O 0 2.6543152671365533e-06
novel O 0 7.029039261396974e-05
missense O 0 0.00884648971259594
mutation O 0 0.0017878294456750154
( O 0 2.9657721825060435e-05
G1758 O 0 0.002996298484504223
- O 0 0.0009231141302734613
- O 0 0.001176186720840633
> O 0 0.0024637077003717422
T O 0 0.001473714830353856
) O 0 1.8521764104661997e-06
encoding O 0 4.426841314852936e-06
the O 0 1.112099312194914e-06
amino O 0 7.74160071159713e-06
acid O 0 6.154123548185453e-05
substitution O 0 5.282200800138526e-05
Gly23 O 0 0.01580805890262127
- O 0 0.00292233400978148
- O 0 0.010856571607291698
> O 0 0.021257011219859123
Val O 0 0.16647784411907196
within O 0 0.00010206570732407272
NPII O 0 0.022869089618325233
. O 0 0.0003049288352485746

The O 0 0.0001422851055394858
mutation O 0 0.002760855248197913
was O 0 2.7344820409780368e-05
confirmed O 0 6.916759593877941e-05
by O 0 2.0310006220825016e-05
restriction O 0 0.00017756540910340846
endonuclease O 0 0.02011609636247158
analysis O 0 0.0003243130922783166
. O 0 0.0002576794649939984

A O 0 0.0005606119520962238
T1 O 0 0.23936115205287933
- O 0 0.0005508892936632037
weighted O 0 9.207515540765598e-05
magnetic O 0 0.00011042538972105831
resonance O 0 0.00044781246106140316
imaging O 0 0.004679843317717314
of O 0 3.74684145754145e-06
the O 0 1.1442591130617075e-05
fathers O 0 0.009499350562691689
pituitary O 1 0.9886196851730347
gland O 1 0.9871583580970764
demonstrates O 0 0.04760118946433067
an O 0 0.00021628857939504087
attenuated O 1 0.9077446460723877
posterior O 1 0.9779585599899292
pituitary O 1 0.9903104901313782
bright O 0 0.2971797585487366
spot O 0 0.003530498594045639
. O 0 0.0004353289841674268

This O 0 8.526287274435163e-05
mutation O 0 0.003086236771196127
may O 0 1.4837787603028119e-05
be O 0 1.3196317922847811e-06
valuable O 0 7.011570232862141e-06
for O 0 3.1543222576146945e-06
developing O 0 0.00018336903303861618
models O 0 3.116824882454239e-05
of O 0 1.606806108611636e-05
dominantly B-Disease 1 0.941712498664856
inherited I-Disease 1 0.9963788390159607
neurodegeneration I-Disease 1 0.9991340041160583
, O 0 1.3198658962210175e-05
as O 0 1.6072376638476271e-06
the O 0 1.3932584579379181e-06
early O 0 5.863753813173389e-06
age O 0 1.5675848771934398e-05
of O 0 6.536596174555598e-06
onset O 1 0.996736466884613
of O 0 0.00018929081852547824
symptoms O 1 0.9995282888412476
suggests O 0 0.0015097061404958367
that O 0 3.1650765777158085e-06
this O 0 2.8910412765981164e-06
mutation O 0 0.002507008146494627
may O 0 8.807935046206694e-06
be O 0 1.080146375898039e-06
particularly O 0 2.1024317902629264e-05
deleterious O 0 0.0028905291110277176
to O 0 4.0241375245386735e-06
the O 0 1.1779339729400817e-05
magnocellular O 1 0.849193811416626
neuron O 1 0.5730378031730652
. O 0 5.988478733343072e-05
. O 0 0.0001320845476584509

Frequent O 0 0.06557291001081467
inactivation O 0 0.3112785816192627
of O 0 0.0005790063296444714
PTEN O 1 0.989151120185852
/ O 1 0.9388371706008911
MMAC1 O 1 0.8883370757102966
in O 0 0.0013489132979884744
primary O 1 0.6023210883140564
prostate B-Disease 1 0.9995183944702148
cancer I-Disease 1 0.9990373849868774
. O 0 0.004954756703227758

Sporadic B-Disease 1 0.9858457446098328
prostate I-Disease 1 0.9992074370384216
carcinoma I-Disease 1 0.9991900324821472
is O 0 0.00010295160609530285
the O 0 1.1759786502807401e-05
most O 0 3.05301982734818e-05
common O 0 0.0028597305063158274
male B-Disease 0 0.08339811116456985
cancer I-Disease 1 0.9990112781524658
in O 0 4.9618302000453696e-06
the O 0 1.4545936437571072e-06
Western O 0 6.277222382777836e-06
world O 0 2.370091806369601e-06
, O 0 7.100224479472672e-07
yet O 0 6.920267310306372e-07
many O 0 2.3854951791690837e-07
of O 0 1.5835561839594448e-07
the O 0 3.8595274531871837e-07
major O 0 6.594186743313912e-06
genetic O 0 7.066419493639842e-05
events O 0 3.970324542024173e-06
involved O 0 4.127549800614361e-06
in O 0 8.901948262973747e-07
the O 0 2.119174496328924e-06
progression O 0 0.024203689768910408
of O 0 3.2862751595530426e-06
this O 0 1.3558843420469202e-05
often O 0 0.0029226811602711678
fatal O 1 0.9992056488990784
cancer B-Disease 1 0.9995599389076233
remain O 0 0.00016758641868364066
to O 0 8.083361535682343e-06
be O 0 1.435174544894835e-05
elucidated O 0 0.04838530346751213
. O 0 0.00013828929513692856

Numerous O 0 0.0034084010403603315
cytogenetic O 1 0.7441210746765137
and O 0 0.00019113965390715748
allelotype O 0 0.14873738586902618
studies O 0 0.0005821002414450049
have O 0 1.3518007108359598e-05
reported O 0 0.0001652818318689242
frequent O 0 0.0012103469343855977
loss O 0 0.0014362683286890388
of O 0 1.2423587577359285e-05
heterozygosity O 1 0.8367844223976135
on O 0 5.784439417766407e-05
chromosomal O 1 0.6208569407463074
arm O 0 0.35642459988594055
10q O 1 0.6313499808311462
in O 0 0.0015626425156369805
sporadic B-Disease 1 0.9848681092262268
prostate I-Disease 1 0.9996932744979858
cancer I-Disease 1 0.9993982315063477
. O 0 0.008745859377086163

Deletion O 0 0.03827134519815445
mapping O 0 0.0011974923545494676
studies O 0 0.0002688801323529333
have O 0 1.0889111763390247e-05
unambiguously O 0 0.00030697882175445557
identified O 0 2.106220563291572e-05
a O 0 4.097890723642195e-06
region O 0 1.261839770450024e-05
of O 0 1.8635070091477246e-06
chromosome O 0 0.0006433188682422042
10q23 O 0 0.0003371977945789695
to O 0 1.0069081781693967e-06
be O 0 4.95694564506266e-07
the O 0 8.127057640194835e-07
minimal O 0 1.9787155906669796e-05
area O 0 9.52652953856159e-06
of O 0 5.5053642427083105e-06
loss O 0 0.0019036730518564582
. O 0 0.00012556888395920396

A O 0 0.001029539038427174
new O 0 0.002077382057905197
tumor B-Disease 1 0.9932257533073425
suppressor O 1 0.9200254678726196
gene O 0 0.2060934156179428
, O 0 0.0005828822613693774
PTEN O 1 0.9945673942565918
/ O 1 0.5857981443405151
MMAC1 O 0 0.2137371003627777
, O 0 1.0415468750579748e-05
was O 0 4.937601261190139e-06
isolated O 0 0.0002575539401732385
recently O 0 1.3533032870327588e-05
at O 0 1.3594803931482602e-06
this O 0 4.228880072787433e-07
region O 0 3.8046946428949013e-06
of O 0 7.987184176272422e-07
chromosome O 0 0.00036992874811403453
10q23 O 0 0.0003201681829523295
and O 0 7.589742949676292e-07
found O 0 1.095719539989659e-06
to O 0 7.02645138517255e-07
be O 0 7.168084152908705e-07
inactivated O 0 6.788822793168947e-05
by O 0 2.6990908281732118e-06
mutation O 0 0.0011731984559446573
in O 0 3.129300239379518e-05
three O 0 0.004509450402110815
prostate B-Disease 1 0.9997726082801819
cancer I-Disease 1 0.999556839466095
cell O 0 0.18065932393074036
lines O 0 0.00196376396343112
. O 0 0.00029482130776159465

We O 0 0.00023990063345991075
screened O 0 0.0073055545799434185
80 O 0 0.02577347308397293
prostate B-Disease 1 0.9991975426673889
tumors I-Disease 1 0.9981366395950317
by O 0 4.7736335545778275e-05
microsatellite O 0 0.013945621438324451
analysis O 0 3.321162876090966e-05
and O 0 4.2241949813615065e-06
found O 0 1.4940048458811361e-05
chromosome O 0 0.00046568160178139806
10q23 O 0 0.00033256938331760466
to O 0 1.157618385150272e-06
be O 0 1.3852774145561852e-06
deleted O 0 1.826655716286041e-05
in O 0 3.7517793316510506e-06
23 O 0 4.034310768474825e-05
cases O 0 0.00038696802221238613
. O 0 7.050575368339196e-05

We O 0 4.805349090020172e-05
then O 0 9.696031156636309e-06
proceeded O 0 8.285868716484401e-06
with O 0 1.514263999524701e-06
sequence O 0 2.7354451503924793e-06
analysis O 0 1.6246330005742493e-06
of O 0 5.929439907959022e-07
the O 0 2.8092133561585797e-06
entire O 0 0.00022804613399785012
PTEN O 1 0.9865766763687134
/ O 0 0.15859681367874146
MMAC1 O 0 0.03457797318696976
coding O 0 0.0003854902752209455
region O 0 4.134493428864516e-05
and O 0 2.9264058412081795e-06
tested O 0 0.0001309900835622102
for O 0 4.37555945609347e-06
homozygous O 0 0.0003539192257449031
deletion O 0 0.0003461141895968467
with O 0 3.163694373142789e-06
new O 0 6.935933924978599e-06
intragenic O 0 0.0015993979759514332
markers O 0 7.008278043940663e-05
in O 0 1.3489869843397173e-06
these O 0 1.540705852676183e-06
23 O 0 1.71005776792299e-05
cases O 0 8.512094791512936e-05
with O 0 1.2253827662789263e-05
10q23 O 0 0.042969439178705215
loss O 0 0.002665292238816619
of O 0 5.706446972908452e-05
heterozygosity O 1 0.798844039440155
. O 0 0.0003718743100762367

The O 0 2.6811794668901712e-05
identification O 0 1.935170621436555e-05
of O 0 1.8507021195546258e-06
the O 0 2.4778250917734113e-06
second O 0 4.468127372092567e-06
mutational O 0 0.00395580567419529
event O 0 9.148185199592263e-06
in O 0 2.3477305148844607e-06
10 O 0 5.190286174183711e-06
( O 0 6.9267716753529385e-06
43 O 0 2.1215315427980386e-05
% O 0 1.2534919733298011e-05
) O 0 0.0001477741898270324
tumors B-Disease 1 0.9984018206596375
establishes O 1 0.8610765933990479
PTEN O 1 0.9969182014465332
/ O 0 0.438285231590271
MMAC1 O 0 0.01267126016318798
as O 0 2.8256110908841947e-06
a O 0 2.6476864150026813e-06
main O 0 4.64546928924392e-06
inactivation O 0 0.00039375515189021826
target O 0 7.177960469562095e-06
of O 0 2.561775772846886e-06
10q O 0 0.02897091954946518
loss O 0 0.03300012648105621
in O 0 0.00038646699977107346
sporadic B-Disease 1 0.9819781184196472
prostate I-Disease 1 0.9998103976249695
cancer I-Disease 1 0.9996650218963623
. O 0 0.00048466442967765033
. O 0 0.00033774523762986064

Risk O 1 0.6689438223838806
reversals O 0 0.10785451531410217
in O 0 0.0002589014475233853
predictive O 0 0.13447995483875275
testing O 0 0.15323315560817719
for O 0 0.04571646824479103
Huntington B-Disease 1 0.9985173344612122
disease I-Disease 1 0.9992460012435913
. O 0 0.00331304594874382

The O 0 8.468270971206948e-05
first O 0 5.86801725148689e-05
predictive O 0 0.015022266656160355
testing O 0 0.01772257313132286
for O 0 0.006082392297685146
Huntington B-Disease 1 0.9992720484733582
disease I-Disease 1 0.9995889067649841
( O 0 0.00036390736931934953
HD B-Disease 0 0.003431478515267372
) O 0 2.6141660782741383e-06
was O 0 6.325570325316221e-07
based O 0 5.690172315553355e-07
on O 0 3.625791009653767e-07
analysis O 0 1.372801875731966e-06
of O 0 9.830420140133356e-07
linked O 0 0.0005066480371169746
polymorphic O 0 0.046921975910663605
DNA O 0 7.773184916004539e-05
markers O 0 9.545595094095916e-05
to O 0 1.0389538829258527e-06
estimate O 0 4.023182100354461e-06
the O 0 7.527520438088686e-07
likelihood O 0 1.5162325325945858e-05
of O 0 1.0012537359216367e-06
inheriting O 0 0.003348102793097496
the O 0 9.781261724128854e-06
mutation O 0 0.001381085254251957
for O 0 5.3903750085737556e-05
HD B-Disease 0 0.011456606909632683
. O 0 0.00023718641023151577

Limits O 0 9.549874812364578e-05
to O 0 8.25485767563805e-06
accuracy O 0 1.4577638467017096e-05
included O 0 4.570186774799367e-06
recombination O 0 2.4592820409452543e-05
between O 0 1.6631823882562458e-06
the O 0 1.1141214599774685e-06
DNA O 0 1.2848042388213798e-05
markers O 0 3.48678877344355e-05
and O 0 1.0074104466184508e-06
the O 0 1.6254853107966483e-06
mutation O 0 0.0003243517130613327
, O 0 2.0253191905794665e-06
pedigree O 0 0.0003172443248331547
structure O 0 1.2591349332069512e-05
, O 0 9.481740903538594e-07
and O 0 7.012881155787909e-07
whether O 0 1.7947512560567702e-06
DNA O 0 5.279034667182714e-06
samples O 0 2.7115033844893333e-06
were O 0 3.384337219358713e-07
available O 0 1.4137908692646306e-06
from O 0 2.2920510218682466e-06
family O 0 2.0052995751029812e-05
members O 0 2.5149827706627548e-05
. O 0 4.192192864138633e-05

With O 0 4.736369373858906e-05
direct O 0 3.754238423425704e-05
tests O 0 2.9203227313701063e-05
for O 0 2.0746576865349198e-06
the O 0 3.998239662905689e-06
HD B-Disease 0 0.011372113600373268
mutation O 0 0.00033872973290272057
, O 0 8.47855744723347e-07
we O 0 4.883880251327355e-07
have O 0 3.876437233429897e-07
assessed O 0 3.816057869698852e-06
the O 0 1.677415184531128e-07
accuracy O 0 8.961649768934876e-07
of O 0 2.1364137126056448e-07
results O 0 1.941830760188168e-06
obtained O 0 1.2814007277484052e-06
by O 0 1.0518837143536075e-06
linkage O 0 9.264623076887801e-05
approaches O 0 2.5728279069880955e-05
when O 0 2.6011648515122943e-06
requested O 0 3.9740671127219684e-06
to O 0 5.346942657524778e-07
do O 0 1.0591878663035459e-06
so O 0 8.759932939028658e-07
by O 0 1.00878617104172e-06
the O 0 2.0835323084611446e-06
test O 0 3.582195859053172e-05
individuals O 0 6.612285505980253e-05
. O 0 6.48842251393944e-05

For O 0 4.179383540758863e-05
six O 0 2.145464350178372e-05
such O 0 6.714247319905553e-06
individuals O 0 1.2390208212309517e-05
, O 0 1.6406638678745367e-06
there O 0 8.634360142423247e-07
was O 0 9.566447261022404e-07
significant O 0 5.30392799191759e-06
disparity O 0 0.00029790474218316376
between O 0 6.407196906366153e-06
the O 0 1.1923304555239156e-05
tests O 0 0.0003628486883826554
. O 0 9.115774446399882e-05

Three O 0 4.942905070492998e-05
went O 0 3.0506011171382852e-05
from O 0 6.313653102552053e-06
a O 0 1.3587191460828763e-05
decreased O 0 0.007945804856717587
risk O 0 0.008497191593050957
to O 0 1.5044098518046667e-06
an O 0 2.1145031041669426e-06
increased O 0 5.2114373829681426e-05
risk O 0 0.004411333706229925
, O 0 7.623213491569913e-07
while O 0 5.260843636278878e-07
in O 0 4.6475688009195437e-07
another O 0 9.185690714730299e-07
three O 0 1.1981503575952956e-06
the O 0 3.3590647490200354e-06
risk O 0 0.01746295765042305
was O 0 1.8340759197599255e-05
decreased O 0 0.0036049161572009325
. O 0 9.872873488347977e-05

Knowledge O 0 0.00012939271982759237
of O 0 5.72273347643204e-06
the O 0 4.4399735088518355e-06
potential O 0 2.353108902752865e-05
reasons O 0 7.2590528361615725e-06
for O 0 1.1260337942076148e-06
these O 0 5.173437216399179e-07
changes O 0 2.136217062798096e-06
in O 0 5.31895977928798e-07
results O 0 2.520327825550339e-06
and O 0 9.70957444224041e-07
impact O 0 1.133556361310184e-05
of O 0 5.010509767089388e-07
these O 0 3.579652457119664e-06
risk O 0 0.025001388043165207
reversals O 0 0.007901616394519806
on O 0 4.329204330133507e-06
both O 0 2.737657086981926e-05
patients O 1 0.9616373777389526
and O 0 3.6881997402815614e-06
the O 0 3.7167721984587843e-06
counseling O 0 0.16612249612808228
team O 0 8.943976354203187e-06
can O 0 1.3754386145592434e-06
assist O 0 9.848447916738223e-06
in O 0 4.826995336770779e-07
the O 0 4.275127309938398e-07
development O 0 3.354381533426931e-06
of O 0 6.283064521994675e-07
strategies O 0 0.00033149501541629434
for O 0 2.5470228592894273e-06
the O 0 4.1203093132935464e-06
prevention O 0 0.41351115703582764
and O 0 2.9872587674617535e-06
, O 0 1.4519562228088034e-06
where O 0 1.248104240403336e-06
necessary O 0 2.301838549101376e-06
, O 0 1.4215676173989777e-06
management O 0 6.872131052659824e-05
of O 0 6.750934176125156e-07
a O 0 1.6901914932532236e-05
risk O 0 0.04391218349337578
reversal O 0 0.0010068148840218782
in O 0 3.419949734961847e-06
any O 0 6.862937880214304e-06
predictive O 0 0.0016883485950529575
testing O 0 0.00033548413193784654
program O 0 0.00012613722356036305
. O 0 2.0286854123696685e-05
. O 0 7.698575063841417e-05

A O 0 0.00037170565337873995
novel O 0 0.0007450989214703441
common O 0 0.0007358946022577584
missense O 0 0.08008872717618942
mutation O 0 0.004606385249644518
G301C O 0 0.0009714442421682179
in O 0 5.879700893274276e-06
the O 0 4.742082182929153e-06
N O 0 0.00014171858492773026
- O 0 0.0005015844944864511
acetylgalactosamine O 0 0.005324222147464752
- O 0 0.0008657342405058444
6 O 0 0.00010810149979079142
- O 0 0.012484611943364143
sulfate O 1 0.9586806297302246
sulfatase O 1 0.9888812899589539
gene O 0 0.007716408930718899
in O 0 0.00012140565377194434
mucopolysaccharidosis B-Disease 0 0.2519369423389435
IVA I-Disease 1 0.8717654943466187
. O 0 0.00042790750740095973

Mucopolysaccharidosis B-Disease 1 0.8593357801437378
IVA I-Disease 1 0.930695116519928
( O 0 0.002348147099837661
MPS B-Disease 0 0.014099745079874992
IVA I-Disease 1 0.9701564311981201
) O 0 0.00012960686581209302
is O 0 6.288973963819444e-05
an O 0 0.0005375027540139854
autosomal B-Disease 1 0.9986415505409241
recessive I-Disease 1 0.9991340041160583
lysosomal I-Disease 1 0.9989033937454224
storage I-Disease 1 0.9822019934654236
disorder I-Disease 1 0.9996135830879211
caused O 1 0.7716954946517944
by O 0 5.621952732326463e-05
a O 0 0.0001911476720124483
genetic B-Disease 0 0.4988364279270172
defect I-Disease 1 0.8880634307861328
in O 0 3.702696994878352e-05
N O 0 0.0007507402333430946
- O 0 0.0027145592030137777
acetylgalactosamine O 0 0.02238120324909687
- O 0 0.0019586365669965744
6 O 0 0.0001712689845589921
- O 0 0.012470747344195843
sulfate O 1 0.9504085183143616
sulfatase O 1 0.9864115118980408
( O 0 0.0009806659072637558
GALNS O 0 0.08461508899927139
) O 0 0.00018087952048517764
. O 0 0.00013724100426770747

In O 0 6.704050611006096e-05
previous O 0 3.920976450899616e-05
studies O 0 4.7392426495207474e-05
, O 0 2.306842361576855e-06
we O 0 9.558549436405883e-07
have O 0 9.265983749173756e-07
found O 0 1.3488867125488468e-06
two O 0 1.5473912071684026e-06
common O 0 4.752113454742357e-05
mutations O 0 0.0038375675212591887
in O 0 5.543914085137658e-06
Caucasians O 0 0.008279569447040558
and O 0 3.7055563097965205e-06
Japanese O 0 2.1893463781452738e-05
, O 0 9.369502549816389e-06
respectively O 0 6.472403038060293e-05
. O 0 7.343739707721397e-05

To O 0 0.00010566408309387043
characterize O 0 0.0027998376172035933
the O 0 2.4754659534664825e-05
mutational O 0 0.053118642419576645
spectrum O 0 6.188704719534144e-05
in O 0 1.927779976540478e-06
various O 0 1.4338788787426893e-06
ethnic O 0 4.876387720287312e-06
groups O 0 3.758977754841908e-06
, O 0 2.7402443265600596e-06
mutations O 0 0.00017608456255402416
in O 0 1.3038534234510735e-06
the O 0 2.5458573418291053e-06
GALNS O 0 0.053149595856666565
gene O 0 0.0006113536073826253
in O 0 1.2118368431401905e-05
Colombian O 0 0.0005020719836466014
MPS B-Disease 0 0.0802735835313797
IVA I-Disease 1 0.9980140924453735
patients O 1 0.9971722960472107
were O 0 6.823787316534435e-06
investigated O 0 0.0016194699564948678
, O 0 2.6003958737419453e-06
and O 0 3.753558075914043e-06
genetic O 0 0.0014446649001911283
backgrounds O 0 0.00018390129844192415
were O 0 1.2289252708796994e-06
extensively O 0 5.1978327974211425e-05
analyzed O 0 2.636261888255831e-05
to O 0 1.1715309256032924e-06
identify O 0 1.1796303624578286e-05
racial O 0 1.0202432349615265e-05
origin O 0 1.8930983287646086e-06
, O 0 7.831682751202607e-07
based O 0 1.3481716223395779e-06
on O 0 1.3725388043894782e-06
mitochondrial O 0 0.00014265012578107417
DNA O 0 5.363337913877331e-05
( O 0 2.254533683299087e-05
mtDNA O 0 0.0001592825137777254
) O 0 3.032085078302771e-05
lineages O 0 0.00045671407133340836
. O 0 9.36234209802933e-05

Three O 0 0.0002500303089618683
novel O 0 0.001893865643069148
missense O 0 0.28130877017974854
mutations O 0 0.11336249858140945
never O 0 8.401991362916306e-05
identified O 0 3.2297190045937896e-05
previously O 0 5.99499253439717e-06
in O 0 1.1700292361638276e-06
other O 0 8.389645813622337e-07
populations O 0 1.959337168955244e-05
and O 0 5.440847985482833e-07
found O 0 7.275550615304383e-07
in O 0 4.203095329557982e-07
16 O 0 9.445910222893872e-07
out O 0 5.381102710089181e-07
of O 0 6.856741947558476e-07
19 O 0 1.270143548026681e-05
Colombian O 0 7.803122571203858e-05
MPS B-Disease 0 0.001508438610471785
IVA I-Disease 1 0.9195351004600525
unrelated O 0 0.0036514545790851116
alleles O 0 0.0018518178258091211
account O 0 2.9035802072030492e-05
for O 0 2.7522168238647282e-05
84 O 0 0.001274328795261681
. O 0 0.000159158167662099

2 O 0 5.493346179719083e-05
% O 0 7.2551638368167914e-06
of O 0 2.3096490622265264e-06
the O 0 4.295243797969306e-06
alleles O 0 0.0002491748018655926
in O 0 6.1121540966269094e-06
this O 0 7.371861102001276e-06
study O 0 0.00019534642342478037
. O 0 0.00011015414929715917

The O 0 0.00016717048129066825
G301C O 0 0.003627947298809886
and O 0 4.9801510613178834e-05
S162F O 0 0.003270340384915471
mutations O 0 0.0015726552810519934
account O 0 3.1563675293000415e-05
for O 0 2.249553108413238e-05
68 O 0 0.00039642496267333627
. O 0 0.0001339084265055135

4 O 0 0.00019413816335145384
% O 0 4.241125861881301e-05
and O 0 2.2878079107613303e-05
10 O 0 7.547609129687771e-05
. O 0 0.00011913757771253586

5 O 0 7.276338874362409e-05
% O 0 9.429418241779786e-06
of O 0 4.654764325096039e-06
mutations O 0 0.0007317020790651441
, O 0 2.8027507141814567e-06
respectively O 0 3.888862465828424e-06
, O 0 9.669175824456033e-07
whereas O 0 3.2469579309690744e-06
the O 0 7.555669867542747e-07
remaining O 0 2.729300831560977e-06
F69V O 0 0.0012595148291438818
is O 0 1.4027511952008354e-06
limited O 0 2.3634331682842458e-06
to O 0 6.740415869899152e-07
a O 0 3.071274932153756e-06
single O 0 1.736794365569949e-05
allele O 0 0.0004139661032240838
. O 0 8.302901551360264e-05

The O 0 0.0002169300860259682
skewed O 0 0.002280354266986251
prevalence O 0 0.06071292236447334
of O 0 1.5593383068335243e-05
G301C O 0 0.0011141977738589048
in O 0 5.514964414032875e-06
only O 0 4.208496648061555e-06
Colombian O 0 0.00030398028320632875
patients O 1 0.938734769821167
and O 0 1.0437563105369918e-05
haplotype O 0 0.025049297139048576
analysis O 0 6.756099992344389e-06
by O 0 1.7819668300944613e-06
restriction O 0 9.13106578082079e-06
fragment O 0 1.614527718629688e-05
length O 0 6.787279744457919e-06
polymorphisms O 0 8.612465171609074e-05
in O 0 2.18332706936053e-06
the O 0 4.923048891214421e-06
GALNS O 0 0.04634179547429085
gene O 0 0.0005422842805273831
suggest O 0 2.747289909166284e-05
that O 0 2.9393920613074442e-06
G301C O 0 0.0005312951398082078
originated O 0 1.4271846339397598e-05
from O 0 2.214184405602282e-06
a O 0 9.289729860029183e-06
common O 0 0.00010930097778327763
ancestor O 0 0.0008757906034588814
. O 0 0.0001421930210199207

Investigation O 0 0.00030873107607476413
of O 0 6.451060471590608e-06
the O 0 6.536932687595254e-06
genetic O 0 0.00015218400221783668
background O 0 1.0891147212532815e-05
by O 0 1.468470486543083e-06
means O 0 2.4506116460543126e-06
of O 0 1.016675696519087e-06
mtDNA O 0 5.1231501856818795e-05
lineages O 0 8.252399129560217e-05
indicate O 0 8.495218025927898e-06
that O 0 7.042155516501225e-07
all O 0 8.56938981996791e-07
our O 0 2.0436020349734463e-05
patients O 1 0.6775951981544495
are O 0 1.7920626760314917e-06
probably O 0 5.635612524201861e-06
of O 0 2.596619196992833e-06
native O 0 3.657237539300695e-05
American O 0 9.063837205758318e-05
descent O 0 0.0008003050461411476

Low O 0 0.0007897000177763402
frequency O 0 0.00025327684124931693
of O 0 7.92264545452781e-05
BRCA1 O 1 0.9828867316246033
germline O 1 0.9769631624221802
mutations O 0 0.17412088811397552
in O 0 6.938692240510136e-05
45 O 0 0.0009188718977384269
German O 0 0.3172857463359833
breast B-Disease 1 0.9995525479316711
/ I-Disease 1 0.9987988471984863
ovarian I-Disease 1 0.9998171925544739
cancer I-Disease 1 0.9996705055236816
families O 0 0.24581469595432281
. O 0 0.0010155061027035117

In O 0 5.850868546986021e-05
this O 0 1.6336118278559297e-05
study O 0 6.0490019677672535e-05
we O 0 1.1976389032497536e-05
investigated O 0 0.0014029599260538816
45 O 0 0.00032155090593732893
German O 0 0.13524767756462097
breast B-Disease 1 0.999660849571228
/ I-Disease 1 0.9990541338920593
ovarian I-Disease 1 0.9999107122421265
cancer I-Disease 1 0.9997991919517517
families O 0 0.06003868579864502
for O 0 0.0004317152197472751
germline O 1 0.990167498588562
mutations O 0 0.159281387925148
in O 0 3.033580469491426e-05
the O 0 5.9187819715589285e-05
BRCA1 O 1 0.9866712689399719
gene O 0 0.04129859805107117
. O 0 0.0002367690613027662

We O 0 0.00010860126349143684
identified O 0 0.00018749201262835413
four O 0 7.285350875463337e-05
germline O 1 0.9043384194374084
mutations O 0 0.21994325518608093
in O 0 0.0001130115197156556
three O 0 0.004845437593758106
breast B-Disease 1 0.9997190833091736
cancer I-Disease 1 0.9997183680534363
families O 0 0.002090469468384981
and O 0 2.2824840925750323e-05
in O 0 7.793588883941993e-05
one O 0 0.0064284647814929485
breast B-Disease 1 0.9998558759689331
- I-Disease 1 0.999480664730072
ovarian I-Disease 1 0.999954104423523
cancer I-Disease 1 0.9999241828918457
family O 0 0.003375457366928458
. O 0 3.622898475441616e-06
among O 0 3.5240275337855564e-06
these O 0 6.869584012747509e-07
were O 0 5.355128109840734e-07
one O 0 2.2820204321760684e-06
frameshift O 0 0.12126002460718155
mutation O 0 0.0008651590324006975
, O 0 1.3202535456002806e-06
one O 0 1.3735930224356707e-06
nonsense O 0 0.00012160611368017271
mutation O 0 0.00017626042244955897
, O 0 9.893000196825597e-07
one O 0 1.1344129688950488e-06
novel O 0 2.3165508537204005e-05
splice O 0 0.0006233844324015081
site O 0 3.7043882912257686e-05
mutation O 0 0.0002815982443280518
, O 0 2.7651992695609806e-06
and O 0 4.224597432767041e-06
one O 0 1.357056407869095e-05
missense O 0 0.00982352253049612
mutation O 0 0.005997003521770239
. O 0 0.00018862956494558603

The O 0 0.00023871552548371255
missense O 0 0.054791923612356186
mutation O 0 0.003975242376327515
was O 0 1.096327105187811e-05
also O 0 4.734712092613336e-06
found O 0 6.958154244784964e-06
in O 0 6.578107331733918e-06
2 O 0 5.078922913526185e-05
. O 0 6.32762530585751e-05

8 O 0 5.351806612452492e-05
% O 0 5.819292255182518e-06
of O 0 1.1578093790376442e-06
the O 0 1.6513351965841139e-06
general O 0 2.9930704386060825e-06
population O 0 1.930951839312911e-06
, O 0 1.2641538660318474e-06
suggesting O 0 1.544247970741708e-05
that O 0 7.791423968228628e-07
it O 0 9.308337780566944e-07
is O 0 5.4708466450392734e-06
not O 0 3.6866029404336587e-05
disease O 1 0.9980579018592834
associated O 0 0.0013680335832759738
. O 0 0.0001124034242820926

The O 0 9.510434028925374e-05
average O 0 0.0003566065279301256
age O 0 0.0006598739419132471
of O 0 0.00033464431180618703
disease O 1 0.9996509552001953
onset O 1 0.9981951117515564
in O 0 0.00015812470519449562
those O 0 0.00013979928917251527
families O 0 0.004121098667383194
harbouring O 1 0.973745584487915
causative O 1 0.8963836431503296
mutations O 0 0.08213257789611816
was O 0 1.8968223230331205e-05
between O 0 4.074217940797098e-05
32 O 0 0.00024014343216549605
. O 0 0.00016416511789429933

3 O 0 0.0005570268258452415
and O 0 0.0001423788780812174
37 O 0 0.0007877526804804802
. O 0 0.00030446608434431255

4 O 0 0.0001484014355810359
years O 0 4.97528089908883e-05
, O 0 6.884136382723227e-06
whereas O 0 2.2681349946651608e-05
the O 0 4.137627456657356e-06
family O 0 5.64739057153929e-05
harbouring O 0 0.07243557274341583
the O 0 1.1071648259530775e-05
missense O 0 0.031668614596128464
mutation O 0 0.0010467655956745148
had O 0 3.424182523303898e-06
an O 0 1.5948410236887867e-06
average O 0 1.6900061382330023e-05
age O 0 1.8010654457611963e-05
of O 0 4.671583155868575e-06
onset O 1 0.8887869119644165
of O 0 2.3819016860215925e-05
51 O 0 0.001198976649902761
. O 0 0.00020711385877802968

2 O 0 0.0011121808784082532
years O 0 0.0008532473002560437
. O 0 0.0006023449241183698

These O 0 7.695455133216456e-05
findings O 0 0.0002526738680899143
show O 0 2.4291481167892925e-05
that O 0 9.173800208372995e-06
BRCA1 O 1 0.5036565065383911
is O 0 7.764826477796305e-06
implicated O 0 0.002020997926592827
in O 0 2.0544487142615253e-06
a O 0 2.712454943321063e-06
small O 0 8.990585229184944e-06
fraction O 0 0.0002821346861310303
of O 0 0.0009197823819704354
breast B-Disease 1 0.9998390674591064
/ I-Disease 1 0.9996323585510254
ovarian I-Disease 1 0.9999525547027588
cancer I-Disease 1 0.9999088048934937
families O 0 0.026911504566669464
suggesting O 0 0.000700764823704958
the O 0 5.173790668777656e-06
involvement O 0 0.0003277211217209697
of O 0 4.85738064526231e-06
another O 0 0.00020965388102922589
susceptibility O 1 0.9549698829650879
gene O 0 0.11602495610713959
( O 0 0.0005212860996834934
s O 0 0.024403385818004608
) O 0 0.0004638158134184778

Paternal O 1 0.7076678276062012
transmission O 1 0.6071930527687073
of O 0 0.05329602211713791
congenital B-Disease 1 0.9986205101013184
myotonic I-Disease 1 0.9981004595756531
dystrophy I-Disease 1 0.9985600113868713
. O 0 0.09485873579978943

We O 0 9.788840543478727e-05
report O 0 5.8210163842886686e-05
a O 0 2.3971742848516442e-05
rare O 0 0.0012295299675315619
case O 0 0.0003302440163679421
of O 0 0.0001840669137891382
paternally O 1 0.994520366191864
transmitted O 1 0.9963579773902893
congenital B-Disease 1 0.9996978044509888
myotonic I-Disease 1 0.9995893836021423
dystrophy I-Disease 1 0.9996405839920044
( O 1 0.9163225889205933
DM B-Disease 1 0.9970651268959045
) O 0 0.0028047733940184116
. O 0 0.0006746671278961003

The O 0 9.7453455964569e-05
proband O 0 0.0018363703275099397
is O 0 1.0564041076577269e-05
a O 0 9.665408470027614e-06
23 O 0 4.501315925153904e-05
year O 0 4.923067899653688e-05
old O 0 0.0016018501482903957
, O 0 0.001419245614670217
mentally B-Disease 1 0.9989066123962402
retarded I-Disease 1 0.9987548589706421
male O 1 0.8919052481651306
who O 1 0.5824460387229919
suffers O 1 0.9992842078208923
severe O 1 0.9993091821670532
muscular B-Disease 1 0.9990754127502441
weakness I-Disease 1 0.9943140745162964
. O 0 0.005796173121780157

He O 0 0.00026149381301365793
presented O 0 0.0004110482695978135
with O 0 0.0011221375316381454
respiratory O 1 0.9993355870246887
and O 0 0.00032225149334408343
feeding O 0 0.1248963475227356
difficulties O 0 0.1742422729730606
at O 0 0.000271368509856984
birth O 0 0.006419110111892223
. O 0 0.00019345319014973938

His O 0 0.0008007910219021142
two O 0 0.0005552885122597218
sibs O 1 0.9892790913581848
suffer O 1 0.9942213296890259
from O 0 0.006081962957978249
childhood O 1 0.9931240677833557
onset O 1 0.9967300891876221
DM B-Disease 1 0.996346652507782
. O 0 0.011204720474779606

Their O 0 6.319983367575333e-05
late O 0 7.433061546180397e-05
father O 0 4.9258007493335754e-05
had O 0 5.49777178093791e-06
the O 0 2.5480724161752732e-06
adult O 0 0.000181773750227876
type O 0 0.00027979130391031504
of O 0 8.436368261754978e-06
DM B-Disease 1 0.9982925057411194
, O 0 1.4404728062800132e-05
with O 0 2.6943900593323633e-05
onset O 1 0.9144888520240784
around O 0 1.209976471727714e-05
30 O 0 4.24352110712789e-05
years O 0 0.00011219129373785108
. O 0 0.00011845224798889831

Only O 0 3.1092185963643715e-05
six O 0 2.0152860088273883e-05
other O 0 8.67569906404242e-06
cases O 0 0.00010611746256472543
of O 0 7.284365892701317e-06
paternal O 0 0.027635429054498672
transmission O 0 0.06566135585308075
of O 0 0.0022184946574270725
congenital B-Disease 1 0.9997805953025818
DM I-Disease 1 0.999438464641571
have O 0 0.0004684901505243033
been O 0 8.935929508879781e-05
reported O 0 0.001350860926322639
recently O 0 0.0010712419170886278
. O 0 0.00014097150415182114

We O 0 7.739177090115845e-05
review O 0 6.470656808232889e-05
the O 0 1.0348657269787509e-05
sex O 0 0.0004817544249817729
related O 0 0.001950315316207707
effects O 0 0.02581367827951908
on O 0 3.4585766115924343e-05
transmission O 0 0.02500351518392563
of O 0 0.0010238406248390675
congenital B-Disease 1 0.9991117119789124
DM I-Disease 1 0.9975993037223816
. O 0 0.007080765441060066

Decreased O 0 0.12686139345169067
fertility O 0 0.32601675391197205
of O 0 2.6884737962973304e-05
males O 0 0.004092693328857422
with O 0 0.00022858381271362305
adult O 1 0.5319904685020447
onset O 1 0.9988724589347839
DM B-Disease 1 0.9989681243896484
and O 0 5.204439366934821e-05
contraction O 0 0.0032588124740868807
of O 0 1.9148455976392142e-06
the O 0 3.7560607779596467e-06
repeat O 0 0.0006208111881278455
upon O 0 1.5043186976981815e-05
male O 0 8.11566278571263e-05
transmission O 0 0.00017718959134072065
contribute O 0 8.096214878605679e-05
to O 0 1.3974743069411488e-06
the O 0 1.1270952882114216e-06
almost O 0 5.0811486289603636e-06
absent O 0 0.00021406523592304438
occurrence O 0 0.0003576621529646218
of O 0 9.015156138048042e-06
paternal O 0 0.023401521146297455
transmission O 0 0.04002012312412262
of O 0 0.0009517608559690416
congenital B-Disease 1 0.999195396900177
DM I-Disease 1 0.9974654912948608
. O 0 0.006423895247280598

Also O 0 3.1934905564412475e-05
the O 0 7.3696396611921955e-06
fathers O 0 4.053461452713236e-05
of O 0 1.8554346752353013e-06
the O 0 8.663461812830064e-06
reported O 0 0.0029186264146119356
congenitally O 1 0.9834432005882263
affected O 0 0.046078965067863464
children O 0 0.00026726486976258457
showed O 0 1.9170591258443892e-05
, O 0 1.3366982329898747e-06
on O 0 1.771839947650733e-06
average O 0 1.080669153452618e-05
, O 0 5.493966909853043e-06
shorter O 0 0.00039088938501663506
CTG O 0 0.15427270531654358
repeat O 0 0.0012388238683342934
lengths O 0 0.0001863414072431624
and O 0 1.6977699488052167e-05
hence O 0 0.0005451632896438241
less O 0 0.005867329891771078
severe O 1 0.9993243217468262
clinical O 1 0.9993990659713745
symptoms O 1 0.9995124340057373
than O 0 9.146756929112598e-05
the O 0 3.681441376102157e-05
mothers O 0 0.1082073524594307
of O 0 2.6019959477707744e-05
children O 0 0.08647538721561432
with O 0 0.027265699580311775
congenital B-Disease 1 0.9995558857917786
DM I-Disease 1 0.9982463121414185
. O 0 0.010293284431099892

We O 0 0.00018109024676959962
conclude O 0 0.00043034180998802185
that O 0 2.6242320018354803e-05
paternal O 0 0.006440091412514448
transmission O 0 0.018477560952305794
of O 0 0.0007733171223662794
congenital B-Disease 1 0.9997864365577698
DM I-Disease 1 0.999447762966156
is O 0 0.000325571745634079
rare O 0 0.008960995823144913
and O 0 2.8120704882894643e-05
preferentially O 0 0.010159214958548546
occurs O 0 0.00033839838579297066
with O 0 3.1944713555276394e-05
onset O 1 0.9667928218841553
of O 0 2.950178532046266e-05
DM B-Disease 1 0.99817955493927
past O 0 5.184605470276438e-05
30 O 0 8.444893865089398e-06
years O 0 4.305463335185777e-06
in O 0 1.7350723737763474e-06
the O 0 4.4330681703286245e-06
father O 0 6.286396092036739e-05
. O 0 1.925153446791228e-05
. O 0 7.685620948905125e-05

The O 0 0.0010210969485342503
RB1 O 1 0.9584726095199585
gene O 0 0.012851472944021225
mutation O 0 0.005722579546272755
in O 0 3.438345811446197e-05
a O 0 6.648382259299979e-05
child O 0 0.021849580109119415
with O 0 0.0017252726247534156
ectopic B-Disease 1 0.9950725436210632
intracranial I-Disease 1 0.9972530007362366
retinoblastoma I-Disease 1 0.9941469430923462
. O 0 0.003318407107144594

The O 0 0.0009681879892013967
RB1 O 1 0.97138512134552
gene O 0 0.04290839284658432
mutation O 0 0.011606181971728802
was O 0 2.4119326553773135e-05
investigated O 0 0.00030900342972017825
in O 0 6.311365723377094e-06
a O 0 2.5066741727641784e-05
child O 0 0.011892307549715042
with O 0 0.000762955576647073
ectopic B-Disease 1 0.9980284571647644
intracranial I-Disease 1 0.9991782307624817
retinoblastoma I-Disease 1 0.9966476559638977
using O 0 4.3300453398842365e-05
DNA O 0 0.00010450848640175536
obtained O 0 5.672970019077184e-06
from O 0 2.1613836906908546e-06
both O 0 2.7399410100770183e-06
the O 0 9.455045983486343e-06
pineal B-Disease 1 0.9447962641716003
and I-Disease 0 0.00022922329662833363
retinal I-Disease 1 0.9990098476409912
tumours I-Disease 1 0.9981532692909241
of O 0 2.1217478206381202e-05
the O 0 0.0001596093934495002
patient O 1 0.9659073948860168
. O 0 0.00027748889988288283

A O 0 0.0002854112535715103
nonsense O 0 0.0008793648448772728
mutation O 0 0.00076191226253286
in O 0 1.6459784092148766e-05
exon O 0 0.00031461307662539184
17 O 0 2.7378215236240067e-05
( O 0 9.996231710829306e-06
codon O 0 5.3195879445411265e-05
556 O 0 0.00030939668067730963
) O 0 4.752876066049794e-06
of O 0 1.240100345967221e-06
the O 0 7.2741049734759144e-06
RB1 O 1 0.9045560956001282
gene O 0 0.00030366715509444475
was O 0 1.8305179310118547e-06
found O 0 1.0148652336283703e-06
to O 0 3.4534147630438383e-07
be O 0 3.400980688184063e-07
present O 0 1.0970956054734415e-06
homozygously O 0 0.00028084349469281733
in O 0 8.471718615510326e-07
both O 0 1.671595782681834e-06
the O 0 5.613893335976172e-06
retinal B-Disease 1 0.9807265400886536
and I-Disease 0 3.0155732019920833e-05
the I-Disease 0 0.00010115230543306097
pineal I-Disease 1 0.9887819886207581
tumours I-Disease 1 0.996212363243103
. O 0 0.0007387122022919357

The O 0 4.3510979594429955e-05
same O 0 2.3041113308863714e-05
mutation O 0 0.0004272119840607047
was O 0 3.6957135307602584e-06
present O 0 3.5262662549939705e-06
heterozygously O 0 0.00046605971874669194
in O 0 1.2544501259981189e-06
the O 0 6.925040452188114e-07
DNA O 0 5.372681243898114e-06
from O 0 5.026495273341425e-07
the O 0 6.006868602526083e-07
constitutional O 0 2.9846275992895244e-06
cells O 0 4.3669770093401894e-05
of O 0 4.185383772892237e-07
the O 0 3.0393869110412197e-06
patient O 0 0.23480819165706635
, O 0 2.0680399757111445e-06
proving O 0 4.954136602464132e-05
it O 0 4.3155907292202755e-07
to O 0 4.62433547454566e-07
be O 0 5.209042797105212e-07
of O 0 2.6841439648706e-06
germline O 0 0.06848299503326416
origin O 0 5.718164538848214e-05
. O 0 8.920197433326393e-05

The O 0 7.573254697490484e-05
initial O 0 0.00019431131659075618
mutation O 0 0.0009867300977930427
was O 0 6.2815643104841e-06
shown O 0 6.46188527753111e-06
to O 0 1.124953996622935e-06
have O 0 1.1515786582094734e-06
occurred O 0 5.69447774978471e-06
in O 0 1.6695804561095429e-06
the O 0 7.376960184046766e-06
paternally O 0 0.006342743523418903
derived O 0 0.0004067343834321946
RB1 O 1 0.9348679184913635
allele O 0 0.008084436878561974
. O 0 0.0002641338505782187

The O 0 7.163865666370839e-05
mutation O 0 0.000533684273250401
is O 0 3.6600356452254346e-06
in O 0 8.888536058293539e-07
an O 0 4.2596056459842657e-07
area O 0 8.073015465015487e-07
of O 0 1.7685837860881293e-07
the O 0 5.124979338688718e-07
gene O 0 7.925700629130006e-06
that O 0 2.72249508270761e-07
encodes O 0 2.349006990698399e-06
the O 0 4.4807308086092235e-07
protein O 0 4.339132829045411e-06
- O 0 4.362889740150422e-05
binding O 0 6.6806005634134635e-06
region O 0 1.3127108104526997e-05
known O 0 3.2369900964113185e-06
as O 0 7.659708671781118e-07
the O 0 1.0297524113411782e-06
pocket O 0 0.0002323529333807528
region O 0 1.4832101442152634e-05
and O 0 1.1568215541046811e-06
has O 0 1.7542780597068486e-06
been O 0 1.2935919357914827e-06
detected O 0 4.2338760977145284e-05
in O 0 8.177889299076924e-07
other O 0 1.4294987522589508e-06
cases O 0 0.00010693374497350305
of O 0 1.1332191206747666e-05
retinoblastoma B-Disease 1 0.9892661571502686
. O 0 8.26552786747925e-05
. O 0 0.00012249889550730586

Low O 0 0.0007562203099951148
levels O 0 0.00017031012976076454
of O 0 1.2228017112647649e-05
beta O 0 0.0005475218640640378
hexosaminidase O 0 0.004136691801249981
A O 0 2.500208756828215e-05
in O 0 1.624117612664122e-05
healthy O 0 0.04421473667025566
individuals O 0 0.00016729230992496014
with O 0 0.00010992948227794841
apparent O 0 0.43255987763404846
deficiency O 1 0.9990460276603699
of O 0 1.5363804777734913e-05
this O 0 2.998390482389368e-05
enzyme O 0 0.004784313030540943
. O 0 0.00011203767644474283

Appreciable O 0 0.007330550346523523
beta O 0 0.003203748492524028
hexosaminidase O 0 0.004752668552100658
A O 0 4.949915091856383e-05
( O 0 2.507164390408434e-05
hex O 0 9.000034333439544e-05
A O 0 1.0851792467292398e-05
) O 0 4.968900157109601e-06
activity O 0 6.527762707264628e-06
has O 0 2.5351630483783083e-06
been O 0 3.070232196478173e-06
detected O 0 0.00035812222631648183
in O 0 1.812342270568479e-05
cultured O 1 0.5293977856636047
skin O 1 0.9991965889930725
fibroblasts O 1 0.9946737289428711
and O 0 0.03463004156947136
melanoma B-Disease 1 0.9998133778572083
tissue O 1 0.9905495047569275
from O 0 0.00026229931972920895
healthy O 1 0.5676677227020264
individuals O 0 0.0004085551481693983
previously O 0 0.00011970788182225078
reported O 0 0.0004886441165581346
as O 0 9.228925591742154e-06
having O 0 0.00029297315631993115
deficiency B-Disease 1 0.9974931478500366
of I-Disease 0 2.513755362087977e-06
hex I-Disease 0 0.000213064398849383
A I-Disease 0 1.3539990504796151e-05
activity O 0 1.9729797713807784e-05
indistinguishable O 0 0.00016739589045755565
from O 0 1.921443981700577e-06
that O 0 2.279651653225301e-06
of O 0 2.2482277927338146e-05
patients O 1 0.9981628060340881
with O 0 0.03157868608832359
Tay B-Disease 1 0.9994544386863708
- I-Disease 1 0.9967402815818787
Sachs I-Disease 1 0.99847811460495
disease I-Disease 1 0.9993027448654175
( O 0 0.02341894805431366
TSD B-Disease 1 0.9891250133514404
) O 0 0.00037580059142783284
. O 0 0.00017097788804676384

Identification O 0 0.0002480987459421158
and O 0 2.101517929986585e-05
quantitation O 0 0.0008419969817623496
of O 0 8.513855391356628e-06
hex O 0 0.00016883231000974774
A O 0 1.3678302821062971e-05
, O 0 7.26979851606302e-06
amounting O 0 7.463512156391516e-05
to O 0 1.0482772268005647e-05
3 O 0 5.688707824447192e-05
. O 0 7.180252578109503e-05

5 O 0 0.00033764238469302654
% O 0 0.00011823219392681494
- O 0 0.001191448885947466
6 O 0 0.00043681359966285527
. O 0 0.0002006738359341398

9 O 0 7.064748933771625e-05
% O 0 8.020571840461344e-06
of O 0 1.6803529661046923e-06
total O 0 4.5629926717083436e-06
beta O 0 0.0002328339614905417
hexosaminidase O 0 0.0030366366263478994
activity O 0 1.069094014383154e-05
, O 0 1.4258798728405964e-06
has O 0 9.252261179426569e-07
been O 0 7.232396797007823e-07
obtained O 0 1.387263068863831e-06
by O 0 1.774948486854555e-06
cellulose O 0 0.0005510541959665716
acetate O 0 0.0036201970651745796
gel O 0 0.22003915905952454
electrophoresis O 0 0.005514064803719521
, O 0 1.6394864360336214e-05
DEAE O 0 0.0067170243710279465
- O 0 0.0004249941557645798
cellulose O 0 0.0007818245212547481
ion O 0 0.00047692618682049215
- O 0 0.0004984261468052864
exchange O 0 3.60890626325272e-05
chromatography O 0 0.0038827164098620415
, O 0 2.7544727345230058e-05
radial O 0 0.1423494964838028
immunodiffusion O 0 0.017637241631746292
, O 0 1.7725562429404818e-05
and O 0 2.0664805560954846e-05
radioimmunoassay O 0 0.008237098343670368
. O 0 0.0001369695964967832

Previous O 0 0.0005103365401737392
family O 0 0.000499161658808589
studies O 0 0.000210395417525433
suggested O 0 3.701532114064321e-05
that O 0 1.7819871800384135e-06
these O 0 2.3848156160966028e-06
individuals O 0 1.234795490745455e-05
may O 0 5.873133432032773e-06
be O 0 1.2579218946484616e-06
compound O 0 8.17503678263165e-05
heterozygotes O 0 0.0048478334210813046
for O 0 1.6579657540205517e-06
the O 0 3.6683102280221647e-06
common O 0 0.00029670860385522246
mutant O 0 0.20819495618343353
TSD B-Disease 1 0.9918528199195862
gene O 0 0.002694817492738366
and O 0 7.684683623665478e-06
a O 0 2.2287336832960136e-05
rare O 0 0.0032798214815557003
( O 0 0.00010644612484611571
allelic O 0 0.17114582657814026
) O 0 0.00010545791883487254
mutant O 0 0.009797883220016956
gene O 0 0.003741522552445531
. O 0 0.00021492174710147083

Thus O 0 0.00011150520003866404
, O 0 1.3232876881374978e-05
the O 0 7.620845735800685e-06
postulated O 0 0.00039932120125740767
rate O 0 3.261649180785753e-05
mutant O 0 0.0010974721517413855
gene O 0 0.0002502590068615973
appears O 0 9.68606946116779e-06
to O 0 5.587473310697533e-07
code O 0 8.077189477262436e-07
for O 0 2.679678345884895e-07
the O 0 2.708882504975918e-07
expression O 0 1.5612774859619094e-06
of O 0 4.025735620416526e-07
low O 0 8.175181392289232e-06
amounts O 0 5.692023478331976e-06
of O 0 2.9029847610217985e-06
hex O 0 0.0002267891395604238
A O 0 7.925306272227317e-05
. O 0 0.00010749829380074516

Heterozygotes O 0 0.46712353825569153
for O 0 4.937322955811396e-05
the O 0 2.787410994642414e-05
rare O 0 0.0021739357616752386
mutant O 0 0.006711980327963829
may O 0 2.4416851374553517e-05
be O 0 2.2715396426065126e-06
indistinguishable O 0 0.0001588353916304186
from O 0 6.695959655189654e-06
heterozygotes O 0 0.007211852818727493
for O 0 6.034317721059779e-06
the O 0 1.6058118490036577e-05
common O 0 0.0008512994390912354
TSD B-Disease 1 0.9838559627532959
mutant O 0 0.06261847168207169
. O 0 0.0004374957352411002

However O 0 8.66433692863211e-05
, O 0 1.514368432253832e-05
direct O 0 1.9190347302355804e-05
visualization O 0 0.00026341635384596884
and O 0 4.476989943213994e-06
quantitation O 0 0.00041940429946407676
of O 0 1.5721186628070427e-06
hex O 0 3.2174288207897916e-05
A O 0 2.8730876238114433e-06
by O 0 1.3765933317699819e-06
the O 0 1.654964421504701e-06
methods O 0 1.9396673451410607e-05
described O 0 0.00024455346283502877
may O 0 7.259843550855294e-05
prevent O 0 0.0011935299262404442
false O 0 0.0005880746757611632
- O 0 0.2863190770149231
positive O 0 0.0718282163143158
prenatal O 1 0.9980105757713318
diagnosis O 1 0.9988595247268677
of O 0 0.00012535543646663427
TSD B-Disease 1 0.9969038367271423
in O 0 8.277170127257705e-05
fetuses O 0 0.19593723118305206
having O 0 2.0904899429297075e-05
the O 0 3.290110498710419e-06
incomplete O 0 0.00012159022298874334
hex B-Disease 0 0.0012189894914627075
A I-Disease 0 0.00020129300537519157
deficiency I-Disease 1 0.9958558678627014
of O 0 1.3402519698502147e-06
the O 0 2.452800345054129e-06
type O 0 0.00013291412324178964
described O 0 2.7512274755281396e-05
in O 0 2.139501702913549e-06
the O 0 3.3273379358433885e-06
four O 0 2.9067301511531696e-05
healthy O 0 0.09047369658946991
individuals O 0 0.002897348254919052

The O 0 0.001900901086628437
tumor B-Disease 1 0.9877418279647827
suppressor O 1 0.9568829536437988
gene O 0 0.3913019895553589
Smad4 O 1 0.8431897163391113
/ O 0 0.27918869256973267
Dpc4 O 0 0.011607450433075428
is O 0 6.34400021226611e-06
required O 0 8.50664855533978e-06
for O 0 4.4906651055498514e-06
gastrulation O 0 0.15107999742031097
and O 0 3.0630731089331675e-06
later O 0 2.8307383672654396e-06
for O 0 3.4322315514145885e-06
anterior O 0 0.12945443391799927
development O 0 1.4879333321005106e-05
of O 0 1.7860704701888608e-06
the O 0 8.365187568415422e-06
mouse O 0 0.00721970247104764
embryo O 0 0.005471513606607914
. O 0 0.0001124581103795208

Mutations O 0 0.04447110742330551
in O 0 7.566533895442262e-05
the O 0 0.00010954973549814895
SMAD4 O 1 0.8830816149711609
/ O 1 0.8854842782020569
DPC4 O 1 0.9816758036613464
tumor B-Disease 1 0.9968344569206238
suppressor O 1 0.6379808783531189
gene O 0 0.0006607896066270769
, O 0 2.462282964188489e-06
a O 0 1.9579549643822247e-06
key O 0 6.245605163712753e-06
signal O 0 1.2295688065933064e-05
transducer O 0 0.00023923504340928048
in O 0 2.5489621293672826e-06
most O 0 6.052478966012131e-06
TGFbeta O 0 0.02266191504895687
- O 0 0.002834442537277937
related O 0 0.00045130951912142336
pathways O 0 0.0009669348364695907
, O 0 1.4946440387575421e-06
are O 0 5.522578021555091e-07
involved O 0 2.4171604309231043e-06
in O 0 1.0537733032833785e-06
50 O 0 4.5660226533073e-06
% O 0 6.222673619049601e-06
of O 0 3.9061451388988644e-05
pancreatic B-Disease 1 0.998264729976654
cancers I-Disease 1 0.9977304339408875
. O 0 0.001133223413489759

Homozygous O 1 0.6419994831085205
Smad4 O 1 0.88337641954422
mutant O 1 0.5402498245239258
mice O 1 0.7903451323509216
die O 0 0.12530137598514557
before O 0 5.796797631774098e-05
day O 0 4.104918843950145e-05
7 O 0 9.528861846774817e-05
. O 0 9.662324009696022e-05

5 O 0 0.0005705652292817831
of O 0 0.00023261339811142534
embryogenesis O 0 0.035711050033569336
. O 0 0.0007291773217730224

Mutant O 0 0.012656169012188911
embryos O 0 0.0005715368315577507
have O 0 1.4387745068233926e-05
reduced O 0 4.231704951962456e-05
size O 0 1.2993564268981572e-05
, O 0 4.834043465962168e-06
fail O 0 0.00015577753947582096
to O 0 2.7819212391477777e-06
gastrulate O 0 0.0008098508114926517
or O 0 4.737769813800696e-06
express O 0 2.7796653739642352e-05
a O 0 1.2174527000752278e-05
mesodermal O 0 0.07532791793346405
marker O 0 0.0004907485563308001
, O 0 7.0923597377259284e-06
and O 0 1.1378692761354614e-05
show O 0 9.376225352752954e-05
abnormal O 0 0.3529147803783417
visceral O 1 0.6589604616165161
endoderm O 1 0.9590429663658142
development O 0 0.0033302686642855406
. O 0 0.0002845561830326915

Growth B-Disease 0 0.2974435091018677
retardation I-Disease 1 0.9925482869148254
of O 0 2.1989320885040797e-05
the O 0 3.960749018006027e-05
Smad4 O 0 0.4399374723434448
- O 0 0.09183533489704132
deficient O 1 0.8323897123336792
embryos O 0 0.0002654101699590683
results O 0 1.458025144529529e-05
from O 0 3.3053318020392908e-06
reduced O 0 7.063832890708e-05
cell O 0 0.00044904692913405597
proliferation O 0 0.0008860926609486341
rather O 0 7.78691810410237e-06
than O 0 1.06961524579674e-05
increased O 0 0.00015018942940514535
apoptosis O 0 0.00847169291228056
. O 0 0.00012012204388156533

Aggregation O 0 0.001942741102539003
of O 0 8.821513620205224e-05
mutant O 0 0.02066580392420292
Smad4 O 0 0.17416046559810638
ES O 0 0.040801387280225754
cells O 0 0.0013351113302633166
with O 0 2.327634319954086e-05
wild O 0 0.0002091423375532031
- O 0 0.0025431641843169928
type O 0 0.002133773872628808
tetraploid O 0 0.1448345184326172
morulae O 0 0.23307645320892334
rescues O 0 0.20827220380306244
the O 0 0.00021026005560997874
gastrulation B-Disease 1 0.9693670868873596
defect I-Disease 1 0.919141948223114
. O 0 0.0007299998542293906

These O 0 5.331146530807018e-05
results O 0 4.832711783819832e-05
indicate O 0 3.101844777120277e-05
that O 0 3.2191221635002876e-06
Smad4 O 0 0.0008804866229183972
is O 0 1.2149484973633662e-06
initially O 0 1.7103538993978873e-06
required O 0 6.039322215656284e-07
for O 0 2.5315435436823464e-07
the O 0 2.9266328738231095e-07
differentiation O 0 6.346680947899586e-06
of O 0 4.85725593080133e-07
the O 0 2.4013754682528088e-06
visceral O 0 0.011014594696462154
endoderm O 0 0.1273106038570404
and O 0 3.0115700155874947e-06
that O 0 1.7493579207439325e-06
the O 0 5.084231361252023e-06
gastrulation B-Disease 1 0.8532736301422119
defect I-Disease 0 0.13486520946025848
in O 0 5.566010258917231e-06
the O 0 6.771142125217011e-06
epiblast O 1 0.7506226897239685
is O 0 8.170894034265075e-06
secondary O 0 7.574200571980327e-05
and O 0 4.861551587964641e-06
non O 0 6.375735392794013e-05
- O 0 0.001131276716478169
cell O 0 0.0006737046642228961
autonomous O 0 0.00039775704499334097
. O 0 0.00016222652629949152

Rescued O 0 0.17787009477615356
embryos O 0 0.028891004621982574
show O 0 0.0038569713942706585
severe O 1 0.9941480159759521
anterior O 1 0.9843616485595703
truncations O 0 0.32688772678375244
, O 0 1.9243749193265103e-05
indicating O 0 4.456404712982476e-05
a O 0 3.046531446670997e-06
second O 0 2.408613909210544e-06
important O 0 2.863999725377653e-06
role O 0 1.2831046660721768e-05
for O 0 9.29687394091161e-06
Smad4 O 0 0.021002719178795815
in O 0 3.96811738028191e-05
anterior O 1 0.8988714218139648
patterning O 1 0.7804123163223267
during O 0 0.0012642942601814866
embryogenesis O 0 0.3323019742965698
. O 0 0.0004185531579423696

Prevalence O 1 0.786456823348999
of O 0 0.00017808389384299517
p16 O 0 0.41157394647598267
and O 0 0.0003359175752848387
CDK4 O 1 0.7748661637306213
germline O 1 0.9851672053337097
mutations O 1 0.5918731093406677
in O 0 0.00027307940763421357
48 O 0 0.026682941243052483
melanoma B-Disease 1 0.9995521903038025
- O 1 0.6690007448196411
prone O 1 0.8451837301254272
families O 0 0.0010109608992934227
in O 0 8.221255120588467e-05
France O 0 0.000845079543069005
. O 0 0.0002816911437548697

The O 0 0.0012732476461678743
French O 0 0.06096101179718971
Familial B-Disease 1 0.9967117309570312
Melanoma I-Disease 1 0.9990608096122742
Study O 0 0.2540459930896759
Group O 0 0.002224163617938757
. O 0 0.0003604135708883405

Germline O 1 0.9591714143753052
mutations O 0 0.04777684435248375
in O 0 3.6102079320698977e-05
the O 0 1.7498987290309742e-05
p16 O 0 0.06623606383800507
and O 0 2.1153879060875624e-05
CDK4 O 0 0.025499334558844566
genes O 0 0.00012487643107306212
have O 0 1.9086376141785877e-06
been O 0 1.4268210861700936e-06
reported O 0 4.9958794079429936e-06
in O 0 6.371827794282581e-07
a O 0 2.5379424641869264e-06
subset O 0 0.00010398124140920117
of O 0 1.7096484953071922e-05
melanoma B-Disease 1 0.9996040463447571
pedigrees O 0 0.12510956823825836
, O 0 8.536814675608184e-06
but O 0 2.7276666969555663e-06
their O 0 4.266987161827274e-06
prevalence O 0 0.23529654741287231
is O 0 3.1681991004006704e-06
not O 0 2.4409182515228167e-06
well O 0 6.44998408461106e-06
known O 0 3.9684011426288635e-05
. O 0 4.982877362635918e-05

We O 0 5.025137579650618e-05
searched O 0 0.0001057602494256571
for O 0 9.784602298168465e-06
such O 0 2.479113572917413e-05
germline O 1 0.8102675676345825
mutations O 0 0.01794416271150112
in O 0 1.1962690223299433e-05
48 O 0 0.0002490997430868447
French O 0 0.0057853893376886845
melanoma B-Disease 1 0.9996970891952515
- O 1 0.5708973407745361
prone O 1 0.716346263885498
families O 0 7.234983058879152e-05
selected O 0 4.516649823926855e-06
according O 0 1.1823984777947771e-06
to O 0 3.4905491475001327e-07
two O 0 4.812691258848645e-07
major O 0 3.83816131943604e-06
criteria O 0 6.660955477855168e-06
families O 0 2.4993291845021304e-06
with O 0 4.4269833665566694e-07
at O 0 9.233610285264149e-07
least O 0 1.2174259609309956e-06
three O 0 1.1117451776954113e-06
affected O 0 4.958820863976143e-05
members O 0 1.604940166544111e-06
( O 0 3.552886028046487e-06
n O 0 1.498145138612017e-05
= O 0 2.9681914384127595e-05
20 O 0 1.6811127352411859e-06
) O 0 9.572671615387662e-07
or O 0 6.987692700022308e-07
families O 0 1.5857157222853857e-06
with O 0 4.1510159576318983e-07
two O 0 5.702841008314863e-07
affected O 0 3.69507833966054e-05
members O 0 4.0916597754403483e-07
, O 0 1.3932491071955155e-07
one O 0 1.3335413484583114e-07
of O 0 9.621859931030485e-08
them O 0 3.3614827543715364e-07
affected O 0 1.2241259355505463e-05
before O 0 4.224212375447678e-07
the O 0 2.1931509763817303e-07
age O 0 7.791870189066685e-07
of O 0 2.406891326245386e-07
50 O 0 2.356622417210019e-06
( O 0 4.283250746084377e-06
n O 0 1.879901537904516e-05
= O 0 5.165314723853953e-05
28 O 0 3.7981401419528993e-06
) O 0 6.659340101577982e-07
, O 0 3.872745821809076e-07
and O 0 3.8839152693981305e-07
one O 0 1.1746320751626627e-06
additional O 0 1.2687612070294563e-05
minor O 0 0.0008772416622377932
criterion O 0 0.0005492783966474235
. O 0 8.784158853814006e-05

Sixteen O 0 0.0008984074229374528
different O 0 0.00017410865984857082
p16 O 1 0.5084477663040161
germline O 1 0.9569697380065918
mutations O 0 0.02833055518567562
were O 0 2.60002639151935e-06
found O 0 3.867363830067916e-06
in O 0 2.0511010916379746e-06
21 O 0 7.899434422142804e-06
families O 0 1.2646285540540703e-05
, O 0 2.116827545250999e-06
while O 0 3.276461939094588e-06
one O 0 8.585344403400086e-06
germline O 0 0.44067344069480896
mutation O 0 0.0056432513520121574
, O 0 1.0791418389999308e-05
Arg24His O 0 0.003471909323707223
, O 0 2.644327651069034e-06
was O 0 1.6440126273664646e-06
detected O 0 6.201618816703558e-05
in O 0 2.94099049824581e-06
the O 0 9.894246431940701e-06
CDK4 O 0 0.06927531212568283
gene O 0 0.004697992466390133
. O 0 0.00011699183232849464

The O 0 3.9458500395994633e-05
frequency O 0 4.629436807590537e-05
of O 0 1.2691968549916055e-05
p16 O 0 0.022923920303583145
gene O 0 0.0005579959833994508
mutation O 0 0.00012364593567326665
in O 0 1.4238795529308845e-06
our O 0 1.6724264924050658e-06
sample O 0 2.5428873868804658e-06
( O 0 1.751685090312094e-06
44 O 0 1.5302620113288867e-06
% O 0 7.279923011083156e-07
) O 0 6.688586609016056e-07
is O 0 2.749767986642837e-07
among O 0 4.411709255691676e-07
the O 0 4.283395469428797e-07
highest O 0 6.014073278493015e-06
rates O 0 8.481083568767644e-06
yet O 0 3.20512913276616e-06
reported O 0 8.14257964520948e-06
and O 0 7.221685791591881e-07
the O 0 1.5771223615956842e-06
CDK4 O 0 0.011189168319106102
mutation O 0 0.00011824585089925677
is O 0 6.718845497744041e-07
the O 0 6.30612760232907e-07
second O 0 2.5885342438414227e-06
mutation O 0 0.0003635231696534902
detected O 0 0.00012312612670939416
in O 0 3.1140018563746708e-06
this O 0 5.422808953881031e-06
gene O 0 0.0008977276738733053
worldwide O 0 0.0005228020600043237
. O 0 0.00012495493865571916

In O 0 6.771385960746557e-05
summary O 0 8.02499198471196e-05
, O 0 6.7503810896596406e-06
our O 0 6.3782872530282475e-06
results O 0 7.449275017279433e-06
show O 0 5.603928002528846e-06
frequent O 0 7.210690091596916e-05
involvement O 0 7.092411397024989e-05
of O 0 2.041626430582255e-06
the O 0 1.5924208128126338e-05
p16 O 1 0.6908277869224548
gene O 0 0.05554298684000969
in O 0 0.0004434935690369457
familial B-Disease 1 0.9991623163223267
melanoma I-Disease 1 0.9997482895851135
and O 0 2.656005381140858e-05
confirm O 0 2.7836889785248786e-05
the O 0 6.678585577901686e-07
role O 0 2.6279390112904366e-06
of O 0 6.191060606397514e-07
the O 0 3.236931434003054e-06
CDK4 O 0 0.1736113727092743
gene O 0 0.002201823052018881
as O 0 1.607825470273383e-05
a O 0 0.0007041320786811411
melanoma B-Disease 1 0.999500036239624
- O 1 0.582875669002533
predisposing O 1 0.918236255645752
gene O 0 0.018497494980692863
. O 0 5.3899897466180846e-05
. O 0 0.00014647624630015343

Progression O 0 0.19058482348918915
of O 0 0.00012713077012449503
somatic O 0 0.045688558369874954
CTG O 0 0.3482530117034912
repeat O 0 0.002281583845615387
length O 0 0.0001344298798358068
heterogeneity O 0 0.004107246641069651
in O 0 2.1611553165712394e-05
the O 0 4.529987199930474e-05
blood O 1 0.7216478586196899
cells O 1 0.5854018926620483
of O 0 0.007518404629081488
myotonic B-Disease 1 0.9994865655899048
dystrophy I-Disease 1 0.9997944235801697
patients O 1 0.9990874528884888
. O 0 0.011551743373274803

The O 0 0.00017013063188642263
genetic O 0 0.0020437196362763643
basis O 0 0.00012497375428210944
of O 0 0.0008188429055735469
myotonic B-Disease 1 0.9993932247161865
dystrophy I-Disease 1 0.9997870326042175
( O 0 0.2783559262752533
DM B-Disease 1 0.9987180233001709
) O 0 2.1291196389938705e-05
is O 0 1.5987654933269368e-06
the O 0 8.30755197966937e-07
expansion O 0 7.396734417852713e-06
of O 0 1.0136841410712805e-06
an O 0 6.031476004864089e-06
unstable O 0 0.09919176250696182
CTG O 0 0.07901310920715332
repeat O 0 0.00013780278095509857
in O 0 1.5451141734956764e-06
the O 0 1.6803720654934295e-06
34 O 0 1.0140796803170815e-05
UTR O 0 0.00022534970776177943
of O 0 1.5315468999688164e-06
the O 0 9.6122039394686e-06
DM B-Disease 1 0.9954267740249634
protein O 0 0.00046630590804852545
kinase O 0 0.015962332487106323
gene O 0 0.00039783588727004826
on O 0 1.4267082406149711e-05
chromosome O 0 0.0010966615518555045
19 O 0 0.0001437260361853987
. O 0 8.361420623259619e-05

One O 0 2.2695845473208465e-05
of O 0 4.763053766509984e-06
the O 0 3.419548647798365e-06
principal O 0 1.2111459909647238e-05
features O 0 5.124391009303508e-06
of O 0 2.005338501476217e-06
the O 0 1.968101605598349e-05
DM B-Disease 1 0.9981753826141357
mutation O 0 0.007794552017003298
is O 0 4.547032858681632e-06
an O 0 2.2983529106568312e-06
extraordinarily O 0 0.0016851229593157768
high O 0 2.5545994503772818e-05
level O 0 1.0240312803944107e-05
of O 0 3.654057991298032e-06
somatic O 0 0.08585755527019501
mosaicism O 1 0.871971845626831
, O 0 5.14791236128076e-06
due O 0 8.870093552104663e-06
to O 0 1.061145212588599e-06
an O 0 1.6738848671593587e-06
extremely O 0 9.726517600938678e-05
high O 0 1.398098720528651e-05
degree O 0 1.2972059266758151e-05
of O 0 1.1715991377059254e-06
somatic O 0 0.00580207584425807
instability O 0 0.0008411573362536728
both O 0 1.5028526831883937e-06
within O 0 1.3240033922556904e-06
and O 0 1.0577947477941052e-06
between O 0 3.2093901154439664e-06
different O 0 1.3833308003086131e-05
tissues O 0 0.01504097506403923
. O 0 0.00012167814566055313

This O 0 9.694590698927641e-05
instability O 0 0.0023435044568032026
appears O 0 6.449138891184703e-05
to O 0 2.2093477127782535e-06
be O 0 8.867555720826203e-07
biased O 0 7.018239557510242e-06
towards O 0 1.4237111827242188e-06
further O 0 1.4128851262285025e-06
expansion O 0 6.229287919268245e-06
and O 0 6.31635373338213e-07
continuous O 0 4.723427991848439e-06
throughout O 0 1.0326939445803873e-06
the O 0 3.342201182476856e-07
life O 0 1.5207386923066224e-06
of O 0 2.2498413443372556e-07
an O 0 3.1752060181133857e-07
individual O 0 1.6655505987728247e-06
, O 0 4.604822549936216e-07
features O 0 1.092372485800297e-06
that O 0 2.0277994394746202e-07
could O 0 3.625949887009483e-07
be O 0 1.8698466419664328e-07
associated O 0 1.3288939726407989e-06
with O 0 4.286525552288367e-07
the O 0 1.0561859653535066e-06
progressive O 0 0.00039901334093883634
nature O 0 0.00011963712313445285
of O 0 8.767055078351405e-06
the O 0 0.00019169104052707553
disease O 1 0.9981443881988525
. O 0 0.0003993684076704085

Although O 0 0.0001696003309916705
increasing O 0 0.00011487759911688045
measured O 0 9.659275383455679e-05
allele O 0 0.0006861239671707153
size O 0 5.063785647507757e-05
between O 0 5.716419764212333e-05
patients O 1 0.9589337706565857
clearly O 0 5.36524603376165e-05
correlates O 0 0.0005578149575740099
with O 0 3.515441449053469e-06
an O 0 4.877405899605947e-06
increased O 0 0.0004090976435691118
severity O 1 0.9801343083381653
of O 0 4.835652362089604e-05
symptoms O 1 0.9992753863334656
and O 0 8.481149052386172e-06
an O 0 3.718896323334775e-06
earlier O 0 2.2547164917341433e-05
age O 0 2.0036535715917125e-05
of O 0 2.587768904049881e-06
onset O 1 0.9407422542572021
, O 0 1.8282097471455927e-06
this O 0 4.505016306666221e-07
correlation O 0 1.260860517504625e-05
is O 0 5.171355610400497e-07
not O 0 3.6303234196566336e-07
precise O 0 2.7211242468183627e-06
and O 0 8.045990398386493e-07
measured O 0 7.647601705684792e-06
allele O 0 3.8148918974911794e-05
length O 0 4.242406248522457e-06
cannot O 0 1.9494252683216473e-06
be O 0 2.019381355466976e-07
used O 0 2.411582897821063e-07
as O 0 3.1372650255434564e-07
an O 0 7.733734150860982e-07
accurate O 0 7.8594193837489e-06
predictor O 0 0.0004816776781808585
of O 0 1.3574697277363157e-06
age O 0 4.512391387834214e-05
of O 0 2.0055787899764255e-05
onset O 1 0.98777836561203
. O 0 0.00031802040757611394

In O 0 4.424472354003228e-05
order O 0 1.2599229194165673e-05
to O 0 5.01325257573626e-06
further O 0 8.6137197286007e-06
characterize O 0 0.0004581748798955232
the O 0 8.480242286168505e-06
dynamics O 0 0.0018584418576210737
of O 0 6.703769759042189e-05
DM B-Disease 1 0.9984325766563416
CTG O 1 0.9829816222190857
repeat O 0 0.1290595978498459
somatic O 0 0.1825537532567978
instability O 0 0.008997567929327488
, O 0 3.992277470388217e-06
we O 0 1.4390709566214355e-06
have O 0 1.1047706038880278e-06
studied O 0 4.905665718979435e-06
repeat O 0 3.6227407690603286e-05
length O 0 3.5538553220249014e-06
changes O 0 3.577488996597822e-06
over O 0 2.5880874545691768e-06
time O 0 4.714620899903821e-06
in O 0 4.940135113429278e-05
111 O 1 0.8463913798332214
myotonic B-Disease 1 0.9997579455375671
dystrophy I-Disease 1 0.9999109506607056
patients O 1 0.9994361996650696
with O 0 0.001957808854058385
varying O 0 0.3002271354198456
clinical O 1 0.9989005327224731
severity O 1 0.9967350363731384
and O 0 8.35746614029631e-05
CTG O 0 0.3435719609260559
repeat O 0 0.00023027212591841817
size O 0 4.626113877748139e-06
over O 0 1.3206300764068146e-06
time O 0 9.453642633161508e-07
intervals O 0 2.6475222512090113e-06
of O 0 6.174250870571996e-07
1 O 0 5.698938366549555e-06
- O 0 7.416897278744727e-05
7 O 0 1.4236286006052978e-05
years O 0 3.350623956066556e-05
. O 0 4.3789292249130085e-05

We O 0 2.9930713935755193e-05
have O 0 5.369372047425713e-06
found O 0 2.4556813968956703e-06
a O 0 1.580754201313539e-06
direct O 0 3.0881039947416866e-06
progression O 0 0.0008564211311750114
of O 0 5.412240398072754e-07
the O 0 7.541402737842873e-07
size O 0 5.883302492293296e-06
heterogeneity O 0 0.000199413625523448
over O 0 2.377671307840501e-06
time O 0 2.2023448309482774e-06
related O 0 3.715685670613311e-05
to O 0 2.331305267944117e-06
initial O 0 5.1881859690183774e-05
CTG O 0 0.04456973448395729
repeat O 0 0.0001528802386019379
size O 0 4.153057034272933e-06
and O 0 5.884278948542487e-07
the O 0 4.957323653798085e-07
time O 0 9.737599384607165e-07
interval O 0 5.297765710565727e-06
and O 0 1.064439175024745e-06
always O 0 3.603278628361295e-06
biased O 0 1.6263124052784406e-05
towards O 0 7.784853551129345e-06
further O 0 1.7960997865884565e-05
expansion O 0 0.00020607556507457048
. O 0 8.740325574763119e-05

Attempts O 0 0.0002425166021566838
to O 0 1.9705938029801473e-05
mathematically O 0 8.189229993149638e-05
model O 0 1.5053317838464864e-05
the O 0 2.244326196887414e-06
dynamics O 0 0.00016788035281933844
have O 0 2.009412128245458e-06
proved O 0 1.070558118954068e-05
only O 0 1.0987479299728875e-06
partially O 0 5.076937304693274e-05
successful O 0 1.4715639736095909e-05
suggesting O 0 3.4564534871606156e-05
that O 0 7.66058576573414e-07
individual O 0 3.700785327964695e-06
specific O 0 1.5790541510796174e-05
genetic O 0 0.0023175538517534733
and O 0 1.900318602565676e-05
/ O 0 0.06211581826210022
or O 0 9.187283467326779e-06
environmental O 0 0.00021197908790782094
factors O 0 1.1932792403968051e-05
also O 0 7.979875249475299e-07
play O 0 6.014296900502814e-07
a O 0 2.000364474952221e-06
role O 0 1.0027626558439806e-05
in O 0 1.0004930118157063e-05
somatic O 0 0.05556141212582588
mosaicism O 1 0.8944230675697327
. O 0 4.679655467043631e-05
. O 0 9.740003588376567e-05

Aspartylglucosaminuria B-Disease 0 0.4798809885978699
among O 0 0.0010754404356703162
Palestinian O 0 0.0027756483759731054
Arabs O 0 0.002514568855985999
. O 0 0.0006150560802780092

Aspartylglucosaminuria B-Disease 1 0.9566063284873962
( O 0 0.009508234448730946
AGU B-Disease 1 0.987858772277832
) O 0 9.160477202385664e-05
is O 0 1.584572237334214e-05
a O 0 5.77856189920567e-05
rare O 0 0.09527504444122314
disorder B-Disease 1 0.9981330037117004
of I-Disease 0 5.9572423197096214e-05
glycoprotein I-Disease 1 0.9495325088500977
metabolism I-Disease 1 0.700101912021637
caused O 0 0.04049646854400635
by O 0 1.6652309568598866e-05
the O 0 3.269315857323818e-05
deficiency B-Disease 1 0.9983131885528564
of I-Disease 0 7.2854077188821975e-06
the I-Disease 0 4.013405123259872e-05
lysosomal I-Disease 1 0.9879065752029419
enzyme I-Disease 0 0.11608824133872986
aspartylglucosaminidase I-Disease 1 0.5197415351867676
( O 0 0.0004394431016407907
AGA O 0 0.08804728090763092
) O 0 7.083969103405252e-05
. O 0 8.682077168487012e-05

AGU B-Disease 1 0.984740674495697
is O 0 0.0012325422139838338
inherited O 1 0.5708737373352051
as O 0 0.0001229972840519622
an O 0 0.0008174700196832418
autosomal O 1 0.9983524084091187
recessive O 1 0.998640239238739
trait O 1 0.6364524960517883
and O 0 3.074995765928179e-05
occurs O 0 0.00010953427408821881
with O 0 2.1224996089586057e-06
a O 0 3.2516527426196262e-06
high O 0 8.823269126878586e-06
frequency O 0 3.293573172413744e-06
in O 0 7.222284921226674e-07
Finland O 0 7.184055448306026e-06
because O 0 2.4055289031821303e-06
of O 0 1.2075337281203247e-06
a O 0 1.363605224469211e-05
founder O 0 0.0008203588076867163
effect O 0 0.000277210958302021
. O 0 0.0001065301985363476

While O 0 0.0002532582439016551
very O 0 0.00023922476975712925
few O 0 0.00044925935799255967
patients O 1 0.9925636649131775
with O 0 0.00037046390934847295
AGU B-Disease 1 0.996528685092926
have O 0 9.262968887924217e-06
been O 0 3.73326270164398e-06
reported O 0 2.515877531550359e-05
from O 0 1.5497540744036087e-06
non O 0 2.3801441784598865e-05
- O 0 0.0002991932851728052
Finnish O 0 0.00014251797983888537
origin O 0 1.5641386198694818e-05
, O 0 1.2872325896751136e-05
we O 0 8.292313577840105e-05
diagnosed O 1 0.9994333386421204
the O 0 0.0001190357215818949
disorder O 1 0.9989407658576965
in O 0 4.5349665015237406e-05
8 O 0 0.0003099068417213857
patients O 1 0.9909175038337708
originating O 0 9.719396621221676e-05
from O 0 5.830385362060042e-06
3 O 0 1.5962874385877512e-05
unrelated O 0 0.0007631061016581953
families O 0 1.5830361007829197e-05
, O 0 7.210619514808059e-07
all O 0 3.800669787779043e-07
Palestinian O 0 1.0023190043284558e-05
Arabs O 0 6.856552772660507e-06
from O 0 9.015431032821652e-07
the O 0 1.3116895161147113e-06
region O 0 1.4064150491321925e-05
of O 0 5.409668119682465e-06
Jerusalem O 0 0.00019669323228299618
. O 0 8.457013609586284e-05

The O 0 0.002552418503910303
clinical O 1 0.9940084218978882
diagnosis O 1 0.9980064034461975
of O 0 0.0005764924571849406
AGU B-Disease 1 0.9973551034927368
is O 0 3.069756712648086e-05
often O 0 1.5725936464150436e-05
difficult O 0 2.59652515524067e-05
, O 0 1.551691298118385e-06
in O 0 5.573891144194931e-07
particular O 0 1.3636902167490916e-06
early O 0 9.504537388238532e-07
in O 0 3.699475712437561e-07
the O 0 4.5806930870639917e-07
course O 0 1.3039581972407177e-05
of O 0 7.068874765536748e-07
the O 0 1.3650479559146333e-05
disease O 1 0.997883141040802
, O 0 2.319639861525502e-06
and O 0 7.68980555676535e-07
most O 0 1.1476078043415328e-06
of O 0 1.053355276781076e-06
the O 0 3.642080264398828e-05
patients O 1 0.9984806180000305
are O 0 0.00013000106264371425
diagnosed O 1 0.9993935823440552
after O 0 1.4796272807870992e-05
the O 0 1.6064194596765446e-06
age O 0 7.364679731836077e-06
of O 0 2.2241310944082215e-06
5 O 0 2.7011150450562127e-05
years O 0 7.378253940260038e-05
. O 0 9.246025729225948e-05

However O 0 0.0001376520231133327
, O 0 2.3365902961813845e-05
since O 0 3.0274073651526123e-05
these O 0 1.6293612134177238e-05
patients O 1 0.9494457840919495
excrete O 0 0.03343932330608368
early O 0 9.63276943366509e-06
large O 0 4.488935246627079e-06
amounts O 0 6.440155630116351e-06
of O 0 1.7171265653814771e-06
aspartylglucosamine O 0 0.0027197275776416063
in O 0 4.275945229892386e-06
urine O 0 0.00022323921439237893
, O 0 4.430355147633236e-06
biochemical O 0 0.000613216427154839
screening O 0 0.00023629097267985344
is O 0 2.7057478746428387e-06
easy O 0 9.21360515349079e-06
by O 0 5.737515493819956e-06
urine O 0 0.0010479335905984044
chromatography O 0 0.010563838295638561
. O 0 4.657866156776436e-05
. O 0 0.00012073836842318997

Detection O 0 0.0029349513351917267
of O 0 6.232305167941377e-05
heterozygous O 0 0.0030393085908144712
carriers O 0 0.00047653180081397295
of O 0 1.748465911077801e-05
the O 0 0.00012073134712409228
ataxia B-Disease 1 0.99762362241745
- I-Disease 1 0.8332724571228027
telangiectasia I-Disease 1 0.9954453706741333
( O 0 0.00016703188885003328
ATM O 0 0.0007542870589531958
) O 0 2.763449629128445e-05
gene O 0 0.0004235331725794822
by O 0 2.3507089281338267e-05
G2 O 1 0.9288671016693115
phase O 0 0.007489936891943216
chromosomal O 0 0.4048747718334198
radiosensitivity O 0 0.10581795871257782
of O 0 8.210443775169551e-05
peripheral O 1 0.9854707717895508
blood O 1 0.9794026017189026
lymphocytes O 1 0.9892686009407043
. O 0 0.0009788741590455174

In O 0 0.007306660991162062
ataxia B-Disease 1 0.9957308173179626
- I-Disease 1 0.9777050018310547
telangiectasia I-Disease 1 0.996410071849823
( O 0 0.0029751115944236517
A B-Disease 0 0.007021882105618715
- I-Disease 1 0.8602996468544006
T I-Disease 1 0.9959762692451477
) O 0 0.0002628869260661304
patients O 1 0.9674638509750366
, O 0 7.535172244388377e-06
mutations O 0 0.0010889101540669799
in O 0 1.5815202232261072e-06
a O 0 2.522698878237861e-06
single O 0 4.131838977627922e-06
gene O 0 0.00015118085138965398
, O 0 2.468358161422657e-06
ATM O 0 7.535469922004268e-05
, O 0 2.3533075363957323e-06
result O 0 2.4618208044557832e-05
in O 0 2.4411170670646243e-05
an O 0 0.0021190845873206854
autosomal B-Disease 1 0.999687910079956
recessive I-Disease 1 0.9997606873512268
syndrome I-Disease 1 0.9999356269836426
that O 0 0.00010837223089765757
embraces O 0 0.00750882551074028
a O 0 1.3871513147023506e-05
variety O 0 4.3764910515164956e-05
of O 0 4.895598976872861e-06
clinical O 1 0.9048906564712524
features O 0 8.521670679328963e-05
and O 0 2.6794104996952228e-05
manifests O 0 0.13014768064022064
extreme O 0 0.003894574474543333
radiosensitivity O 0 0.029480895027518272
and O 0 4.11008204537211e-06
a O 0 6.281396508711623e-06
strong O 0 2.7186675652046688e-05
pre O 0 0.0012997799785807729
- O 0 0.009782461449503899
disposition O 0 0.013709076680243015
to O 0 0.00010869118705159053
malignancy B-Disease 1 0.9777160286903381
. O 0 0.0002829681325238198

Heterozygotes O 0 0.2072402834892273
for O 0 3.774164724745788e-05
the O 0 1.9772029190789908e-05
ATM O 0 0.0004668284673243761
gene O 0 0.0005167239578440785
have O 0 5.740323103964329e-06
no O 0 4.7342200559796765e-06
clinical O 0 0.07825758308172226
expression O 0 2.3855844119680114e-05
of O 0 2.499517677279073e-06
A B-Disease 0 0.0006591637502424419
- I-Disease 0 0.3767433762550354
T I-Disease 1 0.9779406785964966
but O 0 2.5927987735485658e-05
may O 0 0.00020268197113182396
be O 0 2.4984903575386852e-05
cancer B-Disease 1 0.9987149238586426
prone O 0 0.09045718610286713
with O 0 3.3123940283985576e-06
a O 0 5.343182692740811e-06
moderate O 0 0.00014956090308260173
increase O 0 1.82119201781461e-05
in O 0 4.918951617582934e-06
in O 0 1.4718334568897262e-05
vitro O 0 0.009933294728398323
radiosensitivity O 0 0.19333066046237946
. O 0 0.00023194545065052807

We O 0 7.690547499805689e-05
performed O 0 6.765918078599498e-05
a O 0 3.3391028409823775e-05
blind O 0 0.0093560004606843
chromosomal O 0 0.008629039861261845
analysis O 0 2.8755093808285892e-05
on O 0 1.2560468348965514e-05
G2 O 1 0.963090181350708
- O 0 0.012223321944475174
phase O 0 0.007258763536810875
lymphocytes O 1 0.7311435341835022
from O 0 7.853515853639692e-06
7 O 0 3.652344457805157e-05
unrelated O 0 0.0032744898926466703
A B-Disease 0 0.0016287612961605191
- I-Disease 1 0.8111583590507507
T I-Disease 1 0.9968670010566711
patients O 1 0.992141842842102
, O 0 1.1850856026285328e-05
13 O 0 8.095898374449462e-05
obligate O 0 0.04878981411457062
A B-Disease 0 0.0012238145573064685
- I-Disease 1 0.557803750038147
T I-Disease 1 0.994956910610199
heterozygotes O 1 0.7871565818786621
( O 0 4.0870014345273376e-05
parents O 0 1.158953455160372e-05
of O 0 6.095972366892966e-07
the O 0 5.0773796829162166e-06
patients O 1 0.8739717602729797
) O 0 1.4358740827447036e-06
, O 0 5.422407411970198e-07
and O 0 6.588325618395174e-07
14 O 0 2.640908178364043e-06
normal O 0 7.264170562848449e-06
controls O 0 8.821703886496834e-06
following O 0 1.1120027920696884e-05
X O 0 0.000468697864562273
- O 0 0.00016450828115921468
irradiation O 0 0.00037963944487273693
with O 0 3.1366357688966673e-06
1 O 0 1.0436667253088672e-05
Gy O 0 0.04323485493659973
in O 0 1.4963854937377619e-06
order O 0 1.0397141068096971e-06
to O 0 7.67673327572993e-07
evaluate O 0 3.1691593903815374e-05
this O 0 6.391266538230411e-07
cytogenetic O 0 0.0004057541664224118
method O 0 1.508720174570044e-06
as O 0 5.39340760496998e-07
a O 0 1.2151824648753973e-06
tool O 0 1.1270478353253566e-05
for O 0 3.3658020583970938e-06
detection O 0 0.0001651438360568136
of O 0 6.091019713494461e-06
ATM O 0 0.0012385159498080611
carriers O 0 0.002886710688471794
. O 0 0.00019929083646275103

Both O 0 0.0002457241644151509
A B-Disease 0 0.0012653326848521829
- I-Disease 0 0.372448593378067
T I-Disease 1 0.9894744157791138
homozygotes O 1 0.957854688167572
and O 0 8.587322372477502e-05
heterozygotes O 0 0.30659613013267517
showed O 0 0.00015662053192500025
significantly O 0 0.00041597645031288266
increased O 0 4.2911786295007914e-05
levels O 0 0.00012253534805495292
of O 0 1.643877840251662e-05
radiation O 1 0.9945628046989441
- O 1 0.7442744970321655
induced O 1 0.9936255216598511
chromatid O 1 0.9886865615844727
damage O 0 0.23166625201702118
relative O 0 2.9043720132904127e-05
to O 0 1.700663119663659e-06
that O 0 1.4625028370574e-06
of O 0 2.683386355784023e-06
normal O 0 7.280440331669524e-05
controls O 0 0.00015049864305183291
. O 0 0.00011265173088759184

These O 0 3.718560765264556e-05
results O 0 2.9410322895273566e-05
show O 0 1.121489822253352e-05
that O 0 3.068165824515745e-06
the O 0 7.736257430224214e-06
G2 O 1 0.6096463203430176
- O 0 0.002280436921864748
phase O 0 0.0012656652834266424
chromosomal O 0 0.0344795398414135
radiosensitivity O 0 0.0073901028372347355
assay O 0 5.798473284812644e-05
can O 0 1.5427820017066551e-06
be O 0 3.3588904102543893e-07
used O 0 2.9359810582718637e-07
for O 0 3.761657012546493e-07
the O 0 8.249091365541972e-07
detection O 0 7.94790466898121e-05
of O 0 3.0756009437027387e-06
A B-Disease 0 0.000253883219556883
- I-Disease 0 0.26241326332092285
T I-Disease 1 0.9818853735923767
heterozygotes O 1 0.6948052048683167
. O 0 0.00023853671154938638

In O 0 8.653767872601748e-05
combination O 0 0.0003980286419391632
with O 0 2.336438774364069e-05
molecular O 0 0.0012620192719623446
genetic O 0 0.0010489647975191474
analyses O 0 5.9159610827919096e-05
, O 0 1.4596769233321538e-06
this O 0 5.318178182278643e-07
test O 0 3.6244812235963764e-06
may O 0 8.632376307105005e-07
be O 0 1.0858294530180501e-07
of O 0 1.089750796268163e-07
value O 0 4.933290256303735e-07
in O 0 6.603573865504586e-07
studies O 0 1.1609335160756018e-05
of O 0 1.9535830233508023e-06
familial B-Disease 1 0.9435046315193176
and I-Disease 0 7.204793655546382e-05
sporadic I-Disease 0 0.12789013981819153
cancers I-Disease 1 0.9980348944664001
aimed O 0 0.0001781562459655106
at O 0 5.229587713984074e-06
determination O 0 1.630598671908956e-05
of O 0 4.957129817739769e-07
the O 0 1.0417617204439011e-06
potential O 0 2.9270446248119697e-05
involvement O 0 0.00013591356400866061
of O 0 4.451505446922965e-06
ATM O 0 0.02071812003850937
mutations O 0 0.46481752395629883
in O 0 0.000307729555061087
tumor B-Disease 1 0.9986592531204224
risk O 0 0.34776079654693604
or O 0 3.88110383937601e-05
development O 0 0.00022567546693608165
. O 0 2.2739735868526623e-05
. O 0 5.732020872528665e-05

Ataxia B-Disease 1 0.9961342811584473
- I-Disease 1 0.9663755893707275
telangiectasia I-Disease 1 0.9949960708618164
: O 0 0.00016967052943073213
identification O 0 3.661746814032085e-05
and O 0 6.845302777946927e-06
detection O 0 0.00019168536528013647
of O 0 2.5722385998960817e-06
founder O 0 0.0005582926096394658
- O 0 0.0008789058192633092
effect O 0 8.32674340927042e-05
mutations O 0 0.0004165389109402895
in O 0 1.619795398255519e-06
the O 0 2.153745981559041e-06
ATM O 0 0.0003488735237624496
gene O 0 0.0003089624806307256
in O 0 6.696177024423378e-06
ethnic O 0 5.8257362979929894e-05
populations O 0 0.0009493681718595326
. O 0 9.919661533785984e-05

To O 0 4.072478259331547e-05
facilitate O 0 6.931523967068642e-05
the O 0 7.562687642348465e-06
evaluation O 0 7.651193300262094e-05
of O 0 5.049912488175323e-06
ATM O 0 0.0017194694373756647
heterozygotes O 0 0.3349125385284424
for O 0 5.113491351949051e-05
susceptibility O 1 0.8417162299156189
to O 0 2.9124352295184508e-05
other O 0 0.00012201241042930633
diseases O 1 0.9994562268257141
, O 0 3.953017221647315e-05
such O 0 5.181832239031792e-05
as O 0 0.0016648091841489077
breast B-Disease 1 0.9997712969779968
cancer I-Disease 1 0.9995192289352417
, O 0 1.0327282325306442e-05
we O 0 1.0106630270456662e-06
have O 0 6.367964147102612e-07
attempted O 0 2.1825255771545926e-06
to O 0 3.8243720723585284e-07
define O 0 4.961011654813774e-06
the O 0 3.1891963203634077e-07
most O 0 1.0384238748883945e-06
common O 0 8.191758752218448e-06
mutations O 0 0.00026202938170172274
and O 0 7.417675647047872e-07
their O 0 1.4846018530079164e-06
frequencies O 0 1.7483907868154347e-05
in O 0 4.033572258776985e-05
ataxia B-Disease 1 0.998332679271698
- I-Disease 1 0.8381754159927368
telangiectasia I-Disease 1 0.9971135854721069
( O 0 0.00035270731314085424
A B-Disease 0 0.0006943709449842572
- I-Disease 0 0.14394670724868774
T I-Disease 1 0.8665742874145508
) O 0 4.262554648448713e-05
homozygotes O 0 0.05318048596382141
from O 0 8.454555427306332e-06
10 O 0 1.850259468483273e-05
ethnic O 0 7.409912359435111e-05
populations O 0 0.0006767347804270685
. O 0 0.0001543256948934868

Both O 0 0.00016173890617210418
genomic O 0 0.0015143550699576735
mutations O 0 0.002168382052332163
and O 0 5.699943812942365e-06
their O 0 5.0026687858917285e-06
effects O 0 0.0005011568428017199
on O 0 8.070604962995276e-06
cDNA O 0 0.000175877328729257
were O 0 2.237614171463065e-05
characterized O 0 0.010968697257339954
. O 0 0.00022739649284631014

Protein O 0 0.000497027940582484
- O 0 0.00041848659748211503
truncation O 0 0.0002849531010724604
testing O 0 4.234357038512826e-05
of O 0 1.7633154811846907e-06
the O 0 2.254103264931473e-06
entire O 0 1.5885820175753906e-05
ATM O 0 9.178980690194294e-05
cDNA O 0 0.00011662360338959843
detected O 0 0.00013699286500923336
92 O 0 5.8195066230837256e-05
( O 0 8.180656550393905e-06
66 O 0 1.978696855076123e-05
% O 0 4.957488272339106e-06
) O 0 1.0532265150686726e-05
truncating O 0 0.009714649058878422
mutations O 0 0.001961406785994768
in O 0 1.052160223480314e-05
140 O 0 0.0003138605097774416
mutant O 0 0.01285033579915762
alleles O 0 0.013255949132144451
screened O 0 0.002463157055899501
. O 0 0.0001818992750486359

The O 0 0.00012405382585711777
haplotyping O 0 0.013738250359892845
of O 0 2.785611832223367e-05
patients O 1 0.9460627436637878
with O 0 1.53423552546883e-05
identical O 0 0.0002660805475898087
mutations O 0 0.019942959770560265
indicates O 0 2.9203058147686534e-05
that O 0 4.4639688212555484e-07
almost O 0 4.290124309136445e-07
all O 0 1.0401927141856504e-07
of O 0 1.4390418812126882e-07
these O 0 3.7557634868790046e-07
represent O 0 1.7913587271323195e-06
common O 0 1.3491218851413578e-05
ancestry O 0 1.1019611520168837e-05
and O 0 9.91613319456519e-07
that O 0 1.252852939614968e-06
very O 0 6.024979484209325e-06
few O 0 1.778475780156441e-05
spontaneously O 0 0.0030607092194259167
recurring O 0 0.05503113195300102
ATM O 0 0.004385487642139196
mutations O 0 0.03413717821240425
exist O 0 0.00037839903961867094
. O 0 0.00019779133435804397

Assays O 0 0.0016737553523853421
requiring O 0 0.0003489048103801906
minimal O 0 0.00011957121023442596
amounts O 0 1.7911530449055135e-05
of O 0 2.6865204745263327e-06
genomic O 0 0.00010949896386591718
DNA O 0 2.1427815227070823e-05
were O 0 9.389748925059394e-07
designed O 0 6.284751634666463e-06
to O 0 1.1912482023035409e-06
allow O 0 5.875856459169881e-06
rapid O 0 0.0003617568872869015
screening O 0 0.0002078945835819468
for O 0 4.840668225369882e-06
common O 0 8.553543739253655e-05
ethnic O 0 0.00016713638615328819
mutations O 0 0.0394422747194767
. O 0 0.0001969086442841217

These O 0 0.00010628130257828161
rapid O 0 0.0025266774464398623
assays O 0 0.0011687874794006348
detected O 0 0.0033876383677124977
mutations O 0 0.0024124966003000736
in O 0 4.873053967457963e-06
76 O 0 5.580983270192519e-05
% O 0 2.493239890100085e-06
of O 0 1.8929791849586763e-06
Costa O 0 0.00046716901124455035
Rican O 0 0.0005514125805348158
patients O 1 0.9717165231704712
( O 0 9.132232662523165e-06
3 O 0 3.2071227451524464e-06
) O 0 8.835848461785645e-07
, O 0 3.912593626864691e-07
50 O 0 5.96429629240447e-07
% O 0 3.433648885220464e-07
of O 0 5.160935643289122e-07
Norwegian O 0 4.698772318079136e-05
patients O 1 0.7804929614067078
( O 0 3.0596745546063175e-06
1 O 0 1.1932913821510738e-06
) O 0 4.7377244527524454e-07
, O 0 2.902550875205634e-07
25 O 0 4.902991008748359e-07
% O 0 4.471399108751939e-07
of O 0 5.481733751366846e-07
Polish O 0 0.0006561295012943447
patients O 1 0.9386311173439026
( O 0 6.496412879641866e-06
4 O 0 2.234979547210969e-06
) O 0 7.68133986639441e-07
, O 0 3.0066547651586006e-07
and O 0 2.8553114361784537e-07
14 O 0 8.575832453061594e-07
% O 0 3.711526233018958e-07
of O 0 4.3215547407271515e-07
Italian O 0 0.0003018633578903973
patients O 1 0.9698217511177063
( O 0 7.85466909292154e-06
1 O 0 2.0293405214033555e-06
) O 0 8.85029464825493e-07
, O 0 3.870966054364544e-07
as O 0 3.0612048362854694e-07
well O 0 7.812555509190133e-07
as O 0 8.249642178270733e-07
in O 0 4.516856733971508e-06
patients O 1 0.5783601403236389
of O 0 6.643686447205255e-06
Amish O 0 0.03918088600039482
/ O 0 0.14782461524009705
Mennonite O 0 0.0036636528093367815
and O 0 1.5142066331463866e-05
Irish O 0 9.421046706847847e-05
English O 0 7.35637586330995e-05
backgrounds O 0 0.0012384015135467052
. O 0 0.00017060301615856588

Additional O 0 0.000345513311913237
mutations O 0 0.0025397781282663345
were O 0 4.952502877131337e-06
observed O 0 1.4276309229899198e-05
in O 0 1.998488414756139e-06
Japanese O 0 7.389824531855993e-06
, O 0 2.854592139556189e-06
Utah O 0 3.240752266719937e-05
Mormon O 0 1.8942193491966464e-05
, O 0 2.586806658655405e-06
and O 0 4.210190581943607e-06
African O 0 6.923629553057253e-05
American O 0 0.00018731046293396503
patients O 1 0.9725663065910339
. O 0 0.000201034068595618

These O 0 8.542677824152634e-05
assays O 0 0.00021817816013935953
should O 0 2.3264314222615212e-05
facilitate O 0 7.927890692371875e-05
screening O 0 0.00023715768475085497
for O 0 8.84956170921214e-06
A B-Disease 0 0.0002998675627168268
- I-Disease 0 0.1760883629322052
T I-Disease 1 0.9738218784332275
heterozygotes O 0 0.15146060287952423
in O 0 8.336470273206942e-06
the O 0 7.0088763095554896e-06
populations O 0 0.000291370612103492
studied O 0 8.382919622818008e-05
. O 0 1.9245182556915097e-05
. O 0 6.365662557072937e-05

The O 0 0.0020840493962168694
von B-Disease 1 0.9307951331138611
Hippel I-Disease 1 0.9891754984855652
- I-Disease 1 0.9742791652679443
Lindau I-Disease 1 0.9959826469421387
tumor I-Disease 1 0.9973061084747314
suppressor O 1 0.8938964009284973
gene O 0 0.004633164964616299
is O 0 1.2433057236194145e-05
required O 0 1.1101273230451625e-05
for O 0 6.007469437463442e-06
cell O 0 0.00018146861111745238
cycle O 0 0.00016479179612360895
exit O 0 0.00027409198810346425
upon O 0 9.456545376451686e-05
serum O 0 0.05304462090134621
withdrawal O 0 0.0017268905648961663
. O 0 0.00019153811444994062

The O 0 0.00014603570161852986
inactivation O 0 0.003070975188165903
of O 0 2.6396028260933235e-05
the O 0 9.017730917548761e-05
von B-Disease 1 0.689895749092102
Hippel I-Disease 1 0.995161235332489
- I-Disease 1 0.8943614959716797
Lindau I-Disease 1 0.9951871037483215
( I-Disease 0 0.022633079439401627
VHL I-Disease 1 0.9961118102073669
) I-Disease 0 0.014377402141690254
tumor I-Disease 1 0.9983184337615967
suppressor O 1 0.9934436082839966
gene O 1 0.8624559640884399
predisposes O 1 0.9965813755989075
affected O 0 0.1273319125175476
individuals O 0 0.00022964569507166743
to O 0 1.7080235920730047e-05
the O 0 0.00018847460160031915
human O 1 0.9065143465995789
VHL B-Disease 1 0.9996669292449951
cancer I-Disease 1 0.9999289512634277
syndrome I-Disease 1 0.9999150037765503
and O 0 0.0002187616191804409
is O 0 3.6687652027467266e-05
associated O 0 0.00033414282370358706
with O 0 0.00022146219271235168
sporadic B-Disease 1 0.9388576745986938
renal I-Disease 1 0.9997888207435608
cell I-Disease 1 0.9948268532752991
carcinomas I-Disease 1 0.999322772026062
( O 0 0.08629053831100464
RCC B-Disease 1 0.9945900440216064
) O 0 0.0002105469029629603
and O 0 0.00016052898718044162
brain B-Disease 1 0.9827172160148621
hemangioblastomas I-Disease 1 0.5105951428413391
. O 0 0.00035136123187839985

VHL O 1 0.9542331099510193
- O 0 0.03454107418656349
negative O 0 0.00442965654656291
786 O 1 0.541408121585846
- O 0 0.029091428965330124
0 O 0 0.0022185491397976875
RCC B-Disease 1 0.9681807160377502
cells O 0 0.0033423034474253654
are O 0 7.986628588696476e-06
tumorigenic O 0 0.009779884479939938
in O 0 1.9148390492773615e-05
nude O 0 0.011753103695809841
mice O 0 0.01253517810255289
which O 0 2.653631781868171e-06
is O 0 2.3830650661693653e-06
suppressed O 0 4.868616088060662e-05
by O 0 2.8747158467012923e-06
the O 0 6.948870122869266e-06
reintroduction O 0 0.0023796670138835907
of O 0 3.695557461469434e-05
VHL B-Disease 1 0.9801102876663208
. O 0 0.0003860413271468133

Remarkably O 0 0.0069890329614281654
, O 0 2.113867230946198e-05
this O 0 3.724258704096428e-06
occurs O 0 3.210973591194488e-05
without O 0 5.176643298909767e-06
affecting O 0 0.00023771502310410142
the O 0 1.6608809119134094e-06
growth O 0 1.5091838577063754e-05
rate O 0 2.3489353679906344e-06
and O 0 1.063704530679388e-06
cell O 0 5.598146890406497e-05
cycle O 0 4.465623715077527e-05
profile O 0 5.4117292165756226e-05
of O 0 9.186514375869592e-07
these O 0 2.21111827158893e-06
cells O 0 0.0001905771641759202
in O 0 7.84797430242179e-06
culture O 0 0.0001314389955950901
. O 0 9.569601388648152e-05

The O 0 0.00014211251982487738
786 O 0 0.0446888692677021
- O 0 0.0008924382273107767
0 O 0 6.584235961781815e-05
cell O 0 0.00016277318354696035
line O 0 1.0165876119572204e-05
, O 0 2.9496586648747325e-06
like O 0 1.6330852304236032e-05
many O 0 4.68784746772144e-05
cancer B-Disease 1 0.9988126754760742
cells O 0 0.006303874310106039
, O 0 5.10654490426532e-06
fails O 0 8.747546235099435e-05
to O 0 8.623144367447821e-07
exit O 0 1.0649230716808233e-05
the O 0 2.4857397420419147e-06
cell O 0 0.00010441424819873646
cycle O 0 0.00011085540609201416
upon O 0 4.4898177293362096e-05
serum O 0 0.01999794691801071
withdrawal O 0 0.0020677123684436083
. O 0 0.00021039882267359644

Here O 0 5.1629162044264376e-05
, O 0 6.598967956961133e-06
it O 0 1.574552470628987e-06
is O 0 1.3358264823182253e-06
shown O 0 2.2385074771591462e-06
that O 0 6.86115072312532e-07
reintroduction O 0 4.1806353692663833e-05
of O 0 6.122972422417661e-07
the O 0 1.6713487411834649e-06
wild O 0 5.289055479806848e-05
- O 0 0.005303524434566498
type O 0 0.00489896209910512
VHL B-Disease 1 0.9836964011192322
gene O 0 0.002168327337130904
restores O 0 0.0004549353907350451
the O 0 4.270435056241695e-06
ability O 0 7.201440894277766e-05
of O 0 2.0855339244008064e-05
VHL O 1 0.9944546818733215
- O 1 0.6960247159004211
negative O 0 0.4833574891090393
RCC B-Disease 1 0.998335063457489
cancer I-Disease 1 0.9992766976356506
cells O 0 0.010908478870987892
to O 0 4.289394382794853e-06
exit O 0 2.9146744054742157e-05
the O 0 3.3477022043371107e-06
cell O 0 0.00011396709305699915
cycle O 0 0.00013181114627514035
and O 0 1.4387950614036527e-05
enter O 0 0.00016549347492400557
G0 O 1 0.9504533410072327
/ O 0 0.07811010628938675
quiescence O 0 0.17977668344974518
in O 0 5.3830750402994454e-05
low O 0 0.001122753950767219
serum O 0 0.11400799453258514
. O 0 0.0002840149390976876

Both O 0 0.000900010927580297
VHL O 1 0.9735059142112732
- O 0 0.008278747089207172
positive O 0 0.0006337104132398963
and O 0 0.00010442192433401942
VHL O 1 0.9897785782814026
- O 0 0.0830642357468605
negative O 0 0.01157723180949688
RCC B-Disease 1 0.9834913611412048
cells O 0 0.003592076478525996
exit O 0 6.621631473535672e-05
the O 0 4.781249117513653e-06
cell O 0 0.0002143611927749589
cycle O 0 0.00011177462147315964
by O 0 1.2154178875789512e-05
contact O 0 0.00045509266783483326
inhibition O 0 0.0051186950877308846
. O 0 0.00019803761097136885

The O 0 0.0005994703969918191
cyclin O 1 0.617467999458313
- O 0 0.009889348410069942
dependent O 0 0.002433205721899867
kinase O 0 0.12805026769638062
inhibitor O 0 0.11236816644668579
, O 0 2.7935184334637597e-05
p27 O 0 0.2125624716281891
, O 0 1.1056516996177379e-05
accumulates O 0 0.0047332183457911015
upon O 0 1.4921794900146779e-05
serum O 0 0.01320029329508543
withdrawal O 0 5.254187635728158e-05
, O 0 6.76894615025958e-07
only O 0 1.6925862666994362e-07
in O 0 2.1457327648022329e-07
the O 0 3.516523747748579e-07
presence O 0 2.88996329800284e-06
of O 0 1.1532689541127183e-06
VHL B-Disease 1 0.9127060174942017
, O 0 1.6335834516212344e-06
as O 0 4.6718145085833385e-07
a O 0 8.551535870537919e-07
result O 0 1.522914317320101e-06
of O 0 3.4359155165475386e-07
the O 0 9.455959570914274e-07
stabilization O 0 6.0735033912351355e-05
of O 0 1.6913015770114725e-06
the O 0 7.010239642113447e-06
protein O 0 0.00012434186646714807
. O 0 7.790014205966145e-05

We O 0 6.212723383214325e-05
propose O 0 0.00011277812882326543
that O 0 3.905062385456404e-06
the O 0 2.504275244064047e-06
loss O 0 5.2453367970883846e-05
of O 0 2.92707295557193e-06
wild O 0 0.0002046124282060191
- O 0 0.027434781193733215
type O 0 0.02173726260662079
VHL B-Disease 1 0.9910071492195129
gene O 0 0.0006301668472588062
results O 0 9.238769052899443e-06
in O 0 1.165846811090887e-06
a O 0 2.0812367438338697e-06
specific O 0 1.706034345261287e-05
cellular O 0 0.0009117597946897149
defect O 0 0.14671070873737335
in O 0 1.4877176909067202e-05
serum O 0 0.1749979704618454
- O 0 0.0018730921437963843
dependent O 0 0.00012329249875620008
growth O 0 4.650729533750564e-05
control O 0 1.6887495803530328e-05
, O 0 2.564041096775327e-06
which O 0 3.252052692914731e-06
may O 0 7.022466161288321e-05
initiate O 0 0.01768689788877964
tumor B-Disease 1 0.9855033159255981
formation O 0 0.006001334171742201
. O 0 0.00018555788847152144

This O 0 3.057437061215751e-05
is O 0 1.4241310054785572e-05
corrected O 0 0.00011306130909360945
by O 0 2.4701289476070087e-06
the O 0 2.7189712454855908e-06
reintroduction O 0 0.0004380937898531556
of O 0 4.837299002247164e-06
wild O 0 0.00022872464614920318
- O 0 0.014684834517538548
type O 0 0.011823806911706924
VHL B-Disease 1 0.9862270951271057
, O 0 0.00011066719889640808
implicating O 1 0.7994382381439209
VHL B-Disease 1 0.9843438863754272
as O 0 5.583890470006736e-06
the O 0 4.228830221109092e-06
first O 0 1.2313360457483213e-05
tumor B-Disease 1 0.956712007522583
suppressor O 0 0.038529448211193085
involved O 0 8.419627192779444e-06
in O 0 9.380860888086318e-07
the O 0 8.032313303374394e-07
regulation O 0 6.533678970299661e-06
of O 0 6.882226557536342e-07
cell O 0 0.00011859782534884289
cycle O 0 8.873282058630139e-05
exit O 0 4.0256560168927535e-05
, O 0 1.020643139781896e-06
which O 0 3.881538361838466e-07
is O 0 4.477458617202501e-07
consistent O 0 2.5999891022365773e-06
with O 0 7.581597287753539e-07
its O 0 3.368576471984852e-06
gatekeeper O 0 0.02080593630671501
function O 0 2.1537256543524563e-05
in O 0 7.944566277728882e-06
the O 0 2.8799850042560138e-05
kidney O 1 0.9975389242172241
. O 0 5.6622422562213615e-05
. O 0 0.00010925783135462552

Piebaldism B-Disease 1 0.953399658203125
with O 0 0.005306715611368418
deafness B-Disease 1 0.9982632994651794
: O 0 0.0003028605133295059
molecular O 0 0.0010831247782334685
evidence O 0 5.035250433138572e-05
for O 0 2.15717482205946e-05
an O 0 7.208366150734946e-05
expanded O 0 0.022562095895409584
syndrome O 1 0.9989928603172302
. O 0 0.0010632273042574525

In O 0 6.618303450522944e-05
a O 0 4.269059718353674e-05
South O 0 4.339312727097422e-05
African O 0 7.683363219257444e-05
girl O 0 0.001063874107785523
of O 0 1.6978750863927417e-05
Xhosa O 0 0.3998158872127533
stock O 0 0.0030171358957886696
with O 0 0.0007937555783428252
severe O 1 0.9984005093574524
piebaldism B-Disease 1 0.9872074723243713
and O 0 0.025602806359529495
profound O 1 0.9980556964874268
congenital O 1 0.999889612197876
sensorineural B-Disease 1 0.9997106194496155
deafness I-Disease 1 0.9997065663337708
we O 0 0.0001722408051136881
identified O 0 0.00014538338291458786
a O 0 1.2704343134828378e-05
novel O 0 0.00010099723294842988
missense O 0 0.0018272383604198694
substitution O 0 1.2287400750210509e-05
at O 0 2.289529902554932e-06
a O 0 1.8030065120910876e-06
highly O 0 4.681002337747486e-06
conserved O 0 6.550749731104588e-06
residue O 0 1.3264731023809873e-05
in O 0 9.53962626226712e-07
the O 0 1.1621214071055874e-06
intracellular O 0 0.000119973105029203
kinase O 0 0.0003968032542616129
domain O 0 5.669054644386051e-06
of O 0 1.4174466969052446e-06
the O 0 8.879243068804499e-06
KIT O 0 0.026448482647538185
proto O 0 0.21182548999786377
- O 0 0.041059043258428574
oncogene O 1 0.6986979246139526
, O 0 0.00013577275967691094
R796G O 0 0.009079935029149055
. O 0 0.0002477749076206237

Though O 0 0.0016241465928032994
auditory B-Disease 0 0.3546244204044342
anomalies I-Disease 0 0.08949354290962219
have O 0 2.6988571335095912e-05
been O 0 7.549241217930103e-06
observed O 0 2.948283145087771e-05
in O 0 6.3774300542718265e-06
mice O 0 0.007665765471756458
with O 0 1.1983745025645476e-05
dominant O 0 0.0013882607454434037
white O 0 0.028733067214488983
spotting O 1 0.7728891968727112
( O 0 0.0003955898864660412
W O 0 0.4655865728855133
) O 0 1.4667946743429638e-05
due O 0 3.4027187211904675e-05
to O 0 9.203260560752824e-06
KIT O 0 0.2688603401184082
mutations O 0 0.3571107089519501
, O 0 0.00013746891636401415
deafness B-Disease 1 0.999030590057373
is O 0 8.750333108764607e-06
not O 0 3.662850076580071e-06
typical O 0 9.112498810281977e-05
in O 0 1.622244599275291e-05
human O 0 0.0008649996016174555
piebaldism B-Disease 0 0.1462329924106598
. O 0 0.00032332114642485976

Thus O 0 9.99228868749924e-05
, O 0 2.1031417418271303e-05
the O 0 1.16672936201212e-05
occurrence O 0 0.004712826106697321
of O 0 9.762030822457746e-05
sensorineural B-Disease 1 0.9989038705825806
deafness I-Disease 1 0.9995501637458801
in O 0 9.996900917030871e-05
this O 0 2.4534258045605384e-05
patient O 1 0.7669082283973694
extends O 0 0.001556232338771224
considerably O 0 0.00026143447030335665
the O 0 3.1730371574667515e-06
phenotypic O 0 0.00014337533502839506
range O 0 8.775386959314346e-06
of O 0 1.9528397388057783e-06
piebaldism B-Disease 0 0.04256352409720421
due O 0 6.086137000238523e-05
to O 0 7.357364211202366e-06
KIT O 0 0.13336578011512756
gene O 0 0.008486960083246231
mutation O 0 0.0028758251573890448
in O 0 7.302213361981558e-06
humans O 0 0.0005879368400201201
and O 0 6.975082214921713e-06
tightens O 0 0.02149377204477787
the O 0 7.725670002400875e-06
clinical O 0 0.23087525367736816
similarity O 0 7.87205426604487e-05
between O 0 8.530303603038192e-06
piebaldism B-Disease 0 0.004752267152070999
and O 0 1.3402378726823372e-06
the O 0 8.040882448767661e-07
various O 0 4.201310275675496e-06
forms O 0 0.0003811461792793125
of O 0 0.0007388280355371535
Waardenburg B-Disease 1 0.9991177916526794
syndrome I-Disease 1 0.9994908571243286
. O 0 0.0004630639450624585
. O 0 0.0003086357028223574

Cycloheximide O 0 0.018914401531219482
facilitates O 0 0.0009025097824633121
the O 0 1.596864422026556e-05
identification O 0 2.2979009372647852e-05
of O 0 5.050509571447037e-06
aberrant O 0 0.0032014744356274605
transcripts O 0 5.386618067859672e-05
resulting O 0 3.3521584555273876e-05
from O 0 2.9987791094754357e-06
a O 0 5.974046871415339e-06
novel O 0 5.030795728089288e-05
splice O 0 0.00193317502271384
- O 0 0.0019709074404090643
site O 0 5.516765304491855e-05
mutation O 0 0.0007113442406989634
in O 0 6.164199476188514e-06
COL17A1 O 0 0.015460795722901821
in O 0 1.0175779607379809e-05
a O 0 6.977016892051324e-05
patient O 1 0.8888000845909119
with O 0 0.0020443983376026154
generalized O 1 0.9938910007476807
atrophic B-Disease 1 0.998371422290802
benign I-Disease 1 0.9973884224891663
epidermolysis I-Disease 1 0.996557354927063
bullosa I-Disease 1 0.9912511110305786
. O 0 0.015833275392651558

Patients O 1 0.9921848177909851
with O 0 0.015103260055184364
generalized O 1 0.9857111573219299
atrophic B-Disease 1 0.9973909258842468
benign I-Disease 1 0.9976370334625244
epidermolysis I-Disease 1 0.9975270628929138
bullosa I-Disease 1 0.9958524703979492
often O 0 0.0012414033990353346
show O 0 0.00015323694969993085
decreased O 0 0.0018498939462006092
expression O 0 7.575962808914483e-05
of O 0 1.0128329449798912e-05
type O 0 0.032373566180467606
XVII O 1 0.993286669254303
collagen O 1 0.6503389477729797
, O 0 8.21978937892709e-06
a O 0 1.2050604709656909e-05
transmembrane O 0 0.0011105757439509034
hemidesmosomal O 0 0.00292578455992043
protein O 0 8.690675895195454e-05
encoded O 0 5.284130384097807e-05
by O 0 3.6892404750688e-05
COL17A1 O 0 0.014097756706178188
. O 0 0.00017605687025934458

This O 0 6.467473576776683e-05
report O 0 4.024696318083443e-05
documents O 0 1.8754179109237157e-05
a O 0 9.492222488916013e-06
novel O 0 8.753496513236314e-05
splice O 0 0.0025043135974556208
- O 0 0.0015773298218846321
site O 0 7.682016439503059e-05
mutation O 0 0.0007614448550157249
in O 0 9.985541510104667e-06
COL17A1 O 0 0.006130600348114967
in O 0 7.933398592285812e-06
a O 0 4.6944951463956386e-05
patient O 1 0.827955961227417
with O 0 0.0010672310600057244
generalized O 1 0.9945216178894043
atrophic B-Disease 1 0.9989194869995117
benign I-Disease 1 0.9987126588821411
epidermolysis I-Disease 1 0.9987976551055908
bullosa I-Disease 1 0.9979404807090759
, O 0 0.00017602597654331475
and O 0 1.4963174180593342e-05
applies O 0 3.738628947758116e-05
a O 0 4.9515206228534225e-06
new O 0 3.991051471530227e-06
methodology O 0 1.0852962077478878e-05
to O 0 1.1469272749309312e-06
define O 0 1.0595448657113593e-05
and O 0 1.4565620176654193e-06
characterize O 0 0.00018746232672128826
the O 0 3.43877809427795e-06
resulting O 0 6.919510633451864e-05
mRNA O 0 7.674422522541136e-05
splice O 0 0.001745104673318565
variants O 0 0.0005816923221573234
. O 0 0.0001539203803986311

Mutational O 0 0.32300037145614624
analysis O 0 0.00027875317027792335
of O 0 4.050227289553732e-05
COL17A1 O 0 0.01707656867802143
identified O 0 0.0001327061909250915
a O 0 3.902065509464592e-05
maternally O 0 0.08504386246204376
inherited O 1 0.7493760585784912
G O 0 0.04455415531992912
- O 0 0.0009932019747793674
to O 0 1.0492894034541678e-05
- O 0 0.0034145924728363752
T O 0 0.10589217394590378
transversion O 0 0.0005167077761143446
at O 0 2.0845757262577536e-06
the O 0 7.340016168200236e-07
- O 0 1.2309756129980087e-05
1 O 0 2.0907193629682297e-06
position O 0 2.0424149624886923e-06
of O 0 2.5077549707930302e-06
exon O 0 0.00032550038304179907
32 O 0 0.00011260017345193774
. O 0 8.88687209226191e-05

This O 0 0.00014353291771840304
acceptor O 0 0.004234381020069122
splice O 0 0.004292371682822704
- O 0 0.001864228630438447
site O 0 6.539787136716768e-05
mutation O 0 0.00017009071598295122
led O 0 4.402321792440489e-06
to O 0 5.812902372781537e-07
the O 0 8.235736004280625e-07
formation O 0 8.767389772401657e-06
of O 0 9.334224273516156e-07
aberrant O 0 0.0024730912409722805
transcripts O 0 2.8425354685168713e-05
present O 0 4.297603936720407e-06
at O 0 7.488663868571166e-06
extremely O 0 0.0002525276504456997
low O 0 0.00027156053693033755
levels O 0 0.00032584252767264843
. O 0 7.182957051554695e-05

Based O 0 5.72114295209758e-05
on O 0 1.0174858289246913e-05
our O 0 1.0730010217230301e-05
recent O 0 2.768857666524127e-05
finding O 0 3.6050405469723046e-05
that O 0 1.2700551451416686e-05
cycloheximide O 0 0.12496565282344818
stabilized O 0 0.43615224957466125
mutant O 0 0.024943187832832336
COL17A1 O 0 0.08978582918643951
transcripts O 0 9.945272176992148e-05
in O 0 1.0712997209338937e-05
keratinocytes O 0 0.11909057199954987
homozygous O 0 0.0006038681603968143
for O 0 5.2422110456973314e-06
a O 0 1.7508718883618712e-05
frameshift O 0 0.487377405166626
mutation O 0 0.0017814161255955696
, O 0 2.2678336790704634e-06
the O 0 1.1548451084308908e-06
effects O 0 3.145982191199437e-05
of O 0 4.2585455162225117e-07
the O 0 1.1892492466358817e-06
splice O 0 0.0006262001115828753
- O 0 0.00019255200459156185
site O 0 8.902396984922234e-06
mutation O 0 2.192767169617582e-05
on O 0 7.126777177290933e-07
splicing O 0 1.2750320820487104e-05
of O 0 1.4460321153819677e-06
COL17A1 O 0 0.0006527415243908763
transcripts O 0 8.600783985457383e-06
were O 0 6.475366944869165e-07
determined O 0 2.8498645860963734e-06
using O 0 2.2390456706489203e-06
reverse O 0 8.325410453835502e-05
transcriptase O 0 0.0032300425227731466
polymerase O 0 0.00013860796752851456
chain O 0 2.7974796466878615e-05
reaction O 0 5.76321326661855e-06
of O 0 7.314970957850164e-07
total O 0 2.6383402200735873e-06
RNA O 0 2.736117494350765e-05
from O 0 8.677759979036637e-06
keratinocytes O 0 0.014508773572742939
incubated O 0 0.00046559039037674665
for O 0 2.0116814994253218e-05
2 O 0 9.160913759842515e-05
. O 0 9.132776904152706e-05

5 O 0 0.0001619878748897463
h O 0 0.0003766757436096668
in O 0 3.259902541685733e-06
the O 0 1.588005375197099e-06
presence O 0 4.624675966624636e-06
or O 0 2.4461332941427827e-06
absence O 0 1.1911712135770358e-05
of O 0 1.977312194867409e-06
10 O 0 1.6613450497970916e-05
microg O 0 0.005000058561563492
cycloheximide O 0 0.007985862903296947
per O 0 7.025474042166024e-05
ml O 0 0.018773246556520462
. O 0 0.00027547182980924845

Using O 0 4.8694426368456334e-05
this O 0 7.4351869443489704e-06
approach O 0 2.0675568521255627e-05
, O 0 4.577130766847404e-06
an O 0 4.3209875002503395e-06
abnormally O 0 0.0813111662864685
spliced O 0 0.0015346958534792066
transcript O 0 0.0001242982252733782
was O 0 1.973777671082644e-06
identified O 0 2.485284767317353e-06
that O 0 3.7674223563044507e-07
contains O 0 7.273885671565949e-07
an O 0 3.961270635954861e-07
extra O 0 2.2497563350043492e-06
264 O 0 1.6468718968098983e-05
bases O 0 3.7213974337646505e-06
upstream O 0 9.865218089544214e-06
from O 0 2.0276188479328994e-06
exon O 0 5.4954056395217776e-05
32 O 0 6.494306944659911e-06
, O 0 1.7582055988896172e-06
resulting O 0 1.0041578207165003e-05
in O 0 1.8303869637747994e-06
a O 0 1.3671911801793613e-05
premature O 0 0.0718727633357048
termination O 0 0.015129619278013706
codon O 0 0.000291209522401914
27 O 0 4.5553337258752435e-05
bp O 0 0.0004933971213176847
downstream O 0 8.718948811292648e-05
from O 0 9.71461759036174e-06
the O 0 1.862890349002555e-05
cryptic O 0 0.004197268281131983
splice O 0 0.00401600357145071
site O 0 0.0003713348414748907
. O 0 0.0001795693824533373

Three O 0 3.487823050818406e-05
other O 0 1.1683238881232683e-05
splice O 0 0.0003476404817774892
variants O 0 4.0436476410832256e-05
, O 0 1.6548128769500181e-06
including O 0 9.487620218351367e-07
one O 0 6.114989332672849e-07
derived O 0 1.1394982948331744e-06
from O 0 4.872562158197979e-07
the O 0 5.262580202725076e-07
skipping O 0 1.347572288068477e-05
of O 0 7.989972345967544e-07
exon O 0 0.0001508893328718841
32 O 0 7.242243555083405e-06
, O 0 1.465473815187579e-06
were O 0 1.3023347946727881e-06
also O 0 6.660733106400585e-06
identified O 0 7.808452210156247e-05
. O 0 5.7292669225716963e-05

These O 0 4.468021870707162e-05
results O 0 3.308098530396819e-05
indicate O 0 2.209353624493815e-05
the O 0 4.165913196629845e-06
usefulness O 0 0.0002738145994953811
of O 0 7.582952093798667e-06
cycloheximide O 0 0.24888253211975098
treatment O 0 0.41351014375686646
in O 0 3.86422652809415e-06
evaluating O 0 0.00018418068066239357
the O 0 1.9426661310717463e-06
abnormal O 0 0.0005404737312346697
processing O 0 3.2254035886580823e-06
of O 0 7.823553005437134e-07
mRNA O 0 6.501233656308614e-06
due O 0 5.16787804372143e-06
to O 0 1.663707507759682e-06
splice O 0 0.0006271375459618866
- O 0 0.0007893114816397429
site O 0 3.837349504465237e-05
mutations O 0 0.0006431416259147227
, O 0 2.6119730591744883e-06
because O 0 6.1139439821999986e-06
( O 0 4.722148787550395e-06
i O 0 3.3548803912708536e-06
) O 0 3.316857373647508e-06
aberrant O 0 0.00023156141105573624
splicing O 0 3.545389699866064e-05
often O 0 5.290076842356939e-06
generates O 0 2.5836416170932353e-05
a O 0 1.7435439076507464e-05
premature O 0 0.10156812518835068
termination O 0 0.014902499504387379
codon O 0 0.00017759350885171443
, O 0 4.9109830797533505e-06
( O 0 8.611568773631006e-06
ii O 0 0.00010314991959603503
) O 0 3.830149580608122e-06
transcripts O 0 2.3135062292567454e-05
with O 0 1.1975269444519654e-05
premature O 0 0.34377244114875793
termination O 0 0.13453374803066254
codons O 0 0.0012469906359910965
can O 0 7.017516963969683e-06
occur O 0 2.508273973944597e-05
at O 0 2.6069412797369296e-06
low O 0 1.720996260701213e-05
or O 0 5.793593118141871e-06
undetectable O 0 0.03163847699761391
levels O 0 2.4874350856407546e-05
due O 0 3.365185648362967e-06
to O 0 9.189545835397439e-07
nonsense O 0 4.343063847045414e-05
- O 0 8.893188351066783e-05
mediated O 0 0.0003452373784966767
mRNA O 0 1.4146124158287421e-05
decay O 0 5.259085082798265e-05
, O 0 1.6169570926649612e-06
and O 0 1.3549489494835143e-06
( O 0 5.466517905006185e-06
iii O 0 5.997233893140219e-05
) O 0 5.898476729271351e-07
the O 0 2.7260179535915086e-07
levels O 0 1.8444894749336527e-06
of O 0 2.376206253984492e-07
these O 0 3.8230811583161994e-07
transcripts O 0 4.9505856623e-06
can O 0 9.906037803375511e-07
be O 0 7.049204100439965e-07
increased O 0 9.330564353149384e-06
by O 0 1.2637990948860534e-05
cycloheximide O 0 0.005286271218210459
. O 0 0.0001252596266567707

A O 0 0.00038009355193935335
deletion O 0 0.033373408019542694
mutation O 0 0.007774582132697105
in O 0 2.7136944481753744e-05
COL17A1 O 0 0.005698347929865122
in O 0 7.303480288101127e-06
five O 0 1.8361270122113638e-05
Austrian O 0 0.0013962633674964309
families O 0 0.0008372215670533478
with O 0 0.0010455746669322252
generalized O 1 0.9884709119796753
atrophic B-Disease 1 0.9985040426254272
benign I-Disease 1 0.9981451034545898
epidermolysis I-Disease 1 0.9982421398162842
bullosa I-Disease 1 0.994708776473999
represents O 0 0.0028690837789326906
propagation O 0 0.00048059032997116446
of O 0 2.4803766791592352e-05
an O 0 4.8540226998738945e-05
ancestral O 0 0.007527013774961233
allele O 0 0.01110883243381977
. O 0 0.0003680946829263121

Patients O 1 0.992033064365387
with O 0 0.04242303967475891
generalized O 1 0.9897165894508362
atrophic B-Disease 1 0.9976663589477539
benign I-Disease 1 0.9975878000259399
epidermolysis I-Disease 1 0.9975849390029907
bullosa I-Disease 1 0.9964912533760071
, O 0 0.00016821575991343707
a O 0 6.259512883843854e-05
usually O 0 6.158807809697464e-05
nonlethal O 0 0.006950533017516136
form O 0 0.00014395439939107746
of O 0 0.0001264213933609426
junctional B-Disease 1 0.9962092638015747
epidermolysis I-Disease 1 0.9987296462059021
bullosa I-Disease 1 0.9975587129592896
, O 0 0.0004846778465434909
have O 0 0.0001471298310207203
generalized O 1 0.6593521237373352
blistering B-Disease 1 0.9406654238700867
, O 0 0.003758140839636326
nail B-Disease 1 0.9974272847175598
dystrophy I-Disease 1 0.9995249509811401
, O 0 0.11460776627063751
patchy B-Disease 1 0.9981067180633545
alopecia I-Disease 1 0.999580442905426
, O 0 0.017157286405563354
and O 0 0.01532784290611744
dental B-Disease 1 0.9990679621696472
abnormalities I-Disease 1 0.9976795315742493
. O 0 0.0035991352051496506

Skin B-Disease 1 0.9964563250541687
fragility I-Disease 1 0.9716220498085022
in O 0 4.862653440795839e-05
most O 0 2.3982214770512655e-05
cases O 0 0.00047032313887029886
is O 0 4.525480107986368e-06
due O 0 1.2632580364879686e-05
to O 0 1.970127414097078e-06
mutations O 0 0.00028099457267671824
in O 0 1.6534593214601045e-06
the O 0 3.207661166015896e-06
gene O 0 0.0004725115140900016
encoding O 0 0.00048608763609081507
type O 0 0.038152121007442474
XVII O 1 0.9923239946365356
collagen O 1 0.9751638174057007
( O 0 0.0005691964761354029
COL17A1 O 0 0.19722746312618256
) O 0 0.00010728816414484754
. O 0 0.00011078070383518934

Recently O 0 0.0007985190604813397
, O 0 1.8501217709854245e-05
we O 0 6.990598194533959e-06
reported O 0 3.859475691569969e-05
five O 0 1.0043225302069914e-05
Austrian O 0 0.0006914330879226327
families O 0 0.0007504845270887017
with O 0 0.0011644833721220493
generalized O 1 0.9930376410484314
atrophic B-Disease 1 0.9992801547050476
benign I-Disease 1 0.9990077614784241
epidermolysis I-Disease 1 0.9989506006240845
bullosa I-Disease 1 0.9980364441871643
who O 0 0.0004923874512314796
share O 0 4.9647973355604336e-05
the O 0 1.756425990606658e-05
same O 0 5.97145663050469e-05
COL17A1 O 0 0.35343849658966064
mutation O 0 0.05691470950841904
. O 0 0.0002557522093411535

Affected O 0 0.020743340253829956
individuals O 0 7.10467720637098e-05
in O 0 6.09983226240729e-06
three O 0 3.907811787939863e-06
families O 0 1.8732156604528427e-05
are O 0 2.034312728937948e-06
homozygous O 0 0.00026058193179778755
for O 0 4.644592536351411e-06
4003delTC O 0 0.0009842179715633392
, O 0 1.5839443676668452e-06
whereas O 0 4.267858003004221e-06
those O 0 9.295270615439222e-07
in O 0 8.858637556841131e-07
two O 0 1.3912482472733245e-06
others O 0 1.100453118851874e-05
are O 0 8.015226740099024e-06
compound O 0 0.0008281592163257301
heterozygotes O 0 0.26772207021713257
. O 0 0.0001871605054475367

To O 0 3.472785101621412e-05
determine O 0 1.883012919279281e-05
if O 0 4.4261068978812546e-06
the O 0 1.4510245591736748e-06
occurrence O 0 3.387055767234415e-05
of O 0 1.258653924196551e-06
4003delTC O 0 0.0008783465018495917
in O 0 2.5947279027604964e-06
these O 0 2.988600954267895e-06
unrelated O 0 0.0006314166821539402
families O 0 3.6206405638949946e-05
signifies O 0 0.00014992700016591698
propagation O 0 1.9865015929099172e-05
of O 0 8.425084843111108e-07
an O 0 2.4778298666205956e-06
ancestral O 0 0.0005105663440190256
allele O 0 0.0006068299408070743
or O 0 9.443150702281855e-06
a O 0 1.7298931197728962e-05
mutational O 0 0.22394829988479614
hot O 0 0.00034046146902255714
spot O 0 3.7033114494988695e-05
, O 0 5.552348284254549e-06
haplotypes O 0 0.0010945424437522888
were O 0 1.227810116688488e-06
determined O 0 5.478218554344494e-06
for O 0 2.4229393602581695e-06
polymorphisms O 0 8.187862840713933e-05
both O 0 3.0500837056024466e-06
within O 0 5.929286544414936e-06
and O 0 1.4922193258826155e-05
flanking O 0 0.013888769783079624
COL17A1 O 0 0.14639689028263092
. O 0 0.00022477311722468585

Five O 0 0.0003100329777225852
intragenic O 0 0.005060860421508551
polymorphisms O 0 0.0005713187274523079
were O 0 4.909948529530084e-06
chosen O 0 6.848267730674706e-06
based O 0 6.190261956362519e-06
on O 0 3.50504365087545e-06
their O 0 1.5806148439878598e-05
informativeness O 0 0.006035252474248409
. O 0 0.00014291712432168424

One O 0 2.1819054381921887e-05
of O 0 4.080750841239933e-06
these O 0 2.704303369682748e-06
, O 0 1.9168628568877466e-06
not O 0 1.0903657994276728e-06
previously O 0 3.968511009588838e-06
reported O 0 8.719578545424156e-06
, O 0 8.723102951080364e-07
was O 0 8.973451599558757e-07
2988 O 0 0.0001484676613472402
A O 0 2.702653091546381e-06
or O 0 2.7093474272987805e-06
C O 0 3.988923708675429e-05
that O 0 6.495617412838328e-07
introduces O 0 1.1577426448639017e-05
a O 0 1.652844503041706e-06
new O 0 2.521222313589533e-06
restriction O 0 1.0617044608807191e-05
site O 0 8.21554203866981e-06
for O 0 7.884072147135157e-06
Eco0109 O 0 0.00262045138515532
I O 0 8.321917994180694e-05
. O 0 7.64721044106409e-05

All O 0 3.5845532693201676e-05
the O 0 2.3979629986570217e-05
4003delTC O 0 0.003953983541578054
alleles O 0 0.001027589081786573
showed O 0 2.279219370393548e-05
the O 0 2.8907986688864185e-06
same O 0 5.485710516950348e-06
haplotype O 0 0.0026297057047486305
for O 0 3.0136643545120023e-06
these O 0 3.3194492061738856e-06
five O 0 1.7638014469412155e-05
polymorphic O 0 0.05348201096057892
markers O 0 0.0030483955051749945
. O 0 0.00016970741853583604

Fourteen O 0 0.0008826127159409225
microsatellite O 0 0.022469231858849525
polymorphisms O 0 0.0010179330129176378
were O 0 4.490549144975375e-06
selected O 0 4.96348229717114e-06
based O 0 2.5161875782941934e-06
on O 0 1.0192989066126756e-06
their O 0 1.7404171330781537e-06
high O 0 1.962907481356524e-05
heterozygosity O 0 0.005593329668045044
and O 0 1.0588413488221704e-06
their O 0 1.3972049828225863e-06
location O 0 6.887032668601023e-06
within O 0 7.759459549561143e-06
10q23 O 0 0.0012309947051107883
- O 0 0.0011182554299011827
q25 O 0 0.0029028276912868023
near O 0 0.00021591810218524188
COL17A1 O 0 0.056504447013139725
. O 0 0.00018947425996884704

Three O 0 0.0001819651952246204
families O 0 0.00022064568474888802
shared O 0 0.00010904425289481878
microsatellite O 0 0.020744886249303818
polymorphisms O 0 0.002303621033206582
covering O 0 0.0002750165294855833
at O 0 7.493979410355678e-06
most O 0 3.676049800560577e-06
19 O 0 1.1935353541048244e-05
cM O 0 0.0001619637623662129
, O 0 1.2398686521919444e-06
whereas O 0 4.1891003093041945e-06
the O 0 4.924706900055753e-07
others O 0 1.8072378225042485e-06
shared O 0 1.6062142549344571e-06
smaller O 0 2.0836216663155938e-06
regions O 0 6.43027487967629e-06
consistent O 0 5.899168172618374e-06
with O 0 1.0099673772856477e-06
cross O 0 9.008718734548893e-06
- O 0 2.4545071937609464e-05
over O 0 7.669225396966795e-07
events O 0 1.489761530137912e-06
during O 0 9.349288347948459e-07
passage O 0 1.5958862604747992e-06
of O 0 3.290382153409155e-07
this O 0 1.2440283398973406e-06
mutation O 0 6.269040750339627e-05
through O 0 6.213956112333108e-06
several O 0 1.4387868759513367e-05
generations O 0 0.0003034497785847634
. O 0 0.00011667054059216753

These O 0 4.604007335728966e-05
results O 0 4.3379808630561456e-05
indicate O 0 2.5331777578685433e-05
that O 0 4.268187694833614e-06
4003delTC O 0 0.0005305567756295204
occurs O 0 1.2309438716329169e-05
on O 0 1.2810646694561e-06
a O 0 2.8280401238589548e-06
single O 0 1.007168430078309e-05
ancestral O 0 0.0004645436711143702
allele O 0 0.0007083942764438689
. O 0 3.473060132819228e-05
. O 0 8.148574124788865e-05

The O 0 0.0005696306470781565
haptoglobin O 0 0.47719523310661316
- O 0 0.0195721797645092
gene O 0 0.005862694699317217
deletion O 0 0.008901264518499374
responsible O 0 0.0006690988084301353
for O 0 0.00012117700680391863
anhaptoglobinemia B-Disease 0 0.0582900308072567
. O 0 0.00045110308565199375

We O 0 5.111809150548652e-05
have O 0 1.4333430954138748e-05
found O 0 8.108779184112791e-06
an O 0 5.20090952704777e-06
allelic O 0 0.0025602851528674364
deletion O 0 0.00031252644839696586
of O 0 2.903214408433996e-06
the O 0 8.61888111103326e-06
haptoglobin O 0 0.32429009675979614
( O 0 4.3264702981105074e-05
Hp O 0 0.0015750426100566983
) O 0 6.614215180889005e-06
gene O 0 3.428967102081515e-05
from O 0 1.103384875023039e-06
an O 0 1.3788217074761633e-06
individual O 0 1.0403377018519677e-05
with O 0 2.5476118025835603e-05
anhaptoglobinemia B-Disease 0 0.027941275388002396
. O 0 0.00016041543858591467

The O 0 0.00012678767961915582
Hp O 0 0.0032759879250079393
gene O 0 0.0004326382768340409
cluster O 0 0.00015921068552415818
consists O 0 4.4888665797770955e-06
of O 0 9.78920070338063e-07
coding O 0 3.1294945074478164e-05
regions O 0 5.618520845018793e-06
of O 0 4.0832711079019646e-07
the O 0 9.325521546088567e-07
alpha O 0 1.53285036503803e-05
chain O 0 1.3658384887094144e-05
and O 0 1.1720786687874352e-06
beta O 0 3.747220762306824e-05
chain O 0 1.1596057447604835e-05
of O 0 1.0563733212620718e-06
the O 0 5.738637355534593e-06
haptoglobin O 0 0.2554623782634735
gene O 0 0.0007469957345165312
( O 0 1.027627513394691e-05
Hp O 0 0.00012092169345123693
) O 0 7.22831430266524e-07
and O 0 1.8436402626775816e-07
of O 0 1.7778170047222375e-07
the O 0 6.270529979701678e-07
alpha O 0 7.660361916350666e-06
chain O 0 1.261049328604713e-05
and O 0 1.2555321973195532e-06
beta O 0 2.0199557184241712e-05
chain O 0 9.030920409713872e-06
of O 0 7.500061087739596e-07
the O 0 5.720266926800832e-06
haptoglobin O 0 0.35208049416542053
- O 0 0.008181042969226837
related O 0 0.0020561765413731337
gene O 0 0.005125387106090784
( O 0 5.825858534080908e-05
Hpr O 0 0.19187219440937042
) O 0 2.9712400646531023e-06
, O 0 8.705301866029913e-07
in O 0 9.875014939098037e-07
tandem O 0 1.668858931225259e-05
from O 0 1.3878320714866277e-06
the O 0 2.714095444389386e-06
5 O 0 1.4075958461035043e-05
side O 0 5.3154799388721585e-05
. O 0 7.233279757201672e-05

Southern O 0 0.0005562060978263617
blot O 0 0.01537149678915739
and O 0 2.0591154680005275e-05
PCR O 0 0.0003019580617547035
analyses O 0 5.3511994337895885e-05
have O 0 2.799331696223817e-06
indicated O 0 6.210898845893098e-06
that O 0 3.668474732876348e-07
the O 0 4.3016041217924794e-07
individual O 0 1.4083018413657555e-06
with O 0 1.9263427475380013e-06
anhaptoglobinemia B-Disease 0 0.001005688332952559
was O 0 1.7214650824826094e-06
homozygous O 0 4.423953578225337e-05
for O 0 1.2165206726422184e-06
the O 0 1.5243078905768925e-06
gene O 0 0.0002052051859209314
deletion O 0 0.00036722279037348926
and O 0 1.0692618843677337e-06
that O 0 6.858815595478518e-07
the O 0 1.1767097021220252e-06
gene O 0 0.00014888674195390195
deletion O 0 0.0003150086849927902
was O 0 1.0947189821308712e-06
included O 0 1.0014313147621579e-06
at O 0 1.0501375982130412e-06
least O 0 8.833860647428082e-07
from O 0 8.314598858305544e-07
the O 0 1.146511635852221e-06
promoter O 0 8.544193406123668e-05
region O 0 8.250418431998696e-06
of O 0 1.2386713024170604e-06
Hp O 0 0.0005430147284641862
to O 0 5.824266736453865e-06
Hpr O 0 0.07382760941982269
alpha O 0 4.477272887015715e-05
but O 0 3.939442194678122e-06
not O 0 2.2758763407182414e-06
to O 0 6.390744601958431e-06
Hpr O 0 0.1899702548980713
beta O 0 0.0014673327095806599
( O 0 8.163032907759771e-05
Hpdel O 0 0.006616095080971718
) O 0 9.443596354685724e-05
. O 0 7.827454101061448e-05

In O 0 4.447400351637043e-05
addition O 0 2.2128704586066306e-05
, O 0 3.2779717002995312e-06
we O 0 1.4920805142537574e-06
found O 0 1.1713276535374462e-06
seven O 0 1.715151256576064e-06
individuals O 0 4.302492015995085e-06
with O 0 2.341228537261486e-06
hypohaptoglobinemia B-Disease 0 0.0035615002270787954
in O 0 1.193185539705155e-06
three O 0 1.3343433238333091e-06
families O 0 5.865230377821717e-06
, O 0 4.878085064774496e-07
and O 0 2.596354136130685e-07
the O 0 3.367023850842088e-07
genotypes O 0 0.0001680729037616402
of O 0 1.6727840090879909e-07
six O 0 4.897215148957912e-07
of O 0 1.474788575706043e-07
the O 0 2.7549759806788643e-07
seven O 0 1.3266640053188894e-06
individuals O 0 2.7107535061077215e-06
were O 0 3.614415220454248e-07
found O 0 1.5828178447918617e-06
to O 0 1.6465043017888092e-06
be O 0 4.9652908273856156e-06
Hp2 O 0 0.07843532413244247
/ O 0 0.11547867953777313
Hpdel O 0 0.04791904613375664
. O 0 0.00016416417201980948

The O 0 0.00014610437210649252
phenotypes O 0 0.05475800484418869
and O 0 2.4275963369291276e-05
genotypes O 0 0.00609602453187108
in O 0 1.7939436247615959e-06
one O 0 4.98430722473131e-07
of O 0 2.9144169388928276e-07
these O 0 6.873771667414985e-07
three O 0 1.2077238125129952e-06
families O 0 1.0805300007632468e-05
showed O 0 5.913384484301787e-06
the O 0 8.020334689717856e-07
father O 0 6.686687356705079e-06
to O 0 9.536896641293424e-07
be O 0 1.2265905979802483e-06
hypohaptoglobinemic B-Disease 0 0.005282772239297628
( O 0 2.047032830887474e-05
Hp2 O 0 0.006685804110020399
) O 0 4.581646862789057e-06
and O 0 6.414937161025591e-06
Hp2 O 0 0.20370113849639893
/ O 0 0.06616206467151642
Hpdel O 0 0.0036949256900697947
, O 0 1.5970039157764404e-06
the O 0 1.0143824056285666e-06
mother O 0 1.870630876510404e-05
to O 0 9.050336871041509e-07
be O 0 1.1461684152891394e-06
Hp2 O 0 0.00037495375727303326
- O 0 4.9050308007281274e-05
1 O 0 4.083585281478008e-06
and O 0 4.9054833652917296e-06
Hp1 O 0 0.04964253678917885
/ O 0 0.011145291849970818
Hp2 O 0 0.000722318422049284
, O 0 6.455439347519132e-07
one O 0 2.063979849253883e-07
of O 0 1.1727008342177214e-07
the O 0 2.850245834906673e-07
two O 0 4.407277458540193e-07
children O 0 8.671679097460583e-06
to O 0 8.106428595056059e-07
be O 0 1.4310810456663603e-06
hypohaptoglobinemic B-Disease 0 0.0031551835127174854
( O 0 1.4477139302471187e-05
Hp2 O 0 0.003129509976133704
) O 0 4.115942374482984e-06
and O 0 5.495035566127626e-06
Hp2 O 0 0.1248137578368187
/ O 0 0.03542282059788704
Hpdel O 0 0.003553102957084775
, O 0 1.2456619060685625e-06
and O 0 5.05750961110607e-07
the O 0 3.654981242107169e-07
other O 0 6.62775676119054e-07
child O 0 2.7771769964601845e-05
to O 0 9.004990602079488e-07
be O 0 1.440380856365664e-06
Hp1 O 0 0.002331195864826441
and O 0 1.0383158951299265e-05
Hp1 O 0 0.3373427987098694
/ O 0 0.13044220209121704
Hpdel O 0 0.013103277422487736
, O 0 3.2670732252881862e-06
showing O 0 1.3609030247607734e-05
an O 0 4.267886197339976e-06
anomalous O 0 0.006123620085418224
inheritance O 0 0.0002599477011244744
of O 0 7.3956343840109184e-06
Hp O 0 0.07774919271469116
phenotypes O 0 0.06608125567436218
in O 0 6.201299129315885e-06
the O 0 7.500464107579319e-06
child O 0 0.0007931352010928094
with O 0 4.414871727931313e-05
Hp1 O 0 0.18558885157108307
. O 0 0.00024081200535874814

The O 0 0.00044185249134898186
Hp2 O 1 0.6839417815208435
/ O 0 0.4087548553943634
Hpdel O 0 0.05903385952115059
individuals O 0 5.679032619809732e-05
had O 0 5.645262717735022e-06
an O 0 2.249554654554231e-06
extremely O 0 4.7622113925172016e-05
low O 0 1.3709565791941714e-05
level O 0 4.723594884126214e-06
of O 0 1.6379250382669852e-06
Hp O 0 0.0017309767426922917
( O 0 1.5522980902460404e-05
mean O 0 7.073823508108035e-05
+ O 0 0.0032991874031722546
/ O 0 0.0037778622936457396
- O 0 0.00061724305851385
SD O 0 0.0017826138064265251
= O 0 0.00015421213174704462
0 O 0 2.6672345484257676e-05
. O 0 9.523569133307319e-06
049 O 0 0.14894288778305054
+ O 0 0.001944333896972239
/ O 0 0.0009849107591435313
- O 0 0.00011853520118165761
0 O 0 3.479153019725345e-05
. O 0 1.3357984244066756e-05
043 O 0 0.02041838876903057
mg O 0 0.035499606281518936
/ O 0 0.005036758724600077
ml O 0 0.0025016895961016417
; O 0 1.3095547728880774e-05
n O 0 2.4374579879804514e-05
= O 0 4.453256769920699e-05
6 O 0 3.348723794260877e-06
) O 0 7.906999712758989e-07
, O 0 2.686054472178512e-07
compared O 0 5.746736064793367e-07
with O 0 2.0050484295097704e-07
the O 0 3.194626856384275e-07
level O 0 1.64492848853115e-06
( O 0 1.0646128885127837e-06
1 O 0 7.253754574776394e-07
. O 0 6.73124873173947e-07
64 O 0 5.951119419478346e-06
+ O 0 0.00028567531262524426
/ O 0 0.0003354300279170275
- O 0 2.437090915918816e-05
1 O 0 3.897119768225821e-06
. O 0 3.037341230083257e-06
07 O 0 0.0010033691069111228
mg O 0 0.03072410449385643
/ O 0 0.004772703163325787
ml O 0 0.001418841420672834
) O 0 4.096320026292233e-06
obtained O 0 3.307274027974927e-06
from O 0 2.247590373372077e-06
52 O 0 4.968874782207422e-05
healthy O 0 0.006047685164958239
volunteers O 0 0.0003783853317145258
having O 0 0.00011624654871411622
phenotype O 0 0.40469175577163696
Hp2 O 0 0.019561558961868286
, O 0 3.0266598969319602e-06
whereas O 0 1.4258377632359043e-05
the O 0 2.3985969619388925e-06
serum O 0 0.003873826703056693
Hp O 0 0.00025106704561039805
level O 0 2.181890749852755e-06
of O 0 3.0063910116950865e-07
an O 0 6.430284429370658e-07
individual O 0 6.279096396610839e-06
with O 0 1.503038038208615e-05
Hp1 O 0 0.2821394205093384
/ O 0 0.05431433767080307
Hpdel O 0 0.010569261386990547
was O 0 1.5739469745312817e-05
0 O 0 0.0001314610562985763
. O 0 6.698426295770332e-05

50 O 0 0.000692586530931294
mg O 0 0.2930479347705841
/ O 0 0.04457870498299599
ml O 0 0.002296106657013297
, O 0 2.995617705892073e-06
which O 0 7.616862376380595e-07
was O 0 4.924885388390976e-07
approximately O 0 8.222606311392155e-07
half O 0 4.5442223495228973e-07
the O 0 3.33060967250276e-07
level O 0 1.4931779332982842e-06
of O 0 5.276560841593891e-07
Hp O 0 0.00017141930584330112
in O 0 1.6727615275158314e-06
control O 0 1.2207347936055157e-05
sera O 0 0.0002814629697240889
from O 0 1.5041918004499166e-06
the O 0 2.0759061953867786e-06
Hp1 O 0 0.04224514961242676
phenotype O 0 0.04869357869029045
( O 0 4.788536898558959e-06
1 O 0 2.6332074867241317e-06
. O 0 1.46943716572423e-06
26 O 0 9.751271136337891e-06
+ O 0 0.0003201486833859235
/ O 0 0.0004915791214443743
- O 0 4.715138129540719e-05
0 O 0 1.007932223728858e-05
. O 0 2.69077690973063e-06
33 O 0 2.723858051467687e-05
mg O 0 0.004905070178210735
/ O 0 0.0038675221148878336
ml O 0 0.0016453578136861324
; O 0 9.09560731088277e-06
n O 0 2.8840942832175642e-05
= O 0 4.479767449083738e-05
9 O 0 3.890249899995979e-06
) O 0 1.7556955071995617e-06
, O 0 8.263925792562077e-07
showing O 0 7.619131338287843e-06
a O 0 1.0260107956128195e-05
gene O 0 0.0006252051098272204
- O 0 0.001988662639632821
dosage O 0 0.0621647983789444
effect O 0 0.0007574867340736091
. O 0 0.0001768972142599523

The O 0 5.653167318087071e-05
other O 0 2.6601932404446416e-05
allele O 0 0.0006675345357507467
( O 0 2.7530648367246613e-05
Hp2 O 0 0.0005380364018492401
) O 0 3.071195578741026e-06
of O 0 6.880592309244093e-07
individuals O 0 1.4670352356915828e-05
with O 0 1.98274283320643e-05
Hp2 O 1 0.7019097805023193
/ O 0 0.14645810425281525
Hpdel O 0 0.010171568021178246
was O 0 1.3701652505915263e-06
found O 0 9.02226020116359e-07
to O 0 2.8998337597840873e-07
have O 0 1.8818576563717215e-07
, O 0 1.7681436759175995e-07
in O 0 1.6837523730828252e-07
all O 0 3.2460926036037563e-07
exons O 0 1.5448340491275303e-05
, O 0 9.047506068782241e-07
no O 0 1.553671154397307e-06
mutation O 0 5.9888272517127916e-05
, O 0 1.530720510345418e-06
by O 0 3.5309303711983375e-06
DNA O 0 5.280367622617632e-05
sequencing O 0 0.00020661266171373427
. O 0 0.00010306102194590494

On O 0 8.486504157190211e-06
the O 0 2.2301335320662474e-06
basis O 0 1.1834633824037155e-06
of O 0 3.9298217302530247e-07
the O 0 6.490935788860952e-07
present O 0 9.85646124718187e-07
study O 0 3.853591351798968e-06
, O 0 2.507508440885431e-07
the O 0 2.0862073313310248e-07
mechanism O 0 2.3864811282692244e-06
of O 0 4.272954754469538e-07
anhaptoglobinemia B-Disease 0 0.0006638946942985058
and O 0 5.03829141962342e-07
the O 0 4.3269898242215277e-07
mechanism O 0 8.255896318587475e-06
of O 0 1.1872865570694557e-06
anomalous O 0 0.014153404161334038
inheritance O 0 0.0005457183578982949
of O 0 9.01574003364658e-06
Hp O 0 0.22962914407253265
phenotypes O 0 0.1644953489303589
were O 0 7.377339898084756e-06
well O 0 2.9586253731395118e-05
explained O 0 0.0003970423713326454
. O 0 0.00011357587936799973

However O 0 7.043035293463618e-05
, O 0 9.83083555183839e-06
the O 0 5.954105290584266e-06
mechanism O 0 5.141112342244014e-05
of O 0 1.4728625501447823e-05
hypohaptoglobinemia B-Disease 0 0.025750136002898216
remains O 0 0.0009744990966282785
unknown O 0 0.0011350902495905757

ATM O 0 0.020840754732489586
mutations O 0 0.22426031529903412
and O 0 0.00027863308787345886
phenotypes O 1 0.8701674938201904
in O 0 0.0009702028473839164
ataxia B-Disease 1 0.99887615442276
- I-Disease 1 0.9573955535888672
telangiectasia I-Disease 1 0.997925877571106
families O 0 0.0002887421287596226
in O 0 4.475273726711748e-06
the O 0 2.916468019975582e-06
British O 0 8.045569302339572e-06
Isles O 0 0.00017010093142744154
: O 0 3.99022201236221e-06
expression O 0 5.43711075806641e-06
of O 0 1.3515469845515327e-06
mutant O 0 0.0003789267793763429
ATM O 0 0.0001630562182981521
and O 0 4.7214330152201e-06
the O 0 1.1028337212337647e-05
risk O 0 0.33600667119026184
of O 0 0.0005033236229792237
leukemia B-Disease 1 0.9998401403427124
, O 0 0.28897786140441895
lymphoma B-Disease 1 0.9999258518218994
, O 0 0.019842268899083138
and O 0 0.10173152387142181
breast B-Disease 1 0.9996238946914673
cancer I-Disease 1 0.9992788434028625
. O 0 0.005504285916686058

We O 0 4.813577470486052e-05
report O 0 2.1229297999525443e-05
the O 0 5.124288236402208e-06
spectrum O 0 2.8209689844516106e-05
of O 0 3.825276053248672e-06
59 O 0 0.00013382136239670217
ATM O 0 0.0014863357646390796
mutations O 0 0.058539457619190216
observed O 0 0.0004215769295115024
in O 0 0.00015776687359903008
ataxia B-Disease 1 0.9987560510635376
- I-Disease 1 0.9463436603546143
telangiectasia I-Disease 1 0.9982103109359741
( O 0 0.0011310999980196357
A B-Disease 0 0.0018024113960564137
- I-Disease 1 0.5367759466171265
T I-Disease 1 0.9865717887878418
) O 0 8.591023652115837e-05
patients O 1 0.8242238163948059
in O 0 6.10541383139207e-06
the O 0 9.199592568620574e-06
British O 0 7.906812243163586e-05
Isles O 0 0.0034276717342436314
. O 0 0.00017049862071871758

Of O 0 8.203118341043591e-05
51 O 0 0.00038164062425494194
ATM O 0 0.0018336139619350433
mutations O 0 0.020568696781992912
identified O 0 0.0001173961500171572
in O 0 3.817509877990233e-06
families O 0 1.3841543477610685e-05
native O 0 4.02037039748393e-06
to O 0 8.955993280324037e-07
the O 0 1.13779549337778e-06
British O 0 6.485555331892101e-06
Isles O 0 0.00011923305282834917
, O 0 1.3495390476236935e-06
11 O 0 2.8387162274157163e-06
were O 0 7.134576662792824e-07
founder O 0 0.00011219932639505714
mutations O 0 0.00030902260914444923
, O 0 4.604282253239944e-07
and O 0 3.098583363225771e-07
2 O 0 7.90941271588963e-07
of O 0 2.3541645077784779e-07
these O 0 1.0280950846208725e-06
11 O 0 1.6079602573881857e-05
conferred O 0 0.0028940385673195124
a O 0 0.00012414754019118845
milder O 1 0.970708429813385
clinical O 1 0.9961214661598206
phenotype O 1 0.7741286158561707
with O 0 1.2414740012900438e-05
respect O 0 2.3571401470690034e-05
to O 0 8.372673619305715e-06
both O 0 6.603552174055949e-05
cerebellar B-Disease 1 0.9981337189674377
degeneration I-Disease 1 0.999005138874054
and O 0 0.00016225685249082744
cellular O 0 0.0026640084106475115
features O 0 0.0003507989167701453
. O 0 0.00023695269192103297

We O 0 5.101966598886065e-05
report O 0 2.190812665503472e-05
, O 0 2.9875152449676534e-06
in O 0 1.6412540162491496e-06
two O 0 1.6353293403881253e-06
A B-Disease 0 4.795685163117014e-05
- I-Disease 0 0.0305408276617527
T I-Disease 1 0.7127937078475952
families O 0 2.380468686169479e-05
, O 0 1.2075740869477158e-06
an O 0 1.521603394394333e-06
ATM O 0 0.00033204254577867687
mutation O 0 0.002047591842710972
( O 0 2.1875743186683394e-05
7271T O 0 0.0020199797581881285
- O 0 0.0014676486607640982
- O 0 0.002176059177145362
> O 0 0.0030568980146199465
G O 0 0.000404434249503538
) O 0 2.3700101792201167e-06
that O 0 5.469158850246458e-07
may O 0 1.8678733795240987e-06
be O 0 3.5204291748414107e-07
associated O 0 1.775264991010772e-06
with O 0 7.013570666458691e-07
an O 0 3.129984179395251e-06
increased O 0 0.00026662147138267756
risk O 0 0.38537946343421936
of O 0 0.0003217477351427078
breast B-Disease 1 0.9998242259025574
cancer I-Disease 1 0.9997027516365051
in O 0 9.089265950024128e-05
both O 0 7.708668999839574e-05
homozygotes O 1 0.9667670726776123
and O 0 8.330889977514744e-05
heterozygotes O 1 0.729839026927948
( O 0 3.8465896068373695e-05
relative O 0 4.860210174228996e-05
risk O 0 0.0025537407491356134
12 O 0 5.706617685063975e-06
. O 0 1.4342305121317622e-06
7 O 0 6.015644430590328e-06
; O 0 8.242152944148984e-06
P O 0 0.0007503103697672486
= O 0 0.00019927488756366074
. O 0 3.961376023653429e-06
0025 O 0 0.08860257267951965
) O 0 2.85073997474683e-06
, O 0 9.12741029424069e-07
although O 0 8.458317779513891e-07
there O 0 4.966565825270663e-07
is O 0 6.047218334970239e-07
a O 0 3.2337254651793046e-06
less O 0 8.678022277308628e-05
severe O 1 0.9839216470718384
A B-Disease 0 0.001882715499959886
- I-Disease 0 0.489709734916687
T I-Disease 1 0.9880359768867493
phenotype O 0 0.07440648227930069
in O 0 1.4407476101041539e-06
terms O 0 1.4028033774593496e-06
of O 0 5.268856853035686e-07
the O 0 2.43206068262225e-06
degree O 0 0.00015167637320701033
of O 0 6.839599518571049e-05
cerebellar B-Disease 1 0.9980913996696472
degeneration I-Disease 1 0.9985435009002686
. O 0 0.002753379289060831

This O 0 0.0001488633279222995
mutation O 0 0.0043397643603384495
( O 0 0.00011769172851927578
7271T O 0 0.0030919986311346292
- O 0 0.0023681307211518288
- O 0 0.002217985689640045
> O 0 0.0025940320920199156
G O 0 0.0002721564087551087
) O 0 2.223232058895519e-06
also O 0 4.870313432547846e-07
allows O 0 7.672737183384015e-07
expression O 0 8.606129426880216e-07
of O 0 1.8996040296315186e-07
full O 0 9.18989655929181e-07
- O 0 1.06862516986439e-05
length O 0 2.205228611273924e-06
ATM O 0 1.1083036952186376e-05
protein O 0 2.744214043559623e-06
at O 0 9.869592076938716e-07
a O 0 1.1903022141268593e-06
level O 0 3.470517867754097e-06
comparable O 0 1.268328105652472e-05
with O 0 1.4140200619294774e-06
that O 0 2.460578798491042e-06
in O 0 8.288461685879156e-06
unaffected O 0 0.010774713009595871
individuals O 0 0.00018487514171283692
. O 0 0.00010439902689540759

In O 0 3.845162791549228e-05
addition O 0 1.8913780877483077e-05
, O 0 3.0152107228786917e-06
we O 0 9.67229311754636e-07
have O 0 1.3433717640509713e-06
studied O 0 9.48220713326009e-06
18 O 0 1.1172261110914405e-05
A B-Disease 0 0.00027635673177428544
- I-Disease 1 0.6029675602912903
T I-Disease 1 0.9972841739654541
patients O 1 0.990555465221405
, O 0 5.130679710418917e-06
in O 0 3.2114107852976304e-06
15 O 0 1.4013810869073495e-05
families O 0 8.779720519669354e-05
, O 0 1.722734850773122e-05
who O 0 0.0009275484480895102
developed O 1 0.889487087726593
leukemia B-Disease 1 0.999902606010437
, O 0 0.21179769933223724
lymphoma B-Disease 1 0.9999130964279175
, O 0 0.0073279873467981815
preleukemic O 1 0.9923667311668396
T O 1 0.9961728453636169
- O 1 0.5825704336166382
cell O 0 0.17879565060138702
proliferation O 1 0.6801550388336182
, O 0 0.0006668328423984349
or O 0 0.05175643041729927
Hodgkin B-Disease 1 0.9998540878295898
lymphoma I-Disease 1 0.9999125003814697
, O 0 0.00031814994872547686
mostly O 0 0.0001004400837700814
in O 0 0.00012663399684242904
childhood O 1 0.9332193732261658
. O 0 0.0006297780782915652

A O 0 0.00012327675358392298
wide O 0 8.640104351798072e-05
variety O 0 2.828226024575997e-05
of O 0 4.453382189240074e-06
ATM O 0 0.0005505539593286812
mutation O 0 0.0011636451818048954
types O 0 4.418527169036679e-05
, O 0 3.0351463919942034e-06
including O 0 1.0820313946169335e-05
missense O 0 0.03999985381960869
mutations O 0 0.0016638267552480102
and O 0 1.9642241113615455e-06
in O 0 2.1869238935323665e-06
- O 0 0.00018087815260514617
frame O 0 4.099305078852922e-05
deletions O 0 0.0001613044587429613
, O 0 1.470095867261989e-06
were O 0 8.484785780638049e-07
seen O 0 5.926935045863502e-06
in O 0 4.210239239910152e-06
these O 0 2.203550138801802e-05
patients O 1 0.9494231939315796
. O 0 0.00014509477477986366

We O 0 3.531534457579255e-05
also O 0 5.30644183527329e-06
show O 0 3.3107453418779187e-06
that O 0 8.846489549796388e-07
25 O 0 7.206261329884001e-07
% O 0 3.7044398482066754e-07
of O 0 2.74473762829075e-07
all O 0 7.947793960738636e-07
A B-Disease 0 0.00011396274203434587
- I-Disease 0 0.3768104910850525
T I-Disease 1 0.9937602877616882
patients O 1 0.9368075728416443
carried O 0 9.903922546072863e-06
in O 0 3.4524873626651242e-06
- O 0 0.000536248495336622
frame O 0 0.00010381717584095895
deletions O 0 0.0007924447418190539
or O 0 2.2113010345492512e-05
missense O 0 0.017138561233878136
mutations O 0 0.0008963454747572541
, O 0 8.739156101000845e-07
many O 0 2.2880931282998063e-07
of O 0 1.1321094461891335e-07
which O 0 1.6026078242248332e-07
were O 0 1.37313548975726e-07
also O 0 4.073904733559175e-07
associated O 0 2.0903785298287403e-06
with O 0 7.652933504687098e-07
expression O 0 6.148793090687832e-06
of O 0 2.548548764025327e-06
mutant O 0 0.0006452254019677639
ATM O 0 0.0005767579423263669
protein O 0 0.00033666155650280416
. O 0 0.00015857767721172422

The O 0 0.0006155933369882405
DMPK O 1 0.5155075192451477
gene O 0 0.09095603972673416
of O 0 0.0005897315568290651
severely O 1 0.9946632385253906
affected O 1 0.9932848215103149
myotonic B-Disease 1 0.9995672106742859
dystrophy I-Disease 1 0.9998378753662109
patients O 1 0.9995119571685791
is O 0 0.001469612237997353
hypermethylated O 0 0.3787948787212372
proximal O 0 0.39440155029296875
to O 0 9.40754671319155e-06
the O 0 9.043270438269246e-06
largely O 0 4.6443114115390927e-05
expanded O 0 0.0002966107567772269
CTG O 0 0.21319782733917236
repeat O 0 0.00940913986414671
. O 0 0.0002955984091386199

Using O 0 0.00025694395299069583
methylation O 0 0.0007534048636443913
- O 0 0.0009100057650357485
sensitive O 0 0.00022766941401641816
restriction O 0 5.19337372679729e-05
enzymes O 0 3.5641834983835e-05
, O 0 1.9592625903896987e-06
we O 0 1.2515131402324187e-06
characterized O 0 4.743329554912634e-05
the O 0 8.193541702894436e-07
methylation O 0 1.19971464300761e-05
pattern O 0 8.645798516226932e-06
on O 0 4.83988344512909e-07
the O 0 4.7478110332122014e-07
5 O 0 1.0771756251415354e-06
side O 0 1.1644866617643856e-06
of O 0 5.549487696043798e-07
the O 0 1.6598991123828455e-06
CTG O 0 0.019189191982150078
repeat O 0 0.00014023987750988454
in O 0 2.0104223494854523e-06
the O 0 2.65664516518882e-06
DMPK O 0 0.011784359812736511
gene O 0 9.152444545179605e-05
of O 0 1.0378378192399396e-06
normal O 0 7.293900853255764e-05
individuals O 0 1.708926174615044e-05
and O 0 3.827527962130262e-06
of O 0 2.0004403268103488e-05
patients O 1 0.9992000460624695
affected O 1 0.7809024453163147
with O 0 0.07135072350502014
myotonic B-Disease 1 0.9998326301574707
dystrophy I-Disease 1 0.9998227953910828
, O 0 0.00021635954908560961
showing O 0 0.0002873750345315784
expansions O 0 0.000580497202463448
of O 0 4.112654551136075e-06
the O 0 2.0876233975286596e-05
repetitive O 0 0.17430850863456726
sequence O 0 0.00018861824355553836
. O 0 0.0002084932930301875

The O 0 8.437349606538191e-05
gene O 0 0.0003702081157825887
segment O 0 7.521068619098514e-05
analyzed O 0 5.2725230489159e-05
corresponds O 0 2.241300535388291e-05
to O 0 4.2885721995844506e-06
the O 0 7.169900982262334e-06
genomic O 0 0.0007372553227469325
SacI O 0 0.03660093992948532
- O 0 0.0006724854465574026
HindIII O 0 0.0023012724705040455
fragment O 0 8.124846499413252e-05
carrying O 0 2.602643689897377e-05
exons O 0 0.0002630476374179125
11 O 0 5.829532165080309e-05
- O 0 0.0003338705573696643
15 O 0 0.00011056434595957398
. O 0 0.00011037431249860674

There O 0 4.5467277232091874e-05
is O 0 1.5810521290404722e-05
constitutive O 0 0.00043650830048136413
methylation O 0 0.00010807572834892198
in O 0 5.729624717787374e-06
intron O 0 0.011263031512498856
12 O 0 1.307096863456536e-05
at O 0 3.212252977391472e-06
restriction O 0 6.010930519551039e-06
sites O 0 2.2149531559989555e-06
of O 0 9.179245239465672e-07
SacII O 0 0.0007202848792076111
and O 0 3.5644829949887935e-06
HhaI O 0 0.001466434565372765
, O 0 2.5720912617543945e-06
localized O 0 0.0002104995510308072
1 O 0 4.764462119055679e-06
, O 0 1.563621367495216e-06
159 O 0 4.379171514301561e-05
- O 0 2.7152032998856157e-05
1 O 0 2.9539094157371437e-06
, O 0 1.5656163441235549e-06
232 O 0 3.128709795419127e-05
bp O 0 6.719058728776872e-05
upstream O 0 8.080755833361764e-06
of O 0 7.002769848440948e-07
the O 0 1.956163259819732e-06
CTG O 0 0.029058381915092468
repeat O 0 0.00030073444941081107
, O 0 1.7304207631241297e-06
whereas O 0 4.4098014768678695e-06
most O 0 7.378877171504428e-07
, O 0 3.317767323096632e-07
if O 0 2.4338186221939395e-07
not O 0 6.511122307983896e-08
all O 0 3.731983966304142e-08
, O 0 7.727137329993639e-08
of O 0 4.576126144684167e-08
the O 0 1.2197322973861446e-07
other O 0 1.8351290975715528e-07
sites O 0 9.468096209275245e-07
of O 0 7.640331887159846e-07
SacII O 0 0.004482184536755085
, O 0 4.063174856128171e-06
HhaI O 0 0.0021983070764690638
, O 0 2.100694700857275e-06
and O 0 1.4167709423418273e-06
HpaII O 0 0.0003402787842787802
in O 0 9.812025609789998e-07
this O 0 6.000913685966225e-07
region O 0 8.195071131922305e-06
are O 0 1.2485924116845126e-06
unmethylated O 0 0.004719013813883066
, O 0 1.2908684539070236e-06
in O 0 1.103136582969455e-06
normal O 0 1.5349451132351533e-05
individuals O 0 3.579202029868611e-06
and O 0 8.21069590983825e-07
most O 0 1.3605400681626634e-06
of O 0 2.4667015168233775e-06
the O 0 3.4800155845005065e-05
patients O 1 0.9843336939811707
. O 0 0.00023090046306606382

In O 0 2.6595538656692952e-05
a O 0 7.400078629871132e-06
number O 0 3.425534714551759e-06
of O 0 4.1174653233611025e-06
young O 0 0.004196315538138151
and O 0 0.00018360136891715229
severely O 1 0.9956570863723755
affected O 1 0.7668393850326538
patients O 1 0.9962730407714844
, O 0 3.3019357488228707e-06
however O 0 9.889047305478016e-07
, O 0 4.2072304040630115e-07
complete O 0 2.0343145479273517e-06
methylation O 0 5.095288997836178e-06
of O 0 2.1262547988953884e-07
these O 0 4.265174595730059e-07
restriction O 0 2.789093514365959e-06
sites O 0 1.8105363324139034e-06
was O 0 9.010342978399422e-07
found O 0 1.229511440214992e-06
in O 0 1.0973205917252926e-06
the O 0 6.644142558798194e-06
mutated O 0 0.005422667134553194
allele O 0 0.0019095350289717317
. O 0 0.00013320391008164734

In O 0 5.2913914259988815e-05
most O 0 1.210388472827617e-05
of O 0 4.193785116513027e-06
these O 0 2.5424762498005293e-05
patients O 1 0.9546381831169128
, O 0 7.220899078674847e-06
the O 0 9.251323717762716e-06
onset O 1 0.9732614755630493
of O 0 3.2996860682033e-05
the O 0 0.0011773827718570828
disease O 1 0.9995301961898804
was O 0 0.014048176817595959
congenital O 1 0.9992638230323792
. O 0 0.0033185770735144615

Preliminary O 0 0.000459372706245631
in O 0 7.100476796040311e-05
vivo O 0 0.012457747012376785
footprinting O 0 0.34068354964256287
data O 0 1.5053677088872064e-05
gave O 0 1.0466867934155744e-05
evidence O 0 3.5638950066640973e-06
for O 0 1.2298163483137614e-06
protein O 0 2.067911918857135e-05
- O 0 0.00016163116379175335
DNA O 0 2.7138959922012873e-05
contact O 0 1.976522253244184e-05
in O 0 2.127559810105595e-06
normal O 0 2.362316081416793e-05
genes O 0 2.094726551149506e-05
at O 0 2.038048705799156e-06
an O 0 1.9127849100186722e-06
Sp1 O 0 0.00888125505298376
consensus O 0 6.992905127845006e-06
binding O 0 6.429765562643297e-06
site O 0 3.859247499349294e-06
upstream O 0 6.543306881212629e-06
of O 0 6.629109634559427e-07
the O 0 2.1141079287190223e-06
CTG O 0 0.012761121615767479
repeat O 0 9.419887646799907e-05
and O 0 8.29331156637636e-07
for O 0 5.669513143402583e-07
a O 0 8.363236361219606e-07
significant O 0 1.5307555258914363e-06
reduction O 0 6.322257377178175e-06
of O 0 2.759477695235546e-07
this O 0 4.0564975734014297e-07
interaction O 0 4.12621557188686e-06
in O 0 1.3861047136742854e-06
cells O 0 9.255597979063168e-05
with O 0 2.989798304042779e-06
a O 0 2.5448633095948026e-05
hypermethylated O 0 0.0824565589427948
DMPK O 0 0.3285447359085083
gene O 0 0.0022380200680345297
. O 0 4.160641765338369e-05
. O 0 0.00010339709842810407

The O 0 0.0009340365650132298
hemochromatosis B-Disease 1 0.9927899241447449
gene O 0 0.010968481190502644
product O 0 0.00019068349502049387
complexes O 0 0.0008572085062041879
with O 0 8.924380381358787e-06
the O 0 6.82396921547479e-06
transferrin O 0 0.03310640901327133
receptor O 0 0.0016313795931637287
and O 0 6.067047706892481e-06
lowers O 0 0.0017321191262453794
its O 0 5.4872643886483274e-06
affinity O 0 9.539753955323249e-05
for O 0 1.3771336853096727e-05
ligand O 0 0.0008380073122680187
binding O 0 0.00018502911552786827
. O 0 0.00011204973998246714

We O 0 0.00014156204997561872
recently O 0 0.00012742496619466692
reported O 0 3.507997826091014e-05
the O 0 4.140106284467038e-06
positional O 0 4.745130718220025e-05
cloning O 0 0.00010299068526364863
of O 0 2.3288650936592603e-06
a O 0 1.2268583304830827e-05
candidate O 0 8.030717435758561e-05
gene O 0 0.00525365024805069
for O 0 0.0004013342841062695
hereditary B-Disease 1 0.9943282008171082
hemochromatosis I-Disease 1 0.9991024732589722
called O 0 0.19441325962543488
HFE O 1 0.9836472868919373
. O 0 0.0012361611006781459

The O 0 5.724537913920358e-05
gene O 0 0.00030583725310862064
product O 0 1.8298618670087308e-05
, O 0 1.9886704194505e-06
a O 0 1.7098172975238413e-06
member O 0 1.4580853076040512e-06
of O 0 5.890134389119339e-07
the O 0 3.4240451896039303e-06
major O 0 0.0002491823979653418
histocompatibility O 1 0.9954503178596497
complex O 0 0.0016736407997086644
class O 0 0.0002343703235965222
I O 0 4.959572834195569e-05
- O 0 0.00045245280489325523
like O 0 9.0491457740427e-06
family O 0 9.245167348126415e-06
, O 0 6.753072057108511e-07
was O 0 3.665914505290857e-07
found O 0 5.362650767892774e-07
to O 0 4.3454502929307637e-07
have O 0 5.638685820485989e-07
a O 0 2.4365458557440434e-06
mutation O 0 0.0002821556117851287
, O 0 8.42349800223019e-06
Cys O 1 0.8488866686820984
- O 0 0.002253101207315922
282 O 0 0.003564178477972746
- O 0 0.004684961400926113
- O 0 0.007236476521939039
> O 0 0.02738003060221672
Tyr O 1 0.7079655528068542
( O 0 3.141952402074821e-05
C282Y O 0 0.00041319476440548897
) O 0 2.9981099487486063e-06
, O 0 7.957402772262867e-07
in O 0 1.2695131772488821e-06
85 O 0 8.56504721014062e-06
% O 0 2.8472079520724947e-06
of O 0 5.522221727005672e-06
patient O 0 0.2896500527858734
chromosomes O 0 0.002050250768661499
. O 0 0.00021175085566937923

This O 0 8.456312207272276e-05
mutation O 0 0.000876157428137958
eliminates O 0 0.0003291175526101142
the O 0 9.040381883096416e-06
ability O 0 3.18175989377778e-05
of O 0 4.1785983739828225e-06
HFE O 0 0.33096039295196533
to O 0 8.942236490838695e-06
associate O 0 0.00014729700342286378
with O 0 1.7073103663278744e-05
beta2 O 0 0.06548448652029037
- O 0 0.010322490707039833
microglobulin O 0 0.05082075297832489
( O 0 3.175018719048239e-05
beta2m O 0 0.002858716296032071
) O 0 5.16403042638558e-06
and O 0 3.83643782697618e-06
prevents O 0 0.0012018786510452628
cell O 0 0.000686568848323077
- O 0 0.0008088435861282051
surface O 0 0.00042758110794238746
expression O 0 0.00027932567172683775
. O 0 0.0001263553713215515

A O 0 8.272710692835972e-05
second O 0 2.6156072635785677e-05
mutation O 0 0.0003483547770883888
that O 0 3.5070097510470077e-06
has O 0 3.6277801882533822e-06
no O 0 2.839542048604926e-06
effect O 0 1.5035154319775756e-05
on O 0 4.287255706003634e-06
beta2m O 0 0.013371650129556656
association O 0 0.00022568879649043083
, O 0 4.843632723350311e-06
H63D O 0 0.004625145345926285
, O 0 8.598730119047104e-07
was O 0 3.6180949791742023e-07
found O 0 4.1101111492025666e-07
in O 0 2.3545372584976576e-07
eight O 0 6.750998409188469e-07
out O 0 6.691304292871791e-07
of O 0 8.743607509131834e-07
nine O 0 4.3954634747933596e-05
patients O 1 0.9507232904434204
heterozygous O 0 0.0008350273128598928
for O 0 8.245062417699955e-06
the O 0 1.3466679774865042e-05
C282Y O 0 0.022493844851851463
mutant O 0 0.008792919106781483
. O 0 0.00019256173982284963

In O 0 5.180231528356671e-05
this O 0 8.34805268823402e-06
report O 0 8.919921128835995e-06
, O 0 1.730336521177378e-06
we O 0 1.539334107292234e-06
demonstrate O 0 1.098417033063015e-05
in O 0 4.549752702587284e-06
cultured O 0 0.0011500540422275662
293 O 0 0.050482138991355896
cells O 0 0.0527660958468914
overexpressing O 1 0.8952094912528992
wild O 0 0.0004352627438493073
- O 0 0.0022949797566980124
type O 0 0.00045271377894096076
or O 0 2.3382355720968917e-05
mutant O 0 0.0013428546953946352
HFE O 0 0.1465473175048828
proteins O 0 8.79605704540154e-06
that O 0 8.217980962399452e-07
both O 0 7.158567427723028e-07
the O 0 1.326757683273172e-06
wild O 0 2.547742951719556e-05
- O 0 0.00036178709706291556
type O 0 0.00016924556985031813
and O 0 1.0183702215726953e-05
H63D O 0 0.06703711301088333
HFE O 0 0.4488624632358551
proteins O 0 3.554011709638871e-05
form O 0 2.8558815756696276e-05
stable O 0 0.0009343744604848325
complexes O 0 0.0013067026156932116
with O 0 9.722596587380394e-06
the O 0 2.2870573957334273e-05
transferrin O 1 0.5129051208496094
receptor O 0 0.0929330438375473
( O 0 0.00037219247315078974
TfR O 0 0.35359349846839905
) O 0 0.00013623051927424967
. O 0 0.00013242935528978705

The O 0 0.00021197950991336256
C282Y O 0 0.007331987377256155
mutation O 0 0.002359898528084159
nearly O 0 7.856583397369832e-05
completely O 0 4.947140405420214e-05
prevents O 0 0.00018389115575700998
the O 0 2.972855781990802e-06
association O 0 2.0882367607555352e-05
of O 0 1.358255758532323e-06
the O 0 5.808984496979974e-06
mutant O 0 0.0023070976603776217
HFE O 0 0.22660231590270996
protein O 0 8.873679325915873e-05
with O 0 1.909487218654249e-05
the O 0 4.791904575540684e-05
TfR O 1 0.5379034280776978
. O 0 0.0002688047825358808

Studies O 0 0.0005395437474362552
on O 0 2.973622758872807e-05
cell O 0 0.0006667194538749754
- O 0 0.0014833358582109213
associated O 0 0.0001314610562985763
transferrin O 0 0.006472847890108824
at O 0 9.576831871527247e-06
37 O 0 2.9585404263343662e-05
degrees O 0 6.0359161579981446e-05
C O 0 0.0001290842774324119
suggest O 0 8.004105438885745e-06
that O 0 8.213883120333776e-07
the O 0 2.020792862822418e-06
overexpressed O 0 0.014544960111379623
wild O 0 4.405047366162762e-05
- O 0 0.0009408249752596021
type O 0 0.0005823108367621899
HFE O 0 0.20910011231899261
protein O 0 3.810092312050983e-05
decreases O 0 3.8991413020994514e-05
the O 0 1.6065481531768455e-06
affinity O 0 1.7722384654916823e-05
of O 0 1.8697320456340094e-06
the O 0 9.585218322172295e-06
TfR O 0 0.23086711764335632
for O 0 8.565092866774648e-05
transferrin O 0 0.35291364789009094
. O 0 0.00027077950653620064

The O 0 0.00034902224433608353
overexpressed O 0 0.3009532690048218
H63D O 0 0.02678009122610092
protein O 0 0.00014687178190797567
does O 0 1.4047796867089346e-05
not O 0 9.580425057720277e-07
have O 0 6.086759185564006e-07
this O 0 3.265595012180711e-07
effect O 0 2.2891131266078446e-06
, O 0 3.402051049761212e-07
providing O 0 1.707003661977069e-06
the O 0 2.0222837804340088e-07
first O 0 2.3319847741731792e-07
direct O 0 9.082319252229354e-07
evidence O 0 9.000260092761891e-07
for O 0 7.078076009747747e-07
a O 0 2.1566047507803887e-06
functional O 0 2.8524140361696482e-05
consequence O 0 3.234349060221575e-05
of O 0 2.2111330508778337e-06
the O 0 1.8812017515301704e-05
H63D O 0 0.1978999525308609
mutation O 0 0.015273473225533962
. O 0 0.00020402077643666416

Addition O 0 0.00015362536942120641
of O 0 2.9539733077399433e-05
soluble O 0 0.008404906839132309
wild O 0 0.0010116604389622808
- O 0 0.04269369691610336
type O 0 0.08198563754558563
HFE O 1 0.9902303814888
/ O 1 0.5412639379501343
beta2m O 0 0.16727198660373688
heterodimers O 0 0.38308069109916687
to O 0 1.4238186849979684e-05
cultured O 0 0.0033923292066901922
cells O 0 0.0017697865841910243
also O 0 3.1711676911072573e-06
decreased O 0 0.00012380069529172033
the O 0 1.3068622592982138e-06
apparent O 0 9.751796460477635e-05
affinity O 0 2.564516762504354e-05
of O 0 6.562727321579587e-07
the O 0 2.212217168562347e-06
TfR O 0 0.022357098758220673
for O 0 1.3443251418721047e-06
its O 0 2.52517338594771e-06
ligand O 0 0.0002439265517750755
under O 0 6.919640782143688e-06
steady O 0 6.210377614479512e-05
- O 0 0.0003196372417733073
state O 0 3.2771213227533735e-06
conditions O 0 3.9291739085456356e-05
, O 0 1.0416137001811876e-06
both O 0 1.2358241292531602e-06
in O 0 2.8583078801602824e-06
293 O 0 0.002221430651843548
cells O 0 0.0006016024854034185
and O 0 6.91181867296109e-06
in O 0 3.2300733437296e-05
HeLa O 1 0.7377780079841614
cells O 0 0.021337119862437248
. O 0 0.0002169445506297052

Furthermore O 0 0.0004689559282269329
, O 0 1.4074240425543394e-05
at O 0 7.919882591522764e-06
4 O 0 9.402076102560386e-06
degrees O 0 3.0770905141253024e-05
C O 0 3.963458220823668e-05
, O 0 5.224086976340914e-07
the O 0 5.202708166507364e-07
added O 0 3.059038590436103e-06
soluble O 0 0.00033627726952545345
complex O 0 5.152764788363129e-05
of O 0 9.006081199913751e-06
HFE O 1 0.9803066849708557
/ O 0 0.13778966665267944
beta2m O 0 0.01950889267027378
inhibited O 0 0.001202748971991241
binding O 0 1.2150261682108976e-05
of O 0 2.584871026556357e-06
transferrin O 0 0.015081209130585194
to O 0 1.3796549865219276e-05
HeLa O 0 0.18263930082321167
cell O 0 0.0019289256306365132
TfR O 0 0.09450425952672958
in O 0 6.081286301196087e-06
a O 0 1.6232412235694937e-05
concentration O 0 0.00038600878906436265
- O 0 0.0016389365773648024
dependent O 0 0.00030754422186873853
manner O 0 0.000244895025389269
. O 0 0.00013680146366823465

Scatchard O 0 0.0027626848313957453
plots O 0 0.0001207304303534329
of O 0 5.054499524703715e-06
these O 0 2.626531113492092e-06
data O 0 2.032164275078685e-06
indicate O 0 3.7756553865619935e-06
that O 0 4.814380076822999e-07
the O 0 6.601659379157354e-07
added O 0 5.32200101588387e-06
heterodimer O 0 0.005042430013418198
substantially O 0 0.00012787154992111027
reduced O 0 1.5963725672918372e-05
the O 0 2.6523516680754256e-06
affinity O 0 5.130454883328639e-05
of O 0 6.9894385887891985e-06
TfR O 0 0.15252931416034698
for O 0 0.00010248771286569536
transferrin O 0 0.2813817858695984
. O 0 0.00040139228804036975

These O 0 4.619698665919714e-05
results O 0 3.2566145819146186e-05
establish O 0 2.4004961233003996e-05
a O 0 9.221676009474322e-06
molecular O 0 0.00015868492482695729
link O 0 0.00016141892410814762
between O 0 1.345517739537172e-05
HFE O 0 0.19256281852722168
and O 0 2.2823314793640748e-06
a O 0 2.2819876903668046e-06
key O 0 3.894555902661523e-06
protein O 0 8.366239853785373e-06
involved O 0 4.172417902736925e-06
in O 0 1.3119471304889885e-06
iron O 0 0.00018317662761546671
transport O 0 3.3400487154722214e-05
, O 0 2.3757309008942684e-06
the O 0 2.720003521972103e-06
TfR O 0 0.03540196642279625
, O 0 1.3211781606514705e-06
and O 0 9.143353736362769e-07
raise O 0 5.7354254749952815e-06
the O 0 6.618427619287104e-07
possibility O 0 6.653032414760673e-06
that O 0 6.835425097051484e-07
alterations O 0 1.5083508515090216e-05
in O 0 5.325608753992128e-07
this O 0 4.527222756678384e-07
regulatory O 0 4.9398946430301294e-05
mechanism O 0 2.362899795116391e-05
may O 0 4.189324045000831e-06
play O 0 7.943633590912214e-07
a O 0 9.95913183032826e-07
role O 0 5.675307875208091e-06
in O 0 4.134160462854197e-06
the O 0 1.661500209593214e-05
pathogenesis O 1 0.9868452548980713
of O 0 0.0002689627290237695
hereditary B-Disease 1 0.9956386685371399
hemochromatosis I-Disease 1 0.999233603477478
. O 0 0.0008850117446854711
. O 0 0.0003787498571909964

Genomic O 0 0.003199752187356353
organization O 0 0.0003418756532482803
of O 0 3.706780989887193e-05
the O 0 9.410765051143244e-05
UBE3A O 1 0.9359445571899414
/ O 0 0.3240346312522888
E6 O 0 0.1282685250043869
- O 0 0.04056895896792412
AP O 0 0.005954150576144457
gene O 0 0.0013862855266779661
and O 0 4.018085019197315e-05
related O 0 0.002017180435359478
pseudogenes O 0 0.02936728298664093
. O 0 0.0002325140667380765

The O 0 0.0004933669697493315
UBE3A O 0 0.33338239789009094
gene O 0 0.001006093341857195
encodes O 0 0.0002484263968653977
the O 0 2.636945828271564e-05
E6 O 0 0.0024196086451411247
- O 0 0.0013691755011677742
AP O 0 0.0005040612304583192
ubiquitin O 0 0.0009693999891169369
- O 0 0.00024681081413291395
protein O 0 5.2607054385589436e-05
ligase O 0 0.0003902780299540609
and O 0 3.904641744156834e-06
has O 0 4.855583483731607e-06
recently O 0 1.4269028724811506e-05
been O 0 1.5819124428162468e-06
shown O 0 5.825072094012285e-06
to O 0 2.7614307782641845e-06
be O 0 1.5385152437374927e-05
mutated O 1 0.8460497856140137
in O 0 0.07817400991916656
Angelman B-Disease 1 0.9998327493667603
syndrome I-Disease 1 0.9999446868896484
patients O 1 0.9995588660240173
who O 0 0.002536194398999214
lack O 0 0.006658392492681742
15q11 O 0 0.29656165838241577
- O 0 0.05078040063381195
q13 O 0 0.0649990662932396
deletions O 0 0.006430070847272873
or O 0 0.00010999837832059711
chromosome O 0 0.006958669051527977
15 O 0 0.00029374059522524476
paternal O 0 0.039687734097242355
uniparental B-Disease 1 0.9756109118461609
disomy I-Disease 1 0.6854366660118103
. O 0 0.0010940924985334277

Previous O 0 0.0009064067853614688
UBE3A O 0 0.23910070955753326
cDNA O 0 0.0005586905172094703
analysis O 0 5.4407275456469506e-05
has O 0 8.230646926676854e-06
shown O 0 1.0524974641157314e-05
a O 0 5.10683230459108e-06
coding O 0 8.041968249017373e-05
region O 0 1.7278865925618447e-05
of O 0 2.35324478126131e-06
approximately O 0 2.434890848235227e-05
2 O 0 5.064573269919492e-05
. O 0 7.060640928102657e-05

6 O 0 0.00029544797143898904
kb O 0 0.0008913942147046328
and O 0 8.292754500871524e-06
a O 0 6.477815986727364e-06
3 O 0 1.690286626399029e-05
- O 0 0.00019861514738295227
untranslated O 0 0.0021692945156246424
region O 0 6.497561116702855e-05
( O 0 1.4783607184654102e-05
UTR O 0 0.0005466510192491114
) O 0 2.5905790153046837e-06
of O 0 1.0648616353137186e-06
< O 0 0.00030100811272859573
50 O 0 5.598730240308214e-06
bp O 0 0.00011448228906374425
, O 0 1.1728724302884075e-06
whereas O 0 3.213913942090585e-06
Northern O 0 1.8739860934147146e-06
analysis O 0 2.0996951661800267e-06
has O 0 1.1278157217020635e-06
indicated O 0 3.445888751230086e-06
mRNA O 0 3.7607167087116977e-06
sizes O 0 3.995681709056953e-06
of O 0 1.0478746617081924e-06
5 O 0 8.601169611210935e-06
- O 0 0.00011687385995173827
8 O 0 5.09065248479601e-05
kb O 0 0.0025744850281625986
. O 0 0.00014475510397460312

We O 0 3.0544728360837325e-05
have O 0 8.110248927550856e-06
analyzed O 0 2.6840139980777167e-05
additional O 0 8.788971172180027e-06
cDNA O 0 4.422008714755066e-05
clones O 0 0.0001347439392702654
and O 0 1.1325688547003665e-06
provide O 0 2.9690959308936726e-06
evidence O 0 1.6158440985236666e-06
for O 0 8.387822276745283e-07
an O 0 2.0634261090890504e-06
additional O 0 1.9308936316519976e-05
0 O 0 0.00010669357288861647
. O 0 6.167530227685347e-05

5 O 0 0.00021911360090598464
kb O 0 0.000455374683951959
of O 0 9.854855306912214e-06
5 O 0 3.012181696249172e-05
- O 0 0.00021069571084808558
UTR O 0 0.0011071196058765054
and O 0 5.4998699852149e-06
> O 0 0.00014727326924912632
2 O 0 8.42166718939552e-06
kb O 0 0.00011200048902537674
of O 0 4.887761406280333e-06
3 O 0 4.83672229165677e-05
- O 0 0.0010074533056467772
UTR O 0 0.013433108106255531
. O 0 0.000222531525650993

We O 0 3.5940451198257506e-05
have O 0 8.649039955344051e-06
established O 0 6.700239737256197e-06
the O 0 1.9395672552491305e-06
genomic O 0 7.129679579520598e-05
organization O 0 1.5361327314167283e-05
of O 0 2.046888084805687e-06
UBE3A O 0 0.026124203577637672
and O 0 1.5426406889673672e-06
the O 0 1.6231525705734384e-06
sequence O 0 7.676392669964116e-06
of O 0 5.330910880729789e-06
intron O 0 0.06314586848020554
- O 0 0.0042919800616800785
exon O 0 0.004126448649913073
borders O 0 0.0007484875968657434
. O 0 0.0001931033912114799

We O 0 3.077865403611213e-05
have O 0 5.065840014140122e-06
also O 0 2.6285908916179324e-06
mapped O 0 1.1502766938065179e-05
two O 0 1.7845416095951805e-06
highly O 0 1.64259436132852e-05
homologous O 0 0.00019718860858120024
processed O 0 2.3096594304661267e-05
pseudogenes O 0 0.001663304166868329
, O 0 7.347380233113654e-06
UBE3AP1 O 0 0.004005617927759886
and O 0 3.0889759727870114e-06
UBE3AP2 O 0 0.0009327639709226787
, O 0 1.1222066405025544e-06
to O 0 6.411681283680082e-07
chromosomes O 0 4.771442036144435e-06
2 O 0 1.480515720686526e-06
and O 0 5.466062020786921e-07
21 O 0 1.583438461238984e-06
, O 0 4.7263975488931464e-07
respectively O 0 1.2922799896841752e-06
, O 0 6.518578175018774e-07
and O 0 1.0203648344031535e-06
determined O 0 6.1163236750871874e-06
their O 0 5.812497420265572e-06
genomic O 0 0.0005187191418372095
organization O 0 0.000246977258939296
. O 0 8.566988981328905e-05

These O 0 2.7394462449592538e-05
results O 0 1.681238973105792e-05
will O 0 2.281865818076767e-06
form O 0 1.5471667893507401e-06
the O 0 4.6505218165293627e-07
basis O 0 6.775468932573858e-07
for O 0 1.07204937194183e-06
studies O 0 1.0353306606702972e-05
of O 0 2.104440454786527e-06
mutation O 0 0.0003955058054998517
and O 0 1.2004688869637903e-05
imprinting O 0 0.0154872452840209
of O 0 7.237267709570006e-05
UBE3A O 1 0.9556257724761963
. O 0 0.000521095294971019

Mutation O 0 0.10458497703075409
spectrum O 0 0.0036004967987537384
and O 0 0.00031957810278981924
genotype O 1 0.7716176509857178
- O 0 0.3756200075149536
phenotype O 1 0.9448778033256531
analyses O 0 0.017870768904685974
in O 0 0.005209499504417181
Cowden B-Disease 1 0.9988378882408142
disease I-Disease 1 0.9994321465492249
and O 0 0.010555907152593136
Bannayan B-Disease 1 0.9967567324638367
- I-Disease 1 0.9958896040916443
Zonana I-Disease 1 0.9989078044891357
syndrome I-Disease 1 0.9997410178184509
, O 0 0.0013113454915583134
two O 0 0.0013435576111078262
hamartoma B-Disease 1 0.99622642993927
syndromes I-Disease 1 0.9986270666122437
with O 0 0.029205212369561195
germline O 1 0.9926183819770813
PTEN O 1 0.989859402179718
mutation O 1 0.5292202830314636
. O 0 0.0007930279243737459

The O 0 0.0031178321223706007
tumour B-Disease 1 0.9954197406768799
suppressor O 1 0.9761673212051392
gene O 0 0.2738525867462158
PTEN O 1 0.8725940585136414
, O 0 2.0374412997625768e-05
which O 0 8.472014087601565e-06
maps O 0 4.0375358366873115e-05
to O 0 2.0676199710578658e-05
10q23 O 0 0.00368047715164721
. O 0 0.0001367346994811669

3 O 0 6.217891495907679e-05
and O 0 9.38174343900755e-06
encodes O 0 5.575844261329621e-05
a O 0 1.1393133718229365e-05
403 O 0 8.136291580740362e-05
amino O 0 2.8600243240362033e-05
acid O 0 9.908903302857652e-05
dual O 0 7.53524000174366e-05
specificity O 0 0.00031845615012571216
phosphatase O 0 0.09506037086248398
( O 0 3.0145323762553744e-05
protein O 0 9.777235391084105e-05
tyrosine O 0 0.00409354642033577
phosphatase O 0 0.3572103679180145
; O 0 5.3695403039455414e-05
PTPase O 0 0.004663181025534868
) O 0 3.5378402571950573e-06
, O 0 9.324054417447769e-07
was O 0 6.191981469783059e-07
shown O 0 1.963036766028381e-06
recently O 0 2.998112904606387e-06
to O 0 3.5696396594175894e-07
play O 0 6.491338240266487e-07
a O 0 2.473910399203305e-06
broad O 0 8.422028622590005e-05
role O 0 2.4788299924694e-05
in O 0 2.126029721694067e-05
human O 0 0.004195698071271181
malignancy B-Disease 1 0.9896680116653442
. O 0 0.0004251509963069111

Somatic O 1 0.7820088267326355
PTEN O 1 0.9586977362632751
deletions O 0 0.007929339073598385
and O 0 5.0419002946000546e-05
mutations O 0 0.003048466518521309
were O 0 3.8130856410134584e-06
observed O 0 6.281577952904627e-05
in O 0 2.8948157705599442e-05
sporadic B-Disease 0 0.4807315170764923
breast I-Disease 1 0.9994366765022278
, I-Disease 0 0.029505299404263496
brain I-Disease 1 0.9994096755981445
, I-Disease 0 0.16690951585769653
prostate I-Disease 1 0.9998888969421387
and I-Disease 1 0.6786068677902222
kidney I-Disease 1 0.9999101161956787
cancer I-Disease 1 0.9998225569725037
cell O 0 0.08301360160112381
lines O 0 0.00012429384514689445
and O 0 4.894963694823673e-06
in O 0 3.333042059239233e-06
several O 0 1.513961160526378e-05
primary O 0 0.00289631518535316
tumours B-Disease 1 0.9990308284759521
such O 0 0.0005209669470787048
as O 0 0.014647100120782852
endometrial B-Disease 1 0.9995741248130798
carcinomas I-Disease 1 0.9997335076332092
, O 1 0.9828755855560303
malignant B-Disease 1 0.9999101161956787
melanoma I-Disease 1 0.9998860359191895
and O 1 0.8989456295967102
thyroid B-Disease 1 0.9995489716529846
tumours I-Disease 1 0.9988952279090881
. O 0 0.013301219791173935

In O 0 9.424200106877834e-05
addition O 0 6.08797708991915e-05
, O 0 3.510116584948264e-05
PTEN O 1 0.6150680184364319
was O 0 5.072888143331511e-06
identified O 0 1.767111461958848e-05
as O 0 1.8149133893530234e-06
the O 0 5.845295163453557e-06
susceptibility O 1 0.7386668920516968
gene O 0 0.005828512832522392
for O 0 8.111021452350542e-05
two O 0 0.0015297862701117992
hamartoma B-Disease 1 0.999072790145874
syndromes I-Disease 1 0.9997168183326721
Cowden B-Disease 1 0.9993744492530823
disease I-Disease 1 0.9996194839477539
( O 0 0.0016769870417192578
CD B-Disease 0 0.0011702313786372542
; O 0 0.00032577168894931674
MIM O 1 0.9254668354988098
158350 O 0 0.026992641389369965
) O 0 1.712802804831881e-05
and O 0 1.3333089555089828e-05
Bannayan B-Disease 0 0.06493465602397919
- I-Disease 0 0.06418676674365997
Zonana I-Disease 1 0.9835703372955322
( I-Disease 0 0.0001991331810131669
BZS I-Disease 0 0.1592230200767517
) I-Disease 0 5.1121111027896404e-05
or I-Disease 0 0.00011550424824235961
Ruvalcaba I-Disease 1 0.9862827658653259
- I-Disease 1 0.5054009556770325
Riley I-Disease 1 0.7184520959854126
- I-Disease 1 0.8354330062866211
Smith I-Disease 1 0.8821234107017517
syndrome I-Disease 1 0.9993643164634705
( O 0 0.007811511401087046
MIM O 1 0.9829505085945129
153480 O 0 0.2503378093242645
) O 0 0.00032722068135626614
. O 0 0.00019530692952685058

Constitutive O 0 0.011346657760441303
DNA O 0 0.00033647927921265364
from O 0 1.935879117809236e-05
37 O 0 3.993621066911146e-05
CD B-Disease 0 4.081459701410495e-05
families O 0 2.3978167519089766e-05
and O 0 4.682841790781822e-06
seven O 0 2.595431033114437e-05
BZS B-Disease 0 0.2511715292930603
families O 0 9.033334208652377e-05
was O 0 1.2611081729119178e-05
screened O 0 0.00024531196686439216
for O 0 0.0001108923097490333
germline O 1 0.9833804368972778
PTEN O 1 0.9860305786132812
mutations O 0 0.3301081359386444
. O 0 0.00035936833592131734

PTEN O 1 0.9691619873046875
mutations O 0 0.015751320868730545
were O 0 9.73584519670112e-06
identified O 0 1.2440931641322095e-05
in O 0 1.456953782508208e-06
30 O 0 2.3065235836838838e-06
of O 0 6.414653626052313e-07
37 O 0 7.738205567875411e-06
( O 0 3.3304934277111897e-06
81 O 0 1.758038160915021e-05
% O 0 1.3918971717430395e-06
) O 0 1.7245148455913295e-06
CD B-Disease 0 7.282851584022865e-06
families O 0 5.739206244470552e-06
, O 0 1.0247883892589016e-06
including O 0 3.325285661048838e-06
missense O 0 0.0013617707882076502
and O 0 3.2999207633110927e-06
nonsense O 0 0.00010116446355823427
point O 0 9.058316209120676e-06
mutations O 0 0.0007513450109399855
, O 0 3.234977839383646e-06
deletions O 0 0.00012671710283029824
, O 0 5.414865427155746e-06
insertions O 0 0.0003060168819501996
, O 0 5.195139692659723e-06
a O 0 1.664164119574707e-05
deletion O 0 0.038831960409879684
/ O 0 0.01722305826842785
insertion O 0 0.0009069000370800495
and O 0 3.219503560103476e-05
splice O 0 0.003374658292159438
site O 0 0.00043413194362074137
mutations O 0 0.009491350501775742
. O 0 0.0002555128885433078

These O 0 5.2803170547122136e-05
mutations O 0 0.0006220935611054301
were O 0 2.2420263121603057e-06
scattered O 0 4.7979165174183436e-06
over O 0 1.137354047386907e-06
the O 0 7.211444881249918e-07
entire O 0 3.347676738485461e-06
length O 0 3.174308176312479e-06
of O 0 1.0777982879517367e-06
PTEN O 0 0.2089485079050064
, O 0 7.640448984602699e-07
with O 0 2.862512360479741e-07
the O 0 2.728795891471236e-07
exception O 0 1.0277422006765846e-06
of O 0 1.1184186377022343e-07
the O 0 2.6275429831912334e-07
first O 0 4.540717668533034e-07
, O 0 5.024956521992863e-07
fourth O 0 2.4076769022940425e-06
and O 0 1.9443566543486668e-06
last O 0 2.50917837547604e-05
exons O 0 0.0009711259626783431
. O 0 9.604047954780981e-05

A O 0 0.00021828574244864285
hot O 0 0.0004472840519156307
spot O 0 0.00014297464804258198
for O 0 4.7392513806698844e-05
PTEN O 1 0.7938670516014099
mutation O 0 0.000783165916800499
in O 0 3.4477295685064746e-06
CD B-Disease 0 1.043720476445742e-05
was O 0 1.3828407645632979e-06
identified O 0 2.74190142590669e-06
in O 0 7.651458986401849e-07
exon O 0 3.112779086222872e-05
5 O 0 1.2979046459804522e-06
that O 0 3.2092231094793533e-07
contains O 0 7.40875350402348e-07
the O 0 7.107297506081522e-07
PTPase O 0 0.00016919166955631226
core O 0 5.509271886694478e-06
motif O 0 1.2586955563165247e-05
, O 0 3.8964256532381114e-07
with O 0 3.0173862342053326e-07
13 O 0 1.0081024583996623e-06
of O 0 2.804392806865508e-07
30 O 0 1.680304876572336e-06
( O 0 1.5879160173426499e-06
43 O 0 2.8623396701732418e-06
% O 0 1.083690676750848e-06
) O 0 1.7268616829824168e-06
CD B-Disease 0 1.882161814137362e-05
mutations O 0 0.0002564209862612188
identified O 0 8.503663593728561e-06
in O 0 3.018510824404075e-06
this O 0 7.4042295636900235e-06
exon O 0 0.0011107864556834102
. O 0 0.00011851145973196253

Seven O 0 5.152936137164943e-05
of O 0 6.622773071285337e-06
30 O 0 1.3582632163888775e-05
( O 0 5.792190222564386e-06
23 O 0 3.747617029148387e-06
% O 0 9.87478870229097e-07
) O 0 6.326542347778741e-07
were O 0 1.530426914087002e-07
within O 0 2.990129814861575e-07
the O 0 2.160929142291934e-07
core O 0 2.4376381588808727e-06
motif O 0 9.229840543412138e-06
, O 0 3.0218356528166623e-07
the O 0 2.2871810756441846e-07
majority O 0 7.966582984408888e-07
( O 0 6.009653361616074e-07
five O 0 1.8280373126344784e-07
of O 0 8.762877001800007e-08
seven O 0 6.044116389603005e-07
) O 0 3.25279870594386e-07
of O 0 1.415046426700428e-07
which O 0 3.754868487249041e-07
were O 0 1.0970873063342879e-06
missense O 0 0.00287649966776371
mutations O 0 0.0014947176678106189
, O 0 1.6992884184219292e-06
possibly O 0 7.413224011543207e-06
pointing O 0 6.062351076252526e-06
to O 0 3.759196545161103e-07
the O 0 6.435499244616949e-07
functional O 0 7.456893854396185e-06
significance O 0 7.446931249432964e-06
of O 0 1.8371935084360302e-06
this O 0 4.785418695973931e-06
region O 0 0.00014663695765193552
. O 0 8.078508835751563e-05

Germline O 1 0.9803506135940552
PTEN O 1 0.9757615327835083
mutations O 0 0.01749360002577305
were O 0 8.898459782358259e-06
identified O 0 1.3562672393163666e-05
in O 0 1.6002054508135188e-06
four O 0 1.3843687156622764e-06
of O 0 9.436762411496602e-07
seven O 0 6.393585408659419e-06
( O 0 8.312613317684736e-06
57 O 0 2.784804382827133e-05
% O 0 8.689395144756418e-06
) O 0 3.660308357211761e-05
BZS B-Disease 0 0.2654563784599304
families O 0 0.0003553428687155247
studied O 0 0.0002892714401241392
. O 0 0.00014910439494997263

Interestingly O 0 0.004040088038891554
, O 0 3.193652082700282e-05
none O 0 1.6274727386189625e-05
of O 0 1.4408589095182833e-06
these O 0 2.9996886041772086e-06
mutations O 0 0.0007211090996861458
was O 0 2.0419067823240766e-06
observed O 0 7.2142775024985895e-06
in O 0 1.6923567045523669e-06
the O 0 4.543452178040752e-06
PTPase O 0 0.0031737808603793383
core O 0 0.00017480747192166746
motif O 0 0.0013353460235521197
. O 0 0.00013181152462493628

It O 0 3.842692603939213e-05
is O 0 9.131309525400866e-06
also O 0 2.061357008642517e-06
worthy O 0 1.0535669389355462e-05
of O 0 6.026946834936098e-07
note O 0 3.381363740118104e-06
that O 0 5.757883059231972e-07
a O 0 1.1144061318191234e-06
single O 0 2.4340886284335284e-06
nonsense O 0 3.5436725738691166e-05
point O 0 4.91969331051223e-06
mutation O 0 0.00028413382824510336
, O 0 2.827918706316268e-06
R233X O 0 0.00024872974609024823
, O 0 1.0984189202645211e-06
was O 0 5.7437006262262e-07
observed O 0 1.8887776604969986e-06
in O 0 5.176304966880707e-07
the O 0 1.4471632994172978e-06
germline O 0 0.0145180094987154
DNA O 0 1.85376684385119e-05
from O 0 1.7481238501204643e-06
two O 0 2.100993242493132e-06
unrelated O 0 0.000281904503935948
CD B-Disease 0 4.122328755329363e-05
families O 0 3.389127232367173e-05
and O 0 6.538853085658047e-06
one O 0 2.2597534552915022e-05
BZS B-Disease 0 0.29919639229774475
family O 0 0.0004509620775934309
. O 0 0.00013214550563134253

Genotype O 1 0.9652079939842224
- O 0 0.2486046701669693
phenotype O 1 0.6704373359680176
studies O 0 0.00011776334577007219
were O 0 2.371176833548816e-06
not O 0 7.686095386816305e-07
performed O 0 1.3584708540292922e-06
on O 0 3.66368141158091e-07
this O 0 5.078214257991931e-07
small O 0 2.178044724132633e-06
group O 0 8.138279554259498e-06
of O 0 9.296483767684549e-06
BZS B-Disease 0 0.24915926158428192
families O 0 0.00045585198677144945
. O 0 0.00016588717699050903

However O 0 0.000250578741542995
, O 0 9.815049997996539e-05
genotype O 0 0.15212367475032806
- O 0 0.024681413546204567
phenotype O 0 0.2944555878639221
analysis O 0 8.006829739315435e-05
inthe O 0 0.011273257434368134
group O 0 1.2743635124934372e-05
of O 0 1.8737430309556657e-06
CD B-Disease 0 3.258956712670624e-05
families O 0 1.823846105253324e-05
revealed O 0 1.7152808140963316e-05
two O 0 8.083986244855623e-07
possible O 0 3.199698994649225e-06
associations O 0 5.488719125423813e-06
worthy O 0 1.4229091902961954e-05
of O 0 8.518741196894553e-07
follow O 0 5.5293521654675715e-06
- O 0 2.5322457076981664e-05
up O 0 2.619329279696103e-06
in O 0 2.219778707512887e-06
independent O 0 1.0940824722638354e-05
analyses O 0 0.0001554620685055852
. O 0 7.060155621729791e-05

The O 0 3.244394974899478e-05
first O 0 1.0475316230440512e-05
was O 0 3.82689631805988e-06
an O 0 1.8800632233251235e-06
association O 0 5.124499148223549e-05
noted O 0 3.2998266306094592e-06
in O 0 6.689262477266311e-07
the O 0 5.713598056900082e-07
group O 0 1.9091146441496676e-06
of O 0 1.534725470264675e-06
CD B-Disease 0 0.00019849777163472027
families O 0 0.001397849409841001
with O 0 0.007329918444156647
breast B-Disease 1 0.9994623064994812
disease I-Disease 1 0.9991965889930725
. O 0 0.0024423105642199516

A O 0 0.00015254692698363215
correlation O 0 0.00018740729137789458
was O 0 8.980079655884765e-06
observed O 0 1.1340603123244364e-05
between O 0 2.2271665329753887e-06
the O 0 2.4725281946302857e-06
presence O 0 3.3322252420475706e-05
/ O 0 0.003071436658501625
absence O 0 4.1176925151376054e-05
of O 0 2.201551069447305e-06
a O 0 3.7607314880006015e-05
PTEN O 1 0.934766948223114
mutation O 0 0.0016782646998763084
and O 0 2.0337890873634024e-06
the O 0 2.4405692329310114e-06
type O 0 0.0003900905139744282
of O 0 2.0390349163790233e-05
breast O 1 0.9985295534133911
involvement O 0 0.2699930965900421
( O 0 0.0021777786314487457
unaffected O 1 0.83353590965271
versus O 1 0.5382694602012634
benign O 1 0.99544358253479
versus O 1 0.8946565985679626
malignant O 1 0.998475968837738
) O 0 0.00093411048874259
. O 0 0.0003217587945982814

Specifically O 0 0.00015211262507364154
and O 0 8.36131857795408e-06
more O 0 3.270411752964719e-06
directly O 0 4.759484454552876e-06
, O 0 1.4609944400945096e-06
an O 0 1.2364644135232083e-06
association O 0 2.36210416915128e-05
was O 0 6.235441674107278e-07
also O 0 4.158992510383541e-07
observed O 0 1.6965276472546975e-06
between O 0 4.1564587149878207e-07
the O 0 3.797361785018438e-07
presence O 0 2.703622612898471e-06
of O 0 1.4248466868593823e-06
a O 0 0.0001958316715899855
PTEN O 1 0.9958009123802185
mutation O 1 0.8897929191589355
and O 0 0.10723461955785751
malignant B-Disease 1 0.9997709393501282
breast I-Disease 1 0.9997393488883972
disease I-Disease 1 0.9994953870773315
. O 0 0.008225382305681705

Secondly O 0 0.0015940313460305333
, O 0 1.4351676327351015e-05
there O 0 3.650491180451354e-06
appeared O 0 4.262143193045631e-06
to O 0 7.811177624716947e-07
be O 0 3.8959498738222464e-07
an O 0 1.3541169892050675e-06
interdependent O 0 0.003929899539798498
association O 0 0.0001340218586847186
between O 0 5.031962245993782e-06
mutations O 0 0.0004964356194250286
upstream O 0 1.7161579307867214e-05
and O 0 8.346583513230144e-07
within O 0 8.361641334886372e-07
the O 0 1.0056385235657217e-06
PTPase O 0 0.0003156760649289936
core O 0 7.952548003231641e-06
motif O 0 1.5335770513047464e-05
, O 0 6.254177264963801e-07
the O 0 4.572749503495288e-07
core O 0 2.4358000700885896e-06
motif O 0 8.008136319404002e-06
containing O 0 1.4908785033185268e-06
the O 0 7.821919894013263e-07
majority O 0 1.941140226335847e-06
of O 0 1.1021376167263952e-06
missense O 0 0.014289803802967072
mutations O 0 0.0009756859508343041
, O 0 9.007575840769277e-07
and O 0 4.0640327370056184e-07
the O 0 4.3002503957723093e-07
involvement O 0 1.4970653865020722e-05
of O 0 3.9519017036582227e-07
all O 0 5.121002004671027e-07
major O 0 2.4083883545245044e-05
organ O 0 0.006741194985806942
systems O 0 0.006396340671926737
( O 0 6.873691017972305e-05
central O 0 7.830575486877933e-05
nervous O 0 0.27651500701904297
system O 0 0.0009498833678662777
, O 0 0.0008725470979698002
thyroid O 1 0.9994922876358032
, O 0 0.006740805692970753
breast O 1 0.9993249177932739
, O 0 0.006354528479278088
skin O 1 0.9992746710777283
and O 0 0.03650614246726036
gastrointestinal O 1 0.9994789958000183
tract O 1 0.9974391460418701
) O 0 0.0014320373302325606
. O 0 0.00035988393938168883

However O 0 5.933747161179781e-05
, O 0 7.744680260657333e-06
these O 0 2.1480332179635298e-06
observations O 0 9.875215255306102e-06
would O 0 9.156477744909353e-07
need O 0 1.7770385056792293e-06
to O 0 4.053191275943391e-07
be O 0 2.568576462635974e-07
confirmed O 0 1.7440574993088376e-06
by O 0 3.574313325316325e-07
studying O 0 1.6862138636497548e-06
a O 0 7.340491379181913e-07
larger O 0 1.7963815253096982e-06
number O 0 9.570553629600909e-07
of O 0 1.4317828345156158e-06
CD B-Disease 0 4.7267036279663444e-05
families O 0 9.961444447981194e-05
. O 0 8.613549289293587e-05

Molecular O 0 0.29228508472442627
defects O 1 0.9731738567352295
leading O 0 0.00025614851620048285
to O 0 1.6119767678901553e-05
human O 0 0.0002490983169991523
complement B-Disease 0 0.0017469455488026142
component I-Disease 0 0.04635870084166527
C6 I-Disease 1 0.9979153275489807
deficiency I-Disease 1 0.9994569420814514
in O 0 1.7969461623579264e-05
an O 0 1.0518582712393254e-05
African O 0 0.00012354386853985488
- O 0 0.0028591251466423273
American O 0 6.850055797258392e-05
family O 0 0.0002783582604024559
. O 0 9.897853306028992e-05

Complement B-Disease 0 0.0335317887365818
component I-Disease 0 0.3116796016693115
C6 I-Disease 1 0.9942514896392822
deficiency I-Disease 1 0.9991949200630188
( O 0 0.007376655004918575
C6D B-Disease 1 0.6125123500823975
) O 0 8.425804844591767e-05
was O 0 3.479896258795634e-05
diagnosed O 1 0.9964635968208313
in O 0 3.5473301522870315e-06
a O 0 3.97895155401784e-06
16 O 0 9.86072245723335e-06
- O 0 0.00031493118149228394
year O 0 1.5377290765172802e-05
- O 0 0.0007643293938599527
old O 0 7.316805567825213e-05
African O 0 6.884265167172998e-05
- O 0 0.0024897735565900803
American O 0 6.67130880174227e-05
male O 0 0.0034634070470929146
with O 0 0.0036545677576214075
meningococcal B-Disease 1 0.998487114906311
meningitis I-Disease 1 0.9987084865570068
. O 0 0.002444881945848465

The O 0 0.000893330667167902
patients O 1 0.988796591758728
father O 0 0.00034132497967220843
and O 0 6.9176353463262785e-06
two O 0 5.050365416536806e-06
brothers O 0 0.00017956492956727743
also O 0 3.065156533921254e-06
had O 0 4.971620910509955e-06
C6D B-Disease 0 0.003008092986419797
, O 0 1.2739909607262234e-06
but O 0 6.612030460928509e-07
gave O 0 2.27876898861723e-06
no O 0 1.2720169024760253e-06
history O 0 6.66418327455176e-06
of O 0 1.2797783710993826e-05
meningitis B-Disease 1 0.998830258846283
or O 0 0.00012784985301550478
other O 0 0.0001445442030671984
neisserial B-Disease 1 0.9413405060768127
infection I-Disease 1 0.9960719347000122
. O 0 0.00045482421410270035

By O 0 6.551122351083905e-05
using O 0 3.346523953950964e-05
exon O 0 0.0004080826183781028
- O 0 0.00018015610112342983
specific O 0 2.2244059437070973e-05
polymerase O 0 0.0003043909091502428
chain O 0 0.00011345637176418677
reaction O 0 6.463497265940532e-05
( O 0 1.0417694284114987e-05
PCR O 0 0.00012595982116181403
) O 0 5.272484031593194e-06
/ O 0 0.00011913123307749629
single O 0 2.431743041597656e-06
- O 0 4.3386178731452674e-05
strand O 0 3.0178949600667693e-05
conformation O 0 3.119456232525408e-05
polymorphism O 0 2.09987902053399e-05
as O 0 1.3197022781241685e-06
a O 0 1.91540266314405e-06
screening O 0 1.8488148270989768e-05
step O 0 2.7288504043099238e-06
and O 0 3.6752470577994245e-07
nucleotide O 0 2.431156190141337e-06
sequencing O 0 2.927399691543542e-06
of O 0 3.58750213536041e-07
target O 0 2.7365565529180458e-06
exons O 0 1.7920585378305987e-05
, O 0 6.908701379870763e-07
we O 0 4.819819992007979e-07
determined O 0 2.0603272332664346e-06
that O 0 3.470295268925838e-07
the O 0 6.999644597271981e-07
proband O 0 0.00019357017299626023
was O 0 1.7114632555603748e-06
a O 0 3.242260845581768e-06
compound O 0 7.6486830948852e-05
heterozygote O 0 0.0011636440176516771
for O 0 7.346903657889925e-06
two O 0 2.0096797015867196e-05
C6 O 1 0.7638892531394958
gene O 0 0.027519477531313896
mutations O 0 0.04826551303267479
. O 0 0.0002561421715654433

The O 0 3.390145138837397e-05
first O 0 1.3866459994460456e-05
, O 0 8.898450687411241e-06
1195delC O 0 0.00034632295137271285
located O 0 9.341212717117742e-06
in O 0 2.856749233615119e-06
exon O 0 8.955209341365844e-05
7 O 0 4.74392754767905e-06
, O 0 1.0179001037613489e-06
is O 0 7.565808459730761e-07
a O 0 1.4492073887595325e-06
novel O 0 1.5037405319162644e-05
mutation O 0 5.391948070609942e-05
, O 0 5.055956648902793e-07
while O 0 2.726075365444558e-07
the O 0 2.429890173516469e-07
second O 0 7.244815378726344e-07
, O 0 1.266840399694047e-06
1936delG O 0 0.00010900994675466791
in O 0 1.3419721653917804e-06
exon O 0 5.152282756171189e-05
12 O 0 2.702109441088396e-06
, O 0 9.560737908032024e-07
has O 0 1.430132897439762e-06
been O 0 9.770342330739368e-07
described O 0 6.56667407383793e-06
before O 0 1.6860321920830756e-06
to O 0 2.154440153390169e-06
cause O 0 0.0013048247201368213
C6D B-Disease 0 0.007928041741251945
in O 0 1.7167188843814074e-06
an O 0 2.2183839973877184e-06
unrelated O 0 0.0009433720260858536
African O 0 6.084367123548873e-05
- O 0 0.0006320796092040837
American O 0 2.568545278336387e-05
individual O 0 6.816145469201729e-05
. O 0 7.15369387762621e-05

Both O 0 0.0003736061044037342
mutations O 0 0.013139844872057438
result O 0 0.00018480622384231538
in O 0 0.00010066963295685127
premature O 1 0.5178537368774414
termination O 0 0.46759501099586487
codons O 0 0.01312211062759161
and O 0 0.00016782690363470465
C6 O 1 0.8477168083190918
null O 0 0.019971653819084167
alleles O 0 0.046134792268276215
. O 0 0.0006015044637024403

Allele O 0 0.010760841891169548
- O 0 0.0009591846610419452
specific O 0 7.717186235822737e-05
PCR O 0 0.000393044319935143
indicated O 0 3.870437649311498e-05
that O 0 2.0281565866753226e-06
the O 0 2.3679274363530567e-06
probands O 0 0.0006684977561235428
two O 0 4.14446776630939e-06
brothers O 0 0.00016090873396024108
also O 0 5.209110440773657e-06
inherited O 0 0.010621102526783943
the O 0 4.933515810989775e-06
1195delC O 0 0.01974204182624817
mutation O 0 0.00037417764542624354
from O 0 1.6788568473202758e-06
their O 0 3.2243024179479107e-06
heterozygous O 0 0.0006999345496296883
mother O 0 6.372069765347987e-05
and O 0 1.4570816802006448e-06
the O 0 2.5297481442976277e-06
1936delG O 0 0.002316639991477132
mutation O 0 0.00025059879408217967
from O 0 3.3977817111008335e-06
their O 0 6.536047294503078e-06
homozygous O 0 0.001676319632679224
father O 0 0.00010077338083647192
. O 0 2.2295796952676028e-05
. O 0 8.661825268063694e-05

PAX6 O 1 0.9407953023910522
mutations O 1 0.6133096814155579
reviewed O 0 0.012825608253479004
. O 0 0.0015583229251205921

Mutations O 0 0.2962726056575775
in O 0 0.00023816651082597673
PAX6 O 1 0.920486330986023
are O 0 1.662170689087361e-05
responsible O 0 0.00010531923908274621
for O 0 8.475771210214589e-06
human O 0 0.00029273470863699913
aniridia B-Disease 0 0.20517507195472717
and O 0 4.5172441787144635e-06
have O 0 1.5560435713268816e-06
also O 0 1.1672441360133234e-06
been O 0 1.6523906651855214e-06
found O 0 5.114806299388874e-06
in O 0 1.6640387912048027e-05
patients O 1 0.9948760867118835
with O 0 0.0006215589819476008
Peters B-Disease 1 0.9907940030097961
anomaly I-Disease 1 0.9911273121833801
, O 0 0.0009380918927490711
with O 0 0.16630114614963531
congenital B-Disease 1 0.9999167919158936
cataracts I-Disease 1 0.9998908042907715
, O 0 0.002200962044298649
with O 0 0.006918722297996283
autosomal B-Disease 1 0.9985365867614746
dominant I-Disease 1 0.7752647399902344
keratitis I-Disease 1 0.9989376664161682
, O 0 9.445252362638712e-05
and O 0 3.2920801459113136e-05
with O 0 0.0001776948047336191
isolated B-Disease 1 0.5117369294166565
foveal I-Disease 1 0.9866081476211548
hypoplasia I-Disease 1 0.9957992434501648
. O 0 0.0012758485972881317

No O 0 0.00011538778198882937
locus O 0 0.00038570785545744
other O 0 1.2707082532870118e-05
than O 0 1.3483050679496955e-05
chromosome O 0 0.0020541257690638304
11p13 O 0 0.0028629081789404154
has O 0 9.824536391533911e-06
been O 0 6.0035058595531154e-06
implicated O 0 0.00631420873105526
in O 0 1.4108833056525327e-05
aniridia B-Disease 0 0.3416447341442108
, O 0 7.708875273237936e-06
and O 0 8.336596692970488e-06
PAX6 O 1 0.8539918065071106
is O 0 3.132214715151349e-06
clearly O 0 3.4756187687889906e-06
the O 0 5.990746672068781e-07
major O 0 3.4963634334417293e-06
, O 0 6.984734568504791e-07
if O 0 9.915215741784777e-07
not O 0 5.81895335471927e-07
only O 0 8.235335258177656e-07
, O 0 4.117504431633279e-06
gene O 0 0.00027422577841207385
responsible O 0 0.00016512417641934007
. O 0 8.097110548987985e-05

Twenty O 0 0.0002954214869532734
- O 0 0.00026347633684054017
eight O 0 2.3649310605833307e-05
percent O 0 1.6974137906800024e-05
of O 0 6.1167197600298095e-06
identified O 0 0.0008813499007374048
PAX6 O 1 0.9867026805877686
mutations O 0 0.06556348502635956
are O 0 1.399644861521665e-05
C O 0 0.0037013499531894922
- O 0 0.010904604569077492
T O 0 0.08751558512449265
changes O 0 1.6328205674653873e-05
at O 0 7.169394848460797e-06
CpG O 0 0.0015543752815574408
dinucleotides O 0 0.0009408067562617362
, O 0 9.896717756419093e-07
20 O 0 1.094551976166258e-06
% O 0 3.357609443810361e-07
are O 0 2.503668383724289e-07
splicing O 0 4.650043138099136e-06
errors O 0 8.902907211449929e-06
, O 0 5.403596219366591e-07
and O 0 2.747047460616159e-07
more O 0 2.9466346518347564e-07
than O 0 4.875043941865442e-07
30 O 0 1.278150534744782e-06
% O 0 6.585134428860329e-07
are O 0 1.0733332374002202e-06
deletion O 0 0.00026087771402671933
or O 0 1.0764817488961853e-05
insertion O 0 0.0014398496132344007
events O 0 0.00014018546789884567
. O 0 9.978481830330566e-05

There O 0 4.3462619942147285e-05
is O 0 1.387206884828629e-05
a O 0 1.5783420167281292e-05
noticeably O 0 0.0014921408146619797
elevated O 0 0.0008583519957028329
level O 0 4.648340564017417e-06
of O 0 6.796437332923233e-07
mutation O 0 7.188240851974115e-05
in O 0 7.606437861795712e-07
the O 0 8.622092195764708e-07
paired O 0 3.5156939702574164e-05
domain O 0 4.589098352880683e-06
compared O 0 2.452056378388079e-06
with O 0 6.778765282433596e-07
the O 0 6.242307790671475e-07
rest O 0 2.7129931368108373e-06
of O 0 1.1811969216068974e-06
the O 0 1.0852329978661146e-05
gene O 0 0.0008163832826539874
. O 0 8.635953417979181e-05

Increased O 0 0.00044213980436325073
mutation O 0 0.0007534034084528685
in O 0 9.63853108260082e-06
the O 0 6.070155450288439e-06
homeodomain O 0 0.0011344240047037601
is O 0 2.5286892650910886e-06
accounted O 0 4.852222900808556e-06
for O 0 1.4744539384992095e-06
by O 0 2.213563675468322e-06
the O 0 3.822727194346953e-06
hypermutable O 0 0.0035847313702106476
CpG O 0 0.004083910956978798
dinucleotide O 0 0.002657580189406872
in O 0 3.0349607186508365e-05
codon O 0 0.0005974905216135085
240 O 0 0.0005430593155324459
. O 0 0.00018859720148611814

Very O 0 0.00016295020759571344
nearly O 0 6.946967914700508e-05
all O 0 1.2045918083458673e-05
mutations O 0 0.004456897731870413
appear O 0 3.192863368894905e-05
to O 0 2.1276796360325534e-06
cause O 0 0.0004975475021637976
loss O 0 6.203079828992486e-05
of O 0 2.5101954292949813e-07
function O 0 1.8452952872394235e-06
of O 0 3.0562694064428797e-07
the O 0 1.1386335927454638e-06
mutant O 0 0.00041645910823717713
allele O 0 6.748198939021677e-05
, O 0 6.142811344034271e-07
and O 0 2.51424921771104e-07
more O 0 2.5220180077667465e-07
than O 0 4.0511045540370105e-07
80 O 0 1.3518950936486362e-06
% O 0 4.239884390244697e-07
of O 0 6.541588959407818e-07
exonic O 0 0.000507021730300039
substitutions O 0 3.0241668355301954e-05
result O 0 2.3104612409952097e-05
in O 0 1.699308631941676e-05
nonsense O 0 0.0009743993286974728
codons O 0 0.0024249718990176916
. O 0 0.00018400374392513186

In O 0 5.9974110627081245e-05
a O 0 3.737221049959771e-05
gene O 0 0.00019759098358917981
with O 0 6.822895556979347e-06
such O 0 6.947518613742432e-06
extraordinarily O 0 0.0036622327752411366
high O 0 4.895703023066744e-05
sequence O 0 1.0149117770197336e-05
conservation O 0 7.865644874982536e-05
throughout O 0 4.192625510768266e-06
evolution O 0 8.091081326710992e-06
, O 0 1.1583373407120234e-06
there O 0 8.255277066382405e-07
are O 0 1.4305435342976125e-06
presumed O 0 0.0001623809803277254
undiscovered O 0 0.010797729715704918
missense O 0 0.1194031611084938
mutations O 0 0.003840755671262741
, O 0 1.4815497024756041e-06
these O 0 6.226397317732335e-07
are O 0 6.631669862144918e-07
hypothesized O 0 5.264318679110147e-05
to O 0 6.447760938499414e-07
exist O 0 1.5134136219785432e-06
in O 0 7.698640160924697e-07
as O 0 2.1493549411388813e-06
- O 0 0.0004145225102547556
yet O 0 4.31565786129795e-05
unidentified O 0 0.0009199598571285605
phenotypes O 0 0.05260079726576805
. O 0 3.758623279281892e-05
. O 0 0.00010711130744311959

Genetic O 0 0.025119882076978683
heterogeneity O 0 0.01981562376022339
and O 0 5.5611344578210264e-05
penetrance O 0 0.04231341928243637
analysis O 0 3.584895239328034e-05
of O 0 5.757488906965591e-06
the O 0 3.1556755857309327e-05
BRCA1 O 1 0.9842402935028076
and O 0 0.0006438530399464071
BRCA2 O 1 0.9959557056427002
genes O 0 0.17570309340953827
in O 0 0.01050287764519453
breast B-Disease 1 0.9992358684539795
cancer I-Disease 1 0.9989546537399292
families O 0 0.045364703983068466
. O 0 0.0007347618811763823

The O 0 0.1284441351890564
Breast B-Disease 1 0.9981470108032227
Cancer I-Disease 1 0.9987194538116455
Linkage O 1 0.9270289540290833
Consortium O 0 0.12417440861463547
. O 0 0.0012069253716617823

The O 0 0.00012759919627569616
contribution O 0 0.00029998074751347303
of O 0 8.410535519942641e-05
BRCA1 O 1 0.9945440292358398
and O 0 0.004731826018542051
BRCA2 O 1 0.9974371194839478
to O 0 0.06515485048294067
inherited B-Disease 1 0.9994545578956604
breast I-Disease 1 0.9998888969421387
cancer I-Disease 1 0.9998347759246826
was O 0 0.00018714586622081697
assessed O 0 0.005589909385889769
by O 0 7.303285656234948e-06
linkage O 0 0.0007392597035504878
and O 0 5.242675797489937e-06
mutation O 0 0.00041854564915411174
analysis O 0 6.256305823626462e-06
in O 0 1.8620253285916988e-06
237 O 0 0.00037451754906214774
families O 0 7.2761031333357096e-06
, O 0 3.344659660342586e-07
each O 0 2.229596702818526e-07
with O 0 4.3425916373962536e-07
at O 0 8.872190733200114e-07
least O 0 2.236698037449969e-06
four O 0 4.428724423632957e-06
cases O 0 0.0022449123207479715
of O 0 0.0001427179086022079
breast B-Disease 1 0.9997876286506653
cancer I-Disease 1 0.9997411370277405
, O 0 2.4605255021015182e-05
collected O 0 2.9704537155339494e-05
by O 0 6.724840932292864e-05
the O 0 0.002475445158779621
Breast B-Disease 1 0.9997044205665588
Cancer I-Disease 1 0.9996275901794434
Linkage O 1 0.9242830276489258
Consortium O 0 0.13643063604831696
. O 0 0.0006707109278067946

Families O 0 0.0002729890402406454
were O 0 7.387287496385397e-06
included O 0 5.502634394360939e-06
without O 0 4.134696609980892e-06
regard O 0 6.7256164584250655e-06
to O 0 1.0999546020684647e-06
the O 0 1.9576264094212092e-06
occurrence O 0 0.0008668412338010967
of O 0 2.431053144391626e-05
ovarian B-Disease 1 0.9992325305938721
or I-Disease 0 0.000461882067611441
other I-Disease 0 0.0003175484307575971
cancers I-Disease 1 0.9972054362297058
. O 0 0.0006079770973883569

Overall O 0 0.010363764129579067
, O 0 0.0010671624913811684
disease O 1 0.9980169534683228
was O 0 4.1178023820975795e-05
linked O 0 0.0020398583728820086
to O 0 8.527839781891089e-06
BRCA1 O 0 0.4954805076122284
in O 0 2.1601349544653203e-06
an O 0 1.296998902944324e-06
estimated O 0 9.098122973227873e-06
52 O 0 6.213565029611345e-06
% O 0 7.80100776864856e-07
of O 0 5.601013981504366e-07
families O 0 9.606686944607645e-06
, O 0 1.4529106238114764e-06
to O 0 1.8592040760267992e-06
BRCA2 O 0 0.0704130083322525
in O 0 1.2859659364039544e-06
32 O 0 2.264682734676171e-06
% O 0 6.160158818602213e-07
of O 0 3.873647074215114e-07
families O 0 6.517710062325932e-06
, O 0 5.321577987160708e-07
and O 0 4.5019069716545346e-07
to O 0 8.178864732144575e-07
neither O 0 6.901286724314559e-06
gene O 0 1.3607978871732485e-05
in O 0 5.221272658673115e-07
16 O 0 1.364045374430134e-06
% O 0 6.500314952972985e-07
( O 0 1.5542860865025432e-06
95 O 0 3.3880296541610733e-06
% O 0 1.1824841976704192e-06
confidence O 0 1.4947430827305652e-05
interval O 0 4.8064583097584546e-05
[ O 0 0.0003218775091227144
CI O 0 0.18412786722183228
] O 0 6.0375910834409297e-05
6 O 0 4.540468125924235e-06
% O 0 1.4100851331022568e-06
- O 0 2.86583999695722e-05
28 O 0 4.5407750803860836e-06
% O 0 1.6841519254739978e-06
) O 0 2.605425152069074e-06
, O 0 2.894290901167551e-06
suggesting O 0 6.145531369838864e-05
other O 0 1.8759939848678187e-05
predisposition O 1 0.6335254311561584
genes O 0 0.002785551594570279
. O 0 0.00016362470341846347

The O 0 4.726631595985964e-05
majority O 0 3.9330694562522694e-05
( O 0 2.2452966732089408e-05
81 O 0 4.894535959465429e-05
% O 0 3.740461352208513e-06
) O 0 3.0591143058700254e-06
of O 0 2.0999855223635677e-06
the O 0 0.00023040169617161155
breast B-Disease 1 0.9997544884681702
- I-Disease 1 0.999055802822113
ovarian I-Disease 1 0.9999608993530273
cancer I-Disease 1 0.999906063079834
families O 0 0.0074110147543251514
were O 0 4.114843250135891e-06
due O 0 4.901804277324118e-05
to O 0 8.45346676214831e-06
BRCA1 O 1 0.8338133692741394
, O 0 1.691698344075121e-06
with O 0 1.2361448398223729e-06
most O 0 1.9768785932683386e-06
others O 0 6.634240435232641e-06
( O 0 3.4937702366732992e-06
14 O 0 4.4784928832086734e-06
% O 0 2.1441180706460727e-06
) O 0 4.653304131352343e-06
due O 0 2.593327735667117e-05
to O 0 3.0544266337528825e-05
BRCA2 O 1 0.815031886100769
. O 0 0.000168241880601272

Conversely O 0 0.0015016510151326656
, O 0 1.0699723134166561e-05
the O 0 3.2408822789875558e-06
majority O 0 3.988289336120943e-06
of O 0 1.3077175253783935e-06
families O 0 2.5494247893220745e-05
with O 0 1.0742532140284311e-05
male B-Disease 0 0.0021990842651575804
and I-Disease 0 0.00018576023285277188
female I-Disease 1 0.6875956058502197
breast I-Disease 1 0.9998270869255066
cancer I-Disease 1 0.9997256398200989
were O 0 1.6680634871590883e-05
due O 0 0.00018019526032730937
to O 0 2.5850908059510402e-05
BRCA2 O 1 0.978478193283081
( O 0 7.104501128196716e-05
76 O 0 0.00038881911314092577
% O 0 1.897857328003738e-05
) O 0 4.2279130866518244e-05
. O 0 5.593349487753585e-05

The O 0 3.759645187528804e-05
largest O 0 4.411563350004144e-05
proportion O 0 4.5233780838316306e-05
( O 0 1.1034396266040858e-05
67 O 0 1.2959706509718671e-05
% O 0 1.3156634395272704e-06
) O 0 9.67068785939773e-07
of O 0 3.7743342318208306e-07
families O 0 9.40248810366029e-06
due O 0 2.414515392956673e-06
to O 0 4.0414226987195434e-07
other O 0 5.095649839859107e-07
genes O 0 7.3156520556949545e-06
was O 0 4.6289025590340316e-07
found O 0 5.698486233995936e-07
in O 0 4.2911065634143597e-07
families O 0 2.0627926460292656e-06
with O 0 5.499190365299e-07
four O 0 1.1830718449346023e-06
or O 0 1.8892711750595481e-06
five O 0 5.195139692659723e-06
cases O 0 0.00024075715919025242
of O 0 2.6118606911040843e-05
female O 0 0.4407036304473877
breast B-Disease 1 0.9995917677879333
cancer I-Disease 1 0.9992939233779907
only O 0 0.00018950787489302456
. O 0 0.000253695179708302

These O 0 5.287729436531663e-05
estimates O 0 6.836130341980606e-05
were O 0 4.387149601825513e-06
not O 0 4.627194812201196e-06
substantially O 0 0.000134759335196577
affected O 0 6.88633372192271e-05
either O 0 1.935276941367192e-06
by O 0 1.1915516324734199e-06
changing O 0 1.0789070984174032e-05
the O 0 2.44955094785837e-06
assumed O 0 6.549055251525715e-05
penetrance O 0 0.026389917358756065
model O 0 1.2735165910271462e-05
for O 0 6.954187028895831e-06
BRCA1 O 0 0.2694321274757385
or O 0 5.341628366295481e-06
by O 0 1.94599465430656e-06
including O 0 6.174884674692294e-06
or O 0 1.8871442080126144e-05
excluding O 0 0.0003603986115194857
BRCA1 O 1 0.9337471723556519
mutation O 0 0.00975902657955885
data O 0 0.00013691213098354638
. O 0 0.00021798376110382378

Among O 0 0.0003443170862738043
those O 0 9.019759454531595e-05
families O 0 0.0007528486894443631
with O 0 0.0003870144719257951
disease O 1 0.9991303086280823
due O 0 0.0004971793387085199
to O 0 1.0223158824373968e-05
BRCA1 O 1 0.5425862669944763
that O 0 1.4370576764122234e-06
were O 0 5.830096370118554e-07
tested O 0 1.4931473742763046e-05
by O 0 3.681540476918599e-07
one O 0 2.532673590849299e-07
of O 0 1.4009033577622176e-07
the O 0 5.331473289515998e-07
standard O 0 5.921810497966362e-06
screening O 0 7.756302511552349e-05
methods O 0 6.240829407033743e-06
, O 0 1.8107089090335649e-06
mutations O 0 0.00012224102101754397
were O 0 3.606506027153955e-07
detected O 0 1.0785225640574936e-05
in O 0 3.1854756343818735e-07
the O 0 4.1298710584669607e-07
coding O 0 1.6024310752982274e-05
sequence O 0 2.014888877965859e-06
or O 0 1.5239240838127444e-06
splice O 0 3.92341535189189e-05
sites O 0 2.543871914895135e-06
in O 0 5.952329047431704e-07
an O 0 9.127427915700537e-07
estimated O 0 6.452438810811145e-06
63 O 0 1.1582109436858445e-05
% O 0 1.8126524992112536e-06
( O 0 3.098488150499179e-06
95 O 0 1.0670903975551482e-05
% O 0 4.853046448261011e-06
CI O 0 0.04735492169857025
51 O 0 2.2693204300594516e-05
% O 0 6.477809620264452e-06
- O 0 0.00013078040501568466
77 O 0 6.067541107768193e-05
% O 0 1.8090682715410367e-05
) O 0 3.641524745034985e-05
. O 0 6.0107118770247325e-05

The O 0 5.712147685699165e-05
estimated O 0 9.335418872069567e-05
sensitivity O 0 0.00019480701303109527
was O 0 3.3570888717804337e-06
identical O 0 5.850012712471653e-06
for O 0 1.59892101692094e-06
direct O 0 4.429092314239824e-06
sequencing O 0 2.5298659238615073e-05
and O 0 3.6816775264014723e-06
other O 0 7.964722499309573e-06
techniques O 0 0.00015249574789777398
. O 0 0.00011001033271895722

The O 0 0.00021705421386286616
penetrance O 0 0.07631035894155502
of O 0 4.033114601043053e-05
BRCA2 O 1 0.8087285161018372
was O 0 8.646681635582354e-06
estimated O 0 1.3006953849981073e-05
by O 0 2.217975861640298e-06
maximizing O 0 6.387090979842469e-05
the O 0 3.756533487830893e-06
LOD O 0 0.01432095468044281
score O 0 8.12210600997787e-06
in O 0 1.7120140910265036e-05
BRCA2 O 1 0.9566333889961243
- O 0 0.008752310648560524
mutation O 0 0.004275643732398748
families O 0 2.3341470296145417e-05
, O 0 1.570853783050552e-06
over O 0 2.4592179670435144e-06
all O 0 2.742513515840983e-06
possible O 0 4.558910586638376e-05
penetrance O 0 0.027702316641807556
functions O 0 0.00010663050488801673
. O 0 0.00013356866838876158

The O 0 0.00012870792124886066
estimated O 0 0.0006315633072517812
cumulative O 0 0.039719995111227036
risk O 0 0.3746132254600525
of O 0 0.00026085259742103517
breast B-Disease 1 0.9995819926261902
cancer I-Disease 1 0.9991724491119385
reached O 0 6.482644675998017e-05
28 O 0 2.2845853891340084e-05
% O 0 2.7902217425435083e-06
( O 0 5.030292413721327e-06
95 O 0 9.935719390341546e-06
% O 0 3.134366124868393e-06
CI O 0 0.02934669703245163
9 O 0 4.483817519940203e-06
% O 0 1.1553958074728143e-06
- O 0 1.189423073810758e-05
44 O 0 2.28023850468162e-06
% O 0 5.254636334939278e-07
) O 0 5.803728981845779e-07
by O 0 4.4035883206561266e-07
age O 0 2.0034899534948636e-06
50 O 0 1.2346132507445873e-06
years O 0 1.2912255442643072e-06
and O 0 8.154759143508272e-07
84 O 0 1.4493714843410999e-05
% O 0 1.15735451799992e-06
( O 0 2.275839278809144e-06
95 O 0 6.193143235577736e-06
% O 0 2.382774027864798e-06
CI O 0 0.010634013451635838
43 O 0 6.4973414737323765e-06
% O 0 1.301094584960083e-06
- O 0 2.3261718524736352e-05
95 O 0 4.325564077589661e-06
% O 0 1.0783503512357129e-06
) O 0 1.791782437976508e-06
by O 0 1.94126232599956e-06
age O 0 1.5197475477179978e-05
70 O 0 2.7847301680594683e-05
years O 0 5.490340481628664e-05
. O 0 7.236107921926305e-05

The O 0 0.0017936910735443234
corresponding O 1 0.5925230979919434
ovarian B-Disease 1 0.9993057250976562
cancer I-Disease 1 0.999535322189331
risks O 1 0.8649511933326721
were O 0 8.544576121494174e-05
0 O 0 0.0007852644193917513
. O 0 0.00024046235193964094

4 O 0 0.00011201918823644519
% O 0 2.378977842454333e-05
( O 0 1.835801413108129e-05
95 O 0 1.9512035578372888e-05
% O 0 6.608275725739077e-06
CI O 0 0.004744249861687422
0 O 0 1.1154577805427834e-05
% O 0 1.7357543811158394e-06
- O 0 1.3638015843753237e-05
1 O 0 1.5431674000865314e-06
% O 0 5.855320637238037e-07
) O 0 6.234995453269221e-07
by O 0 4.4048064751223137e-07
age O 0 1.6335353620888782e-06
50 O 0 1.1075999282184057e-06
years O 0 1.2535246014522272e-06
and O 0 4.6868220238138747e-07
27 O 0 2.7488947580422973e-06
% O 0 1.1044039638363756e-06
( O 0 2.3039160623739008e-06
95 O 0 5.813762072648387e-06
% O 0 2.5460030883550644e-06
CI O 0 0.0063171833753585815
0 O 0 6.008111085975543e-06
% O 0 1.126699771702988e-06
- O 0 1.7298470993409865e-05
47 O 0 6.908378509251634e-06
% O 0 9.596657264410169e-07
) O 0 1.5138336948439246e-06
by O 0 1.439738070985186e-06
age O 0 1.3377094546740409e-05
70 O 0 2.4664126613060944e-05
years O 0 4.1176685044774786e-05
. O 0 5.726404924644157e-05

The O 0 0.0007097299094311893
lifetime O 1 0.719571590423584
risk O 1 0.9414436221122742
of O 0 0.0036949971690773964
breast B-Disease 1 0.9997133612632751
cancer I-Disease 1 0.9997537732124329
appears O 0 0.016907937824726105
similar O 0 0.00011447912402218208
to O 0 4.745394107885659e-06
the O 0 9.179821063298732e-06
risk O 0 0.07493387162685394
in O 0 3.7988815165590495e-05
BRCA1 O 1 0.9812483787536621
carriers O 0 0.001708170515485108
, O 0 1.686148038970714e-06
but O 0 5.297667371451098e-07
there O 0 2.2814646172264474e-07
was O 0 2.355565840161944e-07
some O 0 2.6791215645971533e-07
suggestion O 0 4.442311364982743e-06
of O 0 3.5056348224316025e-07
a O 0 6.190208750922466e-06
lower O 0 0.00024639960611239076
risk O 0 0.04172125831246376
in O 0 2.984252932947129e-05
BRCA2 O 1 0.9873861074447632
carriers O 0 0.005674522835761309
< O 0 0.0024512840900570154
50 O 0 1.0507594197406434e-05
years O 0 8.4011880971957e-06
of O 0 6.854108505649492e-06
age O 0 0.00014964309229981154
. O 0 8.817501657176763e-05

Eye B-Disease 1 0.9800177812576294
movement I-Disease 0 0.01228316966444254
abnormalities I-Disease 1 0.9844346642494202
correlate O 0 0.05724788457155228
with O 0 0.00032622236176393926
genotype O 1 0.7335371971130371
in O 0 0.0006591417477466166
autosomal O 1 0.9936752915382385
dominant O 1 0.6774165034294128
cerebellar B-Disease 1 0.9977200627326965
ataxia I-Disease 1 0.9981094598770142
type I-Disease 1 0.7291536927223206
I I-Disease 0 0.003786050947383046
. O 0 0.000486009317683056

We O 0 0.00013047746324446052
compared O 0 0.00022667045413982123
horizontal O 0 0.002139029325917363
eye O 1 0.5606145858764648
movements O 0 0.00023407331900671124
( O 0 0.00010935414320556447
visually O 0 0.010709943249821663
guided O 0 0.0012343669077381492
saccades O 1 0.9219152927398682
, O 0 1.9859180611092597e-05
antisaccades O 0 0.002481721807271242
, O 0 2.9845650715287775e-06
and O 0 1.4444966609516996e-06
smooth O 0 3.836866744677536e-05
pursuit O 0 6.339057290460914e-05
) O 0 2.3484558369091246e-06
in O 0 1.0398161975899711e-06
control O 0 9.537639016343746e-06
subjects O 0 3.371772982063703e-05
( O 0 8.260763934231363e-06
n O 0 2.5698216632008553e-05
= O 0 8.762549987295642e-05
14 O 0 4.108593202545308e-06
) O 0 2.1230098354863003e-06
and O 0 2.820635700118146e-06
patients O 0 0.18295438587665558
with O 0 1.4013980944582727e-06
three O 0 1.4189899957273155e-06
forms O 0 1.8272638044436462e-05
of O 0 1.1252952390350401e-05
autosomal O 1 0.9919082522392273
dominant O 0 0.118461012840271
cerebellar B-Disease 1 0.9987419247627258
ataxias I-Disease 1 0.9769705533981323
type I-Disease 0 0.24191325902938843
I I-Disease 0 0.002761086216196418
spinocerebellar B-Disease 1 0.9964469075202942
ataxias I-Disease 0 0.022048374637961388
1 I-Disease 0 1.151963988377247e-05
and I-Disease 0 2.4983069124573376e-06
2 I-Disease 0 8.04940555099165e-06
( O 0 7.374251708824886e-06
SCA1 B-Disease 0 0.0007592566544190049
, O 0 2.544284370742389e-06
n O 0 2.256738480355125e-05
= O 0 5.062559284851886e-05
11 O 0 8.064311259659007e-06
; O 0 5.614722795144189e-06
SCA2 B-Disease 0 0.00031384252361021936
, O 0 2.7954527013207553e-06
n O 0 1.7032851246767677e-05
= O 0 3.787024616030976e-05
10 O 0 5.3673088586947415e-06
) O 0 3.906258370989235e-06
and O 0 7.175578502938151e-06
SCA3 B-Disease 1 0.7156946659088135
/ O 0 0.2849541902542114
Machado B-Disease 0 0.29398733377456665
- I-Disease 0 0.2031642198562622
Joseph I-Disease 0 0.1493009626865387
disease I-Disease 1 0.9982175230979919
( O 0 0.00019388603686820716
MJD B-Disease 0 0.42174527049064636
) O 0 1.8008920960710384e-05
( O 0 2.1722615201724693e-05
n O 0 5.9831869293702766e-05
= O 0 0.00020754443539772183
16 O 0 3.578327232389711e-05
) O 0 3.7800506106577814e-05
. O 0 6.568707613041624e-05

In O 0 0.00021341147657949477
SCA1 B-Disease 0 0.012249660678207874
, O 0 5.4320487834047526e-05
saccade O 0 0.0175519697368145
amplitude O 0 0.00015919793804641813
was O 0 1.5234767488436773e-05
significantly O 0 0.00010525779362069443
increased O 0 1.5758709196234122e-05
, O 0 6.520881015603663e-06
resulting O 0 0.00011408626596676186
in O 0 3.3551070373505354e-05
hypermetria B-Disease 0 0.03193086013197899
. O 0 0.0001912468287628144

The O 0 0.00014986655151005834
smooth O 0 0.0008718959870748222
pursuit O 0 0.0007707318873144686
gain O 0 0.0002577590639702976
was O 0 8.254516433225945e-05
decreased O 0 0.0031763252336531878
. O 0 0.00025318365078419447

In O 0 0.00026602044817991555
SCA2 B-Disease 0 0.022253043949604034
, O 0 9.437599510420114e-05
saccade O 0 0.01556688454002142
velocity O 0 0.00034944608341902494
was O 0 8.893917402019724e-05
markedly O 0 0.025026487186551094
decreased O 0 0.011612921953201294
. O 0 0.00033243687357753515

The O 0 3.1109924748307094e-05
percentage O 0 2.1671177819371223e-05
of O 0 3.5830748856824357e-06
errors O 0 0.00011164882016601041
in O 0 9.608996151655447e-06
antisaccades O 0 0.0064392066560685635
was O 0 5.01234444527654e-06
greatly O 0 0.00011267665104242042
increased O 0 1.0155120435229037e-05
and O 0 2.0132024474150967e-06
was O 0 3.2935447507043136e-06
significantly O 0 0.00037730883923359215
correlated O 0 0.004505692981183529
with O 0 5.3350264352047816e-05
age O 0 0.00307183968834579
at O 0 0.003937846980988979
disease O 1 0.9990170001983643
onset O 1 0.9954476952552795
. O 0 0.0013855721335858107

In O 0 4.168580926489085e-05
addition O 0 2.163136741728522e-05
, O 0 3.939735051972093e-06
a O 0 2.599428853500285e-06
correlation O 0 1.8439073755871505e-05
between O 0 3.0288197194749955e-06
smooth O 0 6.549811223521829e-05
pursuit O 0 8.162511221598834e-05
gain O 0 6.663115527771879e-06
and O 0 7.1349171548718e-07
the O 0 7.098301466612611e-07
number O 0 1.3674761021320592e-06
of O 0 3.5669550015882123e-06
trinucleotide O 0 0.398647665977478
repeats O 0 0.000326796667650342
was O 0 1.8875547539209947e-05
found O 0 5.133508238941431e-05
. O 0 9.800468978937715e-05

In O 0 0.0004731768276542425
SCA3 B-Disease 1 0.5895695090293884
, O 0 0.00017382435908075422
gaze B-Disease 0 0.0683598443865776
- I-Disease 0 0.06694566458463669
evoked I-Disease 0 0.40553033351898193
nystagmus I-Disease 1 0.9836044907569885
was O 0 1.3164417396183126e-05
often O 0 6.325791673589265e-06
present O 0 2.7994465199299157e-06
as O 0 1.6634298845019657e-06
was O 0 5.166365554032382e-06
saccade O 0 0.031422607600688934
hypometria O 0 0.006222922820597887
and O 0 4.920978881273186e-06
smooth O 0 0.0002344221866223961
pursuit O 0 0.0003423490561544895
gain O 0 6.684216350549832e-05
was O 0 3.066421777475625e-05
markedly O 0 0.035093918442726135
decreased O 0 0.006589165423065424
. O 0 0.00022266057203523815

Three O 0 0.00010978962382068858
major O 0 0.00011239677405683324
criteria O 0 7.461291534127668e-05
, O 0 1.6468324247398414e-05
saccade O 0 0.0036380758974701166
amplitude O 0 8.371009607799351e-05
, O 0 1.2138923921156675e-05
saccade O 0 0.0018977111903950572
velocity O 0 1.9324485037941486e-05
, O 0 1.6252311070275027e-06
and O 0 1.0565264574324829e-06
presence O 0 5.004720605938928e-06
of O 0 1.7714107798383338e-06
gaze B-Disease 0 0.06068671494722366
- I-Disease 0 0.04108670726418495
evoked I-Disease 0 0.17230969667434692
nystagmus I-Disease 1 0.9550650119781494
, O 0 2.995572003783309e-06
permitted O 0 2.5825818283919943e-06
the O 0 7.24743472346745e-07
correct O 0 7.714273124292959e-06
assignment O 0 4.350801191321807e-06
of O 0 2.227271806987119e-07
90 O 0 1.1933551604670356e-06
% O 0 3.0663181860290933e-07
of O 0 1.965500473488646e-07
the O 0 8.108277143037412e-07
SCA1 B-Disease 0 0.0007351415115408599
, O 0 7.868102898100915e-07
90 O 0 1.285308599108248e-06
% O 0 2.4140632604030543e-07
of O 0 2.2711228098160063e-07
the O 0 6.23517962594633e-07
SCA2 B-Disease 0 0.0013917761389166117
, O 0 8.007617111616128e-07
and O 0 4.6859685198796797e-07
93 O 0 5.601336397376144e-06
% O 0 4.81919869343983e-07
of O 0 3.708649956024601e-07
the O 0 4.267455096851336e-06
patients O 1 0.9155134558677673
with O 0 1.6654119463055395e-05
SCA3 B-Disease 1 0.6741424798965454
to O 0 2.9888660719734617e-06
their O 0 6.960497103136731e-06
genetically O 0 0.003315252484753728
confirmed O 0 0.0011962250573560596
patient O 0 0.4405985474586487
group O 0 9.621007848181762e-06
and O 0 1.30137266296515e-06
, O 0 1.1258255199209088e-06
therefore O 0 1.8484654447092908e-06
, O 0 1.552733465359779e-06
may O 0 8.172398338501807e-06
help O 0 4.706005711341277e-05
orient O 0 0.007376536261290312
diagnoses O 1 0.912927508354187
of O 0 7.907852705102414e-06
SCA1 B-Disease 0 0.3823498487472534
, O 0 1.939057074196171e-05
SCA2 B-Disease 0 0.029674656689167023
, O 0 3.886949343723245e-06
and O 0 5.6611347645230126e-06
SCA3 B-Disease 0 0.1935025453567505
at O 0 1.062924275174737e-05
early O 0 3.4697230148594826e-05
clinical O 0 0.2870767414569855
stages O 0 0.000180376970092766
of O 0 4.618659659172408e-06
the O 0 6.516398570965976e-05
diseases O 1 0.9973715543746948
. O 0 7.312412344617769e-05
. O 0 0.00013034888252150267

Genetic O 0 0.002286838134750724
basis O 0 6.23800078756176e-05
and O 0 3.975772415287793e-05
molecular O 0 0.0036092386581003666
mechanism O 0 0.009229292161762714
for O 0 0.021853091195225716
idiopathic B-Disease 1 0.9992225170135498
ventricular I-Disease 1 0.9981774091720581
fibrillation I-Disease 1 0.9977688789367676
. O 0 0.010015381500124931

Ventricular B-Disease 1 0.9937688708305359
fibrillation I-Disease 1 0.9960119724273682
causes O 1 0.5394067168235779
more O 0 2.9746093787252903e-05
than O 0 1.4023543371877167e-05
300 O 0 4.1885647078743204e-05
, O 0 9.797880011319648e-06
000 O 0 0.00027598364977166057
sudden O 0 0.01927436888217926
deaths O 0 0.001667169388383627
each O 0 1.753436663420871e-06
year O 0 5.12437145516742e-06
in O 0 2.2494773475045804e-06
the O 0 6.215556368260877e-06
USA O 0 0.00022772389638703316
alone O 0 0.00013400537136476487
. O 0 8.058626553975046e-05

In O 0 4.865525261266157e-05
approximately O 0 3.0081801014603116e-05
5 O 0 1.5030394934001379e-05
- O 0 3.194675446138717e-05
12 O 0 2.6811355837708106e-06
% O 0 4.770286068378482e-07
of O 0 3.0943783713155426e-07
these O 0 7.530219932050386e-07
cases O 0 3.152514545945451e-05
, O 0 7.260966867761454e-07
there O 0 6.04913338975166e-07
are O 0 9.174571573566936e-07
no O 0 9.981837138184346e-06
demonstrable O 1 0.7824986577033997
cardiac O 1 0.9990893602371216
or O 0 0.0005106169846840203
non O 0 0.0294803474098444
- O 1 0.9175211787223816
cardiac O 1 0.9994797110557556
causes O 0 0.13930144906044006
to O 0 1.1861616258102003e-06
account O 0 1.652992750678095e-06
for O 0 5.411785650721868e-07
the O 0 6.734343855896441e-07
episode O 0 9.473205864196643e-06
, O 0 9.336378639090981e-07
which O 0 6.684033451165305e-07
is O 0 1.7828472209657775e-06
therefore O 0 1.0307546290277969e-05
classified O 0 0.007216524798423052
as O 0 0.0013648368185386062
idiopathic B-Disease 1 0.9996137022972107
ventricular I-Disease 1 0.9991719722747803
fibrillation I-Disease 1 0.9993669390678406
( O 0 0.17126621305942535
IVF B-Disease 1 0.9890123605728149
) O 0 0.0007594556082040071
. O 0 0.0003366940072737634

A O 0 0.00024048872001003474
distinct O 0 0.0002716395247261971
group O 0 0.0001182728010462597
of O 0 6.090671740821563e-05
IVF B-Disease 1 0.9981935620307922
patients O 1 0.9981337189674377
has O 0 2.0961293557775207e-05
been O 0 1.7609307860766421e-06
found O 0 1.6786135574875516e-06
to O 0 5.384870860325464e-07
present O 0 1.124709342548158e-06
with O 0 2.020919964706991e-06
a O 0 1.0703111001930665e-05
characteristic O 0 0.0014420958468690515
electrocardiographic O 0 0.1632373034954071
pattern O 0 0.005300119519233704
. O 0 0.00015735311899334192

Because O 0 4.677826655097306e-05
of O 0 2.5007097974594217e-06
the O 0 1.3297484429131146e-06
small O 0 1.8656656948223826e-06
size O 0 2.2629556042375043e-06
of O 0 4.613328030700359e-07
most O 0 2.0430968561413465e-06
pedigrees O 0 0.00022130513389129192
and O 0 1.5020630144135794e-06
the O 0 2.390677082075854e-06
high O 0 0.00012891377264168113
incidence O 1 0.5404690504074097
of O 0 1.0240156370855402e-05
sudden B-Disease 0 0.44228577613830566
death I-Disease 0 0.0017290035029873252
, O 0 2.7709991172741866e-06
however O 0 2.892486236305558e-06
, O 0 2.68560847871413e-06
molecular O 0 0.0004349828523118049
genetic O 0 0.0015400229021906853
studies O 0 7.81659473432228e-05
of O 0 2.8178585580462823e-06
IVF B-Disease 1 0.6352093815803528
have O 0 2.8955555535503663e-06
not O 0 1.5156480230871239e-06
yet O 0 5.940691607975168e-06
been O 0 5.485632300405996e-06
done O 0 4.4062489905627444e-05
. O 0 5.1468508900143206e-05

Because O 0 0.0989854484796524
IVF B-Disease 1 0.9913462996482849
causes O 1 0.9928304553031921
cardiac O 1 0.9984244108200073
rhythm O 1 0.5807756781578064
disturbance O 1 0.7113085985183716
, O 0 2.258594577142503e-05
we O 0 5.7978327276941855e-06
investigated O 0 0.00030842862906865776
whether O 0 1.2851632163801696e-05
malfunction O 0 0.003536848584190011
of O 0 1.0927443554464844e-06
ion O 0 0.0001047413534251973
channels O 0 2.0664332623709925e-05
could O 0 1.4776108400837984e-05
cause O 0 0.009409095160663128
the O 0 3.4505945222917944e-05
disorder O 1 0.9966567754745483
by O 0 1.1481144611025229e-05
studying O 0 0.00028944743098691106
mutations O 0 0.01396052073687315
in O 0 6.861013844172703e-06
the O 0 2.1163359633646905e-05
cardiac O 1 0.9909180402755737
sodium O 0 0.006567999720573425
channel O 0 0.000622978841420263
gene O 0 0.012858480215072632
SCN5A O 0 0.1367020308971405
. O 0 0.00040232663741335273

We O 0 6.623594526899979e-05
have O 0 1.4382215340447146e-05
now O 0 1.2061918823746964e-05
identified O 0 2.3014672478893772e-05
a O 0 1.0229126928607002e-05
missense O 0 0.005388774909079075
mutation O 0 0.0004889078554697335
, O 0 3.195560793756158e-06
a O 0 6.5394892772019375e-06
splice O 0 0.0023168670013546944
- O 0 0.0035915100015699863
donor O 0 0.0019863140769302845
mutation O 0 0.0004112895403522998
, O 0 2.3060483727022074e-06
and O 0 1.444317604182288e-06
a O 0 7.313838068512268e-06
frameshift O 0 0.11535806953907013
mutation O 0 0.000339624093612656
in O 0 1.7172543493870762e-06
the O 0 2.274335656693438e-06
coding O 0 0.00010015269799623638
region O 0 2.0506378859863617e-05
of O 0 3.2411728625447722e-06
SCN5A O 0 0.012390511110424995
in O 0 9.420608876098413e-06
three O 0 3.840736098936759e-05
IVF B-Disease 1 0.7829505205154419
families O 0 0.00085571309318766
. O 0 0.00015725413686595857

We O 0 2.009008858294692e-05
show O 0 8.445997082162648e-06
that O 0 1.1695060493366327e-06
sodium O 0 1.0761533303593751e-05
channels O 0 2.6259249352733605e-06
with O 0 2.0182660591672175e-06
the O 0 4.649209586204961e-06
missense O 0 0.032096900045871735
mutation O 0 0.015273386612534523
recover O 0 0.0492234081029892
from O 0 6.939254490134772e-06
inactivation O 0 0.0049308775924146175
more O 0 3.5016225865547312e-06
rapidly O 0 3.8543414120795205e-05
than O 0 1.2050637678839848e-06
normal O 0 5.130053068569396e-06
and O 0 4.499717931594205e-07
that O 0 4.957867645316583e-07
the O 0 2.0347977169876685e-06
frameshift O 0 0.3059752285480499
mutation O 0 0.0031867993529886007
causes O 0 0.0009044872713275254
the O 0 1.2473403785406845e-06
sodium O 0 2.4206567104556598e-05
channel O 0 5.396713731897762e-06
to O 0 1.2111078149246168e-06
be O 0 1.2711462886727531e-06
non O 0 2.3058037186274305e-05
- O 0 0.00032128303428180516
functional O 0 0.00030244613299146295
. O 0 0.00010376649152021855

Our O 0 0.00011849834118038416
results O 0 7.673017535125837e-05
indicate O 0 5.0114373152609915e-05
that O 0 9.771807526703924e-06
mutations O 0 0.0015159609029069543
in O 0 1.8195152733824216e-05
cardiac O 1 0.9676677584648132
ion O 0 0.0010125571861863136
- O 0 0.0006529648671858013
channel O 0 1.819313911255449e-05
genes O 0 5.3170060709817335e-05
contribute O 0 4.1192983189830557e-05
to O 0 1.1308292187095503e-06
the O 0 2.1341745650715893e-06
risk O 0 0.0015027705812826753
of O 0 6.947452220629202e-06
developing O 0 0.023002304136753082
IVF B-Disease 1 0.7887528538703918
. O 0 4.216703018755652e-05
. O 0 0.00011149839701829478

Molecular O 0 0.01228182204067707
heterogeneity O 0 0.04108492285013199
in O 0 9.1014604549855e-05
mucopolysaccharidosis B-Disease 0 0.08915489912033081
IVA I-Disease 0 0.2563868761062622
in O 0 8.169601642293856e-06
Australia O 0 4.348503352957778e-06
and O 0 1.4621318769059144e-06
Northern O 0 4.6582194954680745e-06
Ireland O 0 5.707766376872314e-06
: O 0 3.5522630241757724e-06
nine O 0 6.453952664742246e-06
novel O 0 6.696848868159577e-05
mutations O 0 0.0022837806027382612
including O 0 1.1122763680759817e-05
T312S O 0 0.002116429153829813
, O 0 3.823908627964556e-06
a O 0 6.002704139973503e-06
common O 0 6.345917063299567e-05
allele O 0 0.0009260159567929804
that O 0 1.6182983017642982e-05
confers O 0 0.06361141800880432
a O 0 0.000617746205534786
mild O 1 0.9925113916397095
phenotype O 1 0.96833735704422
. O 0 0.00041919350042007864

Mucopolysaccharidosis B-Disease 1 0.7768531441688538
IVA I-Disease 1 0.9302831888198853
( O 0 0.0015726328128948808
MPS B-Disease 0 0.009025992825627327
IVA I-Disease 1 0.9637519717216492
) O 0 7.181499677244574e-05
is O 0 3.3049582270905375e-05
an O 0 0.00042287734686397016
autosomal B-Disease 1 0.9984069466590881
recessive I-Disease 1 0.9990135431289673
lysosomal I-Disease 1 0.9991382360458374
storage I-Disease 1 0.9863930344581604
disorder I-Disease 1 0.9996981620788574
caused O 1 0.7480689883232117
by O 0 4.9941187171498314e-05
a O 0 0.00019250778132118285
genetic B-Disease 1 0.6313451528549194
defect I-Disease 1 0.945890486240387
in O 0 4.24221798311919e-05
N O 0 0.0009667979902587831
- O 0 0.0031769985798746347
acetylgalactosamine O 0 0.029709527269005775
- O 0 0.0015594020951539278
6 O 0 0.00016704207519069314
- O 0 0.025264116004109383
sulfate O 1 0.962770402431488
sulfatase O 1 0.9898470044136047
( O 0 0.0007500226492993534
GALNS O 0 0.12659671902656555
) O 0 0.00011507396993692964
. O 0 0.00012174777657492086

Previous O 0 0.0002924699510913342
studies O 0 0.0002543229202274233
of O 0 1.9963126760558225e-05
patients O 1 0.8728704452514648
from O 0 5.069463895779336e-06
a O 0 7.074459063005634e-06
British O 0 1.1176982297911309e-05
- O 0 0.0003235200420022011
Irish O 0 1.4179971913108602e-05
population O 0 2.789114660117775e-06
showed O 0 3.5532182209863095e-06
that O 0 4.3043738173764723e-07
the O 0 8.975813443612424e-07
I113F O 0 0.0006314822821877897
mutation O 0 9.990153921535239e-05
is O 0 4.488651654810383e-07
the O 0 3.9486542391387047e-07
most O 0 1.0191957926508621e-06
common O 0 1.0697805009840522e-05
single O 0 9.647341357776895e-06
mutation O 0 0.004416887182742357
among O 0 0.00012268430145923048
MPS B-Disease 0 0.061282701790332794
IVA I-Disease 1 0.9983388185501099
patients O 1 0.9978415966033936
and O 0 0.00013780855806544423
produces O 0 0.015087209641933441
a O 0 0.003918194677680731
severe O 1 0.9986183643341064
clinical O 1 0.9972904920578003
phenotype O 1 0.991169810295105
. O 0 0.0010789190419018269

We O 0 8.935503865359351e-05
studied O 0 0.00010737474076449871
mutations O 0 0.000521275622304529
in O 0 4.704255388787715e-06
the O 0 4.755528152600164e-06
GALNS O 0 0.021439915522933006
gene O 0 0.0002492541680112481
from O 0 4.6951167860243e-06
23 O 0 2.1533560357056558e-05
additional O 0 5.782134030596353e-05
MPS B-Disease 0 0.011569769121706486
IVA I-Disease 1 0.995880126953125
patients O 1 0.9939031004905701
( O 0 1.6430127288913354e-05
15 O 0 3.1143433716351865e-06
from O 0 8.246660740951484e-07
Australia O 0 1.4825926655248622e-06
, O 0 5.28367138485919e-07
8 O 0 7.877900429775764e-07
from O 0 4.874169690083363e-07
Northern O 0 2.0470247363846283e-06
Ireland O 0 2.2388769593817415e-06
) O 0 9.009672226056864e-07
, O 0 6.598260711143666e-07
with O 0 1.7265208498429274e-06
various O 0 1.5324045307352208e-05
clinical O 1 0.9889974594116211
phenotypes O 1 0.9833093285560608
( O 0 0.0021466314792633057
severe O 1 0.9882761836051941
, O 0 1.0134995136468206e-05
16 O 0 1.4455341442953795e-05
cases O 0 0.0001581268006702885
; O 0 7.722002010268625e-06
intermediate O 0 8.464846905553713e-05
, O 0 2.311508978891652e-06
4 O 0 1.3179552297515329e-05
cases O 0 0.0009851162321865559
; O 0 5.490419061970897e-05
mild O 1 0.6196499466896057
, O 0 8.671166142448783e-06
3 O 0 2.608577415230684e-05
cases O 0 0.0005325342644937336
) O 0 4.985625128028914e-05
. O 0 7.759024447295815e-05

We O 0 5.118111221236177e-05
found O 0 1.2806084669136908e-05
two O 0 3.926778845197987e-06
common O 0 1.807409353205003e-05
mutations O 0 0.00017849239520728588
that O 0 6.215564098965842e-07
together O 0 7.099324079717917e-07
accounted O 0 2.8441195354389492e-06
for O 0 6.495010325124895e-07
32 O 0 2.227536015197984e-06
% O 0 4.460998468402977e-07
of O 0 4.038494409996929e-07
the O 0 1.537400407869427e-06
44 O 0 1.5010310562502127e-05
unrelated O 0 0.0013150301529094577
alleles O 0 0.00263163517229259
in O 0 1.4508124877465889e-05
these O 0 5.1646889914991334e-05
patients O 1 0.9850534796714783
. O 0 0.00021193201246205717

One O 0 5.176335616852157e-05
is O 0 1.5072049791342579e-05
the O 0 1.2768111446348485e-05
T312S O 0 0.001835652976296842
mutation O 0 0.000768201076425612
, O 0 5.160412001714576e-06
a O 0 8.880175300873816e-06
novel O 0 0.0001735712867230177
mutation O 0 0.0013641943223774433
found O 0 2.681598925846629e-05
exclusively O 0 8.94418335519731e-05
in O 0 0.0001177593003376387
milder O 1 0.9710421562194824
patients O 1 0.993597149848938
. O 0 0.00050487054977566

The O 0 2.557129118940793e-05
other O 0 6.615369329665555e-06
is O 0 3.4220440738863545e-06
the O 0 2.2195140445546713e-06
previously O 0 1.0228024621028453e-05
described O 0 7.26243233657442e-05
I113F O 0 0.001662548747844994
that O 0 7.753837053314783e-06
produces O 0 0.00047799982712604105
a O 0 0.000432702450780198
severe O 1 0.9937386512756348
phenotype O 1 0.96889728307724
. O 0 0.0003868037019856274

The O 0 0.0001067815101123415
I113F O 0 0.002324730157852173
and O 0 3.1346229661721736e-05
T312S O 0 0.0044175246730446815
mutations O 0 0.0016951081342995167
accounted O 0 1.9622055333456956e-05
for O 0 3.0931382752896752e-06
8 O 0 3.582828867365606e-06
( O 0 1.5959867596393451e-06
18 O 0 1.0032954378402792e-06
% O 0 4.785779310623184e-07
) O 0 6.691336125186353e-07
and O 0 3.6587476870408864e-07
6 O 0 1.6620297174085863e-06
( O 0 1.20498566502647e-06
14 O 0 1.2733812582155224e-06
% O 0 4.821640118279902e-07
) O 0 6.806854457863665e-07
of O 0 6.049421585885284e-07
44 O 0 1.1868758519995026e-05
unrelated O 0 0.0007130701560527086
alleles O 0 0.0009037274867296219
, O 0 1.576484282850288e-05
respectively O 0 7.270595233421773e-05
. O 0 6.973691051825881e-05

The O 0 8.074395736912265e-05
relatively O 0 0.00017130785272456706
high O 0 0.00014866486890241504
residual O 0 0.0018748348811641335
GALNS O 0 0.05607540160417557
activity O 0 4.182956399745308e-05
seen O 0 1.1495650142023806e-05
when O 0 2.8225945243320893e-06
the O 0 3.545757635947666e-06
T312S O 0 0.0007151042809709907
mutant O 0 0.00039399907109327614
cDNA O 0 0.00011421644012443721
is O 0 1.2120657629566267e-05
overexpressed O 0 0.004942053928971291
in O 0 6.4389396357000805e-06
mutant O 0 0.000633234332781285
cells O 0 0.000246714596869424
provides O 0 1.3290257811604533e-05
an O 0 1.5028870166133856e-06
explanation O 0 2.5844030460575595e-05
for O 0 5.856136795046041e-06
the O 0 3.7977730244165286e-05
mild O 1 0.9961091876029968
phenotype O 1 0.9744879007339478
in O 0 0.00011532595817698166
patients O 1 0.9864934682846069
with O 0 2.439560012135189e-05
this O 0 2.245630821562372e-05
mutation O 0 0.006593749392777681
. O 0 0.00013653250061906874

The O 0 3.245849802624434e-05
distribution O 0 2.0121440684306435e-05
and O 0 2.464852968842024e-06
relative O 0 4.302360594010679e-06
frequencies O 0 2.068706635327544e-06
of O 0 5.284235271574289e-07
the O 0 1.6787112144811545e-06
I113F O 0 0.0006134333088994026
and O 0 3.934110736736329e-06
T312S O 0 0.0029772259294986725
mutations O 0 0.0005553645896725357
in O 0 1.2376240192679688e-06
Australia O 0 1.955644620466046e-06
corresponded O 0 9.548669368086848e-06
to O 0 5.339604740584036e-07
those O 0 6.487891255346767e-07
observed O 0 3.4777208384184632e-06
in O 0 6.498102038676734e-07
Northern O 0 2.0021680029458366e-06
Ireland O 0 9.631166904000565e-07
and O 0 2.2456269732629153e-07
are O 0 1.7691539255793032e-07
unique O 0 6.445609415095532e-07
to O 0 1.717665725209372e-07
these O 0 2.3617764099981287e-07
two O 0 6.742170626239385e-07
populations O 0 1.705380236671772e-05
, O 0 6.892972805871977e-07
suggesting O 0 6.7363225753069855e-06
that O 0 4.326172984292498e-07
both O 0 1.1458023436716758e-06
mutations O 0 0.0002130924549419433
were O 0 5.624308414553525e-07
probably O 0 2.4133689748850884e-06
introduced O 0 1.378595584355935e-06
to O 0 4.6131475528454757e-07
Australia O 0 8.280895258394594e-07
by O 0 7.869250566727715e-07
Irish O 0 4.91542550662416e-06
migrants O 0 5.325544861989329e-06
during O 0 2.580609816504875e-06
the O 0 2.542155016271863e-06
19th O 0 1.9581568267312832e-05
century O 0 3.6173209082335234e-05
. O 0 6.786389712942764e-05

Haplotype O 0 0.11843527108430862
analysis O 0 7.475720485672355e-05
using O 0 2.2434518541558646e-05
6 O 0 2.3509664970333688e-05
RFLPs O 0 0.0005765375681221485
provides O 0 1.1301195627311245e-05
additional O 0 2.660577592905611e-06
data O 0 1.310750349148293e-06
that O 0 6.244153496481886e-07
the O 0 1.2199759567010915e-06
I113F O 0 0.0009071697131730616
mutation O 0 0.00023764887009747326
originated O 0 1.4053344784770161e-05
from O 0 4.087999968760414e-06
a O 0 1.1337770047248341e-05
common O 0 0.00013053110160399228
ancestor O 0 0.000662710634060204
. O 0 0.00015388002793770283

The O 0 4.8494879592908546e-05
other O 0 2.0555367882479914e-05
9 O 0 5.7912777265300974e-05
novel O 0 0.0002386611158726737
mutations O 0 0.0035998434759676456
identified O 0 3.058168294955976e-05
in O 0 1.9508463537931675e-06
these O 0 2.3138909455155954e-06
23 O 0 2.7503225282998756e-05
patients O 0 0.35630086064338684
were O 0 3.0759363767174364e-07
each O 0 4.1332950218020414e-07
limited O 0 1.860954853327712e-06
to O 0 8.725947964194347e-07
a O 0 3.415780838622595e-06
single O 0 9.856453289103229e-06
family O 0 8.873434126144275e-05
. O 0 5.682905612047762e-05

These O 0 2.242703158117365e-05
data O 0 1.0557695532042999e-05
provide O 0 1.3485262570611667e-05
further O 0 4.795286713488167e-06
evidence O 0 5.540352049138164e-06
for O 0 3.973680577473715e-06
extensive O 0 0.0005926878657191992
allelic O 0 0.2608128786087036
heterogeneity O 0 0.035984598100185394
in O 0 4.678749610320665e-05
MPS B-Disease 0 0.0029812848661094904
IVA I-Disease 1 0.9362910389900208
in O 0 1.7444919649278745e-05
British O 0 9.149111428996548e-05
- O 0 0.034078650176525116
Irish O 0 0.0015670080902054906
patients O 1 0.9697756767272949
and O 0 2.8527060749183875e-06
provide O 0 5.778380455012666e-06
evidence O 0 2.0958439108653693e-06
for O 0 5.696644507224846e-07
their O 0 5.102058935335663e-07
transmission O 0 2.5361146981595084e-05
to O 0 6.462048531830078e-07
Australia O 0 1.3763675497102668e-06
by O 0 1.0797612048918381e-06
British O 0 6.849129476904636e-06
- O 0 0.00021913448290433735
Irish O 0 3.6510838981484994e-05
migrants O 0 6.0873269831063226e-05
. O 0 1.769897608028259e-05
. O 0 6.414460949599743e-05

Identification O 0 0.0003280743840150535
of O 0 3.080907845287584e-05
constitutional O 0 0.0006924558547325432
WT1 O 1 0.9924828410148621
mutations O 1 0.578245997428894
, O 0 6.923259206814691e-05
in O 0 0.000132863933686167
patients O 1 0.9980397820472717
with O 0 0.00355804106220603
isolated O 1 0.9925733804702759
diffuse B-Disease 1 0.9993489384651184
mesangial I-Disease 1 0.9997755885124207
sclerosis I-Disease 1 0.9999188184738159
, O 0 0.00013454748841468245
and O 0 8.507930033374578e-06
analysis O 0 2.948136898339726e-05
of O 0 1.4160808859742247e-05
genotype O 1 0.9356854557991028
/ O 1 0.7140251398086548
phenotype O 0 0.3235454261302948
correlations O 0 0.00012291768507566303
by O 0 1.947073087649187e-06
use O 0 1.521243575552944e-06
of O 0 1.3466014934238046e-06
a O 0 1.7651309462962672e-05
computerized O 0 0.011080569587647915
mutation O 0 0.005446652416139841
database O 0 0.0007772474782541394
. O 0 0.00014405339607037604

Constitutional O 0 0.00036146509228274226
mutations O 0 0.0013902434147894382
of O 0 9.211796168528963e-06
the O 0 2.0705283532151952e-05
WT1 O 1 0.8130602240562439
gene O 0 0.0004630107432603836
, O 0 5.5050436458259355e-06
encoding O 0 2.052858872048091e-05
a O 0 9.049922482518014e-06
zinc O 0 0.005962572060525417
- O 0 0.0033703281078487635
finger O 0 0.009317721240222454
transcription O 0 0.0004399007884785533
factor O 0 0.00015315499331336468
involved O 0 8.232724940171465e-05
in O 0 7.260611891979352e-05
renal O 1 0.9994981288909912
and O 0 0.00019442530174273998
gonadal O 1 0.9899935126304626
development O 0 0.00018721618107520044
, O 0 2.818979282892542e-06
are O 0 8.128096169457422e-07
found O 0 3.191702035110211e-06
in O 0 3.157250603180728e-06
most O 0 3.726096838363446e-05
patients O 1 0.9896649718284607
with O 0 0.0011137722758576274
Denys B-Disease 1 0.9972628355026245
- I-Disease 1 0.9947815537452698
Drash I-Disease 1 0.9982378482818604
syndrome I-Disease 1 0.999811589717865
( O 0 0.15818768739700317
DDS B-Disease 1 0.9984453320503235
) O 0 0.0002524007868487388
, O 0 8.539917325833812e-05
or O 0 0.0026270258240401745
diffuse B-Disease 1 0.9977108240127563
mesangial I-Disease 1 0.9995571970939636
sclerosis I-Disease 1 0.9998981952667236
( O 0 0.459412157535553
DMS B-Disease 1 0.9972952008247375
) O 0 0.00010625171853462234
associated O 0 0.0001658498658798635
with O 0 5.2653023885795847e-05
pseudohermaphroditism B-Disease 1 0.9507097005844116
and O 0 0.00038499003858305514
/ O 1 0.8035231232643127
or O 0 0.015375833958387375
Wilms B-Disease 1 0.9989728927612305
tumor I-Disease 1 0.9980890154838562
( O 0 0.003258087672293186
WT B-Disease 1 0.9186007380485535
) O 0 0.00015898403944447637
. O 0 0.00012616682215593755

Most O 0 0.0012654110323637724
mutations O 0 0.40793469548225403
in O 0 0.0019118929049000144
DDS B-Disease 1 0.9977483153343201
patients O 1 0.9943996071815491
lie O 0 0.0006135558360256255
in O 0 7.603299764014082e-06
exon O 0 0.00021867864415980875
8 O 0 7.204226676549297e-06
or O 0 2.6503314529691124e-06
exon O 0 8.33758240332827e-05
9 O 0 5.728767064283602e-06
, O 0 1.7366385236528004e-06
encoding O 0 1.3910485904489178e-05
zinc O 0 0.0008363676024600863
finger O 0 0.000709759711753577
2 O 0 6.908813702466432e-06
or O 0 5.46107776244753e-06
zinc O 0 0.0010648486204445362
finger O 0 0.0006748702726326883
3 O 0 3.8735615817131475e-06
, O 0 9.570462680130731e-07
respectively O 0 1.4534205092786578e-06
, O 0 4.586196382661001e-07
with O 0 6.545058113260893e-07
a O 0 2.1004723294026917e-06
hot O 0 4.697827171185054e-05
spot O 0 3.132570054731332e-05
( O 0 1.4259683666750789e-05
R394W O 0 0.0002371793962083757
) O 0 6.309800937742693e-06
in O 0 5.983317805657862e-06
exon O 0 0.00042537800618447363
9 O 0 0.00010399394523119554
. O 0 7.464201917173341e-05

We O 0 5.061661431682296e-05
analyzed O 0 5.7538945839041844e-05
a O 0 7.31085310690105e-06
series O 0 7.487978109566029e-06
of O 0 2.086454969685292e-06
24 O 0 3.0633291316917166e-05
patients O 1 0.6645734906196594
, O 0 3.180841986250016e-06
10 O 0 5.440949280455243e-06
with O 0 2.692088673938997e-05
isolated B-Disease 0 0.15691328048706055
DMS I-Disease 1 0.9966758489608765
( O 0 0.0005477812374010682
IDMS B-Disease 1 0.9549920558929443
) O 0 7.678691872570198e-06
, O 0 2.2082545001467224e-06
10 O 0 3.4124598187190713e-06
with O 0 1.2227142178744543e-05
DDS B-Disease 1 0.9929723739624023
, O 0 3.7360905480454676e-06
and O 0 2.3748270905343816e-06
4 O 0 1.5528428775724024e-05
with O 0 7.455972081515938e-05
urogenital B-Disease 1 0.993818461894989
abnormalities I-Disease 1 0.9949280023574829
and O 0 0.0003516822471283376
/ O 0 0.3991539776325226
or O 0 0.0004399313766043633
WT B-Disease 1 0.9271389842033386
. O 0 0.0004267593612894416

We O 0 0.00039074296364560723
report O 0 0.0006359826656989753
WT1 O 1 0.8939709067344666
heterozygous O 0 0.013942782767117023
mutations O 0 0.0090406509116292
in O 0 2.4558321456424892e-05
16 O 0 0.00010083142842631787
patients O 1 0.9078810214996338
, O 0 4.249909579812083e-06
4 O 0 5.715097813663306e-06
of O 0 1.980424030989525e-06
whom O 0 8.658274600747973e-05
presented O 0 6.489034421974793e-05
with O 0 0.0001587228907737881
IDMS B-Disease 1 0.982793927192688
. O 0 0.0004260888381395489

One O 0 7.619026291649789e-05
male O 0 0.0002605252666398883
and O 0 1.6640546164126135e-05
two O 0 3.6142173485131934e-05
female O 0 0.09496860206127167
IDMS B-Disease 1 0.99739009141922
patients O 1 0.9983308911323547
with O 0 0.011058708652853966
WT1 O 1 0.9968295693397522
mutations O 1 0.9927046895027161
underwent O 1 0.9954202771186829
normal O 0 0.388424813747406
puberty O 1 0.9783555269241333
. O 0 0.0008582567097619176

Two O 0 0.00017992862558458
mutations O 0 0.048468854278326035
associated O 0 0.0002487665042281151
with O 0 2.465545003360603e-05
IDMS B-Disease 1 0.9332770705223083
are O 0 3.7772545056213858e-06
different O 0 2.352975570829585e-06
from O 0 3.1034119274409022e-06
those O 0 1.2566998520924244e-05
described O 0 0.0010486760875210166
in O 0 0.0005193711840547621
DDS B-Disease 1 0.998487114906311
patients O 1 0.9973553419113159
. O 0 0.000874680932611227

No O 0 0.0013726478209719062
WT1 O 1 0.9645547270774841
mutations O 0 0.0236363522708416
were O 0 8.592422091169283e-06
detected O 0 0.0001332643732894212
in O 0 2.296637376275612e-06
the O 0 2.0923550891893683e-06
six O 0 2.39996279560728e-05
other O 0 0.00013728784688282758
IDMS B-Disease 1 0.9985398054122925
patients O 1 0.99849534034729
, O 0 0.00011648356303339824
suggesting O 0 0.0031549495179206133
genetic O 0 0.024636004120111465
heterogeneity O 0 0.04902932792901993
of O 0 2.8489073883974925e-05
this O 0 0.00021593994460999966
disease O 1 0.9978347420692444
. O 0 0.0004961626837030053

We O 0 0.00032844048109836876
analyzed O 0 0.0050185928121209145
genotype O 1 0.8219837546348572
/ O 0 0.38118883967399597
phenotype O 0 0.1347474902868271
correlations O 0 0.00017308455426245928
, O 0 1.3167505130695645e-06
on O 0 2.8465350965234393e-07
the O 0 1.6039915351484524e-07
basis O 0 2.0470821482376778e-07
of O 0 1.4639384460224392e-07
the O 0 3.308285556613555e-07
constitution O 0 8.87966564278031e-07
of O 0 4.380287919047987e-07
a O 0 9.061598575499374e-06
WT1 O 1 0.6196820139884949
mutation O 0 0.00038118960219435394
database O 0 1.5327670553233474e-05
of O 0 2.1022337932663504e-06
84 O 0 0.00023394770687445998
germ O 0 0.4349512457847595
- O 0 0.0010480777127668262
line O 0 1.6817666619317606e-05
mutations O 0 0.0002058748505078256
, O 0 6.583276217497769e-07
to O 0 4.586550801377598e-07
compare O 0 5.716395207855385e-06
the O 0 3.326445039419923e-07
distribution O 0 1.0046244369732449e-06
and O 0 4.6663106445521407e-07
type O 0 1.8709126379690133e-05
of O 0 9.296840062233969e-07
mutations O 0 0.0007893156143836677
, O 0 1.143342956311244e-06
according O 0 2.167286993426387e-06
to O 0 1.1890564337591059e-06
the O 0 4.297702162148198e-06
different O 0 4.368793815956451e-05
symptoms O 1 0.9910712242126465
. O 0 0.00022313534282147884

This O 0 5.3012248827144504e-05
demonstrated O 0 0.00011970514606218785
( O 0 1.1568950867513195e-05
1 O 0 3.849763743346557e-06
) O 0 2.00376507564215e-06
the O 0 9.848765785136493e-07
association O 0 1.2071758646925446e-05
between O 0 2.4709299850655952e-06
mutations O 0 0.00016726106696296483
in O 0 1.96217956727196e-06
exons O 0 3.3868458558572456e-05
8 O 0 4.281633664504625e-06
and O 0 1.4945399016141891e-06
9 O 0 8.007448741409462e-06
and O 0 8.416400305577554e-06
DMS B-Disease 1 0.8356133699417114
; O 0 7.078426733642118e-06
( O 0 4.871943474427098e-06
2 O 0 4.5619312913913745e-06
) O 0 4.307459676056169e-06
among O 0 2.13847633858677e-05
patients O 1 0.9269430041313171
with O 0 3.717635263456032e-05
DMS B-Disease 1 0.9286819100379944
, O 0 1.2436867109499872e-06
a O 0 9.072234092855069e-07
higher O 0 1.7415958382116514e-06
frequency O 0 1.5692428405600367e-06
of O 0 9.001547596199089e-07
exon O 0 0.00027976915589533746
8 O 0 2.100219535350334e-05
mutations O 0 0.0007651319028809667
among O 0 7.3335195338586345e-06
46 O 0 8.937677921494469e-05
, O 0 6.626614776905626e-05
XY O 1 0.9936854243278503
patients O 1 0.9931046366691589
with O 0 2.3864149625296704e-05
female O 0 0.0027004543226212263
phenotype O 1 0.6370581984519958
than O 0 1.118163072533207e-05
among O 0 2.2807435016147792e-05
46 O 0 0.0002664959174580872
, O 0 0.00012057764251949266
XY O 1 0.9957358837127686
patients O 1 0.9958765506744385
with O 0 5.289630644256249e-05
sexual O 0 0.013068152591586113
ambiguity O 0 0.0046319118700921535
or O 0 0.0001857364986790344
male O 0 0.02074197493493557
phenotype O 1 0.8823347687721252
; O 0 2.0821831640205346e-05
and O 0 2.4404037048952887e-06
( O 0 3.345356390127563e-06
3 O 0 2.0971535832359223e-06
) O 0 1.0330081749998499e-06
statistically O 0 4.2400397433084436e-06
significant O 0 1.8919414515039534e-06
evidence O 0 1.7662590607869788e-06
that O 0 5.519655132957269e-07
mutations O 0 7.453483704011887e-05
in O 0 7.489089739465271e-07
exons O 0 1.875800808193162e-05
8 O 0 2.3293762296816567e-06
and O 0 1.0243096539852559e-06
9 O 0 4.396120857563801e-06
preferentially O 0 2.8611784728127532e-05
affect O 0 7.764574547763914e-06
amino O 0 2.7035296170652146e-06
acids O 0 2.1655266664311057e-06
with O 0 7.792212386448227e-07
different O 0 1.9875365069310647e-06
functions O 0 8.349135896423832e-06
. O 0 1.0554957952990662e-05
. O 0 5.2809311455348507e-05

The O 0 0.0004075747274328023
185delAG O 0 0.21117675304412842
BRCA1 O 1 0.958342969417572
mutation O 0 0.009294725023210049
originated O 0 8.886321302270517e-05
before O 0 4.758844625030179e-06
the O 0 1.3646516663357033e-06
dispersion O 0 3.5288547223899513e-05
of O 0 7.348967301368248e-07
Jews O 0 3.1490712899540085e-06
in O 0 9.612502935851808e-07
the O 0 9.475196520725149e-07
diaspora O 0 1.5650906789232977e-05
and O 0 1.46551019497565e-06
is O 0 1.5782386526552727e-06
not O 0 1.7582525515535963e-06
limited O 0 1.150331627286505e-05
to O 0 1.4216247109288815e-05
Ashkenazim O 0 0.016258124262094498
. O 0 0.00014175452815834433

The O 0 0.00021004445443395525
185delAG O 0 0.05288247764110565
mutation O 0 0.012178381904959679
in O 0 5.773081647930667e-05
BRCA1 O 1 0.8649957180023193
is O 0 2.2985059331404045e-05
detected O 0 0.002038379665464163
in O 0 1.3878512618248351e-05
Ashkenazi O 0 0.04576151818037033
Jews O 0 7.076696783769876e-05
both O 0 3.855179966194555e-05
in O 0 0.0009812042117118835
familial B-Disease 1 0.9996058344841003
breast I-Disease 1 0.9999129772186279
and I-Disease 1 0.8763622045516968
ovarian I-Disease 1 0.9999521970748901
cancer I-Disease 1 0.9998522996902466
and O 0 3.874913090839982e-05
in O 0 6.506692443508655e-06
the O 0 5.8454397731111385e-06
general O 0 4.21399345214013e-05
population O 0 5.51416706002783e-05
. O 0 0.00011495157377794385

All O 0 0.00013917346950620413
tested O 0 0.01271176990121603
Ashkenazi O 0 0.03533272445201874
mutation O 0 0.0033938789274543524
carriers O 0 0.0001533382455818355
share O 0 7.2124748839996755e-06
the O 0 2.0786183085874654e-06
same O 0 6.237944035092369e-06
allelic O 0 0.010851779952645302
pattern O 0 0.00036748513230122626
at O 0 2.0674306142609566e-05
the O 0 4.373612318886444e-05
BRCA1 O 1 0.8878068327903748
locus O 0 0.028988562524318695
. O 0 0.00032081565586850047

Our O 0 9.877392585622147e-05
previous O 0 4.049694325658493e-05
study O 0 6.558236054843292e-05
showed O 0 2.035188299487345e-05
that O 0 2.3498853352066362e-06
this O 0 3.211640432709828e-06
Ashkenazi O 0 0.005842594429850578
mutation O 0 0.0007678702822886407
also O 0 3.217624453100143e-06
occurs O 0 1.6400932508986443e-05
in O 0 1.5386780205517425e-06
Iraqi O 0 8.310671546496451e-06
Jews O 0 4.242321210767841e-06
with O 0 2.673195240276982e-06
a O 0 1.1071953849750571e-05
similar O 0 0.00011385716788936406
allelic O 0 0.14648129045963287
pattern O 0 0.00733440276235342
. O 0 0.00025000839377753437

We O 0 3.78566728613805e-05
extended O 0 1.8534454284235835e-05
our O 0 4.992602953279857e-06
analysis O 0 6.0243814914429095e-06
to O 0 1.1627699905147892e-06
other O 0 1.0734161151049193e-06
non O 0 1.2048628377669957e-05
- O 0 0.00013978501374367625
Ashkenazi O 0 0.0004257390392012894
subsets O 0 3.845647006528452e-05
354 O 0 7.984839612618089e-05
of O 0 2.4536050204915227e-06
Moroccan O 0 2.6257865101797506e-05
origin O 0 6.385627330018906e-06
, O 0 3.863408437609905e-06
200 O 0 1.3661668162967544e-05
Yemenites O 0 0.003692460246384144
and O 0 5.965097443549894e-06
150 O 0 2.783206400636118e-05
Iranian O 0 4.6662513341289014e-05
Jews O 0 0.00010624097194522619
. O 0 9.416187094757333e-05

Heteroduplex O 0 0.014475206844508648
analysis O 0 0.00011503820132929832
complemented O 0 0.00013701844727620482
by O 0 6.798836693633348e-06
direct O 0 1.4626515621785074e-05
DNA O 0 2.4999490051413886e-05
sequencing O 0 3.5559340176405385e-05
of O 0 6.401626706065144e-06
abnormally O 0 0.14355060458183289
migrating O 0 0.000601497245952487
bands O 0 3.036159250768833e-05
were O 0 7.758674655633513e-06
employed O 0 0.00014734674186911434
. O 0 8.915425860323012e-05

Four O 0 3.080020542256534e-05
of O 0 4.601666660164483e-06
Moroccan O 0 3.115992876701057e-05
origin O 0 6.3444904299103655e-06
( O 0 3.214244770788355e-06
1 O 0 1.1092383829236496e-06
. O 0 3.3030588042493036e-07
1 O 0 7.388841822830727e-07
% O 0 4.4977358015785285e-07
) O 0 4.4417589606382535e-07
and O 0 1.9820008390070143e-07
none O 0 7.396765795419924e-07
of O 0 2.2233498953028175e-07
the O 0 1.15271700451558e-06
Yemenites O 0 0.009162914007902145
or O 0 2.0981879060855135e-06
Iranians O 0 3.5038137866649777e-06
was O 0 8.262255164481758e-07
a O 0 1.2427974525053287e-06
carrier O 0 1.81481555046048e-05
of O 0 1.699414724498638e-06
the O 0 9.250168659491464e-06
185delAG O 0 0.008135697804391384
mutation O 0 0.004075468517839909
. O 0 0.00017134510562755167

BRCA1 O 1 0.9751324653625488
allelic O 0 0.2533388137817383
patterns O 0 0.0004605894791893661
were O 0 4.006641120213317e-06
determined O 0 5.358792805054691e-06
for O 0 5.1095867092954e-07
four O 0 3.101114032233454e-07
of O 0 1.7279310782214452e-07
these O 0 4.4454120029513433e-07
individuals O 0 1.8823471918949508e-06
and O 0 3.348872610331455e-07
for O 0 5.251510515336122e-07
12 O 0 2.2018366507836618e-06
additional O 0 5.748650437453762e-06
non O 0 9.141384362010285e-05
- O 0 0.021119818091392517
Ashkenazi O 0 0.19158107042312622
185delAG O 0 0.33286118507385254
mutation O 0 0.15959948301315308
carriers O 0 0.04495915398001671
who O 0 0.0011417956557124853
had O 0 0.011860736645758152
breast B-Disease 1 0.9994437098503113
/ I-Disease 1 0.9978160858154297
ovarian I-Disease 1 0.9997081160545349
cancer I-Disease 1 0.999451220035553
. O 0 0.006845871917903423

Six O 0 0.00042090853094123304
non O 0 0.001481385319493711
- O 0 0.030673058703541756
Ashkenazi O 0 0.038617853075265884
individuals O 0 8.987410546978936e-05
shared O 0 2.8649217711063102e-05
the O 0 8.625229384051636e-06
common O 0 0.0006409522611647844
Ashkenazi O 0 0.2891734540462494
haplotype O 0 0.3858073651790619
, O 0 3.537330712788389e-06
four O 0 1.9747039914363995e-06
had O 0 1.6862396705619176e-06
a O 0 2.8705351269309176e-06
closely O 0 1.7767537428881042e-05
related O 0 7.33877532184124e-05
pattern O 0 3.838187694782391e-05
, O 0 7.899462275418045e-07
and O 0 4.520216521086695e-07
the O 0 6.43145597223338e-07
rest O 0 5.96356176174595e-06
( O 0 5.984858944430016e-06
n O 0 2.4417900931439362e-05
= O 0 4.313057434046641e-05
6 O 0 5.908660568820778e-06
) O 0 3.0561575385945616e-06
displayed O 0 6.2053454712440725e-06
a O 0 1.1126986464660149e-05
distinct O 0 0.00043999572517350316
BRCA1 O 1 0.9571655988693237
allelic O 1 0.5216814875602722
pattern O 0 0.018078835681080818
. O 0 0.0004417489399202168

We O 0 6.08191367064137e-05
conclude O 0 0.00011940827243961394
that O 0 6.7828927967639174e-06
the O 0 1.2517169125203509e-05
185delAG O 0 0.08900520205497742
BRCA1 O 1 0.9762359261512756
mutation O 0 0.019481370225548744
occurs O 0 9.269543807022274e-05
in O 0 2.6023012651421595e-06
some O 0 2.977690655825427e-06
non O 0 0.00014705758076161146
- O 0 0.011677359230816364
Ashkenazi O 0 0.07216531783342361
populations O 0 0.00024572675465606153
at O 0 4.324978363001719e-06
rates O 0 1.086585416487651e-05
comparable O 0 1.2467036867747083e-05
with O 0 1.8480882317817304e-06
that O 0 2.303445853613084e-06
of O 0 1.0812082109623589e-05
Ashkenazim O 0 0.09618031978607178
. O 0 0.00016190818860195577

The O 0 5.610470179817639e-05
majority O 0 4.4449581764638424e-05
of O 0 9.973701708076987e-06
Jewish O 0 0.00016550056170672178
185delAG O 0 0.0506625734269619
mutation O 0 0.012523790821433067
carriers O 0 0.00037615111796185374
have O 0 3.116637117273058e-06
a O 0 4.144815193285467e-06
common O 0 5.587959094555117e-05
allelic O 0 0.04561513289809227
pattern O 0 0.0004353800031822175
, O 0 3.517489858495537e-06
supporting O 0 9.190893251798116e-06
the O 0 2.2099313810031163e-06
founder O 0 0.00013310158101376146
effect O 0 1.9048962712986395e-05
notion O 0 9.105760909733362e-06
, O 0 9.673454997027875e-07
but O 0 4.5414930127662956e-07
dating O 0 3.8783437048550695e-06
the O 0 6.707923034809937e-07
mutations O 0 6.002680311212316e-05
origin O 0 6.084066512812569e-07
to O 0 3.4611599630807177e-07
an O 0 5.861394356543315e-07
earlier O 0 2.383544597250875e-06
date O 0 2.306598162249429e-06
than O 0 3.582241333788261e-06
currently O 0 7.6259279921941925e-06
estimated O 0 4.927666304865852e-05
. O 0 5.024639540351927e-05

However O 0 7.666603778488934e-05
, O 0 1.0603020200505853e-05
the O 0 3.170937816321384e-06
different O 0 6.003712314850418e-06
allelic O 0 0.004481461364775896
pattern O 0 0.00015289410657715052
at O 0 8.044663445616607e-06
the O 0 8.754156624490861e-06
BRCA1 O 1 0.7613348960876465
locus O 0 0.0008493353961966932
even O 0 7.225582521641627e-06
in O 0 2.4883036076062126e-06
some O 0 2.692050202313112e-06
Jewish O 0 6.529835081892088e-05
mutation O 0 0.003116426058113575
carriers O 0 0.00036654373980127275
, O 0 2.6842565148399444e-06
might O 0 5.7329261835548095e-06
suggest O 0 6.080706498323707e-06
that O 0 7.447105190294678e-07
the O 0 2.0283346202631947e-06
mutation O 0 0.00046840644790790975
arose O 0 7.991117308847606e-05
independently O 0 3.451571683399379e-05
. O 0 1.5895002434263006e-05
. O 0 7.10927924956195e-05

Crystal O 0 0.0059733097441494465
structure O 0 0.00014461106911767274
of O 0 1.8736660422291607e-05
the O 0 5.7407189160585403e-05
hemochromatosis B-Disease 1 0.9970314502716064
protein O 0 0.005829773843288422
HFE O 1 0.8255950808525085
and O 0 8.373520358873066e-06
characterization O 0 0.0001290768850594759
of O 0 1.6439593082395731e-06
its O 0 4.625002020475222e-06
interaction O 0 6.966166984057054e-05
with O 0 4.640743281925097e-05
transferrin O 0 0.2445891797542572
receptor O 0 0.01983376033604145
. O 0 0.00021644661319442093

HFE O 1 0.8565115928649902
is O 0 0.00013833146658726037
an O 0 5.5269811127800494e-05
MHC O 0 0.47977331280708313
- O 0 0.0010065985843539238
related O 0 0.00012744392734020948
protein O 0 2.026260699494742e-05
that O 0 2.3388115550915245e-06
is O 0 4.080992312083254e-06
mutated O 0 0.0009734663763083518
in O 0 3.866431143251248e-06
the O 0 1.3226721421233378e-05
iron B-Disease 0 0.35550883412361145
- I-Disease 1 0.9780498147010803
overload I-Disease 1 0.9972277283668518
disease I-Disease 1 0.9994126558303833
hereditary B-Disease 1 0.9973005652427673
hemochromatosis I-Disease 1 0.9982753992080688
. O 0 0.024895112961530685

HFE O 1 0.7755702137947083
binds O 0 0.0032007775735110044
to O 0 0.00010330484656151384
transferrin O 0 0.3330470323562622
receptor O 0 0.03785409778356552
( O 0 0.00011475760402390733
TfR O 0 0.04608512669801712
) O 0 7.246810127981007e-06
and O 0 2.3107309061742853e-06
reduces O 0 7.167527655838057e-05
its O 0 2.5346819256810704e-06
affinity O 0 4.0663428080733865e-05
for O 0 4.387451099319151e-06
iron O 0 0.0005327592371031642
- O 0 0.0005574585520662367
loaded O 0 7.193740020738915e-05
transferrin O 0 0.04003743827342987
, O 0 4.718273339676671e-05
implicating O 0 0.3263179063796997
HFE O 1 0.8946554660797119
in O 0 0.00010159427620237693
iron O 0 0.03030271641910076
metabolism O 0 0.3033750653266907
. O 0 0.0003315964713692665

The O 0 0.0003948173834942281
2 O 0 0.0006583215435966849
. O 0 0.0004335221601650119

6 O 0 0.00027132112882100046
A O 0 8.207507198676467e-05
crystal O 0 0.0009248454589396715
structure O 0 8.82760577951558e-05
of O 0 1.3952576409792528e-05
HFE O 1 0.8430431485176086
reveals O 0 0.0011785360984504223
the O 0 7.437306976498803e-06
locations O 0 2.909908835135866e-05
of O 0 2.3257371140061878e-05
hemochromatosis B-Disease 1 0.9992639422416687
mutations O 0 0.39821857213974
and O 0 1.4454156371357385e-05
a O 0 3.6761968658538535e-05
patch O 0 0.4325448274612427
of O 0 4.515728051046608e-06
histidines O 0 0.01123366691172123
that O 0 1.63054687618569e-06
could O 0 1.646176087888307e-06
be O 0 5.231480599832139e-07
involved O 0 4.886391252512112e-06
in O 0 4.28226212534355e-06
pH O 0 0.01037178747355938
- O 0 0.001457237871363759
dependent O 0 0.0002743947843555361
interactions O 0 0.00039213578565977514
. O 0 0.00010155417112400755

We O 0 7.273577648447827e-05
also O 0 1.6403340850956738e-05
demonstrate O 0 5.112184226163663e-05
that O 0 9.305274033977184e-06
soluble O 0 0.006754317320883274
TfR O 0 0.31504037976264954
and O 0 2.921450686699245e-05
HFE O 1 0.5827789902687073
bind O 0 0.0005361981457099319
tightly O 0 2.262716407130938e-05
at O 0 1.8437033304508077e-06
the O 0 7.604900247315527e-07
basic O 0 5.676368800777709e-06
pH O 0 0.0001371054822811857
of O 0 4.872078989137663e-07
the O 0 1.1745671599783236e-06
cell O 0 7.264441228471696e-05
surface O 0 3.501473838696256e-05
, O 0 1.0327767085982487e-06
but O 0 7.316254482248041e-07
not O 0 4.4639006091529154e-07
at O 0 1.038368509398424e-06
the O 0 1.7207986502398853e-06
acidic O 0 0.0016147653805091977
pH O 0 0.0011667368235066533
of O 0 6.566254342033062e-06
intracellular O 0 0.0025509961415082216
vesicles O 0 0.007893268950283527
. O 0 0.0002013932098634541

TfR O 1 0.947965681552887
HFE O 1 0.9444665312767029
stoichiometry O 0 0.01487413328140974
( O 0 0.00010045425733551383
2 O 0 2.1427058527478948e-05
1 O 0 1.6853453416842967e-05
) O 0 1.057668214343721e-05
differs O 0 4.561823880067095e-05
from O 0 1.2780355064023752e-05
TfR O 0 0.18491680920124054
transferrin O 0 0.06798715144395828
stoichiometry O 0 0.0033878020476549864
( O 0 1.1277186786173843e-05
2 O 0 3.7022607557446463e-06
2 O 0 1.7947102151083527e-06
) O 0 1.1623120599324466e-06
, O 0 6.593706416424538e-07
implying O 0 4.736261416837806e-06
a O 0 4.963152377968072e-07
different O 0 4.395247401589586e-07
mode O 0 2.364456804571091e-06
of O 0 6.448289582294819e-07
binding O 0 1.0217232556897216e-05
for O 0 7.897633622633293e-06
HFE O 0 0.3082873225212097
and O 0 9.431541002413724e-06
transferrin O 0 0.04106610268354416
to O 0 8.673043339513242e-06
TfR O 0 0.08637339621782303
, O 0 2.0578079329425236e-06
consistent O 0 5.460650754685048e-06
with O 0 1.278004333471472e-06
our O 0 3.08740027321619e-06
demonstration O 0 1.7899594240589067e-05
that O 0 4.481842552195303e-06
HFE O 0 0.30965110659599304
, O 0 8.307406460517086e-06
transferrin O 0 0.007018834352493286
, O 0 5.869090728083393e-06
and O 0 7.878496035118587e-06
TfR O 0 0.05619429796934128
form O 0 3.3125561458291486e-05
a O 0 4.525418989942409e-05
ternary O 0 0.002616751240566373
complex O 0 0.0015895420219749212
. O 0 0.0002464856079313904

Identification O 0 9.131278784479946e-05
of O 0 7.237845238705631e-06
three O 0 8.110410817607772e-06
novel O 0 8.167104533640668e-05
mutations O 0 0.0007099564536474645
and O 0 2.0025977391924243e-06
a O 0 2.135738441211288e-06
high O 0 4.2916403799608815e-06
frequency O 0 2.224305262643611e-06
of O 0 9.242014016308531e-07
the O 0 4.3807867768919095e-06
Arg778Leu O 0 0.05029839277267456
mutation O 0 0.01870173215866089
in O 0 4.030350100947544e-05
Korean O 0 0.02300422266125679
patients O 1 0.9970360994338989
with O 0 0.0019725195597857237
Wilson B-Disease 1 0.9586189389228821
disease I-Disease 1 0.9984063506126404
. O 0 0.00136570876929909

Four O 0 0.00033844212885014713
mutations O 0 0.02017165720462799
- O 0 0.0065794032998383045
- O 0 0.004397266544401646
R778L O 0 0.0071783363819122314
, O 0 1.8962073227157816e-05
A874V O 0 0.0012142776977270842
, O 0 6.574181043106364e-06
L1083F O 0 0.00024263132945634425
, O 0 3.479644874460064e-06
and O 0 2.1795158318127505e-06
2304delC O 0 0.0002855979837477207
- O 0 7.098730566212907e-05
- O 0 2.812851198541466e-05
in O 0 1.1742311016860185e-06
the O 0 1.1100923984486144e-06
copper O 0 1.9741504729609005e-05
- O 0 0.00010054682934423909
transporting O 0 6.439109711209312e-05
enzyme O 0 0.00019811507081612945
, O 0 7.228298272821121e-06
P O 0 0.0024543374311178923
- O 0 0.001157122547738254
type O 0 0.0007371127139776945
ATPase O 0 0.09775355458259583
( O 0 3.281560566392727e-05
ATP7B O 0 0.003997339867055416
) O 0 2.3442132714990294e-06
, O 0 1.1326854973958689e-06
were O 0 6.76775812280539e-07
identified O 0 1.2900099136459175e-05
in O 0 7.990955964487512e-06
Korean O 0 0.013206143863499165
Patients O 1 0.997229278087616
with O 0 0.0024188982788473368
Wilson B-Disease 1 0.9595853686332703
disease I-Disease 1 0.9983629584312439
. O 0 0.001032069674693048

Arg778Leu O 0 0.016684837639331818
, O 0 2.466690057190135e-05
the O 0 6.494969511550153e-06
most O 0 6.946299436094705e-06
frequently O 0 2.0410934666870162e-05
reported O 0 3.691647361847572e-05
mutation O 0 4.633040225598961e-05
of O 0 5.203303317102836e-07
this O 0 6.82147629049723e-07
enzyme O 0 2.4571065296186134e-05
, O 0 5.796378559352888e-07
was O 0 2.845085873559583e-07
found O 0 4.897336225440085e-07
in O 0 2.904893676713982e-07
six O 0 1.0623481330185314e-06
of O 0 7.614334549543855e-07
eight O 0 4.1631465137470514e-05
unrelated O 0 0.16520002484321594
patients O 1 0.9918863773345947
studied O 0 5.121909634908661e-05
, O 0 1.8503915271139704e-06
an O 0 2.2431343040807405e-06
allele O 0 6.889926589792594e-05
frequency O 0 1.0357227438362315e-05
of O 0 6.082876097934786e-06
37 O 0 0.0001470668357796967
. O 0 9.078421135200188e-05

5 O 0 8.502449782099575e-05
% O 0 1.242502094100928e-05
, O 0 3.3121539217972895e-06
which O 0 1.4107872630120255e-06
is O 0 9.442343866794545e-07
considerably O 0 1.81190680450527e-05
higher O 0 1.3345506886253133e-06
than O 0 6.84688188812288e-07
those O 0 9.106161655836331e-07
in O 0 1.1919948974536965e-06
other O 0 3.4553593195596477e-06
Asian O 0 0.00014324006042443216
populations O 0 0.0005087531171739101
. O 0 8.463072299491614e-05

The O 0 6.753129127901047e-05
novel O 0 0.0001035566529026255
single O 0 2.2760694264434278e-05
nucleotide O 0 6.722481339238584e-05
deletion O 0 0.0011306905653327703
, O 0 1.0591084901534487e-05
2304delC O 0 0.0009773363126441836
, O 0 3.2113771339936648e-06
was O 0 1.3182896054786397e-06
found O 0 2.479600425431272e-06
in O 0 3.4025483728328254e-06
one O 0 1.9801238522632048e-05
patient O 0 0.40137988328933716
. O 0 0.00013940139615442604

Since O 0 0.00019413483096286654
a O 0 7.484308298444375e-05
mutation O 0 0.0004472857399377972
at O 0 2.419885822746437e-05
cDNA O 0 0.000196131004486233
nucleotide O 0 0.00019922129285987467
2302 O 1 0.5461075901985168
( O 0 6.124131323304027e-05
2302insC O 0 0.001636614790186286
) O 0 4.20471360484953e-06
had O 0 1.7465457631260506e-06
been O 0 8.501575621266966e-07
previously O 0 2.0855022739851847e-06
described O 0 4.124181486986345e-06
, O 0 4.801166824108805e-07
this O 0 2.445027291742008e-07
region O 0 1.8951685660795192e-06
of O 0 4.4469723547990725e-07
the O 0 2.894638782890979e-06
ATP7B O 0 0.11735286563634872
gene O 0 0.001630472601391375
may O 0 3.445182301220484e-05
be O 0 4.380811787996208e-06
susceptible O 0 0.11531679332256317
to O 0 2.5645753339631483e-05
gene O 0 0.05454675108194351
rearrangements O 1 0.7612608671188354
causing O 1 0.9807370901107788
Wilson B-Disease 1 0.9779444336891174
disease I-Disease 1 0.9983901977539062
. O 0 0.0013233625795692205

Disruption O 0 0.0009916550479829311
of O 0 1.5766676369821653e-05
splicing O 0 0.00015021035505924374
regulated O 0 5.006025094189681e-05
by O 0 7.5987918535247445e-06
a O 0 1.4999922314018477e-05
CUG O 0 0.01257189642637968
- O 0 0.0008193181129172444
binding O 0 0.00011904491839231923
protein O 0 0.000512545055244118
in O 0 0.0006674595060758293
myotonic B-Disease 1 0.9970065951347351
dystrophy I-Disease 1 0.998582124710083
. O 0 0.00520035345107317

Myotonic B-Disease 1 0.9960553646087646
dystrophy I-Disease 1 0.9985859394073486
( O 0 0.29807302355766296
DM B-Disease 1 0.9965025186538696
) O 0 0.00016066005628090352
is O 0 1.3655688235303387e-05
caused O 0 0.00031102029606699944
by O 0 2.8389815724949585e-06
a O 0 7.0768746809335425e-06
CTG O 0 0.017284976318478584
expansion O 0 3.1075349397724494e-05
in O 0 1.4908813454894698e-06
the O 0 1.426141011506843e-06
3 O 0 6.066607966204174e-06
untranslated O 0 0.0005084625445306301
region O 0 2.1035028112237342e-05
of O 0 4.237711436871905e-06
the O 0 4.110696681891568e-05
DM B-Disease 1 0.9947172999382019
gene O 0 0.031666360795497894
. O 0 0.0002706352388486266

One O 0 0.00013208278687670827
model O 0 0.00020815285097341985
of O 0 9.537070582155138e-05
DM B-Disease 1 0.9975135326385498
pathogenesis O 1 0.9934258460998535
suggests O 0 0.0006672368617728353
that O 0 3.921210009139031e-06
RNAs O 0 8.042244735406712e-05
from O 0 1.4104913361734361e-06
the O 0 9.395758979735547e-07
expanded O 0 4.575786533678183e-06
allele O 0 2.0794510419364087e-05
create O 0 2.8901645237056073e-06
a O 0 1.1604025758060743e-06
gain O 0 4.465119673113804e-06
- O 0 1.5164553587965202e-05
of O 0 6.676751809209236e-07
- O 0 8.34561578813009e-05
function O 0 7.672695574001409e-06
mutation O 0 3.579238909878768e-05
by O 0 8.846936907502823e-07
the O 0 6.728033667968703e-07
inappropriate O 0 1.0772057976282667e-05
binding O 0 2.0978677639504895e-06
of O 0 6.087525434850249e-07
proteins O 0 5.560296358453343e-06
to O 0 2.5549979909555987e-06
the O 0 1.1537438695086166e-05
CUG O 0 0.01516763586550951
repeats O 0 0.001157535007223487
. O 0 0.00018013599037658423

Data O 0 7.083806849550456e-05
presented O 0 2.9413406082312576e-05
here O 0 4.951926712237764e-06
indicate O 0 5.457485713122878e-06
that O 0 8.677401410750463e-07
the O 0 1.4921217825758504e-06
conserved O 0 1.5770752725075e-05
heterogeneous O 0 0.0006493029650300741
nuclear O 0 0.00024123025650624186
ribonucleoprotein O 0 0.43015116453170776
, O 0 1.5040173821034841e-05
CUG O 0 0.0035553830675780773
- O 0 0.0001453260047128424
binding O 0 2.9257947971927933e-05
protein O 0 6.473069515777752e-05
( O 0 3.780464976443909e-05
CUG O 0 0.020192045718431473
- O 0 0.0012644153321161866
BP O 0 0.0014503193087875843
) O 0 5.7679690144141205e-06
, O 0 1.8235742800243315e-06
may O 0 2.642026402099873e-06
mediate O 0 2.3621583750355057e-05
the O 0 2.104940222125151e-06
trans O 0 0.0003637172922026366
- O 0 0.00015428774349857122
dominant O 0 2.5372808522661217e-05
effect O 0 6.142487109173089e-06
of O 0 1.3248661616671598e-06
the O 0 6.901398592162877e-06
RNA O 0 0.00017655683041084558
. O 0 5.935473018325865e-05

CUG O 0 0.4363763928413391
- O 0 0.008385456167161465
BP O 0 0.0029622737783938646
was O 0 1.1031640497094486e-05
found O 0 5.32342710357625e-06
to O 0 1.6843608818817302e-06
bind O 0 5.460218744701706e-05
to O 0 2.4623227545816917e-06
the O 0 1.1628215361270122e-05
human O 0 0.019196953624486923
cardiac O 1 0.998842179775238
troponin O 1 0.9984536170959473
T O 1 0.9271554946899414
( O 0 7.603217818541452e-05
cTNT O 0 0.0014835253823548555
) O 0 7.415733762172749e-06
pre O 0 6.13931697444059e-05
- O 0 8.894188795238733e-05
messenger O 0 3.975814252044074e-05
RNA O 0 1.5736392015242018e-05
and O 0 1.944341875059763e-06
regulate O 0 2.7176982257515192e-05
its O 0 5.395679181674495e-06
alternative O 0 5.2582876378437504e-05
splicing O 0 0.0006059948354959488
. O 0 0.00013056832540314645

Splicing O 0 0.0007769005605950952
of O 0 4.503875243244693e-05
cTNT O 0 0.011416955851018429
was O 0 4.3516956793610007e-05
disrupted O 0 0.00401397654786706
in O 0 0.0003309847379568964
DM B-Disease 1 0.9984627962112427
striated O 1 0.9958254098892212
muscle O 1 0.8315900564193726
and O 0 1.3630084140459076e-05
in O 0 9.650267202232499e-06
normal O 0 0.0001366687356494367
cells O 0 0.0007950314320623875
expressing O 0 0.0002268706593895331
transcripts O 0 6.327148003038019e-05
that O 0 9.084338671527803e-06
contain O 0 0.00015435556997545063
CUG O 0 0.03910071402788162
repeats O 0 0.001748354872688651
. O 0 0.0001657519896980375

Altered O 0 0.0011922131525352597
expression O 0 0.0001304319448536262
of O 0 1.075746968126623e-05
genes O 0 0.00021324977569747716
regulated O 0 0.00022208387963473797
posttranscriptionally O 0 0.017212936654686928
by O 0 3.2657451811246574e-05
CUG O 0 0.1098071038722992
- O 0 0.0031024254858493805
BP O 0 0.006262696348130703
therefore O 0 2.4285041945404373e-05
may O 0 4.077210905961692e-05
contribute O 0 0.0005758850602433085
to O 0 8.587822230765596e-05
DM B-Disease 1 0.9971210360527039
pathogenesis O 1 0.9915797710418701
. O 0 0.00013588466390501708
. O 0 0.00018579069001134485

Identification O 0 0.000192092644283548
of O 0 1.5112060282262973e-05
a O 0 1.9898689060937613e-05
novel O 0 7.382294279523194e-05
nonsense O 0 0.00024183590721804649
mutation O 0 0.00022679238463751972
and O 0 2.216415396105731e-06
a O 0 5.348285867512459e-06
missense O 0 0.0005949744954705238
substitution O 0 1.1563081898202654e-05
in O 0 2.378147428316879e-06
the O 0 4.732279194286093e-06
vasopressin O 0 0.05528157949447632
- O 0 0.014837565831840038
neurophysin O 0 0.06494294852018356
II O 0 0.004224585369229317
gene O 0 0.00017018821381498128
in O 0 3.7439731386257336e-06
two O 0 4.3097647903778125e-06
Spanish O 0 5.509037509909831e-05
kindreds O 0 0.19984030723571777
with O 0 0.0011648674262687564
familial B-Disease 1 0.9969214797019958
neurohypophyseal I-Disease 1 0.9956510663032532
diabetes I-Disease 1 0.9993096590042114
insipidus I-Disease 1 0.9970002770423889
. O 0 0.010228166356682777

Familial B-Disease 1 0.9925261735916138
neurohypophyseal I-Disease 1 0.9925938248634338
diabetes I-Disease 1 0.999510645866394
insipidus I-Disease 1 0.9984649419784546
( O 0 0.12580014765262604
FNDI B-Disease 1 0.9882065653800964
) O 0 0.00014472639304585755
is O 0 3.478177313809283e-05
an O 0 0.0003652661689557135
autosomal B-Disease 1 0.9984447360038757
dominant I-Disease 1 0.9643906950950623
disease I-Disease 1 0.999742329120636
caused O 1 0.9545274972915649
by O 0 0.0021815234795212746
deficiency O 1 0.9990884065628052
in O 0 4.859329419559799e-05
the O 0 6.973318522796035e-05
antidiuretic O 1 0.9918579459190369
hormone O 1 0.9137450456619263
arginine O 0 0.2883513271808624
vasopressin O 1 0.658804178237915
( O 0 0.0001333630207227543
AVP O 0 0.08630173653364182
) O 0 3.538494638632983e-06
encoded O 0 3.961919901485089e-06
by O 0 2.1935977656539762e-06
the O 0 6.7585360739030875e-06
AVP O 1 0.5011036396026611
- O 0 0.014426012523472309
neurophysin O 0 0.23275864124298096
II O 0 0.07017206400632858
( O 0 0.00020346538804005831
AVP O 1 0.7834248542785645
- O 0 0.008800704032182693
NPII O 0 0.06786099821329117
) O 0 2.1021272914367728e-05
gene O 0 0.00021415995433926582
on O 0 2.152707202185411e-05
chromosome O 0 0.0027648359537124634
20p13 O 0 0.007514716126024723
. O 0 0.0001669376069912687

In O 0 3.5581593692768365e-05
this O 0 7.580666533613112e-06
study O 0 1.9945238818763755e-05
, O 0 1.5394074353025644e-06
we O 0 9.449207709621987e-07
analyzed O 0 6.76513946018531e-06
two O 0 7.572506888209318e-07
families O 0 4.679190169554204e-06
with O 0 1.5266209629771765e-06
FNDI B-Disease 0 0.0020728500094264746
using O 0 1.5745584960313863e-06
direct O 0 3.659693675217568e-06
automated O 0 1.7788592231227085e-05
fluorescent O 0 0.00012088168296031654
, O 0 2.2333110791805666e-06
solid O 0 8.267462362709921e-06
phase O 0 1.801950202207081e-05
, O 0 1.32485217818612e-06
single O 0 1.8223156530439155e-06
- O 0 5.8250807342119515e-05
stranded O 0 6.405670137610286e-05
DNA O 0 1.2264360520930495e-05
sequencing O 0 1.5792333215358667e-05
of O 0 3.2123880373546854e-06
PCR O 0 0.0004061152576468885
- O 0 0.001860913122072816
amplified O 0 0.002722781850025058
AVP O 1 0.6961051225662231
- O 0 0.010607477277517319
NPII O 0 0.08985555171966553
DNA O 0 0.0012883755844086409
. O 0 0.00024556517018936574

In O 0 1.9925997548853047e-05
one O 0 3.513470574034727e-06
of O 0 9.909127811624785e-07
the O 0 1.6392157249356387e-06
families O 0 2.0577883333317004e-05
, O 0 3.6741644180438016e-06
affected O 0 0.00023652268282603472
individuals O 0 7.932633707241621e-06
presented O 0 5.323503501131199e-06
a O 0 4.619562787411269e-06
novel O 0 3.562032725312747e-05
nonsense O 0 0.00020547342137433589
mutation O 0 0.00016269605839625
in O 0 1.5935290775814792e-06
exon O 0 4.6309556637424976e-05
3 O 0 1.848856982178404e-06
of O 0 4.052638757912064e-07
the O 0 6.96459380833403e-07
gene O 0 2.125782339135185e-05
, O 0 6.935959504517086e-07
consisting O 0 1.105822548197466e-06
in O 0 8.558657782486989e-07
a O 0 2.489640110070468e-06
G O 0 0.00018854110385291278
to O 0 2.9007071589148836e-06
T O 0 0.0032377555035054684
transition O 0 1.9885732399416156e-05
at O 0 3.675545031001093e-06
nucleotide O 0 1.5013431948318612e-05
2101 O 0 0.0012760520912706852
, O 0 1.3180671203372185e-06
which O 0 7.567467719127308e-07
produces O 0 6.169916559883859e-06
a O 0 1.5128609902603785e-06
stop O 0 5.745701400883263e-06
signal O 0 6.994505838520126e-06
in O 0 3.26290705743304e-06
codon O 0 6.487035716418177e-05
82 O 0 0.00010420001490274444
( O 0 4.894003723165952e-05
Glu O 0 0.3979024887084961
) O 0 2.6655818146537058e-05
of O 0 1.736029480525758e-05
NPII O 0 0.058092471212148666
. O 0 0.00018771506438497454

The O 0 0.0003123072092421353
premature O 0 0.19443266093730927
termination O 0 0.017737653106451035
eliminates O 0 0.0005281000630930066
part O 0 1.0336308150726836e-05
of O 0 2.123400690834387e-06
the O 0 4.328031536715571e-06
C O 0 0.00046226169797591865
- O 0 0.0002164003817597404
terminal O 0 0.00021908601047471166
domain O 0 4.943934072798584e-06
of O 0 1.0036312687589088e-06
NPII O 0 0.0009221361833624542
, O 0 7.35777518912073e-07
including O 0 1.0140787480850122e-06
a O 0 1.9974345377704594e-06
cysteine O 0 2.806474185490515e-05
residue O 0 3.3340180380037054e-05
in O 0 1.0419017826279742e-06
position O 0 1.8033194919553353e-06
85 O 0 7.874799848650582e-06
, O 0 7.178632586146705e-07
which O 0 3.2768477353783965e-07
could O 0 4.795350037056778e-07
be O 0 1.594530942838901e-07
involved O 0 7.953495924084564e-07
in O 0 4.445725778623455e-07
the O 0 6.736232762705185e-07
correct O 0 1.790797796275001e-05
folding O 0 0.00012705019616987556
of O 0 4.4400499064067844e-06
the O 0 2.7747413696488366e-05
prohormone O 1 0.7191554307937622
. O 0 0.0003442770102992654

In O 0 3.198187187081203e-05
the O 0 6.8259414547355846e-06
second O 0 5.891263754165266e-06
family O 0 8.640261512482539e-06
, O 0 1.3783773056275095e-06
a O 0 2.445568725306657e-06
G279A O 0 7.943177479319274e-05
substitution O 0 3.3741641800588695e-06
at O 0 1.3833815728503396e-06
position O 0 1.3899381201554206e-06
- O 0 7.326627383008599e-06
1 O 0 6.957742471058737e-07
of O 0 2.6875918024416023e-07
the O 0 6.534736485264148e-07
signal O 0 5.025027803640114e-06
peptide O 0 2.938699435617309e-05
was O 0 1.3091575965518132e-06
observed O 0 5.102913291921141e-06
in O 0 1.9269343738415046e-06
all O 0 3.294920816188096e-06
affected O 0 0.00040160564822144806
individuals O 0 0.00011956334492424503
. O 0 9.875001705950126e-05

This O 0 0.00021414364164229482
missense O 0 0.022395260632038116
mutation O 0 0.0043598623014986515
, O 0 2.2433107005781494e-05
which O 0 1.2704974324151408e-05
replaces O 0 0.010747336782515049
Ala O 1 0.7048761248588562
with O 0 0.00015939220611471683
Thr O 1 0.9880401492118835
, O 0 2.1916130208410323e-05
is O 0 1.109430922952015e-05
frequent O 0 0.0041013373993337154
among O 0 0.0004474011075217277
FNDI B-Disease 1 0.9957002401351929
patients O 1 0.9948587417602539
and O 0 3.5301895877637435e-06
is O 0 1.2659659205382923e-06
thought O 0 1.8653828419701313e-06
to O 0 3.501939147554367e-07
reduce O 0 7.958557034726255e-06
the O 0 4.988900741409452e-07
efficiency O 0 8.046213224588428e-06
of O 0 1.8898226699093357e-06
cleavage O 0 0.0019571396987885237
by O 0 7.813800948497374e-06
signal O 0 9.174727892968804e-05
peptidases O 0 0.00422231899574399
. O 0 3.423981252126396e-05
. O 0 7.79088368290104e-05

Genetic O 0 0.07781817764043808
heterogeneity O 0 0.052222684025764465
of O 0 0.0002486965386196971
Saethre B-Disease 1 0.9411591291427612
- I-Disease 1 0.9702087044715881
Chotzen I-Disease 1 0.9950634837150574
syndrome I-Disease 1 0.9994993209838867
, O 0 9.825538290897384e-05
due O 0 0.00010055239545181394
to O 0 1.326786878053099e-05
TWIST O 0 0.0015293550677597523
and O 0 7.339517469517887e-05
FGFR O 0 0.4864557683467865
mutations O 0 0.18158063292503357
. O 0 0.0002955166855826974

Thirty O 0 0.0014186132466420531
- O 0 0.002385443076491356
two O 0 6.230343569768593e-05
unrelated O 0 0.037061408162117004
patients O 1 0.9535670876502991
with O 0 1.8304901459487155e-05
features O 0 4.090147922397591e-05
of O 0 2.154122012143489e-05
Saethre B-Disease 1 0.9738048315048218
- I-Disease 1 0.9726929664611816
Chotzen I-Disease 1 0.9965013265609741
syndrome I-Disease 1 0.999687671661377
, O 0 5.1237417210359126e-05
a O 0 0.00011584949970711023
common O 0 0.017073016613721848
autosomal B-Disease 1 0.9969978332519531
dominant I-Disease 0 0.20965822041034698
condition I-Disease 1 0.8965996503829956
of O 0 0.0002445333811920136
craniosynostosis B-Disease 1 0.9991287589073181
and O 0 0.0071744294837117195
limb B-Disease 1 0.9985571503639221
anomalies I-Disease 1 0.6557978391647339
, O 0 1.0754208233265672e-05
were O 0 1.5720138435426634e-06
screened O 0 5.1932645874330774e-05
for O 0 5.476463684317423e-06
mutations O 0 0.0020311910193413496
in O 0 6.067018603062024e-06
TWIST O 0 0.0006691791932098567
, O 0 1.4702510270581115e-05
FGFR2 O 0 0.014931955374777317
, O 0 1.1948585779464338e-05
and O 0 2.0586991013260558e-05
FGFR3 O 0 0.034542933106422424
. O 0 0.00012776174116879702

Nine O 0 0.00021592552366200835
novel O 0 0.00015895765682216734
and O 0 1.1966319107159507e-05
three O 0 2.255819708807394e-05
recurrent O 1 0.763202428817749
TWIST O 0 0.016071181744337082
mutations O 0 0.007057105656713247
were O 0 3.0898891054675914e-06
found O 0 6.555261279572733e-06
in O 0 4.19200159740285e-06
12 O 0 3.4653912734938785e-05
families O 0 0.00020416616462171078
. O 0 8.397249621339142e-05

Seven O 0 0.00010769795335363597
families O 0 6.201749056344852e-05
were O 0 3.4514471280999715e-06
found O 0 2.6186924060311867e-06
to O 0 1.0159304792978219e-06
have O 0 8.569684268877609e-07
the O 0 1.9556819097488187e-06
FGFR3 O 0 0.041441164910793304
P250R O 0 0.00724834855645895
mutation O 0 0.0004176653746981174
, O 0 9.387662203153013e-07
and O 0 2.522357078760251e-07
one O 0 2.563857606219244e-07
individual O 0 9.892094112728955e-07
was O 0 3.795964005348651e-07
found O 0 6.375316843332257e-07
to O 0 3.8329892504407326e-07
have O 0 1.0157531278309762e-06
an O 0 3.8741823118471075e-06
FGFR2 O 0 0.03462300822138786
VV269 O 0 0.008201155811548233
- O 0 0.0016368110664188862
270 O 0 0.0012399795232340693
deletion O 0 0.02409500442445278
. O 0 0.00019603043620008975

To O 0 3.153072975692339e-05
date O 0 1.3265338566270657e-05
, O 0 3.8862081055413e-06
our O 0 4.2309679884056095e-06
detection O 0 0.00010705280874390155
rate O 0 4.294133759685792e-06
for O 0 3.2240534437733004e-06
TWIST O 0 0.00027773663168773055
or O 0 1.9117720512440428e-05
FGFR O 0 0.052633337676525116
mutations O 0 0.0010633536148816347
is O 0 2.353312083869241e-06
68 O 0 1.3134771506884135e-05
% O 0 1.9051207118536695e-06
in O 0 2.4782079890428577e-06
our O 0 4.4339252781355754e-05
Saethre B-Disease 1 0.8713124990463257
- I-Disease 1 0.9801178574562073
Chotzen I-Disease 1 0.9985639452934265
syndrome I-Disease 1 0.9999169111251831
patients O 1 0.9993731379508972
, O 0 1.8031520085060038e-05
including O 0 1.0765545994217973e-05
our O 0 2.3469994630431756e-05
five O 0 0.00011506244482006878
patients O 1 0.995850682258606
elsewhere O 0 0.0005740574561059475
reported O 0 0.0004025372036267072
with O 0 5.432654870674014e-05
TWIST O 0 0.02601492591202259
mutations O 0 0.1885949820280075
. O 0 0.00020498735830187798

More O 0 4.278042251826264e-05
than O 0 1.728601819195319e-05
35 O 0 2.3299060558201745e-05
different O 0 9.534401215205435e-06
TWIST O 0 0.0003814333176705986
mutations O 0 0.0008512475178577006
are O 0 1.5632351733074756e-06
now O 0 2.600252173579065e-06
known O 0 3.5600630781118525e-06
in O 0 1.7710932525005774e-06
the O 0 3.5968309930467512e-06
literature O 0 5.4449417802970856e-05
. O 0 8.005394920473918e-05

The O 0 4.625345900421962e-05
most O 0 1.533584509161301e-05
common O 0 3.285474667791277e-05
phenotypic O 0 0.0003598425828386098
features O 0 9.073376531887334e-06
, O 0 9.61828050094482e-07
present O 0 5.321963385540585e-07
in O 0 3.5180732993467245e-07
more O 0 3.5989748425890866e-07
than O 0 3.385363811503339e-07
a O 0 5.46872115592123e-07
third O 0 6.861451993245282e-07
of O 0 6.726596666339901e-07
our O 0 2.3068154405336827e-05
patients O 1 0.8915813565254211
with O 0 1.536984200356528e-05
TWIST O 0 0.00354454736225307
mutations O 0 0.009032596834003925
, O 0 4.8700203478801996e-06
are O 0 4.572370926325675e-06
coronal B-Disease 0 0.09608490020036697
synostosis I-Disease 0 0.040352772921323776
, O 0 2.03786876227241e-05
brachycephaly B-Disease 0 0.034070611000061035
, O 0 5.099782720208168e-05
low B-Disease 0 0.011361313052475452
frontal I-Disease 1 0.9958285689353943
hairline I-Disease 1 0.9990966320037842
, O 0 0.0014707028167322278
facial B-Disease 1 0.9976609945297241
asymmetry I-Disease 1 0.9294090270996094
, O 0 0.004290048498660326
ptosis B-Disease 1 0.9986510872840881
, O 0 0.0007823014748282731
hypertelorism B-Disease 1 0.9877339601516724
, O 0 5.469327879836783e-05
broad B-Disease 0 0.001299002906307578
great I-Disease 0 0.00018679947243072093
toes I-Disease 0 0.12066598236560822
, O 0 1.736155172693543e-05
and O 0 2.9196598916314542e-05
clinodactyly B-Disease 0 0.03968524560332298
. O 0 0.0002180434385081753

Significant O 0 0.00047928010462783277
intra O 0 0.0025997604243457317
- O 0 0.001905496115796268
and O 0 4.081389488419518e-05
interfamilial O 0 0.029738621786236763
phenotypic O 0 0.004727949853986502
variability O 0 0.002135743387043476
is O 0 7.66183075029403e-06
present O 0 7.267469300131779e-06
for O 0 7.640574949618895e-06
either O 0 3.0420049370150082e-05
TWIST O 0 0.0040915911085903645
mutations O 0 0.04153632000088692
or O 0 0.0002232792176073417
FGFR O 0 0.45774635672569275
mutations O 0 0.10367283225059509
. O 0 0.00023569089535158128

The O 0 5.5960972531465814e-05
overlap O 0 0.00021506828488782048
in O 0 1.8950324374600314e-05
clinical O 0 0.087104931473732
features O 0 7.193200872279704e-06
and O 0 8.220034715122893e-07
the O 0 6.75232513458468e-07
presence O 0 2.2071658349887002e-06
, O 0 3.347952883814287e-07
in O 0 1.8468836060492322e-07
the O 0 2.0968566616375028e-07
same O 0 4.2946518874487083e-07
genes O 0 3.5774955904344097e-06
, O 0 2.232907689858621e-07
of O 0 2.2060076787511207e-07
mutations O 0 0.00010859701433219016
for O 0 4.903102990283514e-07
more O 0 7.881778856244637e-07
than O 0 1.660345674281416e-06
one O 0 3.6867229482595576e-06
craniosynostotic B-Disease 0 0.11303462088108063
condition I-Disease 0 0.0691395252943039
- O 0 0.0001702961599221453
such O 0 2.4201267478929367e-06
as O 0 4.530956175585743e-06
Saethre B-Disease 0 0.03248116746544838
- I-Disease 0 0.0037179694045335054
Chotzen I-Disease 0 0.02612336538732052
, I-Disease 0 1.4938823369448073e-05
Crouzon I-Disease 0 0.014787450432777405
, I-Disease 0 1.9007118680747226e-05
and I-Disease 0 8.294623694382608e-05
Pfeiffer I-Disease 1 0.9967285394668579
syndromes I-Disease 1 0.99908447265625
- O 0 0.0028597861528396606
support O 0 8.488188541377895e-06
the O 0 2.350140675844159e-06
hypothesis O 0 3.5467623092699796e-05
that O 0 1.4339444760480546e-06
TWIST O 0 5.354614040697925e-05
and O 0 1.7799387705963454e-06
FGFRs O 0 0.0002364715182920918
are O 0 3.3410506716791133e-07
components O 0 7.785808975313557e-07
of O 0 1.7013269371091155e-07
the O 0 4.3522601345102885e-07
same O 0 8.89109628587903e-07
molecular O 0 3.2611606002319604e-05
pathway O 0 4.716401599580422e-05
involved O 0 4.1268058339483105e-06
in O 0 7.600260119033919e-07
the O 0 1.08069968973723e-06
modulation O 0 0.0004546676645986736
of O 0 3.062242467422038e-05
craniofacial O 1 0.9995330572128296
and O 0 0.0007344259065575898
limb O 1 0.993463397026062
development O 0 0.000328676076605916
in O 0 2.49832355621038e-05
humans O 0 0.002036742866039276
. O 0 2.9761586120002903e-05
. O 0 8.781009819358587e-05

Mutation O 0 0.044733550399541855
analysis O 0 0.0005607962957583368
of O 0 0.0003800557169597596
UBE3A O 1 0.9896703362464905
in O 0 0.4665282368659973
Angelman B-Disease 1 0.9991520643234253
syndrome I-Disease 1 0.9997653365135193
patients O 1 0.9983626008033752
. O 0 0.009950699284672737

Angelman B-Disease 1 0.9985106587409973
syndrome I-Disease 1 0.9995377063751221
( O 0 0.004068649373948574
AS B-Disease 0 0.00015056238044053316
) O 0 1.6425536159658805e-05
is O 0 7.366266800090671e-06
caused O 0 0.0004303674795664847
by O 0 9.232887350663077e-06
chromosome O 0 0.0018281291704624891
15q11 O 0 0.008866601623594761
- O 0 0.002171518746763468
q13 O 0 0.0018916657427325845
deletions O 0 0.00022366059420164675
of O 0 3.384961246410967e-06
maternal O 0 0.001644515199586749
origin O 0 9.08509082364617e-06
, O 0 6.529829988721758e-06
by O 0 1.739171420922503e-05
paternal O 0 0.08791149407625198
uniparental B-Disease 1 0.994154155254364
disomy I-Disease 1 0.8567750453948975
( O 0 0.0011504496214911342
UPD B-Disease 1 0.9717578291893005
) O 0 1.2659885214816313e-05
15 O 0 8.163254278770182e-06
, O 0 3.6150570394966053e-06
by O 0 7.685754098929465e-06
imprinting O 0 0.18409363925457
defects O 1 0.8735333681106567
, O 0 5.072975454822881e-06
and O 0 1.920890554174548e-06
by O 0 3.4918250548798824e-06
mutations O 0 0.000770844635553658
in O 0 8.153381713782437e-06
the O 0 2.8885919164167717e-05
UBE3A O 1 0.9620673656463623
gene O 0 0.014572563581168652
. O 0 0.00015725473349448293

UBE3A O 0 0.2257954478263855
encodes O 0 0.0012479169527068734
a O 0 0.00014246988575905561
ubiquitin O 0 0.002558522392064333
- O 0 0.0007624271092936397
protein O 0 0.00019255145161878318
ligase O 0 0.0014134981902316213
and O 0 2.1313280740287155e-05
shows O 0 0.00011087729944847524
brain O 1 0.7895216941833496
- O 0 0.0035283418837934732
specific O 0 0.0002718812902458012
imprinting O 0 0.08724556863307953
. O 0 0.00032356168958358467

Here O 0 0.00020409259013831615
we O 0 6.810415652580559e-05
describe O 0 0.0004920857609249651
UBE3A O 1 0.7301144599914551
coding O 0 0.005270358175039291
- O 0 0.0040069869719445705
region O 0 0.0005337464972399175
mutations O 0 0.024357236921787262
detected O 0 0.0007303038728423417
by O 0 5.5513214647362474e-06
SSCP O 0 0.004174772184342146
analysis O 0 1.2000122296740301e-05
in O 0 3.3567491755093215e-06
13 O 0 1.2110997886338737e-05
AS B-Disease 0 1.2938711734022945e-05
individuals O 0 4.016935417894274e-05
or O 0 3.070693855988793e-05
families O 0 0.000283382018096745
. O 0 0.0001173802520497702

Two O 0 9.213365410687402e-05
identical O 0 0.00021623168140649796
de O 0 0.00025065953377634287
novo O 0 0.00041595601942390203
5 O 0 3.870348882628605e-05
- O 0 0.00024259685596916825
bp O 0 0.00040502301999367774
duplications O 0 0.00027755580958910286
in O 0 9.62344893196132e-06
exon O 0 0.00021788131562061608
16 O 0 1.989971315197181e-05
were O 0 6.938500519027002e-06
found O 0 3.341944466228597e-05
. O 0 5.285279985400848e-05

Among O 0 6.07433175900951e-05
the O 0 7.1057575041777454e-06
other O 0 2.6535915367276175e-06
11 O 0 9.033107744471636e-06
unique O 0 1.1020662896044087e-05
mutations O 0 0.0004701611178461462
, O 0 9.693845868241624e-07
8 O 0 1.154019287241681e-06
were O 0 2.699104300063482e-07
small O 0 1.4412602240554406e-06
deletions O 0 8.985353633761406e-05
or O 0 4.34997173215379e-06
insertions O 0 0.0007022349745966494
predicted O 0 7.89352270658128e-05
to O 0 3.2392938464909093e-06
cause O 0 0.0010733477538451552
frameshifts O 0 0.0029157386161386967
, O 0 1.404147155881219e-06
1 O 0 1.2407343774611945e-06
was O 0 6.271175152505748e-07
a O 0 1.2678242455876898e-06
mutation O 0 2.9284992706379853e-05
to O 0 4.5610076426783053e-07
a O 0 1.1795129921665648e-06
stop O 0 5.973420229565818e-06
codon O 0 1.2142836567363702e-05
, O 0 7.368575438704283e-07
1 O 0 1.0888547876675148e-06
was O 0 7.17006685135857e-07
a O 0 2.4488781491527334e-06
missense O 0 0.0011560473358258605
mutation O 0 0.00016006737132556736
, O 0 6.096937568145222e-07
and O 0 4.892565357295098e-07
1 O 0 1.1842830645036884e-06
was O 0 6.189702617120929e-07
predicted O 0 5.817577402922325e-06
to O 0 6.244272299227305e-07
cause O 0 3.303688208688982e-05
insertion O 0 1.988470830838196e-05
of O 0 4.249129688105313e-07
an O 0 1.541746428301849e-06
isoleucine O 0 0.000660426274407655
in O 0 1.1194829312444199e-06
the O 0 1.0200681117567e-06
hect O 0 0.00014044450654182583
domain O 0 2.8598458357009804e-06
of O 0 4.0068985640573374e-07
the O 0 1.5764577483423636e-06
UBE3A O 0 0.04722333699464798
protein O 0 9.072304237633944e-06
, O 0 8.03031412033306e-07
which O 0 5.600447821052512e-07
functions O 0 1.5223843092826428e-06
in O 0 1.8705169395616394e-06
E2 O 0 0.0006937537691555917
binding O 0 1.9765919205383398e-05
and O 0 7.416271273541497e-06
ubiquitin O 0 0.001114462036639452
transfer O 0 0.00011458320659585297
. O 0 0.0001615852233953774

Eight O 0 5.2022071031387895e-05
of O 0 5.309053904056782e-06
the O 0 6.821730949013727e-06
cases O 0 0.00024569861125200987
were O 0 4.097722467122367e-06
familial O 0 0.46241122484207153
, O 0 4.401268142828485e-06
and O 0 1.9632652765722014e-06
five O 0 5.990169029246317e-06
were O 0 7.188112249423284e-06
sporadic O 0 0.0009567841771058738
. O 0 0.00012440756836440414

In O 0 8.429791341768578e-05
two O 0 4.0196104237111285e-05
familial O 1 0.9637728929519653
cases O 0 0.0032173891086131334
and O 0 9.013040653371718e-06
one O 0 8.042308763833717e-06
sporadic O 0 0.0015280259540304542
case O 0 0.0002090923226205632
, O 0 3.0079852876951918e-05
mosaicism O 1 0.8561697006225586
for O 0 0.00011418857320677489
UBE3A O 1 0.9925615191459656
mutations O 0 0.09427452832460403
was O 0 8.524611075699795e-06
detected O 0 0.00023265377967618406
in O 0 1.4530934322465328e-06
the O 0 7.48392835703271e-07
mother O 0 1.582895674800966e-05
of O 0 5.835519800712063e-07
three O 0 2.3017594230623217e-06
AS B-Disease 0 1.183180484076729e-05
sons O 0 0.00014732185809407383
, O 0 7.756475497444626e-07
in O 0 5.065763843958848e-07
the O 0 1.0266019216942368e-06
maternal O 0 0.001343672745861113
grandfather O 0 3.576038216124289e-05
of O 0 3.80326213189619e-07
two O 0 7.157420327530417e-07
AS B-Disease 0 2.0787292669410817e-06
first O 0 7.500376000280085e-07
cousins O 0 5.3541341912932694e-05
, O 0 4.86541125610529e-07
and O 0 3.732098434738873e-07
in O 0 4.1739440348464996e-07
the O 0 7.177701490945765e-07
mother O 0 1.6944311937550083e-05
of O 0 8.765883308115008e-07
an O 0 5.907691502216039e-06
AS B-Disease 0 0.00014448328875005245
daughter O 0 0.005465374793857336
. O 0 0.0001364585623377934

The O 0 2.4850787667674012e-05
frequencies O 0 2.2183772671269253e-05
with O 0 3.6830856515734922e-06
which O 0 1.5663928252251935e-06
we O 0 2.206212684541242e-06
detected O 0 6.735392526024953e-05
mutations O 0 7.471743447240442e-05
were O 0 7.597201943099208e-07
5 O 0 1.9005947251571342e-06
( O 0 1.4704154409628245e-06
14 O 0 1.1609029115788871e-06
% O 0 3.490256119675905e-07
) O 0 3.659703793346125e-07
of O 0 2.3229729606555338e-07
35 O 0 2.153766445189831e-06
in O 0 1.0592362968964153e-06
sporadic O 0 7.640141120646149e-05
cases O 0 4.004566289950162e-05
and O 0 1.0599457027637982e-06
8 O 0 3.563225391189917e-06
( O 0 1.690221210992604e-06
80 O 0 1.585833615536103e-06
% O 0 3.8606725638601347e-07
) O 0 6.093979436627706e-07
of O 0 2.591982877220289e-07
10 O 0 3.578717269192566e-06
in O 0 1.0922892215603497e-05
familial O 1 0.8047487139701843
cases O 0 0.0041655320674180984
. O 0 5.034721834817901e-05
. O 0 9.537207370158285e-05

The O 0 0.0013090389547869563
hemochromatosis B-Disease 1 0.9897275567054749
845 O 1 0.8885490894317627
G O 0 0.1172616183757782
- O 0 0.004534529522061348
- O 0 0.0018780598184093833
> O 0 0.0007219193503260612
A O 0 9.594610673957504e-06
and O 0 5.319423053151695e-06
187 O 0 0.00018760966486297548
C O 0 0.0007416404550895095
- O 0 0.0014055006904527545
- O 0 0.004304718691855669
> O 0 0.018287701532244682
G O 0 0.01736776903271675
mutations O 0 0.008369405753910542
: O 0 4.6751640184083953e-05
prevalence O 0 0.17324990034103394
in O 0 1.557374889671337e-05
non O 0 0.0004041831416543573
- O 0 0.02952525205910206
Caucasian O 0 0.2154778242111206
populations O 0 0.004807107616215944
. O 0 0.0002839196240529418

Hemochromatosis B-Disease 1 0.9906589984893799
, O 0 0.0010735251707956195
the O 0 0.0013729451457038522
inherited B-Disease 1 0.9978867173194885
disorder I-Disease 1 0.999270498752594
of I-Disease 0 5.251241964288056e-05
iron I-Disease 0 0.288205623626709
metabolism I-Disease 1 0.7030114531517029
, O 0 4.6200777433114126e-05
leads O 0 0.0006153113790787756
, O 0 1.3281135579745751e-05
if O 0 5.411615711636841e-05
untreated O 1 0.8946018218994141
, O 0 8.624488145869691e-06
to O 0 8.240368515544105e-06
progressive O 0 0.015252201817929745
iron B-Disease 0 0.24574336409568787
overload I-Disease 1 0.9692602157592773
and O 0 0.0002388446155237034
premature B-Disease 1 0.9027579426765442
death I-Disease 0 0.029525091871619225
. O 0 0.00026407340192236006

The O 0 0.0020080385729670525
hemochromatosis B-Disease 1 0.9959408044815063
gene O 0 0.2878679037094116
, O 0 0.00038677715929225087
HFE O 1 0.9060032367706299
, O 0 2.200874405389186e-05
recently O 0 6.038235733285546e-05
has O 0 3.85991734219715e-06
been O 0 1.226096969730861e-06
identified O 0 3.457422735664295e-06
, O 0 3.998576687536115e-07
and O 0 2.741452078680595e-07
characterization O 0 2.683909042389132e-05
of O 0 2.806876011618442e-07
this O 0 5.31069815679075e-07
gene O 0 4.647368405130692e-05
has O 0 7.3863333227564e-07
shown O 0 1.0377982562204124e-06
that O 0 1.4035057915862126e-07
it O 0 1.1082639161941188e-07
contains O 0 2.6339054670643236e-07
two O 0 2.676486019481672e-07
mutations O 0 5.109742414788343e-05
that O 0 2.212984355765002e-07
result O 0 8.674638252159639e-07
in O 0 5.200188297749264e-07
amino O 0 3.763888571484131e-06
acid O 0 2.9069020456518047e-05
substitutions O 0 3.066287172259763e-05
- O 0 0.0001099700530176051
cDNA O 0 9.048051288118586e-05
nucleotides O 0 0.00016838697774801403
845 O 0 0.011108706705272198
G O 0 0.001646001823246479
- O 0 0.00043737792293541133
- O 0 0.000365046871593222
> O 0 0.00037458649603649974
A O 0 1.0162057151319459e-05
( O 0 8.14076338429004e-06
C282Y O 0 0.00010723159357439727
) O 0 2.6293430437362986e-06
and O 0 1.953340870386455e-06
187 O 0 6.336555816233158e-05
C O 0 0.0002434476773487404
- O 0 0.0003263747494202107
- O 0 0.0010834108106791973
> O 0 0.004068164620548487
G O 0 0.0019975006580352783
( O 0 6.230860890354961e-05
H63D O 0 0.005641622003167868
) O 0 9.860134014161304e-05
. O 0 0.00010008605022449046

Although O 0 0.010166403837502003
hemochromatosis B-Disease 1 0.9943923354148865
is O 0 9.227177361026406e-05
common O 0 0.00016269156185444444
in O 0 2.1990412278682925e-05
Caucasians O 0 0.05565516650676727
, O 0 1.6842075638123788e-05
affecting O 0 0.008831346407532692
> O 0 0.007242006715387106
= O 0 0.00039991570520214736
1 O 0 1.7610969734960236e-05
/ O 0 0.0007186403963714838
300 O 0 7.171008292061742e-06
individuals O 0 1.8365856249147328e-06
of O 0 3.8831339566058887e-07
northern O 0 2.3578409127367195e-06
European O 0 1.6595604392932728e-06
origin O 0 1.0231341320832144e-06
, O 0 4.4846123614661337e-07
it O 0 3.625569604537304e-07
has O 0 7.818220524313801e-07
not O 0 5.235308435658226e-07
been O 0 7.108591830728983e-07
recognized O 0 4.911714313493576e-06
in O 0 1.6551111912121996e-06
other O 0 6.16333545622183e-06
populations O 0 0.00047570670722052455
. O 0 7.731630466878414e-05

The O 0 3.458685750956647e-05
present O 0 2.0991661585867405e-05
study O 0 1.8832752175512724e-05
used O 0 3.98481506636017e-06
PCR O 0 4.814683779841289e-05
and O 0 1.990025111808791e-06
restriction O 0 1.2685143701673951e-05
- O 0 0.0001440454216208309
enzyme O 0 7.034766167635098e-05
digestion O 0 0.0001367688673781231
to O 0 8.596696829954453e-07
analyze O 0 4.350868039182387e-06
the O 0 4.014820547126874e-07
frequency O 0 1.233318812410289e-06
of O 0 4.827114707950386e-07
the O 0 2.493950887583196e-06
845 O 0 0.010363823734223843
G O 0 0.0010433128336444497
- O 0 0.0002827011630870402
- O 0 0.0002593557583168149
> O 0 0.00016610971943009645
A O 0 4.431588877196191e-06
and O 0 2.4628839128126856e-06
187 O 0 7.149342127377167e-05
C O 0 0.0002234755811514333
- O 0 0.0002707901003304869
- O 0 0.0011267269728705287
> O 0 0.003751237876713276
G O 0 0.000945237057749182
mutations O 0 0.0004360266902949661
in O 0 6.644395853072638e-06
HLA O 0 0.30833813548088074
- O 0 0.0001288452185690403
typed O 0 2.5400380764040165e-05
samples O 0 9.007180779008195e-06
from O 0 2.5008528155012755e-06
non O 0 3.397303953533992e-05
- O 0 0.0007543390966020525
Caucasian O 0 0.008270803838968277
populations O 0 0.00014525119331665337
, O 0 2.993116368088522e-06
comprising O 0 1.1786396498791873e-05
Australian O 0 1.6415702702943236e-05
Aboriginal O 0 0.00010466297680977732
, O 0 2.5588703920220723e-06
Chinese O 0 8.203110155591276e-06
, O 0 3.920170911442256e-06
and O 0 9.824714652495459e-06
Pacific O 0 0.0003238156787119806
Islanders O 0 0.001984919421374798
. O 0 0.00015597252058796585

Results O 0 0.00021801910770591348
showed O 0 7.144000119296834e-05
that O 0 6.900299467815785e-06
the O 0 7.644116521987598e-06
845 O 0 0.03456035628914833
G O 0 0.010297715663909912
- O 0 0.0011914910282939672
- O 0 0.001047667465172708
> O 0 0.0006271207821555436
A O 0 5.899652478547068e-06
mutation O 0 7.891964196460322e-05
was O 0 5.396499886956008e-07
present O 0 5.882118330191588e-07
in O 0 4.099772468180163e-07
these O 0 6.724050649609126e-07
populations O 0 1.7274021956836805e-05
( O 0 2.4542016490158858e-06
allele O 0 1.6497784599778242e-05
frequency O 0 3.1531342301605036e-06
0 O 0 3.2407460821559653e-06
. O 0 4.6330362124535895e-07
32 O 0 1.3050575944362208e-06
% O 0 4.187939453004219e-07
) O 0 6.296579044828832e-07
, O 0 2.7941734970227117e-07
and O 0 2.67187004965308e-07
, O 0 4.324745646044903e-07
furthermore O 0 3.5568527891882695e-06
, O 0 2.977433268824825e-07
it O 0 2.384510082720226e-07
was O 0 3.974260778250027e-07
always O 0 1.0188751957684872e-06
seen O 0 1.8147229638998397e-06
in O 0 1.1210213415324688e-06
conjunction O 0 7.14957423042506e-05
with O 0 3.989951073890552e-05
HLA O 1 0.9903646111488342
haplotypes O 0 0.10860536992549896
common O 0 7.363099575741217e-05
in O 0 8.10978417575825e-06
Caucasians O 0 0.014022053219377995
, O 0 4.8012170736910775e-06
suggesting O 0 5.4313233704306185e-05
that O 0 4.600876764015993e-06
845 O 0 0.06749971210956573
G O 0 0.012925412505865097
- O 0 0.0026434925384819508
- O 0 0.0027151633985340595
> O 0 0.0012880221474915743
A O 0 4.9399372983316425e-06
may O 0 2.211114178862772e-06
have O 0 4.3161097096344747e-07
been O 0 4.2096905872313073e-07
introduced O 0 9.134525384979497e-07
into O 0 7.975370976964768e-07
these O 0 1.8212037957709981e-06
populations O 0 7.70305487094447e-05
by O 0 1.4553133951267228e-05
Caucasian O 0 0.04766887426376343
admixture O 0 0.2293614149093628
. O 0 0.0002677994780242443

187 O 0 0.005275565665215254
C O 0 0.005436515435576439
- O 0 0.002210585866123438
- O 0 0.002066835528239608
> O 0 0.002399356570094824
G O 0 0.0002870039897970855
was O 0 1.6176664985323441e-06
present O 0 1.5571139329040307e-06
at O 0 1.4186476846589358e-06
an O 0 1.3124403039910248e-06
allele O 0 4.224383155815303e-05
frequency O 0 1.2031107871735003e-05
of O 0 5.784687800769461e-06
2 O 0 5.7261644542450085e-05
. O 0 8.030932804103941e-05

68 O 0 0.00020562080317176878
% O 0 1.0114004908245988e-05
in O 0 3.0332887490658322e-06
the O 0 1.710578999336576e-06
two O 0 2.1952364477328956e-06
populations O 0 0.00011228216317249462
analyzed O 0 9.797777602216229e-05
( O 0 1.2766394320351537e-05
Australian O 0 1.4418319551623426e-05
Aboriginal O 0 5.534323281608522e-05
and O 0 4.48272339781397e-06
Chinese O 0 2.4122640752466395e-05
) O 0 3.500495586195029e-05
. O 0 5.0913760787807405e-05

In O 0 3.839721830445342e-05
the O 0 1.2266196790733375e-05
Australian O 0 2.820673216774594e-05
Aboriginal O 0 8.757461182540283e-05
samples O 0 2.0606730686267838e-05
, O 0 4.665350388677325e-06
187 O 0 0.00015511676610913128
C O 0 0.0005299170152284205
- O 0 0.0004969341098330915
- O 0 0.000994407688267529
> O 0 0.0020554019138216972
G O 0 0.0001706733019091189
was O 0 7.64934327435185e-07
found O 0 7.021802161943924e-07
to O 0 3.928641092443286e-07
be O 0 5.550811010834877e-07
associated O 0 9.148778190137818e-06
with O 0 1.129664815380238e-05
HLA O 1 0.9751948714256287
haplotypes O 0 0.1323605477809906
common O 0 6.591548299184069e-05
in O 0 5.586111001321115e-06
Caucasians O 0 0.03956037014722824
, O 0 2.8705351269309176e-06
suggesting O 0 2.879108978959266e-05
that O 0 6.665757723567367e-07
it O 0 5.782359835393436e-07
was O 0 8.905523145585903e-07
introduced O 0 4.99086036143126e-06
by O 0 5.565092124015791e-06
recent O 0 0.00012790411710739136
admixture O 0 0.032855115830898285
. O 0 0.00023783903452567756

In O 0 4.30677791882772e-05
the O 0 8.619266736786813e-06
Chinese O 0 1.6334450265276246e-05
samples O 0 1.9146327758789994e-05
analyzed O 0 3.7011723179602996e-05
, O 0 5.377899469749536e-06
187 O 0 0.00012050729856127873
C O 0 0.00032344693318009377
- O 0 0.0003969835815951228
- O 0 0.000687887251842767
> O 0 0.0009244833490811288
G O 0 0.00011491704208310694
was O 0 8.154362376444624e-07
present O 0 8.646019864499976e-07
in O 0 7.294253236977966e-07
association O 0 1.1731806807802059e-05
with O 0 7.656072398276592e-07
a O 0 1.3464807580021443e-06
wide O 0 7.339494459301932e-06
variety O 0 1.3272285286802799e-05
of O 0 4.974399871571222e-06
HLA O 1 0.9918992519378662
haplotypes O 0 0.05464024469256401
, O 0 3.0340004286699696e-06
showing O 0 1.0930468306469265e-05
this O 0 1.2043767583236331e-06
mutation O 0 0.00012630764103960246
to O 0 5.876427167095244e-07
be O 0 4.683569159169565e-07
widespread O 0 9.175707418762613e-06
and O 0 9.998281029766076e-07
likely O 0 3.954954536311561e-06
to O 0 9.109948564400838e-07
predate O 0 0.0003788697358686477
the O 0 1.24684561342292e-06
more O 0 3.2208356515184278e-06
genetically O 0 0.0001185102155432105
restricted O 0 7.490155985578895e-05
845 O 0 0.07908843457698822
G O 0 0.014582112431526184
- O 0 0.0014887487050145864
- O 0 0.0017432442400604486
> O 0 0.0019284631125628948
A O 0 7.390605605905876e-05
mutation O 0 0.0020736369770020247
. O 0 0.00011712645209627226

Genotype O 1 0.9372240304946899
- O 1 0.6353121995925903
phenotype O 1 0.9560236930847168
correlations O 0 0.27931472659111023
in O 0 0.006514806766062975
attenuated B-Disease 1 0.9833099246025085
adenomatous I-Disease 1 0.9974198341369629
polyposis I-Disease 1 0.9964569211006165
coli I-Disease 1 0.9878880381584167
. O 0 0.010833236388862133

Germ O 1 0.611492931842804
- O 0 0.0032442312221974134
line O 0 0.0001190158654935658
mutations O 0 0.001323009841144085
of O 0 1.0006952834373806e-05
the O 0 9.86886298051104e-05
tumor B-Disease 1 0.9967190623283386
suppressor O 1 0.951187252998352
APC O 0 0.36172476410865784
are O 0 6.301502435235307e-05
implicated O 1 0.6036458611488342
in O 0 0.006208387203514576
attenuated B-Disease 1 0.9960206151008606
adenomatous I-Disease 1 0.9995421171188354
polyposis I-Disease 1 0.999576985836029
coli I-Disease 1 0.999096155166626
( O 0 0.30143991112709045
AAPC B-Disease 1 0.995141863822937
) O 0 9.473242243984714e-05
, O 0 1.753532160364557e-05
a O 0 5.583879101322964e-05
variant O 0 0.0697554349899292
of O 0 0.0012794079957529902
familial B-Disease 1 0.9988020658493042
adenomatous I-Disease 1 0.9992103576660156
polyposis I-Disease 1 0.9991266131401062
( O 1 0.7076348066329956
FAP B-Disease 1 0.9890474677085876
) O 0 0.0010261129355058074
. O 0 0.0004796484427060932

AAPC B-Disease 1 0.9701588153839111
is O 0 5.488828173838556e-05
recognized O 0 4.55744557257276e-05
by O 0 3.954747171519557e-06
the O 0 4.083834483026294e-06
occurrence O 0 0.000100029181339778
of O 0 5.493191565619782e-06
< O 0 0.01198737695813179
100 O 0 0.00010581772949080914
colonic B-Disease 1 0.9900644421577454
adenomas I-Disease 1 0.9660358428955078
and O 0 1.6458950995001942e-05
a O 0 3.150080010527745e-05
later O 0 0.0001855313457781449
onset O 1 0.9973559379577637
of O 0 0.0336243137717247
colorectal B-Disease 1 0.9999122619628906
cancer I-Disease 1 0.9998496770858765
( O 0 0.0037043336778879166
age O 0 0.0009419771959073842
> O 0 0.013836255297064781
40 O 0 3.156169259455055e-05
years O 0 4.507467383518815e-05
) O 0 4.21384975197725e-05
. O 0 7.082814408931881e-05

The O 0 3.5384688089834526e-05
aim O 0 4.440619159140624e-05
of O 0 2.460925998093444e-06
this O 0 2.1432226731121773e-06
study O 0 1.4398629900824744e-05
was O 0 3.019659516212414e-06
to O 0 4.906156846118392e-06
assess O 0 0.008728638291358948
genotype O 1 0.5177811980247498
- O 0 0.08021736145019531
phenotype O 1 0.7993379831314087
correlations O 0 0.021735338494181633
in O 0 0.0003608018159866333
AAPC B-Disease 1 0.988036036491394
families O 0 0.0025676321238279343
. O 0 0.00043696354259736836

By O 0 8.437768701696768e-05
protein O 0 0.0001363902847515419
- O 0 0.000376577751012519
truncation O 0 0.0005794148310087621
test O 0 5.556528776651248e-05
( O 0 1.2827999853470828e-05
PTT O 0 9.053289977600798e-05
) O 0 4.576790615828941e-06
assay O 0 1.284365680476185e-05
, O 0 8.914215641198098e-07
the O 0 7.896524607531319e-07
entire O 0 4.811764483747538e-06
coding O 0 3.1185965781332925e-05
region O 0 5.0471635404392146e-06
of O 0 6.431192218769866e-07
the O 0 2.834455699485261e-06
APC B-Disease 0 0.006930881645530462
gene O 0 0.00036693428410217166
was O 0 3.6075491607334698e-06
screened O 0 4.166386861470528e-05
in O 0 3.2992036267387448e-06
affected O 0 0.00040451466338708997
individuals O 0 2.6134828658541664e-05
from O 0 8.081880878307857e-06
11 O 0 0.0002372766612097621
AAPC B-Disease 1 0.9925954937934875
kindreds O 0 0.08380164951086044
, O 0 4.912013537250459e-06
and O 0 1.8644633428266388e-06
their O 0 3.2495106552232755e-06
phenotypic O 0 0.00047819060273468494
differences O 0 7.474594167433679e-05
were O 0 1.4808524610998575e-05
examined O 0 0.002710385248064995
. O 0 0.00011630597145995125

Five O 0 0.0006375592784024775
novel O 0 0.0013848836533725262
germ O 0 0.35864347219467163
- O 0 0.0026875303592532873
line O 0 0.00012450796202756464
APC B-Disease 0 0.04217178001999855
mutations O 0 0.00427450705319643
were O 0 4.348379206930986e-06
identified O 0 2.3992372007342055e-05
in O 0 7.482495675503742e-06
seven O 0 6.556941661983728e-05
kindreds O 0 0.07963089644908905
. O 0 0.00020920140377711505

Mutations O 0 0.007889819331467152
were O 0 1.1412032108637504e-05
located O 0 7.146594725782052e-06
in O 0 9.463736319048621e-07
three O 0 6.801481617912941e-07
different O 0 6.748719556526339e-07
regions O 0 3.2603563795419177e-06
of O 0 4.2616534301487263e-07
the O 0 1.5165691138463444e-06
APC B-Disease 0 0.001486846012994647
gene O 0 8.549508493160829e-05
( O 0 2.3840243557060603e-06
1 O 0 1.2076915254510823e-06
) O 0 5.041853796683426e-07
at O 0 2.8674523377958394e-07
the O 0 2.1848090625553596e-07
5 O 0 8.736247991691926e-07
end O 0 1.2199759567010915e-06
spanning O 0 9.92198874882888e-06
exons O 0 1.822962803998962e-05
4 O 0 1.8683329017221695e-06
and O 0 5.148630748408323e-07
5 O 0 1.4744933878318989e-06
, O 0 6.406082775356481e-07
( O 0 7.101375558704603e-07
2 O 0 7.987580374901881e-07
) O 0 5.852267577211023e-07
within O 0 5.9065428104077e-07
exon O 0 2.5511249987175688e-05
9 O 0 1.6039059573813574e-06
, O 0 2.946848383089673e-07
and O 0 2.675850510058808e-07
( O 0 6.596901584998704e-07
3 O 0 5.447286071103008e-07
) O 0 3.195175395376282e-07
at O 0 2.951827013930597e-07
the O 0 4.1400014083592396e-07
3 O 0 2.7481478355184663e-06
distal O 0 0.001162861823104322
end O 0 2.919554162872373e-06
of O 0 1.4702640100949793e-06
the O 0 9.732429134601261e-06
gene O 0 0.0008415266056545079
. O 0 9.062385652214289e-05

Variability O 0 0.003846414852887392
in O 0 2.6168096155743115e-05
the O 0 9.069526640814729e-06
number O 0 1.7159060007543303e-05
of O 0 0.0001261094439541921
colorectal B-Disease 1 0.9996908903121948
adenomas I-Disease 1 0.9986293315887451
was O 0 3.668625504360534e-05
most O 0 1.0895573723246343e-05
apparent O 0 0.00036374785122461617
in O 0 3.749490133486688e-06
individuals O 0 1.1824720786535181e-05
with O 0 5.93311051488854e-06
mutations O 0 0.002254777355119586
in O 0 1.8579100924398517e-06
region O 0 1.5817819075891748e-05
1 O 0 3.898621343978448e-06
, O 0 3.009574584211805e-06
and O 0 1.4628914868808351e-05
upper O 0 0.20642651617527008
- O 1 0.9367111325263977
gastrointestinal O 1 0.9993817806243896
manifestations O 1 0.6088979840278625
were O 0 6.897884759382578e-06
more O 0 4.0251721657114103e-05
severe O 1 0.8890443444252014
in O 0 2.0049801605637185e-05
them O 0 3.111271507805213e-05
. O 0 0.00010694863158278167

In O 0 7.49449318391271e-05
individuals O 0 6.10649076406844e-05
with O 0 1.3911335372540634e-05
mutations O 0 0.0009743259870447218
in O 0 2.6316708954254864e-06
either O 0 2.434069983792142e-06
region O 0 8.297492968267761e-06
2 O 0 1.7622512586967787e-06
or O 0 8.936959829952684e-07
region O 0 2.5800020466704154e-06
3 O 0 6.359625217555731e-07
, O 0 1.7862991796846472e-07
the O 0 1.8075810714890395e-07
average O 0 1.4477486729447264e-06
number O 0 4.6193505909286614e-07
of O 0 9.375324907523463e-07
adenomas B-Disease 1 0.8087229132652283
tended O 0 6.399687117664143e-05
to O 0 6.613902883145784e-07
be O 0 3.0922336691219243e-07
lower O 0 1.2509248108472093e-06
than O 0 3.9793735595594626e-07
those O 0 3.811838951151003e-07
in O 0 4.5464156528396416e-07
individuals O 0 3.2133223157870816e-06
with O 0 2.0024106106575346e-06
mutations O 0 0.0005658568697981536
in O 0 1.0775823966469034e-06
region O 0 1.6720849089324474e-05
1 O 0 2.6187199182459153e-06
, O 0 1.7568177099747118e-06
although O 0 3.757816330107744e-06
age O 0 2.764812597888522e-05
at O 0 3.293763074907474e-05
diagnosis O 1 0.9898937344551086
was O 0 3.2686584745533764e-05
similar O 0 0.00037008337676525116
. O 0 0.00018082918541040272

In O 0 0.0001923855597851798
all O 0 0.00010759520228020847
AAPC B-Disease 1 0.9828960299491882
kindreds O 0 0.050614915788173676
, O 0 1.877672730188351e-05
a O 0 1.3813163604936562e-05
predominance O 0 0.0012913000537082553
of O 0 1.391989462717902e-05
right O 0 0.0019233940402045846
- O 1 0.8281344771385193
sided O 1 0.9949455857276917
colorectal B-Disease 1 0.9997321963310242
adenomas I-Disease 1 0.9990565180778503
and O 0 0.15154646337032318
rectal B-Disease 1 0.9992334842681885
polyp I-Disease 1 0.9987213015556335
sparing O 1 0.9412062764167786
was O 0 0.00021876496612094343
observed O 0 0.0007998049259185791
. O 0 0.00014459203521255404

No O 0 0.002019947860389948
desmoid B-Disease 1 0.7729507684707642
tumors I-Disease 1 0.9938468337059021
were O 0 1.580859134264756e-05
found O 0 2.1419520635390654e-05
in O 0 1.148555656982353e-05
these O 0 3.605260280892253e-05
kindreds O 0 0.1001855880022049
. O 0 0.0002593807294033468

Our O 0 7.948677375679836e-05
data O 0 3.080226088059135e-05
suggest O 0 3.9170226955320686e-05
that O 0 3.4659965422179084e-06
, O 0 4.213825832266593e-06
in O 0 1.0483500773261767e-05
AAPC B-Disease 1 0.9877090454101562
families O 0 2.7360625608707778e-05
, O 0 9.414630426363146e-07
the O 0 5.240033829068125e-07
location O 0 1.1978384009125875e-06
of O 0 6.381783350661863e-07
the O 0 4.439482381712878e-06
APC B-Disease 0 0.057107482105493546
mutation O 0 0.00678950734436512
may O 0 7.761082088109106e-05
partially O 0 0.0004918920458294451
predict O 0 0.00034079430042766035
specific O 0 6.4983541960828e-05
phenotypic O 0 0.0024894478265196085
expression O 0 0.0005946847377344966
. O 0 0.00019331967632751912

This O 0 2.486922858224716e-05
should O 0 7.620300948474323e-06
help O 0 8.474097739963327e-06
in O 0 1.0472691656104871e-06
the O 0 9.565671916789142e-07
design O 0 1.022362630465068e-05
of O 0 3.7904362670815317e-06
tailored O 0 0.11983522027730942
clinical O 1 0.9772995710372925
- O 0 0.035404033958911896
management O 0 0.006046751514077187
protocols O 0 0.00036834253114648163
in O 0 3.719914047906059e-06
this O 0 2.9042389542155433e-06
subset O 0 0.00021612882846966386
of O 0 4.8905701987678185e-05
FAP B-Disease 1 0.9962702989578247
patients O 1 0.9964679479598999
. O 0 7.68542304285802e-05
. O 0 0.00013812402903568

Wilms B-Disease 1 0.9873145222663879
' I-Disease 0 0.11792710423469543
tumor I-Disease 1 0.9139770865440369
1 O 0 3.554672366590239e-05
and O 0 9.235581273969728e-06
Dax O 0 0.0010763740865513682
- O 0 0.0001791749964468181
1 O 0 2.328973096155096e-05
modulate O 0 0.002486476441845298
the O 0 1.375060310238041e-05
orphan O 0 0.12131473422050476
nuclear O 0 0.00036730841384269297
receptor O 0 0.011050409637391567
SF O 0 0.34867826104164124
- O 0 0.00013664607831742615
1 O 0 7.119153451640159e-06
in O 0 3.165969928886625e-06
sex O 0 5.4487234592670575e-05
- O 0 0.00027603443595580757
specific O 0 3.967133307014592e-05
gene O 0 0.000828357704449445
expression O 0 0.0001965503761311993
. O 0 0.0001152046097558923

Products O 0 0.0002819458895828575
of O 0 4.2946499888785183e-05
steroidogenic O 1 0.7530604004859924
factor O 0 0.00019340192375238985
1 O 0 4.654669828596525e-05
( O 0 5.8518387959338725e-05
SF O 0 0.18711546063423157
- O 0 0.0001894758897833526
1 O 0 1.255741335626226e-05
) O 0 1.0999158803315368e-05
and O 0 3.45003827533219e-05
Wilms B-Disease 1 0.9972956776618958
tumor I-Disease 1 0.9769247770309448
1 O 0 4.353704571258277e-05
( O 0 5.1633742259582505e-05
WT1 O 0 0.3250812292098999
) O 0 5.1401511882431805e-06
genes O 0 1.1485359209473245e-05
are O 0 6.911897685313306e-07
essential O 0 3.6407564039109275e-06
for O 0 2.9916550374764483e-06
mammalian O 0 0.0010422281920909882
gonadogenesis O 0 0.0087482500821352
prior O 0 2.256704101455398e-05
to O 0 7.609103249706095e-06
sexual O 0 0.0005611631204374135
differentiation O 0 0.0032583042047917843
. O 0 0.00014228497457224876

In O 0 0.00010712581570260227
males O 0 0.0005556194810196757
, O 0 2.998493619088549e-05
SF O 0 0.30904409289360046
- O 0 0.00039206870133057237
1 O 0 1.2809578038286418e-05
participates O 0 0.00012455260730348527
in O 0 3.759472292585997e-06
sexual O 0 6.006219336995855e-05
development O 0 9.0113389887847e-06
by O 0 2.018081204369082e-06
regulating O 0 0.00010461617785040289
expression O 0 1.1353849004080985e-05
of O 0 2.646479742907104e-06
the O 0 1.33546718643629e-05
polypeptide O 0 0.012939637526869774
hormone O 1 0.9117823243141174
Mullerian O 1 0.9917941689491272
inhibiting O 1 0.8076288104057312
substance O 1 0.7797385454177856
( O 0 0.0020033083856105804
MIS O 1 0.9388501048088074
) O 0 0.00025772713706828654
. O 0 0.00022707952302880585

Here O 0 0.00011494214413687587
, O 0 1.595069988979958e-05
we O 0 8.069759132922627e-06
show O 0 2.017822589550633e-05
that O 0 1.5993105989764445e-05
WT1 O 1 0.5970841646194458
- O 0 0.006239597219973803
KTS O 1 0.6694049835205078
isoforms O 0 0.0007015967858023942
associate O 0 0.00031097023747861385
and O 0 1.8314436601940542e-05
synergize O 0 0.326845645904541
with O 0 3.8337064324878156e-05
SF O 1 0.602548360824585
- O 0 0.0003475032572168857
1 O 0 1.5672801964683458e-05
to O 0 9.22445542528294e-06
promote O 0 0.00013433326967060566
MIS O 0 0.3253403306007385
expression O 0 0.00039016827940940857
. O 0 0.0001396981388097629

In O 0 0.00021716891205869615
contrast O 0 0.001062497147358954
, O 0 0.00020623026648536325
WT1 O 1 0.9772816896438599
missense O 0 0.49295687675476074
mutations O 0 0.07620391994714737
, O 0 1.8302283933735453e-05
associated O 0 6.951998511794955e-05
with O 0 1.6793514078017324e-05
male B-Disease 0 0.0028202529065310955
pseudohermaphroditism I-Disease 1 0.8995372653007507
in O 0 0.000562974950298667
Denys B-Disease 1 0.9947934746742249
- I-Disease 1 0.9619700908660889
Drash I-Disease 1 0.9951828122138977
syndrome I-Disease 1 0.9995515942573547
, O 0 0.000171823485288769
fail O 0 0.00673431484028697
to O 0 2.299135121575091e-05
synergize O 1 0.7336890697479248
with O 0 0.00011287603410892189
SF O 1 0.8760034441947937
- O 0 0.0020197653211653233
1 O 0 0.00013111354201100767
. O 0 0.00015337405784521252

Additionally O 0 0.0003117024607490748
, O 0 1.9563778550946154e-05
the O 0 7.514175194955897e-06
X O 0 0.0010920744389295578
- O 0 0.00047376827569678426
linked O 0 0.00033379803062416613
, O 0 8.143340892274864e-06
candidate O 0 2.2134699975140393e-05
dosage O 0 0.0375174805521965
- O 0 0.002353027928620577
sensitive O 0 0.0006632168078795075
sex O 0 0.0005629000952467322
- O 0 0.0029004740063101053
reversal O 0 0.006536461412906647
gene O 0 0.0011242288164794445
, O 0 8.819180948194116e-06
Dax O 0 0.001647848985157907
- O 0 0.0001568777661304921
1 O 0 9.734174454933964e-06
, O 0 7.570068646600703e-06
antagonizes O 0 0.013815515674650669
synergy O 0 0.0007891592103987932
between O 0 2.785925244097598e-05
SF O 0 0.34343093633651733
- O 0 0.00022687975433655083
1 O 0 1.0436308912176173e-05
and O 0 7.367953003267758e-06
WT1 O 0 0.13512662053108215
, O 0 1.919217083923286e-06
most O 0 1.5015360759207397e-06
likely O 0 2.412225285297609e-06
through O 0 8.58541454817896e-07
a O 0 9.107707228395157e-07
direct O 0 3.035838290088577e-06
interaction O 0 1.953650098585058e-05
with O 0 1.4535949048877228e-05
SF O 1 0.5371497273445129
- O 0 0.0007645065197721124
1 O 0 7.338418072322384e-05
. O 0 9.324200073024258e-05

We O 0 0.00012809048348572105
propose O 0 0.00036348230787552893
that O 0 2.4759852749411948e-05
WT1 O 0 0.23102489113807678
and O 0 1.384793267789064e-05
Dax O 0 0.0011574642267078161
- O 0 0.00014728437236044556
1 O 0 1.3312861483427696e-05
functionally O 0 0.00023677154968027025
oppose O 0 1.436263119103387e-05
each O 0 1.0071895530927577e-06
other O 0 1.3951332675787853e-06
in O 0 3.2209156870521838e-06
testis O 0 0.09781329333782196
development O 0 4.2073243093909696e-05
by O 0 1.6481051716255024e-05
modulating O 0 0.16331663727760315
SF O 1 0.6753271222114563
- O 0 0.0005017404910176992
1 O 0 5.5708700529066846e-05
- O 0 0.001356608234345913
mediated O 0 0.01117031741887331
transactivation O 0 0.07584483921527863
. O 0 8.523807628080249e-05
. O 0 0.00016031513223424554

A O 0 0.0011808025883510709
mouse O 0 0.03349714353680611
model O 0 0.0009429407655261457
for O 0 0.002942143939435482
Prader B-Disease 1 0.9981548190116882
- I-Disease 1 0.9962173104286194
Willi I-Disease 1 0.9988221526145935
syndrome I-Disease 1 0.9995554089546204
imprinting O 1 0.9873142838478088
- O 1 0.7946925163269043
centre O 0 0.023725511506199837
mutations O 0 0.25048956274986267
. O 0 0.0004943390376865864

Imprinting O 0 0.008345787413418293
in O 0 4.923466985928826e-05
the O 0 2.0261271856725216e-05
15q11 O 0 0.0023157806135714054
- O 0 0.0011757127940654755
q13 O 0 0.0017026292625814676
region O 0 4.791388346347958e-05
involves O 0 5.9415557188913226e-05
an O 0 5.7012921388377436e-06
imprinting O 0 0.0235928762704134
centre O 0 0.00019122588855680078
( O 0 2.2273310605669394e-05
IC O 0 0.0040113236755132675
) O 0 2.921734903793549e-06
, O 0 1.0202461453445721e-06
mapping O 0 8.81037976796506e-06
in O 0 9.236058531314484e-07
part O 0 1.2151558621553704e-06
to O 0 5.280597861201386e-07
the O 0 8.91524393864529e-07
promoter O 0 4.651554627344012e-05
and O 0 1.0704923170123948e-06
first O 0 2.9157006338209612e-06
exon O 0 0.00016930676065385342
of O 0 1.4561796888301615e-05
SNRPN O 0 0.04442042112350464
. O 0 0.00016789349319878966

Deletion O 0 0.00327895674854517
of O 0 3.276726056355983e-05
this O 0 2.5055293008335866e-05
IC O 0 0.01569429412484169
abolishes O 0 0.014948558993637562
local O 0 3.022788769158069e-05
paternally O 0 0.0041388156823813915
derived O 0 4.420263576321304e-05
gene O 0 0.00040638496284373105
expression O 0 3.611547072068788e-05
and O 0 9.093472726817708e-06
results O 0 0.000178368209162727
in O 0 0.0005053876084275544
Prader B-Disease 1 0.9985600113868713
- I-Disease 1 0.9963896870613098
Willi I-Disease 1 0.9991413354873657
syndrome I-Disease 1 0.9996856451034546
( O 0 0.33880501985549927
PWS B-Disease 1 0.9943353533744812
) O 0 0.0008412154857069254
. O 0 0.0004102919774595648

We O 0 5.250471440376714e-05
have O 0 1.4639827895734925e-05
created O 0 1.7596548786968924e-05
two O 0 9.8551563496585e-06
deletion O 0 0.00917720329016447
mutations O 0 0.014960459433495998
in O 0 2.3502316253143363e-05
mice O 0 0.07311128824949265
to O 0 1.1869301488331985e-05
understand O 0 0.0008883333066478372
PWS B-Disease 1 0.9867647886276245
and O 0 2.107095269821002e-06
the O 0 1.2415678156685317e-06
mechanism O 0 9.409781341673806e-06
of O 0 2.0269576452847105e-06
this O 0 9.325742212240584e-06
IC O 0 0.020586811006069183
. O 0 0.00015119985619094223

Mice O 1 0.9117113947868347
harbouring O 1 0.5171951651573181
an O 0 0.00015847443137317896
intragenic O 0 0.13729530572891235
deletion O 0 0.04591304063796997
in O 0 4.394147254060954e-05
Snrpn O 0 0.05618854984641075
are O 0 1.3962292541691568e-05
phenotypically O 0 0.09120302647352219
normal O 0 0.00010400434257462621
, O 0 3.463561142780236e-06
suggesting O 0 3.725887290784158e-05
that O 0 1.808831143534917e-06
mutations O 0 0.0003279527008999139
of O 0 1.4690588159282925e-06
SNRPN O 0 0.008313065394759178
are O 0 1.321024456046871e-06
not O 0 2.5530978291499196e-06
sufficient O 0 2.2299602278508246e-05
to O 0 2.6385130695416592e-05
induce O 0 0.15077395737171173
PWS B-Disease 1 0.9882935285568237
. O 0 0.00047075687325559556

Mice O 0 0.05649867653846741
with O 0 2.6929052182822488e-05
a O 0 1.9582370441639796e-05
larger O 0 5.3587922593578696e-05
deletion O 0 0.002641378901898861
involving O 0 0.0001711364311631769
both O 0 1.8662367438082583e-05
Snrpn O 0 0.00603206641972065
and O 0 8.930893272918183e-06
the O 0 1.1307793101877905e-05
putative O 0 0.1467539221048355
PWS O 1 0.9977333545684814
- O 0 0.012881572358310223
IC O 0 0.048909563571214676
lack O 0 6.325326103251427e-05
expression O 0 1.0990330338245258e-05
of O 0 1.7645653542786022e-06
the O 0 7.94556581240613e-06
imprinted O 0 0.03393855318427086
genes O 0 0.0011326149106025696
Zfp127 O 0 0.0444718562066555
( O 0 7.243094296427444e-05
mouse O 0 0.0009457677369937301
homologue O 0 0.0015366787556558847
of O 0 7.53305994294351e-06
ZNF127 O 0 0.06163213774561882
) O 0 1.378480465064058e-05
, O 0 9.33030605665408e-06
Ndn O 0 0.17644889652729034
and O 0 6.758826202712953e-06
Ipw O 0 0.003155042650178075
, O 0 5.08836455992423e-06
and O 0 4.075842753081815e-06
manifest O 0 0.0004334700934123248
several O 0 3.244998515583575e-05
phenotypes O 0 0.3656686246395111
common O 0 0.002875285455957055
to O 0 0.0008390512666665018
PWS B-Disease 1 0.9969573020935059
infants O 1 0.9939762353897095
. O 0 0.0009798075770959258

These O 0 1.962475107575301e-05
data O 0 7.240813829412218e-06
demonstrate O 0 9.491018317930866e-06
that O 0 5.230697297520237e-07
both O 0 2.877634699416376e-07
the O 0 1.7360527237997303e-07
position O 0 3.374893822183367e-07
of O 0 1.4788011526434275e-07
the O 0 4.262385289166559e-07
IC O 0 0.0002926551678683609
and O 0 5.091142156743445e-07
its O 0 6.355029995575023e-07
role O 0 1.8470947225068812e-06
in O 0 4.413838894379296e-07
the O 0 4.283473060695542e-07
coordinate O 0 2.0636289264075458e-05
expression O 0 3.2170414669963066e-06
of O 0 4.1930783822863305e-07
genes O 0 9.847978617472108e-06
is O 0 7.39038455321861e-07
conserved O 0 3.3640915262367344e-06
between O 0 1.7441539057472255e-06
mouse O 0 0.0003894609399139881
and O 0 9.249050094695122e-07
human O 0 1.0196770745096728e-05
, O 0 4.524908945313655e-07
and O 0 3.4139139870603685e-07
indicate O 0 2.0129643871769076e-06
that O 0 2.1890971879656718e-07
the O 0 4.211457280689501e-07
mouse O 0 7.958507194416597e-05
is O 0 4.7678028636255476e-07
a O 0 6.588080623259884e-07
suitable O 0 5.083775704406435e-06
model O 0 2.254335186080425e-06
system O 0 2.0122620298934635e-06
in O 0 3.939236137284752e-07
which O 0 2.3819418970560946e-07
to O 0 4.5826158157069585e-07
investigate O 0 1.0712097719078884e-05
the O 0 6.524039122268732e-07
molecular O 0 1.4701458894705866e-05
mechanisms O 0 6.29857004241785e-06
of O 0 6.576185569429072e-07
imprinting O 0 0.00028251955518499017
in O 0 9.894396271192818e-07
this O 0 7.021681653895939e-07
region O 0 3.877460130752297e-06
of O 0 9.168081760435598e-07
the O 0 3.939419002563227e-06
genome O 0 0.00026212434750050306
. O 0 1.9977978809038177e-05
. O 0 6.72721434966661e-05

Mutations O 0 0.004843627568334341
of O 0 1.5062105376273394e-05
the O 0 1.7295402358286083e-05
ATM O 0 0.00112677994184196
gene O 0 0.013409719802439213
detected O 0 0.008903205394744873
in O 0 6.646904512308538e-05
Japanese O 0 0.004771742969751358
ataxia B-Disease 1 0.9990488886833191
- I-Disease 1 0.996070384979248
telangiectasia I-Disease 1 0.9992427825927734
patients O 1 0.9985696077346802
: O 0 8.79016806720756e-05
possible O 0 2.439571835566312e-05
preponderance O 0 0.00068813213147223
of O 0 1.4361644389282446e-06
the O 0 2.624793069117004e-06
two O 0 7.1940785346669145e-06
founder O 0 0.001279562246054411
mutations O 0 0.022499529644846916
4612del165 O 0 0.011456542648375034
and O 0 5.346817124518566e-05
7883del5 O 0 0.013843219727277756
. O 0 0.00014348913100548089

The O 0 9.894654067466035e-05
ATM O 0 0.0008589316857978702
( O 0 0.00011822002852568403
A O 0 0.0002196270797867328
- O 0 0.042085301131010056
T O 1 0.8256551027297974
, O 0 1.8868598999688402e-05
mutated O 0 0.006163066253066063
) O 0 1.3628472515847534e-05
gene O 0 0.00019517623877618462
on O 0 1.070672533387551e-05
human O 0 0.00028890627436339855
chromosome O 0 0.003898396622389555
11q22 O 0 0.0139883728697896
. O 0 0.0002881170657929033

3 O 0 0.00021907786140218377
has O 0 3.419934000703506e-05
recently O 0 4.9737340305000544e-05
been O 0 3.208172074664617e-06
identified O 0 5.022119694331195e-06
as O 0 7.000753043939767e-07
the O 0 1.5430026678586728e-06
gene O 0 0.0001358188601443544
responsible O 0 3.788668618653901e-05
for O 0 1.1111600542790256e-05
the O 0 8.199318108381703e-05
human O 1 0.6294756531715393
recessive B-Disease 1 0.999176561832428
disease I-Disease 1 0.9997517466545105
ataxia B-Disease 1 0.999728262424469
- I-Disease 1 0.9965975880622864
telangiectasia I-Disease 1 0.9984835982322693
( O 0 0.0037767619360238314
A B-Disease 0 0.0044151367619633675
- I-Disease 1 0.5134263038635254
T I-Disease 1 0.9680916666984558
) O 0 0.00016358539869543165
. O 0 0.00015319048543460667

In O 0 3.401362482691184e-05
order O 0 1.5199429981294088e-05
to O 0 3.181412012054352e-06
define O 0 1.914588938234374e-05
the O 0 3.800412059717928e-06
types O 0 0.00010270920756738633
of O 0 3.75269228243269e-05
disease O 1 0.9993218183517456
- O 0 0.2447473555803299
causing O 0 0.3077668845653534
ATM O 0 0.011572145856916904
mutations O 0 0.045356739312410355
in O 0 1.1879007615789305e-05
Japanese O 0 0.00011523954890435562
A B-Disease 0 0.001568454666994512
- I-Disease 1 0.7558196783065796
T I-Disease 1 0.9969209432601929
patients O 1 0.980303168296814
as O 0 1.6717839343982632e-06
well O 0 1.1730884352800786e-06
as O 0 4.816414502784028e-07
to O 0 4.42085735130604e-07
look O 0 4.003551111964043e-06
for O 0 1.6335944792444934e-06
possible O 0 2.650555325089954e-05
mutational O 0 0.11612404137849808
hotspots O 0 0.0011933821951970458
, O 0 5.387729743233649e-06
reverse O 0 5.1666302169905975e-05
- O 0 9.355041402159259e-05
transcribed O 0 2.6727218937594444e-05
RNA O 0 1.41167192850844e-05
derived O 0 4.95320182380965e-06
from O 0 2.5562019345670706e-06
ten O 0 1.1957511560467537e-05
patients O 1 0.6088789701461792
belonging O 0 1.773019539541565e-05
to O 0 2.372570179431932e-06
eight O 0 1.2687599337368738e-05
unrelated O 0 0.0007660452974960208
Japanese O 0 9.242941450793296e-05
A B-Disease 0 0.0007971024024300277
- I-Disease 0 0.320482462644577
T I-Disease 1 0.9562258720397949
families O 0 4.444424121174961e-05
was O 0 1.835641796787968e-06
analyzed O 0 1.875264206319116e-05
for O 0 2.41658881350304e-06
mutations O 0 0.0001624596625333652
by O 0 1.5567455875498126e-06
the O 0 2.892750899263774e-06
restriction O 0 5.649502782034688e-05
endonuclease O 0 0.012044857256114483
fingerprinting O 0 0.0007295534014701843
method O 0 0.0001061621806002222
. O 0 0.00012657218030653894

As O 0 5.464803325594403e-05
has O 0 1.7836460756370798e-05
been O 0 5.50219874639879e-06
reported O 0 2.2902659111423418e-05
by O 0 1.8934341596832382e-06
others O 0 6.94134632794885e-06
, O 0 2.477598172845319e-06
mutations O 0 0.00011873122275574133
that O 0 5.668929361490882e-07
lead O 0 3.063160647798213e-06
to O 0 2.386995447523077e-06
exon O 0 0.00033413965138606727
skipping O 0 0.00021004203881602734
or O 0 1.0127344467036892e-05
premature O 0 0.003148827701807022
protein O 0 1.9124778191326186e-05
truncation O 0 0.00011427613208070397
were O 0 1.076448484127468e-06
also O 0 1.604952444722585e-06
predominant O 0 1.5985420759534463e-05
in O 0 4.018388608528767e-06
our O 0 2.839793341991026e-05
mutants O 0 0.0026779058389365673
. O 0 9.805169975152239e-05

Six O 0 9.494865662418306e-05
different O 0 3.751665281015448e-05
mutations O 0 0.0003826176980510354
were O 0 2.4013249912968604e-06
identified O 0 6.681307695544092e-06
on O 0 1.077792035175662e-06
12 O 0 2.194127091570408e-06
of O 0 8.940258453549177e-07
the O 0 4.075648121215636e-06
16 O 0 5.720575063605793e-05
alleles O 0 0.005480506457388401
examined O 0 0.006664355285465717
. O 0 0.00018264765094500035

Four O 0 7.54956781747751e-05
were O 0 1.373846589558525e-05
deletions O 0 0.00021500166621990502
involving O 0 4.58202775917016e-05
a O 0 6.31920738669578e-06
loss O 0 4.682610961026512e-05
of O 0 7.714214120824181e-07
a O 0 2.1354940145101864e-06
single O 0 5.24537563251215e-06
exon O 0 0.00012923033500555903
exon O 0 0.00012569177488330752
7 O 0 8.558628906030208e-06
, O 0 2.971262574646971e-06
exon O 0 5.204940680414438e-05
16 O 0 5.369658993004123e-06
, O 0 2.4733985810598824e-06
exon O 0 0.00010503961675567552
33 O 0 2.0245415726094507e-05
or O 0 1.412865094607696e-05
exon O 0 0.0005736296880058944
35 O 0 0.00015104684280231595
. O 0 8.951615018304437e-05

The O 0 3.8757229049224406e-05
others O 0 2.8523163564386778e-05
were O 0 2.714483798627043e-06
minute O 0 1.476819124945905e-05
deletions O 0 0.00012250858708284795
, O 0 6.823195235483581e-06
4649delA O 0 0.00020338548347353935
in O 0 4.94087498736917e-06
exon O 0 0.00016939378110691905
33 O 0 2.716837843763642e-05
and O 0 5.101117949379841e-06
7883del5 O 0 0.000668996071908623
in O 0 2.0275789211154915e-05
exon O 0 0.001428017159923911
55 O 0 0.00027992072864435613
. O 0 0.00014700320025440305

The O 0 0.00016077944019343704
mutations O 0 0.013756080530583858
4612del165 O 0 0.005074320361018181
and O 0 1.0362542525399476e-05
7883del5 O 0 0.00033579752198420465
were O 0 9.088029173653922e-07
found O 0 1.241242216565297e-06
in O 0 4.2593092075549066e-07
more O 0 4.4315706304587366e-07
than O 0 5.569719974118925e-07
two O 0 9.270244163417374e-07
unrelated O 0 0.00022425742645282298
families O 0 9.28291046875529e-06
; O 0 1.7068667830244522e-06
44 O 0 2.2947108391235815e-06
% O 0 9.065012704922992e-07
( O 0 1.1362233180989278e-06
7 O 0 6.334511226668837e-07
of O 0 1.738294201913959e-07
16 O 0 6.672232757409802e-07
) O 0 3.847139851131942e-07
of O 0 1.895579231359079e-07
the O 0 8.148392112161673e-07
mutant O 0 0.00017427642887923867
alleles O 0 5.9453810536069795e-05
had O 0 7.880004773141991e-07
one O 0 3.3108042885032773e-07
of O 0 3.7123476204214967e-07
the O 0 1.4228940017346758e-06
two O 0 9.80174900178099e-06
mutations O 0 0.008990941569209099
. O 0 0.00010405058128526434

The O 0 0.00011345723760314286
4612del165 O 0 0.006385022308677435
mutations O 0 0.0011743820505216718
in O 0 3.557673835530295e-06
three O 0 1.355844688077923e-06
different O 0 7.391716394522518e-07
families O 0 2.6822860945685534e-06
were O 0 1.7119779727181594e-07
all O 0 2.5631706535023113e-07
ascribed O 0 8.383804015466012e-06
to O 0 3.957106002872024e-07
the O 0 6.194799198055989e-07
same O 0 3.3596254525036784e-06
T O 0 0.02003917656838894
- O 0 0.0002894258941523731
- O 0 0.00020512948685791343
> O 0 0.00012063468602718785
A O 0 2.3115419480745913e-06
substitution O 0 4.842514499614481e-06
at O 0 1.769087816683168e-06
the O 0 2.3595459879288683e-06
splice O 0 0.0003120535984635353
donor O 0 0.00031531034619547427
site O 0 2.6143305149162188e-05
in O 0 1.7624057363718748e-05
intron O 0 0.021847542375326157
33 O 0 0.00044958299258723855
. O 0 0.00015437795082107186

Microsatellite O 0 0.12490861862897873
genotyping O 0 0.015863141044974327
around O 0 4.176053334958851e-05
the O 0 9.171209967462346e-06
ATM O 0 0.00023552555649075657
locus O 0 0.0006391548085957766
also O 0 5.77130322199082e-06
indicated O 0 1.4395911421161145e-05
that O 0 7.951441034492746e-07
a O 0 2.6137224722333485e-06
common O 0 6.591516284970567e-05
haplotype O 0 0.07256606966257095
was O 0 1.9292547221994027e-06
shared O 0 2.722637646002113e-06
by O 0 1.8704365629673703e-06
the O 0 4.704793809651164e-06
mutant O 0 0.0007508625858463347
alleles O 0 0.0006793829961679876
in O 0 1.2762217920680996e-05
both O 0 4.232229548506439e-05
mutations O 0 0.0238388329744339
. O 0 0.00013090443098917603

This O 0 4.897748294752091e-05
suggests O 0 8.091090421658009e-05
that O 0 3.482088231976377e-06
these O 0 2.7160090212419163e-06
two O 0 5.2527448133332655e-06
founder O 0 0.0010161888785660267
mutations O 0 0.007709358353167772
may O 0 1.3907753782405052e-05
be O 0 1.1551512670848751e-06
predominant O 0 1.8467935660737567e-05
among O 0 1.0079668754769955e-05
Japanese O 0 5.634625267703086e-05
ATM O 0 0.001044358010403812
mutant O 0 0.007390500977635384
alleles O 0 0.010688603855669498
. O 0 0.00022932299179956317

W474C O 0 0.0035380187910050154
amino O 0 0.0002675187715794891
acid O 0 0.0005024461424909532
substitution O 0 9.634557500248775e-05
affects O 0 0.0010275468230247498
early O 0 5.613068879029015e-06
processing O 0 3.805645519605605e-06
of O 0 5.42693953775597e-07
the O 0 9.56662006501574e-07
alpha O 0 1.3277362086228095e-05
- O 0 2.222400507889688e-05
subunit O 0 1.2983271517441608e-05
of O 0 1.162936314358376e-06
beta O 0 0.00014449775335378945
- O 0 0.0004520371730905026
hexosaminidase O 0 0.0006789306062273681
A O 0 5.063604021415813e-06
and O 0 2.1810419639223255e-06
is O 0 3.650449571068748e-06
associated O 0 4.668957262765616e-05
with O 0 5.270748442853801e-05
subacute O 1 0.9974107146263123
G B-Disease 0 0.19478516280651093
( I-Disease 0 0.0002042385603999719
M2 I-Disease 0 0.033868927508592606
) I-Disease 0 0.00011860472295666113
gangliosidosis I-Disease 0 0.020953085273504257
. O 0 0.00018979396554641426

Mutations O 0 0.01201067678630352
in O 0 5.1923827413702384e-05
the O 0 3.542780177667737e-05
HEXA O 1 0.8264662623405457
gene O 0 0.00022394357074517757
, O 0 3.359314405315672e-06
encoding O 0 8.618338142696302e-06
the O 0 2.0731031327159144e-06
alpha O 0 1.3044719707977492e-05
- O 0 2.070937080134172e-05
subunit O 0 1.4575246495951433e-05
of O 0 1.3202787840782548e-06
beta O 0 0.00012731128663290292
- O 0 0.00026814721059054136
hexosaminidase O 0 0.0007524129468947649
A O 0 7.487471521017142e-06
( O 0 7.18228784535313e-06
Hex O 0 2.168767423427198e-05
A O 0 3.394080295038293e-06
) O 0 1.5734987073301454e-06
, O 0 7.733948450550088e-07
that O 0 8.94870254342095e-07
abolish O 0 3.728926458279602e-05
Hex O 0 0.0001612832274986431
A O 0 4.5270935515873134e-05
enzyme O 0 0.003950611688196659
activity O 0 0.0020536771044135094
cause O 1 0.9600909948348999
Tay B-Disease 1 0.9995031356811523
- I-Disease 1 0.9969758987426758
Sachs I-Disease 1 0.9990134239196777
disease I-Disease 1 0.9994344115257263
( O 0 0.003881304059177637
TSD B-Disease 1 0.9916760921478271
) O 0 1.6940337445703335e-05
, O 0 7.302575340872863e-06
the O 0 1.1592231203394476e-05
fatal O 1 0.9872123599052429
infantile B-Disease 1 0.9970332384109497
form I-Disease 0 0.00011057552183046937
of I-Disease 0 9.9713997769868e-06
G I-Disease 0 0.06431562453508377
( I-Disease 0 8.80970255821012e-05
M2 I-Disease 0 0.03792447969317436
) I-Disease 0 2.4237358957179822e-05
gangliosidosis I-Disease 0 0.0033232171554118395
, I-Disease 0 1.1829007235064637e-05
Type I-Disease 0 0.00014272090629674494
1 I-Disease 0 5.755173333454877e-05
. O 0 8.400676597375423e-05

Less O 0 0.026694728061556816
severe O 1 0.9930064678192139
, O 0 0.0077156564220786095
subacute O 1 0.9986385703086853
( O 0 0.2374878227710724
juvenile O 1 0.9976027607917786
- O 1 0.9576790928840637
onset O 1 0.9981548190116882
) O 0 0.00048053078353405
and O 0 0.0009186963434331119
chronic O 1 0.9996925592422485
( O 0 0.005346393678337336
adult O 0 0.07296552509069443
- O 0 0.4962881803512573
onset O 1 0.9966727495193481
) O 0 2.480263174220454e-05
variants O 0 0.00016626802971586585
are O 0 2.9431396342260996e-06
characterized O 0 0.0029261435847729445
by O 0 1.7260204003832769e-06
a O 0 3.309864723632927e-06
broad O 0 0.0002101746795233339
spectrum O 0 0.0002446028811391443
of O 0 5.131266334501561e-06
clinical O 1 0.9368276596069336
manifestations O 0 0.13432365655899048
and O 0 2.856389528460568e-06
are O 0 6.869210551485594e-07
associated O 0 5.243360647000372e-06
with O 0 1.262919909095217e-06
residual O 0 0.00010076251055579633
levels O 0 1.5617239114362746e-05
of O 0 2.2173667275637854e-06
Hex O 0 0.00017634818505030125
A O 0 3.123739952570759e-05
enzyme O 0 0.00040521472692489624
activity O 0 0.00013391174434218556
. O 0 0.00010908097465289757

We O 0 8.216803689720109e-05
identified O 0 0.00016447377856820822
a O 0 6.071940151741728e-05
1422 O 0 0.30905142426490784
G O 0 0.008992488496005535
- O 0 0.0015042057493701577
- O 0 0.0020037698559463024
> O 0 0.0029884784016758204
C O 0 0.0001763461623340845
( O 0 7.083234777383041e-06
amino O 0 1.1288570931355935e-05
acid O 0 7.179033855209127e-05
W474C O 0 0.00017925992142409086
) O 0 1.2984767181478674e-06
substitution O 0 1.5810346667421982e-06
in O 0 2.9542937340920616e-07
the O 0 1.8702033344197844e-07
first O 0 2.157350564857552e-07
position O 0 3.916618140920036e-07
of O 0 3.806201220868388e-07
exon O 0 4.681887730839662e-05
13 O 0 3.4461843370081624e-06
of O 0 1.1149505780849722e-06
HEXA O 0 0.18789345026016235
of O 0 1.7264796952076722e-06
a O 0 7.346364327531774e-06
non O 0 0.00014209515939000994
- O 0 0.00420608464628458
Jewish O 0 0.0003133151913061738
proband O 0 0.030522167682647705
who O 0 8.961462299339473e-05
manifested O 0 0.09442561119794846
a O 0 0.00027782798861153424
subacute O 1 0.9976309537887573
variant O 0 0.06695585697889328
of O 0 3.180607018293813e-05
G B-Disease 0 0.07366709411144257
( I-Disease 0 0.00017327643581666052
M2 I-Disease 0 0.026279568672180176
) I-Disease 0 9.703061368782073e-05
gangliosidosis I-Disease 0 0.02122420072555542
. O 0 0.0001673278893576935

On O 0 2.8321663194219582e-05
the O 0 1.820015131670516e-05
second O 0 3.5588509490480646e-05
maternally O 0 0.06697231531143188
inherited O 0 0.43332573771476746
allele O 0 0.003010822692885995
, O 0 5.978812168905279e-06
we O 0 3.1402094009536086e-06
identified O 0 2.6090825485880487e-05
the O 0 1.2758945558744017e-05
common O 0 0.01961519569158554
infantile O 1 0.9994995594024658
disease O 1 0.9996893405914307
- O 0 0.3880468010902405
causing O 0 0.13308613002300262
4 O 0 7.906631071818992e-05
- O 0 0.00186766660772264
bp O 0 0.0038954445626586676
insertion O 0 0.0014853134052827954
, O 0 2.1363483028835617e-05
+ O 0 0.006242572795599699
TATC O 0 0.0698062852025032
1278 O 0 0.03460443764925003
, O 0 9.583318387740292e-06
in O 0 1.1345308848831337e-05
exon O 0 0.0009308622684329748
11 O 0 0.00018090297817252576
. O 0 0.00013626963482238352

Pulse O 0 0.011577307246625423
- O 0 0.003348538652062416
chase O 0 0.0005978983826935291
analysis O 0 4.629056638805196e-05
using O 0 2.7642192435450852e-05
proband O 0 0.006925212685018778
fibroblasts O 0 0.008434437215328217
revealed O 0 5.128576231072657e-05
that O 0 1.4214509747034754e-06
the O 0 1.7202769413415808e-06
W474C O 0 0.00017119421681854874
- O 0 3.5047945857513696e-05
containing O 0 5.884744496142957e-06
alpha O 0 3.302721233922057e-05
- O 0 0.00011461575195426121
subunit O 0 4.537972927209921e-05
precursor O 0 4.017372339149006e-05
was O 0 1.8558558849690598e-06
normally O 0 3.5394666610955028e-06
synthesized O 0 7.42111024010228e-06
, O 0 8.239734370363294e-07
but O 0 5.826133246955578e-07
not O 0 7.520660574300564e-07
phosphorylated O 0 3.6259207263356075e-05
or O 0 2.297982518939534e-06
secreted O 0 1.4781266145291738e-05
, O 0 7.400640242849477e-07
and O 0 6.963570626794535e-07
the O 0 2.3774150577082764e-06
mature O 0 0.0035949924495071173
lysosomal O 0 0.38949209451675415
alpha O 0 0.00019029315444640815
- O 0 0.0002666885848157108
subunit O 0 0.000101546807854902
was O 0 7.753792488074396e-06
not O 0 1.3684669283975381e-05
detected O 0 0.00048469312605448067
. O 0 9.894870891002938e-05

When O 0 4.928977432427928e-05
the O 0 1.7481874238001183e-05
W474C O 0 0.0003221188089810312
- O 0 7.576504140160978e-05
containing O 0 1.4039814232091885e-05
alpha O 0 5.8079473092220724e-05
- O 0 0.00024623144418001175
subunit O 0 9.176258754450828e-05
was O 0 6.456870778492885e-06
transiently O 0 0.003161892993375659
co O 0 0.00024022313300520182
- O 0 5.5712629546178505e-05
expressed O 0 2.6266313852829626e-06
with O 0 6.687636187052703e-07
the O 0 9.022638778333203e-07
beta O 0 2.3512962798122317e-05
- O 0 2.259572283946909e-05
subunit O 0 1.2000946298940107e-05
to O 0 1.0629288453856134e-06
produce O 0 4.150507265876513e-06
Hex O 0 3.148467294522561e-05
A O 0 5.793549007648835e-06
( O 0 8.43008001538692e-06
alphabeta O 0 0.00047555071068927646
) O 0 2.8727015433105407e-06
in O 0 2.519248937460361e-06
COS O 0 0.026292556896805763
- O 0 0.00013119069626554847
7 O 0 6.303274858510122e-06
cells O 0 3.102578193647787e-05
, O 0 6.333418127724144e-07
the O 0 6.925516231603979e-07
mature O 0 0.00013214173668529838
alpha O 0 3.018703864654526e-05
- O 0 6.28561683697626e-05
subunit O 0 1.3897437384002842e-05
was O 0 6.406595502994605e-07
present O 0 4.949926051267539e-07
, O 0 2.9284811375873687e-07
but O 0 1.7236189364666643e-07
its O 0 2.0996540683881904e-07
level O 0 1.2247834320078255e-06
was O 0 2.929824916009238e-07
much O 0 3.909497650056437e-07
lower O 0 1.3419069091469282e-06
than O 0 3.45434727933025e-07
that O 0 2.578255475782498e-07
from O 0 6.550172884089989e-07
normal O 0 7.156634183047572e-06
alpha O 0 1.6607207726337947e-05
- O 0 8.404747495660558e-05
subunit O 0 6.040580046828836e-05
transfections O 0 0.000566649716347456
, O 0 1.1901660172952688e-06
although O 0 8.596926477366651e-07
higher O 0 9.386704959979397e-07
than O 0 5.434189915831666e-07
in O 0 5.741170525652706e-07
those O 0 1.6861030189829762e-06
cells O 0 0.00016030411643441767
transfected O 0 0.003368883393704891
with O 0 2.4783521439530887e-06
an O 0 3.507250539769302e-06
alpha O 0 0.00014614031533710659
- O 0 0.001602854230441153
subunit O 0 0.00056024658260867
associated O 0 0.00024758814834058285
with O 0 0.00022596160124521703
infantile O 1 0.9931869506835938
TSD B-Disease 1 0.98340904712677
. O 0 0.0011903055710718036

Furthermore O 0 0.00028256321093067527
, O 0 9.189368938677944e-06
the O 0 3.213282525393879e-06
precursor O 0 2.3553784558316693e-05
level O 0 2.7764244805439375e-06
of O 0 5.322846732269682e-07
the O 0 1.4148266700431122e-06
W474C O 0 0.00023882139066699892
alpha O 0 3.978029053541832e-05
- O 0 7.548818393843248e-05
subunit O 0 2.233925806649495e-05
was O 0 9.853697520156857e-07
found O 0 1.0692169780668337e-06
to O 0 6.207105229805165e-07
accumulate O 0 4.122902828385122e-05
in O 0 6.504692464659456e-07
comparison O 0 2.281765773659572e-06
to O 0 6.356890480674338e-07
the O 0 8.241950695264677e-07
normal O 0 1.3989775652589742e-05
alpha O 0 5.1006678404519334e-05
- O 0 0.00020725195645354688
subunit O 0 0.00017954132636077702
precursor O 0 0.0004889674601145089
levels O 0 0.0003917418362107128
. O 0 0.00018762756371870637

We O 0 5.783441156381741e-05
conclude O 0 0.00011928308958886191
that O 0 4.734463800559752e-06
the O 0 1.074287047231337e-05
1422 O 0 0.3398720920085907
G O 0 0.008807082660496235
- O 0 0.0030246928799897432
- O 0 0.005723819602280855
> O 0 0.00862187147140503
C O 0 0.0005135887186042964
mutation O 0 0.00015308316505979747
is O 0 1.5071525467647007e-06
the O 0 1.408727598573023e-06
cause O 0 9.219649655278772e-05
of O 0 3.146465587633429e-06
Hex B-Disease 0 0.001568969921208918
A I-Disease 0 0.0006344708381220698
enzyme I-Disease 1 0.8013899922370911
deficiency I-Disease 1 0.9988861680030823
in O 0 3.3192922273883596e-05
the O 0 4.6424389438470826e-05
proband O 0 0.062201984226703644
. O 0 0.00022738240659236908

The O 0 0.00010199681855738163
resulting O 0 0.0003351813356857747
W474C O 0 0.0005696073640137911
substitution O 0 7.222044951049611e-05
clearly O 0 4.4532058382174e-05
interferes O 0 0.0007371092215180397
with O 0 6.3485640566796064e-06
alpha O 0 4.7641966375522316e-05
- O 0 8.399699436267838e-05
subunit O 0 2.018923441937659e-05
processing O 0 5.857225460204063e-06
, O 0 1.29605552956491e-06
but O 0 6.278997375375184e-07
because O 0 7.059429663058836e-07
the O 0 3.56080619212662e-07
base O 0 1.5204082046693657e-06
substitution O 0 2.8667270726145944e-06
falls O 0 1.276503098779358e-05
at O 0 4.0573874571236956e-07
the O 0 1.851915527595338e-07
first O 0 1.7733432855493447e-07
position O 0 3.9872369939075725e-07
of O 0 3.8397431012526795e-07
exon O 0 8.6910069512669e-05
13 O 0 5.672358838637592e-06
, O 0 2.4586645395174855e-06
aberrant O 0 0.0007798783481121063
splicing O 0 8.324886584887281e-05
may O 0 8.743126272747759e-06
also O 0 1.3650864048031508e-06
contribute O 0 2.4906114049372263e-05
to O 0 2.6680809241952375e-06
Hex B-Disease 0 0.0002494265208952129
A I-Disease 0 9.712429164210334e-05
deficiency I-Disease 1 0.9973064661026001
in O 0 5.97141570324311e-06
this O 0 4.487711066758493e-06
proband O 0 0.009763800539076328
. O 0 1.834985778259579e-05
. O 0 6.540642061736435e-05

Two O 0 0.0007491747965104878
frequent O 0 0.12873338162899017
missense O 1 0.9375271797180176
mutations O 1 0.956436038017273
in O 0 0.010972859337925911
Pendred B-Disease 1 0.9947382807731628
syndrome I-Disease 1 0.999194324016571
. O 0 0.00395392719656229

Pendred B-Disease 1 0.9938830137252808
syndrome I-Disease 1 0.9992249011993408
is O 0 0.07448115944862366
an O 0 0.30452150106430054
autosomal B-Disease 1 0.9993189573287964
recessive I-Disease 1 0.9995496869087219
disorder I-Disease 1 0.999863862991333
characterized O 1 0.9960951209068298
by O 0 0.02236156538128853
early O 1 0.5765847563743591
childhood O 1 0.9987766146659851
deafness B-Disease 1 0.9996606111526489
and O 0 0.45646822452545166
goiter B-Disease 1 0.9987657070159912
. O 0 0.010351059958338737

A O 0 8.203173638321459e-05
century O 0 3.7935962609481066e-05
after O 0 1.765614069881849e-05
its O 0 7.306057796085952e-06
recognition O 0 8.333616278832778e-05
as O 0 1.9058485122513957e-05
a O 0 0.0007903147488832474
syndrome O 1 0.9996047616004944
by O 0 0.00017863319953903556
Vaughan O 0 0.25259387493133545
Pendred O 0 0.3791717290878296
, O 0 3.221002407371998e-05
the O 0 6.900183507241309e-05
disease O 1 0.999320387840271
gene O 0 0.10026805847883224
( O 0 0.00015802447160240263
PDS O 0 0.257762610912323
) O 0 6.658503934886539e-06
was O 0 1.9632072962849634e-06
mapped O 0 3.236256088712253e-05
to O 0 6.677186320303008e-06
chromosome O 0 0.0007300499128177762
7q22 O 0 0.004519951064139605
- O 0 0.003968741279095411
q31 O 0 0.011521119624376297
. O 0 0.00017689181549940258

1 O 0 7.156000356189907e-05
and O 0 9.617137038731016e-06
, O 0 4.6757463678659406e-06
recently O 0 1.61417992785573e-05
, O 0 1.8698088979363092e-06
found O 0 2.919584858318558e-06
to O 0 2.3544614577986067e-06
encode O 0 2.4479477360728197e-05
a O 0 2.6524818167672493e-05
putative O 0 0.010237686336040497
sulfate O 1 0.8610553741455078
transporter O 0 0.2754499316215515
. O 0 0.0003984460199717432

We O 0 9.039048018166795e-05
performed O 0 6.786913581890985e-05
mutation O 0 0.0002267080853926018
analysis O 0 9.306631909566931e-06
of O 0 2.051490582744009e-06
the O 0 1.0606196156004444e-05
PDS B-Disease 1 0.8874544501304626
gene O 0 0.010739436373114586
in O 0 4.348430229583755e-05
patients O 1 0.9659915566444397
from O 0 9.41561575018568e-06
14 O 0 4.252927828929387e-05
Pendred B-Disease 0 0.026325806975364685
families O 0 1.7590340576134622e-05
originating O 0 8.871625141182449e-06
from O 0 9.278027164327796e-07
seven O 0 1.5108366824279074e-06
countries O 0 1.1520158977873507e-06
and O 0 1.5657088852094603e-06
identified O 0 2.483453499735333e-05
all O 0 7.130174708436243e-06
mutations O 0 0.0031391240190714598
. O 0 7.838015881134197e-05

The O 0 9.471173689235002e-05
mutations O 0 0.0010371843818575144
include O 0 1.2715421689790674e-05
three O 0 2.5506328711344395e-06
single O 0 2.8897952688566875e-06
base O 0 6.600239430554211e-06
deletions O 0 4.367947985883802e-05
, O 0 1.5221942248899722e-06
one O 0 1.758366579451831e-06
splice O 0 0.00032911941525526345
site O 0 3.140382978017442e-05
mutation O 0 0.000277313549304381
and O 0 9.573817806085572e-06
10 O 0 4.82412833662238e-05
missense O 0 0.027238231152296066
mutations O 0 0.030936134979128838
. O 0 0.0001704413880361244

One O 0 0.00046540089533664286
missense O 0 0.08786777406930923
mutation O 0 0.01864260993897915
( O 0 9.829284681472927e-05
L236P O 0 0.0020296298898756504
) O 0 5.544485247810371e-06
was O 0 9.71043618847034e-07
found O 0 1.1867454077219008e-06
in O 0 4.6754425397921295e-07
a O 0 1.387284328302485e-06
homozygous O 0 4.138864460401237e-05
state O 0 7.908115549071226e-07
in O 0 6.515160180242674e-07
two O 0 1.5458689404113102e-06
consanguineous O 0 0.01953555829823017
families O 0 1.2986020010430366e-05
and O 0 6.425564151868457e-07
in O 0 6.848266593806329e-07
a O 0 1.8657457303561387e-06
heterozygous O 0 3.535672294674441e-05
state O 0 1.1709165619322448e-06
in O 0 9.02905981092772e-07
five O 0 1.940806896527647e-06
additional O 0 1.0161417776544113e-05
non O 0 0.0001409510732628405
- O 0 0.011358099058270454
consanguineous O 0 0.4052007794380188
families O 0 0.0008483438286930323
. O 0 0.00024091076920740306

Another O 0 0.0009836213430389762
missense O 0 0.11979372054338455
mutation O 0 0.03569645434617996
( O 0 0.00012631872959900647
T416P O 0 0.0013025637017562985
) O 0 4.779029040946625e-06
was O 0 9.620995342629612e-07
found O 0 9.865564152278239e-07
in O 0 5.083525138616096e-07
a O 0 1.451226580684306e-06
homozygous O 0 6.763906276319176e-05
state O 0 8.336162409250392e-07
in O 0 5.631194426314323e-07
one O 0 5.88734906159516e-07
family O 0 2.9047653242741944e-06
and O 0 4.321290703046543e-07
in O 0 5.157929194865574e-07
a O 0 2.399191771473852e-06
heterozygous O 0 5.6615292123751715e-05
state O 0 1.9883423192368355e-06
in O 0 2.0423331079655327e-06
four O 0 9.693730135040823e-06
families O 0 0.00010654573270585388
. O 0 9.677493653725833e-05

Pendred B-Disease 1 0.9376277923583984
patients O 1 0.9860209822654724
in O 0 2.3536631488241255e-05
three O 0 1.9159260773449205e-05
non O 0 0.00033945837640203536
- O 0 0.020122231915593147
consanguineous O 0 0.388997346162796
families O 0 7.308257045224309e-05
were O 0 2.0176134967186954e-06
shown O 0 4.807645382243209e-06
to O 0 1.1025392723240657e-06
be O 0 1.689296254880901e-06
compound O 0 0.00017162012227345258
heterozygotes O 0 0.0324602834880352
for O 0 1.6199783203774132e-05
L236P O 0 0.0036716964095830917
and O 0 4.901388456346467e-05
T416P O 0 0.007466825656592846
. O 0 0.00016460681217722595

In O 0 1.9931167116737925e-05
total O 0 4.6328736971190665e-06
, O 0 1.8978743128172937e-06
one O 0 5.325933898348012e-07
or O 0 6.95495600666618e-07
both O 0 2.923374609054008e-07
of O 0 2.0906765030304086e-07
these O 0 7.33231274807622e-07
mutations O 0 0.00010784882761072367
were O 0 1.9151347885326686e-07
found O 0 3.8860719087097095e-07
in O 0 2.388843824974174e-07
nine O 0 6.137910304460092e-07
of O 0 3.6209530662745237e-07
the O 0 1.8593493678054074e-06
14 O 0 1.5112160326680169e-05
families O 0 7.11589163984172e-05
analyzed O 0 0.00047432610881514847
. O 0 8.849992445902899e-05

The O 0 3.3422249543946236e-05
identification O 0 2.6674228138290346e-05
of O 0 4.332301614340395e-06
two O 0 1.153411631094059e-05
frequent O 0 0.010525529272854328
PDS B-Disease 1 0.8841181993484497
mutations O 0 0.025349130854010582
will O 0 8.84126166056376e-06
facilitate O 0 8.341827924596146e-05
the O 0 3.060233939322643e-05
molecular O 0 0.0936368778347969
diagnosis O 1 0.9976518750190735
of O 0 0.0014807350235059857
Pendred B-Disease 1 0.9966715574264526
syndrome I-Disease 1 0.9994396567344666
. O 0 0.0049705845303833485

Insertional O 0 0.14002200961112976
mutation O 0 0.005566067527979612
by O 0 5.482498090714216e-05
transposable O 0 0.019790926948189735
element O 0 8.290061668958515e-05
, O 0 1.5288036593119614e-05
L1 O 0 0.00700928270816803
, O 0 9.612836947781034e-06
in O 0 6.148487955215387e-06
the O 0 2.5972036382881925e-05
DMD B-Disease 1 0.9979669451713562
gene O 0 0.009983325377106667
results O 0 0.00012942432658746839
in O 0 5.406158379628323e-05
X B-Disease 0 0.1845608800649643
- I-Disease 0 0.3365561068058014
linked I-Disease 1 0.8520289659500122
dilated I-Disease 1 0.9953085780143738
cardiomyopathy I-Disease 1 0.9983537197113037
. O 0 0.006115742959082127

X B-Disease 1 0.7409169673919678
- I-Disease 1 0.7118914723396301
linked I-Disease 1 0.9390284419059753
dilated I-Disease 1 0.997199535369873
cardiomyopathy I-Disease 1 0.9994457364082336
( O 0 0.014534171670675278
XLDCM B-Disease 1 0.7170093655586243
) O 0 4.1156119550578296e-05
is O 0 9.377441529068165e-06
a O 0 5.242715997155756e-05
clinical O 1 0.9326575398445129
phenotype O 0 0.43876269459724426
of O 0 5.0491903493821155e-06
dystrophinopathy B-Disease 0 0.01785154640674591
which O 0 4.370788246887969e-06
is O 0 1.0977551937685348e-05
characterized O 0 0.009901938959956169
by O 0 2.577700615802314e-05
preferential O 0 0.1846601814031601
myocardial B-Disease 1 0.9993137121200562
involvement I-Disease 0 0.06608587503433228
without O 0 8.473650086671114e-05
any O 0 4.787902798852883e-05
overt O 0 0.3177703619003296
clinical O 1 0.9970144033432007
signs O 0 0.40074723958969116
of O 0 0.0018071685917675495
skeletal B-Disease 1 0.9983925223350525
myopathy I-Disease 1 0.998725950717926
. O 0 0.005197564605623484

To O 0 3.677339918795042e-05
date O 0 2.9162983992137015e-05
, O 0 6.468710125773214e-06
several O 0 1.2403615073708352e-05
mutations O 0 0.0029853840824216604
in O 0 2.602400491014123e-05
the O 0 0.0005038055824115872
Duchenne B-Disease 1 0.9995688796043396
muscular I-Disease 1 0.9996801614761353
dystrophy I-Disease 1 0.9998375177383423
gene O 1 0.9909170269966125
, O 0 0.011737197637557983
DMD O 1 0.999302864074707
, O 0 4.175603316980414e-05
have O 0 8.162538506439887e-06
been O 0 5.866416358912829e-06
identified O 0 5.8270034060114995e-05
in O 0 1.7521831978228875e-05
patients O 1 0.9772132635116577
with O 0 1.8155184079660103e-05
XLDCM B-Disease 0 0.2521202266216278
, O 0 2.3732311547064455e-06
but O 0 1.4704463637826848e-06
a O 0 3.24030725096236e-06
pathogenic O 0 0.000906199449673295
correlation O 0 1.2791780136467423e-05
of O 0 1.1152482102261274e-06
these O 0 5.796499863208737e-06
cardiospecific O 0 0.05564088374376297
mutations O 0 0.05871600657701492
in O 0 5.2424660680117086e-05
DMD O 1 0.9987157583236694
with O 0 2.8909616958117113e-05
the O 0 3.342549825902097e-05
XLDCM B-Disease 1 0.7612285614013672
phenotype O 1 0.6251952052116394
has O 0 1.510949368821457e-05
remained O 0 1.415046881447779e-05
to O 0 4.422271103976527e-06
be O 0 8.856721251504496e-06
elucidated O 0 0.0054909586906433105
. O 0 0.00010000161273637787

We O 0 4.987299325875938e-05
report O 0 1.8263142919749953e-05
here O 0 1.9509095636749407e-06
the O 0 7.988555239535344e-07
identification O 0 1.9858939594996627e-06
of O 0 5.053589688941429e-07
a O 0 2.2698159227729775e-06
unique O 0 1.3899903024139348e-05
de O 0 5.778920240118168e-05
novo O 0 0.0005039193783886731
L1 O 0 0.004138210788369179
insertion O 0 0.00015884735330473632
in O 0 3.699613671415136e-06
the O 0 3.93349546357058e-06
muscle O 0 0.07102105021476746
exon O 0 0.0008877093205228448
1 O 0 1.9534805687726475e-05
in O 0 1.8736802303465083e-05
DMD O 1 0.9974621534347534
in O 0 1.7490661775809713e-05
three O 0 3.953982377424836e-05
XLDCM B-Disease 1 0.8924736380577087
patients O 1 0.9848155975341797
from O 0 6.965909506106982e-06
two O 0 7.467440809705295e-06
unrelated O 0 0.004503120668232441
Japanese O 0 0.00020165686146356165
families O 0 0.00040773962973617017
. O 0 0.00010263225703965873

The O 0 4.694799645221792e-05
insertion O 0 0.00021881669817958027
was O 0 6.512180334539153e-06
a O 0 5.829951987834647e-06
5 O 0 6.968261914153118e-06
- O 0 8.358326886082068e-05
truncated O 0 7.711183570791036e-05
form O 0 4.221049493935425e-06
of O 0 1.301288193644723e-06
human O 0 4.454624286154285e-05
L1 O 0 0.010968180373311043
inversely O 0 6.54210161883384e-05
integrated O 0 1.7134774680016562e-05
in O 0 1.3987596503284294e-06
the O 0 1.2091758208043757e-06
5 O 0 5.34028367837891e-06
- O 0 8.064330177148804e-05
untranslated O 0 0.0007190692704170942
region O 0 1.4647788702859543e-05
in O 0 1.5023152855064836e-06
the O 0 1.2950360996910604e-06
muscle O 0 0.022201640531420708
exon O 0 0.00019182507821824402
1 O 0 2.615881840029033e-06
, O 0 7.909594046395796e-07
which O 0 5.316038595992723e-07
affected O 0 1.2711080671579111e-05
the O 0 6.676159500784706e-07
transcription O 0 7.29316525394097e-06
or O 0 6.868463628961763e-07
the O 0 3.314728189707239e-07
stability O 0 3.5370912883081473e-06
of O 0 3.9452214650737005e-07
the O 0 1.2839904002248659e-06
muscle O 0 0.0082558523863554
form O 0 5.944913937128149e-06
of O 0 1.8409185713608167e-06
dystrophin O 0 0.4129038155078888
transcripts O 0 3.5328885132912546e-05
but O 0 8.222637575272529e-07
not O 0 2.4269186837955203e-07
that O 0 1.7443622368773504e-07
of O 0 2.82581140709226e-07
the O 0 2.6952300231641857e-06
brain O 1 0.77431321144104
or O 0 2.9396524041658267e-05
Purkinje O 1 0.7709352374076843
cell O 0 0.0013384170597419143
form O 0 2.0930734535795636e-05
, O 0 2.175474719479098e-06
probably O 0 3.634848553701886e-06
due O 0 1.7878871858556522e-06
to O 0 4.309738415031461e-07
its O 0 8.627512784187275e-07
unique O 0 4.41134079665062e-06
site O 0 7.133452982088784e-06
of O 0 4.201117917546071e-06
integration O 0 0.00013451451377477497
. O 0 9.100835450226441e-05

We O 0 7.680610724491999e-05
speculate O 0 0.00010284181189490482
that O 0 2.2009758140484337e-06
this O 0 9.043537829711568e-07
insertion O 0 1.5467121556866914e-05
of O 0 8.725049838176346e-07
an O 0 3.1799318094272166e-06
L1 O 0 0.0058355024084448814
sequence O 0 1.933134080900345e-05
in O 0 2.762827898550313e-05
DMD O 1 0.9982360601425171
is O 0 4.490801984502468e-06
responsible O 0 8.711648661119398e-06
for O 0 5.84512235946022e-07
some O 0 2.999437640482938e-07
of O 0 1.7951639108559903e-07
the O 0 3.7818068676642724e-07
population O 0 1.4137611969999853e-06
of O 0 9.678918786448776e-07
Japanese O 0 0.0002238103625131771
patients O 1 0.9734140634536743
with O 0 5.762543514720164e-05
XLDCM B-Disease 0 0.4013434946537018
. O 0 5.497754318639636e-05
. O 0 9.418989793630317e-05

Severe O 1 0.9925960898399353
early O 0 0.09603848308324814
- O 1 0.9920084476470947
onset O 1 0.9989437460899353
obesity B-Disease 1 0.9993383288383484
, O 0 0.16258764266967773
adrenal B-Disease 1 0.9987635612487793
insufficiency I-Disease 1 0.9987984895706177
and O 0 0.012522399425506592
red O 1 0.905104398727417
hair O 1 0.9953994154930115
pigmentation O 1 0.9985262155532837
caused O 1 0.9345569014549255
by O 0 0.001664134906604886
POMC O 1 0.9939908385276794
mutations O 1 0.5072473287582397
in O 0 0.00016497293836437166
humans O 0 0.00988847017288208
. O 0 0.000196237291675061

Sequential O 0 0.0008808516431599855
cleavage O 0 0.0007077845511958003
of O 0 9.416244211024605e-06
the O 0 7.352840384555748e-06
precursor O 0 0.00014002033276483417
protein O 0 6.660616782028228e-05
pre O 0 0.00025146236293949187
- O 0 0.0007751346565783024
pro O 0 0.0003013799723703414
- O 0 0.004063791129738092
opiomelanocortin O 0 0.0353502482175827
( O 0 0.0001401627523591742
POMC O 0 0.36850717663764954
) O 0 1.2530043932201806e-05
generates O 0 3.6058998375665396e-05
the O 0 1.50364594446728e-05
melanocortin O 1 0.5978561639785767
peptides O 0 0.0055672843009233475
adrenocorticotrophin O 0 0.06627589464187622
( O 0 0.00015757413348183036
ACTH O 0 0.22565263509750366
) O 0 1.8048791389446706e-05
, O 0 1.9161123418598436e-05
melanocyte O 1 0.7975696325302124
- O 0 0.02747553028166294
stimulating O 1 0.5218179821968079
hormones O 0 0.26138660311698914
( O 0 0.0003178470942657441
MSH O 1 0.953834593296051
) O 0 9.049663276528008e-06
alpha O 0 1.5091552086232696e-05
, O 0 1.3866123254047125e-06
beta O 0 1.2804497600882314e-05
and O 0 6.829417316112085e-07
gamma O 0 3.8975798815954477e-05
as O 0 4.891063554168795e-07
well O 0 7.20275750154542e-07
as O 0 8.323008273691812e-07
the O 0 2.4770620257186238e-06
opioid O 0 0.24430088698863983
- O 0 0.0019287548493593931
receptor O 0 0.004502606112509966
ligand O 0 0.004112750757485628
beta O 0 0.004247942008078098
- O 0 0.014649090357124805
endorphin O 1 0.8333271741867065
. O 0 0.000332135270582512

While O 0 7.676597306272015e-05
a O 0 4.2398478399263695e-05
few O 0 4.89061712869443e-05
cases O 0 0.0005774645251221955
of O 0 3.78053737222217e-05
isolated O 1 0.8543334603309631
ACTH B-Disease 1 0.9984630346298218
deficiency I-Disease 1 0.9995831847190857
have O 0 9.433893137611449e-05
been O 0 5.6002187193371356e-05
reported O 0 0.0036138303112238646
( O 0 0.0007340872543863952
OMIM O 1 0.9930642247200012
201400 O 0 0.08441886305809021
) O 0 2.5664985514595173e-05
, O 0 9.651187610870693e-06
an O 0 4.816203727386892e-05
inherited O 1 0.9899566769599915
POMC O 1 0.9984719157218933
defect O 1 0.9501226544380188
has O 0 2.6297231670469046e-05
not O 0 3.1175645744951908e-06
been O 0 3.7892543787165778e-06
described O 0 3.420857683522627e-05
so O 0 1.2922731002618093e-05
far O 0 4.2964773456333205e-05
. O 0 8.570256613893434e-05

Recent O 0 0.0008201395976357162
studies O 0 0.00020098499953746796
in O 0 1.3261378626339138e-05
animal O 0 0.0001598111557541415
models O 0 3.2029423891799524e-05
elucidated O 0 0.0008251890540122986
a O 0 3.6839953736489406e-06
central O 0 3.82835287382477e-06
role O 0 4.16212515119696e-06
of O 0 1.239199491465115e-06
alpha O 0 0.00013191789912525564
- O 0 0.0015840779524296522
MSH O 1 0.735916018486023
in O 0 1.3587973626272287e-06
the O 0 8.906371817829495e-07
regulation O 0 4.524103587755235e-06
of O 0 4.731439275929006e-07
food O 0 5.206020887271734e-06
intake O 0 3.41030718118418e-05
by O 0 1.6192717566809733e-06
activation O 0 2.4136445063049905e-05
of O 0 1.5189849591479287e-06
the O 0 1.1334958799125161e-05
brain O 1 0.8934671878814697
melanocortin O 1 0.8301601409912109
- O 0 0.0010931622236967087
4 O 0 4.792942127096467e-05
- O 0 0.0023617695551365614
receptor O 0 0.009191547520458698
( O 0 0.00012080206943210214
MC4 O 1 0.9047039747238159
- O 0 0.004296841099858284
R O 0 0.007745100650936365
; O 0 1.1270972208876628e-05
refs O 0 0.00017471000319346786
3 O 0 4.7947651182767e-06
- O 0 1.915270149766002e-05
5 O 0 1.7974165302803158e-06
) O 0 6.295275625234353e-07
and O 0 2.84071546730047e-07
the O 0 5.361903845368943e-07
linkage O 0 4.707154948846437e-05
of O 0 1.8591827029013075e-06
human O 0 0.0009582210332155228
obesity B-Disease 1 0.9929307699203491
to O 0 4.810213795281015e-06
chromosome O 0 0.00011846298730233684
2 O 0 3.1763765946379863e-06
in O 0 1.4941380186428432e-06
close O 0 5.1999868446728215e-06
proximity O 0 1.8387763702776283e-05
to O 0 2.1568948795902543e-06
the O 0 5.107382548885653e-06
POMC O 1 0.5001444816589355
locus O 0 0.00015413246001116931
, O 0 1.579675199536723e-06
led O 0 1.7811071302276105e-06
to O 0 3.8069634911153116e-07
the O 0 4.4065797055736766e-07
proposal O 0 2.501954895706149e-06
of O 0 4.200474847948499e-07
an O 0 2.706392933760071e-06
association O 0 0.00024061738804448396
of O 0 2.0731878976221196e-05
POMC O 1 0.9908788800239563
with O 0 0.00040534770232625306
human O 0 0.18523907661437988
obesity B-Disease 1 0.9969494938850403
. O 0 0.0010100597282871604

The O 0 4.785087003256194e-05
dual O 0 9.61121404543519e-05
role O 0 4.0720082324696705e-05
of O 0 1.0279597518092487e-05
alpha O 0 0.0003840047575067729
- O 0 0.00828348658978939
MSH O 1 0.9647489786148071
in O 0 1.0917580766545143e-05
regulating O 0 0.00042724941158667207
food O 0 8.128125045914203e-05
intake O 0 0.0006523447809740901
and O 0 2.4636292437207885e-05
influencing O 0 0.009294206276535988
hair O 1 0.9616961479187012
pigmentation O 1 0.9981399774551392
predicts O 0 0.15019644796848297
that O 0 1.0606176147121005e-05
the O 0 1.0541257324803155e-05
phenotype O 0 0.23320892453193665
associated O 0 3.4124219382647425e-05
with O 0 7.479042778868461e-06
a O 0 4.583968620863743e-05
defect O 1 0.5132169723510742
in O 0 7.389153324766085e-05
POMC O 1 0.9799860715866089
function O 0 0.00018742229440249503
would O 0 1.7429303625249304e-05
include O 0 0.0006624290253967047
obesity B-Disease 1 0.998620867729187
, O 0 6.795766967115924e-05
alteration O 0 0.047313932329416275
in O 0 0.00037401390727609396
pigmentation O 1 0.99798583984375
and O 0 0.022397316992282867
ACTH B-Disease 1 0.9964652061462402
deficiency I-Disease 1 0.9986454844474792
. O 0 0.0021332409232854843

The O 0 6.68901193421334e-05
observation O 0 0.0002602323074825108
of O 0 1.0713833944464568e-05
these O 0 3.9137743442552164e-05
symptoms O 1 0.9881170988082886
in O 0 6.216801466507604e-06
two O 0 7.5069260674354155e-06
probands O 0 0.03591945767402649
prompted O 0 0.0002727265818975866
us O 0 8.211414751713164e-06
to O 0 1.3331717809705879e-06
search O 0 6.204274541232735e-06
for O 0 3.326655814817059e-06
mutations O 0 0.0005277172895148396
within O 0 7.987390745256562e-06
their O 0 3.275848212069832e-05
POMC O 1 0.9428016543388367
genes O 0 0.0022215936332941055
. O 0 0.00019855075515806675

Patient O 1 0.5494602918624878
1 O 0 4.546814307104796e-05
was O 0 6.396830031007994e-06
found O 0 3.3720280043780804e-06
to O 0 6.472243399002764e-07
be O 0 4.259703132447612e-07
a O 0 1.6183454363272176e-06
compound O 0 3.38483732775785e-05
heterozygote O 0 0.00046244508121162653
for O 0 1.260948693015962e-06
two O 0 1.668326262915798e-06
mutations O 0 0.00021688434935640544
in O 0 2.3829195470170816e-06
exon O 0 0.00030713810701854527
3 O 0 1.3251112250145525e-05
( O 0 1.3230468539404683e-05
G7013T O 0 0.0007764631300233305
, O 0 3.786985644183005e-06
C7133delta O 0 0.0006189846899360418
) O 0 1.6258279629255412e-06
which O 0 6.397236234079173e-07
interfere O 0 1.0038437721959781e-05
with O 0 1.3141184354026336e-06
appropriate O 0 4.399992121761898e-06
synthesis O 0 1.0680902960302774e-05
of O 0 4.663500021706568e-06
ACTH O 0 0.1041487604379654
and O 0 2.210921775258612e-05
alpha O 0 0.0010614065686240792
- O 0 0.027356216683983803
MSH O 1 0.9715762734413147
. O 0 0.00041107417200692

Patient O 0 0.3311271071434021
2 O 0 7.835924770915881e-05
was O 0 1.4359275155584328e-05
homozygous O 0 8.47101619001478e-05
for O 0 3.796923238041927e-06
a O 0 7.388281574094435e-06
mutation O 0 0.0002178977447329089
in O 0 5.040583346271887e-06
exon O 0 0.00044871639693155885
2 O 0 3.0668019462609664e-05
( O 0 3.706746065290645e-05
C3804A O 0 0.0007309103384613991
) O 0 2.911785304604564e-05
which O 0 2.9334862119867466e-05
abolishes O 0 0.03624510020017624
POMC O 1 0.8416672348976135
translation O 0 0.00042854371713474393
. O 0 0.00022441378678195179

These O 0 4.056090983795002e-05
findings O 0 4.342732790973969e-05
represent O 0 4.085427462996449e-06
the O 0 1.1983869399045943e-06
first O 0 1.2720569202429033e-06
examples O 0 4.543213890428888e-06
of O 0 1.389850581290375e-06
a O 0 2.0007531929877587e-05
genetic B-Disease 0 0.08138162642717361
defect I-Disease 1 0.7206372618675232
within O 0 1.8406150047667325e-05
the O 0 2.589146970422007e-05
POMC O 1 0.9877347350120544
gene O 0 0.0018448942573741078
and O 0 7.210282092273701e-06
define O 0 0.00014145059685688466
a O 0 6.42733066342771e-05
new O 0 0.0011121014831587672
monogenic B-Disease 1 0.9980112314224243
endocrine I-Disease 1 0.9991676807403564
disorder I-Disease 1 0.9994087219238281
resulting O 0 0.059052739292383194
in O 0 0.0002373404859099537
early O 0 0.007506445050239563
- O 1 0.9935063123703003
onset O 1 0.9994840621948242
obesity B-Disease 1 0.999745786190033
, O 0 0.11695978045463562
adrenal B-Disease 1 0.9993791580200195
insufficiency I-Disease 1 0.9990721940994263
and O 0 0.00211788690648973
red O 1 0.8445749282836914
hair O 1 0.9942505359649658
pigmentation O 1 0.9976748824119568
. O 0 0.00027238563052378595
. O 0 0.00026211433578282595

A O 0 0.0002489454054739326
European O 0 0.0003297585644759238
multicenter O 1 0.7223865985870361
study O 0 0.0008435878553427756
of O 0 8.931074989959598e-05
phenylalanine B-Disease 1 0.9915218353271484
hydroxylase I-Disease 1 0.9976217150688171
deficiency I-Disease 1 0.9995962977409363
: O 0 0.00012857838009949774
classification O 0 0.0006979110185056925
of O 0 3.1584706903231563e-06
105 O 0 0.00023016895283944905
mutations O 0 0.0012640696950256824
and O 0 1.1291373311905772e-06
a O 0 1.7192667201015865e-06
general O 0 3.6003759760205867e-06
system O 0 1.0915415259660222e-05
for O 0 6.543306881212629e-06
genotype O 0 0.02803986892104149
- O 0 0.00038599150138907135
based O 0 1.747497299220413e-05
prediction O 0 0.00028394992114044726
of O 0 2.3248654542840086e-05
metabolic O 1 0.7110944986343384
phenotype O 1 0.7472318410873413
. O 0 0.00035243789898231626

Phenylketonuria B-Disease 1 0.9909710884094238
( O 0 0.12967100739479065
PKU B-Disease 1 0.9951103329658508
) O 0 0.0005010436289012432
and O 0 0.00038760763709433377
mild B-Disease 1 0.9951243996620178
hyperphenylalaninemia I-Disease 1 0.99470055103302
( O 0 0.012281311675906181
MHP B-Disease 1 0.9959854483604431
) O 0 0.0001790674141375348
are O 0 9.410631173523143e-05
allelic B-Disease 1 0.9934007525444031
disorders I-Disease 1 0.9995946288108826
caused O 0 0.25646325945854187
by O 0 2.0291343389544636e-05
mutations O 0 0.005260208621621132
in O 0 4.568056283460464e-06
the O 0 9.878511264105327e-06
gene O 0 0.0010458570905029774
encoding O 0 0.0007607312290929258
phenylalanine O 0 0.24477119743824005
hydroxylase O 1 0.8680002689361572
( O 0 0.0024670357815921307
PAH O 1 0.9929364323616028
) O 0 0.00029302146867848933
. O 0 0.0001905816898215562

Previous O 0 0.00031859311275184155
studies O 0 0.0001764435728546232
have O 0 6.899345407873625e-06
suggested O 0 1.2400681953295134e-05
that O 0 1.4249500281948713e-06
the O 0 3.6628709949582117e-06
highly O 0 0.000202836818061769
variable O 0 0.009381766431033611
metabolic O 1 0.9479291439056396
phenotypes O 1 0.9678235650062561
of O 0 0.006842584814876318
PAH B-Disease 1 0.9994810223579407
deficiency I-Disease 1 0.9994643330574036
correlate O 1 0.9601485729217529
with O 0 0.04117095097899437
PAH O 1 0.9978983402252197
genotypes O 1 0.976527214050293
. O 0 0.0015115428250283003

We O 0 0.00014386753900907934
identified O 0 0.00015124240599106997
both O 0 3.48946668964345e-05
causative O 0 0.2767649292945862
mutations O 0 0.1461332142353058
in O 0 7.944510434754193e-05
686 O 1 0.8952547907829285
patients O 1 0.9891782999038696
from O 0 1.7963720893021673e-05
seven O 0 4.2032377677969635e-05
European O 0 9.876846161205322e-05
centers O 0 0.0013134130276739597
. O 0 0.0001742890599416569

On O 0 1.1840552360808942e-05
the O 0 2.4795838271529647e-06
basis O 0 1.5581508705508895e-06
of O 0 7.532661925324646e-07
the O 0 1.6123128716571955e-06
phenotypic O 0 0.0002165801852243021
characteristics O 0 7.32012849766761e-05
of O 0 7.288144843187183e-06
297 O 0 0.24416036903858185
functionally O 1 0.7924870848655701
hemizygous O 1 0.9671383500099182
patients O 1 0.9961745738983154
, O 0 3.965412361139897e-06
105 O 0 1.1027916116290726e-05
of O 0 4.3369630020606564e-07
the O 0 7.282596925506368e-07
mutations O 0 0.00010816750000230968
were O 0 1.9985290578006243e-07
assigned O 0 1.0788564850372495e-06
to O 0 2.720117890930851e-07
one O 0 2.685224558263144e-07
of O 0 4.6326650249284285e-07
four O 0 3.899127023032634e-06
arbitrary O 0 3.688755168695934e-05
phenotype O 0 0.044252000749111176
categories O 0 0.000181447176146321
. O 0 0.0001253977679880336

We O 0 5.233664342085831e-05
proposed O 0 4.111437374376692e-05
and O 0 5.8970081227016635e-06
tested O 0 3.5244349419372156e-05
a O 0 2.0481729734456167e-06
simple O 0 3.0057481126277708e-06
model O 0 5.3557937462755945e-06
for O 0 2.495840135452454e-06
correlation O 0 3.956471846322529e-05
between O 0 1.578454794071149e-05
genotype O 0 0.01941472291946411
and O 0 2.067363675450906e-05
phenotypic O 0 0.002754861954599619
outcome O 0 0.0004261733265593648
. O 0 0.00014341555652208626

The O 0 0.00015250244177877903
observed O 0 0.0009319626842625439
phenotype O 0 0.15400542318820953
matched O 0 0.00028642284451052547
the O 0 1.0956215191981755e-05
predicted O 0 0.0003506115172058344
phenotype O 0 0.019388418644666672
in O 0 2.7848886929859873e-06
79 O 0 2.8397391361068003e-05
% O 0 6.345001111185411e-07
of O 0 3.208301961876714e-07
the O 0 8.285532544505259e-07
cases O 0 3.692098107421771e-05
, O 0 5.060279022472969e-07
and O 0 2.7430735372035997e-07
in O 0 3.315328456210409e-07
only O 0 3.3410955779800133e-07
5 O 0 1.3052406302449526e-06
of O 0 9.187460250359436e-07
184 O 0 0.006030372343957424
patients O 1 0.8322268128395081
was O 0 1.0798291896207957e-06
the O 0 1.092149545911525e-06
observed O 0 4.13297166232951e-05
phenotype O 0 0.008805105462670326
more O 0 8.294529152408359e-07
than O 0 6.119241788837826e-07
one O 0 5.988244993204717e-07
category O 0 4.011003511550371e-06
away O 0 1.7442836224290659e-06
from O 0 1.7207198652613442e-06
that O 0 2.7225544272369007e-06
expected O 0 2.3686459826421924e-05
. O 0 4.3918560550082475e-05

Among O 0 8.462789264740422e-05
the O 0 1.2961386346432846e-05
seven O 0 1.7184542230097577e-05
contributing O 0 0.0001716666156426072
centers O 0 6.72300739097409e-05
, O 0 2.063323790935101e-06
the O 0 1.2902530670544365e-06
proportion O 0 1.3497575309884269e-05
of O 0 4.488387276069261e-06
patients O 1 0.9731576442718506
for O 0 6.105856300564483e-06
whom O 0 5.2171202696627006e-05
the O 0 2.591953034425387e-06
observed O 0 0.00015685097605455667
phenotype O 0 0.11159621924161911
did O 0 2.284500624227803e-06
not O 0 4.3579336761467857e-07
match O 0 7.628457296959823e-07
the O 0 9.852569746726658e-07
predicted O 0 6.930551899131387e-05
phenotype O 0 0.0026327355299144983
was O 0 8.161076152646274e-07
4 O 0 1.2072308663846343e-06
% O 0 6.790684210500331e-07
- O 0 1.6385487469960935e-05
23 O 0 3.241083049942972e-06
% O 0 1.5525114349657088e-06
( O 0 8.81205232872162e-06
P O 0 0.0010443455539643764
< O 0 0.0014955654041841626
. O 0 2.9700643153773854e-06
0001 O 0 0.0017825746908783913
) O 0 1.5335009493355756e-06
, O 0 4.894180278824933e-07
suggesting O 0 3.8114133076305734e-06
that O 0 3.0255901606324187e-07
differences O 0 2.465144461893942e-06
in O 0 4.30643922300078e-07
methods O 0 1.9176179648638936e-06
used O 0 9.243133831660089e-07
for O 0 3.1309007226809626e-06
mutation O 0 0.003082705894485116
detection O 0 0.008843776769936085
or O 0 0.0001537779317004606
phenotype O 1 0.8735002279281616
classification O 0 0.007145470939576626
may O 0 8.779337804298848e-06
account O 0 1.8654734503797954e-06
for O 0 8.460762614959094e-07
a O 0 1.8303101114724996e-06
considerable O 0 1.4483546692645177e-05
proportion O 0 2.7010686608264223e-05
of O 0 9.982780284190085e-06
genotype O 1 0.5644421577453613
- O 0 0.15390972793102264
phenotype O 1 0.7434378266334534
inconsistencies O 0 0.0120077570900321
. O 0 0.00031573657179251313

Our O 0 7.226151501527056e-05
data O 0 3.016010668943636e-05
indicate O 0 2.85787318716757e-05
that O 0 4.001039542345097e-06
the O 0 2.1127911168150604e-05
PAH O 1 0.9982574582099915
- O 0 0.021550297737121582
mutation O 0 0.009732909500598907
genotype O 0 0.003722546622157097
is O 0 2.0795878299395554e-06
the O 0 9.663588116382016e-07
main O 0 3.975507752329577e-06
determinant O 0 0.00018006387108471245
of O 0 7.81424023443833e-06
metabolic O 1 0.9503243565559387
phenotype O 1 0.9153562188148499
in O 0 6.680686783511192e-05
most O 0 0.0008272975101135671
patients O 1 0.9982855916023254
with O 0 0.21649892628192902
PAH B-Disease 1 0.9993565678596497
deficiency I-Disease 1 0.9989005327224731
. O 0 0.002361619146540761

In O 0 4.085536420461722e-05
the O 0 6.899977051944006e-06
present O 0 7.475378424715018e-06
study O 0 1.5110330423340201e-05
, O 0 1.41915643325774e-06
the O 0 1.7104795233535697e-06
classification O 0 0.0005102283321321011
of O 0 8.163636266544927e-06
105 O 0 0.03176473081111908
PAH O 1 0.9991917014122009
mutations O 0 0.11698091775178909
may O 0 9.444772331335116e-06
allow O 0 1.6767384067861713e-06
the O 0 5.956111408522702e-07
prediction O 0 9.888804015645292e-06
of O 0 3.7467557945092267e-07
the O 0 2.0344755284895655e-06
biochemical O 0 0.003108235541731119
phenotype O 0 0.1479751169681549
in O 0 4.719479420600692e-06
> O 0 0.0005562574369832873
10 O 0 4.4655753299593925e-06
, O 0 2.951791884697741e-06
000 O 0 7.427330274367705e-05
genotypes O 0 0.014637812972068787
, O 0 1.5574970575471525e-06
which O 0 7.350972168751468e-07
may O 0 1.491120201535523e-06
be O 0 1.848852093644382e-07
useful O 0 1.183666540782724e-06
for O 0 7.107337864908914e-07
the O 0 1.2420307484717341e-06
management O 0 0.0003923678305000067
of O 0 7.241828825499397e-06
hyperphenylalaninemia B-Disease 1 0.6035919785499573
in O 0 0.00018495394033379853
newborns O 1 0.9278886318206787
. O 0 0.00023334645084105432

Somatic O 0 0.01526232436299324
instability O 0 0.0015783567214384675
of O 0 1.7473606931162067e-05
the O 0 2.826742820616346e-05
CTG O 0 0.1583423912525177
repeat O 0 0.004558869171887636
in O 0 4.238384644850157e-05
mice O 0 0.08472087234258652
transgenic O 0 0.006259005516767502
for O 0 8.222697942983359e-05
the O 0 0.0006121863261796534
myotonic B-Disease 1 0.9994997978210449
dystrophy I-Disease 1 0.9998041987419128
region O 0 0.009919095784425735
is O 0 2.700697586988099e-05
age O 0 7.254154479596764e-05
dependent O 0 6.75651099300012e-05
but O 0 2.3649258764635306e-06
not O 0 1.0789932503030286e-06
correlated O 0 4.02804471377749e-05
to O 0 7.705824032200326e-07
the O 0 1.4052390042706975e-06
relative O 0 1.8816916053765453e-05
intertissue O 0 0.0037984915543347597
transcription O 0 0.0003499932063277811
levels O 0 0.00034000768209807575
and O 0 5.584124301094562e-05
proliferative O 1 0.9838340878486633
capacities O 0 0.010571131482720375
. O 0 0.0003819411213044077

A O 0 0.0005273738643154502
( O 0 0.0002595726982690394
CTG O 0 0.025514185428619385
) O 0 2.8236174330231734e-05
nexpansion O 0 0.00024353244225494564
in O 0 2.9731222639384214e-06
the O 0 2.343815594940679e-06
3 O 0 8.409869224124122e-06
- O 0 0.00010597406071610749
untranslated O 0 0.0012510521337389946
region O 0 4.0082722989609465e-05
( O 0 9.797992788662668e-06
UTR O 0 0.00032093559275381267
) O 0 2.0063368992850883e-06
of O 0 9.912265568345902e-07
the O 0 6.200672032719012e-06
DM O 1 0.9937065243721008
protein O 0 0.0007214770885184407
kinase O 0 0.19940517842769623
gene O 0 0.0034732394851744175
( O 0 3.971199112129398e-05
DMPK O 0 0.011704863980412483
) O 0 8.342036380781792e-06
is O 0 5.650918410537997e-06
responsible O 0 0.00023433190654031932
for O 0 0.0003141389461234212
causing O 1 0.9895416498184204
myotonic B-Disease 1 0.9994301199913025
dystrophy I-Disease 1 0.999663233757019
( O 1 0.5787122845649719
DM B-Disease 1 0.9968476891517639
) O 0 0.0013615437783300877
. O 0 0.0004331059753894806

Major O 0 0.0009038566495291889
instability O 0 0.0019257445819675922
, O 0 8.256321962107904e-06
with O 0 3.1844049317442114e-06
very O 0 3.6597564303519903e-06
large O 0 3.416614845264121e-06
expansions O 0 8.099953265627846e-05
between O 0 2.030750010817428e-06
generations O 0 2.7651949494611472e-05
and O 0 1.636438582863775e-06
high O 0 1.0805794772750232e-05
levels O 0 2.0215666154399514e-05
of O 0 2.855370894394582e-06
somatic O 0 0.07533542066812515
mosaicism O 1 0.8269245028495789
, O 0 9.112728548643645e-06
is O 0 7.508286671509268e-06
observed O 0 0.00013897748431190848
in O 0 6.312430195976049e-05
patients O 1 0.9815058708190918
. O 0 0.0002339791681151837

There O 0 2.6641664589988068e-05
is O 0 6.661101451754803e-06
a O 0 4.4388598325895146e-06
good O 0 5.074959517514799e-06
correlation O 0 1.4191526133799925e-05
between O 0 2.825988303811755e-06
repeat O 0 0.0001155789359472692
size O 0 6.8847275542793795e-06
( O 0 3.6478741094470024e-06
at O 0 1.5952228977766936e-06
least O 0 2.264136355734081e-06
in O 0 3.5815035062114475e-06
leucocytes O 0 0.012220697477459908
) O 0 1.4003458090883214e-05
, O 0 2.5868515876936726e-05
clinical O 1 0.9580124616622925
severity O 1 0.9292933940887451
and O 0 1.4586579709430225e-05
age O 0 0.00012678380880970508
of O 0 3.022869350388646e-05
onset O 1 0.9927402138710022
. O 0 0.0005291765555739403

The O 0 0.0007306881598196924
trinucleotide O 1 0.9562345743179321
repeat O 0 0.08211646974086761
instability O 0 0.03590324893593788
mechanisms O 0 0.0014307996025308967
involved O 0 0.00045947605394758284
in O 0 0.00013140855298843235
DM B-Disease 1 0.9981203675270081
and O 0 7.475000893464312e-05
other O 0 8.637254359200597e-05
human O 0 0.1120893657207489
genetic B-Disease 1 0.9926823973655701
diseases I-Disease 1 0.9992462396621704
are O 0 7.381885370705277e-05
unknown O 0 0.00031269926694221795
. O 0 0.0001896969770314172

We O 0 0.00014104547153692693
studied O 0 0.00022861214529257268
somatic O 0 0.0036144054029136896
instability O 0 0.0015257465420290828
by O 0 1.4985566849645693e-05
measuring O 0 0.00012392022472340614
the O 0 1.4146527973935008e-05
CTG O 0 0.060380857437849045
repeat O 0 0.00042778823990374804
length O 0 1.0723708328441717e-05
at O 0 2.407980218777084e-06
several O 0 1.6824343447296997e-06
ages O 0 1.981113564397674e-05
in O 0 7.9866663327266e-07
various O 0 1.6441160823887913e-06
tissues O 0 0.0004248123150318861
of O 0 1.7582525515535963e-06
transgenic O 0 0.004926506895571947
mice O 0 0.019231252372264862
carrying O 0 1.1257169717282522e-05
a O 0 1.23580866784323e-05
( O 0 3.902240132447332e-05
CTG O 0 0.07610172033309937
) O 0 1.3702063370146789e-05
55expansion O 0 0.0008716580341570079
surrounded O 0 2.9481141609721817e-05
by O 0 2.0073705400136532e-06
45 O 0 4.620029358193278e-06
kb O 0 8.74039251357317e-05
of O 0 1.2906517667943262e-06
the O 0 4.031216576549923e-06
human O 0 0.0003327888553030789
DM B-Disease 1 0.996559202671051
region O 0 4.943093881593086e-05
, O 0 2.3826014512451366e-06
using O 0 4.101225385966245e-06
small O 0 1.0203016245213803e-05
- O 0 0.0004693597729783505
pool O 0 0.0004306309565436095
PCR O 0 0.0008613805985078216
. O 0 0.0001659245026530698

These O 0 0.00017716527509037405
mice O 0 0.014145676977932453
have O 0 7.718247616139706e-06
been O 0 3.1663144000049215e-06
shown O 0 4.621289917849936e-06
to O 0 1.7054544514394365e-06
reproduce O 0 6.0693815612467006e-05
the O 0 2.258367885588086e-06
intergenerational O 0 0.0025927098467946053
and O 0 3.6508151879388606e-06
somatic O 0 0.0006089650560170412
instability O 0 0.00015786696167197078
of O 0 1.2449920632207068e-06
the O 0 2.881140972021967e-06
55 O 0 6.837082037236542e-05
CTG O 0 0.26983779668807983
repeat O 0 0.0014654526021331549
suggesting O 0 9.932647662935778e-05
that O 0 1.7080980114769773e-06
surrounding O 0 1.352619528915966e-05
sequences O 0 3.6512851693260018e-06
and O 0 6.909412491040712e-07
the O 0 1.1595673186093336e-06
chromatin O 0 0.0003067003272008151
environment O 0 5.245766806183383e-05
are O 0 1.3673012517756433e-06
involved O 0 1.365881416859338e-05
in O 0 1.2065922419424169e-05
instability O 0 0.008803016506135464
mechanisms O 0 0.0015598373720422387
. O 0 0.00017290787945967168

As O 0 2.9324313800316304e-05
observed O 0 2.851587487384677e-05
in O 0 1.5796541674717446e-06
some O 0 7.138463047340338e-07
of O 0 6.635794989051647e-07
the O 0 3.0318572044052416e-06
tissues O 0 0.031502142548561096
of O 0 0.00011332467693137005
DM B-Disease 1 0.9997637867927551
patients O 1 0.9990478157997131
, O 0 6.578069132956443e-06
there O 0 7.36079300622805e-07
is O 0 6.860882990622486e-07
a O 0 1.7232604250239092e-06
tendency O 0 9.060294541995972e-05
for O 0 2.1567550447798567e-06
repeat O 0 0.0002468011516612023
length O 0 1.0623973139445297e-05
and O 0 3.1056770239956677e-06
somatic O 0 0.005197330843657255
mosaicism O 0 0.17433713376522064
to O 0 1.1403549251554068e-06
increase O 0 1.9335298020450864e-06
with O 0 7.038026410555176e-07
the O 0 6.427016501220351e-07
age O 0 3.871604349114932e-06
of O 0 1.0224787274637492e-06
the O 0 1.1348089174134657e-05
mouse O 0 0.005178412888199091
. O 0 0.00011855349293909967

Furthermore O 0 0.0005073441425338387
, O 0 1.594139394001104e-05
we O 0 4.678641289501684e-06
observed O 0 6.492350166809047e-06
no O 0 1.4012149449627032e-06
correlation O 0 8.083916327450424e-06
between O 0 1.9733711269509513e-06
the O 0 2.83339591078402e-06
somatic O 0 0.005987709853798151
mutation O 0 0.001409673597663641
rate O 0 1.932758095790632e-05
and O 0 1.5906647604424506e-05
tissue O 0 0.11157788336277008
proliferation O 0 0.014780712313950062
capacity O 0 0.00026747595984488726
. O 0 0.00015356151561718434

The O 0 0.00017082472913898528
somatic O 0 0.010229513980448246
mutation O 0 0.004434118513017893
rates O 0 4.106171763851307e-05
in O 0 2.819651399477152e-06
different O 0 2.5775673293537693e-06
tissues O 0 0.0005335626774467528
were O 0 5.400618192652473e-07
also O 0 5.693141247320455e-07
not O 0 4.326429063894466e-07
correlated O 0 3.0109640647424385e-05
to O 0 3.743398337974213e-07
the O 0 5.472539896800299e-07
relative O 0 4.57585656477022e-06
inter O 0 0.00017842809029389173
- O 0 0.000506319513078779
tissue O 0 0.0018071092199534178
difference O 0 5.681633410858922e-06
in O 0 1.0640007985784905e-06
transcriptional O 0 2.7499789212015457e-05
levels O 0 3.2365364859288093e-06
of O 0 3.31884024262763e-07
the O 0 6.469855406976421e-07
three O 0 1.4083864243730204e-06
genes O 0 5.094163861940615e-05
( O 0 1.7303502318100072e-05
DMAHP O 0 0.004651333205401897
, O 0 4.982533027941827e-06
DMPK O 0 0.001890569576062262
and O 0 2.2806061679148115e-06
59 O 0 2.5546187316649593e-05
) O 0 5.088276793685509e-06
surrounding O 0 2.2480948246084154e-05
the O 0 6.624946308875224e-06
repeat O 0 0.0006288139848038554
. O 0 2.354731441300828e-05
. O 0 6.68271241011098e-05

A O 0 0.0009439195273444057
novel O 0 0.003453195095062256
missense O 1 0.6477498412132263
mutation O 0 0.14034362137317657
in O 0 0.00016982978559099138
patients O 1 0.9736522436141968
from O 0 2.1964506231597625e-05
a O 0 0.00023825372045394033
retinoblastoma B-Disease 1 0.9973078966140747
pedigree O 0 0.4721197485923767
showing O 0 0.0009085996425710618
only O 0 1.563893965794705e-05
mild O 1 0.5752401351928711
expression O 0 8.461652032565325e-05
of O 0 9.512486030871514e-06
the O 0 0.00014851863670628518
tumor B-Disease 1 0.9957828521728516
phenotype O 1 0.9553558230400085
. O 0 0.00048665975918993354

We O 0 3.5681216104421765e-05
have O 0 4.110231202503201e-06
used O 0 2.593228828118299e-06
single O 0 4.015940703538945e-06
strand O 0 2.9325377909117378e-05
conformation O 0 4.1561012039892375e-05
polymorphism O 0 2.7948932256549597e-05
analysis O 0 4.511114184424514e-06
to O 0 8.375791935577581e-07
study O 0 4.215252829453675e-06
the O 0 7.433708333337563e-07
27 O 0 4.450555024959613e-06
exons O 0 2.27662967517972e-05
of O 0 1.3451279983200948e-06
the O 0 5.646091722155688e-06
RB1 O 1 0.9645676016807556
gene O 0 0.00037309943581931293
in O 0 1.8847038063540822e-06
individuals O 0 5.817116743855877e-06
from O 0 1.6500820265719085e-06
a O 0 9.439225323149003e-06
family O 0 0.00015111280663404614
showing O 0 0.000759571383241564
mild O 1 0.8108662366867065
expression O 0 0.00010087826376548037
of O 0 1.0888053111557383e-05
the O 0 0.00015548401279374957
retinoblastoma B-Disease 1 0.9931228756904602
phenotype O 1 0.9751801490783691
. O 0 0.0005716291489079595

In O 0 0.00010020588524639606
this O 0 3.0862531275488436e-05
family O 0 0.000706950668245554
affected O 0 0.01881125383079052
individuals O 0 0.000818930275272578
developed O 0 0.07386773824691772
unilateral B-Disease 1 0.8517918586730957
tumors I-Disease 1 0.999269425868988
and O 0 9.22544040804496e-06
, O 0 1.437167270523787e-06
as O 0 5.990632985231059e-07
a O 0 1.0124979326064931e-06
result O 0 2.305014959347318e-06
of O 0 8.98840539775847e-07
linkage O 0 0.0010901858331635594
analysis O 0 5.064066135673784e-05
, O 0 1.777319448592607e-05
unaffected O 0 0.11104730516672134
mutation O 0 0.012219344265758991
carriers O 0 0.00020058067457284778
were O 0 1.0066306685985182e-06
also O 0 1.9437798073340673e-06
identified O 0 9.500744454271626e-06
within O 0 3.627814976425725e-06
the O 0 1.4808440937486012e-05
pedigree O 0 0.002428799867630005
. O 0 0.0001583374396432191

A O 0 8.808702841633931e-05
single O 0 2.5716506570461206e-05
band O 0 1.8669719793251716e-05
shift O 0 3.348695099703036e-05
using O 0 1.0689177543099504e-05
SSCP O 0 0.0020885763224214315
was O 0 3.5216789910919033e-06
identified O 0 9.485192094871309e-06
in O 0 1.5192340470093768e-06
exon O 0 6.947338988538831e-05
21 O 0 4.853379778069211e-06
which O 0 7.662865186830459e-07
resulted O 0 7.562240170955192e-06
in O 0 1.4999402537796414e-06
a O 0 6.003288490319392e-06
missense O 0 0.001622446347028017
mutation O 0 0.00025613728212192655
converting O 0 2.5814446416916326e-05
a O 0 3.304353231214918e-05
cys O 1 0.9207882881164551
- O 0 0.009375369176268578
- O 0 0.00426656287163496
> O 0 0.0026022344827651978
arg O 0 0.0011999065754935145
at O 0 3.2607108551019337e-06
nucleotide O 0 1.0013825885835104e-05
position O 0 4.725126473204e-06
28 O 0 7.02450734024751e-06
in O 0 3.734416395673179e-06
the O 0 1.1003964573319536e-05
exon O 0 0.0008800177602097392
. O 0 0.0001028878177748993

The O 0 0.0002735959133133292
mutation O 0 0.0039952597580850124
destroyed O 0 0.0003887199563905597
an O 0 4.0637449274072424e-05
NdeI O 0 0.011780905537307262
restriction O 0 0.0003010184445884079
enzyme O 0 0.0012054924154654145
site O 0 0.0002609090879559517
. O 0 0.00015167376841418445

Analysis O 0 8.88845679583028e-05
of O 0 5.861617864866275e-06
all O 0 3.3957994673983194e-06
family O 0 1.4332596947497223e-05
members O 0 2.0971476715203607e-06
demonstrated O 0 1.389741100865649e-05
that O 0 1.387818883813452e-06
the O 0 3.695812210935401e-06
missense O 0 0.09171851724386215
mutation O 0 0.06479042023420334
co O 0 0.07234320789575577
- O 0 0.046051234006881714
segregated O 0 0.038899146020412445
with O 0 0.0004037291510030627
patients O 1 0.9988417029380798
with O 0 0.0014114414807409048
tumors B-Disease 1 0.9994415640830994
or O 0 3.756265141419135e-05
who O 0 6.154178208817029e-06
, O 0 6.593818966393883e-07
as O 0 3.403384596367687e-07
a O 0 5.765003834312665e-07
result O 0 1.5520658962486777e-06
of O 0 3.9170475929495296e-07
linkage O 0 0.00024141892208717763
analysis O 0 8.569082638132386e-06
had O 0 2.139065145456698e-06
been O 0 1.0985654625983443e-06
predicted O 0 1.004601381282555e-05
to O 0 1.1126381878057146e-06
carry O 0 7.048692623357056e-06
the O 0 1.146294926002156e-05
predisposing O 0 0.060546986758708954
mutation O 0 0.007177554536610842
. O 0 0.00014414024190045893

These O 0 2.4305547412950546e-05
observations O 0 3.2133812055690214e-05
point O 0 4.080330654687714e-06
to O 0 1.6153541082530865e-06
another O 0 2.5194292447849875e-06
region O 0 5.562826117966324e-06
of O 0 1.0102987744176062e-06
the O 0 7.5190782808931544e-06
RB1 O 1 0.9062378406524658
gene O 0 0.0002760700008366257
where O 0 4.400843863550108e-06
mutations O 0 0.00017334816220682114
only O 0 7.810186843926203e-07
modify O 0 2.2419824745156802e-05
the O 0 4.321834694565041e-07
function O 0 1.5031565681056236e-06
of O 0 2.241149132942155e-07
the O 0 8.129608204399119e-07
gene O 0 4.645906301448122e-05
and O 0 8.108423799058073e-07
raise O 0 7.050010481179925e-06
important O 0 1.7876587889986695e-06
questions O 0 1.3322310223884415e-05
for O 0 6.915273843333125e-06
genetic O 0 0.010272267274558544
counseling O 0 0.24610792100429535
in O 0 5.121146841702284e-06
families O 0 2.0973891878384165e-05
with O 0 4.634398010239238e-06
these O 0 8.884934686648194e-06
distinctive O 0 0.01387416198849678
phenotypes O 1 0.6167245507240295
. O 0 5.880004391656257e-05
. O 0 0.00012332669575698674

Maternal B-Disease 1 0.942308783531189
disomy I-Disease 1 0.8873641490936279
and O 0 0.015286164358258247
Prader B-Disease 1 0.9978982210159302
- I-Disease 1 0.9958641529083252
Willi I-Disease 1 0.9989614486694336
syndrome I-Disease 1 0.9995265007019043
consistent O 0 0.008588184602558613
with O 0 0.00014586729230359197
gamete O 0 0.3177250325679779
complementation O 1 0.8052937984466553
in O 0 1.4277304217102937e-05
a O 0 1.1330841516610235e-05
case O 0 2.8176355044706725e-05
of O 0 4.435766641108785e-06
familial O 1 0.8311401605606079
translocation O 0 0.07247357070446014
( O 0 2.0406769181136042e-05
3 O 0 8.967223948275205e-06
; O 0 4.8585293370706495e-06
15 O 0 4.490553692448884e-06
) O 0 4.544735020317603e-06
( O 0 9.76377759798197e-06
p25 O 0 0.009404181502759457
; O 0 1.0446096894156653e-05
q11 O 0 0.0002961439604405314
. O 0 3.1526533348369412e-06
2 O 0 1.5840070773265325e-05
) O 0 1.898183109005913e-05
. O 0 3.225865293643437e-05

Maternal B-Disease 1 0.9693989753723145
uniparental I-Disease 1 0.9840818643569946
disomy I-Disease 1 0.9129108190536499
( I-Disease 0 0.004696318879723549
UPD I-Disease 1 0.9524550437927246
) I-Disease 0 2.9156308301026e-05
for I-Disease 0 7.222344720503315e-06
chromosome I-Disease 0 0.00019945470558013767
15 I-Disease 0 4.161426659265999e-06
is O 0 9.877237516775494e-07
responsible O 0 3.9284382182813715e-06
for O 0 5.429445195659355e-07
an O 0 6.800553933317133e-07
estimated O 0 5.1194278967159335e-06
30 O 0 2.053179514405201e-06
% O 0 9.856413498710026e-07
of O 0 1.983968786589685e-06
cases O 0 0.0014957999810576439
of O 0 0.0003472626849543303
Prader B-Disease 1 0.9994041919708252
- I-Disease 1 0.9979482293128967
Willi I-Disease 1 0.9992368221282959
syndrome I-Disease 1 0.9996601343154907
( O 0 0.33316147327423096
PWS B-Disease 1 0.9954695701599121
) O 0 0.0012261489173397422
. O 0 0.0004931718576699495

We O 0 5.840945232193917e-05
report O 0 2.6000241632573307e-05
on O 0 3.3218909720744705e-06
an O 0 2.642658955664956e-06
unusual O 0 2.9844948585378006e-05
case O 0 1.495572996645933e-05
of O 0 2.491502300472348e-06
maternal B-Disease 0 0.03450410068035126
disomy I-Disease 0 0.08622602373361588
15 I-Disease 0 4.704749153461307e-05
in O 0 2.460386895108968e-05
PWS B-Disease 1 0.9959554672241211
that O 0 2.0350130398583133e-06
is O 0 9.645285672377213e-07
most O 0 6.680369324385538e-07
consistent O 0 2.8278916488488903e-06
with O 0 7.82039762725617e-07
adjacent O 0 9.725823474582285e-06
- O 0 4.990990782971494e-05
1 O 0 3.287162371634622e-06
segregation O 0 3.255446790717542e-05
of O 0 1.0063859008369036e-06
a O 0 8.025170245673507e-06
paternal O 0 0.004669121000915766
t O 0 0.03392477333545685
( O 0 7.630664185853675e-06
3 O 0 4.724973678094102e-06
; O 0 3.2679208743502386e-06
15 O 0 4.102892035007244e-06
) O 0 4.298530257074162e-06
( O 0 7.612412900925847e-06
p25 O 0 0.0065702530555427074
; O 0 5.7060024118982255e-06
q11 O 0 0.00010414388088975102
. O 0 8.726613600629207e-07
2 O 0 1.6327503544744104e-06
) O 0 9.368218911731674e-07
with O 0 1.1623774298641365e-06
simultaneous O 0 2.3932088879519142e-05
maternal O 0 0.012122100219130516
meiotic O 0 0.2996772825717926
nondisjunction O 0 0.03531094267964363
for O 0 3.955573993152939e-05
chromosome O 0 0.002253144048154354
15 O 0 0.00013058973127044737
. O 0 0.00010405663488199934

The O 0 0.00041344354394823313
patient O 1 0.9012503027915955
( O 0 0.0003517446166370064
J O 0 0.14491865038871765
. O 0 5.416275598690845e-06
B O 0 7.205850852187723e-05
. O 0 8.346671620529378e-07
) O 0 8.354005558430799e-07
, O 0 4.0047552829491906e-07
a O 0 9.923342076945119e-07
17 O 0 5.185151621844852e-06
- O 0 9.599397890269756e-05
year O 0 1.0838388334377669e-05
- O 0 0.001222791150212288
old O 0 0.0001869642874225974
white O 0 0.0010900518391281366
male O 0 0.0003085648058913648
with O 0 7.092654414009303e-05
PWS B-Disease 1 0.9977675676345825
, O 0 3.978526819992112e-06
was O 0 9.715855640024529e-07
found O 0 7.729730668870616e-07
to O 0 3.1812314205126313e-07
have O 0 4.804894615517696e-07
47 O 0 5.090557806397555e-06
chromosomes O 0 8.066957889241166e-06
with O 0 1.5776456621097168e-06
a O 0 9.074016816157382e-06
supernumerary O 0 0.014412100426852703
, O 0 1.3096097973175347e-05
paternal O 0 0.0032954576890915632
der O 0 0.019255101680755615
( O 0 4.471097327041207e-06
15 O 0 1.3289408116179402e-06
) O 0 3.782925261930359e-07
consisting O 0 4.128004604808666e-07
of O 0 1.3224899930719403e-07
the O 0 5.982217317068717e-07
short O 0 6.954439413675573e-06
arm O 0 0.00014270537940319628
and O 0 1.0600588211673312e-06
the O 0 1.980390152311884e-06
proximal O 0 0.08290774375200272
long O 0 9.317843796452507e-05
arm O 0 0.00024237351317424327
of O 0 2.098175855280715e-06
chromosome O 0 0.00037499750033020973
15 O 0 7.621100394317182e-06
, O 0 4.859099590248661e-06
and O 0 2.0406223484314978e-05
distal O 1 0.8774756193161011
chromosome O 0 0.21686017513275146
arm O 0 0.19880476593971252
3p O 1 0.7384385466575623
. O 0 0.0006035136757418513

The O 0 0.00019201537361368537
t O 0 0.005891531705856323
( O 0 2.1784975615446456e-05
3 O 0 7.072286280163098e-06
; O 0 2.7018593300454086e-06
15 O 0 1.6290298390231328e-06
) O 0 6.570549544449023e-07
was O 0 2.1337461930670543e-07
present O 0 3.053778527828399e-07
in O 0 1.9207315915537038e-07
the O 0 2.7546553837964893e-07
balanced O 0 4.398435521579813e-06
state O 0 1.0115289796885918e-06
in O 0 1.483983282923873e-06
the O 0 7.948681741254404e-06
patients O 1 0.9773129224777222
father O 0 0.00011914939386770129
and O 0 7.939453098515514e-06
a O 0 4.65422599518206e-05
sister O 0 0.0009369574254378676
. O 0 0.0001045958197209984

Fluorescent O 0 0.004339494742453098
in O 0 9.03499749256298e-05
situ O 0 0.0032426666002720594
hybridization O 0 0.0002460366813465953
analysis O 0 5.666801371262409e-05
demonstrated O 0 0.0001116075218305923
that O 0 6.091967406973708e-06
the O 0 1.965400588233024e-05
PWS B-Disease 1 0.9947946667671204
critical O 0 0.00043368354090489447
region O 0 0.00010776206181617454
resided O 0 0.00010408481466583908
on O 0 1.0439088100611116e-06
the O 0 9.507963909527462e-07
derivative O 0 5.3160380048211664e-05
chromosome O 0 0.00010594950435915962
3 O 0 1.840669369812531e-06
and O 0 5.198705252951186e-07
that O 0 2.8882777769467793e-07
there O 0 2.9476856866494927e-07
was O 0 4.368660881937103e-07
no O 0 6.311494189503719e-07
deletion O 0 8.289871766464785e-05
of O 0 1.002952899398224e-06
the O 0 7.456211278622504e-06
PWS B-Disease 1 0.9841926097869873
region O 0 1.4577638467017096e-05
on O 0 8.463256335744518e-07
the O 0 9.155115208159259e-07
normal O 0 1.1014127267117146e-05
pair O 0 6.8003278101969045e-06
of O 0 3.1657589261158137e-06
15s O 0 0.016041336581110954
present O 0 2.265084913233295e-05
in O 0 4.6569868572987616e-05
J O 0 0.4513522684574127
. O 0 0.0001519623037893325

B O 0 0.05295342952013016
. O 0 0.0024838189128786325

Methylation O 0 0.0009640997741371393
analysis O 0 7.521183579228818e-05
at O 0 1.5429057384608313e-05
exon O 0 0.00011148477642564103
alpha O 0 1.6817328287288547e-05
of O 0 1.064439175024745e-06
the O 0 2.041612560788053e-06
small O 0 8.968600923253689e-06
nuclear O 0 0.00021844024013262242
ribonucleoprotein O 1 0.6650516986846924
- O 0 0.001784619060344994
associated O 0 8.05440140538849e-05
polypeptide O 0 0.00045110631617717445
N O 0 0.00021511648083105683
( O 0 3.3161119063152e-05
SNRPN O 0 0.004241506103426218
) O 0 8.119318408716936e-06
gene O 0 4.892809738521464e-05
showed O 0 6.34180469205603e-06
a O 0 2.3366112600342603e-06
pattern O 0 2.645199310791213e-05
characteristic O 0 1.8540036762715317e-05
of O 0 6.119562954154389e-07
only O 0 6.852669685031287e-07
the O 0 2.6931311367661692e-06
maternal O 0 0.008364827372133732
chromosome O 0 0.001768631860613823
15 O 0 3.564693543012254e-05
in O 0 3.906100755557418e-05
J O 0 0.45531585812568665
. O 0 0.0001747288479236886

B O 0 0.04253346472978592
. O 0 0.001979161985218525

Maternal B-Disease 0 0.3802964389324188
disomy I-Disease 0 0.02956523187458515
was O 0 5.2820145356236026e-05
confirmed O 0 7.418538734782487e-05
by O 0 7.804225788277108e-06
polymerase O 0 0.00018949883815366775
chain O 0 5.8911959058605134e-05
reaction O 0 1.9964039893238805e-05
analysis O 0 6.8105050559097435e-06
of O 0 3.684550620164373e-06
microsatellite O 0 0.002422085264697671
repeats O 0 8.0893310951069e-05
at O 0 4.850353889196413e-06
the O 0 4.3415707295935135e-06
gamma O 0 0.0014171358197927475
- O 0 0.0009209442650899291
aminobutyric O 0 0.00878919754177332
acid O 0 0.002757952781394124
receptor O 0 0.013440130278468132
beta3 O 0 0.021336080506443977
subunit O 0 0.0010368499206379056
( O 0 0.00011567971523618326
GABRB3 O 0 0.024644838646054268
) O 0 6.942584877833724e-05
locus O 0 0.0013105908874422312
. O 0 0.00017245575145352632

A O 0 0.000647292472422123
niece O 0 0.06565539538860321
( O 0 0.00011540274863364175
B O 0 0.0005063242861069739
. O 0 4.184292720310623e-06
B O 0 6.101623876020312e-05
. O 0 7.631346079506329e-07
) O 0 5.250659000921587e-07
with O 0 3.7233920124890574e-07
45 O 0 1.2052155398123432e-06
chromosomes O 0 3.803308800343075e-06
and O 0 4.1026746089301014e-07
the O 0 5.610219773188874e-07
derivative O 0 1.1354411981301382e-05
3 O 0 1.6616619404885569e-06
but O 0 6.867127240184345e-07
without O 0 1.0635320677465643e-06
the O 0 1.2267823876754846e-06
der O 0 0.0008715080330148339
( O 0 3.1542831493425183e-06
15 O 0 2.7071209842688404e-06
) O 0 2.0140666947554564e-06
demonstrated O 0 1.4873005966364872e-05
a O 0 4.546165655483492e-06
phenotype O 0 0.015675697475671768
consistent O 0 1.4357494364958256e-05
with O 0 1.2352656995062716e-06
that O 0 1.3002139667150914e-06
reported O 0 1.7086882508010603e-05
for O 0 2.8522192678792635e-06
haploinsufficiency O 0 0.0010004967916756868
of O 0 7.722996087977663e-06
distal O 0 0.19374509155750275
3 O 0 0.0001873386645456776
p O 0 0.0023667970672249794
. O 0 0.00014210479275789112

Uniparental B-Disease 1 0.9863682389259338
disomy I-Disease 1 0.8904744982719421
associated O 0 0.0010035113664343953
with O 0 5.1477542001521215e-05
unbalanced O 0 0.01410652231425047
segregation O 0 0.0010996703058481216
of O 0 6.675174518022686e-06
non O 0 0.00026420108042657375
- O 0 0.021334422752261162
Robertsonian O 0 0.3555057644844055
translocations O 0 0.08552221953868866
has O 0 1.565201091580093e-05
been O 0 3.928456862922758e-06
reported O 0 2.579121974122245e-05
previously O 0 3.4080887871823506e-06
but O 0 4.83038434140326e-07
has O 0 4.5008036408944463e-07
not O 0 1.7265803364807653e-07
, O 0 1.748632882936363e-07
to O 0 1.7202820856709877e-07
our O 0 5.862708007953188e-07
knowledge O 0 2.004110911002499e-06
, O 0 4.419845822667412e-07
been O 0 6.742267260051449e-07
observed O 0 2.42307805820019e-06
in O 0 9.392543347530591e-07
a O 0 4.38597862739698e-06
case O 0 4.1740866436157376e-05
of O 0 3.144572474411689e-05
PWS B-Disease 1 0.9920172691345215
. O 0 0.0004088898713234812

Furthermore O 0 0.0007286212057806551
, O 0 2.4035514798015356e-05
our O 0 1.3288762602314819e-05
findings O 0 4.0254872146761045e-05
are O 0 1.4197696600604104e-06
best O 0 3.832748006971087e-06
interpreted O 0 7.165867373259971e-06
as O 0 4.14686337535386e-06
true O 0 5.371706356527284e-05
gamete O 0 0.06825055927038193
complementation O 1 0.8290807008743286
resulting O 0 0.003713995683938265
in O 0 0.0001357301662210375
maternal B-Disease 1 0.7599003314971924
UPD I-Disease 1 0.9882408380508423
15 I-Disease 0 0.0017679020529612899
and O 0 0.0012639883207157254
PWS B-Disease 1 0.9806365370750427

Schwartz B-Disease 1 0.9578785300254822
- I-Disease 1 0.9544855356216431
Jampel I-Disease 1 0.986484706401825
syndrome I-Disease 1 0.9985622763633728
type I-Disease 0 0.012103133834898472
2 I-Disease 0 0.00018156139412894845
and O 0 0.00010244258010061458
Stuve B-Disease 1 0.9173552989959717
- I-Disease 1 0.986541748046875
Wiedemann I-Disease 1 0.9986110925674438
syndrome I-Disease 1 0.9997250437736511
: O 0 9.601648343959823e-05
a O 0 1.1938938769162633e-05
case O 0 2.2156496925163083e-05
for O 0 4.244186584401177e-06
" O 0 1.5840585547266528e-05
lumping O 0 0.010576385073363781
" O 0 7.348621875280514e-05
. O 0 0.00011469252058304846

Recent O 0 0.0007228649919852614
studies O 0 0.0001869315019575879
demonstrated O 0 3.706275674630888e-05
the O 0 1.7465907831137883e-06
existence O 0 5.431669251265703e-06
of O 0 6.053715537746029e-07
a O 0 3.1628408123651752e-06
genetically O 0 9.116079309023917e-05
distinct O 0 2.570189280959312e-05
, O 0 2.0319509985711193e-06
usually O 0 2.8362212560750777e-06
lethal O 0 0.0002391046000411734
form O 0 3.6683559301309288e-06
of O 0 1.61251273311791e-06
the O 0 3.131106495857239e-05
Schwartz B-Disease 1 0.9258359670639038
- I-Disease 1 0.9283071160316467
Jampel I-Disease 1 0.9962467551231384
syndrome I-Disease 1 0.9997885823249817
( O 0 0.07049237936735153
SJS B-Disease 1 0.9963973164558411
) O 0 7.434649887727574e-05
of O 0 5.874987618881278e-05
myotonia B-Disease 1 0.997917115688324
and O 0 0.003947502467781305
skeletal B-Disease 1 0.9985217452049255
dysplasia I-Disease 1 0.9993336796760559
, O 0 3.1825489713810384e-05
which O 0 5.29375574842561e-06
we O 0 1.0246730198559817e-05
called O 0 0.00020665503689087927
SJS B-Disease 1 0.9878844618797302
type I-Disease 0 0.0008617976563982666
2 I-Disease 0 0.00013261193817015737
. O 0 7.967263081809506e-05

This O 0 0.0008222245378419757
disorder O 1 0.9949280023574829
is O 0 2.8787797418772243e-05
reminiscent O 0 0.0005855801282450557
of O 0 4.547275693767006e-06
another O 0 8.272450213553384e-05
rare O 0 0.06133794039487839
condition O 0 0.4603765904903412
, O 0 2.2911222913535312e-05
the O 0 5.150642027729191e-05
Stuve B-Disease 1 0.9769604206085205
- I-Disease 1 0.9911497831344604
Wiedemann I-Disease 1 0.9988313317298889
syndrome I-Disease 1 0.9997707009315491
( O 0 0.004641013685613871
SWS B-Disease 1 0.9556735157966614
) O 0 1.1734357940440532e-05
, O 0 2.1244559320621192e-06
which O 0 1.4875710121486918e-06
comprises O 0 1.4959324289520737e-05
campomelia B-Disease 0 0.008926368318498135
at O 0 2.645888162078336e-05
birth O 0 0.0022355641704052687
with O 0 0.0005290322587825358
skeletal B-Disease 1 0.9982201457023621
dysplasia I-Disease 1 0.9995972514152527
, O 0 0.0017136120004579425
contractures B-Disease 1 0.9965012073516846
, O 0 4.734594403998926e-05
and O 0 2.5295208615716547e-05
early B-Disease 0 0.0001296900591114536
death I-Disease 0 0.0012529226951301098
. O 0 0.0001420142943970859

To O 0 5.202107786317356e-05
test O 0 4.050300776725635e-05
for O 0 1.0013349310611375e-05
possible O 0 4.0903665649238974e-05
nosologic O 0 0.006470508873462677
identity O 0 4.9526162911206484e-05
between O 0 1.3997570022183936e-05
these O 0 4.878440813627094e-05
disorders O 1 0.9980934262275696
, O 0 4.421794983500149e-06
we O 0 1.2468314025682048e-06
reviewed O 0 5.522343144548358e-06
the O 0 3.985138619100326e-07
literature O 0 9.151824542641407e-07
and O 0 3.324383612834936e-07
obtained O 0 6.381217190210009e-07
a O 0 5.987286044728535e-07
follow O 0 1.477879209232924e-06
- O 0 7.0214932748058345e-06
up O 0 3.5223501981818117e-07
of O 0 1.2143514993567806e-07
the O 0 2.3789159797615866e-07
only O 0 2.9064952400403854e-07
two O 0 1.2245521929798997e-06
surviving O 0 0.004201601725071669
patients O 1 0.9385532736778259
, O 0 1.8837802144844318e-06
one O 0 1.815041400732298e-06
with O 0 2.4720689907553606e-05
SJS B-Disease 1 0.9954720735549927
type I-Disease 0 0.0001302750752074644
2 I-Disease 0 3.2682978599041235e-06
at O 0 1.3699064993488719e-06
age O 0 2.4382425181102008e-06
10 O 0 1.0403747410236974e-06
years O 0 1.3766879192189663e-06
and O 0 6.163855346130731e-07
another O 0 3.11825419885281e-06
with O 0 1.2347767551545985e-05
SWS B-Disease 1 0.5183317065238953
at O 0 1.2357744708424434e-05
age O 0 4.410982728586532e-05
7 O 0 2.910630610131193e-05
years O 0 6.790817133150995e-05
. O 0 8.486751175951213e-05

Patients O 1 0.9937549829483032
reported O 0 0.002388455206528306
as O 0 4.196877489448525e-05
having O 0 0.0003241229569539428
either O 0 0.0027350110467523336
neonatal O 1 0.9993512034416199
SJS B-Disease 1 0.998252809047699
or O 0 0.002175073605030775
SWS B-Disease 1 0.9712110161781311
presented O 0 9.507840150035918e-05
a O 0 2.159747964469716e-05
combination O 0 0.00020544228027574718
of O 0 7.1269655563810375e-06
a O 0 0.0005948148900642991
severe O 1 0.9984679818153381
, O 0 0.03538597375154495
prenatal O 1 0.9993002414703369
- O 1 0.9986947178840637
onset O 1 0.9997629523277283
neuromuscular B-Disease 1 0.9998641014099121
disorder I-Disease 1 0.9997915625572205
( O 0 0.43900492787361145
with O 0 0.3701813519001007
congenital B-Disease 1 0.9998849630355835
joint I-Disease 1 0.9969659447669983
contractures I-Disease 1 0.9995908141136169
, O 1 0.5534738302230835
respiratory O 1 0.9998444318771362
and O 0 0.002756447298452258
feeding O 0 0.4764343500137329
difficulties O 0 0.35204625129699707
, O 0 6.414754898287356e-05
tendency O 0 0.030196936801075935
to O 0 4.61906056443695e-05
hyperthermia B-Disease 1 0.998108983039856
, O 0 1.2983655324205756e-05
and O 0 6.265571300900774e-06
frequent O 0 0.0036273025907576084
death O 0 0.0004342246684245765
in O 0 7.032067969703348e-06
infancy O 0 0.030294639989733696
) O 0 3.307712631794857e-06
with O 0 3.5987454793939833e-06
a O 0 1.9411607354413718e-05
distinct O 0 0.0011519633699208498
campomelic B-Disease 1 0.7131013870239258
- I-Disease 1 0.6796759366989136
metaphyseal I-Disease 1 0.9816070795059204
skeletal I-Disease 1 0.9962942004203796
dysplasia I-Disease 1 0.9981212019920349
. O 0 0.0027853555511683226

The O 0 4.3093616113765165e-05
similarity O 0 9.870067879091948e-05
of O 0 6.1347718656179495e-06
the O 0 1.932953455252573e-05
clinical O 1 0.8266560435295105
and O 0 7.54447901272215e-05
radiographic O 1 0.9326386451721191
findings O 0 0.002894745906814933
is O 0 5.578397576755378e-06
so O 0 6.230856342881452e-06
extensive O 0 0.00022743074805475771
that O 0 4.319068011682248e-06
these O 0 3.096004729741253e-05
disorders O 1 0.9988659620285034
appear O 0 3.554255818016827e-05
to O 0 1.2982141015527304e-06
be O 0 8.806497362456867e-07
a O 0 3.0493392841890454e-06
single O 0 1.4431719137064647e-05
entity O 0 0.00029863615054637194
. O 0 9.3392729468178e-05

The O 0 6.239203503355384e-05
follow O 0 4.592176992446184e-05
- O 0 6.92240719217807e-05
up O 0 5.53669724467909e-06
observation O 0 1.5437501133419573e-05
of O 0 7.572889444418252e-07
an O 0 7.173034646257292e-07
identical O 0 7.2596212703501806e-06
and O 0 1.2192524536658311e-06
unique O 0 1.6839892850839533e-05
pattern O 0 0.00037091554258950055
of O 0 1.794112176867202e-05
progressive O 1 0.9418237209320068
bone B-Disease 1 0.9996901750564575
dysplasia I-Disease 1 0.9996540546417236
in O 0 1.8708164134295657e-05
the O 0 5.927782694925554e-06
two O 0 2.3388689442072064e-05
patients O 1 0.9873576164245605
( O 0 1.5348427041317336e-05
one O 0 1.952193770193844e-06
with O 0 4.126576459384523e-05
SJS B-Disease 1 0.9965448975563049
type I-Disease 0 0.00014767136599402875
2 I-Disease 0 3.266306748628267e-06
, O 0 8.000693014764693e-07
one O 0 8.247077403211733e-07
with O 0 7.4484441938693635e-06
SWS B-Disease 1 0.8354808688163757
) O 0 1.2269543731235899e-05
surviving O 0 0.0001680536661297083
beyond O 0 4.48909449914936e-05
infancy O 0 0.007279092445969582
adds O 0 3.1397841667057946e-05
to O 0 7.236756687234447e-07
the O 0 5.455713676383311e-07
evidence O 0 1.7018476228258805e-06
in O 0 8.135572215905995e-07
favor O 0 4.586481736623682e-06
of O 0 3.851394467346836e-06
identity O 0 0.00011513587378431112
. O 0 7.889955304563046e-05

The O 0 0.00019495305605232716
hypothesis O 0 0.0018076812848448753
that O 0 0.00013065077655483037
SWS B-Disease 1 0.9404560923576355
and O 0 0.00021048952476121485
SJS B-Disease 1 0.9934711456298828
type I-Disease 0 0.00023012243036646396
2 I-Disease 0 7.289660970855039e-06
are O 0 1.1659446954581654e-06
the O 0 1.755062839947641e-06
same O 0 1.1971524145337753e-05
disorder O 1 0.9765182137489319
should O 0 3.4451461488060886e-06
be O 0 8.509094868713873e-07
testable O 0 3.025306068593636e-05
by O 0 2.7932808279729215e-06
molecular O 0 4.9633013986749575e-05
methods O 0 2.8041520636179484e-05
. O 0 1.9830415112664923e-05
. O 0 6.646302063018084e-05

A O 0 0.0010416255099698901
mouse O 0 0.04397512972354889
model O 0 0.0009063186589628458
of O 0 0.0010918305488303304
severe O 1 0.9983052015304565
von B-Disease 1 0.9985288381576538
Willebrand I-Disease 1 0.999468982219696
disease I-Disease 1 0.9996899366378784
: O 0 0.32476240396499634
defects O 1 0.9964814186096191
in O 0 0.003450213000178337
hemostasis O 1 0.9945869445800781
and O 0 0.01200620923191309
thrombosis B-Disease 1 0.9977838397026062
. O 0 0.0022286633029580116

von B-Disease 1 0.9376232624053955
Willebrand I-Disease 1 0.9778351187705994
factor I-Disease 0 0.0738808661699295
( I-Disease 0 0.030551323667168617
vWf I-Disease 1 0.9850165843963623
) I-Disease 0 0.466053307056427
deficiency I-Disease 1 0.9993244409561157
causes O 1 0.9971653819084167
severe O 1 0.99905925989151
von B-Disease 1 0.9986347556114197
Willebrand I-Disease 1 0.9994753003120422
disease I-Disease 1 0.9996509552001953
in O 0 0.010648944415152073
humans O 0 0.3554994761943817
. O 0 0.0005182177992537618

We O 0 5.794293974759057e-05
generated O 0 4.0641210944158956e-05
a O 0 2.056111225101631e-05
mouse O 0 0.0004785510536748916
model O 0 1.6363248505513184e-05
for O 0 6.136667707323795e-06
this O 0 1.0795616617542692e-05
disease O 1 0.9868041276931763
by O 0 6.9247371357050724e-06
using O 0 2.182225762226153e-05
gene O 0 0.0013940511271357536
targeting O 0 0.0007408746751025319
. O 0 0.0001599645329406485

vWf B-Disease 1 0.9644636511802673
- I-Disease 1 0.8475469946861267
deficient I-Disease 1 0.992323637008667
mice O 1 0.64705491065979
appeared O 0 0.00014538198593072593
normal O 0 0.00014028119039721787
at O 0 1.0565391676209401e-05
birth O 0 0.00014324851508717984
; O 0 4.797066139872186e-06
they O 0 8.429231570517004e-07
were O 0 1.192545141748269e-06
viable O 0 4.37726775999181e-05
and O 0 1.757029167492874e-05
fertile O 0 0.004324524197727442
. O 0 0.00015425067977048457

Neither O 0 0.03602288290858269
vWf O 1 0.9163957834243774
nor O 0 0.05042874813079834
vWf O 1 0.9559356570243835
propolypeptide O 1 0.7782406210899353
( O 0 0.0056332931853830814
von B-Disease 1 0.9586547613143921
Willebrand I-Disease 1 0.9967783093452454
antigen O 1 0.9864773750305176
II O 0 0.024436105042696
) O 0 1.0124282198376022e-05
were O 0 1.775324221853225e-06
detectable O 0 0.00021612986165564507
in O 0 3.6136232210992603e-06
plasma O 0 0.0005924848956055939
, O 0 7.486407412216067e-06
platelets O 0 0.06514862179756165
, O 0 4.330785486672539e-06
or O 0 1.2718101970676798e-05
endothelial O 0 0.03249749168753624
cells O 0 0.00019427129882387817
of O 0 2.4539069727325113e-06
the O 0 2.2820031517767347e-05
homozygous O 0 0.01869329623878002
mutant O 0 0.03778340667486191
mice O 0 0.3122497797012329
. O 0 0.000380959827452898

The O 0 0.000619623635429889
mutant O 1 0.5763051509857178
mice O 1 0.9769904613494873
exhibited O 0 0.422579288482666
defects O 1 0.9931151270866394
in O 0 0.00014661936438642442
hemostasis O 1 0.9885636568069458
with O 0 6.780871626688167e-05
a O 0 0.00014225149061530828
highly O 0 0.026249291375279427
prolonged O 1 0.9949625730514526
bleeding O 1 0.9976773858070374
time O 0 3.346616358612664e-05
and O 0 2.4955685148597695e-05
spontaneous O 0 0.014560571871697903
bleeding O 1 0.9905942678451538
events O 0 2.3330076146521606e-05
in O 0 4.071545845363289e-06
approximately O 0 9.472004421695601e-06
10 O 0 5.227373549132608e-06
% O 0 5.889859039598377e-06
of O 0 1.539372533443384e-05
neonates O 1 0.7799353003501892
. O 0 0.00015994532441254705

As O 0 4.8048634198494256e-05
in O 0 1.5885092579992488e-05
the O 0 1.4271586223912891e-05
human O 0 0.009199803695082664
disease O 1 0.998542070388794
, O 0 7.270998139574658e-06
the O 0 4.266592441126704e-06
factor O 0 0.0001496733311796561
VIII O 0 0.024406809359788895
level O 0 7.048087354633026e-06
in O 0 1.1584631920413813e-06
these O 0 2.433285544611863e-06
mice O 0 0.00633687898516655
was O 0 1.4046828482605633e-06
reduced O 0 1.0387119800725486e-05
strongly O 0 2.764983037195634e-06
as O 0 2.8245935368431674e-07
a O 0 5.22303082561848e-07
result O 0 1.3769872566626873e-06
of O 0 2.286042786181497e-07
the O 0 6.429983727684885e-07
lack O 0 1.1357249604770914e-05
of O 0 2.0290890461183153e-06
protection O 0 0.0005600356380455196
provided O 0 4.6013956307433546e-05
by O 0 6.260062218643725e-05
vWf O 0 0.23312930762767792
. O 0 0.00016999668150674552

Defective O 1 0.9884725213050842
thrombosis B-Disease 1 0.9976000189781189
in O 0 0.0006975652067922056
mutant O 0 0.1409984976053238
mice O 0 0.24768571555614471
was O 0 7.735557119303849e-06
also O 0 2.4097628283925587e-06
evident O 0 2.5387982532265596e-05
in O 0 9.856789802142885e-07
an O 0 1.0280901960868505e-06
in O 0 4.657028512156103e-06
vivo O 0 0.003560004523023963
model O 0 6.158355972729623e-05
of O 0 8.759215415921062e-05
vascular B-Disease 1 0.9990977048873901
injury I-Disease 1 0.9956359267234802
. O 0 0.0007977666100487113

In O 0 3.9284997910726815e-05
this O 0 7.689725862292107e-06
model O 0 1.2633809092221782e-05
, O 0 3.854377609968651e-06
the O 0 5.738264917454217e-06
exteriorized O 0 0.007227499969303608
mesentery O 0 0.07077846676111221
was O 0 1.3426783880277071e-05
superfused O 0 0.004307016730308533
with O 0 1.372073711536359e-05
ferric O 1 0.6013217568397522
chloride O 0 0.0035669649951159954
and O 0 2.820633199007716e-06
the O 0 1.7020845461956924e-06
accumulation O 0 0.00037857366260141134
of O 0 6.155880782898748e-06
fluorescently O 0 0.3881349563598633
labeled O 0 0.015517185442149639
platelets O 0 0.41918325424194336
was O 0 1.3333063179743476e-05
observed O 0 5.562970181927085e-05
by O 0 2.912546187872067e-05
intravital O 0 0.015763936564326286
microscopy O 0 0.005837029777467251
. O 0 0.00026006295229308307

We O 0 8.620361768407747e-05
conclude O 0 0.0001849562395364046
that O 0 8.918083949538413e-06
these O 0 1.3525371286959853e-05
mice O 0 0.05683939531445503
very O 0 0.00015858584083616734
closely O 0 0.004482530057430267
mimic O 1 0.9949874877929688
severe O 1 0.9994295239448547
human O 1 0.9909605383872986
von B-Disease 1 0.9993051290512085
Willebrand I-Disease 1 0.9997826218605042
disease I-Disease 1 0.9997972846031189
and O 0 3.9042384742060676e-05
will O 0 2.502584948160802e-06
be O 0 5.219595209382533e-07
very O 0 1.2800803688151063e-06
useful O 0 3.158371100653312e-06
for O 0 1.1840742217827938e-06
investigating O 0 2.3658241843804717e-05
the O 0 9.855173175310483e-07
role O 0 5.450656317407265e-06
of O 0 2.3680133836023742e-06
vWf O 0 0.23030847311019897
in O 0 9.235793186235242e-06
normal O 0 0.000535395578481257
physiology O 0 0.09554944932460785
and O 0 2.2770684154238552e-05
in O 0 0.00012966853682883084
disease O 1 0.9985590577125549
models O 0 0.00043444367474876344
. O 0 3.7803205486852676e-05
. O 0 0.00010133864270756021

Oral O 0 0.4181922972202301
contraceptives O 0 0.35622212290763855
and O 0 7.747283962089568e-05
the O 0 6.818999827373773e-05
risk O 0 0.4585099518299103
of O 0 0.0014083037385717034
hereditary B-Disease 1 0.9981139898300171
ovarian I-Disease 1 0.9998031258583069
cancer I-Disease 1 0.9996063113212585
. O 0 0.01137890387326479

Hereditary B-Disease 1 0.9966681599617004
Ovarian I-Disease 1 0.9996227025985718
Cancer I-Disease 1 0.9996187686920166
Clinical O 1 0.9976765513420105
Study O 0 0.404889315366745
Group O 0 0.0035965850111097097
. O 0 0.000350201444234699

BACKGROUND O 0 0.0010848721722140908
Women O 0 0.00017778156325221062
with O 0 1.8745846318779513e-05
mutations O 0 0.001634663320146501
in O 0 4.243769581080414e-06
either O 0 7.697825822106097e-06
the O 0 6.885292805236531e-06
BRCA1 O 1 0.6202142238616943
or O 0 2.0487848814809695e-05
the O 0 1.9025017536478117e-05
BRCA2 O 1 0.9889260530471802
gene O 0 0.0023927297443151474
have O 0 5.982074071653187e-06
a O 0 2.5344004825456068e-05
high O 0 0.0016259474214166403
lifetime O 1 0.5920677781105042
risk O 1 0.9516874551773071
of O 0 0.006285373121500015
ovarian B-Disease 1 0.9997040629386902
cancer I-Disease 1 0.9994959831237793
. O 0 0.007008835207670927

Oral O 1 0.9650498628616333
contraceptives O 1 0.9898247122764587
protect O 1 0.9450819492340088
against O 1 0.6885776519775391
ovarian B-Disease 1 0.9998477697372437
cancer I-Disease 1 0.9997444748878479
in O 0 7.85726442700252e-05
general O 0 2.269155993417371e-05
, O 0 2.3129773580876645e-06
but O 0 7.977128007041756e-07
it O 0 3.912145700724068e-07
is O 0 5.4262045523501e-07
not O 0 3.565941142369411e-07
known O 0 1.6489746030856622e-06
whether O 0 1.7334119775114232e-06
they O 0 5.305757326823368e-07
also O 0 1.2363818768790225e-06
protect O 0 0.00010241004929412156
against O 0 5.334787056199275e-05
hereditary B-Disease 1 0.540590226650238
forms I-Disease 0 0.01371066365391016
of I-Disease 0 0.007926699705421925
ovarian I-Disease 1 0.9997578263282776
cancer I-Disease 1 0.9994701743125916
. O 0 0.005460032727569342

METHODS O 0 0.0006668147980235517
We O 0 0.00013013006537221372
enrolled O 0 0.0029297375585883856
207 O 0 0.012028700672090054
women O 0 0.0036424859426915646
with O 0 0.004099160432815552
hereditary B-Disease 1 0.9988886713981628
ovarian I-Disease 1 0.9999061822891235
cancer I-Disease 1 0.9997864365577698
and O 0 5.0132435717387125e-05
161 O 0 0.0002738344483077526
of O 0 1.2542755030153785e-06
their O 0 2.6665395580494078e-06
sisters O 0 7.43825949029997e-05
as O 0 8.778934557085449e-07
controls O 0 8.011329555301927e-06
in O 0 1.5310577055061003e-06
a O 0 6.619880878133699e-06
case O 0 0.00010274173837387934
- O 0 0.0012750807218253613
control O 0 0.00013898623001296073
study O 0 0.0003501285391394049
. O 0 8.059195533860475e-05

All O 0 5.511071503860876e-05
the O 0 4.6262150135589764e-05
patients O 1 0.8046449422836304
carried O 0 2.2932119463803247e-05
a O 0 3.560901677701622e-05
pathogenic O 0 0.12022306025028229
mutation O 0 0.0022626144345849752
in O 0 1.2096270438632928e-05
either O 0 6.109612149884924e-05
BRCA1 O 1 0.9199450016021729
( O 0 9.41372782108374e-05
179 O 0 0.0015712499152868986
women O 0 0.00018797047960106283
) O 0 1.629797952773515e-05
or O 0 3.855356408166699e-05
BRCA2 O 1 0.8693814873695374
( O 0 5.3940664656693116e-05
28 O 0 6.016285260557197e-05
women O 0 0.00012578003224916756
) O 0 4.664965672418475e-05
. O 0 7.791737880324945e-05

The O 0 8.253571286331862e-05
control O 0 0.0001319886214332655
women O 0 6.439957360271364e-05
were O 0 3.0840601539239287e-06
enrolled O 0 0.00011332370195304975
regardless O 0 5.518546913663158e-06
of O 0 4.925429948343663e-07
whether O 0 3.5921243579650763e-06
or O 0 1.4662706462331698e-06
not O 0 5.922499894950306e-07
they O 0 6.130930501058174e-07
had O 0 2.4590492557763355e-06
either O 0 1.2419654012774117e-05
mutation O 0 0.0009394962689839303
. O 0 6.610400305362418e-05

Lifetime O 0 0.05219927057623863
histories O 0 0.0029850206337869167
of O 0 2.2550735593540594e-05
oral O 0 0.07450482994318008
- O 0 0.02470257692039013
contraceptive O 0 0.14448632299900055
use O 0 4.515039108810015e-06
were O 0 8.204730761462997e-07
obtained O 0 1.8247121715830872e-06
by O 0 9.723640914671705e-07
interview O 0 9.592388778401073e-06
or O 0 1.218119223267422e-06
by O 0 6.769707852072315e-07
written O 0 1.3753467555943644e-06
questionnaire O 0 4.359304512036033e-05
and O 0 7.278298994606303e-07
were O 0 4.851723360843607e-07
compared O 0 1.2463125131034758e-05
between O 0 2.6323577912990004e-05
patients O 1 0.9849469661712646
and O 0 6.151402885734569e-06
control O 0 4.2048413888551295e-05
women O 0 3.567427847883664e-05
, O 0 1.287173290620558e-06
after O 0 3.674774006867665e-06
adjustment O 0 2.2242957129492424e-05
for O 0 1.3306947721503093e-06
year O 0 3.1458896501135314e-06
of O 0 1.0799342362588504e-06
birth O 0 0.00012665294343605638
and O 0 1.1837312740681227e-05
parity O 0 0.001672253361903131
. O 0 0.00013421854237094522

RESULTS O 0 0.00043818404083140194
The O 0 5.255646101431921e-05
adjusted O 0 0.0004420979239512235
odds O 0 0.010934825986623764
ratio O 0 0.012033920735120773
for O 0 0.023356664925813675
ovarian B-Disease 1 0.9998267292976379
cancer I-Disease 1 0.9997584223747253
associated O 0 0.00045219535240903497
with O 0 3.3592921226954786e-06
any O 0 1.7021917528836639e-06
past O 0 4.217701643938199e-06
use O 0 2.275337919854792e-06
of O 0 2.1632438347296556e-06
oral O 0 0.015913663432002068
contraceptives O 0 0.23748867213726044
was O 0 3.632059815572575e-05
0 O 0 0.0003022965101990849
. O 0 0.00011706816439982504

5 O 0 0.00013993305037729442
( O 0 3.346054654684849e-05
95 O 0 1.57003705680836e-05
percent O 0 8.07382366474485e-06
confidence O 0 1.1406461453589145e-05
interval O 0 1.3515158570953645e-05
, O 0 2.039330183833954e-06
0 O 0 4.37085054727504e-06
. O 0 6.897654429849354e-07
3 O 0 1.3757953638560139e-06
to O 0 6.300525683400338e-07
0 O 0 4.912463282380486e-06
. O 0 1.9174881344952155e-06
8 O 0 1.2194002010801341e-05
) O 0 1.7014654076774605e-05
. O 0 3.725265196408145e-05

The O 0 0.00017959816614165902
risk O 0 0.023495467379689217
decreased O 0 0.0003972449048887938
with O 0 4.707567768491572e-06
increasing O 0 1.7992610082728788e-05
duration O 0 5.0394723075442016e-05
of O 0 9.019610160976299e-07
use O 0 3.023388444489683e-06
( O 0 8.810506187728606e-06
P O 0 0.00016564360703341663
for O 0 1.0369078609073767e-06
trend O 0 1.655938285693992e-05
, O 0 1.3777701042272383e-06
< O 0 0.00013192745973356068
0 O 0 4.875806098425528e-06
. O 0 1.0262417617923347e-06
001 O 0 0.00020132256031502038
) O 0 1.156913072009047e-06
; O 0 5.343150064618385e-07
use O 0 2.743798290794075e-07
for O 0 2.8713571964544826e-07
six O 0 7.158553785302502e-07
or O 0 6.657790549979836e-07
more O 0 6.055332164578431e-07
years O 0 2.0775876237166813e-06
was O 0 5.725041205550951e-07
associated O 0 2.1845435185241513e-06
with O 0 7.753783961561567e-07
a O 0 2.0030122414027574e-06
60 O 0 7.359203209489351e-06
percent O 0 1.3515931641450152e-05
reduction O 0 0.00032264748006127775
in O 0 2.4828854293446057e-05
risk O 0 0.05152192339301109
. O 0 0.0001184060747618787

Oral O 1 0.5091139674186707
- O 0 0.20625945925712585
contraceptive O 1 0.9338262677192688
use O 0 0.0006381493294611573
protected O 0 0.09384635835886002
against O 0 0.1112019419670105
ovarian B-Disease 1 0.999829888343811
cancer I-Disease 1 0.999671459197998
both O 0 1.586640973982867e-05
for O 0 4.118195647606626e-06
carriers O 0 0.00010015861334977672
of O 0 1.0185992778133368e-06
the O 0 7.311048648261931e-06
BRCA1 O 1 0.9512137770652771
mutation O 0 0.0130178676918149
( O 0 2.1653904695995152e-05
odds O 0 0.00015380067634396255
ratio O 0 1.3570150258601643e-05
, O 0 9.155832003671094e-07
0 O 0 3.837952590401983e-06
. O 0 4.774200306201237e-07
5 O 0 1.1445997643022565e-06
; O 0 5.603824320132844e-07
95 O 0 1.315638314736134e-06
percent O 0 1.4843159306110465e-06
confidence O 0 2.167824504795135e-06
interval O 0 2.836226485669613e-06
, O 0 4.3236570945737185e-07
0 O 0 9.94830998024554e-07
. O 0 2.1106941971993365e-07
3 O 0 4.512153850555478e-07
to O 0 2.3159211082202091e-07
0 O 0 1.1876240932906512e-06
. O 0 2.2358695161983633e-07
9 O 0 7.129740993150335e-07
) O 0 3.517811819619965e-07
and O 0 2.1557215745815483e-07
for O 0 3.599283786570595e-07
carriers O 0 5.910261279495899e-06
of O 0 4.636554535863979e-07
the O 0 3.825123258138774e-06
BRCA2 O 1 0.9107375741004944
mutation O 0 0.0015961088938638568
( O 0 6.445452072512126e-06
odds O 0 8.623494068160653e-05
ratio O 0 8.430458365182858e-06
, O 0 6.955579578971083e-07
0 O 0 2.3447344119631452e-06
. O 0 4.251618861417228e-07
4 O 0 1.0690844192140503e-06
; O 0 7.981519161148753e-07
95 O 0 1.9829585653496906e-06
percent O 0 1.62574269779725e-06
confidence O 0 2.264211843794328e-06
interval O 0 3.0456192234851187e-06
, O 0 6.232456826182897e-07
0 O 0 1.5471491678908933e-06
. O 0 2.782478532026289e-07
2 O 0 6.690748932669521e-07
to O 0 2.8943026109118364e-07
1 O 0 1.8836616391126881e-06
. O 0 1.217590806845692e-06
1 O 0 8.110867383948062e-06
) O 0 2.0381854483275674e-05
. O 0 4.633004937204532e-05

CONCLUSIONS O 0 0.005471375770866871
Oral O 0 0.1711362898349762
- O 0 0.05896775424480438
contraceptive O 1 0.7151070833206177
use O 0 5.445642818813212e-05
may O 0 0.0001197526216856204
reduce O 0 0.0015411158092319965
the O 0 2.5938126782421023e-05
risk O 1 0.5244729518890381
of O 0 0.0017117798561230302
ovarian B-Disease 1 0.9999181032180786
cancer I-Disease 1 0.9998664855957031
in O 0 0.00018710589210968465
women O 0 0.002612460171803832
with O 0 0.0002119948621839285
pathogenic O 1 0.8801158666610718
mutations O 0 0.11222352832555771
in O 0 3.162773646181449e-05
the O 0 0.00010861753253266215
BRCA1 O 1 0.9817349314689636
or O 0 0.002671494847163558
BRCA2 O 1 0.9821754097938538
gene O 0 0.304525762796402

A O 0 0.00025845301570370793
Japanese O 0 0.00023606039758305997
family O 0 0.00023397647601086646
with O 0 7.886382809374481e-05
adrenoleukodystrophy B-Disease 1 0.9979149699211121
with O 0 2.5203202312695794e-05
a O 0 3.2812538847792894e-05
codon O 0 0.0008888841257430613
291 O 0 0.01657417230308056
deletion O 0 0.02837047539651394
: O 0 4.5342661906033754e-05
a O 0 2.9408638511085883e-05
clinical O 1 0.6037394404411316
, O 0 1.6932488506427035e-05
biochemical O 0 0.009756197221577168
, O 0 3.772869240492582e-05
pathological O 0 0.3119416832923889
, O 0 1.514556151960278e-05
and O 0 1.657924622122664e-05
genetic O 0 0.009675437584519386
report O 0 0.00019119908392895013
. O 0 9.615869930712506e-05

We O 0 8.470902685075998e-05
report O 0 4.767605059896596e-05
a O 0 1.8185697626904584e-05
Japanese O 0 5.844756742590107e-05
family O 0 0.0002753156004473567
with O 0 0.0007228487520478666
adrenoleukodystrophy B-Disease 1 0.999509334564209
( O 0 0.020506735891103745
ALD B-Disease 1 0.9988491535186768
) O 0 8.453821465082001e-06
with O 0 1.4906424894434167e-06
a O 0 1.7644541685513104e-06
three O 0 1.6955667661022744e-06
base O 0 7.748699317744467e-06
pair O 0 2.9683187676710077e-05
deletion O 0 0.004456265363842249
( O 0 4.7762190661160275e-05
delGAG O 0 0.006174701265990734
291 O 0 0.001978109125047922
) O 0 1.0305580872227438e-05
in O 0 1.0263190233672503e-05
the O 0 5.894185960642062e-05
ALD B-Disease 1 0.9975977540016174
gene O 0 0.06781728565692902
. O 0 0.000302513042697683

A O 0 0.00011246582289459184
variety O 0 7.34198183636181e-05
of O 0 1.1144318705191836e-05
phenotypes O 0 0.01189209334552288
were O 0 3.4239149044879014e-06
observed O 0 2.048104943241924e-05
within O 0 4.849932793149492e-06
this O 0 5.748825515183853e-06
family O 0 0.00011405688564991578
. O 0 8.195690315915272e-05

While O 0 0.00011846920097013935
the O 0 5.086222154204734e-05
proband O 0 0.03441065177321434
( O 0 0.00015285024710465223
patient O 0 0.12378625571727753
1 O 0 1.245553357875906e-05
) O 0 3.903227025148226e-06
was O 0 1.232232534675859e-06
classified O 0 2.2101670765550807e-05
as O 0 9.984379403249477e-07
having O 0 3.209509486623574e-06
a O 0 4.981996426067781e-06
rare O 0 0.0005064193974249065
intermediate O 0 0.0003699306689668447
type O 0 0.0002046699810307473
of O 0 6.6631532718020026e-06
adult O 0 0.053408801555633545
cerebral O 1 0.9988468885421753
and O 0 0.0002507331082597375
cerebello O 1 0.9691647291183472
- O 1 0.9132584929466248
brain O 1 0.9968602657318115
stem O 0 0.3117079734802246
forms O 0 0.00021249635028652847
, O 0 8.040583452384453e-06
his O 0 5.542509097722359e-05
younger O 0 0.010468018241226673
brother O 0 0.001816966338083148
( O 0 0.00010413942072773352
patient O 0 0.38994544744491577
2 O 0 1.7292350094066933e-05
) O 0 5.324102403392317e-06
and O 0 5.920539933867985e-06
nephew O 0 0.015419455245137215
( O 0 8.320553024532273e-05
patient O 0 0.3051764667034149
3 O 0 2.2103356968727894e-05
) O 0 1.1868214642163366e-05
had O 0 1.6088009942905046e-05
a O 0 0.00016013270942494273
childhood O 1 0.9935922026634216
ALD B-Disease 1 0.9989210367202759
type O 0 0.2482350766658783
. O 0 0.0005360395298339427

Another O 0 0.0009829993359744549
nephew O 0 0.05180935561656952
( O 0 0.00030627433443441987
patient O 0 0.22022967040538788
4 O 0 1.6024265278247185e-05
) O 0 4.709713721240405e-06
of O 0 1.9232186332374113e-06
patient O 0 0.09713620692491531
1 O 0 8.120913662423845e-06
was O 0 2.155624088118202e-06
classified O 0 9.436572872800753e-05
as O 0 3.022783175765653e-06
having O 0 1.6594289263593964e-05
an O 0 1.8388887838227674e-05
adolescent O 1 0.6227545738220215
form O 0 0.0005774416495114565
. O 0 0.0003179243649356067

The O 0 0.00015435484237968922
tau O 0 0.0020664858166128397
level O 0 5.1139886636519805e-05
in O 0 8.677503501530737e-06
the O 0 1.4755154552403837e-05
cerebrospinal O 1 0.7232797145843506
fluid O 0 0.14457644522190094
( O 0 0.000494958134368062
CSF O 1 0.8001131415367126
) O 0 1.343366238870658e-05
in O 0 4.379792699182872e-06
patient O 0 0.03741971030831337
1 O 0 2.22157041207538e-06
was O 0 6.874938094370009e-07
as O 0 4.389517300751322e-07
high O 0 3.4548979783721734e-06
as O 0 5.710830919269938e-07
that O 0 1.5834897340027965e-06
of O 0 1.376109867123887e-05
patients O 1 0.9987279772758484
with O 0 0.13870102167129517
Alzheimers B-Disease 1 0.9998666048049927
disease I-Disease 1 0.9997172951698303
( O 0 0.0038838565815240145
AD B-Disease 0 0.021928343921899796
) O 0 0.00015133545093704015
. O 0 0.0001665201416471973

His O 0 0.001061876304447651
brain O 1 0.8732916116714478
magnetic O 0 0.0016138601349666715
resonance O 0 0.02943352796137333
image O 0 0.023615891113877296
( O 0 0.0007903147488832474
MRI O 1 0.7585171461105347
) O 0 2.9416913093882613e-05
showed O 0 0.00015656572941225022
abnormalities B-Disease 0 0.4249740540981293
in I-Disease 0 3.893962002621265e-06
the I-Disease 0 4.947537036059657e-06
bilateral I-Disease 0 0.008851361460983753
cerebellar I-Disease 1 0.998596727848053
hemispheres I-Disease 1 0.8769664168357849
and O 0 0.0005559606361202896
brain O 1 0.9962558746337891
stem O 0 0.1865590363740921
, O 0 7.263609859364806e-06
but O 0 1.626685616429313e-06
not O 0 6.917845780662901e-07
in O 0 1.3392119626587373e-06
the O 0 6.524307991639944e-06
cerebral O 1 0.9973427653312683
white O 0 0.002387199318036437
matter O 0 1.2192489521112293e-05
, O 0 1.057889562616765e-06
where O 0 1.0289847978128819e-06
marked O 0 5.242050974629819e-06
reductions O 0 3.9637827285332605e-05
of O 0 1.3357730495044962e-06
the O 0 1.2598676221386995e-05
cerebral O 1 0.9970898032188416
blood O 0 0.03420790284872055
flow O 0 6.160628981888294e-05
and O 0 5.604665147984633e-06
oxygen O 0 0.0008374617318622768
metabolism O 0 0.0036259242333471775
were O 0 1.9933413568651304e-06
clearly O 0 1.1197072126378771e-05
demonstrated O 0 4.120315861655399e-05
by O 0 1.2108203009120189e-05
positron O 0 0.3262796700000763
emission O 0 0.00684687914326787
tomography O 0 0.4175053536891937
( O 0 0.0002850696910172701
PET O 0 0.04271744191646576
) O 0 0.0001238603435922414
. O 0 0.0001289810606976971

In O 0 0.00033456043456681073
patients O 1 0.7945631742477417
2 O 0 1.4923145499778911e-05
and O 0 2.433206645946484e-06
3 O 0 3.5057994409726234e-06
, O 0 1.3828275768901221e-06
the O 0 2.816066626110114e-06
autopsy O 0 0.01236420962959528
findings O 0 0.0011309835826978087
showed O 0 0.00039467174792662263
massive O 0 0.07022099941968918
demyelination B-Disease 1 0.9984965324401855
of I-Disease 0 1.256460109289037e-05
the I-Disease 0 0.00010019337059929967
cerebral I-Disease 1 0.9991852641105652
white I-Disease 0 0.016356829553842545
matter I-Disease 0 2.3735572540317662e-05
with O 0 2.6556572265690193e-06
sparing O 0 0.0013120052171871066
of O 0 8.967599569587037e-07
the O 0 2.2507176709041232e-06
U O 0 0.00153585453517735
- O 0 0.001496706041507423
fibers O 0 0.004508561920374632
, O 0 1.4427674841499538e-06
compatible O 0 8.496489499520976e-06
with O 0 1.5243572306644637e-06
the O 0 3.6372337035572855e-06
findings O 0 0.00032900177757255733
of O 0 4.914245073450729e-05
childhood O 1 0.989449143409729
ALD B-Disease 1 0.99783855676651
. O 0 0.001641375944018364

Oleic O 0 0.03271976113319397
and O 0 0.00015723808610346168
erucic O 0 0.16731959581375122
acids O 0 0.0005472491611726582
( O 0 6.816308450652286e-05
Lorenzos O 0 0.0014460578095167875
Oil O 0 2.348761699977331e-05
) O 0 4.569132215692662e-06
were O 0 1.20613083254284e-06
administered O 0 7.274659583345056e-05
to O 0 2.7303108254272956e-06
patients O 0 0.23878921568393707
1 O 0 1.5602532812408754e-06
and O 0 4.571423914967454e-07
4 O 0 1.4574929991795216e-06
, O 0 7.681098281864251e-07
but O 0 7.677136295569653e-07
sufficient O 0 5.52705341760884e-06
effectiveness O 0 0.00022599115618504584
was O 0 2.9294242267496884e-06
not O 0 2.985168521263404e-06
obtained O 0 2.3813316147425212e-05
. O 0 4.172215994913131e-05

The O 0 8.151698420988396e-05
findings O 0 0.0002863283734768629
in O 0 5.097932898934232e-06
this O 0 1.9047046180276084e-06
family O 0 1.4167266272124834e-05
suggest O 0 1.6749942005844787e-05
that O 0 1.3997578207636252e-06
delGAG291 O 0 0.0002626010973472148
is O 0 4.970882514498953e-07
part O 0 4.6766820105403895e-07
of O 0 3.708225335685711e-07
the O 0 1.979940861929208e-06
cause O 0 0.0014875952620059252
of O 0 6.592180852749152e-06
Japanese O 0 0.0017862864769995213
ALD B-Disease 1 0.9984521865844727
with O 0 0.00013557972852140665
phenotypic O 0 0.02402980625629425
variations O 0 0.001215198659338057
. O 0 0.0002886350848712027

Moreover O 0 0.0008066368754953146
, O 0 1.5578056263620965e-05
although O 0 3.7542026802839246e-06
the O 0 1.2982166026631603e-06
scale O 0 6.256907909119036e-06
of O 0 5.168318466530764e-07
the O 0 1.1240338153584162e-06
study O 0 9.858898010861594e-06
is O 0 9.299695307163347e-07
limited O 0 2.4532914721930865e-06
, O 0 6.196577828632144e-07
there O 0 3.018088534645358e-07
is O 0 3.7556418419626425e-07
a O 0 1.3056314855930395e-06
possibility O 0 2.6803307264344767e-05
that O 0 2.8526599180622725e-06
PET O 0 0.019044004380702972
can O 0 1.1273800737399142e-05
detect O 0 0.003689910052344203
an O 0 2.464035787852481e-05
insidious B-Disease 1 0.890532910823822
lesion I-Disease 1 0.9945735335350037
which O 0 4.936763161822455e-06
is O 0 8.267936209449545e-06
undetectable O 0 0.07670551538467407
by O 0 8.494455869367812e-06
computed O 0 0.0005616149865090847
tomogram O 0 0.07492393255233765
( O 0 0.0001820641045924276
CT O 1 0.7978602051734924
) O 0 8.703659659659024e-06
or O 0 8.00361613073619e-06
MRI O 0 0.03665231913328171
analysis O 0 3.801408865911071e-06
, O 0 6.087310566726956e-07
and O 0 2.0777412146344432e-07
that O 0 1.197820864717869e-07
the O 0 1.8137561141884362e-07
higher O 0 9.33559476834489e-07
level O 0 1.5428452115884284e-06
of O 0 5.560883096222824e-07
tau O 0 0.0005550623754970729
reflects O 0 8.45222530188039e-06
the O 0 8.751800351092243e-07
process O 0 3.3345806969009573e-06
of O 0 8.432452887063846e-06
neuronal B-Disease 1 0.6548216938972473
degeneration I-Disease 1 0.9987562894821167
in O 0 0.009477782063186169
ALD B-Disease 1 0.9974325299263
. O 0 0.0018599374452605844

Lorenzos O 0 0.010689491406083107
Oil O 0 0.00012907122436445206
should O 0 1.5281331798178144e-05
be O 0 1.396208631376794e-06
given O 0 1.4310593314803555e-06
in O 0 6.504780003524502e-07
the O 0 1.1479800150482333e-06
early O 0 6.027134531905176e-06
stage O 0 5.2758572564926e-05
. O 0 1.9360177248017862e-05
. O 0 6.678864156128839e-05

Nonsense O 0 0.0023263541515916586
mutation O 0 0.0010562494862824678
in O 0 1.7581554857315496e-05
exon O 0 0.00020130221673753113
4 O 0 1.1690126484609209e-05
of O 0 2.075706333926064e-06
human O 0 6.071314783184789e-05
complement O 0 0.0006280281231738627
C9 O 1 0.97239089012146
gene O 0 0.0006506285862997174
is O 0 2.1580533484666375e-06
the O 0 1.8947130229207687e-06
major O 0 1.9101975340163335e-05
cause O 0 0.0005065599107183516
of O 0 6.304904218268348e-06
Japanese O 0 0.0004252908402122557
complement B-Disease 0 0.05397238954901695
C9 I-Disease 1 0.9944210648536682
deficiency I-Disease 1 0.997784435749054
. O 0 0.0012419772101566195

Deficiency B-Disease 1 0.9881370663642883
of I-Disease 0 2.0422032321221195e-05
the I-Disease 0 1.1483170055726077e-05
ninth I-Disease 0 4.024727240903303e-05
component I-Disease 0 2.0368815967231058e-05
of I-Disease 0 2.4767218747001607e-06
human I-Disease 0 3.999955515610054e-05
complement I-Disease 0 0.00019057808094657958
( O 0 6.322395347524434e-05
C9 O 1 0.5468255877494812
) O 0 2.8592646685865475e-06
is O 0 8.600714522799535e-07
the O 0 8.379363407584606e-07
most O 0 3.811130000030971e-06
common O 0 0.00017967796884477139
complement B-Disease 0 0.13850124180316925
deficiency I-Disease 1 0.999602735042572
in O 0 6.689972451567883e-06
Japan O 0 2.127806692442391e-05
but O 0 2.458814606143278e-06
is O 0 1.6463158090118668e-06
rare O 0 4.05444334319327e-05
in O 0 2.0446132111828774e-06
other O 0 3.1247975584847154e-06
countries O 0 2.6110164981218986e-05
. O 0 6.929693336132914e-05

We O 0 4.265722964191809e-05
studied O 0 2.9208127671154216e-05
the O 0 4.052467375004198e-06
molecular O 0 4.399791214382276e-05
basis O 0 7.947453013912309e-06
of O 0 2.1135811039130203e-05
C9 B-Disease 1 0.9976118803024292
deficiency I-Disease 1 0.9992011189460754
in O 0 4.0232072933577e-05
four O 0 6.977775774430484e-05
Japanese O 0 0.005591950379312038
C9 B-Disease 1 0.9983586668968201
- I-Disease 1 0.9938899278640747
deficient I-Disease 1 0.9987605810165405
patients O 1 0.9990293979644775
who O 0 0.005549643188714981
had O 0 0.0032172228675335646
suffered O 1 0.9970135688781738
from O 0 0.054257865995168686
meningococcal B-Disease 1 0.999510645866394
meningitis I-Disease 1 0.9992164373397827
. O 0 0.008755762130022049

Direct O 0 0.00022765161702409387
sequencing O 0 0.00015012541553005576
of O 0 1.9281700588180684e-05
amplified O 0 0.00044326894567348063
C9 O 0 0.19627735018730164
cDNA O 0 0.00015191534475889057
and O 0 8.45404701976804e-06
DNA O 0 3.394693703739904e-05
revealed O 0 2.9190807254053652e-05
a O 0 6.374310487444745e-06
nonsense O 0 8.504816651111469e-05
substitution O 0 4.3675023334799334e-05
( O 0 3.734399797394872e-05
CGA O 0 0.0033926230389624834
- O 0 0.001441372325643897
- O 0 0.002387477084994316
> O 0 0.0031600254587829113
TGA O 0 0.019405975937843323
) O 0 4.8870433602132834e-06
at O 0 2.673608150871587e-06
codon O 0 1.4022793948242906e-05
95 O 0 6.1929895309731364e-06
in O 0 1.4846046951788594e-06
exon O 0 2.5955225282814354e-05
4 O 0 2.865926035156008e-06
in O 0 1.1344519634803873e-06
the O 0 2.7757359930546954e-06
four O 0 3.186551475664601e-05
C9 B-Disease 1 0.9783611297607422
- I-Disease 0 0.12512758374214172
deficient I-Disease 1 0.9468070268630981
individuals O 0 0.000684782222378999
. O 0 0.00022702041314914823

An O 0 0.00017058545199688524
allele O 0 0.0018238635966554284
- O 0 0.0006004831520840526
specific O 0 4.980863741366193e-05
polymerase O 0 0.0006513352855108678
chain O 0 0.00025517059839330614
reaction O 0 4.966634151060134e-05
system O 0 1.1427475328673609e-05
designed O 0 8.441317731922027e-06
to O 0 7.48849004139629e-07
detect O 0 3.553082933649421e-05
exclusively O 0 8.235256814259628e-07
only O 0 1.6162881877335167e-07
one O 0 1.6042990580444894e-07
of O 0 1.5309788636841404e-07
the O 0 4.819580681214575e-07
normal O 0 1.3260303603601642e-05
and O 0 2.215231916125049e-06
mutant O 0 0.0010849123355001211
alleles O 0 0.0005030760657973588
indicated O 0 1.0942128938040696e-05
that O 0 2.3778771662819054e-07
all O 0 1.6953794101937092e-07
the O 0 4.0954270730253484e-07
four O 0 3.578553560146247e-06
patients O 0 0.2824735641479492
were O 0 6.388864903783542e-07
homozygous O 0 2.71966346190311e-05
for O 0 5.464946752908872e-07
the O 0 9.74583031165821e-07
mutation O 0 6.3360232161358e-05
in O 0 1.1477949328764225e-06
exon O 0 6.197344191605225e-05
4 O 0 1.81787549990986e-06
and O 0 4.681992891164555e-07
that O 0 4.1578860532354156e-07
the O 0 8.650820291222772e-07
parents O 0 1.1461747817520518e-05
of O 0 1.851542492659064e-06
patient O 0 0.1624675691127777
2 O 0 1.8567197912489064e-05
were O 0 8.950204573920928e-06
heterozygous O 0 0.0010025959927588701
. O 0 7.42908741813153e-05

The O 0 6.357437086990103e-05
common O 0 8.6663116235286e-05
mutation O 0 0.0002767018449958414
at O 0 1.412658912158804e-05
codon O 0 5.815678377985023e-05
95 O 0 1.6297777619911358e-05
in O 0 4.00531916966429e-06
exon O 0 0.00014380717766471207
4 O 0 9.369449799123686e-06
might O 0 6.386577751982259e-06
be O 0 8.85292877228494e-07
responsible O 0 1.0014151484938338e-05
for O 0 4.110254849365447e-06
most O 0 2.444630445097573e-05
Japanese O 0 0.0016638567904010415
C9 B-Disease 1 0.995101809501648
deficiency I-Disease 1 0.9980074763298035
. O 0 0.00015135998546611518
. O 0 0.00017762671632226557

BRCA1 O 1 0.6708875894546509
required O 0 0.0001389605167787522
for O 0 1.9470957340672612e-05
transcription O 0 0.0006025077309459448
- O 0 0.005560627672821283
coupled O 0 0.005119637120515108
repair O 0 0.3067215383052826
of O 0 3.3085372706409544e-05
oxidative O 1 0.6452769637107849
DNA O 0 0.007669118698686361
damage O 1 0.5054691433906555
. O 0 0.00033033406361937523

The O 0 0.011444116942584515
breast B-Disease 1 0.9974237680435181
and I-Disease 0 0.4924602806568146
ovarian I-Disease 1 0.9996527433395386
cancer I-Disease 1 0.9996830224990845
susceptibility O 1 0.997021496295929
gene O 1 0.7571108937263489
BRCA1 O 1 0.9626018404960632
encodes O 0 0.0007108277641236782
a O 0 5.220505045144819e-05
zinc O 0 0.006711280904710293
finger O 0 0.0015117336297407746
protein O 0 5.854451592313126e-05
of O 0 6.83047392158187e-06
unknown O 0 5.8104902564082295e-05
function O 0 0.00020416147890500724
. O 0 0.00016491377027705312

Association O 0 0.00042248048703186214
of O 0 8.772843102633487e-06
the O 0 9.835025593929458e-06
BRCA1 O 0 0.0497903972864151
protein O 0 3.066146746277809e-05
with O 0 3.3282074127782835e-06
the O 0 3.538704049788066e-06
DNA O 0 0.00010906422539846972
repair O 0 0.06477762013673782
protein O 0 0.0002134393434971571
Rad51 O 0 0.35267359018325806
and O 0 2.876997541534365e-06
changes O 0 2.5303224902017973e-06
in O 0 4.520319976109022e-07
the O 0 4.521596110862447e-07
phosphorylation O 0 2.6264558528055204e-06
and O 0 4.6817245902275317e-07
cellular O 0 7.0590390350844245e-06
localization O 0 5.851474725204753e-06
of O 0 3.0095637271188025e-07
the O 0 5.899207735637901e-07
protein O 0 1.231009628099855e-05
after O 0 1.1243962035223376e-05
exposure O 0 0.010443765670061111
to O 0 2.6837035420612665e-06
DNA O 0 7.443141657859087e-05
- O 0 0.0011157112894579768
damaging O 0 0.009346622042357922
agents O 0 4.435219307197258e-05
are O 0 7.206660370684403e-07
consistent O 0 6.294126706052339e-06
with O 0 1.0950656132990844e-06
a O 0 3.92277388527873e-06
role O 0 1.4497032680083066e-05
for O 0 1.5245552276610397e-05
BRCA1 O 1 0.7837730646133423
in O 0 3.608631232054904e-05
DNA O 0 0.0014452922623604536
repair O 1 0.6546694040298462
. O 0 0.00025230602477677166

Here O 0 6.078602382331155e-05
, O 0 9.958617738448083e-06
it O 0 2.773507958409027e-06
is O 0 2.5626898150221677e-06
shown O 0 1.081804384739371e-05
that O 0 6.225486686162185e-06
mouse O 0 0.012695413082838058
embryonic O 0 0.27680492401123047
stem O 1 0.6992011666297913
cells O 0 0.40996962785720825
deficient B-Disease 1 0.9796245098114014
in I-Disease 0 3.7665671698050573e-05
BRCA1 I-Disease 1 0.8932496905326843
are O 0 6.703141480102204e-06
defective O 0 0.016457898542284966
in O 0 2.1244720755930757e-06
the O 0 7.776518486934947e-07
ability O 0 5.880048774997704e-06
to O 0 4.7229099209289416e-07
carry O 0 1.3263401115182205e-06
out O 0 1.2248348184584756e-06
transcription O 0 7.955639739520848e-05
- O 0 0.0007958887726999819
coupled O 0 0.001327292062342167
repair O 0 0.08386300504207611
of O 0 7.842274499125779e-06
oxidative O 0 0.4066421389579773
DNA O 0 0.0025927668903023005
damage O 0 0.12765689194202423
, O 0 3.4664756185520673e-06
and O 0 2.3809363938198658e-06
are O 0 3.597084742068546e-06
hypersensitive O 0 0.10054020583629608
to O 0 1.709537536953576e-05
ionizing O 1 0.7540993094444275
radiation O 0 0.46967071294784546
and O 0 2.2601931050303392e-05
hydrogen O 0 0.000411852786783129
peroxide O 0 0.0410107858479023
. O 0 0.00031248710001818836

These O 0 8.148426422849298e-05
results O 0 8.82446693140082e-05
suggest O 0 0.0001027977850753814
that O 0 1.5146009900490753e-05
BRCA1 O 1 0.6177917122840881
participates O 0 0.0004055702593177557
, O 0 3.137584144496941e-06
directly O 0 4.292434368835529e-06
or O 0 3.786407887673704e-06
indirectly O 0 3.327747981529683e-05
, O 0 1.3278602182253962e-06
in O 0 1.7310858311248012e-06
transcription O 0 0.00011423082469264045
- O 0 0.0024147629737854004
coupled O 0 0.0018385951407253742
repair O 0 0.14773334562778473
of O 0 1.937467277457472e-05
oxidative O 1 0.539130449295044
DNA O 0 0.003693649545311928
damage O 0 0.1588466316461563
. O 0 3.883688623318449e-05
. O 0 7.838233432266861e-05

Truncation O 0 0.010236821137368679
mutations O 0 0.006220904178917408
in O 0 2.9945329515612684e-05
the O 0 1.4209387700248044e-05
transactivation O 0 0.030069487169384956
region O 0 8.582934242440388e-05
of O 0 1.0162600119656418e-05
PAX6 O 1 0.8982456922531128
result O 0 5.916671943850815e-05
in O 0 9.559239515510853e-06
dominant O 0 0.0004720293509308249
- O 0 0.004658155608922243
negative O 0 0.0012488537468016148
mutants O 0 0.010769352316856384
. O 0 0.0001543683756608516

PAX6 O 1 0.8160731792449951
is O 0 3.6505822208710015e-05
a O 0 1.325426001130836e-05
transcription O 0 4.87472971144598e-05
factor O 0 1.1618916687439196e-05
with O 0 1.8683542748476611e-06
two O 0 1.7390018456353573e-06
DNA O 0 1.8286689737578854e-05
- O 0 7.711109356023371e-05
binding O 0 1.3406148354988545e-05
domains O 0 7.435273437295109e-05
( O 0 8.013637852855027e-06
paired O 0 5.106040771352127e-05
box O 0 1.750449519022368e-05
and O 0 4.068006091983989e-06
homeobox O 0 0.04554197937250137
) O 0 3.895042482326971e-06
and O 0 1.8451299865773763e-06
a O 0 7.578498298244085e-06
proline O 0 0.00130005506798625
- O 0 0.0005839770892634988
serine O 0 0.00043817065306939185
- O 0 0.0008397870697081089
threonine O 0 0.0018954849801957607
( O 0 0.000100613986433018
PST O 0 0.01868125982582569
) O 0 3.2864463719306514e-05
- O 0 0.0004282218578737229
rich O 0 0.0004004990041721612
transactivation O 0 0.04144452512264252
domain O 0 0.000515043968334794
. O 0 0.00024849793408066034

PAX6 O 1 0.9775363802909851
regulates O 1 0.5126715302467346
eye O 1 0.8996413946151733
development O 0 0.00042701466009020805
in O 0 2.7545671400730498e-05
animals O 0 0.0003132035199087113
ranging O 0 0.00016525332466699183
from O 0 9.74134400166804e-06
jellyfish O 0 0.0017706644721329212
to O 0 7.391304734483128e-06
Drosophila O 0 0.00036851217737421393
to O 0 1.723824425425846e-05
humans O 0 0.001067486242391169
. O 0 0.000106359068013262

Heterozygous O 0 0.05854949727654457
mutations O 0 0.008828617632389069
in O 0 4.0921222534962e-05
the O 0 2.6848050765693188e-05
human O 0 0.0018549318192526698
PAX6 O 1 0.9820627570152283
gene O 0 0.002498597837984562
result O 0 3.39717444148846e-05
in O 0 4.125086434214609e-06
various O 0 7.790676136210095e-06
phenotypes O 0 0.16027802228927612
, O 0 1.0640897016855888e-05
including O 0 6.018161730025895e-05
aniridia B-Disease 1 0.9488706588745117
, O 0 0.000264140369836241
Peters B-Disease 1 0.9373115301132202
anomaly I-Disease 1 0.9226711988449097
, O 0 0.0005760503117926419
autosomal B-Disease 1 0.9955525994300842
dominant I-Disease 0 0.4142404794692993
keratitis I-Disease 1 0.9984631538391113
, O 0 0.0006577902822755277
and O 0 0.0021730379667133093
familial B-Disease 1 0.9978933930397034
foveal I-Disease 1 0.9952319264411926
dysplasia I-Disease 1 0.9986175298690796
. O 0 0.00572142144665122

It O 0 2.7357027647667564e-05
is O 0 9.924705409503076e-06
believed O 0 1.2506573511927854e-05
that O 0 2.6010484361904673e-06
the O 0 3.68538007933239e-06
mutated O 0 0.0018767669098451734
allele O 0 0.0001796940778149292
of O 0 5.499723101820564e-06
PAX6 O 1 0.6940968036651611
produces O 0 0.00011006218119291589
an O 0 5.0627727432583924e-06
inactive O 0 0.00039023911813274026
protein O 0 4.484897362999618e-05
and O 0 1.0405997272755485e-05
aniridia B-Disease 0 0.3662213981151581
is O 0 1.9036322555621155e-05
caused O 0 0.0025690298061817884
due O 0 5.5327927839243785e-05
to O 0 1.7458050933782943e-05
genetic O 0 0.012043947353959084
haploinsufficiency O 0 0.3138429820537567
. O 0 0.0002413878683000803

However O 0 6.96647257427685e-05
, O 0 1.0391835530754179e-05
several O 0 1.076011722034309e-05
truncation O 0 0.0005955591332167387
mutations O 0 0.0027848074678331614
have O 0 2.4834887426550267e-06
been O 0 1.2089061556253e-06
found O 0 1.3586574141299934e-06
to O 0 6.185052825458115e-07
occur O 0 6.837982255092356e-06
in O 0 6.455032917074277e-07
the O 0 1.35430298087158e-06
C O 0 0.00038664182648062706
- O 0 0.0002822366077452898
terminal O 0 0.0003848425403703004
half O 0 4.954439646098763e-06
of O 0 3.6723777157021686e-06
PAX6 O 1 0.9403672218322754
in O 0 4.412051566760056e-05
patients O 1 0.9354819655418396
with O 0 2.5526924218866043e-05
Aniridia B-Disease 0 0.41087085008621216
resulting O 0 0.00019089049601461738
in O 0 3.5891112020181026e-06
mutant O 0 0.00017131456115748733
proteins O 0 4.219793936499627e-06
that O 0 5.90049069160159e-07
retain O 0 6.181725439091679e-06
the O 0 9.98077211988857e-07
DNA O 0 1.2167817658337299e-05
- O 0 6.109962123446167e-05
binding O 0 7.831444236217067e-06
domains O 0 2.0835856048506685e-05
but O 0 8.653502163724625e-07
have O 0 6.022597176524869e-07
lost O 0 1.6813243064461858e-06
most O 0 5.904926752009487e-07
of O 0 1.0805749752762495e-06
the O 0 5.6859039432310965e-06
transactivation O 0 0.052174583077430725
domain O 0 0.0003228077257517725
. O 0 0.000150477557326667

It O 0 4.0904287743614987e-05
is O 0 1.0366199603595305e-05
not O 0 2.967892669403227e-06
clear O 0 6.048237992217764e-06
whether O 0 4.71313296657172e-06
such O 0 3.335649580549216e-06
mutants O 0 0.000633415998890996
really O 0 3.506339271552861e-05
behave O 0 0.000168881582794711
as O 0 1.7142076558229746e-06
loss O 0 0.00011288184759905562
- O 0 5.699469693354331e-05
of O 0 1.2636089650186477e-06
- O 0 0.00021560459572356194
function O 0 2.722279168665409e-05
mutants O 0 0.0004013461584690958
as O 0 4.394058578327531e-06
predicted O 0 9.257918281946331e-05
by O 0 1.769114714988973e-05
haploinsufficiency O 0 0.00682357931509614
. O 0 0.00013092039444018155

Contrary O 0 0.00015428128244820982
to O 0 6.495681645901641e-06
this O 0 1.5905441159702605e-06
theory O 0 2.4638072773086606e-06
, O 0 5.789842703052273e-07
our O 0 7.874655807427189e-07
data O 0 1.145075771091797e-06
showed O 0 1.966533318409347e-06
that O 0 5.848707473887771e-07
these O 0 9.354238272862858e-07
mutants O 0 7.347024802584201e-05
are O 0 1.1440748721724958e-06
dominant O 0 3.062411997234449e-05
- O 0 0.0004511568695306778
negative O 0 3.923048643628135e-05
in O 0 7.374167580564972e-06
transient O 0 0.15555617213249207
transfection O 0 0.44194296002388
assays O 0 0.00015806290321052074
when O 0 3.4930039873870555e-06
they O 0 9.299411658503232e-07
are O 0 1.3879539437766653e-06
coexpressed O 0 0.00039192987605929375
with O 0 9.858164958131965e-06
wild O 0 0.00016906848759390414
- O 0 0.01584640145301819
type O 0 0.010457878932356834
PAX6 O 1 0.9660949110984802
. O 0 0.000438860384747386

We O 0 2.9802713470417075e-05
found O 0 1.2422923646226991e-05
that O 0 1.6792668020571e-06
the O 0 2.4854412004060578e-06
dominant O 0 5.25586110597942e-05
- O 0 0.0012174919247627258
negative O 0 0.00014765080413781106
effects O 0 0.0012451326474547386
result O 0 7.139891295082634e-06
from O 0 7.981374778864847e-07
the O 0 9.639400104788365e-07
enhanced O 0 8.341581269633025e-05
DNA O 0 2.0280256649130024e-05
binding O 0 7.987291610334069e-06
ability O 0 9.71357076196e-06
of O 0 2.385780135227833e-06
these O 0 1.4438533980865031e-05
mutants O 0 0.0021980488672852516
. O 0 0.00010979654325637966

Kinetic O 0 0.0005076039233244956
studies O 0 6.575337465619668e-05
of O 0 3.4448141832399415e-06
binding O 0 1.8334289052290842e-05
and O 0 5.517742010852089e-06
dissociation O 0 0.001448821509256959
revealed O 0 4.247820834279992e-05
that O 0 1.0477048135726363e-06
various O 0 2.012217692026752e-06
truncation O 0 0.0002435609931126237
mutants O 0 0.0001786948851076886
have O 0 1.2072792969775037e-06
3 O 0 2.8975055101909675e-06
- O 0 2.1169475076021627e-05
5 O 0 3.403567461646162e-06
- O 0 2.0547566236928105e-05
fold O 0 1.2936737221025396e-05
higher O 0 3.647801122497185e-06
affinity O 0 6.285728886723518e-06
to O 0 5.150221795702237e-07
various O 0 7.949780069793633e-07
DNA O 0 9.675147339294199e-06
- O 0 3.3940137655008584e-05
binding O 0 5.062647232989548e-06
sites O 0 2.583389687060844e-06
when O 0 1.303014414588688e-06
compared O 0 3.109090584985097e-06
with O 0 2.0868728825007565e-06
the O 0 5.080165010440396e-06
wild O 0 0.0001876984169939533
- O 0 0.017248952761292458
type O 0 0.010874949395656586
PAX6 O 1 0.9607287645339966
. O 0 0.00036980496952310205

These O 0 4.573135811369866e-05
results O 0 2.838526233972516e-05
provide O 0 9.619604497856926e-06
a O 0 2.9493662623281125e-06
new O 0 3.117555479548173e-06
insight O 0 2.9200718927313574e-05
into O 0 1.3776807463727891e-06
the O 0 1.6104841051856056e-06
role O 0 8.840890586725436e-06
of O 0 5.127974418428494e-06
mutant O 0 0.04696345701813698
PAX6 O 1 0.9832859635353088
in O 0 0.00011119705595774576
causing O 0 0.24523784220218658
aniridia B-Disease 1 0.7636955976486206
. O 0 7.572712638648227e-05
. O 0 0.00014623593597207218

Reversal O 0 0.4044884443283081
of O 0 0.006209390237927437
severe O 1 0.998180627822876
hypertrophic B-Disease 1 0.9995204210281372
cardiomyopathy I-Disease 1 0.9996901750564575
and O 0 0.0015186411328613758
excellent O 0 0.025236569344997406
neuropsychologic O 0 0.10634875297546387
outcome O 0 0.00012335999053902924
in O 0 8.321489076479338e-06
very B-Disease 0 1.7527381714899093e-05
- I-Disease 0 0.0006446402403526008
long I-Disease 0 0.00017469300655648112
- I-Disease 0 0.002309640869498253
chain I-Disease 0 0.0016805303748697042
acyl I-Disease 0 0.2063356339931488
- I-Disease 0 0.10724630206823349
coenzyme I-Disease 1 0.6182339191436768
A I-Disease 0 0.01004980131983757
dehydrogenase I-Disease 1 0.9870200157165527
deficiency I-Disease 1 0.9970013499259949
. O 0 0.0014971478376537561

Very B-Disease 0 0.0004739676951430738
- I-Disease 0 0.0014971892815083265
long I-Disease 0 0.0005231343093328178
- I-Disease 0 0.001869406783953309
chain I-Disease 0 0.0012352713383734226
acyl I-Disease 0 0.09876281768083572
- I-Disease 0 0.013896869495511055
coenzyme I-Disease 0 0.14633846282958984
A I-Disease 0 0.000838010513689369
dehydrogenase I-Disease 1 0.968765914440155
( I-Disease 0 0.001770384842529893
VLCAD I-Disease 1 0.9104828238487244
) I-Disease 0 0.0021199972834438086
deficiency I-Disease 1 0.999293327331543
is O 0 3.948127414332703e-05
a O 0 0.00019075839372817427
disorder O 1 0.9980366826057434
of O 0 1.1107161299150903e-05
fatty O 0 0.12361321598291397
acid O 0 0.014374679885804653
beta O 0 0.010837442241609097
oxidation O 0 0.0011093270732089877
that O 0 6.1865084717283025e-06
reportedly O 0 0.00019825111667159945
has O 0 9.812673852138687e-06
high O 0 2.6367999453213997e-05
rates O 0 3.0048830012674443e-05
of O 0 9.28925146581605e-06
morbidity O 1 0.83011794090271
and O 0 0.00010436617594677955
mortality O 0 0.4116111099720001
. O 0 0.0002241768379462883

We O 0 4.2742089135572314e-05
describe O 0 4.0689687011763453e-05
the O 0 3.0587993933295365e-06
outcome O 0 5.557126314670313e-06
of O 0 6.814622679485183e-07
a O 0 2.043400854745414e-06
5 O 0 5.950642844254617e-06
- O 0 0.00016450074326712638
year O 0 1.6526015315321274e-05
- O 0 0.0015702088130638003
old O 0 0.00034228150616399944
girl O 0 0.015559736639261246
with O 0 0.0007680700509808958
VLCAD B-Disease 1 0.9983488321304321
deficiency I-Disease 1 0.9997857213020325
who O 0 4.6206594561226666e-05
was O 0 1.6435831184935523e-06
first O 0 7.332963605222176e-07
seen O 0 3.7549937133007916e-06
at O 0 1.3267905387692736e-06
5 O 0 3.831662525044521e-06
months O 0 1.043157226376934e-05
of O 0 3.3946726034628227e-06
age O 0 0.0022966833785176277
with O 0 0.03239736333489418
severe O 1 0.9997286200523376
hypertrophic B-Disease 1 0.9998606443405151
cardiomyopathy I-Disease 1 0.9999006986618042
, O 1 0.8098277449607849
hepatomegaly B-Disease 1 0.9993970394134521
, O 0 0.23943284153938293
encephalopathy B-Disease 1 0.9989224672317505
, O 0 0.0011153796222060919
and O 0 0.000898245198186487
hypotonia B-Disease 1 0.9881226420402527
. O 0 0.0008752541616559029

Biochemical O 1 0.7106934785842896
studies O 0 0.2273477166891098
indicated O 1 0.5992392897605896
VLCAD B-Disease 1 0.9977326393127441
deficiency I-Disease 1 0.9996040463447571
caused O 0 0.24884989857673645
by O 0 2.0030862287967466e-05
a O 0 3.108041710220277e-05
stable O 0 0.0016205975553020835
yet O 0 0.0001357401197310537
inactive O 0 0.008555373176932335
enzyme O 0 0.0023602894507348537
. O 0 0.00014524979633279145

Molecular O 0 0.0023100401740521193
genetic O 0 0.0006883243331685662
analysis O 0 3.2763138733571395e-05
of O 0 5.726664312533103e-06
her O 0 0.00020334978762548417
VLCAD O 1 0.728833794593811
gene O 0 0.0136396000161767
revealed O 0 0.0007677605608478189
a O 0 2.767722435237374e-05
T1372C O 0 0.008382078260183334
( O 0 3.762829874176532e-05
F458L O 0 0.0028003063052892685
) O 0 2.4723285605432466e-05
missense O 0 0.009085521101951599
mutation O 0 0.0006198362680152059
and O 0 7.792697033437435e-06
a O 0 4.518760397331789e-05
1668 O 0 0.3589136600494385
ACAG O 0 0.45946672558784485
1669 O 0 0.29458022117614746
splice O 0 0.04257635399699211
site O 0 0.0008081625564955175
mutation O 0 0.01079315785318613
. O 0 0.00020010597654618323

After O 0 0.0009056989219971001
initial O 0 0.0018063206225633621
treatment O 1 0.6126396656036377
with O 0 7.024536898825318e-05
intravenous O 1 0.5390914678573608
glucose O 0 0.08284508436918259
and O 0 0.00011886434367625043
carnitine O 1 0.9829958081245422
, O 0 1.8393131540506147e-05
the O 0 1.1912132322322577e-05
patient O 0 0.2537524998188019
has O 0 1.0636585102474783e-05
thrived O 0 0.0002966141328215599
on O 0 1.3284150099934777e-06
a O 0 3.1216166007652646e-06
low O 0 3.53741597791668e-05
- O 0 0.0003516224096529186
fat O 0 0.00020626249897759408
diet O 0 0.00019000726751983166
supplemented O 0 2.4323913748958148e-05
with O 0 5.067955953563796e-06
medium O 0 5.457709266920574e-05
- O 0 0.0003685968113131821
chain O 0 0.0001605785801075399
triglyceride O 0 0.001728853560052812
oil O 0 2.9172802896937355e-05
and O 0 1.6011799743864685e-05
carnitine O 1 0.523543119430542
and O 0 1.6067431715782732e-05
avoidance O 0 0.06434663385152817
of O 0 4.736233677249402e-05
fasting O 0 0.014293027110397816
. O 0 0.00021655726595781744

Her O 0 0.04972759634256363
ventricular O 1 0.9932624697685242
hypertrophy O 1 0.9950852990150452
resolved O 0 0.003109234618023038
significantly O 0 0.000365779415005818
over O 0 8.025553142942954e-06
1 O 0 6.696438504150137e-06
year O 0 5.931780833634548e-06
, O 0 1.6561074289711541e-06
and O 0 3.1067818326846464e-06
cognitively O 0 0.13143837451934814
, O 0 1.6265305475826608e-06
she O 0 1.6322660485457163e-06
is O 0 5.412136943050427e-07
in O 0 6.710732236570038e-07
the O 0 1.218541115122207e-06
superior O 0 5.2352621423779055e-05
range O 0 1.7396225302945822e-05
for O 0 8.386954505112953e-06
age O 0 0.00011941123375436291
. O 0 7.333893154282123e-05

Clinical O 1 0.966245710849762
recognition O 0 0.004706614185124636
of O 0 0.0006164933438412845
VLCAD B-Disease 1 0.9973742961883545
deficiency I-Disease 1 0.9995296001434326
is O 0 2.1649857444572262e-05
important O 0 5.896963557461277e-06
because O 0 3.1687973205407616e-06
it O 0 2.624527724037762e-07
is O 0 1.9844407006530673e-07
one O 0 1.488533030169492e-07
of O 0 2.1627020885262027e-07
the O 0 1.1575973530852934e-06
few O 0 1.5499577784794383e-05
directly O 0 0.00037092631100676954
treatable O 1 0.9991695880889893
causes O 1 0.8632940053939819
of O 0 0.00034536345629021525
cardiomyopathy B-Disease 1 0.9997660517692566
in O 0 0.0004973966861143708
children O 0 0.009109125472605228
. O 0 5.099524787510745e-05
. O 0 0.00011117818212369457

Cloning O 0 0.0009753499180078506
of O 0 1.3855964425601996e-05
a O 0 1.6786578271421604e-05
novel O 0 3.613710941863246e-05
member O 0 4.838946551899426e-06
of O 0 1.0686521818570327e-06
the O 0 3.2399643714597914e-06
low O 0 0.00014221310266293585
- O 0 0.006055974401533604
density O 0 0.0023441268131136894
lipoprotein O 1 0.9818294048309326
receptor O 0 0.17410790920257568
family O 0 0.0013342109741643071
. O 0 0.0003275583731010556

A O 0 0.00024092066450975835
gene O 0 0.0004789713420905173
encoding O 0 9.219280036631972e-05
a O 0 1.8436699974699877e-05
novel O 0 5.301715646055527e-05
transmembrane O 0 0.0003100170288234949
protein O 0 2.9044163966318592e-05
was O 0 1.9520298337738495e-06
identified O 0 4.0621757761982735e-06
by O 0 9.549967217026278e-07
DNA O 0 4.456526312424103e-06
sequence O 0 2.3479924493585713e-06
analysis O 0 4.119570803595707e-06
within O 0 3.1909594326862134e-06
the O 0 8.084887667791918e-06
insulin B-Disease 1 0.596077561378479
- I-Disease 1 0.7836156487464905
dependent I-Disease 1 0.8748297691345215
diabetes I-Disease 1 0.9998388290405273
mellitus I-Disease 1 0.9993496537208557
( O 0 0.0035696220584213734
IDDM B-Disease 1 0.5698737502098083
) O 0 9.289658191846684e-05
locus O 0 0.0035038944333791733
IDDM4 O 0 0.052214451134204865
on O 0 7.960404764162377e-05
chromosome O 0 0.004590838216245174
11q13 O 0 0.011257992126047611
. O 0 0.0002673194103408605

Based O 0 5.25919022038579e-05
on O 0 6.184467110870173e-06
its O 0 6.536334240081487e-06
chromosomal O 0 0.0006909528747200966
position O 0 4.440024440555135e-06
, O 0 1.5623021454302943e-06
this O 0 9.863842933555134e-07
gene O 0 3.6026653106091544e-05
is O 0 1.0572219935056637e-06
a O 0 2.2933083982934477e-06
candidate O 0 1.0278647096129134e-05
for O 0 1.9071103452006355e-05
conferring O 0 0.30128026008605957
susceptibility O 1 0.9839417338371277
to O 0 0.0007792297983542085
diabetes B-Disease 1 0.9989067316055298
. O 0 0.000867581635247916

The O 0 0.00012143125059083104
gene O 0 0.0008227410726249218
, O 0 2.6213854653178714e-05
termed O 0 0.0007970025762915611
low O 0 0.00026053967303596437
- O 0 0.002899961546063423
density O 0 0.0005856119096279144
lipoprotein O 1 0.9470204710960388
receptor O 0 0.0045115030370652676
related O 0 0.00012676784535869956
protein O 0 3.1471045076614246e-05
5 O 0 1.2416681784088723e-05
( O 0 9.829251212067902e-06
LRP5 O 0 0.0007158219814300537
) O 0 1.4926198446119088e-06
, O 0 7.606003009641427e-07
encodes O 0 4.619562787411269e-06
a O 0 9.78307866716932e-07
protein O 0 3.3671890378172975e-06
of O 0 8.199443186640565e-07
1615 O 0 4.418801108840853e-05
amino O 0 3.2775526506156893e-06
acids O 0 3.2358850603486644e-06
that O 0 3.865118856083427e-07
contains O 0 6.422035312425578e-07
conserved O 0 1.9057948748013587e-06
modules O 0 2.2231686216400703e-06
which O 0 1.8315833472115628e-07
are O 0 1.584459425885143e-07
characteristic O 0 1.5353710978160962e-06
of O 0 2.7346862907506875e-07
the O 0 9.77539343693934e-07
low O 0 7.99344852566719e-05
- O 0 0.002091406611725688
density O 0 0.00140888593159616
lipoprotein O 1 0.9877612590789795
( O 0 0.0011122333817183971
LDL O 1 0.9929372668266296
) O 0 0.00018009341147262603
receptor O 0 0.01958981156349182
family O 0 0.0006565874209627509
. O 0 0.0001959403743967414

These O 0 4.113214527023956e-05
modules O 0 8.673785487189889e-05
include O 0 1.124003938457463e-05
a O 0 5.4710344556951895e-06
putative O 0 0.0001876279420685023
signal O 0 9.299800694861915e-06
peptide O 0 2.4314216716447845e-05
for O 0 8.413875889345945e-07
protein O 0 3.5127336559526157e-06
export O 0 2.7330670491210185e-06
, O 0 1.1370210586392204e-06
four O 0 3.4026520552288275e-06
epidermal O 1 0.6016963720321655
growth O 0 0.00011529803305165842
factor O 0 7.960390212247148e-05
( O 0 2.5117158656939864e-05
EGF O 0 0.08490986377000809
) O 0 6.826619028288405e-06
repeats O 0 3.049239603569731e-05
with O 0 3.6910289509251015e-06
associated O 0 2.395017145317979e-05
spacer O 0 0.000515559921041131
domains O 0 9.080932068172842e-05
, O 0 5.447293915494811e-06
three O 0 1.3540004147216678e-05
LDL O 1 0.977091372013092
- O 0 0.005831436719745398
receptor O 0 0.011910462751984596
( O 0 3.8254420360317454e-05
LDLR O 0 0.004171187523752451
) O 0 3.698851742228726e-06
repeats O 0 1.6099260392365977e-05
, O 0 6.784748052268696e-07
a O 0 8.520609071638319e-07
single O 0 1.5678245972594596e-06
transmembrane O 0 7.925426325527951e-05
spanning O 0 4.592584082274698e-05
domain O 0 1.227038592332974e-05
, O 0 1.4705976809636923e-06
and O 0 1.6521447605555295e-06
a O 0 1.0136619494005572e-05
cytoplasmic O 0 0.0005806531407870352
domain O 0 0.00023824848176445812
. O 0 9.548544767312706e-05

The O 0 2.2393092876882292e-05
encoded O 0 2.1917720005149022e-05
protein O 0 2.6230860385112464e-05
has O 0 4.689254637924023e-06
a O 0 2.426017090328969e-06
unique O 0 6.651953754044371e-06
organization O 0 1.2488551874412224e-05
of O 0 2.293575334988418e-06
EGF O 0 0.43141552805900574
and O 0 1.7132961147581227e-05
LDLR O 0 0.1352965384721756
repeats O 0 0.0005222892505116761
; O 0 9.051579581864644e-06
therefore O 0 3.379297368155676e-06
, O 0 2.5801791707635857e-06
LRP5 O 0 0.0028814971446990967
likely O 0 7.782729881000705e-06
represents O 0 5.654573669744423e-06
a O 0 1.9749036255234387e-06
new O 0 2.182236357839429e-06
category O 0 7.001513949944638e-06
of O 0 1.354835148958955e-06
the O 0 1.2059963410138153e-05
LDLR O 0 0.10148230195045471
family O 0 0.0004910427378490567
. O 0 0.00016077468171715736

Both O 0 0.00016488769324496388
human O 0 0.00042199427844025195
and O 0 4.2458446841919795e-05
mouse O 0 0.02518400177359581
LRP5 O 0 0.16412673890590668
cDNAs O 0 0.008527752943336964
have O 0 5.9431454246805515e-06
been O 0 2.6005941435869318e-06
isolated O 0 1.966154195542913e-05
and O 0 5.184357405596529e-07
the O 0 4.837806955038104e-07
encoded O 0 2.3742315988783957e-06
mature O 0 4.5098924601916224e-05
proteins O 0 2.009414174608537e-06
are O 0 2.852470117886696e-07
95 O 0 1.7707790220811148e-06
% O 0 6.362367344081576e-07
identical O 0 3.1569616112392396e-06
, O 0 7.532898962381296e-07
indicating O 0 8.783626071817707e-06
a O 0 1.9518026874720817e-06
high O 0 1.1635182090685703e-05
degree O 0 1.4783804545004386e-05
of O 0 3.0361566132341977e-06
evolutionary O 0 0.00027999014127999544
conservation O 0 0.0012419524136930704
. O 0 3.320561154396273e-05
. O 0 8.693610288901255e-05

The O 0 0.0002162129239877686
APC B-Disease 0 0.027833640575408936
variants O 0 0.000818852218799293
I1307K O 0 0.00662367045879364
and O 0 2.7779666197602637e-05
E1317Q O 0 0.016036257147789
are O 0 1.5031770999485161e-05
associated O 0 0.0014496648218482733
with O 0 0.006620392203330994
colorectal B-Disease 1 0.9999004602432251
tumors I-Disease 1 0.9997803568840027
, O 0 3.641173680080101e-05
but O 0 4.005594291811576e-06
not O 0 1.148255819316546e-06
always O 0 2.022493390541058e-06
with O 0 1.4042395832802868e-06
a O 0 8.594224709668197e-06
family O 0 6.835230306023732e-05
history O 0 9.265479457098991e-05
. O 0 0.00010236151865683496

Classical O 0 0.42575186491012573
familial B-Disease 1 0.9963793158531189
adenomatous I-Disease 1 0.9983356595039368
polyposis I-Disease 1 0.9986530542373657
( O 0 0.3700346350669861
FAP B-Disease 1 0.9918163418769836
) O 0 0.00015793726197443902
is O 0 1.9538776541594416e-05
a O 0 3.410677891224623e-05
high O 0 0.002023496897891164
- O 1 0.7249728441238403
penetrance O 1 0.9968585968017578
autosomal B-Disease 1 0.9990293979644775
dominant I-Disease 1 0.9634475708007812
disease I-Disease 1 0.9996436834335327
that O 0 0.00030113180400803685
predisposes O 1 0.9935466647148132
to O 0 8.705984328116756e-06
hundreds O 0 0.00010357728751841933
or O 0 2.1988356820656918e-05
thousands O 0 0.0003807233297266066
of O 0 0.00039191864198073745
colorectal B-Disease 1 0.9998657703399658
adenomas I-Disease 1 0.9994468092918396
and I-Disease 0 0.0062814257107675076
carcinoma I-Disease 1 0.999398946762085
and O 0 1.5251558579620905e-05
that O 0 4.725883627543226e-06
results O 0 2.130401298927609e-05
from O 0 1.2413343029038515e-05
truncating O 0 0.0965227484703064
mutations O 0 0.0056621660478413105
in O 0 1.2268770660739392e-05
the O 0 2.3302927729673684e-05
APC B-Disease 0 0.10678698122501373
gene O 0 0.0073192790150642395
. O 0 0.0001853041467256844

A O 0 0.0006437702104449272
variant O 0 0.04578104615211487
of O 0 0.0003426888142712414
FAP B-Disease 1 0.9946957230567932
is O 0 0.15287241339683533
attenuated B-Disease 1 0.9970318078994751
adenomatous I-Disease 1 0.999589741230011
polyposis I-Disease 1 0.9996007084846497
coli I-Disease 1 0.9976207613945007
, O 0 4.3262974941171706e-05
which O 0 4.877099399891449e-06
results O 0 1.4732910130987875e-05
from O 0 6.968899924686411e-06
germ O 0 0.2972774803638458
- O 0 0.0006323432317003608
line O 0 9.330662578577176e-06
mutations O 0 0.00013831700198352337
in O 0 5.310829465088318e-07
the O 0 3.9369373894260207e-07
5 O 0 7.746659207441553e-07
and O 0 3.08669768855907e-07
3 O 0 1.3970651480121887e-06
regions O 0 4.098219051229535e-06
of O 0 1.0762513511508587e-06
the O 0 1.1465508578112349e-05
APC B-Disease 0 0.02222243882715702
gene O 0 0.0025205647107213736
. O 0 0.00017272417608182877

Attenuated B-Disease 1 0.9842662811279297
adenomatous I-Disease 1 0.9976587295532227
polyposis I-Disease 1 0.9988765120506287
coli I-Disease 1 0.9987794756889343
patients O 1 0.998267412185669
have O 0 0.0003939068119507283
" O 0 0.00016424464411102235
multiple O 0 0.011485951952636242
" O 0 0.006557940039783716
colorectal B-Disease 1 0.9997231364250183
adenomas I-Disease 1 0.9991262555122375
( O 0 0.0001521248195786029
typically O 0 2.0690813471446745e-05
fewer O 0 1.0668087270460092e-05
than O 0 2.0133254565735115e-06
100 O 0 3.114961373285041e-06
) O 0 2.0962077087460784e-06
without O 0 2.5138776891253656e-06
the O 0 4.9274685807176866e-06
florid O 0 0.2879393994808197
phenotype O 0 0.10107306391000748
of O 0 2.019085150095634e-05
classical O 0 0.00047158010420389473
FAP B-Disease 1 0.9750652313232422
. O 0 0.0004265803727321327

Another O 0 0.0002237446460640058
group O 0 9.925034828484058e-05
of O 0 2.8123144147684798e-05
patients O 1 0.9876930117607117
with O 0 8.926272130338475e-05
multiple O 0 0.020943669602274895
adenomas B-Disease 1 0.9933986663818359
has O 0 3.416338950046338e-05
no O 0 8.794891982688569e-06
mutations O 0 0.0007975157350301743
in O 0 1.4675046031698002e-06
the O 0 2.300087317053112e-06
APC B-Disease 0 0.020298585295677185
gene O 0 0.00021680166537407786
, O 0 1.2436747738320264e-06
and O 0 1.0047402838608832e-06
their O 0 2.3406614673149306e-06
phenotype O 0 0.037018515169620514
probably O 0 5.418631644715788e-06
results O 0 1.6023892612793134e-06
from O 0 5.970146048639435e-07
variation O 0 2.61325385508826e-06
at O 0 1.2766276995535009e-06
a O 0 1.4769126437386149e-06
locus O 0 9.772238990990445e-05
, O 0 2.2522035578731447e-06
or O 0 3.790302571360371e-06
loci O 0 0.0002665635256562382
, O 0 2.022992930506007e-06
elsewhere O 0 8.085481567832176e-06
in O 0 2.296203774676542e-06
the O 0 6.483873221441172e-06
genome O 0 0.0009393629152327776
. O 0 0.00010260896669933572

Recently O 0 0.0007123149116523564
, O 0 1.92832994798664e-05
however O 0 7.2164243647421245e-06
, O 0 4.5501997192332055e-06
a O 0 9.851435606833547e-06
missense O 0 0.002904120134189725
variant O 0 0.0007648175815120339
of O 0 6.439013304770924e-06
APC B-Disease 0 0.07038037478923798
( O 0 5.1123060984537005e-05
I1307K O 0 0.002792384009808302
) O 0 4.527716555458028e-06
was O 0 1.3470740896082134e-06
described O 0 1.4291185834736098e-05
that O 0 2.51673463935731e-06
confers O 0 0.0026553948409855366
an O 0 7.394561635010177e-06
increased O 0 0.0009522040490992367
risk O 1 0.7648574113845825
of O 0 0.004031405318528414
colorectal B-Disease 1 0.9998980760574341
tumors I-Disease 1 0.9997335076332092
, O 0 9.26487919059582e-05
including O 0 0.00016969074204098433
multiple O 0 0.10250354558229446
adenomas B-Disease 1 0.9948874115943909
, O 0 6.138275057310238e-05
in O 0 7.001611083978787e-05
Ashkenazim O 0 0.2325783520936966
. O 0 0.0003257794596720487

We O 0 3.897133865393698e-05
have O 0 7.911881766631268e-06
studied O 0 7.952685336931609e-06
a O 0 2.147084842363256e-06
set O 0 2.0459767711145105e-06
of O 0 3.4003296605078503e-06
164 O 0 0.037567559629678726
patients O 1 0.9974592328071594
with O 0 0.0022038868628442287
multiple O 1 0.9748964905738831
colorectal B-Disease 1 0.9998986721038818
adenomas I-Disease 1 0.9995961785316467
and I-Disease 0 0.006176219787448645
/ I-Disease 1 0.9294953346252441
or I-Disease 0 0.0021127338986843824
carcinoma I-Disease 1 0.9991657733917236
and O 0 7.519999780924991e-05
analyzed O 0 0.00285959430038929
codons O 0 0.005409207660704851
1263 O 0 0.24184130132198334
- O 0 0.004839352332055569
1377 O 0 0.07274894416332245
( O 0 5.7759501942200586e-05
exon O 0 0.0005429749726317823
15G O 0 0.0015608357498422265
) O 0 4.7069479478523135e-06
of O 0 9.184954592456052e-07
the O 0 2.634651764310547e-06
APC B-Disease 0 0.0025314013473689556
gene O 0 0.0002222435869043693
for O 0 1.3282110558066051e-05
germ O 0 0.4634963870048523
- O 0 0.0014250286621972919
line O 0 8.671817340655252e-05
variants O 0 0.00039312150329351425
. O 0 0.0001417346647940576

Three O 0 0.00034609780414029956
patients O 1 0.8611723780632019
with O 0 1.3501219655154273e-05
the O 0 9.745107490743976e-06
I1307K O 0 0.009818565100431442
allele O 0 0.0005510668270289898
were O 0 2.0682887225120794e-06
detected O 0 4.608368908520788e-05
, O 0 1.353006837234716e-06
each O 0 1.3276816162033356e-06
of O 0 4.496960627875524e-06
Ashkenazi O 0 0.011229286901652813
descent O 0 0.00045534217497333884
. O 0 0.00012288872676435858

Four O 0 0.0009897692361846566
patients O 1 0.977556049823761
had O 0 4.426718078320846e-05
a O 0 5.044025965617038e-05
germ O 1 0.5328753590583801
- O 0 0.0022956542670726776
line O 0 6.967774243094027e-05
E1317Q O 0 0.012994417920708656
missense O 0 0.039715781807899475
variant O 0 0.001079045468941331
of O 0 4.144194463151507e-06
APC O 0 0.002302645705640316
that O 0 1.1343837513777544e-06
was O 0 6.118780788710865e-07
not O 0 2.8672363328041683e-07
present O 0 3.651204565358057e-07
in O 0 3.100359720065171e-07
controls O 0 2.5464375994488364e-06
; O 0 5.453414360090392e-07
one O 0 1.5360521388174675e-07
of O 0 1.1623038176367118e-07
these O 0 3.053219188586809e-07
individuals O 0 1.8265367316416814e-06
had O 0 6.237243610485166e-07
an O 0 5.612125164589088e-07
unusually O 0 0.00011143535084556788
large O 0 1.6973885976767633e-06
number O 0 8.891129823496158e-07
of O 0 2.3063914795784513e-06
metaplastic B-Disease 0 0.0699496641755104
polyps I-Disease 1 0.5906394124031067
of I-Disease 0 5.308041636453709e-06
the I-Disease 0 1.9073575458605774e-05
colorectum I-Disease 0 0.027810974046587944
. O 0 0.0001717165287118405

There O 0 4.120744779356755e-05
is O 0 1.0581050446489826e-05
increasing O 0 1.3614092495117802e-05
evidence O 0 5.214428256294923e-06
that O 0 8.558193371754896e-07
there O 0 1.413480731571326e-06
exist O 0 6.969464720896212e-06
germ O 0 0.05727768689393997
- O 0 0.00013292756921146065
line O 0 4.425549377629068e-06
variants O 0 7.54414577386342e-06
of O 0 5.430491114566394e-07
the O 0 2.953937837446574e-06
APC B-Disease 0 0.011026454158127308
gene O 0 0.00025705815642140806
that O 0 3.2124521567311604e-06
predispose O 0 0.010431895032525063
to O 0 1.0608902130115894e-06
the O 0 1.1836192470582318e-06
development O 0 3.4164986573159695e-05
of O 0 2.3756181690259837e-05
multiple O 1 0.9313450455665588
colorectal B-Disease 1 0.9998902082443237
adenomas I-Disease 1 0.9997302889823914
and I-Disease 0 0.03273577243089676
carcinoma I-Disease 1 0.999742329120636
, O 0 2.9167211323510855e-05
but O 0 3.2699908842914738e-06
without O 0 2.7260514343652176e-06
the O 0 3.4495481031626696e-06
florid O 1 0.7727481126785278
phenotype O 0 0.25292906165122986
of O 0 4.61017043562606e-06
classical O 0 0.0001424182701157406
FAP B-Disease 1 0.9886406660079956
, O 0 5.971973678242648e-06
and O 0 2.6987870569428196e-06
possibly O 0 3.120875408058055e-05
with O 0 1.2324650924711023e-05
importance O 0 0.0021497204434126616
for O 0 0.11342236399650574
colorectal B-Disease 1 0.9999275207519531
cancer I-Disease 1 0.9999017715454102
risk O 1 0.7848439812660217
in O 0 1.0652806849975605e-05
the O 0 4.424675807968015e-06
general O 0 1.824644823500421e-05
population O 0 1.618039095774293e-05
. O 0 1.4226106941350736e-05
. O 0 5.921153206145391e-05

Genomic O 0 0.003845589468255639
structure O 0 0.0002535459934733808
of O 0 2.801858317980077e-05
the O 0 0.00016215816140174866
human O 1 0.664282500743866
congenital B-Disease 1 0.9996457099914551
chloride I-Disease 1 0.9976882934570312
diarrhea I-Disease 1 0.9996788501739502
( O 1 0.6138421893119812
CLD B-Disease 1 0.9953763484954834
) O 0 0.0012253561289981008
gene O 0 0.0365343801677227
. O 0 0.0003594313748180866

Congenital B-Disease 1 0.9981679916381836
chloride I-Disease 1 0.9930292963981628
diarrhea I-Disease 1 0.9993330836296082
( O 0 0.34233230352401733
CLD B-Disease 1 0.9968737363815308
) O 0 0.0001311159139731899
is O 0 1.8607915990287438e-05
caused O 0 0.0016469047404825687
by O 0 5.861830231879139e-06
mutations O 0 0.0007135099731385708
in O 0 2.695296871024766e-06
a O 0 5.752461675001541e-06
gene O 0 0.00013226072769612074
which O 0 3.1537419999949634e-06
encodes O 0 0.00016270832566078752
an O 0 8.370689465664327e-05
intestinal O 1 0.9944353103637695
anion O 1 0.7347568869590759
transporter O 1 0.6310552954673767
. O 0 0.0005303621874190867

We O 0 5.250240792520344e-05
report O 0 2.386207961535547e-05
here O 0 3.6414023725228617e-06
the O 0 1.354620735583012e-06
complete O 0 6.85905797581654e-06
genomic O 0 7.918771734694019e-05
organization O 0 1.1417278983572032e-05
of O 0 1.7121490145655116e-06
the O 0 6.202292752277572e-06
human O 0 0.0019250535406172276
CLD B-Disease 1 0.9944104552268982
gene O 0 0.001082173315808177
which O 0 3.573567255443777e-06
spans O 0 0.0001865440426627174
approximately O 0 1.8559498130343854e-05
39kb O 0 0.0007861830526962876
, O 0 3.3604712825763272e-06
and O 0 1.7925241309058038e-06
comprises O 0 1.6219939425354823e-05
21 O 0 4.558588989311829e-05
exons O 0 0.0008304096991196275
. O 0 0.00011195331171620637

All O 0 0.0002383900573477149
exon O 0 0.004957679659128189
/ O 0 0.0051061175763607025
intron O 0 0.004311190918087959
boundaries O 0 4.963424362358637e-05
conform O 0 0.00010331666271667928
to O 0 9.420770766155329e-06
the O 0 2.503064570191782e-05
GT O 0 0.16793948411941528
/ O 0 0.10726406425237656
AG O 0 0.36961829662323
rule O 0 0.00030996237182989717
. O 0 0.00012059190339641646

An O 0 2.1713047317462042e-05
analysis O 0 1.1855355296574999e-05
of O 0 1.7095287603297038e-06
the O 0 3.4264953683305066e-06
putative O 0 0.0005528065958060324
promoter O 0 0.0004284805909264833
region O 0 2.9461918529705144e-05
sequence O 0 1.2672725461015943e-05
shows O 0 7.102362815203378e-06
a O 0 8.089198672678322e-06
putative O 0 0.0026699260342866182
TATA O 0 0.03324218466877937
box O 0 6.150544504635036e-05
and O 0 7.93371600593673e-06
predicts O 0 0.0006698922370560467
multiple O 0 6.201169162523001e-05
transcription O 0 9.180285269394517e-05
factor O 0 5.833720206283033e-05
binding O 0 6.196711910888553e-05
sites O 0 0.00010744501923909411
. O 0 0.00011116640962427482

The O 0 5.569924178416841e-05
genomic O 0 0.0003199371858499944
structure O 0 5.024060374125838e-05
was O 0 4.727736722998088e-06
determined O 0 4.868947598879458e-06
using O 0 1.0610186791382148e-06
DNA O 0 3.77538162865676e-06
from O 0 4.5344387444856693e-07
several O 0 5.293854314913915e-07
sources O 0 1.176762452814728e-06
including O 0 1.215945417243347e-06
multiple O 0 2.2108564735390246e-05
large O 0 7.1307185862679034e-06
- O 0 0.00035443046363070607
insert O 0 0.0007602071855217218
libaries O 0 0.004354095086455345
and O 0 6.044420388207072e-06
genomic O 0 0.00030224869260564446
DNA O 0 0.0001207981476909481
from O 0 2.9652119337697513e-05
Finnish O 0 0.10543505847454071
CLD B-Disease 1 0.9975780844688416
patients O 1 0.9946140646934509
and O 0 8.436899952357635e-05
controls O 0 0.0007225980516523123
. O 0 0.00019806556520052254

Exon O 0 0.010418809950351715
- O 0 0.0015486844349652529
specific O 0 7.329347863560542e-05
primers O 0 0.001162131899036467
developed O 0 6.839390698587522e-05
in O 0 2.7490127649798524e-06
this O 0 1.385570726597507e-06
study O 0 1.6240279364865273e-05
will O 0 2.757304628175916e-06
facilitate O 0 0.00010467824904480949
mutation O 0 0.007455384358763695
screening O 0 0.002412099391222
studies O 0 0.00020496897923294455
of O 0 1.9363867977517657e-05
patients O 1 0.9938784241676331
with O 0 0.00014088471652939916
the O 0 0.0004058648191858083
disease O 1 0.9980886578559875
. O 0 0.0009412374929524958

Genomic O 0 0.0013229026226326823
sequencing O 0 0.00021503385505639017
of O 0 2.0989020413253456e-05
a O 0 9.601008787285537e-05
BAC O 1 0.7140254378318787
clone O 0 0.39439597725868225
H O 1 0.5780142545700073
_ O 0 0.00012500975572038442
RG364P16 O 0 0.002157744253054261
revealed O 0 2.997767660417594e-05
the O 0 8.075048754108138e-07
presence O 0 2.5362705855513923e-06
of O 0 4.1473123246760224e-07
another O 0 1.65313770139619e-06
, O 0 1.5658582697142265e-06
highly O 0 1.4779434422962368e-05
homologous O 0 0.00017727680096868426
gene O 0 5.553016308113001e-05
3 O 0 2.7312146357871825e-06
of O 0 7.962132713146275e-07
the O 0 7.19191120879259e-06
CLD B-Disease 1 0.9891611933708191
gene O 0 0.00021161579934414476
, O 0 1.2725338365271455e-06
with O 0 9.96355879578914e-07
a O 0 1.973269490918028e-06
similar O 0 9.745209354150575e-06
genomic O 0 0.0002500835107639432
structure O 0 4.580005770549178e-05
, O 0 5.91955722484272e-06
recently O 0 8.577255357522517e-05
identified O 0 6.069450682844035e-05
as O 0 7.379795533779543e-06
the O 0 9.358681563753635e-05
Pendred B-Disease 1 0.9965204000473022
syndrome I-Disease 1 0.9997027516365051
gene O 1 0.5252519845962524
( O 0 0.0007097075576893985
PDS B-Disease 1 0.6183152198791504
) O 0 6.12473304499872e-05
. O 0 3.571117122191936e-05
. O 0 9.416079410584643e-05

The O 0 0.0004173507622908801
APCI1307K O 1 0.813666820526123
allele O 0 0.4567872881889343
and O 0 0.005324156489223242
cancer B-Disease 1 0.9993013143539429
risk O 0 0.25180667638778687
in O 0 9.507614777248818e-06
a O 0 1.0642550478223711e-05
community O 0 3.6329569411464036e-05
- O 0 0.0003888330247718841
based O 0 1.0741825462901033e-05
study O 0 5.670304017257877e-05
of O 0 7.927061233203858e-06
Ashkenazi O 0 0.02271832898259163
Jews O 0 0.00023446869454346597
. O 0 0.00011789086420321837

Mutations O 0 0.2364458292722702
in O 0 0.00014167359040584415
APC O 0 0.1138356477022171
are O 0 9.770840551936999e-05
classically O 1 0.7754102349281311
associated O 0 0.01292163971811533
with O 0 0.02892807498574257
familial B-Disease 1 0.9991661310195923
adenomatous I-Disease 1 0.9995999932289124
polyposis I-Disease 1 0.9996242523193359
( O 1 0.6006799340248108
FAP B-Disease 1 0.9958919286727905
) O 0 0.00020341493654996157
, O 0 2.749465056695044e-05
a O 0 0.00017343727813567966
highly O 0 0.1775691658258438
penetrant O 1 0.9979032278060913
autosomal B-Disease 1 0.9993522763252258
dominant I-Disease 1 0.9945386052131653
disorder I-Disease 1 0.9998186230659485
characterized O 1 0.9963181018829346
by O 0 0.01835954561829567
multiple O 1 0.9929599165916443
intestinal O 1 0.9997991919517517
polyps B-Disease 1 0.9988774657249451
and O 0 0.00014596511027775705
, O 0 3.4977496397914365e-05
without O 0 0.00010719674173742533
surgical O 1 0.9829292297363281
intervention O 0 0.003221507417038083
, O 0 8.908988093025982e-06
the O 0 7.5142038440390024e-06
development O 0 0.0016506746178492904
of O 0 0.003136285813525319
colorectal B-Disease 1 0.999849796295166
cancer I-Disease 1 0.999776303768158
( O 0 0.032167863100767136
CRC B-Disease 1 0.907947838306427
) O 0 0.00023537178640253842
. O 0 0.000159349205205217

APC B-Disease 0 0.09102165699005127
is O 0 0.00019249270553700626
a O 0 0.0006501466850750148
tumour O 1 0.9956240057945251
- O 0 0.15058010816574097
suppressor O 1 0.7315739989280701
gene O 0 0.005590635817497969
, O 0 1.625242475711275e-05
and O 0 1.935587715706788e-05
somatic O 0 0.09200139343738556
loss O 0 0.06330165266990662
occurs O 0 0.004034088924527168
in O 0 0.00023977849923539907
tumours B-Disease 1 0.9953027963638306
. O 0 0.0007730721845291555

The O 0 0.0006094385171309114
germline O 1 0.8658592700958252
T O 0 0.3471429944038391
- O 0 0.0006161445053294301
to O 0 9.813468750508036e-06
- O 0 0.00026273331604897976
A O 0 2.037417834799271e-05
transversion O 0 0.0016560275107622147
responsible O 0 2.4640781703055836e-05
for O 0 2.3769230210746173e-06
the O 0 4.473908120417036e-06
APC O 0 0.0035943195689469576
I1307K O 0 0.0008840055670589209
allele O 0 8.37538464111276e-05
converts O 0 1.0027119969890919e-05
the O 0 2.1705657218262786e-06
wild O 0 1.68927144841291e-05
- O 0 6.751880573574454e-05
type O 0 2.7564907213672996e-05
sequence O 0 6.096639481256716e-06
to O 0 2.6621944471116876e-06
a O 0 1.6440330000477843e-05
homopolymer O 0 0.40097156167030334
tract O 1 0.9838632345199585
( O 0 0.00021768719307146966
A8 O 0 0.2945266366004944
) O 0 6.842535185569432e-06
that O 0 2.010629486903781e-06
is O 0 4.8373453864769544e-06
genetically O 0 0.0007545520202256739
unstable O 0 0.11340329051017761
and O 0 2.2801235900260508e-05
prone O 0 0.11779221147298813
to O 0 3.206523979315534e-05
somatic O 0 0.09124655276536942
mutation O 0 0.04242958500981331
. O 0 0.000278116058325395

The O 0 0.00013822731852997094
I1307K O 0 0.0032262851018458605
allele O 0 0.0010023429058492184
was O 0 1.915794564411044e-05
found O 0 2.3079530365066603e-05
in O 0 1.6078438420663588e-05
6 O 0 0.00011971107596764341
. O 0 9.918885916704312e-05

1 O 0 0.00011289303074590862
% O 0 1.93328542081872e-05
of O 0 1.1994652595603839e-05
unselected O 0 0.10653886198997498
Ashkenazi O 0 0.03223142772912979
Jews O 0 3.0159359084791504e-05
and O 0 3.969514182244893e-06
higher O 0 1.6538928321097046e-05
proportions O 0 0.0010553478496149182
of O 0 3.1660244985687314e-06
Ashkenazim O 0 0.07179795205593109
with O 0 1.3840221981809009e-05
family O 0 6.88745712977834e-05
or O 0 7.951160114316735e-06
personal O 0 7.680368435103446e-05
histories O 0 0.0018600649200379848
of O 0 1.0403467058495153e-05
CRC B-Disease 0 0.4784086048603058
( O 0 7.482203363906592e-05
ref O 0 0.007735176011919975
. O 0 9.455550753045827e-06
2 O 0 2.6965442884829827e-05
) O 0 3.727703006006777e-05
. O 0 5.166275514056906e-05

To O 0 5.091541606816463e-05
evaluate O 0 0.00028687159647233784
the O 0 6.169374955788953e-06
role O 0 1.0795802154461853e-05
of O 0 3.923177700926317e-06
I1307K O 0 0.020987629890441895
in O 0 9.013433009386063e-05
cancer B-Disease 1 0.9981058835983276
, O 0 9.978059097193182e-06
we O 0 6.470659627666464e-06
genotyped O 0 0.002513868035748601
5 O 0 2.2482106942334212e-05
, O 0 2.3608972696820274e-05
081 O 0 0.4864915907382965
Ashkenazi O 0 0.017383400350809097
volunteers O 0 9.228093404090032e-05
in O 0 6.166457296785666e-06
a O 0 1.2795977454516105e-05
community O 0 4.295707185519859e-05
survey O 0 0.0001439368206774816
. O 0 0.00010206230217590928

Risk O 1 0.6832128167152405
of O 0 0.0003727158182300627
developing O 1 0.9522545337677002
colorectal B-Disease 1 0.9994931221008301
, I-Disease 0 0.008253015577793121
breast I-Disease 1 0.9987319111824036
and I-Disease 0 7.160763925639912e-05
other I-Disease 0 6.454288813984022e-05
cancers I-Disease 1 0.9961368441581726
were O 0 3.480195800875663e-06
compared O 0 5.20099674758967e-05
between O 0 2.5256302251364104e-05
genotyped O 0 0.23626308143138885
I1307K O 0 0.07983849197626114
carriers O 0 0.0008461875258944929
and O 0 4.026118403999135e-06
non O 0 3.3862481359392405e-05
- O 0 0.00026885888655669987
carriers O 0 5.1997565606143326e-05
and O 0 8.393358825742325e-07
their O 0 9.377300216328877e-07
first O 0 3.8086554923211224e-06
- O 0 0.0005962355062365532
degree O 0 0.0003024715115316212
relatives O 0 0.0007953353342600167
. O 0 0.0001267980842385441

Sperm O 0 0.002141987206414342
DNA O 0 0.0005059763789176941
analysis O 0 0.00014960512635298073
in O 0 5.200133455218747e-05
a O 0 0.00045192299876362085
Friedreich B-Disease 1 0.9954752326011658
ataxia I-Disease 1 0.998132050037384
premutation O 1 0.9245831370353699
carrier O 0 0.01909710466861725
suggests O 0 0.0003657557535916567
both O 0 1.349914600723423e-05
meiotic O 0 0.009572573006153107
and O 0 8.578224878874607e-06
mitotic O 0 0.0003991940466221422
expansion O 0 5.311198765411973e-05
in O 0 6.583077265531756e-06
the O 0 1.4709214156027883e-05
FRDA B-Disease 0 0.10252834111452103
gene O 0 0.0041253939270973206
. O 0 0.00018778971571009606

Friedreich B-Disease 1 0.9811950325965881
ataxia I-Disease 1 0.9902448654174805
is O 0 0.00021391935297288
usually O 0 6.940075400052592e-05
caused O 0 0.0003747587907128036
by O 0 2.755785089902929e-06
an O 0 1.498101823926845e-06
expansion O 0 1.0182799087488092e-05
of O 0 2.1184591787459794e-06
a O 0 1.9354954929440282e-05
GAA O 0 0.0037822327576577663
trinucleotide O 0 0.430775910615921
repeat O 0 0.00047901246580295265
in O 0 6.629319614148699e-06
intron O 0 0.003809120040386915
1 O 0 9.164548828266561e-06
of O 0 4.008835276181344e-06
the O 0 1.7463111362303607e-05
FRDA B-Disease 0 0.0639110878109932
gene O 0 0.004431757610291243
. O 0 0.0001794384588720277

Occasionally O 0 0.00039653436397202313
, O 0 1.7867547285277396e-05
a O 0 9.901467819872778e-06
fully O 0 3.1512488931184635e-05
expanded O 0 2.18290642806096e-05
allele O 0 0.0001473887386964634
has O 0 2.9693139822484227e-06
been O 0 1.0068303026855574e-06
found O 0 1.3114905641486985e-06
to O 0 6.241337473511521e-07
arise O 0 3.5814511647913605e-05
from O 0 6.66425762574363e-07
a O 0 1.5405942122015404e-06
premutation O 0 9.715069609228522e-05
of O 0 7.435565976265934e-07
100 O 0 3.624574446803308e-06
or O 0 4.954297764925286e-06
less O 0 4.15329632232897e-05
triplet O 0 0.048027317970991135
repeats O 0 0.0022937438916414976
. O 0 0.0001841947523644194

We O 0 7.276199903571978e-05
have O 0 1.6267156752292067e-05
examined O 0 6.882243906147778e-05
the O 0 3.651518227343331e-06
sperm O 0 3.1115501769818366e-05
DNA O 0 1.7817761545302346e-05
of O 0 2.964532086480176e-06
a O 0 3.00221327051986e-05
premutation O 0 0.04341041296720505
carrier O 0 0.003853708505630493
. O 0 0.00019354026881046593

This O 0 0.00010689978807931766
mans O 0 0.0009402260184288025
leucocyte O 0 0.0034899318125098944
DNA O 0 9.34812196646817e-05
showed O 0 1.534539660497103e-05
one O 0 2.7130138278153026e-06
normal O 0 2.2938638721825555e-05
allele O 0 4.0830786019796506e-05
and O 0 1.6460364804515848e-06
one O 0 1.8734392597252736e-06
allele O 0 3.213185118511319e-05
of O 0 1.8821066305463319e-06
approximately O 0 1.962991700565908e-05
100 O 0 3.8777157897129655e-05
repeats O 0 0.0006510944804176688
. O 0 0.00016131490701809525

His O 0 0.00012380778207443655
sperm O 0 0.000261743989540264
showed O 0 3.5977453080704436e-05
an O 0 4.835472736886004e-06
expanded O 0 1.3742724149778951e-05
allele O 0 5.5317694204859436e-05
in O 0 1.5535214288320276e-06
a O 0 2.2690105652145576e-06
tight O 0 1.083716779248789e-05
range O 0 5.54618782189209e-06
centering O 0 1.7477606888860464e-05
on O 0 8.420859671787184e-07
a O 0 1.872653342616104e-06
size O 0 5.703913302568253e-06
of O 0 3.4135860005335417e-06
approximately O 0 5.728130417992361e-05
320 O 0 0.003405527677386999
trinucleotide O 1 0.7261353731155396
repeats O 0 0.0031043551862239838
. O 0 0.0002588481002021581

His O 0 0.0012029019417241216
affected O 0 0.024036508053541183
son O 0 0.0010058748302981257
has O 0 2.2080897906562313e-05
repeat O 0 0.00041898636845871806
sizes O 0 5.8941292081726715e-05
of O 0 1.3314410352904815e-05
1040 O 0 0.026665745303034782
and O 0 4.493201777222566e-05
540 O 0 0.007533548399806023
. O 0 0.0002428833831800148

These O 0 2.6880868972511962e-05
data O 0 1.190443344967207e-05
suggest O 0 1.751960917317774e-05
that O 0 1.2403535265548271e-06
expansion O 0 7.662202733627055e-06
occurs O 0 4.7540183913952205e-06
in O 0 4.104055904008419e-07
two O 0 4.556121098175936e-07
stages O 0 5.696286734746536e-06
, O 0 2.8689538567050477e-07
the O 0 1.9028203723792103e-07
first O 0 3.755247917069937e-07
during O 0 2.1599948922812473e-06
meiosis O 0 0.00014454848133027554
followed O 0 2.2315800833894173e-06
by O 0 9.250832704310596e-07
a O 0 3.2966183880489552e-06
second O 0 7.905771781224757e-06
mitotic O 0 0.0009907042840495706
expansion O 0 0.0005305955419316888
. O 0 0.0001315868430538103

We O 0 3.648671190603636e-05
also O 0 6.338146704365499e-06
show O 0 4.7425710363313556e-06
that O 0 7.866174200898968e-07
in O 0 6.756292236786976e-07
all O 0 5.637755862153426e-07
informative O 0 5.525083906832151e-05
carrier O 0 0.0004172970657236874
father O 0 3.762524647754617e-05
to O 0 2.932465577032417e-06
affected O 0 0.0005521699204109609
child O 0 0.00014605170872528106
transmissions O 0 2.1694790120818652e-05
, O 0 5.897947517041757e-07
with O 0 4.693992252668977e-07
the O 0 5.286433406581637e-07
notable O 0 2.3621937543794047e-06
exception O 0 3.1772158308740472e-06
of O 0 3.207674978966679e-07
the O 0 1.5515227005380439e-06
premutation O 0 0.002286283066496253
carrier O 0 0.00010779886360978708
, O 0 1.6922213035286404e-06
the O 0 1.2552233101814636e-06
expansion O 0 1.471336781833088e-05
size O 0 1.762120155035518e-05
decreases O 0 0.00012735911877825856
. O 0 2.0507533918134868e-05
. O 0 6.888429197715595e-05

The O 0 0.0001921404618769884
R496H O 0 0.006302868016064167
mutation O 0 0.001350146485492587
of O 0 1.4860020201012958e-05
arylsulfatase O 0 0.01987706683576107
A O 0 8.816786430543289e-05
does O 0 0.00011991672363365069
not O 0 5.321637945598923e-05
cause O 0 0.08617483079433441
metachromatic B-Disease 1 0.9447625279426575
leukodystrophy I-Disease 1 0.9924184083938599
. O 0 0.0011622150195762515

Deficiency B-Disease 1 0.992201566696167
of I-Disease 0 0.0001398310123477131
arylsulfatase I-Disease 0 0.16555286943912506
A I-Disease 0 0.0006623222725465894
( O 0 0.0009119840105995536
ARSA O 1 0.9839122891426086
) O 0 0.0003817924007307738
enzyme O 0 0.018425744026899338
activity O 0 0.002329091774299741
causes O 1 0.947984516620636
metachromatic B-Disease 1 0.9906874299049377
leukodystrophy I-Disease 1 0.9964812994003296
( O 0 0.04286254942417145
MLD B-Disease 1 0.9816116690635681
) O 0 0.0005943257128819823
. O 0 0.0003217179619241506

A O 0 0.00012568352394737303
number O 0 3.83136430173181e-05
of O 0 4.131442619836889e-05
ARSA O 1 0.9802412986755371
gene O 0 0.10600638389587402
mutations O 0 0.13908348977565765
responsible O 0 0.0009863154264166951
for O 0 0.0001528476132079959
MLD B-Disease 1 0.9917872548103333
have O 0 2.5711869966471568e-05
been O 0 2.1224319425527938e-05
identified O 0 0.00019912443531211466
. O 0 0.00010188085434492677

Recently O 0 0.0004680176789406687
, O 0 1.4267109690990765e-05
the O 0 8.380614417546894e-06
R496H O 0 0.0015141329495236278
mutation O 0 0.000355532334651798
of O 0 4.409283974382561e-06
ARSA O 1 0.62498539686203
was O 0 4.278123014955781e-06
proposed O 0 6.827725883340463e-06
to O 0 7.180098009484936e-07
be O 0 5.782039806945249e-07
a O 0 2.8186834697407903e-06
cause O 0 0.00029991380870342255
of O 0 6.496919922938105e-06
MLD B-Disease 1 0.9950577020645142
( O 0 0.0002499824040569365
Draghia O 0 0.2340005487203598
et O 0 0.00933358445763588
al O 0 0.0003510811657179147
. O 0 4.36502295997343e-06
, O 0 5.4656998145219404e-06
1997 O 0 5.375057662604377e-05
) O 0 2.361235056014266e-05
. O 0 4.6993685828056186e-05

We O 0 0.00010495309834368527
have O 0 3.0466006137430668e-05
investigated O 0 0.00015156420704443008
the O 0 8.048838026297744e-06
R496H O 0 0.0018547129584476352
mutation O 0 0.000475076783914119
and O 0 2.076395276162657e-06
found O 0 1.8283037661603885e-06
this O 0 6.167736046336358e-07
mutation O 0 4.0338567487197e-05
at O 0 8.696165423316415e-07
a O 0 1.069735048986331e-06
relatively O 0 4.924781933368649e-06
high O 0 2.0375784970383393e-06
frequency O 0 1.5993723536666948e-06
in O 0 4.871196210842754e-07
an O 0 6.210278797880164e-07
African O 0 3.577932375264936e-06
American O 0 2.1771370484202635e-06
population O 0 3.0262963264249265e-06
( O 0 5.521305865840986e-06
f O 0 2.9602990252897143e-05
= O 0 2.7829250029753894e-05
0 O 0 4.109251676709391e-06
. O 0 1.2108445162084536e-06
09 O 0 3.7757487007183954e-05
, O 0 3.4671534194785636e-06
n O 0 3.817854667431675e-05
= O 0 0.0001218762481585145
61 O 0 6.067922731745057e-05
subjects O 0 0.00011914758215425536
) O 0 5.218389560468495e-05
. O 0 7.511593139497563e-05

The O 0 0.0005218192818574607
ARSA O 1 0.9241476058959961
enzyme O 0 0.00214762962423265
activity O 0 5.5257161875488237e-05
in O 0 4.388467914395733e-06
subjects O 0 1.9253588106948882e-05
with O 0 1.494100956733746e-06
and O 0 1.1438773981353734e-06
without O 0 1.7728252714732662e-06
the O 0 1.7998042949329829e-06
R496H O 0 0.003900962183251977
mutation O 0 0.0007944026147015393
was O 0 1.3023658311794861e-06
determined O 0 3.6570977499650326e-06
and O 0 5.850436650689517e-07
found O 0 2.0697132185887313e-06
to O 0 1.5009619573902455e-06
be O 0 3.975166237069061e-06
normal O 0 6.738706724718213e-05
. O 0 4.261076173861511e-05

It O 0 3.371175262145698e-05
is O 0 1.2717362551484257e-05
therefore O 0 7.89373279985739e-06
concluded O 0 2.1277051928336732e-05
that O 0 1.2816145726901595e-06
the O 0 2.3684376628807513e-06
R496H O 0 0.0021722170058637857
mutation O 0 0.0005030041793361306
of O 0 5.313420388119994e-06
ARSA O 1 0.9382659196853638
does O 0 1.5317780707846396e-05
not O 0 1.5812578340046457e-06
negatively O 0 4.92952240165323e-05
influence O 0 3.2844420729816193e-06
the O 0 1.3059278671789798e-06
activity O 0 6.8306039793242235e-06
of O 0 2.66889014710614e-06
ARSA O 1 0.5139259099960327
and O 0 3.2826637834659778e-06
is O 0 2.416653387626866e-06
not O 0 3.1073686841409653e-06
a O 0 1.5268164133885875e-05
cause O 0 0.0035877525806427
of O 0 0.00013948809646535665
MLD B-Disease 1 0.9802374243736267

Down O 0 0.000606996298301965
- O 0 0.0009777238592505455
regulation O 0 0.00015104308840818703
of O 0 2.5081830244744197e-05
transmembrane O 0 0.15419787168502808
carbonic O 1 0.9845839738845825
anhydrases O 1 0.942376971244812
in O 0 0.007749594748020172
renal B-Disease 1 0.9996360540390015
cell I-Disease 1 0.9921675324440002
carcinoma I-Disease 1 0.9996640682220459
cell O 0 0.04828270897269249
lines O 0 0.0001717104751151055
by O 0 2.260617839056067e-05
wild O 0 0.0006902157911099494
- O 0 0.08633755892515182
type O 0 0.041141577064991
von B-Disease 1 0.8153587579727173
Hippel I-Disease 1 0.9910504817962646
- I-Disease 1 0.749885618686676
Lindau I-Disease 1 0.9827610850334167
transgenes O 1 0.792447030544281
. O 0 0.0005370283033698797

To O 0 0.00017534970538690686
discover O 0 0.0013058838667348027
genes O 0 0.0004977889475412667
involved O 0 0.00021470116917043924
in O 0 0.00010745667532319203
von B-Disease 1 0.7877733111381531
Hippel I-Disease 1 0.9940115809440613
- I-Disease 1 0.6684638857841492
Lindau I-Disease 1 0.9946631193161011
( O 0 0.0032926457934081554
VHL B-Disease 1 0.9889790415763855
) O 0 0.0001518678618595004
- O 0 0.014489450491964817
mediated O 0 0.24894888699054718
carcinogenesis O 1 0.987369954586029
, O 0 2.5139826902886853e-05
we O 0 1.3047480933892075e-05
used O 0 0.00033799733500927687
renal B-Disease 1 0.9995954632759094
cell I-Disease 1 0.9094175100326538
carcinoma I-Disease 1 0.9994434714317322
cell O 0 0.10895328223705292
lines O 0 0.0014214979019016027
stably O 0 0.20499597489833832
transfected O 0 0.395345002412796
with O 0 9.07142020878382e-05
wild O 0 0.0010090816067531705
- O 0 0.0366673581302166
type O 0 0.03187805414199829
VHL O 1 0.9853928685188293
- O 0 0.07702762633562088
expressing O 0 0.02564108744263649
transgenes O 1 0.5126147270202637
. O 0 0.0005307404207997024

Large O 0 0.00019176324713043869
- O 0 0.0003684624389279634
scale O 0 0.00014826480764895678
RNA O 0 9.882330050459132e-05
differential O 0 7.469734555343166e-05
display O 0 1.3834825040248688e-05
technology O 0 1.1470287972770166e-05
applied O 0 5.1488350436557084e-06
to O 0 5.828156304232834e-07
these O 0 8.283201395897777e-07
cell O 0 1.821317164285574e-05
lines O 0 5.272463567962404e-06
identified O 0 9.47352236835286e-06
several O 0 2.6954485292662866e-06
differentially O 0 0.0007775567355565727
expressed O 0 1.1287375855317805e-05
genes O 0 1.8170461771660484e-05
, O 0 1.138239440479083e-06
including O 0 2.3110371785151074e-06
an O 0 6.117280008766102e-06
alpha O 0 0.0009179066983051598
carbonic O 1 0.7681305408477783
anhydrase O 1 0.8842825889587402
gene O 0 0.010642866604030132
, O 0 7.284669845830649e-05
termed O 0 0.0225180983543396
CA12 O 0 0.24260278046131134
. O 0 0.000418631243519485

The O 0 3.504105916363187e-05
deduced O 0 8.908619929570705e-05
protein O 0 3.412483783904463e-05
sequence O 0 1.0647362614690792e-05
was O 0 2.7864109597430797e-06
classified O 0 1.742039603414014e-05
as O 0 1.1057003348469152e-06
a O 0 1.4466913853539154e-06
one O 0 1.7744440583555843e-06
- O 0 8.916557271732017e-05
pass O 0 1.5132481166801881e-05
transmembrane O 0 0.000905164866708219
CA O 0 0.00023046716523822397
possessing O 0 3.1375213438877836e-05
an O 0 2.778175030471175e-06
apparently O 0 2.301506719959434e-05
intact O 0 4.292926314519718e-05
catalytic O 0 4.4772048568120226e-05
domain O 0 1.3013356692681555e-05
in O 0 3.2121122330863727e-06
the O 0 5.304807473294204e-06
extracellular O 0 0.0005646887002512813
CA O 0 0.0006035442347638309
module O 0 0.0006097092409618199
. O 0 0.000141321710543707

Reintroduced O 0 0.018098732456564903
wild O 0 0.0025108209811151028
- O 0 0.04407300055027008
type O 0 0.023907287046313286
VHL B-Disease 1 0.9752833247184753
strongly O 0 0.00038778025191277266
inhibited O 0 0.0014403845416381955
the O 0 7.542376351921121e-06
overexpression O 0 0.0005277168238535523
of O 0 1.8064658888761187e-06
the O 0 6.518554982903879e-06
CA12 O 0 0.1263287514448166
gene O 0 0.0013521905057132244
in O 0 1.1870049092976842e-05
the O 0 6.465790647780523e-05
parental O 1 0.8620619177818298
renal B-Disease 1 0.99955815076828
cell I-Disease 1 0.9859769344329834
carcinoma I-Disease 1 0.999163031578064
cell O 0 0.18022474646568298
lines O 0 0.002661478240042925
. O 0 0.0003766122099477798

Similar O 0 0.00022808657377026975
results O 0 4.306268601794727e-05
were O 0 5.8334999266662635e-06
obtained O 0 7.438534339598846e-06
with O 0 1.5670784705434926e-05
CA9 O 1 0.8337810635566711
, O 0 5.9767940001620445e-06
encoding O 0 2.2642921976512298e-05
another O 0 1.1616732990660239e-05
transmembrane O 0 0.0008767068502493203
CA O 0 0.0001275389950023964
with O 0 2.592506916698767e-06
an O 0 4.496235760598211e-06
intact O 0 0.0001589067542226985
catalytic O 0 0.00039245575317181647
domain O 0 0.00020877814677078277
. O 0 0.0001443135115550831

Although O 0 6.0856669733766466e-05
both O 0 7.965512850205414e-06
domains O 0 2.107815998897422e-05
of O 0 2.151475428036065e-06
the O 0 6.286226380325388e-06
VHL B-Disease 1 0.6222172975540161
protein O 0 5.826241977047175e-05
contribute O 0 7.628746971022338e-05
to O 0 1.7972795376408612e-06
regulation O 0 8.168354725057725e-06
of O 0 1.463979174332053e-06
CA12 O 0 0.006093419156968594
expression O 0 1.2279703696549404e-05
, O 0 1.1216737902941532e-06
the O 0 1.5050326283017057e-06
elongin O 0 0.000535131897777319
binding O 0 1.6588688595220447e-05
domain O 0 2.441280048515182e-05
alone O 0 3.8960562960710377e-05
could O 0 1.5037534467410296e-05
effectively O 0 0.00016705194138921797
regulate O 0 0.0054254611022770405
CA9 O 1 0.9627723097801208
expression O 0 0.0006632711156271398
. O 0 0.00020875544578302652

We O 0 0.0002655174757819623
mapped O 0 0.0013777405256405473
CA12 O 0 0.04336708411574364
and O 0 0.00013704458251595497
CA9 O 1 0.9630721807479858
loci O 0 0.004937931429594755
to O 0 4.548032666207291e-05
chromosome O 0 0.001356421154923737
bands O 0 0.000160499126650393
15q22 O 0 0.003085749689489603
and O 0 5.9435784351080656e-05
17q21 O 0 0.009957080706954002
. O 0 0.00022919007460586727

2 O 0 0.00015446644101757556
respectively O 0 4.23103483626619e-05
, O 0 9.311213034379762e-06
regions O 0 8.620962034910917e-05
prone O 0 0.009141596034169197
to O 0 4.9097002374765e-06
amplification O 0 0.0002069208276225254
in O 0 6.34827347312239e-06
some O 0 1.82361836778e-05
human O 0 0.014511472545564175
cancers B-Disease 1 0.996664822101593
. O 0 0.00048542272998020053

Additional O 0 0.00012342329137027264
experiments O 0 7.054341404000297e-05
are O 0 2.9130990242265398e-06
needed O 0 5.06116566612036e-06
to O 0 1.0351650416851044e-06
define O 0 6.7673076955543365e-06
the O 0 1.0272659665133688e-06
role O 0 6.259527253860142e-06
of O 0 4.18496347265318e-06
CA O 0 0.009086793288588524
IX O 0 0.45167163014411926
and O 0 1.9278537365607917e-05
CA O 0 0.005162832792848349
XII O 0 0.22477319836616516
enzymes O 0 1.8461631043464877e-05
in O 0 1.1314829180264496e-06
the O 0 8.74759507496492e-07
regulation O 0 6.80257244312088e-06
of O 0 6.134404770818946e-07
pH O 0 0.00027348558069206774
in O 0 1.0556723282206804e-06
the O 0 1.1711076695064548e-06
extracellular O 0 0.0001978937943931669
microenvironment O 0 0.08599088340997696
and O 0 2.497794639566564e-06
its O 0 3.0041719583095983e-06
potential O 0 0.00020935024076607078
impact O 0 0.0006248895078897476
on O 0 5.139592394698411e-05
cancer B-Disease 1 0.998222291469574
cell O 0 0.01500366535037756
growth O 0 0.001686601317487657
. O 0 0.00018024217570200562

A O 0 0.00019835398416034877
gene O 0 0.00034530748962424695
encoding O 0 8.954424265539274e-05
a O 0 2.3523796699009836e-05
transmembrane O 0 0.001780190272256732
protein O 0 0.00047391848056577146
is O 0 7.140988600440323e-05
mutated O 0 0.41738709807395935
in O 0 0.001079319859854877
patients O 1 0.9990653395652771
with O 1 0.5797860026359558
diabetes B-Disease 1 0.999923586845398
mellitus I-Disease 1 0.999731719493866
and O 0 0.4574264585971832
optic B-Disease 1 0.999311089515686
atrophy I-Disease 1 0.9995166063308716
( O 1 0.9605579376220703
Wolfram B-Disease 1 0.9984685778617859
syndrome I-Disease 1 0.9994508624076843
) O 0 0.003250728128477931
. O 0 0.0006510317325592041

Wolfram B-Disease 1 0.9914236664772034
syndrome I-Disease 1 0.9989871382713318
( O 1 0.5325021743774414
WFS B-Disease 1 0.9932548999786377
; O 0 0.032183628529310226
OMIM O 1 0.9915384650230408
222300 O 0 0.20258091390132904
) O 0 0.00010906151146627963
is O 0 6.636226316913962e-05
an O 0 0.0013378753792494535
autosomal B-Disease 1 0.9989031553268433
recessive I-Disease 1 0.9994081258773804
neurodegenerative I-Disease 1 0.9998525381088257
disorder I-Disease 1 0.9996805191040039
defined O 0 0.08040259778499603
by O 0 0.0007456821040250361
young O 0 0.411093145608902
- O 1 0.9355654120445251
onset O 1 0.9980936646461487
non O 0 0.47616657614707947
- O 1 0.9848314523696899
immune O 1 0.9981505274772644
insulin B-Disease 1 0.9964439272880554
- I-Disease 1 0.9909092783927917
dependent I-Disease 1 0.9879606366157532
diabetes I-Disease 1 0.9998204112052917
mellitus I-Disease 1 0.9994482398033142
and O 0 0.02221955917775631
progressive O 1 0.9701797962188721
optic B-Disease 1 0.9978960752487183
atrophy I-Disease 1 0.9955310225486755
. O 0 0.003675879677757621

Linkage O 0 0.002405265113338828
to O 0 4.5705070078838617e-05
markers O 0 0.00027574269915930927
on O 0 1.661211899772752e-05
chromosome O 0 0.0021607906091958284
4p O 0 0.10618076473474503
was O 0 1.3049547305854503e-05
confirmed O 0 3.5478718928061426e-05
in O 0 4.063074356963625e-06
five O 0 1.6462374333059415e-05
families O 0 0.000180697490577586
. O 0 8.387429261347279e-05

On O 0 1.481855633755913e-05
the O 0 3.5581012980401283e-06
basis O 0 7.3820478974084835e-06
of O 0 8.998717021313496e-06
meiotic O 1 0.7290484309196472
recombinants O 1 0.8318750262260437
and O 0 0.0017984905280172825
disease O 1 0.999312162399292
- O 0 0.15814776718616486
associated O 0 0.002224485157057643
haplotypes O 0 0.10900386422872543
, O 0 1.2862508810940199e-05
the O 0 2.1530808226088993e-05
WFS B-Disease 1 0.9930918216705322
gene O 0 0.0013911989517509937
was O 0 7.835888936824631e-06
localized O 0 0.0008997314726002514
to O 0 4.969175279256888e-06
a O 0 3.673869650810957e-05
BAC O 1 0.6061947345733643
/ O 0 0.06271927803754807
P1 O 0 0.05127149075269699
contig O 0 0.000917320023290813
of O 0 2.234732164652087e-06
less O 0 1.0092441698361654e-05
than O 0 1.4667442883364856e-05
250 O 0 0.00014562423166353256
kb O 0 0.004880477208644152
. O 0 0.00020229833899065852

Mutations O 0 0.01215363759547472
in O 0 3.7108842661837116e-05
a O 0 2.6822892323252745e-05
novel O 0 0.00020821078214794397
gene O 0 0.0007653498905710876
( O 0 3.108676173724234e-05
WFS1 O 0 0.001977606676518917
) O 0 3.943674073525472e-06
encoding O 0 9.948586011887528e-06
a O 0 3.0156595585140167e-06
putative O 0 0.00016036161105148494
transmembrane O 0 0.00016355139086954296
protein O 0 1.4422458662011195e-05
were O 0 6.767719469280564e-07
found O 0 1.0674564236978767e-06
in O 0 4.6885878646207857e-07
all O 0 6.552571676365915e-07
affected O 0 0.00012494658585637808
individuals O 0 9.874065654003061e-06
in O 0 2.854415015463019e-06
six O 0 4.779545997735113e-05
WFS B-Disease 1 0.9946969747543335
families O 0 5.772052827524021e-05
, O 0 1.6535066151845967e-06
and O 0 1.1345298389642267e-06
these O 0 2.375445546931587e-06
mutations O 0 0.000441927055362612
were O 0 1.5162784166022902e-06
associated O 0 2.4918705094023608e-05
with O 0 1.7092294001486152e-05
the O 0 0.00029752496629953384
disease O 1 0.9987679123878479
phenotype O 1 0.9845882058143616
. O 0 0.0005455177742987871

WFS1 O 0 0.1403876394033432
appears O 0 0.00041094174957834184
to O 0 9.927478458848782e-06
function O 0 2.315788879059255e-05
in O 0 5.626118763757404e-06
survival O 0 0.0011081747943535447
of O 0 4.764294317283202e-06
islet O 0 0.032800476998090744
beta O 0 0.006291935220360756
- O 0 0.0068837120197713375
cells O 0 0.003688097931444645
and O 0 1.859906296886038e-05
neurons O 0 0.005620255134999752
. O 0 2.118585689458996e-05
. O 0 6.488100189017132e-05

Stable O 0 0.0011345499660819769
interaction O 0 9.242659143637866e-05
between O 0 9.052469067682978e-06
the O 0 3.5623454550659517e-06
products O 0 9.79109881882323e-06
of O 0 2.4877556370483944e-06
the O 0 2.505610609659925e-05
BRCA1 O 1 0.9891619682312012
and O 0 0.001390112447552383
BRCA2 O 1 0.9971235394477844
tumor B-Disease 1 0.9978285431861877
suppressor O 0 0.46129265427589417
genes O 0 0.00039136369014158845
in O 0 1.3493445294443518e-05
mitotic O 0 0.004793164785951376
and O 0 6.52849703328684e-05
meiotic O 1 0.8003408908843994
cells O 0 0.08141249418258667
. O 0 0.00031508345273323357

BRCA1 O 1 0.9747398495674133
and O 0 0.00027265274547971785
BRCA2 O 1 0.8809441924095154
account O 0 2.6693951440392993e-05
for O 0 5.488033821166027e-06
most O 0 8.516909474565182e-06
cases O 0 0.0002472288906574249
of O 0 9.62428475759225e-06
familial O 1 0.9956879019737244
, O 0 0.000945489329751581
early O 0 0.0552668459713459
onset O 1 0.9996088147163391
breast B-Disease 1 0.999777615070343
and I-Disease 0 0.042570773512125015
/ I-Disease 1 0.9962867498397827
or I-Disease 1 0.5210716724395752
ovarian I-Disease 1 0.9998828172683716
cancer I-Disease 1 0.9997565150260925
and O 0 1.807305852707941e-05
encode O 0 2.7096501071355306e-05
products O 0 1.1191584235348273e-05
that O 0 1.2390057690936374e-06
each O 0 2.069756646960741e-06
interact O 0 0.00010143048712052405
with O 0 1.8382259440841153e-05
hRAD51 O 0 0.009009693749248981
. O 0 0.00011477238149382174

Results O 0 0.00025814175023697317
presented O 0 6.35635806247592e-05
here O 0 1.2423847692843992e-05
show O 0 1.0970162293233443e-05
that O 0 6.929480605322169e-06
BRCA1 O 1 0.5683237314224243
and O 0 2.752156615315471e-05
BRCA2 O 1 0.9074080586433411
coexist O 0 0.0006494966219179332
in O 0 3.294619091320783e-06
a O 0 6.222174761205679e-06
biochemical O 0 0.0005738004110753536
complex O 0 9.776583465281874e-05
and O 0 7.786442438373342e-06
colocalize O 0 0.007524570450186729
in O 0 1.2075385711796116e-05
subnuclear O 0 0.019119931384921074
foci O 0 0.016781989485025406
in O 0 5.6656172091607004e-06
somatic O 0 0.0025802436284720898
cells O 0 0.00017779444169718772
and O 0 7.724527790742286e-07
on O 0 6.162432555356645e-07
the O 0 1.182643131869554e-06
axial O 0 0.00020060554379597306
elements O 0 4.953825282427715e-06
of O 0 5.01283193443669e-06
developing O 0 0.005522652994841337
synaptonemal O 0 0.21338199079036713
complexes O 0 0.057193368673324585
. O 0 0.00025789474602788687

Like O 0 0.004241980146616697
BRCA1 O 1 0.9605246782302856
and O 0 0.000491150189191103
RAD51 O 1 0.9671223163604736
, O 0 0.0005528545007109642
BRCA2 O 1 0.9742432832717896
relocates O 0 0.14293210208415985
to O 0 9.574621799401939e-05
PCNA O 1 0.5976307988166809
+ O 0 0.005809721536934376
replication O 0 0.0004153662302996963
sites O 0 3.639063288574107e-05
following O 0 3.7455203710123897e-05
exposure O 0 0.014525474980473518
of O 0 1.0744366591097787e-05
S O 0 0.017460323870182037
phase O 0 0.0017690175445750356
cells O 0 0.00259683676995337
to O 0 4.3700678361346945e-05
hydroxyurea O 1 0.8824981451034546
or O 0 0.0004964217660017312
UV O 1 0.9546594619750977
irradiation O 0 0.11167597025632858
. O 0 0.0003773225180339068

Thus O 0 0.00027028247131966054
, O 0 8.880782115738839e-05
BRCA1 O 1 0.8105425238609314
and O 0 6.133985152700916e-05
BRCA2 O 1 0.8644471168518066
participate O 0 1.453022468922427e-05
, O 0 1.44343630381627e-06
together O 0 9.314251201431034e-07
, O 0 6.92103981236869e-07
in O 0 9.565744676365284e-07
a O 0 2.7135934033140074e-06
pathway O 0 0.00016238314856309444
( O 0 1.1768313015636522e-05
s O 0 0.00017624429892748594
) O 0 1.5341635162258171e-06
associated O 0 1.800013706088066e-06
with O 0 4.7315569418060477e-07
the O 0 6.967948706915195e-07
activation O 0 1.0700151506171096e-05
of O 0 7.619506732226e-07
double O 0 2.466294972691685e-05
- O 0 0.00033919973066076636
strand O 0 0.00011320111661916599
break O 0 6.246739940252155e-05
repair O 0 0.055783193558454514
and O 0 2.625138222356327e-05
/ O 0 0.007560607511550188
or O 0 4.434593574842438e-05
homologous O 0 0.0014475060161203146
recombination O 0 0.001982121728360653
. O 0 0.0001279614371014759

Dysfunction O 1 0.9659030437469482
of O 0 2.3514869099017233e-05
this O 0 1.1639398508123122e-05
pathway O 0 0.00030426093144342303
may O 0 6.906402632012032e-06
be O 0 4.5309158736017707e-07
a O 0 8.615162983005575e-07
general O 0 3.058011770917801e-06
phenomenon O 0 2.79571922874311e-05
in O 0 4.22251673626306e-07
the O 0 4.900298335996922e-07
majority O 0 1.8572723092802335e-06
of O 0 1.0633474403221044e-06
cases O 0 0.0006719310185872018
of O 0 5.489916293299757e-05
hereditary B-Disease 1 0.9969959259033203
breast I-Disease 1 0.9996737241744995
and I-Disease 0 0.044808268547058105
/ I-Disease 1 0.9975517392158508
or I-Disease 1 0.8292806148529053
ovarian I-Disease 1 0.9999064207077026
cancer I-Disease 1 0.9997580647468567
. O 0 0.0008522612624801695
. O 0 0.0003645021060947329

A O 0 0.0003788650210481137
novel O 0 0.0007556629716418684
Arg362Ser O 0 0.02007119171321392
mutation O 0 0.0006080291932448745
in O 0 6.460369149863254e-06
the O 0 7.373900189122651e-06
sterol O 0 0.006428839638829231
27 O 0 0.00010072389704873785
- O 0 0.003551381640136242
hydroxylase O 0 0.31176573038101196
gene O 0 0.0014838099014014006
( O 0 3.4087628591805696e-05
CYP27 O 0 0.003984235692769289
) O 0 3.4094409784302115e-06
: O 0 1.596198330844345e-06
its O 0 1.267606535293453e-06
effects O 0 3.868039129883982e-05
on O 0 1.1721389228114276e-06
pre O 0 1.8591083062347025e-05
- O 0 2.969955312437378e-05
mRNA O 0 1.6032472558435984e-05
splicing O 0 5.034011337556876e-05
and O 0 1.0410285540274344e-05
enzyme O 0 0.0002712888235691935
activity O 0 0.00015443668235093355
. O 0 0.00012152947601862252

A O 0 0.0002141450677299872
novel O 0 0.00023286016948986799
C O 0 0.0002014662022702396
to O 0 3.057341245948919e-06
A O 0 5.224916549195768e-06
mutation O 0 5.00838432344608e-05
in O 0 1.3105216112307971e-06
the O 0 2.997000819959794e-06
sterol O 0 0.005582868587225676
27 O 0 8.284150680992752e-05
- O 0 0.006568622309714556
hydroxylase O 0 0.33075734972953796
gene O 0 0.0015597548335790634
( O 0 2.229581878054887e-05
CYP27 O 0 0.0020878014620393515
) O 0 2.796337867039256e-06
was O 0 1.133225737248722e-06
identified O 0 4.023911060357932e-06
by O 0 1.2288152220207849e-06
sequencing O 0 2.3183631128631532e-05
amplified O 0 0.00021884716989006847
CYP27 O 0 0.014222719706594944
gene O 0 0.0001800219906726852
products O 0 1.542896825412754e-05
from O 0 2.9378818453551503e-06
a O 0 2.2837075448478572e-05
patient O 0 0.413985937833786
with O 0 0.00010020550689660013
cerebrotendinous B-Disease 1 0.9645655751228333
xanthomatosis I-Disease 1 0.9444549083709717
( O 0 0.0015895389951765537
CTX B-Disease 1 0.9883852005004883
) O 0 0.000232660211622715
. O 0 0.0001911050349008292

The O 0 0.00014280420145951211
mutation O 0 0.0010411294642835855
changed O 0 4.902500950265676e-05
the O 0 1.068036272044992e-05
adrenodoxin O 0 0.0017053710762411356
cofactor O 0 0.0007948447018861771
binding O 0 8.312353020301089e-05
residue O 0 0.00047447168617509305
362Arg O 0 0.0022975618485361338
to O 0 1.4733205716765951e-05
362Ser O 0 0.00805399939417839
( O 0 7.263111183419824e-05
CGT O 0 0.018740901723504066
362Arg O 0 0.022059187293052673
to O 0 2.8197049687150866e-05
AGT O 1 0.9899619817733765
362Ser O 0 0.020188171416521072
) O 0 5.580780907621374e-06
, O 0 1.3702306205232162e-06
and O 0 1.0373767054261407e-06
was O 0 1.3353527492654393e-06
responsible O 0 3.8606023736065254e-05
for O 0 2.5996818294515833e-05
deficiency O 1 0.9987025260925293
in O 0 5.196754955250071e-06
the O 0 5.388254066929221e-06
sterol O 0 0.08130429685115814
27 O 0 0.0001224851148435846
- O 0 0.0023978804238140583
hydroxylase O 0 0.027214262634515762
activity O 0 1.0830348401213996e-05
, O 0 1.0065904234579648e-06
as O 0 6.417774329747772e-07
confirmed O 0 3.4012211926892633e-06
by O 0 5.506012712430675e-07
expression O 0 2.2228589386941167e-06
of O 0 1.0884167522817734e-06
mutant O 0 0.00014540099073201418
cDNA O 0 6.296319043030962e-05
into O 0 1.4686478607472964e-05
COS O 0 0.06464560329914093
- O 0 0.0007682698778808117
1 O 0 0.00010886306699831039
cells O 0 0.0010217007948085666
. O 0 0.000143858342198655

Quantitative O 0 0.0004766676283907145
analysis O 0 5.390909791458398e-05
showed O 0 1.4971367818361614e-05
that O 0 1.2935278164150077e-06
the O 0 1.0672487178453594e-06
expression O 0 5.541546670428943e-06
of O 0 2.222653392891516e-06
CYP27 O 0 0.004513180814683437
gene O 0 0.00010527425911277533
mRNA O 0 1.7161088180728257e-05
in O 0 3.0069411423028214e-06
the O 0 6.104953627072973e-06
patient O 0 0.02010953053832054
represented O 0 3.52680217474699e-05
52 O 0 0.00027390808099880815
. O 0 0.00012206396786496043

5 O 0 6.168436812004074e-05
% O 0 9.958921509678476e-06
of O 0 3.415064156797598e-06
the O 0 9.761003639141563e-06
normal O 0 0.0001221991697093472
level O 0 0.00014879960508551449
. O 0 0.00012754775525536388

As O 0 3.1063853384694085e-05
the O 0 1.2689402865362354e-05
mutation O 0 0.00019628294103313237
occurred O 0 1.419975706085097e-05
at O 0 2.5782064767554402e-06
the O 0 1.0075930276798317e-06
penultimate O 0 1.9973787857452407e-05
nucleotide O 0 7.4257118285459e-06
of O 0 1.129596057580784e-06
exon O 0 6.187842518556863e-05
6 O 0 5.291878551361151e-06
( O 0 2.2462040760728996e-06
- O 0 6.997401669650571e-06
2 O 0 1.2968133660251624e-06
position O 0 6.538813295264845e-07
of O 0 4.3160272866771265e-07
exon O 0 3.9762919186614454e-05
6 O 0 8.446214451396372e-06
- O 0 8.850565791362897e-05
intron O 0 0.002688317559659481
6 O 0 1.0525868674449157e-05
splice O 0 0.00010101312363985926
site O 0 4.420504865265684e-06
) O 0 9.431912530999398e-07
of O 0 3.145158871120657e-07
the O 0 7.727975912530383e-07
gene O 0 3.609918712754734e-05
, O 0 8.565892812839593e-07
we O 0 8.094741019704088e-07
hypothesized O 0 2.8830161681980826e-05
that O 0 4.850224968322436e-07
the O 0 1.0550604656600626e-06
mutation O 0 0.0003324156568851322
may O 0 8.055979378696065e-06
partially O 0 3.354598447913304e-05
affect O 0 9.904621947498526e-06
the O 0 6.888641905788973e-07
normal O 0 6.103737177909352e-06
splicing O 0 1.6042933566495776e-05
efficiency O 0 1.4870964150759391e-05
in O 0 2.741775915637845e-06
exon O 0 0.00010630055476212874
6 O 0 5.694738774764119e-06
and O 0 1.3493034884959343e-06
cause O 0 0.00012357307423371822
alternative O 0 6.901675078552216e-06
splicing O 0 3.554676004569046e-05
elsewhere O 0 9.13000349100912e-06
, O 0 1.128203052758181e-06
which O 0 8.316993103107961e-07
resulted O 0 1.0581686183286365e-05
in O 0 2.2787125999457203e-06
decreased O 0 0.00033077775151468813
transcript O 0 0.00010484306403668597
in O 0 5.076363322586985e-06
the O 0 1.8265494873048738e-05
patient O 0 0.467312753200531
. O 0 0.0001408696552971378

Transfection O 0 0.14064888656139374
of O 0 5.1605682529043406e-05
constructed O 0 0.00012857813271693885
minigenes O 0 0.0011593721574172378
, O 0 3.854208443954121e-06
with O 0 1.9629319467640016e-06
or O 0 1.8081723283103202e-06
without O 0 1.0486064638826065e-06
the O 0 1.0047067462437553e-06
mutation O 0 5.4368272685678676e-05
, O 0 1.2812968179787276e-06
into O 0 2.6391103347123135e-06
COS O 0 0.0497155487537384
- O 0 0.0001388598611811176
1 O 0 6.568434400833212e-06
cells O 0 9.337626397609711e-05
confirmed O 0 8.798725502856541e-06
that O 0 7.071383265611075e-07
the O 0 1.2220847338539897e-06
mutant O 0 0.000411404442274943
minigene O 0 0.0006029693176969886
was O 0 1.490362592448946e-06
responsible O 0 3.6945014016964706e-06
for O 0 8.483773967782327e-07
a O 0 1.9046229908781243e-06
mRNA O 0 7.780221494613215e-06
species O 0 7.903345249360427e-06
alternatively O 0 2.8454913262976333e-05
spliced O 0 8.290472032967955e-05
at O 0 2.777769850581535e-06
an O 0 3.0983580927568255e-06
activated O 0 0.00030524065368808806
cryptic O 0 0.0005527517641894519
5 O 0 9.075401976588182e-06
splice O 0 0.0001490444119554013
site O 0 1.3297102668730076e-05
88 O 0 2.302868051629048e-05
bp O 0 7.993829785846174e-05
upstream O 0 9.658534509071615e-06
from O 0 9.5230012675529e-07
the O 0 1.0410714139652555e-06
3 O 0 2.6964175958710257e-06
end O 0 2.6195268674200634e-06
of O 0 2.5717479275044752e-06
exon O 0 0.00036949431523680687
6 O 0 7.667196041438729e-05
. O 0 6.223456148291007e-05

Our O 0 3.334303983137943e-05
data O 0 1.0172741895075887e-05
suggest O 0 1.2812632121494971e-05
that O 0 8.729660407880147e-07
the O 0 8.534434527973644e-07
C O 0 2.1118463337188587e-05
to O 0 6.534201020258479e-07
A O 0 1.2813115972676314e-06
mutation O 0 1.2097470062144566e-05
at O 0 4.061955962697539e-07
the O 0 3.0404720519072725e-07
penultimate O 0 1.1473503946035635e-05
nucleotide O 0 3.469041985226795e-06
of O 0 6.162796921671543e-07
exon O 0 4.030980562674813e-05
6 O 0 2.5507908958388725e-06
of O 0 6.189944770085276e-07
the O 0 1.9916956262022723e-06
CYP27 O 0 0.020410513505339622
gene O 0 0.00017093763744924217
not O 0 1.6376063740608515e-06
only O 0 1.8226181737190927e-06
causes O 0 0.007357093505561352
the O 0 1.9136305127176456e-05
deficiency B-Disease 1 0.9969688057899475
in I-Disease 0 3.5744740216614446e-06
the I-Disease 0 3.757859531106078e-06
sterol I-Disease 0 0.052898578345775604
27 I-Disease 0 7.821381586836651e-05
- I-Disease 0 0.00422269944101572
hydroxylase I-Disease 0 0.1115437000989914
activity I-Disease 0 1.6091278666863218e-05
, O 0 1.1277296607659082e-06
but O 0 8.15874159343366e-07
also O 0 7.044728249638865e-07
partially O 0 1.2898204658995382e-05
leads O 0 3.985468538303394e-06
to O 0 6.609647016375675e-07
alternative O 0 3.904656750819413e-06
pre O 0 1.8077247659675777e-05
- O 0 1.894515662570484e-05
mRNA O 0 9.714432053442579e-06
splicing O 0 1.8709733922150917e-05
of O 0 2.3506563593400642e-06
the O 0 9.790043804969173e-06
gene O 0 0.0005829230649396777
. O 0 0.00012062386667821556

To O 0 2.251325895485934e-05
our O 0 9.823197615332901e-06
knowledge O 0 9.577580385666806e-06
, O 0 1.1578237035791972e-06
this O 0 3.6108906442677835e-07
is O 0 3.301191213722632e-07
the O 0 2.7343918418409885e-07
first O 0 4.2905540453830326e-07
report O 0 2.085090500258957e-06
regarding O 0 2.796380613290239e-06
effects O 0 4.227034150972031e-05
on O 0 4.810258928955591e-07
pre O 0 1.530285953776911e-05
- O 0 1.651947786740493e-05
mRNA O 0 3.5013051729038125e-06
splicing O 0 4.88422028865898e-06
of O 0 5.053748850514239e-07
a O 0 1.811835204534873e-06
mutation O 0 2.7015632440452464e-05
at O 0 6.635718818870373e-07
the O 0 3.981529346219759e-07
- O 0 9.128201782004908e-06
2 O 0 1.2361425660856185e-06
position O 0 7.801194215062424e-07
of O 0 6.275099622143898e-07
a O 0 3.230769380024867e-06
5 O 0 1.779492049536202e-05
splice O 0 0.00075573252979666
site O 0 0.00016074127051979303
. O 0 9.149529796559364e-05

ATM O 0 0.08613455295562744
germline O 1 0.9683312177658081
mutations O 0 0.41081565618515015
in O 0 0.0002673171111382544
classical O 0 0.0117316460236907
ataxia B-Disease 1 0.999030351638794
- I-Disease 1 0.995148241519928
telangiectasia I-Disease 1 0.9988204836845398
patients O 1 0.9970728158950806
in O 0 3.2604799343971536e-05
the O 0 1.8217358956462704e-05
Dutch O 0 0.00022138406347949058
population O 0 9.4039918622002e-05
. O 0 0.0001556391507619992

Germline O 1 0.902474045753479
mutations O 0 0.0241695549339056
in O 0 2.481670890119858e-05
the O 0 1.0531491170695517e-05
ATM O 0 0.000681613280903548
gene O 0 0.0006665640976279974
are O 0 5.457662155095022e-06
responsible O 0 0.00016746882465668023
for O 0 0.00010284288873663172
the O 0 0.005435870960354805
autosomal B-Disease 1 0.9993871450424194
recessive I-Disease 1 0.9997133612632751
disorder I-Disease 1 0.9998838901519775
ataxia B-Disease 1 0.9996956586837769
- I-Disease 1 0.9964613318443298
telangiectasia I-Disease 1 0.9981061220169067
( O 0 0.009660393930971622
A B-Disease 0 0.009876054711639881
- I-Disease 0 0.48973026871681213
T I-Disease 1 0.9526045322418213
) O 0 0.00022918418108019978
. O 0 0.00015906651969999075

In O 0 6.18208505329676e-05
our O 0 2.69595802819822e-05
study O 0 2.536995270929765e-05
, O 0 1.4756018344996846e-06
we O 0 6.428475671782508e-07
have O 0 5.181792062103341e-07
determined O 0 1.6420633528468898e-06
the O 0 6.639593266299926e-07
ATM O 0 5.399588917498477e-05
mutation O 0 0.000184005155460909
spectrum O 0 1.7461581592215225e-05
in O 0 2.1878668121644296e-06
19 O 0 8.876203537511174e-06
classical O 0 1.3068750376987737e-05
A B-Disease 0 0.00070541090099141
- I-Disease 1 0.7227795124053955
T I-Disease 1 0.9979198575019836
patients O 1 0.9936462640762329
, O 0 3.771538331420743e-06
including O 0 3.0219355267036008e-06
some O 0 1.9943377083109226e-06
immigrant O 0 5.8325796999270096e-05
populations O 0 2.8436114007490687e-05
, O 0 4.844861791752919e-07
as O 0 2.5369308787048794e-07
well O 0 3.3370321261827485e-07
as O 0 3.4263933912370703e-07
12 O 0 1.415288238604262e-06
of O 0 8.120658208099485e-07
Dutch O 0 1.9640103346318938e-05
ethnic O 0 2.1883797671762295e-05
origin O 0 4.79196387459524e-05
. O 0 8.935674122767523e-05

Both O 0 3.633390224422328e-05
the O 0 9.745247552928049e-06
protein O 0 4.4508498831419274e-05
truncation O 0 0.00022309024643618613
test O 0 3.2653933885740116e-05
( O 0 8.597462510806508e-06
PTT O 0 7.195783837232739e-05
) O 0 2.507764520487399e-06
and O 0 9.355844667879865e-07
the O 0 1.3808165704176645e-06
restriction O 0 2.7493026209413074e-05
endonuclease O 0 0.011541969142854214
fingerprinting O 0 0.0008429684094153345
( O 0 2.1771269530290738e-05
REF O 0 0.0013635577633976936
) O 0 1.492094611421635e-06
method O 0 9.245558203474502e-07
were O 0 1.437993688568895e-07
used O 0 1.8536277934799728e-07
and O 0 2.216993664205802e-07
compared O 0 1.0480285936864675e-06
for O 0 3.2203584510170913e-07
their O 0 5.324928338268364e-07
detection O 0 9.169340046355501e-05
efficiency O 0 1.3685765225091018e-05
, O 0 1.1216651500944863e-06
identifying O 0 3.4352910006418824e-05
76 O 0 1.7404056052328087e-05
% O 0 5.365417337088729e-07
and O 0 3.7475774661288597e-07
60 O 0 9.54885535975336e-07
% O 0 3.350275221691845e-07
of O 0 3.76349390762698e-07
the O 0 2.3181714823294897e-06
mutations O 0 0.001419561100192368
, O 0 1.0602231668599416e-05
respectively O 0 5.6978289649123326e-05
. O 0 6.661665247520432e-05

Most O 0 0.0014109904877841473
patients O 1 0.9669196605682373
were O 0 7.416575044771889e-06
found O 0 9.291661626775749e-06
to O 0 4.698700195149286e-06
be O 0 7.351978638325818e-06
compound O 0 0.0005151198711246252
heterozygote O 0 0.08151222765445709
. O 0 0.00027087194030173123

Seventeen O 0 0.0008322662324644625
mutations O 0 0.0025394049007445574
were O 0 4.948386504111113e-06
distinct O 0 9.67057167144958e-06
, O 0 9.036400001605216e-07
of O 0 3.956411660510639e-07
which O 0 5.457254133034439e-07
10 O 0 1.5176470924416208e-06
were O 0 8.255788657152152e-07
not O 0 2.0370287074911175e-06
reported O 0 4.9137717724079266e-05
previously O 0 4.0062772313831374e-05
. O 0 5.150509241502732e-05

Mutations O 0 0.021776467561721802
are O 0 3.227027991670184e-05
small O 0 3.835015377262607e-05
deletions O 0 0.00039908697362989187
or O 0 1.8371814803685993e-05
point O 0 2.6356183298048563e-05
mutations O 0 0.0036625720094889402
frequently O 0 0.00019307874026708305
affecting O 0 0.003959912806749344
splice O 0 0.0072028455324471
sites O 0 0.00029633939266204834
. O 0 0.00017589845811016858

Moreover O 0 0.00134238600730896
, O 0 6.013176971464418e-05
a O 0 6.837916589574888e-05
16 O 0 0.00021379068493843079
. O 0 0.00020239423611201346

7 O 0 0.0004715962859336287
- O 0 0.0011015040799975395
kb O 0 0.001939409994520247
genomic O 0 0.00025147965061478317
deletion O 0 0.0001422494533471763
of O 0 1.2529795867521898e-06
the O 0 8.204511914300383e-07
3 O 0 1.614685743334121e-06
end O 0 8.881680741978926e-07
of O 0 2.1907345626459573e-07
the O 0 8.439994871878298e-07
gene O 0 3.8723130273865536e-05
, O 0 5.819886155222775e-07
most O 0 6.02760735546326e-07
likely O 0 1.3307683275343152e-06
a O 0 4.3451726128296286e-07
result O 0 7.843461844458943e-07
of O 0 2.4360014094781945e-07
recombination O 0 7.405076758004725e-06
between O 0 6.448314593399118e-07
two O 0 5.584969926530903e-07
LINE O 0 2.80721792478289e-06
elements O 0 2.939582827821141e-06
, O 0 2.9882335184083786e-06
was O 0 6.2177259678719565e-06
identified O 0 0.00010091935109812766
. O 0 6.380760169122368e-05

The O 0 4.4753098336514086e-05
most O 0 1.76935427589342e-05
frequently O 0 4.8966881877277046e-05
found O 0 1.420291209797142e-05
mutation O 0 0.000331366085447371
, O 0 2.0649047201004578e-06
identified O 0 4.512396117206663e-06
in O 0 8.45449562802969e-07
three O 0 2.2366552911989857e-06
unrelated O 0 0.0003599860647227615
Turkish O 0 8.427765715168789e-05
A B-Disease 0 0.00045420287642627954
- I-Disease 0 0.21492432057857513
T I-Disease 1 0.9530744552612305
individuals O 0 4.852023266721517e-05
, O 0 1.9142285054840613e-06
was O 0 8.533075401828683e-07
previously O 0 2.480014472894254e-06
described O 0 4.369087946543004e-06
to O 0 3.7103797012605355e-07
be O 0 3.676656206152984e-07
a O 0 1.8248582591695595e-06
Turkish O 0 2.8941725759068504e-05
A B-Disease 0 0.00016931560821831226
- I-Disease 0 0.08354870975017548
T I-Disease 1 0.9508829116821289
founder O 0 0.01438345666974783
mutation O 0 0.019616372883319855
. O 0 0.00022459383762907237

The O 0 3.942137482226826e-05
presence O 0 3.132139681838453e-05
of O 0 4.17271303376765e-06
a O 0 1.7522097550681792e-05
founder O 0 0.0008589426870457828
mutation O 0 0.001496069016866386
among O 0 9.208396477333736e-06
relatively O 0 1.4271736290538684e-05
small O 0 2.6655479814508e-06
ethnic O 0 3.219318841729546e-06
population O 0 2.5160579752991907e-06
groups O 0 1.4362766478370759e-06
in O 0 7.862349207243824e-07
Western O 0 4.482462827581912e-06
Europe O 0 5.067361598776188e-06
could O 0 1.3978554989080294e-06
indicate O 0 4.461101980268722e-06
a O 0 1.876437863757019e-06
high O 0 9.041632438311353e-06
carrier O 0 5.445399074233137e-05
frequency O 0 7.793470103933942e-06
in O 0 3.1565823519486003e-06
such O 0 6.879542524984572e-06
communities O 0 0.00010432866838527843
. O 0 7.364679913735017e-05

In O 0 0.00027546711498871446
patients O 1 0.5832030177116394
of O 0 5.85996349400375e-06
Dutch O 0 3.3007814636221156e-05
ethnic O 0 6.74179864290636e-06
origin O 0 4.567607447825139e-06
, O 0 1.7427506691092276e-06
however O 0 1.540760194984614e-06
, O 0 1.0097776339534903e-06
no O 0 1.1876579719682923e-06
significant O 0 6.79857112118043e-06
founder O 0 0.0001974717597477138
effect O 0 3.0306542612379417e-05
could O 0 6.4698087953729555e-06
be O 0 3.547479082044447e-06
identified O 0 6.231211591511965e-05
. O 0 4.4293356040725484e-05

The O 0 6.447920895880088e-05
observed O 0 0.00021635273878928274
genetic O 0 0.0007572969770990312
heterogeneity O 0 0.0012715510092675686
including O 0 6.127743290562648e-06
the O 0 1.8736536731012166e-06
relative O 0 7.757786988804583e-06
high O 0 8.090024493867531e-06
percentage O 0 4.3879445001948625e-06
of O 0 1.3597514225693885e-06
splice O 0 0.0012586578959599137
- O 0 0.0014046350261196494
site O 0 4.581154644256458e-05
mutations O 0 0.0005573852686211467
had O 0 3.145205710097798e-06
no O 0 3.2500436191185145e-06
reflection O 0 4.3217944039497524e-05
on O 0 5.312168468663003e-06
the O 0 1.8752964024315588e-05
phenotype O 0 0.15958158671855927
. O 0 0.00013720226706936955

All O 0 0.0007448425749316812
patients O 1 0.9897083640098572
manifested O 0 0.12150818854570389
classical O 0 0.00015546502254437655
A B-Disease 0 0.0006382077117450535
- I-Disease 0 0.0742257684469223
T I-Disease 1 0.5846339464187622
and O 0 5.756209702667547e-06
increased O 0 3.517669392749667e-05
cellular O 0 0.0004208292521070689
radioresistant O 0 0.01245675515383482
DNA O 0 0.0003335219225846231
synthesis O 0 0.00032415855093859136
. O 0 0.00014530259068123996

Determination O 0 0.0001908882986754179
of O 0 5.564226739807054e-06
the O 0 5.0838725655921735e-06
genomic O 0 6.051309173926711e-05
structure O 0 9.784788744582329e-06
of O 0 1.991315912164282e-06
the O 0 7.253419880726142e-06
COL4A4 O 0 0.03992101177573204
gene O 0 0.0003617732727434486
and O 0 6.7823875724570826e-06
of O 0 1.446590613340959e-05
novel O 0 0.024803822860121727
mutations O 1 0.9806572794914246
causing O 1 0.9951251149177551
autosomal B-Disease 1 0.9989829659461975
recessive I-Disease 1 0.999071478843689
Alport I-Disease 1 0.9989799857139587
syndrome I-Disease 1 0.9993195533752441
. O 0 0.037463512271642685

Autosomal B-Disease 1 0.9962672591209412
recessive I-Disease 1 0.9981968998908997
Alport I-Disease 1 0.9989039897918701
syndrome I-Disease 1 0.9995656609535217
is O 0 0.0033434072975069284
a O 0 0.002930414630100131
progressive O 1 0.9084374904632568
hematuric B-Disease 1 0.9953722357749939
glomerulonephritis I-Disease 1 0.9993101358413696
characterized O 1 0.9932149648666382
by O 0 0.008599084801971912
glomerular B-Disease 1 0.9983605742454529
basement I-Disease 1 0.8737625479698181
membrane I-Disease 0 0.47860077023506165
abnormalities I-Disease 1 0.9958472847938538
and O 0 2.7771478926297277e-05
associated O 0 7.807849033270031e-05
with O 0 5.388927093008533e-06
mutations O 0 0.0012258896604180336
in O 0 1.6427839000243694e-06
either O 0 2.1016444406996015e-06
the O 0 1.6295706473101745e-06
COL4A3 O 0 0.005109073128551245
or O 0 2.8911458684888203e-06
the O 0 2.5795002329687122e-06
COL4A4 O 0 0.008858694694936275
gene O 0 5.9806141507579014e-05
, O 0 9.046953550750914e-07
which O 0 4.849715651289443e-07
encode O 0 3.985232979175635e-06
the O 0 1.5763495184728527e-06
alpha3 O 0 0.0009601282072253525
and O 0 1.0454038601892535e-05
alpha4 O 0 0.10434898734092712
type O 0 0.03497077897191048
IV O 1 0.7637205719947815
collagen O 1 0.9310696721076965
chains O 0 0.002049933886155486
, O 0 3.06045294564683e-05
respectively O 0 0.00010600509267533198
. O 0 0.00012145070650149137

To O 0 3.108803866780363e-05
date O 0 2.068791218334809e-05
, O 0 6.827321612945525e-06
mutation O 0 0.00024866877356544137
screening O 0 5.756781320087612e-05
in O 0 1.1834702036139788e-06
the O 0 7.06410389739176e-07
two O 0 1.3230870763436542e-06
genes O 0 3.762761480174959e-05
has O 0 3.5469074646243826e-06
been O 0 2.8099232167733135e-06
hampered O 0 0.002976902760565281
by O 0 8.890485787560465e-07
the O 0 8.202508752219728e-07
lack O 0 7.704289600951597e-06
of O 0 2.1135797396709677e-06
genomic O 0 0.0002751565771177411
structure O 0 9.788756869966164e-05
information O 0 7.830934191588312e-05
. O 0 9.136069274973124e-05

We O 0 4.592483674059622e-05
report O 0 1.7417105482309125e-05
here O 0 2.8964252578589367e-06
the O 0 7.899560046098486e-07
complete O 0 2.412888079561526e-06
characterization O 0 1.3871988812752534e-05
of O 0 4.3978468511340907e-07
the O 0 8.336973564837535e-07
48 O 0 4.176614311290905e-06
exons O 0 1.3627809494209941e-05
of O 0 6.581229285984591e-07
the O 0 2.3004274680715753e-06
COL4A4 O 0 0.017969885841012
gene O 0 0.00013394725101534277
, O 0 1.4571122619599919e-06
a O 0 2.5777296741580358e-06
comprehensive O 0 0.00020082063565496355
gene O 0 0.00019171752501279116
screen O 0 7.705406460445374e-06
, O 0 5.471407575896592e-07
and O 0 2.9816354185641103e-07
the O 0 4.331254785938654e-07
subsequent O 0 5.022435743740061e-06
detection O 0 5.1557424740167335e-05
of O 0 8.372924185096053e-07
10 O 0 9.866892469290178e-06
novel O 0 0.0004368017253000289
mutations O 0 0.03331834077835083
in O 0 7.639244722668082e-05
eight O 0 0.03493795171380043
patients O 1 0.9996086955070496
diagnosed O 1 0.9997853636741638
with O 1 0.8281967639923096
autosomal B-Disease 1 0.9993138313293457
recessive I-Disease 1 0.9989832043647766
Alport I-Disease 1 0.9988526105880737
syndrome I-Disease 1 0.9993435740470886
. O 0 0.0458407998085022

Furthermore O 0 0.00040453471592627466
, O 0 1.0848149941011798e-05
we O 0 3.2294481115968665e-06
identified O 0 5.810702077724272e-06
a O 0 2.5248170913982904e-06
glycine O 0 1.96586534002563e-05
to O 0 1.3518950936486362e-06
alanine O 0 6.37526172795333e-05
substitution O 0 7.91576076153433e-06
in O 0 1.537887214908551e-06
the O 0 2.4373871383431833e-06
collagenous O 0 0.3802875578403473
domain O 0 1.6725491150282323e-05
that O 0 1.476359216212586e-06
is O 0 2.5625870421208674e-06
apparently O 0 1.3945418686489575e-05
silent O 0 3.2032050512498245e-05
in O 0 1.206899355565838e-06
the O 0 2.0062796011188766e-06
heterozygous O 0 0.0002674440620467067
carriers O 0 8.044498827075586e-05
, O 0 5.050057097832905e-06
in O 0 6.947809652046999e-06
11 O 0 7.441849447786808e-05
. O 0 5.432722173281945e-05

5 O 0 4.2586099880281836e-05
% O 0 3.8026125821488677e-06
of O 0 1.285799044126179e-06
all O 0 1.0901037512667244e-06
control O 0 9.603883881936781e-06
individuals O 0 6.521390332636656e-06
, O 0 5.250739150142181e-07
and O 0 3.1216771390063514e-07
in O 0 3.604498033382697e-07
one O 0 5.813789698549954e-07
control O 0 4.103932951693423e-06
individual O 0 4.4901598812430166e-06
homozygous O 0 5.145918839843944e-05
for O 0 2.392346459600958e-06
this O 0 4.139159045735141e-06
glycine O 0 0.00015555310528725386
substitution O 0 0.00013338489225134254
. O 0 8.475832873955369e-05

There O 0 3.733943958650343e-05
has O 0 8.35874379845336e-06
been O 0 2.5917850052792346e-06
no O 0 1.2360198979877168e-06
previous O 0 1.564010517540737e-06
finding O 0 2.914905280704261e-06
of O 0 3.624612077146594e-07
a O 0 1.5464941043319413e-06
glycine O 0 2.319247323612217e-05
substitution O 0 4.734518370241858e-06
that O 0 7.006884743532282e-07
is O 0 5.871295911674679e-07
not O 0 5.449426794257306e-07
associated O 0 2.7091923584521282e-06
with O 0 8.21392234229279e-07
any O 0 2.945914047813858e-06
obvious O 0 0.0005632905522361398
phenotype O 0 0.31327879428863525
in O 0 2.2536953110829927e-05
homozygous O 0 0.004185819998383522
individuals O 0 0.0002076322998618707
. O 0 0.00013164521078579128

Founder O 0 0.3687575161457062
BRCA1 O 1 0.9822147488594055
and O 0 0.001441907836124301
BRCA2 O 1 0.9900467991828918
mutations O 0 0.2629818022251129
in O 0 0.00012208259431645274
French O 0 0.0017432809108868241
Canadian O 0 0.0852040946483612
breast B-Disease 1 0.9994545578956604
and I-Disease 1 0.774657130241394
ovarian I-Disease 1 0.999841570854187
cancer I-Disease 1 0.999731719493866
families O 0 0.4013519585132599
. O 0 0.0013916025636717677

We O 0 2.929605579993222e-05
have O 0 5.524903372133849e-06
identified O 0 8.960556442616507e-06
four O 0 3.252275973864016e-06
mutations O 0 9.288639557780698e-05
in O 0 9.783162795429234e-07
each O 0 5.917159455748333e-07
of O 0 1.8108660242432961e-06
the O 0 0.00021834154904354364
breast B-Disease 1 0.999695897102356
cancer I-Disease 1 0.9997783303260803
- O 1 0.7975294589996338
susceptibility O 1 0.9912698268890381
genes O 0 0.035048991441726685
, O 0 0.00016897564637474716
BRCA1 O 1 0.9803739786148071
and O 0 0.0001037178371916525
BRCA2 O 1 0.9807689189910889
, O 0 1.4217073839972727e-05
in O 0 1.382283699058462e-05
French O 0 0.002233335515484214
Canadian O 0 0.2659815847873688
breast B-Disease 1 0.9997580647468567
cancer I-Disease 1 0.9998667240142822
and O 1 0.8973590135574341
breast B-Disease 1 0.9998737573623657
/ I-Disease 1 0.9995691180229187
ovarian I-Disease 1 0.9999040365219116
cancer I-Disease 1 0.9997913241386414
families O 0 0.05082869157195091
from O 0 0.0003110950638074428
Quebec O 0 0.009244905784726143
. O 0 0.00041883360245265067

To O 0 0.00017874872719403356
identify O 0 0.001463352469727397
founder O 0 0.0032033768948167562
effects O 0 0.011706224642693996
, O 0 1.3135648259776644e-05
we O 0 7.570753950858489e-06
examined O 0 0.0004949246067553759
independently O 0 3.310506508569233e-05
ascertained O 0 0.0009285450214520097
French O 0 0.00013664855214301497
Canadian O 0 0.0007747514173388481
cancer B-Disease 1 0.9978306889533997
families O 0 2.4659468181198463e-05
for O 0 8.119109793369716e-07
the O 0 5.119483716953255e-07
distribution O 0 1.2234572750458028e-06
of O 0 8.978673236015311e-07
these O 0 3.4662014058994828e-06
eight O 0 4.1068451537285e-05
mutations O 0 0.006718634627759457
. O 0 0.00013517979823518544

Mutations O 0 0.012267825193703175
were O 0 1.2378161954984535e-05
found O 0 1.2242952834640164e-05
in O 0 4.861579782300396e-06
41 O 0 1.738680475682486e-05
of O 0 6.865307568659773e-06
97 O 0 0.00036309193819761276
families O 0 0.0002619959122966975
. O 0 0.0001197359524667263

Six O 0 8.065284055192024e-05
of O 0 8.614492799097206e-06
eight O 0 2.6979436370311305e-05
mutations O 0 0.0004552423197310418
were O 0 3.474458708296879e-06
observed O 0 1.4696468497277237e-05
at O 0 5.4601923693553545e-06
least O 0 1.8690188881009817e-05
twice O 0 8.872080798028037e-05
. O 0 6.363969441736117e-05

The O 0 0.00040841070585884154
BRCA1 O 1 0.9615346193313599
C4446T O 0 0.06991932541131973
mutation O 0 0.0024376497603952885
was O 0 5.032960416428978e-06
the O 0 2.006694785450236e-06
most O 0 2.68127882918634e-06
common O 0 3.541449405020103e-05
mutation O 0 0.0007558694342151284
found O 0 4.131539299123688e-06
, O 0 1.4304043816082412e-06
followed O 0 4.637837719201343e-06
by O 0 4.3199820538575295e-06
the O 0 2.357302037125919e-05
BRCA2 O 1 0.9771847128868103
8765delAG O 0 0.23016643524169922
mutation O 0 0.03719189763069153
. O 0 0.00023674312978982925

Together O 0 5.7370962167624384e-05
, O 0 1.2451056136342231e-05
these O 0 4.168115083302837e-06
mutations O 0 0.00019893581338692456
were O 0 5.249827950137842e-07
found O 0 9.368094424644369e-07
in O 0 4.6839932110742666e-07
28 O 0 1.9007578657692648e-06
of O 0 4.7295310423578485e-07
41 O 0 1.773584335751366e-05
families O 0 1.2737558790831827e-05
identified O 0 7.862726306484547e-06
to O 0 1.035681407302036e-06
have O 0 2.5187755454680882e-06
a O 0 1.733548015181441e-05
mutation O 0 0.0015176451997831464
. O 0 0.00011738271859940141

The O 0 5.2357114327605814e-05
odds O 0 0.00010581854439806193
of O 0 2.2630936200584983e-06
detection O 0 3.549035682226531e-05
of O 0 6.397693823601003e-07
any O 0 4.974282887815207e-07
of O 0 3.6922642721037846e-07
the O 0 1.165637740996317e-06
four O 0 1.3119873983669095e-05
BRCA1 O 1 0.9457764029502869
mutations O 0 0.016887355595827103
was O 0 1.745988083712291e-05
18 O 0 6.93698602844961e-05
. O 0 9.729421435622498e-05

7x O 1 0.7597623467445374
greater O 0 0.00020139128901064396
if O 0 2.6138492103200406e-05
one O 0 5.007079380447976e-06
or O 0 6.850645149825141e-06
more O 0 7.822233783372212e-06
cases O 0 0.003057080088183284
of O 0 0.0005493676289916039
ovarian B-Disease 1 0.9999027252197266
cancer I-Disease 1 0.9998038411140442
were O 0 6.304904218268348e-06
also O 0 2.7900407530978555e-06
present O 0 3.965178166254191e-06
in O 0 3.492204541544197e-06
the O 0 9.222642802342307e-06
family O 0 0.0002143354358850047
. O 0 8.53386809467338e-05

The O 0 5.7376764743821695e-05
odds O 0 0.00016164564294740558
of O 0 3.6515775718726218e-06
detection O 0 4.2502440919633955e-05
of O 0 7.032846838228579e-07
any O 0 5.52911274098733e-07
of O 0 4.468794827516831e-07
the O 0 2.5424362775083864e-06
four O 0 2.3004533431958407e-05
BRCA2 O 1 0.9412512183189392
mutations O 0 0.008855913765728474
was O 0 2.2551337679033168e-05
5 O 0 7.142126560211182e-05
. O 0 6.590768316527829e-05

3x O 0 0.022578062489628792
greater O 0 0.00015607044042553753
if O 0 1.2073140169377439e-05
there O 0 1.6239173419307917e-06
were O 0 4.537557742878562e-07
at O 0 1.175369447992125e-06
least O 0 2.441430297039915e-06
five O 0 4.9448958634457085e-06
cases O 0 0.001111864112317562
of O 0 0.0001230275520356372
breast B-Disease 1 0.9996939897537231
cancer I-Disease 1 0.9995356798171997
in O 0 6.686874985462055e-05
the O 0 3.453672252362594e-05
family O 0 0.0006363858701661229
. O 0 0.00014396935875993222

Interestingly O 0 0.0021784771233797073
, O 0 1.4726982954016421e-05
the O 0 5.999699624226196e-06
presence O 0 1.8653792722034268e-05
of O 0 5.109526227897732e-06
a O 0 0.0017187028424814343
breast B-Disease 1 0.9995813965797424
cancer I-Disease 1 0.9997072815895081
case O 0 0.0075818318873643875
< O 0 0.0559094063937664
36 O 0 2.8426249627955258e-05
years O 0 4.411656391312135e-06
of O 0 7.920131110950024e-07
age O 0 1.853929461503867e-05
was O 0 1.2036946372973034e-06
strongly O 0 4.941105999023421e-06
predictive O 0 2.162938835681416e-05
of O 0 2.891063957122242e-07
the O 0 3.714819740707753e-07
presence O 0 1.2211166904307902e-06
of O 0 2.0171871994989488e-07
any O 0 3.084325896907103e-07
of O 0 3.3499014762128354e-07
the O 0 1.5287450878531672e-06
eight O 0 2.3847107513574883e-05
mutations O 0 0.010791609063744545
screened O 0 0.0009864987805485725
. O 0 0.00011157582048326731

Carriers O 0 0.0004377214645501226
of O 0 7.15170835974277e-06
the O 0 3.1129475246416405e-06
same O 0 4.135386916459538e-06
mutation O 0 0.00010305394971510395
, O 0 9.238525535693043e-07
from O 0 5.456395228975452e-07
different O 0 6.698340371258382e-07
families O 0 5.5435866670450196e-06
, O 0 8.994820177576912e-07
shared O 0 5.735781087423675e-06
similar O 0 3.6164863558951765e-05
haplotypes O 0 0.019324390217661858
, O 0 1.8754628854367184e-06
indicating O 0 1.0544575161475223e-05
that O 0 4.503392858623556e-07
the O 0 8.928976740207872e-07
mutant O 0 0.0003083597985096276
alleles O 0 0.00011272221308900043
were O 0 3.591301549477066e-07
likely O 0 1.3559960052589304e-06
to O 0 2.178619240567059e-07
be O 0 1.6279274461794557e-07
identical O 0 9.86069153441349e-07
by O 0 3.1095987651497126e-07
descent O 0 1.635775447539345e-06
for O 0 5.440661539068969e-07
a O 0 2.232444330729777e-06
mutation O 0 0.00012297499051783234
in O 0 1.5223553191390238e-06
the O 0 3.7484105632756837e-06
founder O 0 0.0004392592527437955
population O 0 3.9654616557527333e-05
. O 0 8.537466055713594e-05

The O 0 4.895628444501199e-05
identification O 0 5.356085239327513e-05
of O 0 1.0834294698724989e-05
common O 0 0.0008894390775822103
BRCA1 O 1 0.9832237958908081
and O 0 0.0002066710003418848
BRCA2 O 1 0.9892361760139465
mutations O 0 0.0651487335562706
will O 0 1.0383376320532989e-05
facilitate O 0 0.00011702932533808053
carrier O 0 0.0013703142758458853
detection O 0 0.002332156291231513
in O 0 2.8490756449173205e-05
French O 0 0.0014129409100860357
Canadian O 0 0.19981364905834198
breast B-Disease 1 0.9997391104698181
cancer I-Disease 1 0.9998431205749512
and O 1 0.9031783938407898
breast B-Disease 1 0.9998533725738525
/ I-Disease 1 0.9993496537208557
ovarian I-Disease 1 0.9998912811279297
cancer I-Disease 1 0.9997898936271667
families O 0 0.39197278022766113
. O 0 0.0016346056945621967

Are O 0 0.00027379998937249184
Dp71 O 0 0.03271222114562988
and O 0 0.00023091323964763433
Dp140 O 0 0.42008084058761597
brain O 1 0.9919551014900208
dystrophin O 1 0.9860903024673462
isoforms O 0 0.02563580870628357
related O 0 0.02439606562256813
to O 0 0.0002414097252767533
cognitive B-Disease 1 0.9781362414360046
impairment I-Disease 1 0.9976988434791565
in O 0 0.11801949143409729
Duchenne B-Disease 1 0.999129593372345
muscular I-Disease 1 0.998761773109436
dystrophy I-Disease 1 0.998948872089386
? O 1 0.9431760907173157

Molecular O 0 0.006472173612564802
study O 0 0.0005012997426092625
and O 0 2.4362705516978167e-05
neuropsychological O 0 0.014464128762483597
analysis O 0 1.6431724361609668e-05
were O 0 2.1880252916162135e-06
performed O 0 8.753455404075794e-06
concurrently O 0 1.798868106561713e-05
on O 0 1.1536338206497021e-05
49 O 0 0.003680853173136711
patients O 1 0.9977728724479675
with O 0 0.05416957661509514
Duchenne B-Disease 1 0.9996637105941772
muscular I-Disease 1 0.999727189540863
dystrophy I-Disease 1 0.9998242259025574
( O 1 0.568906307220459
DMD B-Disease 1 0.9992297887802124
) O 0 2.9535733119701035e-05
in O 0 2.3434847662429092e-06
order O 0 1.7395690292687505e-06
to O 0 9.033072956299293e-07
find O 0 3.1650765777158085e-06
a O 0 3.1652878078602953e-06
molecular O 0 8.55117104947567e-05
explanation O 0 2.8129423299105838e-05
for O 0 4.597569386532996e-06
the O 0 1.4691676369693596e-05
cognitive B-Disease 1 0.7455864548683167
impairment I-Disease 1 0.9935852885246277
observed O 0 0.001817244221456349
in O 0 0.0001141234824899584
most O 0 0.00177408114541322
DMD B-Disease 1 0.9985023736953735
patients O 1 0.9967049956321716
. O 0 0.0009527488728053868

Complete O 0 0.00015962445468176156
analysis O 0 2.8416192435543053e-05
of O 0 3.1702454634796595e-06
the O 0 6.845002644695342e-06
dystrophin O 0 0.4419969916343689
gene O 0 0.0003653288586065173
was O 0 1.9615770270320354e-06
performed O 0 2.177583610318834e-06
to O 0 3.7650806916644797e-07
define O 0 1.9989304291812005e-06
the O 0 4.027087356917036e-07
localization O 0 9.697409950604197e-06
of O 0 6.266463969950564e-07
deletions O 0 7.295569957932457e-05
and O 0 1.5980551779648522e-06
duplications O 0 0.00023785333905834705
in O 0 2.1048958842584398e-06
relation O 0 1.141564644058235e-05
to O 0 2.0084121388208587e-06
the O 0 7.638622264494188e-06
different O 0 5.716763189411722e-05
DMD B-Disease 1 0.9955198764801025
promoters O 0 0.057518064975738525
. O 0 0.00032370301778428257

Qualitative O 0 0.00032138137612491846
analysis O 0 2.7429754482000135e-05
of O 0 4.272806108929217e-06
the O 0 4.144720151089132e-06
Dp71 O 0 0.002432262757793069
transcript O 0 4.890859781880863e-05
and O 0 1.1584222647798015e-06
testing O 0 5.073299689684063e-06
for O 0 4.814715452994278e-07
the O 0 4.172145793290838e-07
specific O 0 1.229110466738348e-06
first O 0 8.2641940934991e-07
exon O 0 2.3571221390739083e-05
of O 0 8.426723638876865e-07
Dp140 O 0 0.00016698092804290354
were O 0 9.422814173376537e-07
also O 0 1.3559520084527321e-06
carried O 0 5.404840976552805e-06
out O 0 7.719159839325584e-06
. O 0 3.556893716449849e-05

Neuropsychological O 1 0.5095586180686951
analysis O 0 0.0006851014331914485
assessed O 0 0.0055541712790727615
verbal O 0 0.0029374228324741125
and O 0 6.601631321245804e-05
visuospatial O 1 0.8124830722808838
intelligence O 0 0.00039645307697355747
, O 0 1.976639214262832e-05
verbal O 0 0.000639290374238044
memory O 0 0.000385408871807158
, O 0 7.242844276333926e-06
and O 0 6.756847596989246e-06
reading O 0 0.0001139206942752935
skills O 0 0.0007313353708013892
. O 0 0.0001263035519514233

Comparison O 0 0.0002528358018025756
of O 0 1.599743882252369e-05
molecular O 0 0.00031529227271676064
and O 0 1.7249938537133858e-05
psychometric O 0 0.0798642486333847
findings O 0 0.0006203930242918432
demonstrated O 0 9.875161777017638e-05
that O 0 2.7565051823330577e-06
deletions O 0 0.0001582592522026971
and O 0 1.853521098382771e-06
duplications O 0 0.00020493693591561168
that O 0 9.577922810422024e-07
were O 0 5.512506504601333e-07
localized O 0 0.00014464538253378123
in O 0 7.335537475228193e-07
the O 0 7.990977906047192e-07
distal O 0 0.0057458942756056786
part O 0 1.3196720374253346e-06
of O 0 4.3717199105230975e-07
the O 0 1.3683422821486602e-06
gene O 0 0.0002225497883046046
seemed O 0 1.3301845683599822e-05
to O 0 1.2720339555016835e-06
be O 0 1.6044612038967898e-06
preferentially O 0 0.0004865085647907108
associated O 0 8.263510244432837e-05
with O 0 6.2444647483062e-05
cognitive B-Disease 1 0.7409464120864868
impairment I-Disease 1 0.990487277507782
. O 0 0.00041054945904761553

Two O 0 0.0001102946771425195
altered O 0 0.00039963077870197594
Dp71 O 0 0.0012716903584077954
transcripts O 0 4.540635200100951e-05
and O 0 2.9452849048539065e-06
two O 0 2.7988858164462727e-06
deleted O 0 3.808363544521853e-05
Dp140 O 0 0.0002249206299893558
DNA O 0 1.4305721379059833e-05
sequences O 0 6.003471753501799e-06
were O 0 8.572267233830644e-07
found O 0 2.548123575252248e-06
in O 0 3.7918571251793765e-06
four O 0 9.46317522902973e-05
patients O 1 0.99834144115448
with O 0 0.050952889025211334
severe O 1 0.9993484616279602
cerebral B-Disease 1 0.9995397329330444
dysfunction I-Disease 1 0.9986327290534973
. O 0 0.006722110323607922

These O 0 5.61830383958295e-05
findings O 0 0.00011612534581217915
suggest O 0 1.8110775272361934e-05
that O 0 1.037267907122441e-06
some O 0 7.558768970739038e-07
sequences O 0 3.8727084756828845e-06
located O 0 1.5077679336172878e-06
in O 0 6.591102987840713e-07
the O 0 8.787017122813268e-07
distal O 0 0.0010203429264947772
part O 0 1.0414765938548953e-06
of O 0 4.0661649336470873e-07
the O 0 9.06680213574873e-07
gene O 0 4.632183481589891e-05
and O 0 6.767099876014981e-07
, O 0 6.539387413795339e-07
in O 0 5.781995469078538e-07
particular O 0 2.6260649974574335e-06
, O 0 2.345622306165751e-06
some O 0 8.03682632977143e-06
DMD B-Disease 1 0.9980269074440002
isoforms O 0 0.00028408452635630965
expressed O 0 2.3719147066003643e-05
in O 0 2.771234221654595e-06
the O 0 6.710944489896065e-06
brain O 1 0.9451934695243835
may O 0 3.0090008294791915e-05
be O 0 8.487326681461127e-07
related O 0 7.691339851589873e-05
to O 0 3.2626332995278062e-06
the O 0 1.7289597963099368e-05
cognitive B-Disease 1 0.9549553990364075
impairment I-Disease 1 0.9981809854507446
associated O 0 0.013585197739303112
with O 0 0.001574029098264873
DMD B-Disease 1 0.9984263181686401
. O 0 0.00016016417066566646
. O 0 0.00016999992658384144

I1307K O 0 0.15275472402572632
APC O 0 0.0597311407327652
and O 0 0.00011830673611257225
hMLH1 O 0 0.016068484634160995
mutations O 0 0.003101394744589925
in O 0 6.450199180108029e-06
a O 0 9.749671335157473e-06
non O 0 0.00018687162082642317
- O 0 0.004639361519366503
Jewish O 0 0.00020847658743150532
family O 0 0.0002400253142695874
with O 0 0.00021861361165065318
hereditary B-Disease 1 0.9509199857711792
non I-Disease 1 0.8788667321205139
- I-Disease 1 0.9962009787559509
polyposis I-Disease 1 0.9993065595626831
colorectal I-Disease 1 0.9996814727783203
cancer I-Disease 1 0.9992241859436035
. O 0 0.019346678629517555

We O 0 6.093844058341347e-05
describe O 0 0.00013406759535428137
a O 0 2.6585039449855685e-05
French O 0 0.0001574014313519001
Canadian O 0 0.0009761769324541092
hereditary B-Disease 1 0.9563371539115906
non I-Disease 1 0.9127264022827148
- I-Disease 1 0.997605562210083
polyposis I-Disease 1 0.9997187256813049
colorectal I-Disease 1 0.9999046325683594
cancer I-Disease 1 0.9998749494552612
( O 1 0.7552694082260132
HNPCC B-Disease 1 0.9985091090202332
) O 0 0.0004214985528960824
kindred O 0 0.15842299163341522
which O 0 7.419539542752318e-06
carries O 0 3.878411007463001e-05
a O 0 2.3265269192052074e-05
novel O 0 0.0005460432730615139
truncating O 0 0.34267330169677734
mutation O 0 0.021074071526527405
in O 0 9.415433305548504e-05
hMLH1 O 0 0.06300275027751923
. O 0 0.00033009826438501477

Interestingly O 0 0.0026194581296294928
, O 0 3.758594539249316e-05
the O 0 2.1702777303289622e-05
I1307K O 0 0.003637805813923478
APC O 0 0.02090914361178875
polymorphism O 0 0.000470927421702072
, O 0 7.868629836593755e-06
associated O 0 1.7728301827446558e-05
with O 0 3.50135519511241e-06
an O 0 9.695143489807379e-06
increased O 0 0.0015726749552413821
risk O 1 0.8832394480705261
of O 0 0.00886330846697092
colorectal B-Disease 1 0.9999291896820068
cancer I-Disease 1 0.9998303651809692
, O 0 3.869942884193733e-05
is O 0 4.097589680895908e-06
also O 0 1.5470989183086203e-06
present O 0 2.246328449473367e-06
in O 0 2.740150193858426e-06
this O 0 5.287045951263281e-06
family O 0 0.00010766561172204092
. O 0 8.628298382973298e-05

The O 0 0.0001599071838427335
I1307K O 0 0.003630112623795867
polymorphism O 0 0.0005160804139450192
has O 0 9.908854735840578e-06
previously O 0 5.141759629623266e-06
only O 0 8.408998724007688e-07
been O 0 1.0461692454555305e-06
identified O 0 4.126514795643743e-06
in O 0 8.962717856775271e-07
individuals O 0 3.329623496028944e-06
of O 0 1.767371031746734e-06
self O 0 0.0007988414145074785
- O 0 0.03069259226322174
reported O 0 0.0031095894519239664
Ashkenazi O 0 0.10419325530529022
Jewish O 0 0.00048548332415521145
origins O 0 0.0011363433441147208
. O 0 0.00022915421868674457

In O 0 3.81424069928471e-05
addition O 0 2.064837644866202e-05
, O 0 3.3188002817041706e-06
in O 0 1.3742755982093513e-06
this O 0 9.321342986368109e-07
family O 0 5.5039622566255275e-06
, O 0 7.188580184447346e-07
there O 0 6.160117322906444e-07
appears O 0 3.1247857350535924e-06
to O 0 1.8775301668938482e-07
be O 0 1.9071552515015355e-07
no O 0 3.95389577079186e-07
relationship O 0 5.1771321523119695e-06
between O 0 6.583363756362814e-07
the O 0 9.210392590830452e-07
I1307K O 0 0.0005243583582341671
polymorphism O 0 4.73575055366382e-05
and O 0 6.666901981589035e-07
the O 0 7.626558158335683e-07
presence O 0 7.729384378762916e-06
or O 0 7.381625891866861e-06
absence O 0 0.00037642286042682827
of O 0 2.5468587409704924e-05
cancer B-Disease 1 0.9984293580055237
. O 0 7.481739157810807e-05
. O 0 0.0001400323526468128

Identification O 0 0.00010320097499061376
of O 0 8.094253644230776e-06
a O 0 1.728948154777754e-05
novel O 0 6.406953616533428e-05
mutation O 0 9.251847950508818e-05
of O 0 1.7036436474882066e-06
the O 0 5.330097337719053e-06
CPO O 0 0.00038178585236892104
gene O 0 0.00021315687627065927
in O 0 6.595538707188098e-06
a O 0 1.8887016267399304e-05
Japanese O 0 0.0003212389419786632
hereditary B-Disease 0 0.4399518370628357
coproporphyria I-Disease 1 0.5965997576713562
family O 0 0.0031541171483695507
. O 0 0.0003488986403681338

Hereditary B-Disease 1 0.9681748747825623
coproporphyria I-Disease 1 0.9042931795120239
( O 0 0.006500530056655407
HCP B-Disease 1 0.9776192903518677
) O 0 7.770872616674751e-05
is O 0 2.558668165875133e-05
an O 0 0.00014523486606776714
autosomal B-Disease 1 0.9981562495231628
dominant I-Disease 1 0.9254167079925537
disease I-Disease 1 0.999700665473938
characterized O 1 0.8801578283309937
by O 0 9.620493074180558e-05
a O 0 0.001466870424337685
deficiency B-Disease 1 0.9992164373397827
of I-Disease 0 5.174450416234322e-05
coproporphyrinogen I-Disease 1 0.8435204029083252
oxidase I-Disease 1 0.6288698315620422
( O 0 6.873933307360858e-05
CPO O 0 0.0005313048022799194
) O 0 8.242813237302471e-06
caused O 0 0.00019556930055841804
by O 0 1.6545698144909693e-06
a O 0 4.214256023260532e-06
mutation O 0 0.00014056333748158067
in O 0 3.7815434552612714e-06
the O 0 1.2172529750387184e-05
CPO O 0 0.0012437949189916253
gene O 0 0.0022865987848490477
. O 0 0.000186384393600747

Only O 0 2.976215364469681e-05
11 O 0 4.262664515408687e-05
mutations O 0 0.0002435663336655125
of O 0 1.538060359962401e-06
the O 0 3.5661728361446876e-06
gene O 0 0.00032155824010260403
have O 0 4.430972239788389e-06
been O 0 6.918994131410727e-06
reported O 0 0.0004272304940968752
in O 0 0.0002082151622744277
HCP B-Disease 1 0.9961608648300171
patients O 1 0.9961897730827332
. O 0 0.0005364228854887187

We O 0 9.802478598430753e-05
report O 0 4.190518302493729e-05
another O 0 1.9639579477370717e-05
mutation O 0 0.00024339384981431067
in O 0 8.271564183814917e-06
a O 0 1.998114021262154e-05
Japanese O 0 0.00011885448475368321
family O 0 0.00040622346568852663
. O 0 0.00014652781828772277

Polymerase O 0 0.008223759941756725
chain O 0 0.0012257063062861562
reaction O 0 0.00027786241844296455
- O 0 0.00020191428484395146
single O 0 2.599183608253952e-05
strand O 0 0.00016402523033320904
conformational O 0 0.0003442394081503153
polymorphism O 0 6.36480690445751e-05
and O 0 1.6995120404317277e-06
direct O 0 3.5573277727962704e-06
sequence O 0 6.142487109173089e-06
analyses O 0 2.3184073143056594e-05
demonstrated O 0 1.9238759705331177e-05
a O 0 4.285669547243742e-06
C O 0 4.352973701315932e-05
to O 0 1.3090975699014962e-06
T O 0 0.0002129269123543054
substitution O 0 3.1390597996505676e-06
in O 0 7.032900271042308e-07
exon O 0 1.0273354746459518e-05
1 O 0 6.635661975451512e-07
of O 0 3.107769543930772e-07
the O 0 6.407640853467456e-07
CPO O 0 2.4280801881104708e-05
gene O 0 1.2213625268486794e-05
at O 0 1.2035133067911374e-06
nucleotide O 0 3.984039722126909e-06
position O 0 1.5661286170143285e-06
85 O 0 4.016231741843512e-06
, O 0 5.97384826050984e-07
which O 0 4.312176429266401e-07
lies O 0 3.1785250484972494e-06
in O 0 6.373238079504517e-07
the O 0 1.259086047866731e-06
putative O 0 0.000318200298352167
presequence O 0 0.0008055035141296685
for O 0 5.743542715208605e-06
targeting O 0 7.097898196661845e-05
to O 0 1.72745330928592e-05
mitochondria O 0 0.0006341232801787555
. O 0 7.607788575114682e-05

This O 0 4.6380184357985854e-05
mutation O 0 0.00019354985852260143
changes O 0 1.2206871360831428e-05
the O 0 2.562987901910674e-06
codon O 0 2.6553874704404734e-05
for O 0 3.0806090762780514e-06
glutamine O 0 5.4138457926455885e-05
to O 0 2.578708063083468e-06
a O 0 4.767002792505082e-06
termination O 0 0.00040072452975437045
codon O 0 4.7446963435504586e-05
at O 0 4.983664439350832e-06
amino O 0 1.6856443835422397e-05
acid O 0 0.00014920423564035445
position O 0 3.471205855021253e-05
29 O 0 0.00011568821355467662
. O 0 7.58442038204521e-05

MaeI O 0 0.01368937361985445
restriction O 0 0.00014835785259492695
analysis O 0 2.756269896053709e-05
showed O 0 1.7142603610409424e-05
two O 0 1.7341725424557808e-06
other O 0 2.2880808501213323e-06
carriers O 0 4.9687278078636155e-05
in O 0 3.5610612485470483e-06
the O 0 7.522176929342095e-06
family O 0 0.00015451064973603934
. O 0 8.13135047792457e-05

The O 0 0.00021386267326306552
C O 0 0.007072924170643091
- O 0 0.022558100521564484
T O 0 0.41767174005508423
mutation O 0 0.0005048243328928947
is O 0 2.520291900509619e-06
located O 0 3.724173438968137e-06
within O 0 1.5398333061966696e-06
a O 0 3.0837661597615806e-06
recently O 0 1.721217813610565e-05
proposed O 0 1.3488195691024885e-05
putative O 0 9.084361954592168e-05
alternative O 0 1.2600551599462051e-05
translation O 0 1.0906759598583449e-05
initiation O 0 7.513119635405019e-05
codon O 0 0.00011501779954414815
( O 0 2.2826559870736673e-05
TIC O 0 0.03994575887918472
- O 0 4.7394139983225614e-05
1 O 0 3.4773891002259916e-06
) O 0 1.79073697381682e-06
, O 0 7.991283155206474e-07
supporting O 0 4.8703732318244874e-06
that O 0 2.7814223813038552e-06
TIC O 0 0.06198229268193245
- O 0 5.786916517536156e-05
1 O 0 2.9505170004995307e-06
is O 0 1.2954313888258184e-06
the O 0 2.0315171695983736e-06
real O 0 3.252083115512505e-05
TIC O 0 0.058167893439531326
rather O 0 8.508214705216233e-06
than O 0 1.4569632185157388e-05
TIC O 0 0.11499681323766708
- O 0 0.0002619909355416894
2 O 0 2.7113354008179158e-05
. O 0 1.3303546438692138e-05
. O 0 5.050735126133077e-05

Human B-Disease 0 0.028802046552300453
complement I-Disease 0 0.06632672995328903
factor I-Disease 1 0.5738767385482788
H I-Disease 1 0.994598388671875
deficiency I-Disease 1 0.9990348815917969
associated O 1 0.8087989687919617
with O 1 0.7072909474372864
hemolytic B-Disease 1 0.9993739724159241
uremic I-Disease 1 0.9994483590126038
syndrome I-Disease 1 0.9992141723632812
. O 0 0.09919878095388412

This O 0 4.380303289508447e-05
study O 0 5.982690709060989e-05
reports O 0 1.2610854355443735e-05
on O 0 2.0269499145797454e-06
six O 0 9.688747923064511e-06
cases O 0 0.0002325486420886591
of O 0 9.150147889158688e-06
deficiency B-Disease 1 0.9988906979560852
in I-Disease 0 4.771633030031808e-06
the I-Disease 0 3.3615419852139894e-06
human I-Disease 0 6.741625111317262e-05
complement I-Disease 0 0.00015115374117158353
regulatory I-Disease 0 0.0007817634614184499
protein I-Disease 0 0.0003581360506359488
Factor I-Disease 0 0.0015463288873434067
H I-Disease 0 0.3351022005081177
( O 0 0.00011203659960301593
FH O 0 0.3489481806755066
) O 0 2.772630068648141e-06
in O 0 8.57715690472105e-07
the O 0 1.4288772263171268e-06
context O 0 1.3837635378877167e-05
of O 0 1.3358582691580523e-05
an O 0 0.003538974095135927
acute B-Disease 1 0.9996370077133179
renal I-Disease 1 0.9998990297317505
disease I-Disease 1 0.9996510744094849
. O 0 0.0355822890996933

Five O 0 3.919129812857136e-05
of O 0 4.453976998775033e-06
the O 0 5.37488494956051e-06
cases O 0 8.4118997619953e-05
were O 0 1.8493083189241588e-06
observed O 0 3.3614800486247987e-05
in O 0 1.4276827641879208e-05
children O 0 0.005412595812231302
presenting O 0 0.320892870426178
with O 1 0.8122711181640625
idiopathic O 1 0.9998846054077148
hemolytic B-Disease 1 0.9999330043792725
uremic I-Disease 1 0.9999008178710938
syndrome I-Disease 1 0.9998836517333984
( O 1 0.9840696454048157
HUS B-Disease 1 0.9980471134185791
) O 0 0.0041353958658874035
. O 0 0.0006402312428690493

Two O 0 2.772559309960343e-05
of O 0 6.341024345601909e-06
the O 0 8.60189084050944e-06
children O 0 0.0026773540303111076
exhibited O 0 0.01840345375239849
a O 0 0.0010850022081285715
homozygous O 1 0.9532347917556763
deficiency O 1 0.9997432827949524
characterized O 0 0.1319608986377716
by O 0 3.475506218819646e-06
the O 0 1.5039020127005642e-06
absence O 0 1.1196858395123854e-05
of O 0 4.102271589090378e-07
the O 0 8.471298542644945e-07
150 O 0 7.700014975853264e-06
- O 0 0.00029659742722287774
kD O 0 0.011651303619146347
form O 0 3.342393938510213e-06
of O 0 9.58252712734975e-07
Factor O 0 6.951083923922852e-05
H O 0 0.004954242147505283
and O 0 7.22798347396747e-07
the O 0 5.952102242190449e-07
presence O 0 3.1944427973940037e-06
, O 0 7.926614671305288e-07
upon O 0 1.5455681250386988e-06
immunoblotting O 0 8.850835729390383e-05
, O 0 5.586525162470934e-07
of O 0 3.601247726692236e-07
the O 0 1.2928198884765152e-06
42 O 0 2.6564539439277723e-05
- O 0 0.0013317809207364917
kD O 0 0.2139003425836563
Factor O 0 0.0001359564485028386
H O 0 0.0028314872179180384
- O 0 4.002741115982644e-05
like O 0 3.3602277653699275e-06
protein O 0 1.3744219359068666e-05
1 O 0 1.0057526196760591e-05
( O 0 1.6414420315413736e-05
FHL O 0 0.159646674990654
- O 0 5.9820285969180986e-05
1 O 0 3.5625048440124374e-06
) O 0 1.4061223509997944e-06
and O 0 7.522669420723105e-07
other O 0 3.070531192861381e-06
FH O 1 0.9139987230300903
- O 0 0.001279224525205791
related O 0 0.00018668283883016557
protein O 0 8.63274181028828e-05
( O 0 3.6881290725432336e-05
FHR O 0 0.010552937164902687
) O 0 2.9581682611024007e-05
bands O 0 8.662172331241891e-05
. O 0 7.73231586208567e-05

Southern O 0 0.0006220401846803725
blot O 0 0.007744979113340378
and O 0 1.4096405720920302e-05
PCR O 0 7.588000153191388e-05
analysis O 0 6.068963102734415e-06
of O 0 1.183800918624911e-06
DNA O 0 7.63845400797436e-06
of O 0 1.0409543165224022e-06
one O 0 5.37038613401819e-06
patient O 0 0.49780428409576416
with O 0 0.00015796013758517802
homozygous O 1 0.7155014276504517
deficiency O 1 0.9993009567260742
ruled O 0 0.00011862021347042173
out O 0 1.4831499584033736e-06
the O 0 5.584884661402612e-07
presence O 0 1.6065419004007708e-06
of O 0 2.516626409487799e-07
a O 0 8.791728305368451e-07
large O 0 2.7641947326628724e-06
deletion O 0 0.00023450152366422117
of O 0 1.1828337846964132e-06
the O 0 7.853424904169515e-06
FH O 1 0.9798985719680786
gene O 0 0.0009085438214242458
as O 0 3.662800963866175e-06
the O 0 6.228153324627783e-06
underlying O 0 0.0028879381716251373
defect O 1 0.5965364575386047
for O 0 7.381977047771215e-05
the O 0 0.00021669670240953565
deficiency O 1 0.9978339076042175
. O 0 0.0005917123053222895

The O 0 3.156000457238406e-05
other O 0 7.091825409588637e-06
four O 0 9.054290785570629e-06
children O 0 9.082110045710579e-05
presented O 0 3.919159644283354e-05
with O 0 8.236180292442441e-05
heterozygous O 1 0.583929717540741
deficiency O 1 0.9993147850036621
and O 0 2.750928615569137e-05
exhibited O 0 0.0009767090668901801
a O 0 1.0146330168936402e-05
normal O 0 0.00010197960364166647
immunoblotting O 0 0.001081911032088101
pattern O 0 2.3112634153221734e-05
of O 0 8.507513484801166e-07
proteins O 0 6.615679012611508e-06
of O 0 2.3834058993088547e-06
the O 0 2.6241119485348463e-05
FH O 1 0.9840732216835022
family O 0 0.0010772963287308812
. O 0 0.00024054813547991216

Factor B-Disease 0 0.382906973361969
H I-Disease 1 0.9853721261024475
deficiency I-Disease 1 0.9964931607246399
is O 0 2.4530094378860667e-05
the O 0 1.3217831110523548e-05
only O 0 2.4404000214417465e-05
complement B-Disease 0 0.35352882742881775
deficiency I-Disease 1 0.9994454979896545
associated O 0 0.014027637429535389
with O 0 0.001060455571860075
HUS B-Disease 1 0.9947235584259033
. O 0 0.000866872607730329

These O 0 5.168275674805045e-05
observations O 0 9.810913616092876e-05
suggest O 0 4.620615436579101e-05
a O 0 8.65446145326132e-06
role O 0 3.789376569329761e-05
for O 0 4.19592070102226e-05
FH O 1 0.984636664390564
and O 0 8.663684275234118e-05
/ O 0 0.18054251372814178
or O 0 0.0002051065966952592
FH O 1 0.9898527264595032
receptors O 0 0.03223837539553642
in O 0 1.7278503946727142e-05
the O 0 4.997063660994172e-05
pathogenesis O 1 0.9930693507194519
of O 0 0.0010100827785208821
idiopathic O 1 0.9992663264274597
HUS B-Disease 1 0.9975429773330688
. O 0 0.00047972664469853044
. O 0 0.0002509770856704563

Further O 0 9.793462231755257e-05
evidence O 0 2.4138333174050786e-05
for O 0 5.9062044783786405e-06
a O 0 1.2428599802660756e-05
major O 0 0.00010411033144919202
ancient O 0 0.0010652781929820776
mutation O 1 0.7982040643692017
underlying O 1 0.9652696251869202
myotonic B-Disease 1 0.9996035695075989
dystrophy I-Disease 1 0.9997246861457825
from O 0 0.0007159123197197914
linkage O 0 0.319993793964386
disequilibrium O 1 0.8680939674377441
studies O 0 0.0004903107765130699
in O 0 5.9375820455898065e-06
the O 0 6.420960289688082e-06
Japanese O 0 5.952569335931912e-05
population O 0 6.656978803221136e-05
. O 0 0.00011936842929571867

The O 0 0.04036344215273857
myotonic B-Disease 1 0.9974938631057739
dystrophy I-Disease 1 0.9991570711135864
( O 0 0.3482022285461426
DM B-Disease 1 0.9980204105377197
) O 0 0.00038797472370788455
mutation O 0 0.010018445551395416
is O 0 9.92090099316556e-06
an O 0 1.0084937457577325e-05
unstable O 0 0.08745083212852478
( O 0 7.082644879119471e-05
CTG O 0 0.09152194857597351
) O 0 8.158639502653386e-06
n O 0 2.1694273527828045e-05
repeat O 0 5.8452638768358156e-05
, O 0 6.80438176914322e-07
present O 0 6.383566528711526e-07
at O 0 4.119820289361087e-07
a O 0 4.6300721123770927e-07
copy O 0 9.251697292711469e-07
number O 0 1.9266039430476667e-07
of O 0 2.0634878694636427e-07
5 O 0 1.4901848999215872e-06
- O 0 1.4147581168799661e-05
37 O 0 5.509665243152995e-06
repeats O 0 1.0159945304621942e-05
on O 0 6.844022664154181e-07
normal O 0 6.635936188104097e-06
chromosomes O 0 8.189930667867884e-06
but O 0 9.142988233179494e-07
amplified O 0 8.782904842519201e-06
to O 0 1.0946489510388346e-06
50 O 0 3.2376015042245854e-06
- O 0 7.139313674997538e-05
3000 O 0 0.00016577048518229276
copies O 0 1.6598120055277832e-05
on O 0 3.455886690062471e-05
DM B-Disease 1 0.9787235260009766
chromosomes O 0 0.0014514585491269827
. O 0 0.00021235374151729047

Previous O 0 0.0005214873235672712
findings O 0 0.0006310599856078625
in O 0 2.625315755722113e-05
Caucasian O 0 0.007137008011341095
populations O 0 0.0003124909708276391
of O 0 7.767277566017583e-06
a O 0 0.00018023840675596148
DM B-Disease 1 0.9983211159706116
founder O 0 0.06387157738208771
chromosome O 0 0.011590361595153809
raise O 0 4.141478711972013e-05
a O 0 2.6961195089825196e-06
question O 0 2.70250893663615e-06
about O 0 8.461786933366966e-07
the O 0 6.437045954044152e-07
molecular O 0 2.3004051399766468e-05
events O 0 3.0054443413973786e-06
involved O 0 3.155980493829702e-06
in O 0 1.2111354408261832e-06
the O 0 3.1409731491294224e-06
expansion O 0 0.00022016109141986817
mutation O 0 0.003078315407037735
. O 0 0.00013322295853868127

To O 0 5.582851736107841e-05
investigate O 0 0.0003191917494405061
whether O 0 2.595482874312438e-05
a O 0 1.4680932508781552e-05
founder O 0 0.0004934431635774672
chromosome O 0 0.0008451028843410313
for O 0 6.5995973272947595e-06
the O 0 2.2228645320865326e-05
DM B-Disease 1 0.997875452041626
mutation O 0 0.009884712286293507
exists O 0 2.240663525299169e-05
in O 0 1.1126603567390703e-06
the O 0 5.666302627105324e-07
Japanese O 0 4.598292889568256e-06
population O 0 1.731498741719406e-06
, O 0 9.591441312295501e-07
we O 0 1.504210445091303e-06
genotyped O 0 0.00036180642200633883
families O 0 8.352257282240316e-06
using O 0 4.734852154797409e-06
polymorphic O 0 0.007279036566615105
markers O 0 0.00017383330850861967
near O 0 1.2414196135068778e-05
the O 0 3.951745839003706e-06
( O 0 1.8624392396304756e-05
CTG O 0 0.01862916350364685
) O 0 1.014277950162068e-05
n O 0 2.908532587753143e-05
repeat O 0 0.00010042064968729392
region O 0 3.014285357494373e-05
and O 0 1.0011611266236287e-05
constructed O 0 0.00014095134974922985
haplotypes O 0 0.022998983040452003
. O 0 0.00011189832730451599

Six O 0 0.00015101990720722824
different O 0 4.251338395988569e-05
haplotypes O 0 0.0042075649835169315
were O 0 7.317451945709763e-06
found O 0 2.1908523194724694e-05
and O 0 3.9755523175699636e-05
DM B-Disease 1 0.9973121881484985
alleles O 0 0.029298191890120506
were O 0 1.0863636816793587e-05
always O 0 6.61397643852979e-05
haplotype O 0 0.07080164551734924
A O 0 0.00013965257676318288
. O 0 0.00012805298320017755

To O 0 2.4628634491818957e-05
find O 0 1.642365714360494e-05
an O 0 1.7024531189235859e-06
origin O 0 1.4889434396536672e-06
of O 0 6.378588182087697e-07
the O 0 2.195001798099838e-06
( O 0 1.672794678597711e-05
CTG O 0 0.024375904351472855
) O 0 8.169320608431008e-06
n O 0 3.921541429008357e-05
repeat O 0 0.0002808432618621737
mutation O 0 9.166297240881249e-05
and O 0 6.185430834193539e-07
to O 0 6.250718911360309e-07
investigate O 0 6.82283052810817e-06
the O 0 4.546099034996587e-07
mechanism O 0 1.9854053334711352e-06
of O 0 2.81017037195852e-07
the O 0 6.767164109078294e-07
expansion O 0 1.7880945961223915e-05
mutation O 0 0.0001075583859346807
in O 0 5.667783398166648e-07
the O 0 3.89782286447371e-07
Japanese O 0 3.66493236469978e-06
population O 0 1.099627411349502e-06
we O 0 7.577361316180031e-07
have O 0 1.212760480484576e-06
studied O 0 6.568101980519714e-06
90 O 0 1.4086971532378811e-05
Japanese O 0 0.00016202896949835122
DM B-Disease 1 0.9965188503265381
families O 0 0.00013747675984632224
comprising O 0 3.772649870370515e-05
190 O 0 0.00028942644712515175
affected O 0 0.0006541970069520175
and O 0 9.454414794163313e-06
130 O 0 0.00019897811580449343
unaffected O 0 0.005066635552793741
members O 0 4.902047658106312e-05
. O 0 0.00010330642544431612

The O 0 4.184967474429868e-05
results O 0 5.024706479161978e-05
suggest O 0 2.733764995355159e-05
that O 0 1.9269343738415046e-06
a O 0 2.8123788524681004e-06
few O 0 4.6085092435532715e-06
common O 0 4.340359737398103e-05
ancestral O 0 0.0016682586865499616
mutations O 0 0.0028779087588191032
in O 0 1.9885756046278402e-06
both O 0 3.79255152438418e-06
Caucasian O 0 0.008214742876589298
and O 0 2.4320049760717666e-06
Japanese O 0 1.3285416571306996e-05
populations O 0 5.095994856674224e-05
have O 0 5.804050715596532e-07
originated O 0 2.3066290850692894e-06
by O 0 4.112761757824046e-07
expansion O 0 2.5903516416292405e-06
of O 0 3.2160801310965326e-07
an O 0 1.268583787350508e-06
ancestral O 0 6.244202813832089e-05
n O 0 3.6970308428863063e-05
= O 0 5.700752808479592e-05
5 O 0 4.673918283515377e-06
repeat O 0 2.9325601644814014e-05
to O 0 2.4496816877217498e-06
n O 0 3.1929212127579376e-05
= O 0 5.5630658607697114e-05
19 O 0 1.5497449567192234e-05
- O 0 6.923120963620022e-05
37 O 0 6.80055090924725e-05
copies O 0 6.701130041619763e-05
. O 0 9.45920473895967e-05

These O 0 2.9104667191859335e-05
data O 0 1.3578564903582446e-05
support O 0 1.3823271729052067e-05
multistep O 0 0.00048576382687315345
models O 0 2.5824048861977644e-05
of O 0 4.857732619711896e-06
triplet O 0 0.04276496544480324
repeat O 0 0.0012317935470491648
expansion O 0 3.5337005101609975e-05
that O 0 9.816779993343516e-07
have O 0 8.192986342692166e-07
been O 0 9.249288837054337e-07
proposed O 0 5.140660960023524e-06
for O 0 3.826352894975571e-06
both O 0 4.189483661320992e-05
DM B-Disease 1 0.9979864358901978
and O 0 0.00022070840350352228
Friedreichs B-Disease 1 0.8295886516571045
ataxia I-Disease 1 0.9962666630744934
. O 0 0.0001334581756964326
. O 0 0.00022884004283696413

The O 0 6.530570681206882e-05
molecular O 0 0.00028060126351192594
basis O 0 3.79587581846863e-05
of O 0 5.824625623063184e-05
C6 B-Disease 1 0.9969930648803711
deficiency I-Disease 1 0.9993441700935364
in O 0 1.752525713527575e-05
the O 0 4.448085292096948e-06
western O 0 2.990811481140554e-05
Cape O 0 0.00043875540723092854
, O 0 1.4704501154483296e-05
South O 0 3.5458429920254275e-05
Africa O 0 0.00018108973745256662
. O 0 0.00012181362399132922

Deficiency B-Disease 1 0.9915755391120911
of I-Disease 0 1.2323745977482758e-05
the I-Disease 0 5.422291906143073e-06
sixth I-Disease 0 1.8810744222719222e-05
component I-Disease 0 1.6001633412088268e-05
of I-Disease 0 1.9031358533538878e-06
human I-Disease 0 4.5059805415803567e-05
complement I-Disease 0 0.00020343007054179907
( O 0 5.9242032875772566e-05
C6 O 0 0.38195499777793884
) O 0 5.1954166337964125e-06
has O 0 1.9185654309694655e-06
been O 0 7.551377052550379e-07
reported O 0 3.3308176625723718e-06
in O 0 2.715488562898827e-07
a O 0 3.3955424783016497e-07
number O 0 2.569678656527685e-07
of O 0 2.800277059122891e-07
families O 0 3.663345751192537e-06
from O 0 6.75923104154208e-07
the O 0 1.0058955695058103e-06
western O 0 1.2254972716618795e-05
Cape O 0 0.00022616035130340606
, O 0 6.309030140982941e-06
South O 0 2.40968402067665e-05
Africa O 0 9.630386193748564e-05
. O 0 7.49274913687259e-05

Meningococcal B-Disease 1 0.9980738162994385
disease I-Disease 1 0.9989029169082642
is O 0 0.0006997568416409194
endemic O 0 0.06713484227657318
in O 0 7.909391570137814e-06
the O 0 4.407883807289181e-06
Cape O 0 7.387773075606674e-05
and O 0 1.1262120551691623e-06
almost O 0 1.2846077197536943e-06
all O 0 6.794984983571339e-07
pedigrees O 0 0.00016891701670829207
of O 0 2.5912709133990575e-06
total O 0 0.0002259213215438649
C6 B-Disease 1 0.9988162517547607
deficiency I-Disease 1 0.9997926354408264
( O 0 0.0017080764519050717
C6Q0 O 0 0.45377328991889954
) O 0 1.1989254744548816e-05
have O 0 3.268556611146778e-06
been O 0 4.4624634938372765e-06
ascertained O 0 0.00045732181752100587
because O 0 2.6423631425132044e-05
of O 0 3.305743302917108e-05
recurrent O 1 0.9960895776748657
disease O 1 0.9989261031150818
. O 0 0.0018231094582006335

We O 0 3.4624215913936496e-05
have O 0 5.986662927170983e-06
sequenced O 0 2.936128294095397e-05
the O 0 1.917639792736736e-06
expressed O 0 6.621206921408884e-06
exons O 0 1.4731773262610659e-05
of O 0 1.0367783715992118e-06
the O 0 3.1261447475117166e-06
C6 O 0 0.21079352498054504
gene O 0 0.00017370341811329126
from O 0 1.2637066220122506e-06
selected O 0 3.042373691641842e-06
cases O 0 1.666152456891723e-05
and O 0 7.51873869830888e-07
have O 0 8.503182016283972e-07
found O 0 1.7513075363240205e-06
three O 0 3.245688503739075e-06
molecular O 0 0.003943649120628834
defects O 1 0.8057011365890503
leading O 0 6.016824772814289e-05
to O 0 5.4608171922154725e-06
total O 0 0.00011798037303378806
deficiency O 1 0.9994688630104065
879delG O 0 0.08093925565481186
, O 0 2.8694182674371405e-06
which O 0 5.945509542470973e-07
is O 0 6.82267284446425e-07
the O 0 9.04888679542637e-07
common O 0 5.413871258497238e-05
defect O 0 0.06952184438705444
in O 0 1.7099509932450019e-06
the O 0 1.89029299235699e-06
Cape O 0 0.00016241875709965825
and O 0 2.708303782128496e-06
hitherto O 0 0.0002458277449477464
unreported O 0 0.00128181092441082
, O 0 2.3254517600435065e-06
and O 0 2.6988823265128303e-06
1195delC O 0 0.002201273338869214
and O 0 3.432827497817925e-06
1936delG O 0 0.0006468964857049286
, O 0 9.451189839637664e-07
which O 0 3.290645906872669e-07
have O 0 5.057249268247688e-07
been O 0 7.423436159115226e-07
previously O 0 2.6566196993371705e-06
reported O 0 1.1258275662839878e-05
in O 0 2.1748357994511025e-06
African O 0 3.220234430045821e-05
- O 0 0.0011590132489800453
Americans O 0 0.00022876699222251773
. O 0 8.72656746651046e-05

We O 0 4.7926634579198435e-05
also O 0 8.755809176363982e-06
show O 0 7.036710485408548e-06
that O 0 1.8473236877980526e-06
the O 0 3.3736491786839906e-06
879delG O 0 0.0013610355090349913
and O 0 1.619541217223741e-05
1195delC O 0 0.14022935926914215
defects O 1 0.9099151492118835
are O 0 6.410289188352181e-06
associated O 0 7.048934639897197e-05
with O 0 2.500134905858431e-05
characteristic O 0 0.05874482914805412
C6 O 1 0.9940358400344849
/ O 1 0.6935935020446777
C7 O 1 0.8777649402618408
region O 0 0.0003719993110280484
DNA O 0 0.00028419317095540464
marker O 0 0.0006824296433478594
haplotypes O 0 0.009518114849925041
, O 0 3.2897464734560344e-06
although O 0 2.8108531751058763e-06
small O 0 3.7728477764176205e-06
variations O 0 1.7322869098279625e-05
were O 0 4.961532340530539e-06
observed O 0 0.00011017180077033117
. O 0 5.064476499683224e-05

The O 0 0.0002755779423750937
1936delG O 0 0.0765971913933754
defect O 0 0.12907075881958008
was O 0 8.904010428523179e-06
observed O 0 1.3678745744982734e-05
only O 0 8.073292292465339e-07
once O 0 1.4478508774118382e-06
in O 0 6.226895834515744e-07
the O 0 6.645826715612202e-07
Cape O 0 2.720075826800894e-05
, O 0 9.097377073885582e-07
but O 0 1.0471035238879267e-06
its O 0 4.316276317695156e-06
associated O 0 8.012811304070055e-05
haplotype O 0 0.03391361981630325
could O 0 7.169613581936574e-06
be O 0 6.057727659936063e-06
deduced O 0 0.0001386460498906672
. O 0 5.992865771986544e-05

The O 0 2.8623466278077103e-05
data O 0 1.8095428458764218e-05
from O 0 3.4158947528339922e-06
the O 0 2.985814944622689e-06
haplotypes O 0 0.0011389354476705194
indicate O 0 8.275911568489391e-06
that O 0 6.27705105671339e-07
these O 0 5.449541049529216e-07
three O 0 1.996470928133931e-06
molecular O 0 0.0010339716682210565
defects O 0 0.4117453396320343
account O 0 5.212568794377148e-06
for O 0 2.042792857537279e-06
the O 0 2.8379231480357703e-06
defects O 0 0.24614258110523224
in O 0 1.0422893410577672e-06
all O 0 5.26195776728855e-07
the O 0 1.8209884729003534e-06
38 O 0 9.560754551785067e-05
unrelated O 0 0.006513634230941534
C6Q0 O 0 0.16370466351509094
individuals O 0 2.2536114556714892e-05
we O 0 1.7194469137393753e-06
have O 0 1.0820084526130813e-06
studied O 0 4.976070158591028e-06
from O 0 1.7095189832616597e-06
the O 0 6.328495146590285e-06
Cape O 0 0.00042723293881863356
. O 0 5.278595199342817e-05

We O 0 3.139328691759147e-05
have O 0 5.3662392929254565e-06
also O 0 2.527447577449493e-06
observed O 0 7.507356258429354e-06
the O 0 2.7991395654680673e-06
879delG O 0 0.0026834525633603334
defect O 0 0.010130545124411583
in O 0 3.3482863273093244e-06
two O 0 6.8218805608921684e-06
Dutch O 0 0.0006663966923952103
C6 B-Disease 1 0.9944731593132019
- I-Disease 1 0.5318089127540588
deficient I-Disease 1 0.9943810105323792
kindreds O 0 0.13871844112873077
, O 0 8.440480996796396e-06
but O 0 2.7868284178111935e-06
the O 0 4.338296548667131e-06
879delG O 0 0.015464243479073048
defect O 0 0.04262062534689903
in O 0 3.4367781154287513e-06
the O 0 2.361842462050845e-06
Cape O 0 0.00021219448535703123
probably O 0 6.187877261254471e-06
did O 0 1.122307253353938e-06
not O 0 3.5019490951526677e-07
come O 0 9.183868314721622e-07
from O 0 8.119558856378717e-07
The O 0 1.4694174979013042e-06
Netherlands O 0 2.700290860957466e-05
. O 0 9.374025466968305e-06
. O 0 4.023943984066136e-05

Complement B-Disease 1 0.6315281391143799
C7 I-Disease 1 0.9935916066169739
deficiency I-Disease 1 0.9983750581741333
: O 0 0.00020477207726798952
seven O 0 3.8224661693675444e-05
further O 0 6.103882333263755e-05
molecular O 0 0.007649974897503853
defects O 1 0.7998992800712585
and O 0 1.0193912203249056e-05
their O 0 1.4251796528697014e-05
associated O 0 0.0004185089492239058
marker O 0 0.004971582442522049
haplotypes O 0 0.23264047503471375
. O 0 0.00023362049250863492

Seven O 0 0.0002687246014829725
further O 0 7.755443948553875e-05
molecular O 0 0.0002923004503827542
bases O 0 9.340885299025103e-05
of O 0 0.00010013540304498747
C7 B-Disease 1 0.9959195852279663
deficiency I-Disease 1 0.9989161491394043
are O 0 0.00014185067266225815
described O 0 0.0023211606312543154
. O 0 0.00027112982934340835

All O 0 2.535372186684981e-05
these O 0 1.4186545740813017e-05
new O 0 2.5822424504440278e-05
molecular O 0 0.0008054086938500404
defects O 0 0.36538127064704895
involve O 0 8.618002175353467e-05
single O 0 5.311803761287592e-06
- O 0 5.569286804529838e-05
nucleotide O 0 1.2965145288035274e-05
events O 0 5.592897196038393e-06
, O 0 1.64090022281016e-06
deletions O 0 1.875822272268124e-05
and O 0 6.713516427225841e-07
substitutions O 0 3.923521944670938e-06
, O 0 5.159266720511368e-07
some O 0 2.268135830263418e-07
of O 0 3.3112587516370695e-07
which O 0 9.670604868006194e-07
alter O 0 9.527989459456876e-05
splice O 0 0.0002832663885783404
sites O 0 1.0087795089930296e-05
, O 0 3.628721515269717e-06
and O 0 5.3897906582278665e-06
others O 0 4.097268538316712e-05
codons O 0 0.0006914969999343157
. O 0 9.433100785827264e-05

They O 0 2.7847938326885924e-05
are O 0 5.320904620020883e-06
distributed O 0 1.1498073035909329e-05
along O 0 5.990203590044985e-06
the O 0 5.152902758709388e-06
C7 O 0 0.13887865841388702
gene O 0 0.00016526575200259686
, O 0 1.8290625121153425e-06
but O 0 1.0194330570811871e-06
predominantly O 0 2.154452431568643e-06
towards O 0 2.145318603652413e-06
the O 0 1.5874466043896973e-06
3 O 0 1.3198318811191712e-05
end O 0 3.166509486618452e-05
. O 0 5.3412422857945785e-05

All O 0 2.6498981242184527e-05
were O 0 1.2476230040192604e-05
found O 0 1.6239830074482597e-05
in O 0 1.604643875907641e-05
compound O 0 0.0004923151573166251
heterozygous O 0 0.0032667922787368298
individuals O 0 0.0003244831459596753
. O 0 0.00016276277892757207

The O 0 0.0008910686010494828
C6 O 1 0.9696899056434631
/ O 1 0.7771795392036438
C7 O 1 0.9649676084518433
marker O 0 0.03848164528608322
haplotypes O 0 0.4054882228374481
associated O 0 0.00022235294454731047
with O 0 2.5085466404561885e-05
most O 0 0.00010049393313238397
C7 B-Disease 1 0.9837606549263
defects I-Disease 1 0.9585981369018555
are O 0 2.0088271412532777e-05
tabulated O 0 0.00017434240726288408
. O 0 2.335373756068293e-05
. O 0 7.168552838265896e-05

A O 0 0.00032784175709821284
genome O 0 0.000886613386683166
- O 0 0.0004877785104326904
wide O 0 0.00010313014354323968
search O 0 7.330047083087265e-05
for O 0 4.073216041433625e-05
chromosomal O 0 0.4035801887512207
loci O 0 0.3846338093280792
linked O 0 0.4564482867717743
to O 0 0.0015775684732943773
mental O 1 0.999239444732666
health O 1 0.9981290698051453
wellness O 1 0.9957333207130432
in O 0 0.00013340907753445208
relatives O 0 0.004257614258676767
at O 0 0.00016184183186851442
high O 0 0.01352745108306408
risk O 1 0.9732679128646851
for O 0 0.09304986894130707
bipolar B-Disease 1 0.9998612403869629
affective I-Disease 1 0.999613344669342
disorder I-Disease 1 0.9995684027671814
among O 0 0.0003028714854735881
the O 0 2.651900467753876e-05
Old O 0 0.0004170590254943818
Order O 0 7.81018752604723e-05
Amish O 0 0.0025222974363714457
. O 0 0.0001673368242336437

Bipolar B-Disease 1 0.9984695315361023
affective I-Disease 1 0.9979074001312256
disorder I-Disease 1 0.9991455078125
( O 1 0.6333635449409485
BPAD B-Disease 1 0.9958325028419495
; O 0 0.48081982135772705
manic B-Disease 1 0.999395489692688
- I-Disease 1 0.9980764389038086
depressive I-Disease 1 0.9997387528419495
illness I-Disease 1 0.9995065927505493
) O 0 0.00017656390264164656
is O 0 2.496851811883971e-05
characterized O 0 0.01297302357852459
by O 0 8.458918273390736e-06
episodes O 0 0.00014470858150161803
of O 0 1.7887086869450286e-05
mania B-Disease 1 0.9945541620254517
and O 0 0.00013944925740361214
/ O 0 0.2954285740852356
or O 0 0.00023420860816258937
hypomania B-Disease 1 0.995908260345459
interspersed O 0 0.0023093358613550663
with O 0 3.175533493049443e-05
periods O 0 0.000975277042016387
of O 0 8.324442023877054e-05
depression B-Disease 1 0.9924730062484741
. O 0 0.0005465248832479119

Compelling O 0 0.0007706661708652973
evidence O 0 7.457719766534865e-05
supports O 0 7.77142122387886e-05
a O 0 9.889124157780316e-06
significant O 0 2.5973622541641816e-05
genetic O 0 0.0003928899532184005
component O 0 4.859783439314924e-05
in O 0 6.121960723248776e-06
the O 0 1.368897756037768e-05
susceptibility O 0 0.36328616738319397
to O 0 6.74123948556371e-05
develop O 0 0.14594429731369019
BPAD B-Disease 1 0.9412892460823059
. O 0 0.0003618307237047702

To O 0 3.930579259758815e-05
date O 0 1.6729702110751532e-05
, O 0 3.357351261001895e-06
however O 0 2.246574695163872e-06
, O 0 1.427109623364231e-06
linkage O 0 0.0001363966439384967
studies O 0 1.4124799236014951e-05
have O 0 7.591045800836582e-07
attempted O 0 3.2874067983357236e-06
only O 0 3.9919700611790176e-07
to O 0 9.979991091313423e-07
identify O 0 7.52764826756902e-05
chromosomal O 0 0.06619628518819809
loci O 0 0.004265821538865566
that O 0 4.505473043536767e-06
cause O 0 0.0008386251865886152
or O 0 4.8915012484940235e-06
increase O 0 1.7370563000440598e-05
the O 0 5.433938440546626e-06
risk O 0 0.004844007547944784
of O 0 1.4774304872844368e-05
developing O 0 0.05918382853269577
BPAD B-Disease 1 0.9396231770515442
. O 0 0.0003443993045948446

To O 0 4.648344111046754e-05
determine O 0 3.983093120041303e-05
whether O 0 8.667479050927795e-06
there O 0 1.7657234820944723e-06
could O 0 2.615649918880081e-06
be O 0 1.5251570175678353e-06
protective O 0 0.010708923451602459
alleles O 0 0.0008797796326689422
that O 0 3.00545275422337e-06
prevent O 0 0.0003828184853773564
or O 0 6.599748303415254e-06
reduce O 0 0.00031821304582990706
the O 0 4.80604558106279e-06
risk O 0 0.0029459118377417326
of O 0 2.4502423912053928e-06
developing O 0 0.005487553775310516
BPAD B-Disease 0 0.4865228831768036
, O 0 3.1679514904681128e-06
similar O 0 4.873900252277963e-06
to O 0 8.748295385885285e-07
what O 0 1.9497711036819965e-06
is O 0 1.3056687748758122e-06
observed O 0 1.3085161299386527e-05
in O 0 5.284515282255597e-06
other O 0 8.015416824491695e-05
genetic B-Disease 1 0.9876258969306946
disorders I-Disease 1 0.9997904896736145
, O 0 7.993814506335184e-05
we O 0 3.941708928323351e-05
used O 0 0.0006198826595209539
mental O 1 0.9991515874862671
health O 1 0.9982965588569641
wellness O 1 0.9975798726081848
( O 0 0.00040404367609880865
absence O 0 0.0009396913810633123
of O 0 1.2773080925398972e-05
any O 0 0.0009304144186899066
psychiatric B-Disease 1 0.9995924830436707
disorder I-Disease 1 0.9994993209838867
) O 0 1.638283174543176e-05
as O 0 1.608550292075961e-06
the O 0 2.40749341173796e-06
phenotype O 0 0.016893120482563972
in O 0 1.5617941926393542e-06
our O 0 4.156912382313749e-06
genome O 0 0.0002356300101382658
- O 0 0.0002502063289284706
wide O 0 3.472020398476161e-05
linkage O 0 0.0005313478177413344
scan O 0 0.0004025859816465527
of O 0 9.216068406203703e-07
several O 0 2.0243383005436044e-06
large O 0 8.308166798087768e-06
multigeneration O 0 0.004358706995844841
Old O 0 7.564802217530087e-05
Order O 0 1.4238907169783488e-05
Amish O 0 0.0024694681633263826
pedigrees O 0 0.019758448004722595
exhibiting O 0 0.0160929374396801
an O 0 2.3529943064204417e-05
extremely O 0 0.004446179606020451
high O 0 0.0019293075893074274
incidence O 1 0.9442273378372192
of O 0 0.00010163361002923921
BPAD B-Disease 1 0.9642190337181091
. O 0 0.0005412104655988514

We O 0 4.83443945995532e-05
have O 0 7.942694537632633e-06
found O 0 3.7452800825121813e-06
strong O 0 2.709042519200011e-06
evidence O 0 1.8561851220511016e-06
for O 0 1.018182615553087e-06
a O 0 3.167873046550085e-06
locus O 0 0.0001373968116240576
on O 0 7.4241402217012364e-06
chromosome O 0 0.00100886810105294
4p O 0 0.05390674248337746
at O 0 1.6270198102574795e-05
D4S2949 O 0 0.0010549678700044751
( O 0 1.3501540706783999e-05
maximum O 0 1.792588591342792e-05
GENEHUNTER O 0 0.002210701582953334
- O 0 0.00010980701335938647
PLUS O 0 4.506461846176535e-05
nonparametric O 0 0.0002588918141555041
linkage O 0 0.00010322054731659591
score O 0 1.0226230187981855e-05
= O 0 3.866239785565995e-05
4 O 0 5.8067407735507e-06
. O 0 1.688038423708349e-06
05 O 0 7.859272591304034e-05
, O 0 3.024478473889758e-06
P O 0 0.0001707279880065471
= O 0 1.9389053704799153e-05
5 O 0 1.92362585949013e-06
. O 0 6.126546736595628e-07
22 O 0 2.1266127987473737e-06
x O 0 8.921418157115113e-06
10 O 0 1.406807768944418e-06
( O 0 1.7082347767427564e-06
- O 0 1.6318273992510512e-05
4 O 0 3.858754553220933e-06
) O 0 3.157747642035247e-06
; O 0 3.7734018860646756e-06
SIBPAL O 0 0.000844760739710182
Pempirical O 0 0.0002170832158299163
value O 0 3.887779712385964e-06
< O 0 0.00010747134365374222
3 O 0 5.2758236961381044e-06
x O 0 2.0563680664054118e-05
10 O 0 2.7333226171322167e-06
( O 0 2.9363834528339794e-06
- O 0 1.3626354302687105e-05
5 O 0 1.9836018054775195e-06
) O 0 7.471519438695395e-07
) O 0 7.090075087035075e-07
and O 0 4.3936046267845086e-07
suggestive O 0 7.115946209523827e-05
evidence O 0 1.1936056125705363e-06
for O 0 7.649729809600103e-07
a O 0 2.3299671738641337e-06
locus O 0 0.0002601484884507954
on O 0 7.649148756172508e-06
chromosome O 0 0.0116111533716321
4q O 1 0.9031004905700684
at O 0 1.7769703845260665e-05
D4S397 O 0 0.001202380284667015
( O 0 9.405034688825253e-06
maximum O 0 1.2082780813216232e-05
GENEHUNTER O 0 0.0023156043607741594
- O 0 9.808742470340803e-05
PLUS O 0 2.97412188956514e-05
nonparametric O 0 0.00024679081980139017
linkage O 0 9.664904064266011e-05
score O 0 6.111006314313272e-06
= O 0 2.85260994132841e-05
3 O 0 2.7141109057993162e-06
. O 0 8.729677460905805e-07
29 O 0 3.4340127967880107e-06
, O 0 1.7342188129987335e-06
P O 0 6.391685747075826e-05
= O 0 1.8094580809702165e-05
2 O 0 1.8335964568905183e-06
. O 0 6.431511110349675e-07
57 O 0 5.52876144865877e-06
x O 0 1.2630413039005361e-05
10 O 0 1.912392917802208e-06
( O 0 2.438117007841356e-06
- O 0 1.4483451195701491e-05
3 O 0 2.680874558791402e-06
) O 0 2.2196561531018233e-06
; O 0 3.8014234178262996e-06
SIBPAL O 0 0.0006396023673005402
Pempirical O 0 0.00019120438082609326
value O 0 2.9737061595369596e-06
< O 0 0.00010890542034758255
1 O 0 3.304342271803762e-06
x O 0 1.869979860202875e-05
10 O 0 3.3336650631099474e-06
( O 0 4.060262199345743e-06
- O 0 1.866799357230775e-05
3 O 0 3.5114608181174845e-06
) O 0 2.122576688634581e-06
) O 0 1.1755655577871948e-06
that O 0 6.502323230961338e-07
are O 0 2.0506593045865884e-06
linked O 0 0.0013155669439584017
to O 0 9.844012674875557e-05
mental O 1 0.9971882700920105
health O 1 0.9894385933876038
wellness O 1 0.9896273612976074
. O 0 0.0006945952773094177

These O 0 4.645339140552096e-05
findings O 0 8.877513027982786e-05
are O 0 1.6875217170309043e-06
consistent O 0 8.026280738704372e-06
with O 0 1.2118264294258552e-06
the O 0 1.3927801774116233e-06
hypothesis O 0 2.221823888248764e-05
that O 0 8.957155159805552e-07
certain O 0 5.748036073782714e-06
alleles O 0 0.0007925935206003487
could O 0 7.024440037639579e-06
prevent O 0 0.00021962099708616734
or O 0 1.5808409443707205e-05
modify O 0 0.0016146041452884674
the O 0 1.7649676010478288e-05
clinical O 1 0.8685567378997803
manifestations O 0 0.39529159665107727
of O 0 2.816571395669598e-05
BPAD B-Disease 1 0.9405857920646667
and O 0 3.6206543882144615e-05
perhaps O 0 0.0006054975092411041
other O 0 0.00011739703768398613
related O 1 0.5269802808761597
affective B-Disease 1 0.9977268576622009
disorders I-Disease 1 0.9988725781440735
. O 0 0.0028646590653806925

Segregation O 0 0.4067995250225067
distortion O 0 0.3840249180793762
in O 0 0.025712257251143456
myotonic B-Disease 1 0.9949952363967896
dystrophy I-Disease 1 0.9975405931472778
. O 0 0.01755279116332531

Myotonic B-Disease 1 0.9953144788742065
dystrophy I-Disease 1 0.9984440207481384
( O 1 0.6412115693092346
DM B-Disease 1 0.9969940185546875
) O 0 0.00032987367012538016
is O 0 4.742515739053488e-05
an O 0 0.00013513366866391152
autosomal B-Disease 1 0.9968392848968506
dominant I-Disease 1 0.5532011389732361
disease I-Disease 1 0.9993690848350525
which O 0 5.055063411418814e-06
, O 0 1.977661213459214e-06
in O 0 8.809478799776116e-07
the O 0 1.22456265216897e-06
typical O 0 9.49350869632326e-05
pedigree O 0 0.000699025287758559
, O 0 1.4697482129122363e-06
shows O 0 2.2423878363042604e-06
a O 0 2.426394075882854e-06
three O 0 4.33343802797026e-06
generation O 0 0.00010844199277926236
anticipation O 0 0.00035157165257260203
cascade O 0 0.01088085025548935
. O 0 0.00021994541748426855

This O 0 0.00012115321442252025
results O 0 0.0005156287807039917
in O 0 0.000898216909263283
infertility B-Disease 1 0.9991287589073181
and O 1 0.7266848087310791
congenital B-Disease 1 0.9998894929885864
myotonic I-Disease 1 0.9998273253440857
dystrophy I-Disease 1 0.9998416900634766
( O 0 0.12024304270744324
CDM B-Disease 1 0.9717535376548767
) O 0 2.396195850451477e-05
with O 0 5.285643965180498e-06
the O 0 6.283462880674051e-06
disappearance O 0 0.0014878006186336279
of O 0 1.531556154077407e-05
DM B-Disease 1 0.9972015619277954
in O 0 3.971168916905299e-05
that O 0 3.34854812535923e-05
pedigree O 0 0.025622854009270668
. O 0 0.00021603217464871705

The O 0 3.3980879379669204e-05
concept O 0 4.9132890126202255e-05
of O 0 7.380689567071386e-06
segregation O 0 0.000599999213591218
distortion O 0 0.00021028571063652635
, O 0 3.0046705887798453e-06
where O 0 9.266089477932837e-07
there O 0 5.506495881490991e-07
is O 0 5.498833957062743e-07
preferential O 0 7.772761819069274e-06
transmission O 0 5.567730568145635e-06
of O 0 2.5930731339940394e-07
the O 0 7.228893537103431e-07
larger O 0 6.509454124170588e-06
allele O 0 0.00013551459414884448
at O 0 3.7773047552036587e-06
the O 0 8.451806024822872e-06
DM B-Disease 1 0.9970736503601074
locus O 0 0.0014373287558555603
, O 0 3.0441267426795093e-06
has O 0 1.591700424796727e-06
been O 0 7.164741759879689e-07
put O 0 1.8863546529246378e-06
forward O 0 1.9650167359941406e-06
to O 0 1.062961246134364e-06
explain O 0 2.392542410234455e-05
partially O 0 2.77395829471061e-05
the O 0 1.501838141848566e-06
maintenance O 0 0.0002093115181196481
of O 0 4.367396286397707e-06
DM B-Disease 1 0.994498074054718
in O 0 8.714448995306157e-06
the O 0 8.335992788488511e-06
population O 0 4.159757008892484e-05
. O 0 8.835404150886461e-05

In O 0 5.800845246994868e-05
a O 0 2.646193388500251e-05
survey O 0 5.092056017019786e-05
of O 0 1.2098382285330445e-05
DM B-Disease 1 0.9930220246315002
in O 0 8.801201147434767e-06
Northern O 0 3.229682261007838e-05
Ireland O 0 1.9462788259261288e-05
, O 0 7.4403292273927946e-06
59 O 0 0.00010381816537119448
pedigrees O 0 0.0010429512476548553
were O 0 1.806123873393517e-05
ascertained O 0 0.0015621063066646457
. O 0 0.0001241326390299946

Sibships O 0 0.013217025436460972
where O 0 2.476431654940825e-05
the O 0 4.7440412345167715e-06
status O 0 4.958661065757042e-06
of O 0 3.2444830821987125e-07
all O 0 3.182852026384353e-07
the O 0 4.6723445734642155e-07
members O 0 8.934974289331876e-07
had O 0 9.02945600955718e-07
been O 0 7.70797043969651e-07
identified O 0 3.4490910820750287e-06
were O 0 3.254772025229613e-07
examined O 0 1.7244821719941683e-05
to O 0 2.546245525536506e-07
determine O 0 1.163182560048881e-06
the O 0 3.6823479376835166e-07
transmission O 0 1.0355784979765303e-05
of O 0 6.973033919166483e-07
the O 0 8.303382855956443e-06
DM B-Disease 1 0.997962474822998
expansion O 0 0.00025571658625267446
from O 0 1.0914103768300265e-05
affected O 0 0.001171332085505128
parents O 0 3.1558407499687746e-05
to O 0 3.0768273973080795e-06
their O 0 7.953094609547406e-06
offspring O 0 0.0011066714068874717
. O 0 8.323306974489242e-05

Where O 0 0.00014187204942572862
the O 0 5.687096563633531e-05
transmitting O 0 0.005123558454215527
parent O 0 0.006228840909898281
was O 0 2.5246259610867128e-05
male O 0 0.00027577270520851016
, O 0 2.858145671780221e-05
58 O 0 0.0004902317887172103
. O 0 0.00015260688087437302

3 O 0 6.246453995117918e-05
% O 0 8.418423021794297e-06
of O 0 1.9246715510234935e-06
the O 0 2.4817602479743073e-06
offspring O 0 0.00011333180736983195
were O 0 1.438703179701406e-06
affected O 0 8.127721957862377e-05
, O 0 5.506826141754573e-07
and O 0 2.7243493150308495e-07
in O 0 3.116192317520472e-07
the O 0 3.9520071482002095e-07
case O 0 3.1674921956437174e-06
of O 0 5.661516411237244e-07
a O 0 1.1308871762594208e-05
female O 0 0.0003904205223079771
transmitting O 0 0.019344979897141457
parent O 0 0.00965940859168768
, O 0 3.0286750188679434e-05
68 O 0 0.0004014221194665879
. O 0 9.6703261078801e-05

7 O 0 0.00030741607770323753
% O 0 7.130305311875418e-05
were O 0 3.3736516343196854e-05
affected O 0 0.0009237111080437899
. O 0 0.00015207694377750158

Studies O 0 0.0006588252726942301
on O 0 4.56238049082458e-05
meiotic O 0 0.027585243806242943
drive O 0 0.00017253500118386
in O 0 4.479519702726975e-05
DM B-Disease 1 0.9955472946166992
have O 0 7.0962964855425525e-06
shown O 0 6.088296231610002e-06
increased O 0 5.063164280727506e-06
transmission O 0 1.0051552635559347e-05
of O 0 5.847129500580195e-07
the O 0 1.1419590464356588e-06
larger O 0 8.550861821277067e-06
allele O 0 8.789723506197333e-05
at O 0 4.977916887582978e-06
the O 0 1.395262916048523e-05
DM B-Disease 1 0.9945533275604248
locus O 0 0.0026997802779078484
in O 0 3.20104300044477e-05
non O 0 0.0012584296055138111
- O 0 0.2595018744468689
DM O 1 0.9969701766967773
heterozygotes O 1 0.7916294932365417
for O 0 0.000228964228881523
CTGn O 0 0.12496771663427353
. O 0 0.00029021783848293126

This O 0 3.8702677557012066e-05
study O 0 6.917643622728065e-05
provides O 0 2.360974031034857e-05
further O 0 6.07492165727308e-06
evidence O 0 5.5906252782733645e-06
that O 0 2.034545559581602e-06
the O 0 6.490158739325125e-06
DM B-Disease 1 0.9960266351699829
expansion O 0 0.0002428727166261524
tends O 0 0.00011733549763448536
to O 0 3.481845624264679e-06
be O 0 5.961264378129272e-06
transmitted O 0 0.0006825890741311014
preferentially O 0 0.0010299269342795014
. O 0 8.016693027457222e-05

Diagnosis O 1 0.9846263527870178
of O 0 0.004919292870908976
hemochromatosis B-Disease 1 0.988689124584198
. O 0 0.005853733047842979

If O 0 0.03921402990818024
untreated O 1 0.9957505464553833
, O 0 0.03660213202238083
hemochromatosis B-Disease 1 0.9993545413017273
can O 0 0.14541541039943695
cause O 1 0.9893989562988281
serious O 1 0.9960917830467224
illness O 1 0.9993922710418701
and O 0 9.569200483383611e-05
early B-Disease 0 0.00015530321979895234
death I-Disease 0 0.002416149713099003
, O 0 8.754039299674332e-06
but O 0 7.144236860767705e-06
the O 0 2.9645332688232884e-05
disease O 1 0.9990217685699463
is O 0 2.3779710318194702e-05
still O 0 5.562396836467087e-05
substantially O 0 0.008510368876159191
under O 0 0.0004146909050177783
- O 1 0.812374472618103
diagnosed O 1 0.9987868666648865
. O 0 0.0004402951162774116

The O 0 6.89288426656276e-05
cornerstone O 0 0.00042577701970003545
of O 0 1.0149775334866717e-05
screening O 0 0.00039388923323713243
and O 0 7.001487119850935e-06
case O 0 2.22394555748906e-05
detection O 0 0.0001288788771489635
is O 0 1.1902659480256261e-06
the O 0 1.0160466672459734e-06
measurement O 0 8.522068128513638e-06
of O 0 2.609851662782603e-06
serum O 0 0.019508183002471924
transferrin O 0 0.06228938698768616
saturation O 0 0.0010905254166573286
and O 0 1.0770486369438004e-05
the O 0 2.4206266971305013e-05
serum O 0 0.030982229858636856
ferritin O 0 0.12712228298187256
level O 0 0.0004533248720690608
. O 0 0.00022952770814299583

Once O 0 0.0007178388768807054
the O 0 0.00015080692537594587
diagnosis O 1 0.9949185252189636
is O 0 6.0635611589532346e-05
suspected O 0 0.0018568381201475859
, O 0 2.4081633455352858e-05
physicians O 0 0.07336722314357758
must O 0 8.289457582577597e-06
use O 0 1.4278542948886752e-05
serum O 0 0.12249984592199326
ferritin O 0 0.2785000503063202
levels O 0 0.0007517425110563636
and O 0 5.464698915602639e-05
hepatic O 1 0.9975844621658325
iron O 0 0.07031454145908356
stores O 0 0.0005025455611757934
on O 0 0.00017045147251337767
liver O 1 0.9991569519042969
biopsy O 1 0.9960730075836182
specimens O 0 0.06693445891141891
to O 0 4.349654045654461e-05
assess O 0 0.18354405462741852
patients O 1 0.9530290961265564
for O 0 3.1104016215977026e-06
the O 0 2.4045609734457685e-06
presence O 0 1.5002668988017831e-05
of O 0 8.440505553153343e-06
iron B-Disease 0 0.035187702625989914
overload I-Disease 1 0.8700449466705322
. O 0 0.0004374586569610983

Liver O 1 0.9973861575126648
biopsy O 1 0.9635010361671448
is O 0 2.1133795598871075e-05
also O 0 2.4329583538929e-06
used O 0 1.0695056289478089e-06
to O 0 6.213726919668261e-07
establish O 0 3.855061549984384e-06
the O 0 6.649186730101064e-07
presence O 0 6.9608490775863174e-06
or O 0 3.953676241508219e-06
absence O 0 6.237829074962065e-05
of O 0 4.472645741770975e-06
cirrhosis B-Disease 1 0.9991164803504944
, O 0 1.7500220565125346e-05
which O 0 6.935681994946208e-06
can O 0 5.506263914867304e-05
affect O 0 0.03808201476931572
prognosis O 1 0.997805655002594
and O 0 0.00013035011943429708
management O 0 0.052476298063993454
. O 0 0.00018450742936693132

A O 0 0.00019084938685409725
DNA O 0 0.0001519109937362373
- O 0 0.00012126428919145837
based O 0 7.063335033308249e-06
test O 0 8.475795766571537e-06
for O 0 1.8221487607661402e-06
the O 0 4.4173316382511985e-06
HFE O 0 0.48387208580970764
gene O 0 0.0001144648267654702
is O 0 9.556271152177942e-07
commercially O 0 2.153856712538982e-06
available O 0 6.143994824014953e-07
, O 0 2.533668919113552e-07
but O 0 1.659391131170196e-07
its O 0 2.4623739136586664e-07
place O 0 4.2122604781980044e-07
in O 0 6.682918183287256e-07
the O 0 5.336332833394408e-06
diagnosis O 1 0.989974319934845
of O 0 4.8024085117504e-05
hemochromatosis B-Disease 1 0.9993082284927368
is O 0 6.841869617346674e-05
still O 0 4.727176929009147e-05
being O 0 3.425280738156289e-05
evaluated O 0 0.00574002368375659
. O 0 0.00010945492249447852

Currently O 0 5.633824548567645e-05
, O 0 5.210198196436977e-06
the O 0 1.2915247680211905e-06
most O 0 1.0871168569792644e-06
useful O 0 2.483571506672888e-06
role O 0 2.1677913082385203e-06
for O 0 4.4384310626810475e-07
this O 0 2.777515817342646e-07
test O 0 1.447783120056556e-06
is O 0 2.707674013890937e-07
in O 0 4.202406103104295e-07
the O 0 8.888374622983974e-07
detection O 0 0.0003898399882018566
of O 0 5.101083843328524e-06
hemochromatosis B-Disease 1 0.9984663724899292
in O 0 4.213753982185153e-06
the O 0 2.0187915197311668e-06
family O 0 2.0906634745188057e-05
members O 0 2.197808726123185e-06
of O 0 3.327959802845726e-06
patients O 1 0.9499135613441467
with O 0 7.550206191808684e-06
a O 0 1.59112605615519e-05
proven O 0 0.0031429706141352654
case O 0 0.00010188493615714833
of O 0 6.787861821067054e-06
the O 0 0.0001495343749411404
disease O 1 0.9976212382316589
. O 0 0.0004881520289927721

It O 0 7.697039836784825e-05
is O 0 2.891584881581366e-05
crucial O 0 0.000285955989966169
to O 0 0.0007833726704120636
diagnose O 1 0.9989187717437744
hemochromatosis B-Disease 1 0.9992885589599609
before O 1 0.5020728707313538
hepatic B-Disease 1 0.9994651675224304
cirrhosis I-Disease 1 0.9996416568756104
develops O 1 0.9980428218841553
because O 1 0.5824856758117676
phlebotomy O 1 0.9986281394958496
therapy O 1 0.999146580696106
can O 0 0.20879052579402924
avert O 1 0.9980736970901489
serious O 1 0.9994091987609863
chronic O 1 0.9999597072601318
disease O 1 0.9998350143432617
and O 0 0.00016934597806539387
can O 0 1.7647418644628488e-05
even O 0 6.6233924371772446e-06
lead O 0 1.0103515705850441e-05
to O 0 2.428132575005293e-06
normal O 0 0.00010213122732238844
life O 0 0.0001511328446213156
expectancy O 0 0.009460313245654106
. O 0 1.9240704205003567e-05
. O 0 6.866000330774114e-05

Prevalence O 0 0.2606988847255707
of O 0 3.796382952714339e-05
the O 0 3.421571818762459e-05
I1307K O 0 0.06716479361057281
APC B-Disease 0 0.10612673312425613
gene O 0 0.001591087318956852
variant O 0 0.000957248208578676
in O 0 4.625831479643239e-06
Israeli O 0 1.1375372196198441e-05
Jews O 0 5.7172778724634554e-06
of O 0 1.3017076980759157e-06
differing O 0 2.3740756660117768e-05
ethnic O 0 2.425194725219626e-05
origin O 0 3.266006751800887e-05
and O 0 0.00018941014423035085
risk O 1 0.9423914551734924
for O 0 0.07919564843177795
colorectal B-Disease 1 0.9997054934501648
cancer I-Disease 1 0.9994267225265503
. O 0 0.007340744603425264

BACKGROUND O 0 0.0035274471156299114
& O 0 0.0049053216353058815
AIMS O 0 0.0004562924732454121
Israeli O 0 4.812769475392997e-05
Jews O 0 1.1519694453454576e-05
of O 0 1.3705756600757013e-06
European O 0 1.1014736628567334e-05
birth O 0 9.830221824813634e-05
, O 0 2.141114237019792e-06
i O 0 3.0151131795719266e-06
. O 0 1.2233639381520334e-06
e O 0 1.7088041204260662e-05
. O 0 9.454886367166182e-07
, O 0 2.2815263491793303e-06
Ashkenazim O 0 0.0009546575020067394
, O 0 2.071354174404405e-06
have O 0 2.9357786388573004e-06
the O 0 1.414299458701862e-05
highest O 0 0.18472246825695038
colorectal B-Disease 1 0.9998986721038818
cancer I-Disease 1 0.9998440742492676
incidence O 1 0.976068377494812
of O 0 7.847577762731817e-06
any O 0 1.0545199074840639e-05
Israeli O 0 8.356047328561544e-05
ethnic O 0 8.623305620858446e-05
group O 0 0.00015527095820289105
. O 0 0.00011781827925005928

The O 0 0.00026834337040781975
I1307K O 0 0.030522774904966354
APC B-Disease 0 0.12918616831302643
gene O 0 0.003250699955970049
variant O 0 0.0016384044429287314
was O 0 1.7869591829366982e-05
found O 0 1.4526704944728408e-05
in O 0 1.1488394193293061e-05
6 O 0 0.00010585064592305571
. O 0 0.00010871285485336557

1 O 0 4.1866158426273614e-05
% O 0 6.25838220003061e-06
of O 0 1.9358897134225117e-06
American O 0 4.348341462900862e-06
Jews O 0 5.78299432163476e-06
, O 0 1.4343931979965419e-06
28 O 0 4.135733888688264e-06
% O 0 1.7733731283442467e-06
of O 0 4.282413101464044e-06
their O 0 0.0025036584120243788
familial O 1 0.9998125433921814
colorectal B-Disease 1 0.9999746084213257
cancer I-Disease 1 0.999946117401123
cases O 1 0.5141657590866089
, O 0 1.850700755312573e-05
but O 0 3.939486759918509e-06
not O 0 1.907149339785974e-06
in O 0 3.880844815284945e-06
non O 0 9.481963934376836e-05
- O 0 0.0029522464610636234
Jews O 0 0.0002487055317033082
. O 0 0.00015305046690627933

We O 0 0.00010666935850167647
assessed O 0 0.00047274172538891435
the O 0 2.106533975165803e-05
I1307K O 0 0.012187747284770012
prevalence O 0 0.19388553500175476
in O 0 5.8997197811549995e-06
Israeli O 0 1.2497273019107524e-05
Jews O 0 5.4845645536261145e-06
of O 0 1.044037276187737e-06
differing O 0 3.269727676524781e-05
ethnic O 0 2.757108632067684e-05
origin O 0 3.674486288218759e-05
and O 0 0.00013687167665921152
risk O 1 0.9548478126525879
for O 0 0.19541387259960175
colorectal B-Disease 1 0.9997995495796204
cancer I-Disease 1 0.9994621872901917
. O 0 0.004967875313013792

METHODS O 0 0.0003241943777538836
DNA O 0 0.00016931658319663256
samples O 0 4.4089134462410584e-05
from O 0 6.304014732450014e-06
500 O 0 2.7565014534047805e-05
unrelated O 0 0.00012438526027835906
Jews O 0 3.544682385836495e-06
of O 0 5.39194161319756e-07
European O 0 2.574673317212728e-06
or O 0 2.29000602303131e-06
non O 0 1.1736282431229483e-05
- O 0 5.3021052735857666e-05
European O 0 1.6259257336059818e-06
origin O 0 9.319227842752298e-07
, O 0 5.412632617662894e-07
with O 0 4.843688543587632e-07
or O 0 9.329738190899661e-07
without O 0 7.978231337801844e-07
a O 0 1.944445557455765e-06
personal O 0 3.319965617265552e-05
and O 0 7.993859981070273e-06
/ O 0 0.015138674527406693
or O 0 5.625292033073492e-06
family O 0 1.3783187569060829e-05
history O 0 6.436471267079469e-06
of O 0 4.037056896777358e-06
neoplasia B-Disease 1 0.9728270769119263
, O 0 3.3092176181526156e-06
were O 0 7.417336291837273e-07
examined O 0 4.797515430254862e-05
for O 0 8.586618491790432e-07
the O 0 1.1998299669357948e-06
I1307K O 0 0.0005769169074483216
variant O 0 0.00010767301137093455
by O 0 1.3743685940426076e-06
the O 0 2.4708617729629623e-06
allele O 0 0.0001387946103932336
- O 0 0.000115618844574783
specific O 0 1.9961889847763814e-05
oligonucleotide O 0 0.0038150050677359104
( O 0 7.001397898420691e-05
ASO O 0 0.022768892347812653
) O 0 2.37914573517628e-05
method O 0 5.091987986816093e-05
. O 0 8.810483268462121e-05

RESULTS O 0 0.000558774103410542
In O 0 3.582369754440151e-05
persons O 0 0.0001968622673302889
at O 0 4.596707003656775e-05
average O 0 0.0017490440513938665
risk O 1 0.9543693661689758
for O 0 0.11392941325902939
colorectal B-Disease 1 0.9999281167984009
cancer I-Disease 1 0.9998866319656372
, O 0 0.0003483446198515594
I1307K O 0 0.0382404625415802
was O 0 4.551849087874871e-06
found O 0 5.367078756535193e-06
in O 0 5.607381353911478e-06
5 O 0 5.374288957682438e-05
. O 0 7.145825657062232e-05

0 O 0 0.00016777538985479623
% O 0 1.2746843822242226e-05
of O 0 3.1520398806605954e-06
120 O 0 1.9522458387655206e-05
European O 0 1.1487047231639735e-05
and O 0 1.1141661161673255e-05
1 O 0 5.689098543371074e-05
. O 0 9.73679925664328e-05

6 O 0 0.00013893084542360157
% O 0 1.5249784155457746e-05
of O 0 4.680752226704499e-06
188 O 0 0.00013128994032740593
non O 0 5.376821354730055e-05
- O 0 0.000297616352327168
European O 0 1.6342164599336684e-05
Jews O 0 2.6761650588014163e-05
( O 0 1.897593028843403e-05
P O 0 0.0008419760852120817
= O 0 0.00014417651982512325
0 O 0 2.274502912769094e-05
. O 0 5.244331077847164e-06
08 O 0 0.00023934156342875212
) O 0 4.188864477328025e-05
. O 0 5.4460841056425124e-05

It O 0 0.00015249953139573336
occurred O 0 0.0002653433766681701
in O 0 4.744709440274164e-05
15 O 0 0.0001354554115096107
. O 0 0.0001593929628143087

4 O 0 6.464507896453142e-05
% O 0 1.0852019840967841e-05
of O 0 6.5350877775927074e-06
52 O 0 0.00021330182789824903
Ashkenazi O 0 0.04609709605574608
Israelis O 0 0.00220309104770422
with O 0 0.0007427347009070218
familial O 1 0.998812198638916
cancer B-Disease 1 0.9995092153549194
( O 0 0.0017971992492675781
P O 0 0.06165296956896782
= O 0 0.0005541160935536027
0 O 0 1.8694949176278897e-05
. O 0 1.7006956340992474e-06
02 O 0 0.0006944530177861452
) O 0 1.4465838376054307e-06
and O 0 3.608411986988358e-07
was O 0 4.290034780751739e-07
not O 0 5.273089414004062e-07
detected O 0 2.2024176359991543e-05
in O 0 9.305151138505607e-07
51 O 0 1.1009685294993687e-05
non O 0 2.9924378395662643e-05
- O 0 0.00027818529633805156
European O 0 1.713420351734385e-05
Jews O 0 5.74031364521943e-05
at O 0 6.223622767720371e-05
increased O 0 0.013350536115467548
cancer B-Disease 1 0.9985673427581787
risk O 1 0.7419758439064026
. O 0 0.0003197631158400327

Colorectal B-Disease 1 0.9970518350601196
neoplasia I-Disease 1 0.9947212934494019
occurred O 0 0.008931097574532032
personally O 0 0.0023557350505143404
or O 0 1.0315116014680825e-05
in O 0 1.5628684195689857e-06
the O 0 1.0369217307015788e-06
families O 0 4.648872618417954e-06
of O 0 5.403359182309941e-07
13 O 0 2.7132778086524922e-06
of O 0 1.0164916375288158e-06
20 O 0 1.3627862244902644e-05
Ashkenazi O 0 0.015518582426011562
I1307K O 0 0.008933614008128643
carriers O 0 0.0003183438384439796
, O 0 1.5808205944267684e-06
8 O 0 1.5194196976153762e-06
of O 0 4.814600629288179e-07
whom O 0 7.679812370042782e-06
also O 0 6.385715778378653e-07
had O 0 8.57398390508024e-07
a O 0 1.3308471125128563e-06
personal O 0 9.03538239072077e-06
or O 0 6.639544608333381e-06
family O 0 2.7541022063815035e-05
history O 0 3.0420918847084977e-05
of O 0 2.5102837753365748e-05
noncolonic O 1 0.6993439793586731
neoplasia B-Disease 1 0.989581823348999
. O 0 0.000559361360501498

CONCLUSIONS O 0 0.0012584746582433581
The O 0 0.00013459021283779293
I1307K O 0 0.05432668328285217
APC O 0 0.179209902882576
variant O 0 0.017228739336133003
may O 0 5.050677282270044e-05
represent O 0 1.5111598258954473e-05
a O 0 4.8709935072110966e-05
susceptibility O 1 0.8861551880836487
gene O 0 0.03687071427702904
for O 0 0.0002721579803619534
colorectal B-Disease 1 0.9993777275085449
, I-Disease 0 1.9345321561559103e-05
or I-Disease 0 1.1342117431922816e-05
other I-Disease 0 5.297574261931004e-06
, I-Disease 0 5.116008105687797e-05
cancers I-Disease 1 0.997448742389679
in O 0 4.358739170129411e-05
Ashkenazi O 0 0.07011962682008743
Jews O 0 4.2167997889919207e-05
, O 0 4.231964794598753e-06
and O 0 4.389552032080246e-06
partially O 0 0.00030226915259845555
explains O 0 0.00016353298269677907
the O 0 6.630040388699854e-06
higher O 0 0.00030908238841220737
incidence O 1 0.9921361207962036
of O 0 0.005233600735664368
colorectal B-Disease 1 0.9998883008956909
cancer I-Disease 1 0.9997555613517761
in O 0 0.0002807147684507072
European O 0 0.000589318631682545
Israelis O 0 0.0066921343095600605
. O 0 0.0003001936129294336

Systematic O 0 0.0020063312258571386
analysis O 0 0.00019082389189861715
of O 0 5.768079427070916e-05
coproporphyrinogen O 1 0.7301492094993591
oxidase O 1 0.9242534041404724
gene O 0 0.28323984146118164
defects O 1 0.9811220169067383
in O 0 0.00018709126743488014
hereditary B-Disease 1 0.6410462260246277
coproporphyria I-Disease 1 0.501152753829956
and O 0 0.00021103007020428777
mutation O 0 0.15472815930843353
update O 0 0.01488175056874752
. O 0 0.0003560342884156853

Hereditary B-Disease 1 0.9494837522506714
coproporphyria I-Disease 1 0.7531840801239014
( O 0 0.005415091756731272
HC B-Disease 1 0.9909692406654358
) O 0 0.0002696626470424235
is O 0 0.00012206257088109851
an O 0 0.001450036303140223
acute O 1 0.9995515942573547
hepatic B-Disease 1 0.9997348189353943
porphyria I-Disease 1 0.9995736479759216
with O 0 0.18275493383407593
autosomal O 1 0.9986593723297119
dominant O 0 0.46023133397102356
inheritance O 1 0.6656630039215088
caused O 1 0.528728723526001
by O 0 0.00015150468971114606
deficient B-Disease 1 0.9728280901908875
activity I-Disease 0 0.00021471914078574628
of I-Disease 0 2.0079653040738776e-05
coproporphyrinogen I-Disease 1 0.5119321346282959
III I-Disease 0 0.3889908194541931
oxidase I-Disease 0 0.1961371749639511
( O 0 0.00011545953020686284
CPO O 0 0.0009010134963318706
) O 0 7.203927816590294e-05
. O 0 0.00011139508569613099

Clinical O 1 0.9914628863334656
manifestations O 1 0.731827974319458
of O 0 7.546615961473435e-05
the O 0 0.0013119151117280126
disease O 1 0.9993903636932373
are O 0 0.00020214062533341348
characterized O 1 0.9118931293487549
by O 0 0.0020020180381834507
acute O 1 0.9995197057723999
attacks O 1 0.6258591413497925
of O 0 0.02270336262881756
neurological B-Disease 1 0.9999040365219116
dysfunction I-Disease 1 0.9997044205665588
often O 0 0.02140323631465435
precipitated O 1 0.9139413833618164
by O 0 9.91411943687126e-05
drugs O 0 0.08016256242990494
, O 0 6.59576035104692e-05
fasting O 0 0.061057381331920624
, O 0 0.00016063063230831176
cyclical O 1 0.9549972414970398
hormonal O 1 0.9741339087486267
changes O 0 0.0023291914258152246
, O 0 0.00030323865939863026
or O 0 0.011361687444150448
infectious B-Disease 1 0.9985463619232178
diseases I-Disease 1 0.9990886449813843
. O 0 0.003094363259151578

Skin O 1 0.9962335228919983
photosensitivity O 1 0.991181492805481
may O 0 0.000699765223544091
also O 0 1.5929355868138373e-05
be O 0 8.534836524631828e-06
present O 0 3.856132025248371e-05
. O 0 7.411920523736626e-05

The O 0 5.4998989071464166e-05
seven O 0 3.4537217288743705e-05
exons O 0 0.0001648568722885102
, O 0 8.260228241852019e-06
the O 0 4.168528448644793e-06
exon O 0 0.00048777894699014723
/ O 0 0.0010682832216843963
intron O 0 0.0008759929332882166
boundaries O 0 2.100942992910859e-06
and O 0 4.93741310947371e-07
part O 0 6.359152280310809e-07
of O 0 2.637952718487213e-07
3 O 0 1.8626362816576147e-06
noncoding O 0 6.486058555310592e-05
sequence O 0 1.9585377231123857e-06
of O 0 4.697808151377103e-07
the O 0 1.42934061386768e-06
CPO O 0 7.527849083999172e-05
gene O 0 4.017851097160019e-05
were O 0 9.483368330620578e-07
systematically O 0 1.7767097233445384e-05
analyzed O 0 9.128427336690947e-06
by O 0 1.4886552435200429e-06
an O 0 2.209552121712477e-06
exon O 0 0.00010958421626128256
- O 0 7.916952017694712e-05
by O 0 9.49100012803683e-06
- O 0 0.000496703025419265
exon O 0 0.0018709939904510975
denaturing O 0 0.25749436020851135
gradient O 0 0.0022125777322798967
gel O 0 0.32070016860961914
electrophoresis O 0 0.038862671703100204
( O 0 9.113011037698016e-05
DGGE O 0 0.005403113551437855
) O 0 5.122851234773407e-06
strategy O 0 1.0798778930620756e-05
followed O 0 2.0774409676960204e-06
by O 0 8.613100703769305e-07
direct O 0 2.7970368137175683e-06
sequencing O 0 1.3315934666024987e-05
in O 0 3.322163138363976e-06
seven O 0 3.0505601898767054e-05
unrelated O 0 0.10384528338909149
heterozygous O 1 0.5679951310157776
HC B-Disease 1 0.9982012510299683
patients O 1 0.9969943761825562
from O 0 2.9725508284172975e-05
France O 0 0.00014366630057338625
, O 0 9.091218998946715e-06
Holland O 0 0.0005427467986010015
, O 0 4.352543783170404e-06
and O 0 6.2153426370059606e-06
Czech O 0 0.0002804627874866128
Republic O 0 0.00012301300012040883
. O 0 0.00011348645784892142

Seven O 0 0.00033488593180663884
novel O 0 0.0005549758789129555
mutations O 0 0.0015785821015015244
and O 0 4.800562237505801e-06
two O 0 3.69034592040407e-06
new O 0 1.3427130397758447e-05
polymorphisms O 0 0.0007867481908760965
were O 0 1.4980351807025727e-05
detected O 0 0.001467058202251792
. O 0 9.589972614776343e-05

Among O 0 0.00010451068374095485
these O 0 1.554179470986128e-05
mutations O 0 0.0003692863683681935
two O 0 4.968852863385109e-06
are O 0 5.3192611630947795e-06
missense O 0 0.004908038768917322
( O 0 3.33858079102356e-05
G197W O 0 0.0013710047351196408
, O 0 4.154288944846485e-06
W427R O 0 0.00022107147378847003
) O 0 1.2607152939381194e-06
, O 0 4.007009408724116e-07
two O 0 5.047983222539187e-07
are O 0 7.804245001352683e-07
nonsense O 0 5.0157592340838164e-05
( O 0 6.720820692862617e-06
Q306X O 0 0.0004919276689179242
, O 0 1.920498561958084e-06
Q385X O 0 0.00012206536484882236
) O 0 7.730238849035231e-07
, O 0 2.463654027451412e-07
two O 0 2.912669287979952e-07
are O 0 4.2480277784306963e-07
small O 0 2.5054839625227032e-06
deletions O 0 0.00014500803081318736
( O 0 1.3173583283787593e-05
662de14bp O 0 0.00044770489330403507
; O 0 6.3779466472624335e-06
1168del3bp O 0 0.00029065809212625027
removing O 0 3.260790617787279e-05
a O 0 3.6527546853903914e-06
glycine O 0 3.7514862924581394e-05
at O 0 3.032958829862764e-06
position O 0 3.455814066910534e-06
390 O 0 7.206648297142237e-05
) O 0 1.4381545270225615e-06
, O 0 3.747913410734327e-07
and O 0 2.1394086502368737e-07
one O 0 3.0965040309638425e-07
is O 0 4.7317371354438365e-07
a O 0 1.6767256738603464e-06
splicing O 0 7.902183278929442e-05
mutation O 0 0.0005262726335786283
( O 0 2.1213108993833885e-05
IVS1 O 0 0.00800797063857317
- O 0 0.001228540320880711
15c O 0 0.022141940891742706
- O 0 0.0008261012844741344
- O 0 0.0010202486300840974
> O 0 0.0012065357295796275
g O 0 9.146512456936762e-05
) O 0 3.1056590614753077e-06
which O 0 1.3081042880003224e-06
creates O 0 1.6802290701889433e-05
a O 0 8.17661657492863e-06
new O 0 2.2190310119185597e-05
acceptor O 0 0.002275692066177726
splice O 0 0.00415395712479949
site O 0 0.00036048138281330466
. O 0 0.0001690829813014716

The O 0 7.387209188891575e-05
pathological O 0 0.007612628396600485
significance O 0 2.7879317713086493e-05
of O 0 2.1861230834474554e-06
the O 0 2.693200258363504e-06
point O 0 1.1688253835018259e-05
mutations O 0 0.007107578217983246
G197W O 0 0.004081149119883776
, O 0 4.335128778620856e-06
W427R O 0 0.0002704907674342394
, O 0 6.8720544277312e-07
and O 0 4.1672228690003976e-07
the O 0 5.208298148318136e-07
in O 0 1.2281496992727625e-06
- O 0 0.00010885819210670888
frame O 0 7.552490569651127e-05
deletion O 0 0.002756480360403657
390delGly O 0 0.0007313775131478906
were O 0 1.0700881603042944e-06
assessed O 0 1.3836315702064894e-05
by O 0 5.090763579573832e-07
their O 0 5.140711323292635e-07
respective O 0 2.5492879558441928e-06
expression O 0 2.8719673537125345e-06
in O 0 6.311675520009885e-07
a O 0 2.358803612878546e-06
prokaryotic O 0 7.977937639225274e-05
system O 0 9.917249371937942e-06
using O 0 8.12492726254277e-06
site O 0 4.665717642637901e-05
- O 0 0.0008347139228135347
directed O 0 0.00018439981795381755
mutagenesis O 0 0.008249507285654545
. O 0 0.00016314531967509538

These O 0 9.181852510664612e-05
mutations O 0 0.005253042560070753
resulted O 0 6.84327824274078e-05
in O 0 3.344290917084436e-06
the O 0 2.7972153020527912e-06
absence O 0 4.185762009001337e-05
or O 0 4.648243248084327e-06
a O 0 6.176486294862116e-06
dramatic O 0 0.0001354099513264373
decrease O 0 0.00022245410946197808
of O 0 1.1072576853621285e-05
CPO O 0 0.0014283980708569288
activity O 0 0.0001918791967909783
. O 0 0.00012339140812400728

The O 0 2.738683542702347e-05
two O 0 1.2699098078883253e-05
polymorphisms O 0 0.00020162819419056177
were O 0 3.4735312510747463e-06
localized O 0 0.0004380054597277194
in O 0 2.955352101707831e-06
noncoding O 0 0.0005097061512060463
part O 0 1.5073208032845287e-06
of O 0 4.506082120769861e-07
the O 0 1.213761379403877e-06
gene O 0 2.9006274417042732e-05
1 O 0 3.860462129523512e-06
) O 0 2.952934892164194e-06
a O 0 5.420688921731198e-06
C O 0 0.0007463759393431246
/ O 0 0.002555134240537882
G O 0 0.0003541045298334211
polymorphism O 0 3.478336657281034e-05
in O 0 1.7584990246177767e-06
the O 0 3.0528133265761426e-06
promotor O 0 0.02642763964831829
region O 0 3.649969585239887e-05
, O 0 3.867559826176148e-06
142 O 0 3.327652666484937e-05
bp O 0 0.00011688188533298671
upstream O 0 1.5937745047267526e-05
from O 0 1.479962406847335e-06
the O 0 1.665509216763894e-06
transcriptional O 0 6.903527537360787e-05
initiation O 0 8.45850445330143e-05
site O 0 2.797009983623866e-05
( O 0 2.1414129150798544e-05
- O 0 0.001290306099690497
142C O 0 0.018494999036192894
/ O 0 0.006130989640951157
G O 0 0.00028919504256919026
) O 0 1.3750556036029593e-06
, O 0 5.140261123415257e-07
and O 0 2.889255483751185e-07
2 O 0 1.1589107771214913e-06
) O 0 7.185988692981482e-07
a O 0 1.3072200317765237e-06
6 O 0 4.861199158767704e-06
bp O 0 0.0001546810381114483
deletion O 0 0.0003091761318501085
polymorphism O 0 1.7256748833460733e-05
in O 0 7.098735181898519e-07
the O 0 6.648958219557244e-07
3 O 0 3.2125901725521544e-06
noncoding O 0 6.84068218106404e-05
part O 0 1.0293842933606356e-06
of O 0 3.9285362163354876e-07
the O 0 1.3610838323074859e-06
CPO O 0 0.0001140849562943913
gene O 0 8.490215259371325e-05
, O 0 3.116313109785551e-06
574 O 0 0.0005252607516013086
bp O 0 0.00011815375910373405
downstream O 0 1.0885675692406949e-05
of O 0 3.603690572617779e-07
the O 0 4.281582164367137e-07
last O 0 9.893377637126832e-07
base O 0 1.1942136097786715e-06
of O 0 5.259820454739383e-07
the O 0 2.1505707081814762e-06
normal O 0 5.6027718528639525e-05
termination O 0 0.005053969100117683
codon O 0 0.0005051276530139148
( O 0 8.746478852117434e-05
+ O 0 0.0037338268011808395
574 O 0 0.05570080876350403
delATTCTT O 0 0.021819373592734337
) O 0 0.00012361208791844547
. O 0 9.529498493066058e-05

Five O 0 0.0004046600661240518
intragenic O 0 0.022820742800831795
dimorphisms O 0 0.009017672389745712
are O 0 5.9027920542575885e-06
now O 0 5.2906671044183895e-06
well O 0 2.567669980635401e-06
characterized O 0 0.0002192906104028225
and O 0 1.4063141406950308e-06
the O 0 1.1603052598729846e-06
high O 0 7.754429134365637e-06
degree O 0 1.1160866961290594e-05
of O 0 2.02196088139317e-06
allelic O 0 0.11014305800199509
heterogeneity O 0 0.0861593708395958
in O 0 3.82089929189533e-05
HC B-Disease 1 0.9784452319145203
is O 0 6.3424399741052184e-06
demonstrated O 0 1.7911495888256468e-05
with O 0 7.733357847428124e-07
seven O 0 1.3698698921871255e-06
new O 0 7.528410606028046e-07
different O 0 5.937758373875113e-07
mutations O 0 3.0385835998458788e-05
making O 0 5.989033411424316e-07
a O 0 4.794604819835513e-07
total O 0 7.7886460303489e-07
of O 0 8.222308451877325e-07
nineteen O 0 0.0003507718211039901
CPO O 0 0.012374060228466988
gene B-Disease 0 0.0654042661190033
defects I-Disease 1 0.9655686020851135
reported O 0 0.0005057250382378697
so O 0 9.713978215586394e-06
far O 0 2.200320341216866e-05
. O 0 1.7946407751878724e-05
. O 0 5.996764593874104e-05

Coincidence O 0 0.0004718314448837191
of O 0 1.1756131243600976e-05
two O 0 1.14674330689013e-05
novel O 0 0.00011708413512678817
arylsulfatase O 0 0.0031423296313732862
A O 0 4.193820495856926e-05
alleles O 0 0.001292372471652925
and O 0 2.0729743482661434e-05
mutation O 0 0.011765106581151485
459 O 0 0.2842060625553131
+ O 0 0.02097984589636326
1G O 0 0.0200171060860157
> O 0 0.0008649509982205927
A O 0 8.315443665196653e-06
within O 0 3.061828920181142e-06
a O 0 5.74187788515701e-06
family O 0 6.026311166351661e-05
with O 0 5.576886542257853e-05
metachromatic B-Disease 1 0.9465806484222412
leukodystrophy I-Disease 1 0.9974443912506104
: O 0 3.8001209759386256e-05
molecular O 0 8.577516564400867e-05
basis O 0 8.415678166784346e-06
of O 0 1.2644983144127764e-05
phenotypic O 0 0.007968972437083721
heterogeneity O 0 0.07168997824192047
. O 0 0.00039562402525916696

In O 0 4.218509275233373e-05
a O 0 1.879720548458863e-05
family O 0 2.426385981380008e-05
with O 0 3.105934638369945e-06
three O 0 4.6917198233131785e-06
siblings O 0 0.0005389222642406821
, O 0 3.4504200812079944e-06
one O 0 2.7425737698649755e-06
developed O 0 0.0001612706109881401
classical O 0 0.00010948852286674082
late O 0 0.004092248156666756
infantile O 1 0.9989482760429382
metachromatic B-Disease 1 0.9979913234710693
leukodystrophy I-Disease 1 0.9992921352386475
( O 0 0.0726407915353775
MLD B-Disease 1 0.9967893362045288
) O 0 0.0001014510853565298
, O 0 3.3934244129341096e-05
fatal O 1 0.8184285759925842
at O 0 9.841650353337172e-06
age O 0 3.123204078292474e-05
5 O 0 6.919588031450985e-06
years O 0 6.485679023171542e-06
, O 0 3.1209676762955496e-06
with O 0 1.7933067283593118e-05
deficient O 1 0.8951588869094849
arylsulfatase O 0 0.04044431820511818
A O 0 6.681081868009642e-05
( O 0 8.753095607971773e-05
ARSA O 1 0.8630841374397278
) O 0 7.361842563113896e-06
activity O 0 9.163290997094009e-06
and O 0 3.539105591698899e-06
increased O 0 5.439202141133137e-05
galactosylsulfatide O 0 0.05145738646388054
( O 0 0.0001640086411498487
GS O 1 0.7253752946853638
) O 0 9.05540437088348e-05
excretion O 0 0.0023718036245554686
. O 0 0.00012103150220355019

The O 0 4.236227323417552e-05
two O 0 1.4102630302659236e-05
other O 0 9.344045793113764e-06
siblings O 0 0.0008773591835051775
, O 0 7.306594397959998e-06
apparently O 0 3.0960341973695904e-05
healthy O 0 0.00043338126852177083
at O 0 2.2228377929423004e-06
12 O 0 3.5634122923511313e-06
( O 0 2.4183686946344096e-06
1 O 0 3.4708555176621303e-06
/ O 0 0.0001710747746983543
2 O 0 1.549371290821e-06
) O 0 7.329915092668671e-07
and O 0 3.7032529576208617e-07
15 O 0 9.119909805122006e-07
years O 0 1.0986744882757193e-06
, O 0 4.0200271200774296e-07
respectively O 0 8.446468200418167e-07
, O 0 3.2849516173882876e-07
and O 0 2.583759339813696e-07
their O 0 7.348056101363909e-07
father O 0 1.9101247744401917e-05
, O 0 1.7070215108105913e-06
apparently O 0 2.047698581009172e-05
healthy O 0 0.0005579470889642835
as O 0 1.0301346264895983e-06
well O 0 1.6545715197935351e-06
, O 0 2.717973075050395e-06
presented O 0 3.646302502602339e-05
ARSA O 1 0.6002094149589539
and O 0 9.038175448949914e-06
GS O 0 0.17067144811153412
values O 0 7.157719210226787e-06
within O 0 3.0371850243682275e-06
the O 0 3.31369574269047e-06
range O 0 3.660000948002562e-05
of O 0 4.247318793204613e-05
MLD B-Disease 1 0.994146466255188
patients O 1 0.9942666888237
. O 0 0.0004465347738005221

Mutation O 0 0.02633683569729328
screening O 0 0.0008104321314021945
and O 0 1.0080053471028805e-05
sequence O 0 1.7997210306930356e-05
analysis O 0 1.8136302969651297e-05
disclosed O 0 7.453056605299935e-05
the O 0 1.8761176079351571e-06
involvement O 0 1.9171962776454166e-05
of O 0 8.393839721065888e-07
three O 0 2.9044495022390038e-06
different O 0 8.384395187022164e-06
ARSA O 1 0.9161267280578613
mutations O 0 0.0015755945350974798
being O 0 2.8188394480821444e-06
the O 0 1.5867383353906916e-06
molecular O 0 2.5582414309610613e-05
basis O 0 5.4696047300240025e-06
of O 0 7.055949481582502e-06
intrafamilial O 0 0.02648353762924671
phenotypic O 0 0.014896394684910774
heterogeneity O 0 0.06830503791570663
. O 0 0.0002916957892011851

The O 0 0.0004533916071522981
late O 0 0.013293636031448841
infantile O 1 0.9987043142318726
patient O 1 0.997596800327301
inherited O 1 0.8839438557624817
from O 0 2.92682416329626e-05
his O 0 4.715934119303711e-05
mother O 0 0.0003798796678893268
the O 0 4.50594143330818e-06
frequent O 0 0.0013197503285482526
0 O 0 0.00023948037414811552
- O 0 0.0066979313269257545
type O 0 0.0014873712789267302
mutation O 0 0.008127983659505844
459 O 0 0.2110098898410797
+ O 0 0.020926350727677345
1G O 0 0.039889171719551086
> O 0 0.0013400038005784154
A O 0 4.602974513545632e-06
, O 0 1.056396513376967e-06
and O 0 5.234539912635228e-07
from O 0 7.081675335030013e-07
his O 0 1.9769652226386825e-06
father O 0 9.391805178893264e-06
a O 0 1.724110347822716e-06
novel O 0 1.0493474292161409e-05
, O 0 1.2029717026962317e-06
single O 0 2.181670197387575e-06
basepair O 0 0.00047282560262829065
microdeletion O 0 0.00015465581964235753
of O 0 1.3502096862794133e-06
guanine O 0 1.615051405678969e-05
at O 0 2.4499643132003257e-06
nucleotide O 0 6.754857167834416e-06
7 O 0 4.563658421830041e-06
in O 0 1.8788463194141514e-06
exon O 0 9.370111365569755e-05
1 O 0 1.8334341802983545e-05
( O 0 3.759906758205034e-05
7delG O 0 0.0020048439037054777
) O 0 6.448966450989246e-05
. O 0 8.02496142568998e-05

The O 0 0.00014563034346792847
two O 0 9.204943489748985e-05
clinically O 1 0.7182245254516602
unaffected O 0 0.15420471131801605
siblings O 0 0.006098344922065735
carried O 0 4.0446811908623204e-05
the O 0 2.7216354283154942e-05
maternal O 0 0.10590995103120804
mutation O 0 0.11255055665969849
459 O 1 0.5808773636817932
+ O 0 0.0640137791633606
1G O 0 0.06582777947187424
> O 0 0.0019506568787619472
A O 0 7.5851935434911866e-06
and O 0 1.1925360468012514e-06
, O 0 8.190018547793443e-07
on O 0 7.037033356027678e-07
their O 0 1.6042546349126496e-06
paternal O 0 0.0001930242287926376
allele O 0 0.00010471777932252735
, O 0 2.3607253751833923e-06
a O 0 3.4841743854485685e-06
novel O 0 3.172899960190989e-05
cytosine O 0 8.039239037316293e-05
to O 0 5.122778020449914e-06
thymidine O 0 0.0004753191315103322
transition O 0 1.9911141862394288e-05
at O 0 4.910393272439251e-06
nucleotide O 0 2.4675089662196115e-05
2435 O 0 0.006859764456748962
in O 0 4.5627402869286016e-06
exon O 0 9.161666093859822e-05
8 O 0 4.515004548011348e-06
, O 0 9.117449053519522e-07
resulting O 0 4.5174169827078e-06
in O 0 8.369196393687162e-07
substitution O 0 4.258872195350705e-06
of O 0 1.948561248354963e-06
alanine O 0 0.0014655705308541656
464 O 0 0.02042989991605282
by O 0 2.7632257115328684e-05
valine O 0 0.03623225912451744
( O 0 0.0001658390974625945
A464V O 0 0.012621353380382061
) O 0 0.00010002756607718766
. O 0 9.126107761403546e-05

The O 0 0.00028356851544231176
fathers O 0 0.0026979960966855288
genotype O 0 0.016239222139120102
thus O 0 0.00012344752030912787
was O 0 9.398783004144207e-05
7delG O 0 0.061298906803131104
/ O 0 0.07757905125617981
A464V O 0 0.017545973882079124
. O 0 0.0003011972876265645

Mutation O 0 0.08204717189073563
A464V O 0 0.005607236176729202
was O 0 1.6759944628574885e-05
not O 0 5.389471880334895e-06
found O 0 5.6129993026843295e-06
in O 0 4.785226792591857e-06
18 O 0 7.457613537553698e-05
unrelated O 0 0.4585729241371155
MLD B-Disease 1 0.9980301260948181
patients O 1 0.9953378438949585
and O 0 3.5456501791486517e-05
50 O 0 9.905898332362995e-05
controls O 0 0.0003988707612734288
. O 0 0.00016583008982706815

A464V O 0 0.0172861497849226
, O 0 0.00010294355161022395
although O 0 5.597393828793429e-05
clearly O 0 0.00016220241377595812
modifying O 0 0.02296978235244751
ARSA O 1 0.9832046627998352
and O 0 0.00016199637320823967
GS O 1 0.9864704012870789
levels O 0 0.0006587046664208174
, O 0 1.2336785403022077e-05
apparently O 0 8.082098793238401e-05
bears O 0 0.0005519883707165718
little O 0 1.338892434432637e-05
significance O 0 3.996623127022758e-05
for O 0 3.2845160603756085e-05
clinical O 1 0.9237175583839417
manifestation O 0 0.17911918461322784
of O 0 4.3442403693916276e-05
MLD B-Disease 1 0.9938204884529114
, O 0 8.32568111945875e-05
mimicking O 0 0.08805367350578308
the O 0 7.636818918399513e-05
frequent O 0 0.10966893285512924
ARSA O 1 0.9749447703361511
pseudodeficiency O 0 0.43065235018730164
allele O 0 0.026646941900253296
. O 0 0.0005606645136140287

Our O 0 0.00011360816279193386
results O 0 6.051926902728155e-05
demonstrate O 0 5.374319516704418e-05
that O 0 3.083166120632086e-06
in O 0 3.6726823964272626e-06
certain O 0 2.059515827568248e-05
genetic O 0 0.01030708011239767
conditions O 0 0.16710157692432404
MLD B-Disease 1 0.9972835779190063
- O 0 0.12080784142017365
like O 0 0.0008246396901085973
ARSA O 1 0.9813887476921082
and O 0 2.74208105111029e-05
GS O 1 0.7568041682243347
values O 0 9.398696420248598e-06
need O 0 5.4264191930997185e-06
not O 0 7.810320994394715e-07
be O 0 1.0716221368056722e-06
paralleled O 0 0.0005268314853310585
by O 0 5.877902003703639e-05
clinical O 1 0.9971206188201904
disease O 1 0.9994055032730103
, O 0 1.1287484085187316e-05
a O 0 1.5553579942206852e-05
finding O 0 0.000176714122062549
with O 0 0.00010887780808843672
serious O 1 0.749047040939331
diagnostic O 1 0.9527274370193481
and O 0 0.00026883938699029386
prognostic O 1 0.969647228717804
implications O 0 0.2734089493751526
. O 0 0.0003706827701535076

Moreover O 0 0.0019369389628991485
, O 0 0.00010643708810675889
further O 0 0.0002240967151010409
ARSA O 1 0.9438570737838745
alleles O 0 0.04980381205677986
functionally O 0 0.009998520836234093
similar O 0 3.777416350203566e-05
to O 0 5.9745311773440335e-06
A464V O 0 0.0011704631615430117
might O 0 7.000325695116771e-06
exist O 0 1.5518749023613054e-06
which O 0 2.0025430558234802e-07
, O 0 2.8835330567744677e-07
together O 0 3.8428055404438055e-07
with O 0 1.2481328894864419e-06
0 O 0 3.6445017030928284e-05
- O 0 0.002158315386623144
type O 0 0.0016139999497681856
mutations O 0 0.026576919481158257
, O 0 1.896751746244263e-05
may O 0 0.00024446810130029917
cause O 0 0.3073851466178894
pathological O 1 0.9872947335243225
ARSA O 1 0.9951860308647156
and O 0 0.00026101706316694617
GS O 1 0.9916355609893799
levels O 0 0.0008689449750818312
, O 0 5.327891813067254e-06
but O 0 5.269935172691476e-06
not O 0 1.3362686331674922e-05
clinical O 1 0.8765075206756592
outbreak O 1 0.8169723153114319
of O 0 8.66409027366899e-06
the O 0 0.00016210097237490118
disease O 1 0.9985314607620239
. O 0 9.094277629628778e-05
. O 0 0.00017569816554896533

Human O 1 0.9362585544586182
MLH1 O 1 0.9904078841209412
deficiency O 1 0.9986811280250549
predisposes O 1 0.9938323497772217
to O 0 0.048431575298309326
hematological B-Disease 1 0.9963024854660034
malignancy I-Disease 1 0.997260570526123
and O 0 0.013597330078482628
neurofibromatosis B-Disease 1 0.9978677034378052
type I-Disease 0 0.040115054696798325
1 I-Disease 0 0.0006112508126534522
. O 0 0.00034238171065226197

Heterozygous O 0 0.08199980854988098
germ O 1 0.5134629607200623
- O 0 0.0018824124708771706
line O 0 6.590950943063945e-05
mutations O 0 0.0006705090054310858
in O 0 4.19127809436759e-06
the O 0 6.845675216027303e-06
DNA O 0 0.0003467922215349972
mismatch O 0 0.35258883237838745
repair O 1 0.8350602984428406
genes O 0 0.006693243980407715
lead O 0 0.0006020002765581012
to O 0 0.0002994013193529099
hereditary B-Disease 1 0.985759437084198
nonpolyposis I-Disease 1 0.9956899285316467
colorectal I-Disease 1 0.9997195601463318
cancer I-Disease 1 0.9993816614151001
. O 0 0.009410304948687553

The O 0 0.006230606697499752
disease O 1 0.9986155033111572
susceptibility O 1 0.9503596425056458
of O 0 2.6647685444913805e-05
individuals O 0 0.0003660613438114524
who O 0 3.899052171618678e-05
constitutionally O 0 0.0001274024834856391
lack O 0 6.959207530599087e-05
both O 0 6.696738637401722e-06
wild O 0 0.00010317321721231565
- O 0 0.0031003467738628387
type O 0 0.0018686862895265222
alleles O 0 0.002935526892542839
is O 0 1.867775063146837e-05
unknown O 0 0.00012440234422683716
. O 0 9.019037679536268e-05

We O 0 4.690673449658789e-05
have O 0 1.1218556210224051e-05
identified O 0 2.0690853489213623e-05
three O 0 6.143072823761031e-06
offspring O 0 0.0002443094563204795
in O 0 1.7498987290309742e-05
a O 0 0.0007480622152797878
hereditary B-Disease 1 0.998271107673645
nonpolyposis I-Disease 1 0.9995046854019165
colorectal I-Disease 1 0.9999611377716064
cancer I-Disease 1 0.9999350309371948
family O 1 0.8526862263679504
who O 0 0.03271905705332756
developed O 1 0.8860191702842712
hematological B-Disease 1 0.9992977380752563
malignancy I-Disease 1 0.9990498423576355
at O 0 5.584933387581259e-05
a O 0 9.595618394087069e-06
very O 0 1.2212727597216144e-05
early O 0 5.31316709384555e-06
age O 0 6.315225164144067e-06
, O 0 5.483302061293216e-07
and O 0 2.6459548507773434e-07
at O 0 4.009903591395414e-07
least O 0 3.7065387914481107e-07
two O 0 1.7916850936217088e-07
of O 0 2.3572580687414302e-07
them O 0 1.0571211532806046e-06
displayed O 0 2.0029390725539997e-05
signs O 0 0.00021335917699616402
of O 0 1.5282526874216273e-05
neurofibromatosis B-Disease 1 0.9986912608146667
type I-Disease 0 0.005877283867448568
1 I-Disease 0 0.00013748384662903845
( O 0 0.00023267774668056518
NF1 B-Disease 1 0.7421749234199524
) O 0 0.00010280378046445549
. O 0 0.0001581705582793802

DNA O 0 0.00022344745229929686
sequence O 0 4.095729309483431e-05
analysis O 0 2.838014370354358e-05
and O 0 6.8011327130079735e-06
allele O 0 0.00015724812692496926
- O 0 6.0925769503228366e-05
specific O 0 8.371811418328434e-06
amplification O 0 4.583164263749495e-05
in O 0 2.7408086680225097e-06
two O 0 4.535512744041625e-06
siblings O 0 0.0012193326838314533
revealed O 0 0.0002434040798107162
a O 0 6.17839687038213e-05
homozygous O 0 0.05157146230340004
MLH1 O 1 0.9859685897827148
mutation O 0 0.11477132886648178
( O 0 0.00019324156164657325
C676T O 0 0.01359676755964756
- O 0 0.005128972232341766
- O 0 0.011318257078528404
> O 0 0.02215786650776863
Arg226Stop O 0 0.027328215539455414
) O 0 8.422229439020157e-05
. O 0 0.0001016267342492938

Thus O 0 0.0001695689425105229
, O 0 2.6198209525318816e-05
a O 0 4.709830682259053e-05
homozygous O 0 0.0050610327161848545
germ O 1 0.7180830240249634
- O 0 0.01424353290349245
line O 0 0.000482901930809021
MLH1 O 1 0.9846214056015015
mutation O 0 0.0854015126824379
and O 0 0.00019275464001111686
consequent O 1 0.9430447220802307
mismatch O 1 0.9947702288627625
repair O 1 0.9984951019287109
deficiency O 1 0.9995645880699158
results O 0 0.0014739737380295992
in O 0 6.869982462376356e-05
a O 0 0.0013743808958679438
mutator O 1 0.99797123670578
phenotype O 1 0.997895359992981
characterized O 1 0.9915396571159363
by O 0 0.02193314954638481
leukemia B-Disease 1 0.9998094439506531
and O 0 0.011690784245729446
/ O 1 0.9879684448242188
or O 0 0.10079893469810486
lymphoma B-Disease 1 0.9998619556427002
associated O 0 0.06467179954051971
with O 0 0.002273854333907366
neurofibromatosis B-Disease 1 0.9990021586418152
type I-Disease 0 0.03364076092839241
1 I-Disease 0 0.00011998317495454103
. O 0 3.377682514837943e-05
. O 0 9.301296813646331e-05

Missense O 0 0.10193224251270294
mutations O 0 0.0042409286834299564
in O 0 1.072644954547286e-05
the O 0 2.1798277884954587e-06
most O 0 2.051590172413853e-06
ancient O 0 5.062160198576748e-06
residues O 0 1.2574310858326498e-05
of O 0 1.5613846926498809e-06
the O 0 1.0929019481409341e-05
PAX6 O 1 0.9229563474655151
paired O 0 0.0012984242057427764
domain O 0 0.00014874142652843148
underlie O 0 0.06686927378177643
a O 0 2.901457264670171e-05
spectrum O 0 0.0011111688800156116
of O 0 7.988099969225004e-05
human O 1 0.8142646551132202
congenital B-Disease 1 0.9995723366737366
eye I-Disease 1 0.9977706670761108
malformations I-Disease 1 0.9974271655082703
. O 0 0.005007332656532526

Mutations O 0 0.012539492920041084
of O 0 4.5196142309578136e-05
the O 0 6.598074833163992e-05
human O 0 0.03358073905110359
PAX6 O 1 0.9959700107574463
gene O 1 0.8805094361305237
underlie O 1 0.996410071849823
aniridia B-Disease 1 0.9970614314079285
( O 0 0.051935482770204544
congenital B-Disease 1 0.9995461106300354
absence I-Disease 0 0.0018587160157039762
of I-Disease 0 4.04388083552476e-06
the I-Disease 0 2.464042881911155e-05
iris I-Disease 1 0.9199821352958679
) O 0 1.1985493983956985e-05
, O 0 3.3785947834985564e-06
a O 0 1.231448732141871e-05
rare O 0 0.003351738676428795
dominant O 0 0.0029555554501712322
malformation B-Disease 1 0.9657118916511536
of I-Disease 0 1.4890690181346145e-05
the I-Disease 0 7.663037104066461e-05
eye I-Disease 1 0.925087571144104
. O 0 0.0003123072092421353

The O 0 0.00010034455044660717
spectrum O 0 0.0005122686852701008
of O 0 7.775779522489756e-05
PAX6 O 1 0.991758406162262
mutations O 1 0.7368718385696411
in O 0 0.0004978606011718512
aniridia B-Disease 1 0.9927847385406494
patients O 1 0.9965464472770691
is O 0 1.1192737474630121e-05
highly O 0 6.071117604733445e-05
biased O 0 3.77026190108154e-05
, O 0 1.054686208590283e-06
with O 0 9.031626859723474e-07
92 O 0 1.1730866390280426e-05
% O 0 5.528848419089627e-07
of O 0 2.6797039254233823e-07
all O 0 6.123953539827198e-07
reported O 0 5.731933924835175e-05
mutations O 0 0.0006619364721700549
leading O 0 8.348881237907335e-06
to O 0 2.267600166305783e-06
premature O 0 0.0029144661966711283
truncation O 0 4.456851092982106e-05
of O 0 6.163901957734197e-07
the O 0 1.026206518872641e-06
protein O 0 1.2921080269734375e-05
( O 0 4.271152192814043e-06
nonsense O 0 3.737064980668947e-05
, O 0 1.3410497103905072e-06
splicing O 0 1.6484447769471444e-05
, O 0 2.0149618649156764e-06
insertions O 0 7.933168672025204e-05
and O 0 1.5538103070866782e-06
deletions O 0 3.154796650051139e-05
) O 0 6.19031084170274e-07
and O 0 2.111618186972919e-07
just O 0 3.333107372327504e-07
2 O 0 4.621897744527814e-07
% O 0 2.2886605677285843e-07
leading O 0 5.45950797459227e-07
to O 0 1.480248812413265e-07
substitution O 0 5.484013172463165e-07
of O 0 1.4439440576552443e-07
one O 0 4.382155509574659e-07
amino O 0 3.3591704777791165e-06
acid O 0 2.3705260900896974e-05
by O 0 1.9778251498792088e-06
another O 0 9.267325367545709e-06
( O 0 3.867043415084481e-05
missense O 0 0.003903232282027602
) O 0 6.071905590943061e-05
. O 0 8.870811871020123e-05

The O 0 6.27883491688408e-05
extraordinary O 0 0.00015603115025442094
conservation O 0 8.926885493565351e-05
of O 0 3.0531164156855084e-06
the O 0 5.025612608733354e-06
PAX6 O 0 0.10527071356773376
protein O 0 1.5644400264136493e-05
at O 0 1.7989084426517366e-06
the O 0 9.560610578773776e-07
amino O 0 7.21193873687298e-06
acid O 0 7.742822344880551e-05
level O 0 1.811734000511933e-05
amongst O 0 5.7614997786004096e-05
vertebrates O 0 0.0031521792989224195
predicts O 0 0.012681995518505573
that O 0 2.5627439754316583e-05
pathological O 1 0.8349729180335999
missense O 1 0.6747622489929199
mutations O 0 0.1565818339586258
should O 0 6.119532372395042e-06
in O 0 1.3842986845702399e-06
fact O 0 2.798429477479658e-06
be O 0 5.1619247187773e-07
common O 0 4.92222261527786e-06
even O 0 1.6198912362597184e-06
though O 0 1.2164928193669766e-06
they O 0 2.921295561009174e-07
are O 0 5.415854502643924e-07
hardly O 0 1.5465588148799725e-05
ever O 0 7.485265541617991e-06
seen O 0 3.7977293686708435e-05
in O 0 5.20707035320811e-05
aniridia B-Disease 1 0.9245932698249817
patients O 1 0.9920471906661987
. O 0 0.0003680394438561052

This O 0 3.1836658308748156e-05
indicates O 0 4.071072180522606e-05
that O 0 2.349800070078345e-06
there O 0 9.5959421742009e-07
is O 0 1.1966692454734584e-06
a O 0 3.632821290011634e-06
heavy O 0 0.00020332458370830864
ascertainment O 0 0.2529546916484833
bias O 0 0.00012379148392938077
in O 0 1.295290644520719e-06
the O 0 1.4955422784623806e-06
selection O 0 4.217464265821036e-06
of O 0 5.362980118661653e-06
patients O 1 0.9830915331840515
for O 0 0.00010719674173742533
PAX6 O 1 0.9918580651283264
mutation O 0 0.0049460348673164845
analysis O 0 1.3592842151410878e-05
and O 0 2.447019824103336e-06
that O 0 2.0806332940992434e-06
the O 0 6.981990281929029e-06
missing O 0 0.0014559001429006457
PAX6 O 1 0.9923567771911621
missense O 1 0.8865706920623779
mutations O 0 0.46901074051856995
frequently O 0 0.0013057433534413576
may O 0 0.0006777463131584227
underlie O 1 0.8503552079200745
phenotypes O 1 0.5766530632972717
distinct O 0 0.0005594546091742814
from O 0 7.195852958830073e-05
textbook O 0 0.1040477529168129
aniridia B-Disease 1 0.8952134251594543
. O 0 0.0004597003571689129

Here O 0 0.00010077097249450162
we O 0 1.3793760444968939e-05
present O 0 1.5877762052696198e-05
four O 0 2.6174284357693978e-05
novel O 0 0.0009074165136553347
PAX6 O 1 0.9858815670013428
missense O 0 0.34296685457229614
mutations O 0 0.008891839534044266
, O 0 5.272559519653441e-06
two O 0 2.8401241252140608e-06
in O 0 6.951958766876487e-06
association O 0 0.0007335501140914857
with O 0 0.0002472118940204382
atypical O 1 0.9962049126625061
phenotypes O 1 0.9888854026794434
ectopia B-Disease 1 0.9265424013137817
pupillae I-Disease 1 0.8497478365898132
( O 0 0.0006509526865556836
displaced B-Disease 0 0.056544408202171326
pupils I-Disease 0 0.006768984720110893
) O 0 0.00010798600123962387
and O 0 0.0004837395390495658
congenital B-Disease 1 0.9997323155403137
nystagmus I-Disease 1 0.9985319375991821
( O 0 0.000474185508210212
searching B-Disease 0 0.0009959375020116568
gaze I-Disease 0 0.010464977473020554
) O 0 2.8574195312103257e-06
, O 0 6.173373208184785e-07
and O 0 3.4319072028665687e-07
two O 0 3.9716425703772984e-07
in O 0 1.2497526995502994e-06
association O 0 4.6904999180696905e-05
with O 0 5.656936082232278e-06
more O 0 2.559807944635395e-05
recognizable O 0 0.02098442241549492
aniridia B-Disease 1 0.847391664981842
phenotypes O 1 0.6846060752868652
. O 0 0.000542633468285203

Strikingly O 0 0.004986772779375315
, O 0 1.5620009435224347e-05
all O 0 3.3154976790683577e-06
four O 0 4.884141617367277e-06
mutations O 0 0.00022654945496469736
are O 0 1.0314321343685151e-06
located O 0 2.0852417037531268e-06
within O 0 1.174892076960532e-06
the O 0 2.665934289325378e-06
PAX6 O 1 0.5013580322265625
paired O 0 0.00014220603043213487
domain O 0 9.800833140616305e-06
and O 0 1.2743920478897053e-06
affect O 0 1.3108742678014096e-05
amino O 0 3.1928955195326125e-06
acids O 0 3.631636673162575e-06
which O 0 4.639075541490456e-07
are O 0 3.858574473269982e-07
highly O 0 2.1173646018723957e-06
conserved O 0 2.891871190513484e-06
in O 0 5.007404979551211e-07
all O 0 5.380292122936225e-07
known O 0 4.23024994233856e-06
paired O 0 5.108387995278463e-05
domain O 0 4.69819460704457e-05
proteins O 0 8.556586544727907e-05
. O 0 7.53538406570442e-05

Our O 0 7.717127300566062e-05
results O 0 3.217431731172837e-05
support O 0 4.368720965430839e-06
the O 0 1.5270868516381597e-06
hypothesis O 0 9.047523235494737e-06
that O 0 4.348194408976269e-07
the O 0 4.2934030375363363e-07
under O 0 1.0574235602689441e-06
- O 0 1.7226509953616187e-05
representation O 0 2.0138015770498896e-06
of O 0 2.3149107164499583e-06
missense O 0 0.049850840121507645
mutations O 0 0.035470400005578995
is O 0 1.4709438801219221e-05
caused O 0 0.002191574312746525
by O 0 9.299170415033586e-06
ascertainment O 0 0.4301467835903168
bias O 0 0.00026168659678660333
and O 0 2.363983185205143e-06
suggest O 0 1.2735008567688055e-05
that O 0 1.0422008926980197e-06
a O 0 3.1210865927278064e-06
substantial O 0 0.00010861835471587256
burden O 0 0.04461352899670601
of O 0 0.00014597081462852657
PAX6 B-Disease 1 0.9987789988517761
- I-Disease 1 0.9703003168106079
related I-Disease 1 0.8526129126548767
disease I-Disease 1 0.9989792108535767
remains O 0 0.00015803064161445946
to O 0 4.547969638224458e-06
be O 0 4.169633484707447e-06
uncovered O 0 0.0003154146543238312
. O 0 2.5798748538363725e-05
. O 0 7.534334872616455e-05

The O 0 9.234174649463966e-05
chromosomal O 0 0.0018855768721550703
order O 0 1.9120274373563007e-05
of O 0 4.313271801947849e-06
genes O 0 9.106791549129412e-05
controlling O 0 0.00032755365828052163
the O 0 1.3193776794651058e-05
major O 0 0.0005025948630645871
histocompatibility O 1 0.9938074946403503
complex O 0 0.0022840434685349464
, O 0 3.768126407521777e-05
properdin O 0 0.042314235121011734
factor O 0 0.0002905323344748467
B O 0 0.000727713224478066
, O 0 2.604349447210552e-06
and O 0 3.772074478547438e-06
deficiency B-Disease 1 0.8939672708511353
of I-Disease 0 3.5736078984882624e-07
the I-Disease 0 5.225755899118667e-07
second I-Disease 0 1.7017779327943572e-06
component I-Disease 0 1.1452842045400757e-05
of I-Disease 0 3.0826545298623387e-06
complement I-Disease 0 0.00017666511121205986
. O 0 7.321524026338011e-05

The O 0 4.867813186137937e-05
relationship O 0 8.805276593193412e-05
of O 0 2.9669927243958227e-06
the O 0 3.4506108477216912e-06
genes O 0 6.366246088873595e-05
coding O 0 0.00016602865071035922
for O 0 8.602342859376222e-06
HLA O 0 0.27623268961906433
to O 0 2.8497506718849763e-06
those O 0 2.794964757413254e-06
coding O 0 0.00011419467045925558
for O 0 8.681708095537033e-06
properdin O 0 0.03368431702256203
Factor O 0 0.0004871457058470696
B O 0 0.0018742908723652363
allotypes O 0 0.00174265680834651
and O 0 2.3437885374733014e-06
for O 0 7.009831733739702e-06
deficiency B-Disease 1 0.938855767250061
of I-Disease 0 5.884082270313229e-07
the I-Disease 0 5.171567636352847e-07
second I-Disease 0 8.045238359954965e-07
component I-Disease 0 3.6773474221263314e-06
of I-Disease 0 1.1161835118400631e-06
complement I-Disease 0 5.147607225808315e-05
( O 0 3.943713090848178e-05
C2 O 1 0.736423671245575
) O 0 4.947654815623537e-06
was O 0 1.5143102700676536e-06
studied O 0 7.961623850860633e-06
in O 0 2.9263474061735906e-06
families O 0 5.051568950875662e-05
of O 0 2.5078745238715783e-05
patients O 1 0.9980403780937195
with O 0 0.009065144695341587
connective O 1 0.9985439777374268
tissue O 1 0.9984297156333923
disorders O 1 0.9990286827087402
. O 0 0.007591023109853268

Patients O 1 0.9769579172134399
were O 0 1.173274631582899e-05
selected O 0 1.1167638149345294e-05
because O 0 6.517635029013036e-06
they O 0 1.1674356983348844e-06
were O 0 1.9543433609214844e-06
heterozygous O 0 0.00029572867788374424
or O 0 3.646542245405726e-05
homozygous O 0 0.015511204488575459
for O 0 0.0009101149626076221
C2 B-Disease 1 0.99715256690979
deficiency I-Disease 1 0.9983308911323547
. O 0 0.0023577127140015364

12 O 0 0.00023100791440811008
families O 0 0.00016720747225917876
with O 0 3.524280327837914e-05
15 O 0 0.00010459304030518979
matings O 0 0.10490661859512329
informative O 0 0.010554512031376362
for O 0 0.00403056712821126
C2 B-Disease 1 0.9981083869934082
deficiency I-Disease 1 0.9991300702095032
were O 0 6.638214108534157e-05
found O 0 0.00021426635794341564
. O 0 0.0001618655805941671

Of O 0 7.018730684649199e-05
57 O 0 0.00021410179033409804
informative O 0 0.00035940087400376797
meioses O 0 0.0011356237810105085
, O 0 3.5508401197148487e-06
two O 0 2.0225957086950075e-06
crossovers O 0 1.912964762595948e-05
were O 0 1.1272929896222195e-06
noted O 0 6.3066604525374714e-06
between O 0 9.272665010939818e-06
the O 0 0.00012868705380242318
C2 B-Disease 1 0.9992851614952087
deficiency I-Disease 1 0.9997133612632751
gene O 0 0.016102716326713562
and O 0 9.970583050744608e-06
the O 0 2.0811170543311164e-05
HLA O 1 0.9838626980781555
- O 0 0.010292423889040947
B O 0 0.0016966356197372079
gene O 0 7.0834496000316e-05
, O 0 8.99620147265523e-07
with O 0 8.046343396017619e-07
a O 0 2.4560185920563526e-06
recombinant O 0 0.00010871119593502954
fraction O 0 2.065881562884897e-05
of O 0 5.747060640715063e-06
0 O 0 0.00012811088527087122
. O 0 9.562595369061455e-05

035 O 1 0.7960057854652405
. O 0 0.009476183913648129

A O 0 0.00017862112144939601
lod O 0 0.002173695480450988
score O 0 7.827091394574381e-06
of O 0 1.7305956134805456e-06
13 O 0 4.267837539373431e-06
was O 0 1.0912812058450072e-06
calculated O 0 4.753220309794415e-06
for O 0 5.532200248126173e-06
linkage O 0 0.005283213220536709
between O 0 0.001847099862061441
C2 B-Disease 1 0.9994308352470398
deficiency I-Disease 1 0.9997705817222595
and O 0 0.001511231530457735
HLA O 1 0.9965728521347046
- O 0 0.022555772215127945
B O 0 0.0005313141737133265
at O 0 1.8866406890083454e-06
a O 0 1.2746131687890738e-06
maximum O 0 3.5710529573407257e-06
likelihood O 0 6.894964826642536e-06
value O 0 6.167971378090442e-07
of O 0 3.2442727615489275e-07
the O 0 8.198066439035756e-07
recombinant O 0 6.073572876630351e-05
fraction O 0 1.805650390451774e-05
of O 0 6.58602903058636e-06
0 O 0 0.00013985928671900183
. O 0 7.811930845491588e-05

04 O 0 0.2499324530363083
. O 0 0.00448911776766181

18 O 0 0.0001538405631436035
families O 0 6.110643153078854e-05
with O 0 1.2296719432924874e-05
21 O 0 2.555734863562975e-05
informative O 0 0.0001327183417743072
matings O 0 0.005972908344119787
for O 0 5.97584767092485e-06
both O 0 9.307306754635647e-06
properdin O 0 0.028506822884082794
Factor O 0 0.00036345559055916965
B O 0 0.002003516536206007
allotype O 0 0.011569082736968994
and O 0 3.191837458871305e-05
HLA O 1 0.9358080625534058
- O 0 0.0022691090125590563
B O 0 0.0003900200827047229
were O 0 6.78158585287747e-06
found O 0 3.135914812446572e-05
. O 0 7.133896724553779e-05

Of O 0 4.2037267121486366e-05
72 O 0 0.00022706242452841252
informative O 0 0.00023401930229738355
meioses O 0 0.0018601631745696068
, O 0 4.130818069825182e-06
three O 0 2.7252146992395865e-06
recombinants O 0 0.0002453486667945981
were O 0 7.490125994991104e-07
found O 0 1.2473177548599779e-06
, O 0 6.609079719055444e-07
giving O 0 3.0748913104616804e-06
a O 0 2.803686584229581e-06
recombinant O 0 0.00010754095274023712
fraction O 0 1.9657303710118867e-05
of O 0 4.724477548734285e-06
0 O 0 0.00010498703340999782
. O 0 7.221190753625706e-05

042 O 0 0.10964937508106232
. O 0 0.004340542946010828

A O 0 0.0002924256259575486
lod O 0 0.0017656879499554634
score O 0 1.3396255781117361e-05
of O 0 3.842068963422207e-06
16 O 0 1.1560458005988039e-05
between O 0 1.772552786860615e-05
HLA O 1 0.9404817223548889
- O 0 0.0041757626459002495
B O 0 0.0008074828656390309
and O 0 5.264666015136754e-06
Factor O 0 5.312728535500355e-05
B O 0 0.00022685318253934383
allotypes O 0 0.0003548019740264863
was O 0 1.1286764447504538e-06
calculated O 0 2.23497499973746e-06
at O 0 7.33745423531218e-07
a O 0 7.161019084378495e-07
maximum O 0 1.6285670199067681e-06
likelihood O 0 4.905165042146109e-06
value O 0 4.933007744511997e-07
of O 0 2.6411294129502494e-07
the O 0 1.0745325198513456e-06
recombinant O 0 4.30838372267317e-05
fraction O 0 1.2688677088590339e-05
of O 0 4.465051461011171e-06
0 O 0 0.00010335529805161059
. O 0 5.874125054106116e-05

04 O 0 0.17519161105155945
. O 0 0.003980180714279413

A O 0 9.181274799630046e-05
crossover O 0 6.904054316692054e-05
was O 0 8.292035090562422e-06
shown O 0 5.952856554358732e-06
to O 0 1.2270386378077092e-06
have O 0 7.138149840102415e-07
occurred O 0 2.6078414521180093e-06
between O 0 1.0023218237620313e-06
genes O 0 1.7180969734909013e-05
for O 0 1.7627875195103115e-06
Factor O 0 0.00010010465484810993
B O 0 0.0008566398173570633
and O 0 1.3320760444912594e-05
HLA O 1 0.9306167364120483
- O 0 0.003040580078959465
D O 0 0.005701261106878519
, O 0 1.998023208216182e-06
in O 0 1.929286099766614e-06
which O 0 5.754728135798359e-06
HLA O 1 0.9593507647514343
- O 0 0.02118198201060295
D O 0 0.1565989851951599
segregared O 0 0.011554596945643425
with O 0 3.563979407772422e-05
HLA O 1 0.823512613773346
- O 0 0.0006033886456862092
A O 0 4.034788071294315e-05
and O 0 3.948119774577208e-05
B O 0 0.0016589517472311854
. O 0 0.0001448581024305895

These O 0 6.254804611671716e-05
studies O 0 0.00010006438969867304
suggest O 0 2.211676473962143e-05
that O 0 1.2663691677516908e-06
the O 0 1.8765149434329942e-06
genes O 0 2.8109416234656237e-05
for O 0 6.263713657972403e-06
Factor O 0 0.0004933509626425803
B O 0 0.017089946195483208
and O 0 0.00022841735335532576
C2 B-Disease 1 0.9994381070137024
deficiency I-Disease 1 0.9996891021728516
are O 0 5.747641353082145e-06
located O 0 4.694512426794972e-06
outside O 0 2.2238873498281464e-06
those O 0 1.6051453712861985e-06
for O 0 4.738411462312797e-06
HLA O 0 0.42019084095954895
, O 0 6.111444577072689e-07
that O 0 2.8363410820020363e-07
the O 0 3.531829122493946e-07
order O 0 9.123294262280979e-07
of O 0 1.0412442179585923e-06
genese O 0 0.002785284072160721
is O 0 8.386018635064829e-06
HLA O 1 0.5120390057563782
- O 0 0.00023182827862910926
A O 0 1.0481831850484014e-05
, O 0 4.026483111374546e-06
- O 0 0.0012564468197524548
B O 0 0.0004345940542407334
, O 0 5.965604032098781e-06
- O 0 0.0016041304916143417
D O 0 0.015031497925519943
, O 0 7.771353011776228e-06
Factor O 0 0.00025635227211751044
B O 0 0.011530501767992973
allotype O 0 0.1886928826570511
, O 0 0.0004102829843759537
C2 B-Disease 1 0.999338686466217
deficiency I-Disease 1 0.9995505213737488
, O 0 4.6256200221250765e-06
that O 0 9.19948945465876e-07
the O 0 2.4468097308272263e-06
genes O 0 0.0001759665901772678
coding O 0 0.0056175957433879375
for O 0 0.001649087411351502
C2 B-Disease 1 0.9994064569473267
deficiency I-Disease 1 0.9997689127922058
and O 0 4.786533099832013e-05
Factor O 0 0.0004969810834154487
B O 0 0.001111565507017076
allotypes O 0 0.0005020021344535053
are O 0 1.1724787327693775e-06
approximately O 0 3.3389146665285807e-06
3 O 0 3.5150389976479346e-06
- O 0 5.736177263315767e-05
- O 0 5.080928895040415e-05
5 O 0 5.2290292842371855e-06
centimorgans O 0 0.0002101986901834607
from O 0 2.1001997083658352e-06
the O 0 4.121897291042842e-06
HLA O 0 0.48796403408050537
- O 0 0.00027169781969860196
A O 0 1.5707753846072592e-05
and O 0 1.5587331290589646e-05
HLA O 1 0.9403476119041443
- O 0 0.005408043507486582
B O 0 0.0010135658085346222
loci O 0 0.00026711609098128974
, O 0 8.4865496319253e-07
and O 0 3.6945823467249284e-07
that O 0 2.900657989357569e-07
the O 0 4.5510486756938917e-07
apparent O 0 3.2372430723626167e-05
lack O 0 1.2660851098189596e-05
of O 0 9.595923984306864e-07
recombinants O 0 0.0013154747430235147
between O 0 2.743994400589145e-06
the O 0 3.921210009139031e-06
Factor O 0 0.0006806490127928555
B O 0 0.04765086621046066
gene O 0 0.04434704780578613
and O 0 0.0009303594706580043
C2 B-Disease 1 0.999510645866394
deficiency I-Disease 1 0.9997895359992981
gene O 0 0.0772324949502945
suggests O 0 0.00014120532432571054
that O 0 9.065401513908e-07
these O 0 4.5816892679795274e-07
two O 0 1.014478243632766e-06
genes O 0 1.575771784700919e-05
lie O 0 9.680907169240527e-06
in O 0 7.97173584032862e-07
close O 0 3.8676776057400275e-06
proximity O 0 1.1404395081626717e-05
to O 0 1.5999581819414743e-06
one O 0 4.962724688084563e-06
another O 0 2.9468044886016287e-05
. O 0 6.113540439400822e-05

Distribution O 0 0.00017694612324703485
of O 0 3.893419125233777e-05
emerin O 0 0.008684832602739334
and O 0 3.618452319642529e-05
lamins O 0 0.23213396966457367
in O 0 1.3935979950474575e-05
the O 0 1.4889809790474828e-05
heart O 0 0.2849290370941162
and O 0 4.1580038669053465e-05
implications O 0 0.036301739513874054
for O 0 0.0004721381119452417
Emery B-Disease 1 0.9837406277656555
- I-Disease 1 0.9817492961883545
Dreifuss I-Disease 1 0.99819415807724
muscular I-Disease 1 0.9987336993217468
dystrophy I-Disease 1 0.9988701939582825
. O 0 0.020369255915284157

Emerin O 0 0.006893489044159651
is O 0 2.476717418176122e-05
a O 0 1.245703151653288e-05
nuclear O 0 2.7072424927609973e-05
membrane O 0 2.8279375328565948e-05
protein O 0 1.4225183804228436e-05
which O 0 1.9807321223197505e-06
is O 0 2.553336571509135e-06
missing O 0 5.148795389686711e-05
or O 0 2.552740988903679e-05
defective O 1 0.559500515460968
in O 0 0.00029657481354661286
Emery B-Disease 1 0.9876939058303833
- I-Disease 1 0.989722728729248
Dreifuss I-Disease 1 0.9986633062362671
muscular I-Disease 1 0.9991881251335144
dystrophy I-Disease 1 0.9995824694633484
( O 0 0.2784097194671631
EDMD B-Disease 1 0.9884575009346008
) O 0 0.0005812064046040177
. O 0 0.00032258746796287596

It O 0 1.9295535821584053e-05
is O 0 3.3119010822701966e-06
one O 0 1.1721500641215243e-06
member O 0 1.3108015082252678e-06
of O 0 3.7562904253718443e-07
a O 0 1.5167267974902643e-06
family O 0 8.855826308717951e-06
of O 0 2.4328539893758716e-06
lamina O 1 0.9431144595146179
- O 0 0.002405468374490738
associated O 0 2.7812111511593685e-05
proteins O 0 6.40141934127314e-06
which O 0 2.0365332602523267e-06
includes O 0 1.4957427083572838e-05
LAP1 O 0 0.02116203121840954
, O 0 2.28626358875772e-05
LAP2 O 0 0.028871452435851097
and O 0 5.6748151109786704e-05
lamin O 1 0.9681951999664307
B O 0 0.11154297739267349
receptor O 0 0.07198385894298553
( O 0 0.0009219289058819413
LBR O 1 0.9795397520065308
) O 0 0.00017066598229575902
. O 0 0.0001731530501274392

A O 0 0.00011941396951442584
panel O 0 0.00010727250628406182
of O 0 9.473287718719803e-06
16 O 0 0.00010594476043479517
monoclonal O 0 0.3785193860530853
antibodies O 0 0.1475067138671875
( O 0 0.0001905646058730781
mAbs O 0 0.2052140086889267
) O 0 5.300545581121696e-06
has O 0 1.3420553841569927e-06
been O 0 6.855466949673428e-07
mapped O 0 3.959766672778642e-06
to O 0 3.9725557599012973e-07
six O 0 7.948574420879595e-07
specific O 0 1.5578237935187644e-06
sites O 0 1.8538252106736763e-06
throughout O 0 1.766162995409104e-06
the O 0 1.1496956631162902e-06
emerin O 0 0.00017182479496113956
molecule O 0 1.8121763787348755e-05
using O 0 5.469865755003411e-06
phage O 0 0.05660318583250046
- O 0 0.0001777859724825248
displayed O 0 1.740702828101348e-05
peptide O 0 9.129467071034014e-05
libraries O 0 6.625230525969528e-06
and O 0 7.375521136054886e-07
has O 0 8.422498467552941e-07
been O 0 5.860466103513318e-07
used O 0 8.536892437405186e-07
to O 0 1.758143639563059e-06
localize O 0 0.007150354795157909
emerin O 0 0.005157141946256161
in O 0 7.290933353942819e-06
human O 0 0.00020153747755102813
and O 0 6.847359327366576e-05
rabbit O 1 0.7250106334686279
heart O 1 0.9197304844856262
. O 0 0.0004942863015457988

Several O 0 0.0003534246061462909
mAbs O 0 0.21874076128005981
against O 0 5.512758798431605e-05
different O 0 3.381620263098739e-05
emerin O 0 0.04675629734992981
epitopes O 0 0.08072643727064133
did O 0 1.9959279597969726e-05
not O 0 3.7842926303710556e-06
recognize O 0 0.00015589670510962605
intercalated O 0 0.01059822179377079
discs O 0 0.00011408919817768037
in O 0 2.404193992333603e-06
the O 0 4.122447535337415e-06
heart O 0 0.12300051003694534
, O 0 2.4001483325264417e-06
though O 0 3.231462869734969e-06
they O 0 8.649921028336394e-07
recognized O 0 1.739592698868364e-05
cardiomyocyte O 0 0.0034705568104982376
nuclei O 0 0.0002113401860697195
strongly O 0 8.907441952032968e-06
, O 0 7.790748099978373e-07
both O 0 6.388536348822527e-07
at O 0 6.779139880563889e-07
the O 0 8.466824397146411e-07
rim O 0 9.139902249444276e-05
and O 0 1.3945373211754486e-06
in O 0 3.499118975014426e-06
intranuclear O 0 0.003052206477150321
spots O 0 0.00019089505076408386
or O 0 2.284552829223685e-05
channels O 0 9.64518403634429e-05
. O 0 8.199818694265559e-05

A O 0 0.0026037869974970818
polyclonal O 1 0.8609334230422974
rabbit O 1 0.6753749251365662
antiserum O 1 0.6347414255142212
against O 0 0.00018347115837968886
emerin O 0 0.014783143997192383
did O 0 2.316994869033806e-05
recognize O 0 3.859601201838814e-05
both O 0 2.014865685850964e-06
nuclear O 0 1.7081882106140256e-05
membrane O 0 2.4275177565868944e-05
and O 0 2.3757581857353216e-06
intercalated O 0 0.002810845384374261
discs O 0 5.0809674576157704e-05
but O 0 1.1615608173087821e-06
, O 0 8.224056955441483e-07
after O 0 1.662763679632917e-06
affinity O 0 1.1761558198486455e-05
purification O 0 3.565577571862377e-05
against O 0 2.44012221628509e-06
a O 0 2.082328592223348e-06
pure O 0 1.4045867828826886e-05
- O 0 0.0007177380612120032
emerin O 0 0.0017888337606564164
band O 0 3.836865744233364e-06
on O 0 6.527947107315413e-07
a O 0 1.4910947356838733e-06
western O 0 4.357486432127189e-06
blot O 0 0.0016580175142735243
, O 0 1.5653297396056587e-06
it O 0 8.8940817022376e-07
stained O 0 0.0018494996475055814
only O 0 1.2497146144596627e-06
the O 0 3.658751438706531e-06
nuclear O 0 9.405759919900447e-05
membrane O 0 0.00030169589444994926
. O 0 0.0001132278994191438

These O 0 4.537458153208718e-05
results O 0 3.004069185408298e-05
would O 0 2.9307432214409346e-06
not O 0 1.2577731922647217e-06
be O 0 6.358121140692674e-07
expected O 0 2.4105856937239878e-06
if O 0 3.112092599621974e-06
immunostaining O 0 0.0002559044223744422
at O 0 2.479863042026409e-06
intercalated O 0 0.0012739087687805295
discs O 0 2.623601358209271e-05
were O 0 4.3306849306645745e-07
due O 0 1.3506166851584567e-06
to O 0 2.8542007157739135e-07
a O 0 5.079066909274843e-07
product O 0 1.0648981287886272e-06
of O 0 3.651539088878053e-07
the O 0 1.6962768540906836e-06
emerin O 0 0.010272571817040443
gene O 0 0.00014680133608635515
and O 0 9.107941991715052e-07
, O 0 7.223904390230018e-07
therefore O 0 7.664282861696847e-07
, O 0 3.2980602782117785e-07
cast O 0 8.524966688128188e-07
some O 0 5.284064172883518e-07
doubt O 0 6.227506219147472e-06
upon O 0 1.6350470559700625e-06
the O 0 2.017192173298099e-06
hypothesis O 0 0.001750146853737533
that O 0 0.00015959111624397337
cardiac B-Disease 1 0.9994547963142395
defects I-Disease 1 0.9974741339683533
in O 0 0.0001547857973491773
EDMD B-Disease 1 0.8840330243110657
are O 0 5.340956249710871e-06
caused O 0 0.0008227347279898822
by O 0 2.6878376502281753e-06
absence O 0 3.171508797095157e-05
of O 0 3.319097913845326e-06
emerin O 0 0.014892631210386753
from O 0 2.5959805498132482e-05
intercalated O 0 0.08457201719284058
discs O 0 0.00284005724824965
. O 0 0.00015152490232139826

Although O 0 0.0002145169855793938
emerin O 0 0.0013718459522351623
was O 0 8.263805284514092e-06
abundant O 0 1.2506656275945716e-05
in O 0 1.4091092452872545e-06
the O 0 1.4209440450940747e-06
membranes O 0 8.503422577632591e-05
of O 0 1.4796208915868192e-06
cardiomyocyte O 0 0.004042655695229769
nuclei O 0 0.0001888341794256121
, O 0 1.2952708630109555e-06
it O 0 6.134627028586692e-07
was O 0 8.951348036134732e-07
absent O 0 1.7145415768027306e-05
from O 0 1.1969375464104814e-06
many O 0 2.893004875659244e-06
non O 0 0.0001595824578544125
- O 0 0.027201198041439056
myocyte O 1 0.8687822818756104
cells O 0 0.0021212466526776552
in O 0 1.110235280066263e-05
the O 0 2.2977388653089292e-05
heart O 0 0.3484792411327362
. O 0 0.0001834454305935651

This O 0 2.4669396225363016e-05
distribution O 0 1.7466874851379544e-05
of O 0 4.344035005487967e-06
emerin O 0 0.0009943812619894743
was O 0 1.7041733144651516e-06
similar O 0 1.7731533716869308e-06
to O 0 3.982699183779914e-07
that O 0 3.005338840011973e-07
of O 0 6.741148581568268e-07
lamin O 0 0.26388978958129883
A O 0 5.343636075849645e-06
, O 0 1.145620899478672e-06
a O 0 1.7076483800337883e-06
candidate O 0 5.924894594500074e-06
gene O 0 7.102529343683273e-05
for O 0 2.4519160888303304e-06
an O 0 7.38995140636689e-06
autosomal O 1 0.6278484463691711
form O 0 7.454449951183051e-05
of O 0 3.9948550693225116e-05
EDMD B-Disease 1 0.9670229554176331
. O 0 0.0003328097809571773

In O 0 0.00034428603248670697
contrast O 0 0.0011407921556383371
, O 0 0.00025748152984306216
lamin O 1 0.9789592623710632
B1 O 1 0.9749644994735718
was O 0 3.210541763110086e-05
absent O 0 0.00022501713829115033
from O 0 8.778049050306436e-06
cardiomyocyte O 0 0.005641159601509571
nuclei O 0 0.0006073842523619533
, O 0 7.704848030698486e-06
showing O 0 6.285208655754104e-05
that O 0 1.7762080460670404e-05
lamin O 1 0.9390297532081604
B1 O 1 0.8729435801506042
is O 0 3.0068606520217145e-06
not O 0 8.847164281178266e-07
essential O 0 1.6091886436697678e-06
for O 0 1.1000458925991552e-06
localization O 0 1.8766811990644783e-05
of O 0 1.5618611541867722e-06
emerin O 0 0.0005515854572877288
to O 0 3.74303772332496e-06
the O 0 6.066075457056286e-06
nuclear O 0 0.00043497950537130237
lamina O 1 0.6115121245384216
. O 0 0.0002159335563192144

Lamin O 1 0.9731613397598267
B1 O 1 0.946954607963562
is O 0 6.270625453907996e-05
also O 0 1.0798788935062476e-05
almost O 0 1.607969716133084e-05
completely O 0 6.275764462770894e-05
absent O 0 0.0007859223987907171
from O 0 7.409411045955494e-05
skeletal O 1 0.9561084508895874
muscle O 1 0.9269886016845703
nuclei O 0 0.04839335381984711
. O 0 0.00047354999696835876

In O 0 0.00021292426390573382
EDMD B-Disease 0 0.06848333030939102
, O 0 9.836911885940935e-06
the O 0 3.5525811199477175e-06
additional O 0 1.4087105228099972e-05
absence O 0 0.000109700886241626
of O 0 1.8161104890168644e-05
lamin O 1 0.9941132664680481
B1 O 1 0.9952671527862549
from O 0 0.00017491102335043252
heart O 1 0.9277751445770264
and O 0 0.0002154021931346506
skeletal O 1 0.9965793490409851
muscle O 1 0.9891431927680969
nuclei O 0 0.022847479209303856
which O 0 9.958076589100529e-06
already O 0 7.019240001682192e-05
lack O 0 0.00019245638395659626
emerin O 0 0.036664992570877075
may O 0 1.4619374269386753e-05
offer O 0 5.950109425612027e-06
an O 0 9.965582421500585e-07
alternative O 0 5.617840542981867e-06
explanation O 0 1.0498739356989972e-05
of O 0 9.252790960090351e-07
why O 0 1.3453008250507992e-05
these O 0 2.0852298803220037e-06
tissues O 0 0.0058237407356500626
are O 0 3.246307869630982e-06
particularly O 0 9.642856457503513e-05
affected O 0 0.0009600335615687072
. O 0 1.3720108654524665e-05
. O 0 5.088522084406577e-05

Genetic O 0 0.0017995737725868821
mapping O 0 0.0003050300292670727
of O 0 1.1737492059182841e-05
the O 0 2.1240901332930662e-05
copper B-Disease 0 0.00163114198949188
toxicosis I-Disease 1 0.9776057600975037
locus O 0 0.009194768033921719
in O 0 0.00011043433914892375
Bedlington O 1 0.9669110774993896
terriers O 0 0.26633521914482117
to O 0 1.6729765775380656e-05
dog O 0 0.0022589080035686493
chromosome O 0 0.00027959371800534427
10 O 0 3.5931898310082033e-06
, O 0 1.0052607422039728e-06
in O 0 8.334826588907163e-07
a O 0 1.9888466340489686e-06
region O 0 3.4237851650686935e-05
syntenic O 0 0.0021033589728176594
to O 0 6.157442840049043e-06
human O 0 0.00015706560225225985
chromosome O 0 0.002040592487901449
region O 0 0.0002819066576194018
2p13 O 0 0.0348266176879406
- O 0 0.014027011580765247
p16 O 0 0.34733647108078003
. O 0 0.00036947178887203336

Abnormal O 1 0.9852227568626404
hepatic B-Disease 1 0.9938145875930786
copper I-Disease 0 0.025075729936361313
accumulation I-Disease 0 0.09881198406219482
is O 0 6.863295857328922e-05
recognized O 0 0.0003059746231883764
as O 0 3.353392457938753e-05
an O 0 0.0007666251040063798
inherited B-Disease 1 0.9991075396537781
disorder I-Disease 1 0.9998332262039185
in O 0 0.0006075637647882104
man O 0 0.006223026663064957
, O 0 8.954927761806175e-05
mouse O 0 0.04253978654742241
, O 0 4.031807111459784e-05
rat O 0 0.2395821362733841
and O 0 5.6241085985675454e-05
dog O 0 0.011206982657313347
. O 0 0.0001894334563985467

The O 0 9.30720561882481e-05
major O 0 0.000294132943963632
cause O 0 0.004227262455970049
of O 0 2.365655018365942e-05
hepatic B-Disease 1 0.9963287711143494
copper I-Disease 0 0.008818537928164005
accumulation I-Disease 0 0.03018255904316902
in O 0 1.820695433707442e-05
man O 0 0.00014973741781432182
is O 0 9.794031029741745e-06
a O 0 9.746535215526819e-05
dysfunctional O 1 0.9800127148628235
ATP7B O 1 0.9790230393409729
gene O 0 0.2869989275932312
, O 0 0.000492889666929841
causing O 1 0.9534757137298584
Wilson B-Disease 1 0.9829732179641724
disease I-Disease 1 0.9992426633834839
( O 0 0.013925480656325817
WD B-Disease 1 0.9886133670806885
) O 0 0.0003161953645758331
. O 0 0.0001552457979414612

Mutations O 0 0.02322874404489994
in O 0 3.1457722798222676e-05
the O 0 1.3643414604302961e-05
ATP7B O 0 0.017101075500249863
genes O 0 0.0001289029751205817
have O 0 3.567322664821404e-06
also O 0 2.2069134502089582e-06
been O 0 3.3275759960815776e-06
demonstrated O 0 3.281022509327158e-05
in O 0 9.787121598492377e-06
mouse O 0 0.0015826794551685452
and O 0 3.7486504879780114e-05
rat O 0 0.12589141726493835
. O 0 0.00016754692478571087

The O 0 0.00017379733617417514
ATP7B O 0 0.10562140494585037
gene O 0 0.0011217923602089286
has O 0 1.080551646737149e-05
been O 0 2.5421986720175482e-06
excluded O 0 5.94243692830787e-06
in O 0 7.871232128309202e-07
the O 0 1.4227475730876904e-06
much O 0 2.326389221707359e-05
rarer O 0 0.27299851179122925
human O 0 0.004956637974828482
copper B-Disease 0 0.35663312673568726
overload I-Disease 1 0.9984728693962097
disease O 1 0.9995797276496887
non B-Disease 0 0.11131992191076279
- I-Disease 1 0.5686846971511841
Indian I-Disease 0 0.00781982485204935
childhood I-Disease 1 0.9980447292327881
cirrhosis I-Disease 1 0.999442994594574
, O 0 0.0007490280549973249
indicating O 0 0.03627342730760574
genetic O 0 0.31154242157936096
heterogeneity O 1 0.5821652412414551
. O 0 0.0006760206306353211

By O 0 0.00020786326786037534
investigating O 0 0.0009554114658385515
the O 0 8.184662874555215e-05
common O 0 0.011392585933208466
autosomal O 1 0.9958351850509644
recessive O 1 0.9960653185844421
copper B-Disease 1 0.7721222043037415
toxicosis I-Disease 1 0.9970836043357849
( O 0 0.021060505881905556
CT B-Disease 1 0.9927339553833008
) O 0 5.180073276278563e-05
in O 0 2.932909774244763e-05
Bedlington O 1 0.9499475955963135
terriers O 0 0.21357814967632294
, O 0 5.515584689419484e-06
we O 0 1.111994379243697e-06
have O 0 9.205527362610155e-07
identified O 0 3.8126677281979937e-06
a O 0 1.773232952473336e-06
new O 0 6.297381332842633e-06
locus O 0 0.001248055836185813
involved O 0 0.00031601902446709573
in O 0 0.0004901924985460937
progressive O 1 0.9938544034957886
liver B-Disease 1 0.9997506737709045
disease I-Disease 1 0.9995294809341431
. O 0 0.0076637244783341885

We O 0 0.00020922694238834083
examined O 0 0.0012168805114924908
whether O 0 5.012913607060909e-05
the O 0 3.5680877772392705e-05
WD B-Disease 1 0.9881455898284912
gene O 0 0.025160150602459908
ATP7B O 0 0.0895964652299881
was O 0 8.521913514414337e-06
also O 0 6.294973445619689e-06
causative O 0 0.00674187857657671
for O 0 2.2824948246125132e-05
CT B-Disease 1 0.9322381615638733
by O 0 4.793160314875422e-06
investigating O 0 0.00016009363753255457
the O 0 6.60701562082977e-06
chromosomal O 0 0.036378826946020126
co O 0 0.002068581525236368
- O 0 0.0004918592167086899
localization O 0 0.0001233710499946028
of O 0 2.023317165367189e-06
ATP7B O 0 0.004893442615866661
and O 0 3.3649930628598668e-06
C04107 O 0 0.0002010507305385545
, O 0 1.7112838577304501e-06
using O 0 4.071794137416873e-06
fluorescence O 0 0.0003064203483518213
in O 0 5.817865712742787e-06
situ O 0 0.0022339054848998785
hybridization O 0 0.000185662109288387
( O 0 2.8440807000151835e-05
FISH O 0 5.6000473705353215e-05
) O 0 5.2969702664995566e-05
. O 0 7.116244523786008e-05

C04107 O 0 0.010155124589800835
is O 0 6.175110320327803e-05
an O 0 2.711857814574614e-05
anonymous O 0 0.0005248489324003458
microsatellite O 0 0.09119822829961777
marker O 0 0.004336424171924591
closely O 0 0.00033118989085778594
linked O 0 0.0031532340217381716
to O 0 0.00010132763418368995
CT B-Disease 1 0.9198352694511414
. O 0 0.0002692547277547419

However O 0 0.00025748592452146113
, O 0 0.00010435384319862351
BAC O 0 0.041296735405921936
clones O 0 0.0031325523741543293
containing O 0 8.107155008474365e-05
ATP7B O 0 0.02168325148522854
and O 0 1.0722829756559804e-05
C04107 O 0 0.0006228071870282292
mapped O 0 4.5306096581043676e-05
to O 0 2.5032197754626395e-06
the O 0 5.730613793275552e-06
canine O 0 0.28024885058403015
chromosome O 0 0.0017181262373924255
regions O 0 0.00017704909259919077
CFA22q11 O 0 0.011413403786718845
and O 0 7.941089279484004e-06
CFA10q26 O 0 0.005826637148857117
, O 0 3.5505286177794915e-06
respectively O 0 7.154968898248626e-06
, O 0 2.7632720502879238e-06
demonstrating O 0 3.684662442537956e-05
that O 0 7.756285413051955e-06
WD B-Disease 1 0.731876790523529
cannot O 0 1.54361805471126e-05
be O 0 3.0067001262068516e-06
homologous O 0 0.00033621524926275015
to O 0 2.9343309506657533e-05
CT B-Disease 1 0.8399767875671387
. O 0 0.00011016843927791342

The O 0 9.118870366364717e-05
copper O 0 0.0002785122487694025
transport O 0 0.0003718679363373667
genes O 0 0.0011584326857700944
CTR1 O 0 0.05130130052566528
and O 0 1.385193445457844e-05
CTR2 O 0 0.0038194910157471895
were O 0 9.270597729482688e-07
also O 0 9.60934926297341e-07
excluded O 0 3.821305654128082e-06
as O 0 6.62744639612356e-07
candidate O 0 3.935356289730407e-06
genes O 0 2.058734571619425e-05
for O 0 6.353348453558283e-06
CT B-Disease 1 0.692089855670929
since O 0 6.296396350080613e-06
they O 0 7.958382184369839e-07
both O 0 1.9012692291653366e-06
mapped O 0 6.360207771649584e-05
to O 0 1.7272719560423866e-05
canine O 0 0.38575106859207153
chromosome O 0 0.008110886439681053
region O 0 0.001141341170296073
CFA11q22 O 0 0.08287026733160019
. O 0 0.00024085106269922107

2 O 0 0.0015061621088534594
- O 0 0.0026341532357037067
22 O 0 0.001007365994155407
. O 0 0.0004985292325727642

5 O 0 0.004571893252432346
. O 0 0.0018918747082352638

A O 0 0.00013904985098633915
transcribed O 0 0.00013420727918855846
sequence O 0 3.604098310461268e-05
identified O 0 2.3303728085011244e-05
from O 0 2.4884816411940847e-06
the O 0 2.6301154321117792e-06
C04107 O 0 0.0006045004702173173
- O 0 0.0001893489243229851
containing O 0 2.137658702849876e-05
BAC O 0 0.01827906258404255
was O 0 2.1433124857139774e-06
found O 0 1.0670349865904427e-06
to O 0 3.538342809861206e-07
be O 0 3.931849619220884e-07
homologous O 0 1.5699772120569833e-05
to O 0 7.918379196780734e-07
a O 0 2.398724973318167e-06
gene O 0 9.148448589257896e-05
expressed O 0 9.62306421570247e-06
from O 0 2.79733012575889e-06
human O 0 0.00011584110325202346
chromosome O 0 0.0029889713041484356
2p13 O 0 0.010184288956224918
- O 0 0.002136177383363247
p16 O 0 0.009845963679254055
, O 0 2.1833479877386708e-06
a O 0 1.8904319176726858e-06
region O 0 6.944736014702357e-06
devoid O 0 9.767969459062442e-06
of O 0 7.947066364977218e-07
any O 0 2.6643278943083715e-06
positional O 0 8.585602336097509e-05
candidate O 0 4.21518343500793e-05
genes O 0 0.0003272050525993109
. O 0 8.931330376071855e-05

Molecular O 0 0.0006164105143398046
analysis O 0 3.2809286494739354e-05
of O 0 3.7549509670498082e-06
the O 0 8.577938388043549e-06
APC B-Disease 0 0.0056420848704874516
gene O 0 0.00024036149261519313
in O 0 4.978111519449158e-06
205 O 0 0.00028302724240347743
families O 0 6.233957537915558e-05
: O 0 2.4831837436067872e-05
extended O 0 0.00015111856919247657
genotype O 0 0.20141270756721497
- O 0 0.04471689835190773
phenotype O 1 0.6143233776092529
correlations O 0 0.0010875241132453084
in O 0 1.9833991245832294e-05
FAP B-Disease 1 0.7945582866668701
and O 0 3.388368668311159e-06
evidence O 0 3.1804718219063943e-06
for O 0 7.604740517308528e-07
the O 0 7.470571858902986e-07
role O 0 4.383252417028416e-06
of O 0 2.7484804832056398e-06
APC B-Disease 0 0.01348244957625866
amino O 0 0.00011449942394392565
acid O 0 0.025432780385017395
changes O 0 0.002633168827742338
in O 0 0.023590177297592163
colorectal B-Disease 1 0.9997596144676208
cancer I-Disease 1 0.9996782541275024
predisposition O 1 0.9950472116470337
. O 0 0.00544733926653862

BACKGROUND O 0 0.01671852543950081
/ O 0 0.10511139035224915
AIMS O 0 0.0009768441086634994
The O 0 2.1881587599636987e-05
development O 0 0.0006638807826675475
of O 0 0.0006013365346007049
colorectal B-Disease 1 0.999863862991333
cancer I-Disease 1 0.9997362494468689
and O 0 1.694589627732057e-05
a O 0 1.292158503929386e-05
variable O 0 0.0002739012998063117
range O 0 3.869750798912719e-05
of O 0 1.2473660717660096e-05
extracolonic O 1 0.9306580424308777
manifestations O 1 0.9775171279907227
in O 0 0.030679047107696533
familial B-Disease 1 0.9995866417884827
adenomatous I-Disease 1 0.9997265934944153
polyposis I-Disease 1 0.9997392296791077
( O 1 0.5482743978500366
FAP B-Disease 1 0.9958742260932922
) O 0 2.4685492462594993e-05
is O 0 2.163103545171907e-06
the O 0 1.2765668770953198e-06
result O 0 2.8736246804328403e-06
of O 0 9.265223184229399e-07
the O 0 3.6822605125053087e-06
dominant O 0 0.0003725112183019519
inheritance O 0 0.020286310464143753
of O 0 0.003507214365527034
adenomatous B-Disease 1 0.9993603825569153
polyposis I-Disease 1 0.9995391368865967
coli I-Disease 1 0.9982072114944458
( O 0 0.03497552499175072
APC B-Disease 1 0.7099605202674866
) O 0 0.00039886904414743185
gene O 0 0.015980208292603493
mutations O 0 0.04504333809018135
. O 0 0.0004295682592783123

In O 0 3.866969564114697e-05
this O 0 6.6068387241102755e-06
study O 0 1.563550904393196e-05
, O 0 2.0158288407401415e-06
direct O 0 5.502776275534416e-06
mutation O 0 4.9217065679840744e-05
analysis O 0 3.812565864791395e-06
of O 0 9.515729288978036e-07
the O 0 3.7363079172791913e-06
APC B-Disease 0 0.008198689669370651
gene O 0 0.0001566519058542326
was O 0 1.7646460719333845e-06
performed O 0 4.486658326641191e-06
to O 0 1.95112716028234e-06
determine O 0 4.1663472075015306e-05
genotype O 0 0.06582382321357727
- O 0 0.01199190691113472
phenotype O 0 0.13924814760684967
correlations O 0 0.0001831177796702832
for O 0 5.714634426112752e-06
nine O 0 2.3326403606915846e-05
extracolonic O 0 0.030634064227342606
manifestations O 0 0.01752283424139023
and O 0 2.562240069892141e-06
to O 0 1.6654839782859199e-06
investigate O 0 0.00011345453094691038
the O 0 3.5265288715891074e-06
incidence O 0 0.2419450730085373
of O 0 9.596715244697407e-06
APC B-Disease 0 0.24287556111812592
mutations O 0 0.1262945979833603
in O 0 0.00010635085345711559
non O 0 0.118466317653656
- O 1 0.9922288060188293
FAP O 1 0.9985764026641846
colorectal B-Disease 1 0.999666690826416
cancer I-Disease 1 0.999351441860199
. O 0 0.011735632084310055

METHODS O 0 0.0003784376021940261
The O 0 6.587312236661091e-05
APC B-Disease 0 0.006374274380505085
gene O 0 0.0003903308243025094
was O 0 1.215493193740258e-05
analysed O 0 7.812996045686305e-05
in O 0 9.494603546045255e-06
190 O 0 0.000334275362547487
unrelated O 0 0.007936559617519379
FAP B-Disease 1 0.9537101984024048
and O 0 3.764728535315953e-05
15 O 0 0.00026219082064926624
non O 0 0.07674888521432877
- O 1 0.9945523142814636
FAP O 1 0.9992632269859314
colorectal B-Disease 1 0.9998867511749268
cancer I-Disease 1 0.9998791217803955
patients O 1 0.998503565788269
using O 0 0.0005619479925371706
denaturing O 1 0.9173093438148499
gradient O 0 0.016920719295740128
gel O 0 0.3323415517807007
electrophoresis O 0 0.0029505514539778233
, O 0 2.804231826303294e-06
the O 0 1.9261663055658573e-06
protein O 0 1.762326792231761e-05
truncation O 0 0.0001330360973952338
test O 0 8.70417534315493e-06
, O 0 1.6367663420169265e-06
and O 0 2.1815349100506864e-06
direct O 0 1.8876140529755503e-05
sequencing O 0 0.00021971944079268724
. O 0 0.00010823899356182665

RESULTS O 0 0.0011028096778318286
Chain O 0 0.0010756492847576737
terminating O 0 0.001299543771892786
signals O 0 4.8507641622563824e-05
were O 0 3.0388537197723053e-06
only O 0 2.726813363551628e-06
identified O 0 3.619729250203818e-05
in O 0 1.3984266843181103e-05
patients O 1 0.8562665581703186
belonging O 0 3.7962672649882734e-05
to O 0 4.9203313210455235e-06
the O 0 1.6335805412381887e-05
FAP B-Disease 1 0.9880899786949158
group O 0 0.0002508227771613747
( O 0 0.00021604474750347435
105 O 0 0.003962172195315361
patients O 1 0.9828540086746216
) O 0 0.00014719423779752105
. O 0 0.00011674933193717152

Amino O 0 0.0003524706407915801
acid O 0 0.0007005498628132045
changes O 0 4.053979500895366e-05
were O 0 3.595918769860873e-06
identified O 0 1.1530431947903708e-05
in O 0 1.971373421838507e-06
four O 0 7.67403525969712e-06
patients O 1 0.7149210572242737
, O 0 9.202349815495836e-07
three O 0 5.415968189481646e-07
of O 0 5.24636959653435e-07
whom O 0 1.576565409777686e-05
belonged O 0 7.257696324813878e-06
to O 0 9.556089253237587e-07
the O 0 3.272361936978996e-06
non O 0 0.0004960359074175358
- O 0 0.29337459802627563
FAP O 1 0.9951927661895752
group O 0 0.004498474299907684
of O 0 0.01208554022014141
colorectal B-Disease 1 0.9998164772987366
cancer I-Disease 1 0.9997901320457458
patients O 1 0.9988835453987122
. O 0 0.005793219897896051

Genotype O 1 0.9299246072769165
- O 0 0.2007416933774948
phenotype O 1 0.6784018874168396
correlations O 0 0.003451705677434802
identified O 0 9.406369645148516e-05
significant O 0 1.7092947018682025e-05
differences O 0 1.631920713407453e-05
in O 0 1.8350448272030917e-06
the O 0 1.3940134522272274e-06
nature O 0 1.6288733604596928e-05
of O 0 1.410889581165975e-06
certain O 0 6.524625496240333e-05
extracolonic O 1 0.7403587102890015
manifestations O 1 0.9086074829101562
in O 0 0.0015637112082913518
FAP B-Disease 1 0.9987003803253174
patients O 1 0.996945321559906
belonging O 0 0.00017620870494283736
to O 0 8.709937901585363e-06
three O 0 2.2639100279775448e-05
mutation O 0 0.0046979282051324844
subgroups O 0 0.0016344485338777304
. O 0 0.000173690146766603

CONCLUSIONS O 0 0.0033248839899897575
Extended O 0 0.0012743215775117278
genotype O 0 0.44192779064178467
- O 0 0.05014186352491379
phenotype O 0 0.2831687033176422
correlations O 0 0.00028498409665189683
made O 0 3.8681018850184046e-06
in O 0 1.922078126881388e-06
this O 0 9.396654832016793e-07
study O 0 2.1073237803648226e-05
may O 0 3.6162466585665243e-06
have O 0 3.135057795589091e-07
the O 0 3.0230199854486273e-07
potential O 0 3.2834993817232316e-06
to O 0 4.1586159227335884e-07
determine O 0 1.3853883729098015e-06
the O 0 5.305043941916665e-07
most O 0 1.4539543826685986e-06
appropriate O 0 1.488106408942258e-05
surveillance O 0 0.0005743962829001248
and O 0 6.06499525019899e-05
prophylactic O 1 0.9963125586509705
treatment O 1 0.9975209832191467
regimens O 1 0.9955918192863464
for O 0 0.00013536037295125425
those O 0 0.0006532032857649028
patients O 1 0.9987095594406128
with O 0 0.00022968884150031954
mutations O 1 0.6673671007156372
associated O 0 0.0007209973409771919
with O 0 7.28976956452243e-05
life O 0 0.011631989851593971
threatening O 1 0.9333390593528748
conditions O 0 0.1798284500837326
. O 0 0.0004378253361210227

This O 0 3.695937994052656e-05
study O 0 7.091328734531999e-05
also O 0 2.828503966156859e-06
provided O 0 3.1373629099107347e-06
evidence O 0 1.916221208375646e-06
for O 0 7.552932856924599e-07
the O 0 1.6599022956143017e-06
pathological O 0 0.016514601185917854
nature O 0 1.2721874554699752e-05
of O 0 7.063833891152171e-07
amino O 0 1.066226923285285e-05
acid O 0 0.00033340524532832205
changes O 0 1.678156877460424e-05
in O 0 4.968440862285206e-06
APC O 0 0.013699409551918507
associated O 0 4.326561247580685e-05
with O 0 8.066081136348657e-06
both O 0 5.6670607591513544e-05
FAP B-Disease 1 0.9937902092933655
and O 0 0.0002643142070155591
non O 0 0.29580679535865784
- O 1 0.9971899390220642
FAP O 1 0.9994649291038513
colorectal B-Disease 1 0.9998805522918701
cancer I-Disease 1 0.9998853206634521
patients O 1 0.9987941980361938
. O 0 0.0012360246619209647
. O 0 0.0005960747948847711

Inherited B-Disease 1 0.9961419701576233
colorectal I-Disease 1 0.9992875456809998
polyposis I-Disease 1 0.9993663430213928
and O 1 0.6797847151756287
cancer B-Disease 1 0.9992782473564148
risk O 0 0.3436512351036072
of O 0 2.1922360247117467e-05
the O 0 6.371177732944489e-05
APC O 0 0.27410730719566345
I1307K O 0 0.09595202654600143
polymorphism O 0 0.007385584060102701
. O 0 0.000292890181299299

Germ O 0 0.426553875207901
- O 0 0.0013275968376547098
line O 0 8.205153426388279e-05
and O 0 2.2499050828628242e-05
somatic O 0 0.006950993090867996
truncating O 0 0.07437105476856232
mutations O 0 0.001521397614851594
of O 0 3.632277412179974e-06
the O 0 7.71515624364838e-06
APC B-Disease 0 0.025701137259602547
gene O 0 0.0006639895727857947
are O 0 4.760488081956282e-06
thought O 0 4.190630352240987e-05
to O 0 5.453849007608369e-05
initiate O 1 0.9329050183296204
colorectal B-Disease 1 0.99977046251297
tumor I-Disease 1 0.9993771910667419
formation O 1 0.96505206823349
in O 1 0.5199490785598755
familial B-Disease 1 0.999648928642273
adenomatous I-Disease 1 0.9998089671134949
polyposis I-Disease 1 0.999839186668396
syndrome I-Disease 1 0.9998317956924438
and O 0 0.42802396416664124
sporadic O 1 0.9931291341781616
colorectal O 1 0.9994568228721619
carcinogenesis O 1 0.9963950514793396
, O 0 0.0008122024592012167
respectively O 0 0.0006137607851997018
. O 0 0.00026580519624985754

Recently O 0 0.0006853414233773947
, O 0 3.491177631076425e-05
an O 0 2.1343181288102642e-05
isoleucine O 0 0.005854462739080191
- O 0 0.0011566211469471455
- O 0 0.0011753152357414365
> O 0 0.001744091627188027
lysine O 0 0.0006883048918098211
polymorphism O 0 0.0001537688513053581
at O 0 2.0159068299108185e-05
codon O 0 0.00023206313198897988
1307 O 0 0.008893519639968872
( O 0 1.5920517398626544e-05
I1307K O 0 0.00015713270113337785
) O 0 1.8009408222496859e-06
of O 0 3.937583414881374e-07
the O 0 2.2633182652498363e-06
APC B-Disease 0 0.004582391586154699
gene O 0 0.00012144560605520383
has O 0 1.6193212104553822e-06
been O 0 6.886579058118514e-07
identified O 0 2.484232709321077e-06
in O 0 3.907470045305672e-07
6 O 0 1.562060901960649e-06
% O 0 6.188728889355843e-07
- O 0 9.76919909589924e-06
7 O 0 1.5809547448952799e-06
% O 0 6.606458669011772e-07
of O 0 4.685789463110268e-07
the O 0 3.472252728897729e-06
Ashkenazi O 0 0.0057274107821285725
Jewish O 0 8.163569873431697e-05
population O 0 4.155594069743529e-05
. O 0 9.132384730037302e-05

To O 0 0.00010634020873112604
assess O 0 0.0007725624600425363
the O 0 9.403958756593056e-06
risk O 0 0.00033803077531047165
of O 0 1.6832367464303388e-06
this O 0 4.402531430969248e-06
common O 0 0.00023114892246667296
APC B-Disease 0 0.476961225271225
allelic O 1 0.8224215507507324
variant O 1 0.5859790444374084
in O 0 0.0018392859492450953
colorectal O 1 0.9996501207351685
carcinogenesis O 1 0.9962660670280457
, O 0 1.8740161976893432e-05
we O 0 2.8403626401996007e-06
have O 0 1.5488453755096998e-06
analyzed O 0 7.1057775130611844e-06
a O 0 2.0626550849556224e-06
large O 0 5.321148364600958e-06
cohort O 0 0.00037047980003990233
of O 0 5.6352364481426775e-06
unselected O 1 0.5716145634651184
Ashkenazi O 0 0.2657514214515686
Jewish O 0 0.0008732378482818604
subjects O 0 0.0060414401814341545
with O 0 0.004034977871924639
adenomatous B-Disease 1 0.9994655251502991
polyps I-Disease 1 0.9984920024871826
and O 0 0.00040680725942365825
. O 0 0.0004552963364403695
or O 0 0.08122612535953522
colorectal B-Disease 1 0.9998817443847656
cancer I-Disease 1 0.9997255206108093
, I-Disease 0 3.3552736567799e-05
for O 0 1.4764557818125468e-05
the O 0 3.676168853417039e-05
APC O 0 0.1594245284795761
I1307K O 0 0.038676925003528595
polymorphism O 0 0.0031281893607228994
. O 0 0.0002239999594166875

The O 0 0.000270735879894346
APC O 0 0.04090903699398041
I1307K O 0 0.007178193423897028
allele O 0 0.0009485452901571989
was O 0 8.777228686085436e-06
identified O 0 1.2529231753433123e-05
in O 0 2.052466925306362e-06
48 O 0 6.362904969137162e-06
( O 0 2.083806521113729e-06
10 O 0 1.0861044756893534e-06
. O 0 4.4521073050418636e-07
1 O 0 1.4081446124691865e-06
% O 0 1.5136200772758457e-06
) O 0 3.1780764402356e-06
of O 0 6.065150046197232e-06
476 O 0 0.24107657372951508
patients O 1 0.9903879761695862
. O 0 0.0002004242705879733

Compared O 0 8.307929965667427e-05
with O 0 4.4387115849531256e-06
the O 0 1.739837898639962e-06
frequency O 0 2.683959792193491e-06
in O 0 5.066662538411038e-07
two O 0 5.475588977787993e-07
separate O 0 1.8051330243906705e-06
population O 0 1.3009308759137639e-06
control O 0 4.1876542127283756e-06
groups O 0 1.750218984852836e-06
, O 0 1.2464342944440432e-06
the O 0 2.291262262588134e-06
APC O 0 0.012576690874993801
I1307K O 0 0.00462642777711153
allele O 0 0.00025290812482126057
is O 0 2.671589527381002e-06
associated O 0 5.966406206425745e-06
with O 0 1.2391593600113993e-06
an O 0 1.3746557669946924e-06
estimated O 0 1.34595275085303e-05
relative O 0 2.979103555844631e-05
risk O 0 0.0011686538346111774
of O 0 5.531841452466324e-06
1 O 0 7.005370571278036e-05
. O 0 6.995951116550714e-05

5 O 0 0.0008006972493603826
- O 0 0.0013868911191821098
1 O 0 0.00043957046000286937
. O 0 0.00038621784187853336

7 O 0 0.001137362327426672
for O 0 0.0011996483663097024
colorectal B-Disease 1 0.9977346658706665
neoplasia I-Disease 1 0.992443859577179
( O 0 0.0003646455006673932
both O 0 5.9229038015473634e-05
P O 0 0.014661422930657864
= O 0 0.001429105643182993
. O 0 3.046190795430448e-05
01 O 0 0.009822117164731026
) O 0 9.962470358004794e-05
. O 0 0.00014214801194611937

Furthermore O 0 0.0007667475147172809
, O 0 2.789780410239473e-05
compared O 0 4.912895383313298e-05
with O 0 1.8887105397880077e-05
noncarriers O 0 0.015594382770359516
, O 0 3.137120438623242e-05
APC O 0 0.048574794083833694
I1307K O 0 0.005879050586372614
carriers O 0 0.0002522403665352613
had O 0 5.3255294005793985e-06
increased O 0 8.851959137246013e-06
numbers O 0 6.519039743579924e-06
of O 0 1.0252096217300277e-05
adenomas B-Disease 1 0.9939168095588684
and O 0 0.004517124034464359
colorectal B-Disease 1 0.9997420907020569
cancers I-Disease 1 0.9993960857391357
per O 0 0.0007610676111653447
patient O 1 0.9839856028556824
( O 0 0.00030399387469515204
P O 0 0.015236489474773407
= O 0 0.0004454531881492585
. O 0 2.567993306001881e-06
03 O 0 0.0006117220618762076
) O 0 1.4739141533937072e-06
, O 0 4.5251161395754025e-07
as O 0 3.4286978234376875e-07
well O 0 6.20952107510675e-07
as O 0 7.71978477587254e-07
a O 0 6.88681575411465e-06
younger O 0 0.00032835223828442395
age O 0 0.00017784973897505552
at O 0 0.00013183942064642906
diagnosis O 1 0.9931598901748657
. O 0 0.000300241430522874

We O 0 7.292732334462926e-05
conclude O 0 0.00014005466073285788
that O 0 6.239800313778687e-06
the O 0 8.914707905205432e-06
APC O 0 0.016265874728560448
I1307K O 0 0.013007749803364277
variant O 0 0.002764421980828047
leads O 0 0.00010678985563572496
to O 0 5.221414539846592e-06
increased O 0 0.00017340319755021483
adenoma B-Disease 1 0.9970417618751526
formation O 0 0.0002756709582172334
and O 0 1.809276227504597e-06
directly O 0 3.318208428026992e-06
contributes O 0 6.94535265211016e-05
to O 0 7.510082014050568e-07
3 O 0 1.9576450540625956e-06
% O 0 9.369684335069906e-07
- O 0 1.1313984941807576e-05
4 O 0 1.910546188810258e-06
% O 0 1.3345201068659662e-06
of O 0 1.4787505051572225e-06
all O 0 1.7025689885485917e-05
Ashkenazi O 1 0.7634260058403015
Jewish O 1 0.5242864489555359
colorectal B-Disease 1 0.9995594620704651
cancer I-Disease 1 0.9993422627449036
. O 0 0.004187068436294794

The O 0 9.006678737932816e-05
estimated O 0 0.00020802188373636454
relative O 0 0.00024159668828360736
risk O 0 0.027983540669083595
for O 0 2.0915929781040177e-05
carriers O 0 0.003258360316976905
may O 0 7.770412776153535e-05
justify O 0 0.000505985866766423
specific O 0 5.616825001197867e-05
clinical O 1 0.5333129167556763
screening O 0 0.00020407079136930406
for O 0 1.303508952332777e-06
the O 0 1.6420053725596517e-06
360 O 0 3.7251658795867115e-05
, O 0 2.3545962903881446e-06
000 O 0 2.9823582735843956e-05
Americans O 0 6.120215402916074e-06
expected O 0 1.896786670840811e-06
to O 0 7.273150686160079e-07
harbor O 0 2.775244320218917e-05
this O 0 7.110131150511734e-07
allele O 0 2.5528019250486977e-05
, O 0 8.020296036193031e-07
and O 0 6.907126817168319e-07
genetic O 0 4.1432558646192774e-05
testing O 0 9.810343726712745e-06
in O 0 4.568251199543738e-07
the O 0 4.089783374183753e-07
setting O 0 2.2501083094539354e-06
of O 0 7.969334205881751e-07
long O 0 3.8011792639736086e-05
- O 0 0.0003645519900601357
term O 0 6.301225948845968e-05
- O 0 0.0010777167044579983
outcome O 0 7.934167661005631e-05
studies O 0 0.00024301913799718022
may O 0 9.46557629504241e-05
impact O 0 0.0020327267702668905
significantly O 0 0.11806763708591461
on O 0 0.006820246111601591
colorectal B-Disease 1 0.9999037981033325
cancer I-Disease 1 0.9998844861984253
prevention O 1 0.9976341724395752
in O 0 7.246576569741592e-05
this O 0 1.7327694877167232e-05
population O 0 8.043924026424065e-05
. O 0 8.556472312193364e-05

Localization O 0 0.0013274992816150188
of O 0 4.335635821917094e-05
human O 0 0.0006445223116315901
BRCA1 O 1 0.6847067475318909
and O 0 8.984944543044548e-06
its O 0 7.479678060917649e-06
loss O 0 0.0006882832385599613
in O 0 7.815649041731376e-06
high O 0 0.00014016729255672544
- O 0 0.005573251284658909
grade O 0 0.0015322442632168531
, O 0 3.05506146105472e-05
non B-Disease 0 0.0019018540624529123
- I-Disease 1 0.6657344102859497
inherited I-Disease 1 0.9952405691146851
breast I-Disease 1 0.9988952279090881
carcinomas I-Disease 1 0.9972176551818848
. O 0 0.0028669938910752535

Although O 0 7.191271288320422e-05
the O 0 1.5064634681039024e-05
link O 0 0.00011402751988498494
between O 0 2.3779120965627953e-05
the O 0 0.00011647534847725183
BRCA1 O 1 0.9967254400253296
tumour B-Disease 1 0.9989892840385437
- O 1 0.8559865355491638
suppressor O 1 0.9870328903198242
gene O 0 0.451847642660141
and O 0 0.0022049536928534508
hereditary B-Disease 1 0.9982587695121765
breast I-Disease 1 0.9998134970664978
and I-Disease 1 0.8460255265235901
ovarian I-Disease 1 0.9999501705169678
cancer I-Disease 1 0.9998558759689331
is O 0 0.00012312190665397793
established O 0 2.6621322831488214e-05
, O 0 2.3189675175672164e-06
the O 0 9.574863497618935e-07
role O 0 4.93840207127505e-06
, O 0 8.568294447286462e-07
if O 0 7.326259492401732e-07
any O 0 5.279993615658896e-07
, O 0 6.343634026961809e-07
of O 0 1.2742801800413872e-06
BRCA1 O 1 0.7605029940605164
in O 0 2.845122253347654e-05
non B-Disease 0 0.005625955760478973
- I-Disease 1 0.8557048439979553
familial I-Disease 1 0.9984319806098938
cancers I-Disease 1 0.9987695813179016
is O 0 0.0002605091140139848
unclear O 0 0.0010048900730907917
. O 0 0.00013501902867574245

BRCA1 O 1 0.9862440228462219
mutations O 0 0.4541986882686615
are O 0 5.929833059781231e-05
rare O 0 0.003226792672649026
in O 0 4.420356344780885e-05
sporadic B-Disease 0 0.10672150552272797
cancers I-Disease 1 0.9984765648841858
, O 0 1.0930332791758701e-05
but O 0 4.765466655953787e-06
loss O 0 0.00038478535134345293
of O 0 5.579472144745523e-06
BRCA1 O 1 0.9222251772880554
resulting O 0 0.00023590269847773015
from O 0 5.493731350725284e-06
reduced O 0 4.202772834105417e-05
expression O 0 1.2810444786737207e-05
or O 0 3.6535072922561085e-06
incorrect O 0 2.2291373170446604e-05
subcellular O 0 0.00015159642498474568
localization O 0 0.00010397411097073928
is O 0 2.4602218218205962e-06
postulated O 0 4.421342964633368e-05
to O 0 6.577841418220487e-07
be O 0 4.570103158130223e-07
important O 0 1.2864172731497092e-06
in O 0 5.586543011304457e-06
non B-Disease 0 0.0017955610528588295
- I-Disease 1 0.8539806008338928
familial I-Disease 1 0.9985248446464539
breast I-Disease 1 0.9993723034858704
and I-Disease 0 0.3725449740886688
ovarian I-Disease 1 0.999592125415802
cancers I-Disease 1 0.999062716960907
. O 0 0.007862604223191738

Epigenetic O 0 0.27805960178375244
loss O 0 0.009804046712815762
, O 0 1.665974377829116e-05
however O 0 4.877080300502712e-06
, O 0 1.6226356365223182e-06
has O 0 1.684270728219417e-06
not O 0 7.804364372532291e-07
received O 0 4.3501663640199695e-06
general O 0 4.517950856097741e-06
acceptance O 0 4.941840234096162e-05
due O 0 9.467389645578805e-06
to O 0 1.0278342870151391e-06
controversy O 0 1.164399418485118e-05
regarding O 0 2.713862386372057e-06
the O 0 8.899936005946074e-07
subcellular O 0 7.047563849482685e-05
localization O 0 4.841955887968652e-05
of O 0 2.7295557174511487e-06
BRCA1 O 0 0.3528917729854584
proteins O 0 8.841143426252529e-06
, O 0 9.070296300706104e-07
reports O 0 1.5860634903219761e-06
of O 0 2.5268062131544866e-07
which O 0 3.9199809975798416e-07
have O 0 7.07495871665742e-07
ranged O 0 1.2536414033093024e-05
from O 0 6.173903557282756e-07
exclusively O 0 2.3539766971225617e-06
nuclear O 0 8.174401955329813e-06
, O 0 9.427892564417562e-07
to O 0 8.942303679759789e-07
conditionally O 0 7.073755841702223e-05
nuclear O 0 6.133396709628869e-06
, O 0 1.2276860843485338e-06
to O 0 1.3377847380979802e-06
the O 0 6.0568727349163964e-06
ER O 1 0.6253516674041748
/ O 0 0.008908816613256931
golgi O 0 0.004404974170029163
, O 0 2.8156046028016135e-06
to O 0 2.9027298751316266e-06
cytoplasmic O 0 8.804411481833085e-05
invaginations O 0 0.00034596171462908387
into O 0 4.577060735755367e-06
the O 0 9.061728633241728e-06
nucleus O 0 0.0004428037500474602
. O 0 0.00010660448606358841

In O 0 3.4866527130361646e-05
an O 0 8.006349162315018e-06
attempt O 0 1.253513437404763e-05
to O 0 2.7740845780499512e-06
resolve O 0 6.83435719111003e-05
this O 0 9.475503475186997e-07
issue O 0 2.2958579393161926e-06
, O 0 1.2329001037869602e-06
we O 0 1.1533735460034222e-06
have O 0 2.9220582291600294e-06
comprehensively O 0 0.0032069480512291193
characterized O 0 0.013054284267127514
19 O 0 0.000191979474038817
anti O 0 0.006701669190078974
- O 0 0.40508154034614563
BRCA1 O 1 0.9905433058738708
antibodies O 1 0.5783748030662537
. O 0 0.00030725932447239757

These O 0 0.00011698035086737946
reagents O 0 0.002018043538555503
detect O 0 0.000696674338541925
a O 0 2.9502292818506248e-05
220 O 0 8.916285150917247e-05
- O 0 0.0006101742619648576
kD O 0 0.034032899886369705
protein O 0 7.647035818081349e-05
localized O 0 0.0005042311386205256
in O 0 3.2817058581713354e-06
discrete O 0 3.370393824297935e-05
nuclear O 0 3.922495307051577e-05
foci O 0 0.0005928734899498522
in O 0 2.235653028037632e-06
all O 0 1.7190765220220783e-06
epithelial O 0 0.01440290454775095
cell O 0 0.0001404128852300346
lines O 0 1.1120579074486159e-05
, O 0 1.565140109960339e-06
including O 0 2.320852445336641e-06
those O 0 3.462781933194492e-06
derived O 0 4.226002056384459e-05
from O 0 0.0001457257749279961
breast B-Disease 1 0.9971067309379578
malignancies I-Disease 1 0.9923402070999146
. O 0 0.0009663982782512903

Immunohistochemical O 1 0.9584778547286987
staining O 1 0.5755163431167603
of O 0 0.00030211961711756885
human O 0 0.23760278522968292
breast O 1 0.9985910058021545
specimens O 0 0.26574957370758057
also O 0 0.0002245739015052095
revealed O 0 0.05956152454018593
BRCA1 O 1 0.9905279874801636
nuclear O 0 0.026560071855783463
foci O 1 0.9642924070358276
in O 0 0.01234472543001175
benign O 1 0.9989644289016724
breast O 1 0.9996416568756104
, O 0 0.2755593955516815
invasive B-Disease 1 0.9991353154182434
lobular I-Disease 1 0.999643087387085
cancers I-Disease 1 0.9994184970855713
and O 0 0.0010485842358320951
low B-Disease 0 0.07187631726264954
- I-Disease 1 0.7959823608398438
grade I-Disease 1 0.7732449173927307
ductal I-Disease 1 0.9975430965423584
carcinomas I-Disease 1 0.9953122138977051
. O 0 0.0021406139712780714

Conversely O 0 0.01254356186836958
, O 0 0.00011883622937602922
BRCA1 O 1 0.5584681630134583
expression O 0 8.967976464191452e-05
was O 0 6.533118266816018e-06
reduced O 0 3.134644066449255e-05
or O 0 8.407735549553763e-06
undetectable O 0 0.02679814212024212
in O 0 1.1665007377814618e-06
the O 0 7.372110530923237e-07
majority O 0 2.17684032577381e-06
of O 0 8.673893034938374e-07
high O 0 0.00010861441114684567
- O 0 0.0143583994358778
grade O 0 0.012782791629433632
, O 0 0.00025025784270837903
ductal B-Disease 1 0.9992565512657166
carcinomas I-Disease 1 0.998883068561554
, O 0 3.995647421106696e-05
suggesting O 0 0.00018718048522714525
that O 0 2.629262780828867e-06
absence O 0 6.669178401352838e-05
of O 0 5.021659944759449e-06
BRCA1 O 1 0.9408676028251648
may O 0 5.758912448072806e-05
contribute O 0 8.924519352149218e-05
to O 0 1.0200378710578661e-06
the O 0 2.095284571623779e-06
pathogenesis O 0 0.06685493886470795
of O 0 6.324050900730072e-07
a O 0 2.671288939382066e-06
significant O 0 9.734712875797413e-06
percentage O 0 2.2460977561422624e-05
of O 0 1.4302393537946045e-05
sporadic B-Disease 1 0.6844987869262695
breast I-Disease 1 0.9992976188659668
cancers I-Disease 1 0.9988411068916321
. O 0 0.00034808070631697774
. O 0 0.00024149537784978747

